data_1n88_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1n88 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.552 ' CG1' HG13 ' A' ' 8' ' ' ILE . 66.3 t . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.875 0.369 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.673 ' CG2' ' CD1' ' A' ' 28' ' ' PHE . 29.0 mt -84.99 104.44 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.657 -1.277 . . . . 0.0 110.749 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.2 mt -75.42 -93.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.761 . . . . 0.0 110.987 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.33 157.77 34.18 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.122 -0.986 . . . . 0.0 110.92 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 48.8 Cg_endo -77.01 160.95 33.24 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.149 1.605 . . . . 0.0 110.415 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.516 ' CG1' ' O ' ' A' ' 27' ' ' THR . 1.2 p -115.31 116.56 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 109.831 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.4 mm? -98.85 112.06 24.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.401 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -155.36 157.42 37.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.048 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 5.5 tm-20 -43.52 -61.24 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 110.069 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.74 -17.68 3.76 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.31 -0.869 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.571 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -99.4 -52.16 3.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 109.995 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.605 ' CE1' ' CG1' ' A' ' 96' ' ' ILE . 2.1 m-85 -56.47 -58.1 9.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.157 -0.964 . . . . 0.0 109.931 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.66 -12.82 37.18 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.272 -0.892 . . . . 0.0 109.186 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 21' ' ' PHE . . . -86.31 -47.19 5.02 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 7.7 m-30 -47.88 -28.42 2.63 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -38.31 -38.26 0.35 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.399 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.15 -17.88 23.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.359 -0.838 . . . . 0.0 110.44 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 118.05 4.52 14.32 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 1.7 mmtm -81.69 135.72 35.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -1.123 . . . . 0.0 109.505 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.577 ' CD1' HD13 ' A' ' 92' ' ' LEU . 21.1 m-85 -127.15 111.16 13.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.017 -1.052 . . . . 0.0 112.167 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 24.9 m -77.99 140.05 39.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.673 ' CD1' ' CG2' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -137.5 164.33 28.97 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.066 -1.021 . . . . 0.0 111.349 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.429 ' CZ3' HG21 ' A' ' 59' ' ' VAL . 70.7 m95 -99.31 122.59 42.67 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 2.6 p -144.02 156.71 15.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.787 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.554 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -62.36 151.73 81.58 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.778 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.9 Cg_endo -73.41 71.12 3.87 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.183 1.622 . . . . 0.0 110.047 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.57 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.3 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.57 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -44.27 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.94 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -42.67 144.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 110.338 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -42.53 -52.86 4.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 109.909 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.8 m -62.37 -36.51 82.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.2 OUTLIER -56.47 -44.14 80.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.184 -0.947 . . . . 0.0 109.569 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.524 ' CA ' HD12 ' A' ' 8' ' ' ILE . 1.7 mt -57.61 -32.56 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.315 -0.865 . . . . 0.0 108.805 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 6.4 ttmm -59.25 -45.81 90.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.851 . . . . 0.0 109.621 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.536 ' O ' ' CG2' ' A' ' 45' ' ' THR . 2.8 m-80 -71.83 -34.0 68.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.645 -0.659 . . . . 0.0 111.146 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.466 ' HB1' HG11 ' A' ' 7' ' ' VAL . . . -57.51 -50.16 73.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.176 . . . . 0.0 110.501 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.63 ' CG1' ' CE2' ' A' ' 47' ' ' PHE . 3.3 m -76.25 -34.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.879 -1.138 . . . . 0.0 110.641 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -60.95 -29.84 69.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.031 -1.043 . . . . 0.0 110.374 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 41' ' ' ASN . 34.4 p -78.52 -46.47 19.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.51 -55.03 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 110.72 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.63 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 6.6 m-30 -71.54 -14.72 62.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.065 -1.022 . . . . 0.0 110.141 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 16.0 mttm 42.48 47.03 4.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.147 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.88 -163.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.569 -0.707 . . . . 0.0 110.008 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.578 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 1.2 tmtp? -118.08 110.27 17.43 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.431 -0.793 . . . . 0.0 109.709 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.53 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 30.0 t -78.63 119.72 28.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.359 -0.838 . . . . 0.0 110.043 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.561 HG11 ' CA ' ' A' ' 83' ' ' VAL . 10.9 p -110.0 7.02 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.309 -0.87 . . . . 0.0 110.025 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER 169.68 119.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 109.987 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.538 HG23 ' CG1' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -121.12 120.83 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.115 -0.99 . . . . 0.0 110.072 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.471 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -121.63 115.95 23.69 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.23 178.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.537 ' CA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.35 150.62 37.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.147 -0.97 . . . . 0.0 110.588 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 pp -141.5 154.88 45.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 109.79 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.43 134.04 50.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.42 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.367 -0.833 . . . . 0.0 110.092 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.156 0.503 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.466 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 12.8 tttt -123.59 140.92 52.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -0.945 . . . . 0.0 110.648 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' THR . 2.1 ttpt -107.97 150.55 26.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.333 -0.855 . . . . 0.0 109.623 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -133.18 121.79 23.06 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.056 -1.027 . . . . 0.0 112.495 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.607 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -101.62 111.95 33.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.538 ' CG1' HG23 ' A' ' 54' ' ' VAL . 3.8 t -107.46 131.24 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.435 -0.791 . . . . 0.0 110.454 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.494 ' HG3' ' N ' ' A' ' 83' ' ' VAL . 2.3 tp60 -111.38 146.63 36.8 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.923 -1.111 . . . . 0.0 108.952 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.561 ' CA ' HG11 ' A' ' 52' ' ' VAL . 1.5 m -114.52 156.08 15.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.654 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.521 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -57.34 178.79 0.15 Allowed Pre-proline 0 C--N 1.29 -1.981 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.525 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.5 Cg_endo -72.7 145.16 40.82 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 O-C-N 124.149 1.605 . . . . 0.0 110.572 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.84 -18.38 47.62 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.516 ' NE2' ' CB ' ' A' ' 50' ' ' LYS . 57.7 mt-30 -94.59 171.58 8.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 110.557 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 3.1 pttt 179.68 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.823 . . . . 0.0 110.303 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.566 HD12 ' CD2' ' A' ' 26' ' ' TYR . 7.5 mt -63.08 118.62 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.95 . . . . 0.0 110.085 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -76.59 -14.74 59.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -0.826 . . . . 0.0 110.678 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.532 ' CB ' HD23 ' A' ' 92' ' ' LEU . . . -56.23 -34.67 66.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 110.946 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.577 HD13 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.23 -23.5 12.56 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.985 -1.072 . . . . 0.0 110.149 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -65.67 -43.24 89.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.259 -0.901 . . . . 0.0 110.289 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.3 8.27 75.31 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.525 ' CD2' HD21 ' A' ' 13' ' ' LEU . 2.3 tp -88.58 24.87 1.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -1.155 . . . . 0.0 110.245 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.605 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 6.9 mt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.248 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.559 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 39.0 t . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 122.128 0.966 . . . . 0.0 109.281 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.581 HG22 ' CG ' ' A' ' 28' ' ' PHE . 8.7 mt -115.05 95.48 3.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.487 -0.758 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.6 mt -79.04 -97.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.553 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.16 167.28 9.51 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.076 -1.015 . . . . 0.0 110.497 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HG2' ' CD2' ' A' ' 95' ' ' LEU . 46.7 Cg_endo -73.68 171.11 18.47 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.14 1.6 . . . . 0.0 110.529 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.467 HG23 ' HE2' ' A' ' 78' ' ' LYS . 3.0 m -115.36 144.32 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.411 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.3 mm? -102.65 107.49 18.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.212 -0.93 . . . . 0.0 110.328 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 17' ' ' ALA . 5.5 m -164.9 134.79 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.868 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' SER . 7.2 mt-10 -42.88 -59.34 2.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.117 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 -17.44 6.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.958 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.16 17.24 17.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.887 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.641 ' CD1' ' CE1' ' A' ' 21' ' ' PHE . 2.2 m-85 -139.18 -38.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.388 -0.82 . . . . 0.0 109.933 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.35 80.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.05 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 25' ' ' LYS . . . -95.52 -34.95 5.84 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.09 -17.73 64.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 18' ' ' TYR . . . -70.5 -17.05 62.96 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.725 -0.61 . . . . 0.0 110.654 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -88.7 16.37 6.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 110.341 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 102.07 -2.06 51.33 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.48 136.45 34.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.514 -0.992 . . . . 0.0 109.534 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 99.5 m-85 -126.69 116.01 20.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 0.0 111.626 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 3.7 m -83.26 141.29 31.97 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.639 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 26.5 m-85 -134.06 164.37 27.47 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.33 -0.856 . . . . 0.0 110.933 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.57 ' CZ3' HG22 ' A' ' 59' ' ' VAL . 19.6 m95 -97.01 122.35 39.91 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.559 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 11.6 p -138.69 164.91 25.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.059 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.587 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 1.6 t60 -81.13 152.85 71.66 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.304 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 44.5 Cg_endo -70.89 65.7 2.46 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.06 1.558 . . . . 0.0 109.727 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.73 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.665 -179.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.468 ' HB1' HG22 ' A' ' 30' ' ' VAL . . . -42.42 95.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.44 -0.787 . . . . 0.0 109.602 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -39.39 134.27 1.23 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.382 -0.824 . . . . 0.0 110.894 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.499 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 1.9 mttt -46.9 -48.02 21.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.83 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.8 m -62.04 -39.53 92.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 0.0 109.424 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 4.7 mt-10 -55.83 -40.9 73.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 108.937 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.538 ' CA ' HD12 ' A' ' 8' ' ' ILE . 30.6 mt -58.0 -31.03 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.469 -0.77 . . . . 0.0 109.003 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HA ' HG11 ' A' ' 51' ' ' VAL . 3.8 tttt -59.54 -47.3 86.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.777 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.458 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.4 m-80 -72.75 -34.02 66.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.701 -0.624 . . . . 0.0 111.194 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.529 ' HB2' ' CD1' ' A' ' 8' ' ' ILE . . . -58.0 -50.43 73.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.786 -1.196 . . . . 0.0 110.553 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 28' ' ' PHE . 3.7 m -67.3 -32.84 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.651 -1.281 . . . . 0.0 109.489 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -69.04 -44.51 72.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 108.812 178.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -79.07 -16.44 56.77 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -104.23 -67.44 0.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.498 -0.751 . . . . 0.0 110.315 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.604 ' CE2' ' CE1' ' A' ' 28' ' ' PHE . 52.4 m-85 -71.95 -21.91 61.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.0 110.343 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 64.94 46.4 2.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -123.56 -158.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.512 -0.743 . . . . 0.0 110.136 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.555 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -116.89 110.4 18.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 109.762 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' A' ' 43' ' ' VAL . 92.3 t -78.73 120.4 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.931 . . . . 0.0 110.321 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.548 HG13 ' CA ' ' A' ' 83' ' ' VAL . 10.1 p -112.83 3.85 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.263 -0.898 . . . . 0.0 109.988 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 1.8 mttp 169.12 119.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.055 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.87 131.39 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.048 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.499 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 13.1 t30 -131.17 115.97 17.07 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.34 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -116.61 161.36 19.29 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.193 -0.942 . . . . 0.0 109.945 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -156.65 170.83 21.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.383 -0.823 . . . . 0.0 110.188 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 129.77 34.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 110.219 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.583 ' CG1' ' CD ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.48 -0.762 . . . . 0.0 110.074 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.474 ' HB3' HG23 ' A' ' 59' ' ' VAL . 4.3 mpt_? . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.226 0.536 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.534 ' HG2' ' CG1' ' A' ' 30' ' ' VAL . 10.4 tttt -120.87 133.69 55.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.583 ' CD ' ' CG1' ' A' ' 59' ' ' VAL . 3.8 mttt -110.23 151.48 27.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.367 -0.833 . . . . 0.0 109.942 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -123.14 119.77 31.25 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.933 -1.104 . . . . 0.0 112.193 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.627 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.5 mp -102.42 111.88 33.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 24.0 t -111.08 136.09 48.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.486 -0.759 . . . . 0.0 110.433 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 23' ' ' GLU . 1.9 tp60 -111.47 151.32 28.72 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.222 -0.924 . . . . 0.0 108.868 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.548 ' CA ' HG13 ' A' ' 52' ' ' VAL . 2.0 m -112.68 155.71 13.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 C-N-CA 118.069 -1.453 . . . . 0.0 109.531 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -49.16 179.03 0.03 OUTLIER Pre-proline 0 C--N 1.291 -1.936 0 O-C-N 121.543 -0.723 . . . . 0.0 110.482 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.4 Cg_endo -71.79 140.07 34.76 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.22 1.642 . . . . 0.0 110.492 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.19 -24.58 12.97 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.504 ' NE2' ' HB2' ' A' ' 50' ' ' LYS . 87.1 mt-30 -95.82 164.37 12.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -1.148 . . . . 0.0 110.619 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER 179.43 108.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.245 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.58 ' HB ' ' CE1' ' A' ' 26' ' ' TYR . 91.4 mt -51.11 91.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.126 -0.984 . . . . 0.0 109.541 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 88' ' ' LYS . 4.1 mm-40 -63.01 -13.39 34.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 111.206 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.524 ' CB ' HD23 ' A' ' 92' ' ' LEU . . . -54.65 -33.76 61.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 110.804 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -106.87 -23.67 12.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.952 -1.092 . . . . 0.0 110.507 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -48.95 -30.97 6.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.163 -0.961 . . . . 0.0 110.14 -179.149 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.404 ' N ' ' HG3' ' A' ' 93' ' ' GLU . . . -103.48 -19.89 11.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.502 ' CD2' ' HG2' ' A' ' 11' ' ' PRO . 26.7 tp -53.13 -19.14 2.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -1.114 . . . . 0.0 110.054 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.638 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 32.4 mt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.131 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.56 ' CG1' HG13 ' A' ' 8' ' ' ILE . 58.2 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 120.991 0.424 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.661 ' CG2' ' CG ' ' A' ' 28' ' ' PHE . 24.0 mt -88.28 113.19 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 120.681 -1.262 . . . . 0.0 111.268 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -92.06 -88.22 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.291 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.03 150.85 40.91 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.45 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.487 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.8 Cg_endo -74.32 -178.21 3.8 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.065 1.561 . . . . 0.0 110.177 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.469 ' O ' HG21 ' A' ' 12' ' ' VAL . 1.9 m -115.16 133.33 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.149 -0.969 . . . . 0.0 110.347 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.567 HD13 ' CE2' ' A' ' 18' ' ' TYR . 3.2 mm? -103.12 112.83 25.87 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.193 -0.942 . . . . 0.0 110.185 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 17' ' ' ALA . 60.6 m -163.79 128.65 2.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.145 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -42.96 -58.63 2.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.898 . . . . 0.0 110.048 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -17.63 3.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 110.215 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.7 -48.04 5.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 110.149 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.567 ' CE2' HD13 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -52.79 -33.1 47.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 109.772 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.47 -21.6 66.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -100.81 -37.59 3.64 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 105.683 -2.967 . . . . 0.0 105.683 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -64.64 -19.17 65.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' TYR . . . -93.36 4.63 53.66 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.219 0.533 . . . . 0.0 110.629 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -111.87 16.58 20.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.764 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 95.69 -24.82 27.79 Favored Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 39.7 mttm -81.79 140.42 34.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.352 -1.087 . . . . 0.0 109.153 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.585 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 35.4 m-85 -126.92 110.18 12.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.803 -1.186 . . . . 0.0 112.234 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.524 ' CG2' ' HD3' ' A' ' 78' ' ' LYS . 28.3 m -80.57 118.25 21.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.661 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -116.99 164.97 13.9 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 111.638 -178.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.572 ' CH2' HG13 ' A' ' 59' ' ' VAL . 7.4 m95 -97.81 123.0 41.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 2.0 p -145.56 157.45 12.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 C-N-CA 118.195 -1.402 . . . . 0.0 111.712 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.575 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -59.21 149.57 67.3 Favored Pre-proline 0 C--N 1.297 -1.679 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.044 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.575 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 47.7 Cg_endo -73.02 71.57 3.47 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.061 1.558 . . . . 0.0 109.808 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.48 -33.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.417 -0.802 . . . . 0.0 109.932 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HB3' ' CG1' ' A' ' 7' ' ' VAL . . . -42.36 93.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.484 -0.76 . . . . 0.0 109.799 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -42.17 141.68 0.88 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 110.443 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 4.3 mmtp -42.63 -41.13 2.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.372 -0.83 . . . . 0.0 109.778 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 62.1 m -70.97 -35.93 72.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.728 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 5.8 mt-10 -58.54 -42.53 88.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.553 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.53 HG22 ' CG2' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -57.48 -31.68 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HG3' ' CB ' ' A' ' 51' ' ' VAL . 8.1 tttm -62.97 -46.37 88.02 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.552 -0.717 . . . . 0.0 109.627 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.532 ' O ' ' CG2' ' A' ' 45' ' ' THR . 38.4 m-80 -72.97 -34.12 66.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.601 -0.687 . . . . 0.0 110.921 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.456 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -57.74 -50.27 73.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.932 -1.105 . . . . 0.0 110.43 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 2.7 m -76.64 -36.61 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.869 -1.144 . . . . 0.0 110.654 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -56.92 -32.31 65.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.942 -1.099 . . . . 0.0 110.256 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 41' ' ' ASN . 35.4 p -77.99 -46.01 22.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.234 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.06 -55.61 4.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 0.0 110.735 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.596 ' CE1' ' CG2' ' A' ' 89' ' ' ILE . 21.0 m-85 -71.67 -21.33 61.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.155 -0.966 . . . . 0.0 110.372 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 51.08 44.52 28.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -115.29 -162.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.633 -0.667 . . . . 0.0 109.923 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.576 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 8.0 tmtt? -117.2 108.32 15.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.893 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.524 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . 33.5 t -78.44 119.64 27.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.242 -0.911 . . . . 0.0 109.769 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.567 HG11 ' CA ' ' A' ' 83' ' ' VAL . 3.3 p -107.26 -12.75 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.43 -0.794 . . . . 0.0 110.167 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -173.15 123.4 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.979 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.53 ' CG2' HG22 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -123.63 131.2 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.192 -0.942 . . . . 0.0 110.085 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.471 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 2.5 m-20 -131.07 115.82 16.95 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.538 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -114.8 146.04 41.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 pp -128.01 153.45 46.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.279 -0.888 . . . . 0.0 110.608 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -66.32 118.32 9.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.144 -0.973 . . . . 0.0 109.279 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.572 HG13 ' CH2' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.246 -0.909 . . . . 0.0 110.013 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.563 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.328 0.585 . . . . 0.0 110.365 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.526 ' CA ' HG22 ' A' ' 59' ' ' VAL . 19.9 tttt -123.5 137.51 54.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.561 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 6.9 mttt -101.06 147.69 25.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.164 -0.96 . . . . 0.0 109.936 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -133.44 121.87 22.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.0 111.873 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.623 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -98.67 111.7 28.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' TYR . 2.4 t -107.41 122.27 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.505 -0.747 . . . . 0.0 110.659 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.518 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 4.5 tp-100 -104.37 142.81 33.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 109.016 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.567 ' CA ' HG11 ' A' ' 52' ' ' VAL . 1.1 m -109.76 156.99 10.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 C-N-CA 118.15 -1.42 . . . . 0.0 109.896 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.506 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -72.14 178.83 1.19 Allowed Pre-proline 0 C--N 1.291 -1.965 0 O-C-N 121.65 -0.656 . . . . 0.0 110.235 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.1 Cg_endo -73.04 140.4 31.29 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 124.234 1.65 . . . . 0.0 110.345 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.63 -30.36 9.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.452 ' HB2' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -112.19 176.39 5.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.204 -1.174 . . . . 0.0 110.467 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.3 OUTLIER 179.3 115.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 110.331 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.596 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 39.5 mt -67.91 60.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.174 -0.954 . . . . 0.0 109.655 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 88' ' ' LYS . 14.1 pt-20 -58.2 -13.08 4.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.445 -0.785 . . . . 0.0 111.022 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.24 -16.63 2.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.989 -1.07 . . . . 0.0 110.627 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.21 -23.23 12.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.062 -1.024 . . . . 0.0 109.634 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.4 -19.75 6.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.352 -0.842 . . . . 0.0 110.332 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.08 -20.16 11.67 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.5 tp -46.36 -24.37 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.566 HG13 ' CE2' ' A' ' 18' ' ' TYR . 2.0 mp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.21 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.562 ' CG1' HG13 ' A' ' 8' ' ' ILE . 39.6 t . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.279 0.562 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.641 ' CG2' ' CG ' ' A' ' 28' ' ' PHE . 16.2 mt 24.56 51.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.302 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 29' ' ' TRP . 3.5 mt -44.71 -99.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.307 -0.87 . . . . 0.0 111.262 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -99.56 151.68 37.53 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.924 -1.11 . . . . 0.0 110.816 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.632 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 49.8 Cg_endo -76.33 153.6 35.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.103 1.581 . . . . 0.0 110.519 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.522 HG11 ' CG2' ' A' ' 27' ' ' THR . 1.5 p -115.15 105.21 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.058 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.12 106.75 17.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.57 -178.54 5.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.184 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -57.34 -67.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.251 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -45.66 74.46 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.258 -0.901 . . . . 0.0 110.354 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 21' ' ' PHE . . . -56.21 -48.9 75.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.575 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 1.9 m-85 -57.9 -33.33 68.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.875 . . . . 0.0 110.147 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.37 -8.88 49.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.858 . . . . 0.0 109.865 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -103.33 -38.23 2.88 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -74.94 -18.88 60.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.571 -0.958 . . . . 0.0 108.873 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 18' ' ' TYR . . . -56.92 -20.7 24.79 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.702 -0.624 . . . . 0.0 110.729 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.6 17.27 5.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.38 -0.825 . . . . 0.0 110.059 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.04 0.89 67.74 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 48.8 mttt -82.79 143.47 30.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.567 -0.961 . . . . 0.0 109.545 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.615 ' CD2' ' CD1' ' A' ' 89' ' ' ILE . 22.9 m-85 -128.01 99.41 5.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.611 -1.306 . . . . 0.0 111.083 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.7 m -74.63 127.32 32.83 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.641 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -131.44 165.23 23.98 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.314 -0.866 . . . . 0.0 111.162 -178.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.512 ' O ' ' N ' ' A' ' 9' ' ' LEU . 46.1 m95 -100.0 123.27 44.06 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 7' ' ' VAL . 2.0 p -142.55 164.81 17.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.081 -176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.562 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 2.5 t60 -65.34 149.76 96.64 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.545 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 48.1 Cg_endo -73.18 67.49 4.22 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.088 1.573 . . . . 0.0 109.434 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.72 -32.19 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.405 -0.81 . . . . 0.0 110.062 -178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -41.09 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.692 . . . . 0.0 109.882 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -45.99 142.12 2.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.0 110.388 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -42.81 -38.62 2.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.841 . . . . 0.0 109.675 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.6 m -73.17 -36.24 66.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.556 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -59.32 -43.46 92.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.158 -0.963 . . . . 0.0 109.207 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.539 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 13.4 mt -57.75 -30.46 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.523 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 14.5 tttt -65.29 -45.09 85.82 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.595 0.712 . . . . 0.0 110.127 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.566 ' O ' ' CG2' ' A' ' 45' ' ' THR . 10.1 m-80 -71.27 -49.31 44.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.59 -0.694 . . . . 0.0 111.905 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.475 ' O ' ' OG1' ' A' ' 45' ' ' THR . . . -57.16 -51.07 70.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.792 -1.192 . . . . 0.0 110.946 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.405 HG21 ' CE2' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -59.45 -40.92 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.84 -1.162 . . . . 0.0 110.249 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -65.6 -29.56 70.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.181 -0.949 . . . . 0.0 110.755 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.566 ' CG2' ' O ' ' A' ' 41' ' ' ASN . 28.1 p -66.17 -47.08 75.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.081 . . . . 0.0 110.979 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.56 -56.67 3.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 111.338 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.571 ' CD2' HD12 ' A' ' 89' ' ' ILE . 8.8 m-85 -71.59 -21.19 61.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.147 -0.971 . . . . 0.0 110.694 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 31.1 mtmt 48.42 41.02 16.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 109.665 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -102.87 -161.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.721 -0.612 . . . . 0.0 109.625 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.551 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 6.0 tmtm? -114.48 112.38 22.9 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.68 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.523 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 48.8 t -77.64 119.79 27.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 84' ' ' ALA . 41.1 t -114.21 -14.5 10.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.487 -0.758 . . . . 0.0 110.554 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.9 OUTLIER -178.75 115.1 0.07 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.463 -0.773 . . . . 0.0 109.998 179.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.522 HG22 ' CG1' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -112.76 130.9 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.808 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 80' ' ' ILE . 17.3 m120 -130.48 115.96 17.54 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.793 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.528 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -114.58 160.27 19.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.6 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 pp -141.71 166.64 24.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.592 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -77.47 118.36 19.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.127 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.573 ' CG2' ' N ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.284 -0.885 . . . . 0.0 110.187 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.483 ' HG2' ' HB ' ' A' ' 59' ' ' VAL . 6.8 ttm180 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.264 0.554 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.532 ' CA ' HG21 ' A' ' 59' ' ' VAL . 13.7 tttt -123.06 139.21 54.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.912 . . . . 0.0 110.076 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.573 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 15.4 mttt -101.88 147.22 26.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.335 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' PHE . . . -131.49 126.71 35.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.12 -0.987 . . . . 0.0 111.847 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.6 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -105.61 111.77 36.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.522 ' CG1' HG22 ' A' ' 54' ' ' VAL . 1.4 t -96.44 141.47 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.435 -0.791 . . . . 0.0 110.284 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 53' ' ' LYS . 7.5 tp60 -121.13 142.46 49.84 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.376 -0.828 . . . . 0.0 109.507 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 84' ' ' ALA . 2.6 m -125.24 156.65 34.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.437 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 52' ' ' VAL . . . -44.19 171.87 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.798 0 CA-C-O 121.302 0.572 . . . . 0.0 110.854 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.8 53.94 4.6 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 O-C-N 124.39 1.732 . . . . 0.0 110.232 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -167.42 -47.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.519 ' N ' ' OE1' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -51.04 -173.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -1.155 . . . . 0.0 110.848 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 3.4 pttt 178.98 80.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.505 -0.747 . . . . 0.0 110.416 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.615 ' CD1' ' CD2' ' A' ' 26' ' ' TYR . 5.2 mt -47.69 109.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.736 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 4.7 mm-40 -67.43 -14.64 63.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 0.0 110.74 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.433 ' HB2' HD21 ' A' ' 92' ' ' LEU . . . -57.47 -36.8 71.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.201 -0.937 . . . . 0.0 110.84 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.99 -23.55 12.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.009 -1.057 . . . . 0.0 110.107 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.0 mm-40 -60.63 -31.9 71.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -0.903 . . . . 0.0 110.239 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.35 -12.8 40.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.425 HD23 HD21 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -80.4 -10.66 59.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.208 -1.172 . . . . 0.0 110.203 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 18' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.03 -0.985 . . . . 0.0 110.216 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.462 HG11 HG21 ' A' ' 30' ' ' VAL . 3.0 t . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.64 ' CG2' ' CD2' ' A' ' 28' ' ' PHE . 2.7 mt -57.55 152.0 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.16 -0.962 . . . . 0.0 110.315 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 29' ' ' TRP . 2.2 mt -132.87 -99.34 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.479 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.58 153.66 42.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.02 . . . . 0.0 110.504 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HG3' ' CD2' ' A' ' 92' ' ' LEU . 47.7 Cg_endo -74.94 161.53 38.76 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.07 1.563 . . . . 0.0 110.354 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.561 HG12 ' CD1' ' A' ' 29' ' ' TRP . 2.7 m -104.86 143.02 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.226 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 18' ' ' TYR . 3.2 mm? -102.41 106.89 17.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -154.78 142.11 19.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.997 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 9.7 tm-20 -42.52 -52.65 4.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.895 . . . . 0.0 110.145 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -54.72 -42.02 71.02 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.107 -0.996 . . . . 0.0 110.094 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.54 ' N ' ' CG ' ' A' ' 16' ' ' LYS . . . -65.97 -63.24 1.13 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.34 -0.85 . . . . 0.0 110.028 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.538 ' CE2' HD11 ' A' ' 13' ' ' LEU . 1.6 m-85 -48.8 -30.66 5.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 110.302 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.21 -9.2 55.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.48 -38.39 1.78 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -73.61 -23.47 59.91 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.533 -0.98 . . . . 0.0 108.974 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -51.39 -21.09 2.06 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.628 -0.67 . . . . 0.0 110.064 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.36 16.37 13.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.266 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.73 2.36 65.08 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 77.0 mttt -82.26 142.53 32.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -1.14 . . . . 0.0 109.544 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 19.9 m-85 -127.7 104.23 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.751 -1.218 . . . . 0.0 112.073 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.8 m -76.01 124.54 27.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.64 ' CD2' ' CG2' ' A' ' 8' ' ' ILE . 14.9 m-85 -124.72 164.92 18.91 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.525 -0.734 . . . . 0.0 110.989 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.572 ' CZ3' HG23 ' A' ' 59' ' ' VAL . 33.4 m95 -102.88 122.24 44.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.462 HG21 HG11 ' A' ' 7' ' ' VAL . 5.2 p -144.49 165.49 12.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.496 -1.282 . . . . 0.0 111.81 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.475 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 1.5 t60 -60.81 148.53 82.65 Favored Pre-proline 0 C--N 1.297 -1.678 0 O-C-N 121.927 -0.483 . . . . 0.0 110.495 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.9 Cg_endo -72.39 71.05 3.14 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.15 1.605 . . . . 0.0 109.915 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.538 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.18 -33.85 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.947 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -50.3 90.63 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.412 -0.805 . . . . 0.0 109.98 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -48.41 176.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -69.01 -28.84 66.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 110.185 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.2 m -75.06 -52.25 11.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.872 . . . . 0.0 110.583 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 35' ' ' THR . 89.4 mt-10 -55.1 -42.82 73.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.919 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CA ' HD11 ' A' ' 8' ' ' ILE . 26.7 mt -57.07 -30.69 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.163 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.545 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 10.1 tttp -62.87 -47.29 83.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.867 . . . . 0.0 111.322 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -62.39 -35.06 78.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.452 -0.78 . . . . 0.0 112.695 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . -69.85 -50.26 44.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.484 -1.385 . . . . 0.0 111.896 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 39' ' ' ILE . 14.4 m -69.87 -32.14 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.575 -1.328 . . . . 0.0 110.787 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.53 ' CG ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -60.33 -52.68 64.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.989 -1.069 . . . . 0.0 109.91 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -79.84 -24.43 41.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 110.251 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -84.8 -64.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.877 . . . . 0.0 110.505 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.515 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 11.3 m-85 -71.69 -21.22 61.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 109.991 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER 66.48 44.12 2.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.377 -0.827 . . . . 0.0 110.335 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.579 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -125.77 -162.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.585 -0.697 . . . . 0.0 109.858 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.579 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -115.01 114.74 25.8 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 109.811 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.545 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 11.7 t -77.95 119.76 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.266 -0.896 . . . . 0.0 109.236 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.527 HG21 ' N ' ' A' ' 84' ' ' ALA . 25.5 t -114.01 -14.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.521 -0.737 . . . . 0.0 110.721 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.15 115.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -0.792 . . . . 0.0 110.091 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 0.9 OUTLIER -113.03 116.77 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.653 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -116.43 116.26 27.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.377 -0.827 . . . . 0.0 109.679 179.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.538 ' OG1' ' CE ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -115.92 155.26 28.3 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.89 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.514 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -144.89 161.02 40.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 109.922 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -82.35 124.36 29.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.0 110.408 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.572 HG23 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.592 -0.692 . . . . 0.0 110.005 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.214 0.531 . . . . 0.0 110.365 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.538 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 0.3 OUTLIER -124.06 141.96 51.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 110.155 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 1.9 ptpt -100.96 150.2 23.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.004 -1.06 . . . . 0.0 109.518 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -117.95 128.63 54.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.147 -0.971 . . . . 0.0 112.124 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.607 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -105.57 111.74 36.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.413 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.569 HG23 ' CE2' ' A' ' 28' ' ' PHE . 13.5 t -102.83 137.62 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.48 -0.763 . . . . 0.0 110.724 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 39.1 tp60 -117.93 153.47 33.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.866 . . . . 0.0 109.831 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 84' ' ' ALA . 2.4 m -125.34 157.11 34.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.697 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.527 ' N ' HG21 ' A' ' 52' ' ' VAL . . . -45.47 177.2 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.686 0 CA-C-O 121.275 0.559 . . . . 0.0 110.926 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.8 Cg_endo -73.48 140.53 30.16 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.25 1.658 . . . . 0.0 110.299 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.27 -21.71 19.48 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.511 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 49.1 mt-30 -89.28 167.22 13.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -1.16 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HA ' ' OH ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER 179.67 99.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 110.522 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.579 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 24.5 mt -44.12 104.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 109.623 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 15.4 mm-40 -56.34 -13.97 2.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.455 -0.778 . . . . 0.0 111.677 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.508 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . -55.0 -36.46 65.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.861 -1.149 . . . . 0.0 110.732 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.576 HD11 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.56 -23.33 12.5 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.046 -1.034 . . . . 0.0 109.827 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 15.3 mm-40 -49.99 -44.6 51.09 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.444 -0.785 . . . . 0.0 110.555 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.59 1.57 58.5 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.46 ' O ' ' OH ' ' A' ' 18' ' ' TYR . 15.9 tp -77.52 3.06 14.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -1.172 . . . . 0.0 110.196 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.299 -179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.552 ' CG1' HG13 ' A' ' 8' ' ' ILE . 62.0 t . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 120.93 0.395 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.561 ' HA ' ' CG1' ' A' ' 30' ' ' VAL . 37.3 mt -88.25 104.15 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.852 -1.155 . . . . 0.0 110.925 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 mt -70.39 -98.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.855 . . . . 0.0 110.352 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.46 159.26 31.43 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.024 -1.048 . . . . 0.0 110.467 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 48.3 Cg_endo -75.0 171.09 19.01 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.088 1.572 . . . . 0.0 110.5 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.578 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.19 132.85 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.917 . . . . 0.0 110.315 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.1 mm? -103.23 106.65 17.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.131 -0.98 . . . . 0.0 110.114 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.438 ' OG ' ' C ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -165.72 140.82 4.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.938 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -43.03 -41.03 3.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.121 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -54.64 -24.55 22.08 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.247 -0.908 . . . . 0.0 110.145 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -100.74 -51.4 3.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.521 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.5 m-85 -54.77 -47.33 74.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.71 -9.41 43.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.88 . . . . 0.0 109.012 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 21' ' ' PHE . . . -98.29 -41.27 3.26 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.864 -2.495 . . . . 0.0 106.864 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.609 ' CE1' ' HA ' ' A' ' 26' ' ' TYR . 4.4 m-30 -48.4 -27.36 2.56 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -37.8 -42.91 0.63 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.62 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.45 -18.25 21.69 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.384 -0.823 . . . . 0.0 110.573 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.509 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 123.01 5.15 8.24 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HG2' ' HB2' ' A' ' 82' ' ' GLN . 23.7 mttt -82.67 127.96 33.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 109.596 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.657 ' CB ' ' CZ ' ' A' ' 28' ' ' PHE . 65.9 m-85 -127.11 114.66 18.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.711 -1.243 . . . . 0.0 112.297 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 5.4 m -81.47 123.98 29.06 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.469 0.652 . . . . 0.0 110.61 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 26' ' ' TYR . 61.5 m-85 -122.27 148.67 44.71 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.435 -0.79 . . . . 0.0 110.538 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.578 ' CD1' HG12 ' A' ' 12' ' ' VAL . 96.9 m95 -76.62 122.8 25.16 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.561 ' CG1' ' HA ' ' A' ' 8' ' ' ILE . 1.9 m -135.91 154.65 34.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.866 -1.146 . . . . 0.0 111.412 -177.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.517 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -52.26 130.92 42.42 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 176.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.529 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 38.8 Cg_endo -65.01 72.99 0.23 Allowed 'Trans proline' 0 C--N 1.294 -2.315 0 O-C-N 123.443 1.233 . . . . 0.0 109.361 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 31' ' ' HIS . 0.1 OUTLIER 179.68 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -41.75 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.387 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -38.36 128.11 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.499 -0.751 . . . . 0.0 110.81 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.542 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 1.5 mttt -41.96 -31.79 0.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.417 -0.802 . . . . 0.0 109.674 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.0 m -72.97 -51.06 19.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.84 . . . . 0.0 109.473 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 4.2 mt-10 -55.43 -38.94 69.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.162 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.508 ' CA ' HD12 ' A' ' 8' ' ' ILE . 38.6 mt -58.08 -30.68 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -0.847 . . . . 0.0 108.969 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 37' ' ' THR . 3.5 tttm -62.04 -47.51 84.43 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.716 0.769 . . . . 0.0 110.083 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.42 -33.93 67.47 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.693 -0.629 . . . . 0.0 111.052 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.24 -50.89 71.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.861 -1.149 . . . . 0.0 110.643 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.512 HG13 ' CD2' ' A' ' 47' ' ' PHE . 1.1 m -64.72 -33.26 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.517 -1.364 . . . . 0.0 109.783 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -58.48 -29.05 65.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.848 . . . . 0.0 110.326 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 46' ' ' ALA . 1.3 p -77.99 -48.94 15.06 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.109 -0.994 . . . . 0.0 110.346 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . -82.94 -56.24 3.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.543 -0.723 . . . . 0.0 110.907 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.512 ' CD2' HG13 ' A' ' 43' ' ' VAL . 14.3 m-85 -71.41 -11.34 60.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.124 -0.985 . . . . 0.0 110.092 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 21.9 mtpt 41.7 47.86 3.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.434 -0.791 . . . . 0.0 110.17 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -122.01 -164.25 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.52 -0.738 . . . . 0.0 109.987 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.568 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -116.64 109.94 17.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.415 -0.803 . . . . 0.0 109.636 179.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.523 ' CG1' HG12 ' A' ' 81' ' ' VAL . 61.0 t -78.23 148.13 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.196 -0.94 . . . . 0.0 109.974 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.543 ' CG1' ' HG3' ' A' ' 82' ' ' GLN . 7.1 p -139.46 9.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 110.082 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.08 117.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 109.948 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.58 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.24 117.26 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 110.116 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.542 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 20.2 m-20 -115.96 115.67 26.58 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.355 -0.841 . . . . 0.0 109.428 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -114.63 167.05 11.09 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 110.024 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.77 160.63 36.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.489 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -75.51 130.85 39.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.063 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.576 HG21 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.452 -0.78 . . . . 0.0 110.486 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 59' ' ' VAL . 1.6 mpt_? . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.171 0.51 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.529 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 29.1 tttt -123.06 128.12 49.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.118 -0.989 . . . . 0.0 110.62 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.539 ' HB3' ' CG2' ' A' ' 27' ' ' THR . 13.4 mtmt -101.34 148.25 25.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.376 -0.827 . . . . 0.0 108.99 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.66 118.96 25.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.97 -1.081 . . . . 0.0 112.007 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 17.5 mt -97.15 110.53 25.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.812 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.58 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 21.9 t -105.99 133.07 51.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.759 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.543 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 42.0 tp60 -111.25 153.46 25.84 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.922 -1.111 . . . . 0.0 109.103 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.7 m -114.66 155.76 15.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 118.179 -1.408 . . . . 0.0 109.611 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.519 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -49.92 178.93 0.03 OUTLIER Pre-proline 0 C--N 1.289 -2.023 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.353 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -72.45 142.39 36.72 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.244 1.655 . . . . 0.0 110.546 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.37 -36.83 3.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 11.7 mt-30 -80.53 173.03 13.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.136 . . . . 0.0 110.618 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 179.63 93.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -0.793 . . . . 0.0 110.216 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.572 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 14.8 mt -43.09 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -0.971 . . . . 0.0 110.026 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.456 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 2.9 mt-10 -75.17 -14.19 60.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 0.0 110.744 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.11 -24.03 23.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.096 -1.002 . . . . 0.0 110.506 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -105.86 -23.2 12.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.11 -0.994 . . . . 0.0 109.592 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 40.0 mm-40 -60.66 -23.17 64.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.399 -0.813 . . . . 0.0 110.196 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.97 -19.47 8.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.4 tp -50.47 -21.05 1.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -1.123 . . . . 0.0 110.13 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.521 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 43.8 mt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.141 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.532 ' CG1' HG13 ' A' ' 8' ' ' ILE . 84.6 t . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.951 0.405 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.581 ' CG2' ' HB3' ' A' ' 28' ' ' PHE . 9.8 mt -84.22 88.65 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 0.0 111.143 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.97 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.408 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.51 164.78 13.99 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.574 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.3 Cg_endo -80.22 155.04 22.21 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.013 1.533 . . . . 0.0 110.261 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.589 ' HB ' ' CD1' ' A' ' 29' ' ' TRP . 1.8 p -115.24 112.54 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.085 -1.009 . . . . 0.0 110.32 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.563 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 2.6 mm? -102.55 110.72 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.923 . . . . 0.0 110.391 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -144.71 162.46 36.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.981 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' SER . 52.9 mt-10 -42.79 -65.32 0.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -14.61 32.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 110.344 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' PHE . . . -100.51 23.74 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 110.418 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.563 ' CZ ' HD11 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -134.36 -49.67 0.79 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.075 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.75 -35.29 80.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.102 -0.999 . . . . 0.0 109.324 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -88.76 -34.4 9.15 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.596 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -72.47 -8.69 56.38 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -78.2 -16.59 57.72 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.54 -0.725 . . . . 0.0 110.813 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 2.0 mm-40 -88.74 17.36 5.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.527 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.577 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 101.56 -3.35 53.57 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.52 ' CG ' ' OE1' ' A' ' 82' ' ' GLN . 28.3 mttt -82.44 137.04 34.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.603 -0.94 . . . . 0.0 109.516 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 99.3 m-85 -127.15 112.21 14.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.708 -1.245 . . . . 0.0 111.435 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 3.9 m -82.38 127.96 33.76 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.63 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 22.7 m-85 -123.08 147.43 46.74 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.163 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.604 ' CZ3' ' CG ' ' A' ' 76' ' ' ARG . 3.9 m95 -84.35 122.6 29.16 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.516 ' CG1' ' HA ' ' A' ' 8' ' ' ILE . 1.5 m -138.51 164.07 27.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 118.207 -1.397 . . . . 0.0 112.043 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -61.64 134.36 93.76 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 176.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.44 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 38.3 Cg_endo -64.2 75.9 0.18 Allowed 'Trans proline' 0 C--N 1.293 -2.359 0 O-C-N 123.22 1.116 . . . . 0.0 109.398 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.47 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.529 ' HB3' ' CG1' ' A' ' 7' ' ' VAL . . . -38.46 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.821 -0.55 . . . . 0.0 109.84 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -46.76 140.58 4.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.108 -0.995 . . . . 0.0 110.76 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.487 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 8.6 mttt -43.42 -45.36 6.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.308 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 3.4 m -61.01 -48.53 81.37 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 109.296 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.426 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 2.1 mt-10 -58.43 -44.51 89.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.358 -0.839 . . . . 0.0 109.356 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.524 ' CG2' HD11 ' A' ' 8' ' ' ILE . 15.3 mt -57.3 -30.71 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.535 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 54.9 tttt -66.55 -47.6 72.32 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.425 -0.797 . . . . 0.0 109.366 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.525 ' O ' ' CG2' ' A' ' 45' ' ' THR . 72.2 m-20 -73.65 -34.38 64.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.625 -0.672 . . . . 0.0 110.8 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.499 ' HB3' HG12 ' A' ' 7' ' ' VAL . . . -57.96 -50.49 73.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.84 -1.163 . . . . 0.0 110.365 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.63 ' CG1' ' CE2' ' A' ' 28' ' ' PHE . 3.2 m -73.47 -36.33 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.837 -1.164 . . . . 0.0 110.022 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -58.0 -34.71 70.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.088 -1.008 . . . . 0.0 109.48 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 41' ' ' ASN . 39.9 p -79.3 -45.06 20.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.511 -0.743 . . . . 0.0 110.078 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.46 -56.83 3.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.384 -0.822 . . . . 0.0 111.018 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.576 ' CD1' HG23 ' A' ' 89' ' ' ILE . 6.4 m-85 -71.49 -21.39 61.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.018 -1.051 . . . . 0.0 110.245 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.95 44.45 19.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 110.38 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -123.55 -164.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.515 -0.74 . . . . 0.0 109.791 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.573 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.23 107.3 15.1 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 109.489 179.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.535 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 75.6 t -78.07 119.4 26.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.214 -0.929 . . . . 0.0 110.026 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.1 p -103.43 -0.21 10.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 110.086 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.91 141.58 0.11 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.82 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.581 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -134.3 127.73 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.073 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.487 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 47.0 t30 -131.27 115.1 15.86 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.406 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.32 149.23 39.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -130.68 170.98 13.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 110.665 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.425 ' CD2' ' C ' ' A' ' 58' ' ' HIS . 5.0 t-160 -80.23 115.56 19.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 110.007 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.527 ' CG1' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.349 -0.845 . . . . 0.0 110.042 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.604 ' CG ' ' CZ3' ' A' ' 29' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.176 0.512 . . . . 0.0 109.646 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.512 ' NZ ' ' OG1' ' A' ' 56' ' ' THR . 4.3 tttp -123.06 140.84 52.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.144 -0.972 . . . . 0.0 110.753 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HD2' ' CG2' ' A' ' 27' ' ' THR . 0.4 OUTLIER -106.96 143.33 35.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.427 -0.796 . . . . 0.0 109.646 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -133.69 118.96 18.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.083 -1.011 . . . . 0.0 111.247 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.62 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -100.83 111.85 31.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.523 0.678 . . . . 0.0 109.911 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.581 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 35.1 t -109.1 136.09 46.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 110.265 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.522 ' HB3' ' CG ' ' A' ' 53' ' ' LYS . 6.6 tp60 -110.33 153.44 24.9 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.102 -0.999 . . . . 0.0 109.0 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.443 ' C ' HG13 ' A' ' 52' ' ' VAL . 2.3 m -116.18 155.44 17.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.832 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.54 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -50.09 179.26 0.03 OUTLIER Pre-proline 0 C--N 1.288 -2.066 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.617 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 41.5 Cg_endo -71.5 141.31 38.13 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.366 1.719 . . . . 0.0 110.499 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.6 -25.48 11.13 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.525 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 60.3 mt-30 -94.05 163.77 13.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -1.164 . . . . 0.0 110.689 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.521 ' O ' ' CD ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER 179.51 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.457 -0.777 . . . . 0.0 110.113 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.576 HG23 ' CD1' ' A' ' 47' ' ' PHE . 9.4 mt -44.28 95.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.953 . . . . 0.0 109.596 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.529 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -68.53 -13.27 62.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.439 -0.788 . . . . 0.0 111.155 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.502 ' CB ' HD21 ' A' ' 92' ' ' LEU . . . -54.44 -35.08 62.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.087 -1.008 . . . . 0.0 110.969 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -106.89 -23.67 12.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.889 -1.132 . . . . 0.0 110.773 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 1.9 pp20? -51.1 -22.93 2.73 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.038 -1.039 . . . . 0.0 110.234 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -99.08 -23.77 11.11 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.462 ' HB3' ' OH ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -42.75 -29.58 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -1.128 . . . . 0.0 110.147 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.547 HG13 ' CE1' ' A' ' 18' ' ' TYR . 2.6 mp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 30' ' ' VAL . 99.1 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.252 0.549 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.609 ' CG2' ' CD2' ' A' ' 28' ' ' PHE . 3.6 mt -86.1 90.55 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.846 -1.159 . . . . 0.0 111.26 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -97.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.811 . . . . 0.0 110.198 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.38 162.36 20.21 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.998 . . . . 0.0 110.242 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.96 163.5 36.73 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.994 1.523 . . . . 0.0 110.388 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.626 ' CG1' ' CD1' ' A' ' 29' ' ' TRP . 2.4 m -115.13 139.4 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.942 . . . . 0.0 110.317 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.569 HD11 ' CE2' ' A' ' 18' ' ' TYR . 3.2 mm? -102.67 111.48 23.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -0.958 . . . . 0.0 110.042 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 15' ' ' GLU . 54.3 m -145.66 139.56 26.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 110.183 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 8.7 tm-20 -42.79 -58.71 2.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 110.176 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -42.26 71.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.264 -0.897 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -58.93 -66.0 0.57 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.569 ' CE2' HD11 ' A' ' 13' ' ' LEU . 1.6 m-85 -44.92 -31.08 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 110.58 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.77 -8.77 48.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -110.98 -31.97 2.75 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -76.08 -17.22 59.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.686 -0.891 . . . . 0.0 108.92 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.615 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -57.0 -21.31 29.72 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.791 -0.568 . . . . 0.0 110.725 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -88.99 17.08 6.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.51 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.11 0.18 66.0 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.527 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 1.7 mttp -82.36 137.21 34.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -1.015 . . . . 0.0 109.064 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.619 ' CB ' ' CZ ' ' A' ' 28' ' ' PHE . 27.6 m-85 -128.86 105.52 8.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.34 -1.475 . . . . 0.0 112.244 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 4.3 m -74.88 141.02 44.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.445 0.641 . . . . 0.0 109.37 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.619 ' CZ ' ' CB ' ' A' ' 26' ' ' TYR . 21.7 m-85 -133.3 166.18 23.09 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.434 -0.791 . . . . 0.0 110.032 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.626 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 14.0 m95 -98.28 122.96 42.08 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.537 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 2.0 p -143.9 160.39 16.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 C-N-CA 117.792 -1.563 . . . . 0.0 112.768 -176.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.587 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -62.2 151.99 79.86 Favored Pre-proline 0 C--N 1.3 -1.572 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.69 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.9 Cg_endo -73.06 69.54 3.85 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.082 1.569 . . . . 0.0 109.647 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.2 OUTLIER 179.72 -34.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.399 -0.813 . . . . 0.0 110.017 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB1' ' CG2' ' A' ' 30' ' ' VAL . . . -43.75 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.381 -0.825 . . . . 0.0 109.603 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -41.55 136.04 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.535 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.529 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 7.5 mttt -43.74 -41.34 4.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 109.385 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.5 m -67.66 -40.26 84.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.267 -0.896 . . . . 0.0 108.997 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.517 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 5.1 mt-10 -55.79 -39.46 71.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.899 . . . . 0.0 108.763 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.533 ' CG2' HD11 ' A' ' 8' ' ' ILE . 32.3 mt -57.75 -34.66 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.6 ttmt -57.99 -47.91 81.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.37 -0.831 . . . . 0.0 109.945 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -73.79 -34.82 64.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.696 -0.627 . . . . 0.0 111.345 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.527 ' CB ' HG13 ' A' ' 8' ' ' ILE . . . -58.77 -50.5 73.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.824 -1.173 . . . . 0.0 110.672 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.563 HG13 ' CE2' ' A' ' 28' ' ' PHE . 2.6 m -65.02 -33.21 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.774 -1.204 . . . . 0.0 109.811 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -60.65 -44.29 96.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 0.0 109.204 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.06 -15.28 58.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.0 109.323 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.66 -68.79 0.81 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.406 -0.809 . . . . 0.0 110.459 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.538 ' CD2' HD12 ' A' ' 89' ' ' ILE . 29.9 m-85 -74.08 -21.56 59.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 4.3 tttp 65.15 47.21 2.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 110.107 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.544 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -125.29 -162.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.498 -0.752 . . . . 0.0 110.413 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.544 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -118.29 114.58 23.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.473 -0.767 . . . . 0.0 109.788 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.534 ' CG2' HG22 ' A' ' 43' ' ' VAL . 90.4 t -78.94 123.31 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.0 110.435 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.482 HG11 ' O ' ' A' ' 82' ' ' GLN . 8.4 p -114.93 9.94 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.924 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.55 120.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.402 -0.811 . . . . 0.0 109.902 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.12 125.51 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.196 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.529 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -125.12 115.6 20.72 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.224 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -119.2 150.46 40.04 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.902 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.528 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 3.3 pp -146.86 145.38 29.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.408 -0.807 . . . . 0.0 110.054 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 132.49 44.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.357 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.366 -0.834 . . . . 0.0 110.106 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.557 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 1.8 tpt180 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.214 0.53 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.443 ' O ' HG11 ' A' ' 30' ' ' VAL . 11.3 tttp -110.03 129.41 55.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 10.4 ptpt -114.65 151.51 33.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.996 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -122.23 125.71 46.64 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.0 112.585 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.527 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 22.7 mt -104.22 110.93 31.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.452 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 97.9 t -104.26 134.55 45.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 110.346 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.519 ' HG3' ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -102.51 150.71 23.12 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.171 -0.956 . . . . 0.0 108.704 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.519 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.4 m -115.33 156.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 118.069 -1.452 . . . . 0.0 109.754 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -67.65 -179.71 0.49 Allowed Pre-proline 0 C--N 1.288 -2.104 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.163 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.0 Cg_endo -73.2 139.53 29.52 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 O-C-N 124.264 1.665 . . . . 0.0 110.195 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.503 ' O ' ' CE ' ' A' ' 88' ' ' LYS . . . 109.09 -48.31 0.95 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.465 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -94.07 176.87 6.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.16 -1.2 . . . . 0.0 110.672 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 86' ' ' GLY . 0.4 OUTLIER 179.56 100.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -0.772 . . . . 0.0 110.088 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.575 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 10.4 mt -44.19 108.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 110.05 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 10.0 mm-40 -75.75 -13.65 60.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -0.803 . . . . 0.0 110.799 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' CB ' HD23 ' A' ' 92' ' ' LEU . . . -54.82 -31.38 59.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.0 110.577 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.575 HD11 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.31 -23.04 12.66 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.19 -0.944 . . . . 0.0 109.715 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 36.1 mm-40 -50.84 -35.25 31.51 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 110.382 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -94.78 -24.22 18.41 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 92' ' ' LEU . 1.3 mp -43.0 -27.22 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -1.181 . . . . 0.0 110.173 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.562 HD12 ' CD1' ' A' ' 18' ' ' TYR . 22.8 mm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.18 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.526 ' O ' ' CD2' ' A' ' 9' ' ' LEU . 3.3 t . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.583 HG23 ' CD1' ' A' ' 28' ' ' PHE . 3.8 mt -57.04 120.33 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.157 -0.965 . . . . 0.0 110.121 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -111.65 -89.59 0.51 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.175 -0.953 . . . . 0.0 110.297 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.25 142.42 24.55 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.095 -1.003 . . . . 0.0 110.212 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.593 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 47.5 Cg_endo -73.69 175.73 10.33 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.058 1.557 . . . . 0.0 110.506 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.61 ' CG1' ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.08 133.15 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.926 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.98 110.23 22.07 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.152 -0.968 . . . . 0.0 110.293 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 71.7 m -166.07 138.39 3.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 110.008 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 14' ' ' SER . 13.2 mt-10 -43.41 -46.36 6.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 110.064 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.72 -18.05 4.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.574 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -101.62 -49.81 3.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.752 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.576 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.4 m-85 -58.64 -44.74 90.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.496 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -12.61 38.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 108.876 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' N ' ' A' ' 22' ' ' ALA . . . -98.95 -39.59 3.53 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CE2' HD12 ' A' ' 92' ' ' LEU . 3.6 m-30 -49.96 -25.43 3.28 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 20' ' ' GLY . . . -40.21 -31.68 0.14 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.724 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 3.6 tp10 -104.05 -1.26 27.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.771 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.543 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 103.52 9.1 39.11 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 15.4 mttt -82.58 131.54 35.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -1.133 . . . . 0.0 109.668 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 89' ' ' ILE . 70.1 m-85 -126.86 108.09 10.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.887 -1.133 . . . . 0.0 112.003 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 27.1 m -75.85 121.9 23.3 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.593 ' CE1' ' N ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER -116.4 164.03 15.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 110.618 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.61 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 68.1 m95 -97.5 123.22 41.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.527 ' HA ' ' CD2' ' A' ' 9' ' ' LEU . 2.6 p -151.4 164.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 C-N-CA 117.827 -1.549 . . . . 0.0 111.997 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -51.01 140.46 20.89 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.207 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.501 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.4 Cg_endo -72.17 76.57 2.14 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.06 1.558 . . . . 0.0 110.059 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.41 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 179.03 -33.81 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.418 -0.801 . . . . 0.0 110.03 -178.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 39' ' ' ILE . . . -48.43 107.5 0.13 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 110.194 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.46 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -59.45 147.51 36.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -0.927 . . . . 0.0 110.012 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.515 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 21.8 mttt -46.56 -34.4 4.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 110.102 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 m -75.18 -51.19 13.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 110.447 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 1.8 mt-10 -55.19 -42.82 73.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.779 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 20.9 mt -57.19 -30.59 35.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.529 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 ttpm? -62.71 -46.35 88.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 111.046 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.401 ' O ' HG21 ' A' ' 45' ' ' THR . 13.5 m-80 -58.97 -34.89 72.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.421 -0.799 . . . . 0.0 112.336 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB2' HD11 ' A' ' 8' ' ' ILE . . . -72.43 -49.27 34.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.666 -1.271 . . . . 0.0 111.652 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.582 HG22 ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -69.52 -37.63 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.888 -1.133 . . . . 0.0 110.84 -178.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.68 -44.12 81.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.072 -1.017 . . . . 0.0 110.424 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 41' ' ' ASN . 34.0 p -78.99 -46.19 18.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 110.295 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.68 -55.93 22.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.311 -0.868 . . . . 0.0 110.554 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.582 ' CD1' HG22 ' A' ' 43' ' ' VAL . 70.6 m-85 -83.2 3.02 32.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.112 -0.992 . . . . 0.0 110.333 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 4.5 pttm 38.23 42.57 0.51 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.735 0.779 . . . . 0.0 110.326 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -115.39 -165.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.599 -0.688 . . . . 0.0 109.792 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 2.8 tmtm? -118.27 103.16 9.56 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.443 -0.785 . . . . 0.0 109.831 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.529 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 97.7 t -78.37 119.63 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.36 -0.838 . . . . 0.0 109.69 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.565 HG11 ' CA ' ' A' ' 83' ' ' VAL . 7.3 p -101.02 -5.61 9.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -0.903 . . . . 0.0 110.381 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER 176.08 119.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.344 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.502 HG21 ' CG1' ' A' ' 81' ' ' VAL . 1.1 t -109.56 124.51 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 109.743 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.515 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 12.9 m120 -122.83 116.32 23.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.219 -0.926 . . . . 0.0 109.818 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.543 ' OG1' ' CE ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -110.17 155.43 21.98 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.36 -0.837 . . . . 0.0 110.185 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -138.58 156.96 47.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.778 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.32 122.91 25.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.463 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.561 HG21 ' CZ3' ' A' ' 29' ' ' TRP . 4.3 m . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.701 -0.625 . . . . 0.0 110.21 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.512 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.098 0.475 . . . . 0.0 110.116 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.543 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 0.1 OUTLIER -121.92 142.14 50.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 0.0 110.379 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HE2' ' CZ2' ' A' ' 29' ' ' TRP . 1.8 mttt -100.91 151.22 22.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 109.718 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 28' ' ' PHE . . . -119.55 119.24 33.22 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.985 -1.072 . . . . 0.0 111.944 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.533 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 9.1 mt -95.95 110.87 25.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 109.527 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.527 ' CG1' HG13 ' A' ' 43' ' ' VAL . 2.9 t -99.8 125.95 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.14 -0.975 . . . . 0.0 110.263 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER -106.75 143.15 35.27 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.011 -1.056 . . . . 0.0 108.932 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.565 ' CA ' HG11 ' A' ' 52' ' ' VAL . 1.3 m -115.0 156.84 15.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.442 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . . . -68.18 177.17 1.1 Allowed Pre-proline 0 C--N 1.29 -1.999 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.671 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -73.49 141.91 32.2 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.348 1.709 . . . . 0.0 110.36 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.97 -26.74 14.52 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.451 ' OE1' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -113.72 177.68 4.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -1.132 . . . . 0.0 110.305 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.6 OUTLIER 179.71 122.68 0.06 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -0.933 . . . . 0.0 110.373 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 12.5 mt -73.6 93.94 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 110.101 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 20.0 pt-20 -72.55 -14.66 61.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.855 . . . . 0.0 110.409 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.461 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -55.7 -23.82 30.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.892 . . . . 0.0 110.495 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.577 HD12 ' CE2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -106.22 -23.01 12.69 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.174 -0.954 . . . . 0.0 109.713 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.3 mm-40 -61.34 -31.06 70.92 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.359 -0.838 . . . . 0.0 110.369 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.68 -6.22 56.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 92' ' ' LEU . 1.1 tp -61.86 -12.07 15.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.167 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.576 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 2.9 mp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.15 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.555 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 46.4 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.807 0.813 . . . . 0.0 109.075 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.582 HG21 ' CD2' ' A' ' 28' ' ' PHE . 6.4 mt -110.59 67.77 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 121.232 -0.918 . . . . 0.0 109.932 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 mt -54.28 -94.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.806 . . . . 0.0 110.742 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.17 150.45 36.73 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 110.61 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.22 162.02 37.22 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.121 1.59 . . . . 0.0 110.276 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.508 HG12 ' CG2' ' A' ' 27' ' ' THR . 1.1 p -115.35 110.33 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.287 -0.883 . . . . 0.0 110.027 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.12 106.92 17.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.245 -0.909 . . . . 0.0 110.234 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.76 174.58 10.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 110.253 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -55.7 -65.58 0.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.317 -0.865 . . . . 0.0 110.243 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -54.69 -34.79 62.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.169 -0.957 . . . . 0.0 110.302 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 21' ' ' PHE . . . -71.98 -49.52 36.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.156 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 13' ' ' LEU . 1.3 m-85 -58.07 -31.53 67.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.39 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.46 -8.52 50.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 110.177 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -107.63 -35.41 2.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.401 -1.879 . . . . 0.0 108.401 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -76.02 -16.6 59.93 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.63 -0.924 . . . . 0.0 109.118 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.622 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -59.09 -20.29 52.09 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.442 0.639 . . . . 0.0 110.75 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -88.86 17.27 5.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.395 -0.816 . . . . 0.0 110.434 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.29 -0.25 65.95 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.518 ' HG3' ' NE2' ' A' ' 82' ' ' GLN . 19.7 mttt -82.4 142.71 31.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.572 -0.958 . . . . 0.0 109.395 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 22.9 m-85 -128.29 110.65 12.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.676 -1.265 . . . . 0.0 111.368 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 3.0 m -81.55 131.18 35.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.478 0.656 . . . . 0.0 109.277 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.648 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 23.3 m-85 -124.65 165.06 18.57 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.488 -0.758 . . . . 0.0 110.672 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.637 ' CE3' ' CG ' ' A' ' 76' ' ' ARG . 3.1 m95 -103.12 122.29 44.38 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 2.6 p -139.42 161.57 27.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 C-N-CA 118.025 -1.47 . . . . 0.0 112.327 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.583 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -74.03 150.26 87.87 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.259 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 44.0 Cg_endo -70.31 67.14 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.986 1.519 . . . . 0.0 109.729 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.88 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.577 -0.702 . . . . 0.0 109.575 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -43.98 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.338 -0.851 . . . . 0.0 109.306 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -38.0 130.86 1.13 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.496 -0.752 . . . . 0.0 110.964 -179.127 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 1.5 mttt -42.84 -43.31 3.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 109.619 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 4.5 m -61.79 -44.52 96.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.485 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 19.6 mm-40 -55.36 -38.83 69.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.392 -0.817 . . . . 0.0 109.422 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.542 ' CA ' HD12 ' A' ' 8' ' ' ILE . 25.0 mt -57.38 -30.87 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.527 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 59.9 tttm -67.85 -47.05 70.04 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.444 -0.785 . . . . 0.0 109.582 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.466 ' O ' ' HB ' ' A' ' 45' ' ' THR . 58.0 m-80 -73.6 -34.31 65.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.604 -0.685 . . . . 0.0 111.325 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.454 ' HB3' HD11 ' A' ' 8' ' ' ILE . . . -58.15 -50.56 73.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.739 -1.226 . . . . 0.0 110.454 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.648 ' CG1' ' CE2' ' A' ' 28' ' ' PHE . 3.6 m -68.31 -32.89 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.854 -1.154 . . . . 0.0 109.372 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CD ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.42 -42.02 79.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.12 -0.987 . . . . 0.0 108.483 178.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.9 OUTLIER -79.52 -12.8 59.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 178.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.8 -62.2 1.57 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 110.678 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.54 ' CD1' HG22 ' A' ' 89' ' ' ILE . 24.0 m-85 -71.59 -22.48 61.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.996 -1.065 . . . . 0.0 110.071 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER 65.88 46.78 2.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.845 . . . . 0.0 110.038 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.427 ' O ' ' CD ' ' A' ' 44' ' ' GLU . 1.2 p -125.28 -164.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.631 -0.668 . . . . 0.0 110.412 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . 1.3 tmtp? -118.46 106.73 13.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.451 -0.781 . . . . 0.0 109.763 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.527 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 40.6 t -78.8 140.54 16.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 110.542 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 82' ' ' GLN . 13.6 p -118.91 -6.46 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.616 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -179.18 131.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.529 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -120.26 129.47 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.918 -1.114 . . . . 0.0 110.117 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.475 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 3.8 m-80 -131.53 115.71 16.49 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.437 -0.789 . . . . 0.0 109.387 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -115.5 159.58 21.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 109.311 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.533 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -148.33 144.71 27.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.11 -0.993 . . . . 0.0 110.968 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.05 103.36 2.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.858 . . . . 0.0 109.034 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.526 ' CG2' ' HG2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.538 0 O-C-N 121.385 -0.822 . . . . 0.0 109.319 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.637 ' CG ' ' CE3' ' A' ' 29' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.397 0.618 . . . . 0.0 111.102 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.533 ' CE ' HG12 ' A' ' 30' ' ' VAL . 4.8 ptmt -98.59 141.2 31.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.402 -0.812 . . . . 0.0 110.18 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 19.2 ptpt -109.3 151.41 26.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -0.936 . . . . 0.0 110.483 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -116.9 122.68 45.01 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.234 -0.916 . . . . 0.0 111.931 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.632 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.5 mp -103.18 112.77 37.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.559 -0.713 . . . . 0.0 109.468 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 23.8 t -113.3 128.68 69.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.417 -0.802 . . . . 0.0 110.866 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.616 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 1.5 tp60 -98.82 153.36 18.83 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.193 -0.942 . . . . 0.0 108.679 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 84' ' ' ALA . 1.5 m -116.66 156.69 17.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 C-N-CA 118.264 -1.375 . . . . 0.0 108.679 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.52 ' CB ' ' OE1' ' A' ' 87' ' ' GLN . . . -69.27 178.79 0.85 Allowed Pre-proline 0 C--N 1.285 -2.229 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.002 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.6 138.41 26.68 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 124.243 1.654 . . . . 0.0 110.458 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.42 -30.1 8.52 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.52 ' OE1' ' CB ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -111.69 176.9 4.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.242 . . . . 0.0 110.705 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 90' ' ' GLU . 8.2 ptpt 179.46 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.459 -0.776 . . . . 0.0 110.012 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 14.9 mt -45.07 95.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.002 . . . . 0.0 110.075 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 88' ' ' LYS . 1.1 pt-20 -68.13 -13.89 62.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.384 -0.823 . . . . 0.0 110.666 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.96 -28.68 53.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.125 -0.985 . . . . 0.0 110.347 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.498 ' CD1' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.23 -23.04 12.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.492 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 13.9 mm-40 -51.07 -31.92 20.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.436 -0.79 . . . . 0.0 110.45 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -98.02 -26.63 9.45 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.466 HD21 HD22 ' A' ' 13' ' ' LEU . 1.4 mp -43.56 -26.18 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.227 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 94' ' ' GLY . 40.5 mt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.23 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 45.7 t . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 121.183 0.516 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.652 ' CG2' ' CG ' ' A' ' 28' ' ' PHE . 5.7 mt -86.37 100.2 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.861 -1.15 . . . . 0.0 111.109 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -91.63 -86.01 0.23 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.226 -0.921 . . . . 0.0 111.067 179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.544 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -107.99 140.64 21.85 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.9 -1.125 . . . . 0.0 110.592 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.628 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.1 Cg_endo -72.96 170.38 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.079 1.568 . . . . 0.0 110.393 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.579 HG13 ' CD1' ' A' ' 29' ' ' TRP . 1.6 m -115.27 133.16 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.165 -0.959 . . . . 0.0 110.405 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.576 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -102.83 112.66 25.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.163 -0.961 . . . . 0.0 110.215 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 15' ' ' GLU . 40.5 m -159.69 145.62 15.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.007 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' SER . 36.5 mt-10 -42.76 -54.13 4.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 110.165 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -54.61 -28.17 44.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 0.0 110.182 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -87.05 -55.41 3.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.625 ' CE1' ' CG1' ' A' ' 96' ' ' ILE . 1.4 m-85 -53.7 -26.24 21.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.02 -15.65 31.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -101.49 -36.44 3.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -77.67 -23.08 49.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.574 -0.956 . . . . 0.0 108.835 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 18' ' ' TYR . . . -50.61 -20.58 1.24 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.606 -0.684 . . . . 0.0 110.338 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.3 13.63 25.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.53 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.467 ' C ' ' NE2' ' A' ' 82' ' ' GLN . . . 99.94 -0.53 56.34 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 20.7 mttt -82.38 147.45 28.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -1.138 . . . . 0.0 109.396 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.641 ' CE2' ' CD1' ' A' ' 89' ' ' ILE . 22.0 m-85 -128.07 102.88 6.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.693 -1.254 . . . . 0.0 112.209 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.532 ' CG2' ' CD ' ' A' ' 78' ' ' LYS . 3.4 m -75.82 125.92 30.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.652 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -130.28 164.96 23.44 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.934 -1.103 . . . . 0.0 112.085 -177.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.579 ' CD1' HG13 ' A' ' 12' ' ' VAL . 24.9 m95 -101.33 123.31 45.22 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 1.4 p -145.96 158.81 11.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 117.772 -1.571 . . . . 0.0 112.003 -176.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.579 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -59.97 151.17 66.34 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.852 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 49.0 Cg_endo -73.36 70.01 4.03 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.227 1.646 . . . . 0.0 109.763 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.57 -33.42 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 110.071 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.518 ' HB3' ' CG1' ' A' ' 7' ' ' VAL . . . -42.61 93.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.45 -0.781 . . . . 0.0 109.831 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -51.52 140.29 18.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 110.421 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.514 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 8.5 mttt -42.26 -43.27 3.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.88 . . . . 0.0 110.027 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -64.32 -53.36 50.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.865 . . . . 0.0 110.07 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.8 OUTLIER -55.47 -40.43 71.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.549 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 14.9 mt -57.68 -31.4 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.271 -0.893 . . . . 0.0 108.968 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 37' ' ' THR . 6.7 tttt -63.12 -42.54 99.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.371 -0.831 . . . . 0.0 109.833 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.541 ' O ' ' CG2' ' A' ' 45' ' ' THR . 44.1 m-80 -71.39 -44.89 64.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.69 -0.631 . . . . 0.0 111.836 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.464 ' HA ' HG22 ' A' ' 45' ' ' THR . . . -57.78 -52.11 66.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.768 -1.208 . . . . 0.0 110.964 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.571 HG23 ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -59.69 -38.64 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.547 -1.346 . . . . 0.0 109.862 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -64.37 -32.73 74.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 41' ' ' ASN . 26.7 p -62.95 -47.47 83.07 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.153 -0.967 . . . . 0.0 110.65 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.88 -52.11 5.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.222 -0.924 . . . . 0.0 110.828 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.598 ' CG ' HD11 ' A' ' 89' ' ' ILE . 78.1 m-85 -71.76 -21.39 61.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.231 -0.918 . . . . 0.0 110.499 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 14.0 mtpt 46.83 42.62 12.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.669 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.39 -162.59 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 121.398 0.618 . . . . 0.0 109.727 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.565 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.21 107.55 15.44 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.881 179.09 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.563 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 22.8 t -78.33 119.5 27.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.261 -0.9 . . . . 0.0 109.316 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 8.4 p -105.9 9.06 9.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.248 -0.908 . . . . 0.0 110.683 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.15 117.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 110.46 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.528 HG22 ' CG1' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -115.28 116.66 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.0 109.519 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.514 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 82.8 m-20 -118.56 115.87 25.46 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 109.409 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.529 ' CA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -115.0 162.45 16.96 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.987 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.79 153.01 30.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 110.469 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.36 130.59 43.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.745 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.29 -0.881 . . . . 0.0 110.154 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.226 0.536 . . . . 0.0 109.899 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.524 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 51.1 tttt -117.86 128.59 54.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.573 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -101.7 151.11 22.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.56 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -129.4 131.41 46.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.915 -1.115 . . . . 0.0 112.053 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -110.63 111.43 36.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.528 ' CG1' HG22 ' A' ' 54' ' ' VAL . 2.6 t -106.16 133.92 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.505 -0.747 . . . . 0.0 110.431 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.541 ' HG3' ' N ' ' A' ' 83' ' ' VAL . 4.7 tp60 -117.14 152.77 34.04 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.005 -1.06 . . . . 0.0 108.674 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.541 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.4 m -118.79 155.76 20.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.142 -1.423 . . . . 0.0 109.711 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -50.85 174.11 0.09 OUTLIER Pre-proline 0 C--N 1.289 -2.024 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.871 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.8 Cg_endo -76.66 55.54 4.85 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.307 1.688 . . . . 0.0 110.609 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -163.81 -50.28 0.02 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.526 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -51.27 -172.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -1.174 . . . . 0.0 111.025 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 179.25 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.63 -0.669 . . . . 0.0 110.172 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.641 ' CD1' ' CE2' ' A' ' 26' ' ' TYR . 5.6 mt -68.72 109.16 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.0 110.146 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 3.3 mt-10 -78.3 -14.49 59.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.585 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.457 ' HB1' HD21 ' A' ' 92' ' ' LEU . . . -56.29 -33.04 65.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 111.137 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -106.11 -23.44 12.61 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.952 -1.092 . . . . 0.0 110.138 -179.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mm-40 -62.71 -23.02 66.94 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.179 -0.95 . . . . 0.0 110.228 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -113.51 -26.32 3.99 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 8.0 tp -42.87 -27.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -1.132 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.625 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 52.0 mt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.215 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.465 HG13 HG21 ' A' ' 30' ' ' VAL . 3.2 t . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.234 0.54 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.598 HG23 ' CB ' ' A' ' 28' ' ' PHE . 4.9 mt -56.12 156.07 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 121.217 -0.927 . . . . 0.0 110.812 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.416 ' N ' HG21 ' A' ' 8' ' ' ILE . 14.2 mt -143.52 -93.78 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 110.155 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.21 149.81 39.68 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.068 -1.02 . . . . 0.0 110.277 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.452 ' HG3' ' CD2' ' A' ' 92' ' ' LEU . 45.9 Cg_endo -73.33 173.57 13.54 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.1 1.579 . . . . 0.0 110.357 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.523 HG12 ' CE2' ' A' ' 29' ' ' TRP . 2.4 m -112.8 139.35 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.206 -0.934 . . . . 0.0 110.152 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.575 HD13 ' CZ ' ' A' ' 18' ' ' TYR . 3.2 mm? -102.77 112.28 24.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.197 -0.939 . . . . 0.0 110.243 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -161.99 138.07 7.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 0.0 110.098 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 2.2 tm-20 -42.87 -50.11 5.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.178 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -46.75 74.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.849 . . . . 0.0 110.23 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -67.86 -60.37 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.187 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.575 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 1.2 m-85 -44.61 -29.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.117 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.75 -19.27 23.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.86 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -96.19 -40.55 3.97 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.244 -1.943 . . . . 0.0 108.244 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.626 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -69.79 -17.08 63.39 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.638 -0.919 . . . . 0.0 108.952 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.626 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -58.34 -21.2 48.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.272 0.558 . . . . 0.0 110.89 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -88.53 16.96 5.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.25 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.67 1.96 65.52 Favored Glycine 0 N--CA 1.48 1.594 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 24.7 mttm -82.24 137.7 34.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.607 -0.937 . . . . 0.0 109.246 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 24.8 m-85 -128.76 103.89 7.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.518 -1.363 . . . . 0.0 112.007 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.561 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 1.4 m -75.03 140.96 43.91 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.619 -0.676 . . . . 0.0 109.339 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.611 ' CZ ' ' CE2' ' A' ' 47' ' ' PHE . 22.0 m-85 -134.56 165.64 24.74 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.453 -0.779 . . . . 0.0 110.438 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.523 ' CE2' HG12 ' A' ' 12' ' ' VAL . 10.0 m95 -98.96 122.33 42.07 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 7.4 p -148.06 165.68 5.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.617 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.474 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -61.14 152.91 69.8 Favored Pre-proline 0 C--N 1.298 -1.669 0 O-C-N 121.851 -0.53 . . . . 0.0 110.383 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.466 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.9 Cg_endo -73.4 71.53 3.77 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.099 1.578 . . . . 0.0 110.349 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.02 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.264 -0.898 . . . . 0.0 110.101 -179.256 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 33' ' ' LYS . . . -42.74 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 110.186 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -48.09 155.81 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 110.26 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.544 ' CD ' ' O ' ' A' ' 54' ' ' VAL . 7.2 mmtp -57.33 -36.25 70.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.88 . . . . 0.0 110.204 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -75.14 -50.21 17.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.458 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 23.0 mt-10 -54.97 -37.92 67.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.942 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.535 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 17.8 mt -57.91 -30.83 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 109.401 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.529 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 2.4 ttpt -61.69 -45.89 92.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 111.096 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -58.9 -36.67 75.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 112.314 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HB1' HD13 ' A' ' 8' ' ' ILE . . . -73.22 -50.49 22.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.603 -1.311 . . . . 0.0 111.685 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.464 HG12 ' CE2' ' A' ' 47' ' ' PHE . 4.7 m -66.01 -30.57 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.518 -1.364 . . . . 0.0 110.583 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -62.76 -52.41 63.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.088 -1.007 . . . . 0.0 109.964 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -79.72 -15.72 56.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.895 . . . . 0.0 110.224 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.25 -62.05 1.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.471 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.611 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 9.7 m-85 -71.73 -15.96 62.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.183 -0.948 . . . . 0.0 110.096 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 5.9 mmtt 61.56 45.36 8.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.48 -0.762 . . . . 0.0 110.235 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -128.28 -162.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.528 -0.733 . . . . 0.0 110.007 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.561 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.06 106.14 12.58 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 109.358 178.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.529 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 97.8 t -78.23 119.77 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.322 -0.861 . . . . 0.0 110.184 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 82' ' ' GLN . 7.6 p -106.01 -3.97 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.545 ' HG3' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 178.34 147.94 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.859 . . . . 0.0 109.875 179.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.566 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 1.1 t -132.79 131.32 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.002 -1.061 . . . . 0.0 109.871 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.508 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -131.61 115.88 16.66 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.39 -0.819 . . . . 0.0 109.22 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -113.83 166.27 11.74 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.39 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 7.0 mt -143.17 179.76 6.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.432 -0.793 . . . . 0.0 109.852 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -104.15 102.17 11.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.339 -0.85 . . . . 0.0 109.387 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.532 ' CG1' ' HE2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.271 -0.893 . . . . 0.0 110.095 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.399 0.619 . . . . 0.0 110.531 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.516 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 5.9 ptmt -123.15 141.19 52.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.982 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 5.2 ptpt -101.57 151.12 22.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.105 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -115.48 119.96 37.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.217 -0.927 . . . . 0.0 112.25 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 12.8 mt -98.2 110.78 26.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.784 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 50.4 t -103.63 133.04 48.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.91 -1.119 . . . . 0.0 110.257 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.545 ' CB ' ' HG3' ' A' ' 53' ' ' LYS . 1.4 tp60 -102.71 153.28 20.29 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.07 -1.019 . . . . 0.0 109.065 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.1 m -120.94 156.19 24.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 C-N-CA 118.35 -1.34 . . . . 0.0 109.053 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -63.3 177.74 0.44 Allowed Pre-proline 0 C--N 1.286 -2.168 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.194 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.6 Cg_endo -74.23 138.92 25.77 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 124.233 1.649 . . . . 0.0 110.301 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.47 -30.32 10.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.81 176.35 5.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.112 -1.228 . . . . 0.0 110.548 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 7.9 pttt 179.56 104.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.449 -0.782 . . . . 0.0 110.195 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.555 HG21 ' CG ' ' A' ' 47' ' ' PHE . 9.8 mt -42.65 100.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 3.1 mm-40 -63.06 -13.72 39.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.419 -0.801 . . . . 0.0 110.985 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.481 ' CB ' HD21 ' A' ' 92' ' ' LEU . . . -54.75 -32.73 60.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.099 -1.0 . . . . 0.0 110.418 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.574 HD13 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.12 -23.02 12.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.148 -0.97 . . . . 0.0 109.599 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 64.9 mm-40 -48.05 -58.76 4.03 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.38 -0.825 . . . . 0.0 110.423 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -76.5 -33.66 47.22 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 8.0 tp -41.64 -27.34 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.299 -1.118 . . . . 0.0 110.331 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.468 HG23 HD13 ' A' ' 96' ' ' ILE . 50.4 mt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.263 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.549 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 40.9 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 122.046 0.926 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.584 HG23 ' CD2' ' A' ' 28' ' ' PHE . 4.7 mt -114.06 99.04 7.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 O-C-N 121.326 -0.859 . . . . 0.0 110.068 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.0 mt -93.05 -95.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.328 -0.857 . . . . 0.0 110.854 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.95 154.95 41.8 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.7 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.451 ' HB3' HD23 ' A' ' 92' ' ' LEU . 49.3 Cg_endo -75.61 158.17 39.9 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.134 1.597 . . . . 0.0 110.167 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 27' ' ' THR . 1.5 p -115.2 117.24 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.5 mm? -102.07 106.96 17.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 110.174 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -144.72 152.8 40.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.6 tt0 -43.07 -63.78 0.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -25.8 28.46 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.39 -51.19 7.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.143 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.561 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 2.1 m-85 -55.75 -32.47 63.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.17 -8.48 51.09 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.256 -0.903 . . . . 0.0 109.901 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.76 -34.0 3.4 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.584 -1.807 . . . . 0.0 108.584 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -79.37 -19.81 49.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.574 -0.956 . . . . 0.0 109.026 179.244 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -54.6 -17.65 3.55 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.65 -0.656 . . . . 0.0 110.879 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.8 OUTLIER -93.17 17.07 11.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.507 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.53 -2.01 67.07 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 1.7 mttp -82.13 139.51 34.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.524 -0.986 . . . . 0.0 109.376 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 23.8 m-85 -128.42 102.88 6.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.533 -1.354 . . . . 0.0 112.033 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 8.1 m -74.88 141.15 44.2 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.449 0.642 . . . . 0.0 109.659 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.64 ' CZ ' ' CE2' ' A' ' 47' ' ' PHE . 44.8 m-85 -134.22 165.18 25.7 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.49 -0.756 . . . . 0.0 110.056 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.579 ' CZ3' ' HG2' ' A' ' 76' ' ' ARG . 52.9 m95 -89.92 122.0 32.54 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 10.6 p -134.14 165.26 32.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 118.344 -1.342 . . . . 0.0 112.394 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.585 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 1.9 t60 -82.75 152.4 66.22 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.297 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 43.8 Cg_endo -70.61 65.56 2.29 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.173 1.617 . . . . 0.0 109.544 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.87 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.559 -0.713 . . . . 0.0 109.647 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -48.37 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.501 -0.75 . . . . 0.0 109.575 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -40.31 134.35 1.66 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.301 -0.875 . . . . 0.0 110.797 -179.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.521 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 3.5 tttm -42.4 -43.36 3.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.7 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 5.2 m -61.27 -44.32 97.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.92 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 35' ' ' THR . 6.7 mt-10 -55.13 -39.61 69.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.376 -0.827 . . . . 0.0 109.494 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.529 ' CA ' HD12 ' A' ' 8' ' ' ILE . 10.4 mt -57.67 -30.67 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.379 -0.826 . . . . 0.0 108.914 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.507 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 9.6 tttt -61.79 -47.64 84.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.827 . . . . 0.0 109.541 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.437 ' O ' ' HB ' ' A' ' 45' ' ' THR . 24.3 m-80 -73.48 -34.33 65.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.653 -0.654 . . . . 0.0 110.97 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.534 ' HB1' ' CD1' ' A' ' 8' ' ' ILE . . . -58.37 -50.27 74.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.912 -1.118 . . . . 0.0 110.656 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.592 HG13 ' CE2' ' A' ' 28' ' ' PHE . 2.7 m -68.11 -36.94 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.715 -1.241 . . . . 0.0 109.835 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -63.36 -42.6 98.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.092 -1.005 . . . . 0.0 108.886 179.154 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -79.2 -20.43 48.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.578 -0.701 . . . . 0.0 109.315 179.083 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 42' ' ' ALA . . . -100.04 -67.14 0.87 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 110.456 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.64 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 62.6 m-85 -72.58 -21.61 61.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 110.432 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 64.06 47.87 3.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.311 -0.868 . . . . 0.0 110.274 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -122.28 -158.82 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.483 -0.761 . . . . 0.0 110.062 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.551 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -117.16 111.3 19.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.436 179.209 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.507 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 57.7 t -78.3 119.8 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.189 -0.944 . . . . 0.0 110.424 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.554 HG13 ' CA ' ' A' ' 83' ' ' VAL . 12.2 p -113.8 -1.41 9.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.489 -0.757 . . . . 0.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 175.83 119.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.81 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.548 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -113.68 132.04 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 110.304 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 80' ' ' ILE . 2.4 m120 -131.05 115.56 16.61 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.457 -0.777 . . . . 0.0 109.573 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -116.28 144.61 44.01 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 109.982 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.45 162.01 34.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -0.804 . . . . 0.0 109.973 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 127.49 32.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.565 HG23 ' CZ3' ' A' ' 29' ' ' TRP . 1.9 m . . . . . 0 C--N 1.3 -1.565 0 O-C-N 121.607 -0.683 . . . . 0.0 109.979 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.579 ' HG2' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.286 0.565 . . . . 0.0 110.018 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.539 ' CE ' HG12 ' A' ' 30' ' ' VAL . 10.0 tttt -110.18 141.87 42.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.554 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HE2' ' CG1' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -116.57 151.32 36.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.417 -0.802 . . . . 0.0 109.82 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.98 123.24 36.66 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.997 -1.064 . . . . 0.0 112.63 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 55' ' ' ASN . 14.9 mt -103.29 111.36 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.829 -0.544 . . . . 0.0 110.019 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.548 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 60.2 t -104.29 130.37 55.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.94 -1.1 . . . . 0.0 109.969 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 83' ' ' VAL . 3.6 tp60 -102.64 149.76 24.11 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.143 -0.973 . . . . 0.0 109.205 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.554 ' CA ' HG13 ' A' ' 52' ' ' VAL . 1.5 m -112.89 156.65 13.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 118.45 -1.3 . . . . 0.0 109.405 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.489 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . . . -62.87 175.49 0.64 Allowed Pre-proline 0 C--N 1.291 -1.951 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.916 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 84' ' ' ALA . 44.3 Cg_endo -76.26 55.29 4.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.525 1.803 . . . . 0.0 110.415 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -158.67 -37.08 0.02 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.513 ' NE2' ' HB2' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -110.64 -179.57 3.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.297 -1.12 . . . . 0.0 110.219 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.459 ' HA ' HG22 ' A' ' 83' ' ' VAL . 2.6 pttt -176.17 100.35 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.617 ' CG2' ' CD1' ' A' ' 47' ' ' PHE . 11.2 mt -42.35 113.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.006 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 1.2 pt-20 -77.95 -13.36 59.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 0.0 110.914 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.447 ' HB2' HD21 ' A' ' 92' ' ' LEU . . . -54.52 -28.8 47.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.064 -1.022 . . . . 0.0 110.575 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.26 -23.15 12.64 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.077 -1.014 . . . . 0.0 109.605 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' O ' HD13 ' A' ' 96' ' ' ILE . 20.5 mm-40 -58.14 -37.69 75.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.487 -0.758 . . . . 0.0 110.296 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.42 25.08 29.41 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.457 HD23 HD23 ' A' ' 13' ' ' LEU . 1.2 tp -106.45 -15.1 14.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -1.143 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.453 HG13 ' CE1' ' A' ' 18' ' ' TYR . 2.7 mp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.197 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.566 ' O ' ' C ' ' A' ' 8' ' ' ILE . 74.7 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.877 0.37 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.632 HG23 ' CD2' ' A' ' 28' ' ' PHE . 58.0 mt 11.59 86.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.222 0.534 . . . . 0.0 112.283 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.1 mt -68.29 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 110.149 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.41 158.54 33.59 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.956 -1.09 . . . . 0.0 110.359 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.35 161.69 42.07 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.012 1.533 . . . . 0.0 110.344 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.582 ' CG1' ' NE1' ' A' ' 29' ' ' TRP . 2.2 m -104.65 135.13 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.145 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.85 107.18 17.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.118 -0.989 . . . . 0.0 110.334 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 15' ' ' GLU . 14.9 m -162.11 147.16 12.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.947 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.1 tt0 -42.78 -55.48 3.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.917 . . . . 0.0 109.989 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -29.95 54.56 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 110.154 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -82.96 -64.88 1.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 1.6 m-85 -42.95 -51.72 5.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.299 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.74 -24.56 67.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.21 -0.931 . . . . 0.0 109.943 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -87.43 -44.75 5.47 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.52 -23.9 56.74 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.509 -0.995 . . . . 0.0 108.957 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 18' ' ' TYR . . . -50.43 -21.57 1.52 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.657 -0.652 . . . . 0.0 110.204 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.516 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -91.85 16.26 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.235 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.63 0.02 64.9 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 14.6 mttt -82.18 146.95 29.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -1.128 . . . . 0.0 109.694 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.63 ' CE2' ' CD1' ' A' ' 89' ' ' ILE . 22.3 m-85 -127.31 104.69 8.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.773 -1.204 . . . . 0.0 112.0 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 3.9 m -78.27 131.43 37.08 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.632 ' CD2' HG23 ' A' ' 8' ' ' ILE . 24.1 m-85 -136.32 164.42 28.14 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.177 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.582 ' NE1' ' CG1' ' A' ' 12' ' ' VAL . 99.6 m95 -100.43 121.91 42.32 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.547 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.6 p -145.78 164.99 10.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.503 -176.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.595 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -73.46 171.47 10.58 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.767 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 48.4 Cg_endo -75.18 -53.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.927 1.488 . . . . 0.0 109.374 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' THR 0.252 0.0 OUTLIER -47.12 -22.63 0.39 Allowed 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.678 178.927 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . . . -67.02 61.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.363 -0.835 . . . . 0.0 109.617 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -38.33 148.65 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.65 -0.656 . . . . 0.0 110.919 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 54' ' ' VAL . 14.1 mttt -42.67 -46.56 5.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -0.826 . . . . 0.0 109.955 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.463 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -58.78 -53.06 62.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.325 -0.86 . . . . 0.0 110.025 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -55.4 -41.85 73.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.862 . . . . 0.0 109.701 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.536 HG23 ' CD1' ' A' ' 8' ' ' ILE . 21.9 mt -57.63 -31.44 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.182 -0.949 . . . . 0.0 108.87 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.516 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 15.7 tttp -63.27 -45.35 91.9 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.368 -0.832 . . . . 0.0 109.864 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.453 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.3 m-80 -71.22 -34.36 70.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.688 -0.633 . . . . 0.0 111.412 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.56 -50.73 72.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.768 -1.208 . . . . 0.0 110.6 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.537 HG13 ' CE2' ' A' ' 47' ' ' PHE . 2.9 m -71.05 -34.19 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.838 -1.163 . . . . 0.0 109.582 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -64.88 -38.06 89.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.28 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -79.22 -33.43 43.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.516 -0.74 . . . . 0.0 109.72 179.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.12 -62.42 1.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.39 -0.819 . . . . 0.0 110.72 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.563 ' CG ' HG23 ' A' ' 89' ' ' ILE . 21.8 m-85 -71.69 -21.45 61.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.415 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 7.4 mttt 60.64 46.89 8.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 0.0 110.272 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -123.19 -162.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.472 -0.768 . . . . 0.0 110.163 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 2.2 tmtm? -118.16 111.41 18.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.411 -0.805 . . . . 0.0 109.845 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.516 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 64.9 t -78.74 119.53 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.579 HG12 ' CA ' ' A' ' 83' ' ' VAL . 12.1 p -107.81 7.54 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.984 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER 169.25 117.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.814 . . . . 0.0 110.07 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.574 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -119.01 117.25 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.948 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 80' ' ' ILE . 2.5 m120 -116.27 116.11 27.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.285 -0.884 . . . . 0.0 109.523 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.547 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -114.82 139.76 49.48 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.356 -0.84 . . . . 0.0 109.809 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 58' ' ' HIS . 1.4 pp -125.36 167.81 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.646 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.446 ' O ' HD12 ' A' ' 57' ' ' LEU . 23.7 t-160 -72.95 128.23 34.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.465 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.566 HG12 ' CZ3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.54 ' CG ' ' HB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.126 0.489 . . . . 0.0 110.308 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.529 ' O ' ' CG1' ' A' ' 30' ' ' VAL . 20.9 tttt -123.21 135.06 54.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 109.398 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 56' ' ' THR . 5.2 ttpp -101.36 150.59 22.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.08 -1.012 . . . . 0.0 109.926 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -132.53 130.88 40.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.099 -1.001 . . . . 0.0 112.626 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.599 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -111.93 111.86 37.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.574 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 20.2 t -108.65 130.35 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.312 -0.868 . . . . 0.0 111.189 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.52 ' HG3' ' N ' ' A' ' 83' ' ' VAL . 3.1 tp60 -105.88 148.18 27.89 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.321 -0.862 . . . . 0.0 108.706 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.579 ' CA ' HG12 ' A' ' 52' ' ' VAL . 1.2 m -114.74 156.88 15.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.696 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.493 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -69.13 178.34 0.95 Allowed Pre-proline 0 C--N 1.291 -1.972 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.026 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 44.3 Cg_endo -74.16 139.36 26.54 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 O-C-N 124.23 1.648 . . . . 0.0 110.552 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.94 -40.17 2.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.482 ' OE1' ' HB2' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -96.44 -179.51 4.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.107 -1.231 . . . . 0.0 110.718 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 90' ' ' GLU . 5.6 ptmt 179.39 90.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 110.266 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.63 ' CD1' ' CE2' ' A' ' 26' ' ' TYR . 15.5 mt -46.28 97.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.076 -1.015 . . . . 0.0 109.821 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -58.26 -13.6 5.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.402 -0.811 . . . . 0.0 111.125 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.518 ' CB ' HD22 ' A' ' 92' ' ' LEU . . . -54.99 -36.7 65.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.052 -1.03 . . . . 0.0 110.823 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.599 ' CD1' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.8 -23.07 12.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.936 -1.103 . . . . 0.0 109.921 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 7.5 mm-40 -54.79 -40.1 69.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 110.409 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.81 -6.65 67.2 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 1.3 mp -63.47 -28.72 70.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -1.163 . . . . 0.0 110.126 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.557 HD12 ' CD1' ' A' ' 18' ' ' TYR . 17.4 mm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.16 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.541 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 60.8 t . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.847 0.356 . . . . 0.0 111.657 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.608 HG23 ' CD2' ' A' ' 28' ' ' PHE . 17.1 mt -81.6 93.8 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.775 -1.203 . . . . 0.0 112.118 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 29' ' ' TRP . 39.4 mt -70.06 -106.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.365 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' TRP . . . -108.51 162.92 18.23 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.786 -1.196 . . . . 0.0 110.769 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -75.05 166.56 28.89 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.0 1.527 . . . . 0.0 110.545 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.584 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.5 m -115.25 137.95 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.565 HD13 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -102.8 113.03 26.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 110.294 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.468 ' OG ' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -152.54 146.64 25.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 110.103 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -42.72 -60.41 1.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 110.283 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -54.63 -42.22 70.95 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 110.371 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.542 ' N ' ' CG ' ' A' ' 16' ' ' LYS . . . -63.11 -60.01 4.01 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 1.3 m-85 -48.69 -36.24 15.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 0.0 110.106 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.37 -8.66 50.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.049 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.57 -34.77 4.02 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -79.06 -20.77 48.01 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.569 -0.959 . . . . 0.0 108.801 179.107 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.33 -21.45 5.71 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.705 -0.622 . . . . 0.0 110.819 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.91 17.19 5.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.35 -0.844 . . . . 0.0 110.48 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.72 -1.2 68.33 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.527 ' HD3' ' CG2' ' A' ' 80' ' ' ILE . 5.3 mttt -82.15 142.43 32.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.496 -1.002 . . . . 0.0 109.229 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 89' ' ' ILE . 21.3 m-85 -128.01 113.09 15.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.611 -1.306 . . . . 0.0 111.743 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 9.2 m -84.25 122.35 28.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.608 ' CD2' HG23 ' A' ' 8' ' ' ILE . 19.8 m-85 -116.8 165.33 13.43 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.562 -0.712 . . . . 0.0 110.991 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.584 ' CD1' HG12 ' A' ' 12' ' ' VAL . 22.8 m95 -99.74 123.1 43.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 177.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 1.4 p -144.22 156.28 15.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 117.407 -1.717 . . . . 0.0 112.463 -176.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.589 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -62.64 151.45 83.93 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.832 -179.359 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.3 Cg_endo -72.13 69.19 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.001 1.527 . . . . 0.0 109.478 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.77 -32.49 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.483 -0.761 . . . . 0.0 109.774 -178.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.524 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -40.29 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.758 -0.589 . . . . 0.0 109.897 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -42.87 137.45 2.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.087 -1.008 . . . . 0.0 110.533 -179.132 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.512 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -42.21 -39.18 1.97 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 0.0 109.737 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 14.3 m -74.79 -33.99 62.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.678 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -60.4 -43.96 96.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.385 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.557 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 10.2 mt -57.36 -30.33 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 37' ' ' THR . 30.0 tttt -66.51 -44.53 82.28 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.518 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.478 ' O ' ' HB ' ' A' ' 45' ' ' THR . 1.7 m-80 -73.35 -45.35 55.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.707 -0.621 . . . . 0.0 112.037 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.492 ' HB2' HD12 ' A' ' 8' ' ' ILE . . . -58.36 -51.82 68.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.583 -1.323 . . . . 0.0 110.462 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.56 HG21 ' CE2' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -61.3 -47.38 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 110.296 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -58.33 -43.26 88.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.066 -1.021 . . . . 0.0 109.536 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -73.76 -13.57 60.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.521 -0.737 . . . . 0.0 109.737 179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.61 -69.03 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.393 -0.817 . . . . 0.0 110.351 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.54 ' CD1' HG23 ' A' ' 89' ' ' ILE . 17.1 m-85 -71.99 -21.56 61.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.893 . . . . 0.0 110.11 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.3 mttt 62.72 43.12 7.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.406 -0.809 . . . . 0.0 109.934 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -113.65 -159.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.635 -0.666 . . . . 0.0 109.952 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.567 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.16 105.06 11.41 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 109.946 179.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.424 HG13 HG23 ' A' ' 54' ' ' VAL . 21.5 t -78.67 119.61 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.898 . . . . 0.0 109.783 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.575 HG13 ' CA ' ' A' ' 83' ' ' VAL . 14.6 p -113.27 11.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 110.244 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 4.1 mttt 169.47 119.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.035 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.566 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 1.1 t -123.62 116.71 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 110.101 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.512 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -119.8 115.86 24.71 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.36 -0.838 . . . . 0.0 109.203 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -117.16 150.2 39.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.973 . . . . 0.0 110.043 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.532 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -148.42 149.0 30.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 110.1 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.481 ' NE2' ' HB3' ' A' ' 32' ' ' PRO . 1.1 m80 -66.63 127.31 31.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.176 -0.953 . . . . 0.0 110.58 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.52 HG22 ' CZ3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.689 -0.632 . . . . 0.0 110.225 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.529 ' CG ' ' CZ3' ' A' ' 29' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.189 0.518 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.498 ' NZ ' ' OG1' ' A' ' 56' ' ' THR . 8.8 tttp -123.22 125.88 45.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.512 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 5.2 ptpt -101.73 151.51 21.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 109.471 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.82 120.29 28.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.895 -1.128 . . . . 0.0 112.592 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.617 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -96.19 112.53 28.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 40.7 t -113.09 126.34 70.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.378 -0.826 . . . . 0.0 110.661 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.488 ' O ' HG13 ' A' ' 52' ' ' VAL . 34.1 tp60 -102.19 151.41 22.23 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.08 -1.013 . . . . 0.0 108.888 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.575 ' CA ' HG13 ' A' ' 52' ' ' VAL . 1.1 m -118.82 157.04 20.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 118.451 -1.3 . . . . 0.0 109.647 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.511 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -69.29 178.83 0.84 Allowed Pre-proline 0 C--N 1.29 -1.986 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.302 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.3 140.81 31.12 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 O-C-N 124.343 1.707 . . . . 0.0 110.438 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.22 -32.47 6.82 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.491 ' OE1' ' CB ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.94 173.41 6.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -1.155 . . . . 0.0 110.49 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 90' ' ' GLU . 1.1 pttp 178.8 110.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.463 -0.773 . . . . 0.0 110.364 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 13.1 mt -63.44 77.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 109.698 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.83 -14.1 0.88 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.473 -0.767 . . . . 0.0 111.465 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.431 ' HB3' HD21 ' A' ' 92' ' ' LEU . . . -54.49 -21.01 8.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.913 -1.117 . . . . 0.0 110.999 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.84 -24.19 12.14 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.926 -1.109 . . . . 0.0 110.165 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 93' ' ' GLU . 8.4 mp0 -54.04 -26.86 28.78 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.275 -0.89 . . . . 0.0 110.237 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.42 -15.79 31.37 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.462 ' HB3' ' OH ' ' A' ' 18' ' ' TYR . 1.0 OUTLIER -53.36 -31.81 46.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -1.115 . . . . 0.0 110.118 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.564 HG13 ' CE1' ' A' ' 18' ' ' TYR . 71.8 mt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.138 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.492 ' C ' HG21 ' A' ' 30' ' ' VAL . 2.8 t . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.157 0.503 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.539 ' CD1' HG22 ' A' ' 39' ' ' ILE . 3.5 mt -50.56 149.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.192 -0.942 . . . . 0.0 109.626 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -143.01 -92.75 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.138 -0.976 . . . . 0.0 110.572 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.67 138.15 21.42 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 46.4 Cg_endo -74.18 173.51 14.02 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.011 1.532 . . . . 0.0 110.11 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.578 ' CG1' ' NE1' ' A' ' 29' ' ' TRP . 1.4 m -105.34 129.21 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.234 -0.916 . . . . 0.0 110.17 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.1 mm? -103.37 107.14 17.85 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.241 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -158.87 148.64 19.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.014 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.45 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 13.6 mm-40 -43.25 -52.83 5.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.33 -0.856 . . . . 0.0 109.98 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.6 -41.42 69.92 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.157 -0.964 . . . . 0.0 110.006 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -73.25 -61.77 1.7 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.571 ' CZ ' HD11 ' A' ' 13' ' ' LEU . 1.4 m-85 -46.73 -32.93 3.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.949 . . . . 0.0 110.197 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 15' ' ' GLU . . . -90.39 -8.76 49.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 0.0 110.02 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.438 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -106.63 -38.17 2.27 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.13 -19.0 61.22 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.582 -0.952 . . . . 0.0 108.938 179.112 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -22.08 22.86 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.588 -0.695 . . . . 0.0 110.364 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -88.75 17.01 5.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 110.074 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.426 ' C ' ' OE1' ' A' ' 82' ' ' GLN . . . 91.37 3.74 69.06 Favored Glycine 0 N--CA 1.48 1.59 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 41.2 mttt -82.67 139.68 33.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -1.044 . . . . 0.0 109.48 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.59 ' CZ ' ' HB ' ' A' ' 89' ' ' ILE . 21.4 m-85 -127.64 100.1 5.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.67 -1.269 . . . . 0.0 111.481 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 17.7 m -80.64 116.2 20.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' CZ ' ' CZ ' ' A' ' 47' ' ' PHE . 3.5 m-85 -119.24 163.22 17.43 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 109.992 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.578 ' NE1' ' CG1' ' A' ' 12' ' ' VAL . 97.2 m95 -98.9 122.08 41.68 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.492 HG21 ' C ' ' A' ' 7' ' ' VAL . 9.8 p -131.17 165.31 31.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 118.493 -1.283 . . . . 0.0 112.193 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.434 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -60.29 147.65 81.22 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.067 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.79 70.96 3.43 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.22 1.642 . . . . 0.0 109.93 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.94 -33.19 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.368 -0.833 . . . . 0.0 110.076 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HB3' HG13 ' A' ' 39' ' ' ILE . . . -53.39 108.44 0.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.382 -0.824 . . . . 0.0 110.363 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 36.3 p -60.0 -170.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 110.153 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -77.33 -43.67 32.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.918 . . . . 0.0 110.336 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.3 m -71.56 -43.78 65.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.74 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 9.2 mt-10 -55.59 -46.21 77.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.361 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.539 HG22 ' CD1' ' A' ' 8' ' ' ILE . 27.1 mt -56.77 -30.4 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.911 . . . . 0.0 109.942 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 27.2 tttm -60.01 -44.69 94.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 111.664 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.45 ' O ' HG21 ' A' ' 45' ' ' THR . 54.9 m-80 -58.23 -36.55 73.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.302 -0.874 . . . . 0.0 112.685 -177.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.41 ' HB1' HD13 ' A' ' 8' ' ' ILE . . . -73.23 -50.2 23.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.658 -1.276 . . . . 0.0 111.965 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.561 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -67.01 -43.02 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.791 -1.193 . . . . 0.0 110.748 -179.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.7 -42.1 78.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.929 -1.107 . . . . 0.0 110.149 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 41' ' ' ASN . 33.6 p -79.21 -46.68 17.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 0.0 109.98 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.2 -67.81 0.38 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.827 . . . . 0.0 110.494 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.617 ' CZ ' ' CZ ' ' A' ' 28' ' ' PHE . 90.5 m-85 -72.14 -3.84 25.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.89 . . . . 0.0 110.455 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 3.0 mtpp 43.35 42.81 3.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.455 -0.778 . . . . 0.0 110.347 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -112.39 -166.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.53 -0.731 . . . . 0.0 109.681 179.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.558 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -109.31 109.19 20.03 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.286 178.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.53 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 22.7 t -77.34 119.64 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.161 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 84' ' ' ALA . 6.2 t -111.79 -6.81 11.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.493 0.663 . . . . 0.0 110.667 -178.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.506 ' CG ' ' HB3' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 175.87 135.97 0.05 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.526 -0.734 . . . . 0.0 109.069 179.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.524 HG22 ' CG1' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -132.38 118.49 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 1.7 m120 -117.33 115.94 26.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.294 -0.878 . . . . 0.0 109.574 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.1 151.08 36.3 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.528 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 1.2 pp -147.79 143.01 27.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 110.323 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -67.26 127.2 31.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.54 HG22 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.508 -0.745 . . . . 0.0 110.032 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.536 ' CG ' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.236 0.541 . . . . 0.0 110.104 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.485 ' CE ' HD11 ' A' ' 39' ' ' ILE . 9.2 tttt -123.29 127.41 48.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.925 . . . . 0.0 110.387 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 13.7 ptpt -102.71 151.11 22.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.038 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -122.88 125.9 46.27 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.023 -1.048 . . . . 0.0 112.258 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -100.77 111.88 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.612 -0.68 . . . . 0.0 109.204 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.524 ' CG1' HG22 ' A' ' 54' ' ' VAL . 1.6 t -100.01 144.56 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.356 -0.84 . . . . 0.0 110.35 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.506 ' HB3' ' CG ' ' A' ' 53' ' ' LYS . 42.6 tp60 -124.52 147.94 48.07 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.129 -0.982 . . . . 0.0 109.486 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -125.17 156.5 34.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.219 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.536 ' N ' HG22 ' A' ' 52' ' ' VAL . . . -43.83 173.23 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 CA-C-O 121.216 0.532 . . . . 0.0 111.194 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 84' ' ' ALA . 44.4 Cg_endo -76.11 54.42 4.16 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 O-C-N 124.347 1.709 . . . . 0.0 110.459 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -169.22 -50.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.537 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 5.2 mp0 -50.86 179.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 110.314 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER 179.53 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.889 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 6.9 mt -64.54 77.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.057 -1.027 . . . . 0.0 109.207 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 88' ' ' LYS . 14.0 pt-20 -53.67 -14.36 0.87 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.384 -0.823 . . . . 0.0 111.263 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -54.43 -22.2 11.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.913 -1.117 . . . . 0.0 110.295 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -106.24 -23.27 12.61 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.219 -0.926 . . . . 0.0 109.629 179.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 90' ' ' GLU . 5.3 mm-40 -61.29 -52.21 65.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.456 -0.778 . . . . 0.0 110.459 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.6 4.57 83.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 18.6 tp -75.13 -17.34 60.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 110.226 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.564 HG12 ' CZ ' ' A' ' 18' ' ' TYR . 52.3 mt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.208 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.454 HG12 HG21 ' A' ' 30' ' ' VAL . 4.7 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.58 HG21 ' CD2' ' A' ' 28' ' ' PHE . 4.9 mt -61.34 151.86 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 121.127 -0.983 . . . . 0.0 110.004 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 mt -133.69 -99.74 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 110.367 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.83 155.42 40.76 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 110.344 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HG3' ' CD2' ' A' ' 92' ' ' LEU . 47.2 Cg_endo -73.92 155.52 48.25 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.036 1.545 . . . . 0.0 110.113 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.519 HG13 ' CE ' ' A' ' 78' ' ' LYS . 2.7 m -99.58 141.25 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.264 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.3 mm? -102.78 110.51 22.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -162.62 142.29 9.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.901 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.3 mm-40 -42.64 -47.16 5.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 110.106 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -54.81 -48.5 72.7 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.205 -0.934 . . . . 0.0 110.129 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -65.93 -62.45 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.123 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.616 ' CZ ' ' CG1' ' A' ' 96' ' ' ILE . 1.1 m-85 -45.95 -31.45 2.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.87 . . . . 0.0 110.375 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.42 -8.67 49.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.05 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.54 -37.17 1.95 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.53 -19.95 60.78 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 108.953 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.94 -21.31 11.28 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.427 0.632 . . . . 0.0 110.392 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -92.31 16.45 11.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.31 -0.868 . . . . 0.0 110.261 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.91 2.99 64.29 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HG3' ' NE2' ' A' ' 82' ' ' GLN . 17.5 mttm -82.58 142.18 31.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -1.133 . . . . 0.0 109.488 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.618 ' CE2' ' CD1' ' A' ' 89' ' ' ILE . 22.8 m-85 -127.62 103.95 7.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.707 -1.246 . . . . 0.0 111.461 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 4.3 m -76.76 126.78 31.56 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.455 0.645 . . . . 0.0 109.451 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.582 ' CE2' HG22 ' A' ' 43' ' ' VAL . 15.2 m-85 -125.95 164.67 20.28 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.48 -0.762 . . . . 0.0 110.861 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.63 ' CZ3' ' CD ' ' A' ' 76' ' ' ARG . 18.6 m95 -97.74 122.14 40.48 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 77' ' ' LYS . 9.8 p -146.06 166.72 8.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 118.816 -1.154 . . . . 0.0 111.585 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.435 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -69.6 151.86 96.45 Favored Pre-proline 0 C--N 1.297 -1.695 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.557 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.0 69.12 4.75 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.169 1.615 . . . . 0.0 109.988 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.22 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.307 -0.871 . . . . 0.0 110.039 -179.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HB3' ' CG1' ' A' ' 39' ' ' ILE . . . -41.71 101.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.506 -0.746 . . . . 0.0 110.373 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -53.27 135.94 37.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 2.6 mttp -42.21 -46.81 4.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.298 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -60.4 -53.24 59.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.551 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 17.5 mt-10 -55.72 -42.29 75.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 109.688 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.532 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 11.5 mt -57.74 -30.99 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.627 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 22.2 tttt -60.73 -45.51 93.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.623 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -64.32 -46.39 83.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.467 -0.77 . . . . 0.0 111.989 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.76 -40.6 84.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.716 -1.24 . . . . 0.0 111.092 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.582 HG22 ' CE2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -76.3 -44.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.916 -1.115 . . . . 0.0 110.367 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.2 -37.8 70.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.961 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.8 p -79.44 -45.22 19.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.969 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.22 -62.69 1.28 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.449 -0.782 . . . . 0.0 110.734 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 89' ' ' ILE . 46.3 m-85 -71.8 -21.37 61.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 0.0 110.387 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 61.82 40.91 12.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.425 -0.797 . . . . 0.0 110.371 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -118.14 -164.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.512 -0.743 . . . . 0.0 110.034 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.86 101.45 8.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.458 -0.776 . . . . 0.0 109.386 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.582 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 25.6 t -78.3 119.24 26.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.365 -0.834 . . . . 0.0 110.197 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 82' ' ' GLN . 8.1 p -102.3 -2.37 9.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.52 -0.738 . . . . 0.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.579 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.42 143.44 0.14 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.293 -0.88 . . . . 0.0 110.09 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.526 HG23 ' CG1' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -133.96 118.35 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 0.0 110.146 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.479 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 1.7 t-20 -118.85 115.97 25.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.208 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.519 ' OG1' ' CE ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -115.99 165.48 13.06 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.17 -178.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.7 150.2 28.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.797 . . . . 0.0 109.984 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -67.17 125.77 27.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.095 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.355 -0.84 . . . . 0.0 109.889 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.63 ' CD ' ' CZ3' ' A' ' 29' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.519 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 8.7 tttt -119.84 141.9 49.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 110.456 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.566 ' HE3' ' CZ2' ' A' ' 29' ' ' TRP . 2.1 tptm -101.2 146.84 26.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 109.725 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -128.23 123.53 34.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.201 -0.937 . . . . 0.0 111.382 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.632 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -106.17 113.0 41.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.462 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.526 ' CG1' HG23 ' A' ' 54' ' ' VAL . 5.9 t -104.27 133.28 48.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.479 -0.763 . . . . 0.0 110.428 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.579 ' CB ' ' CG ' ' A' ' 53' ' ' LYS . 3.1 tp60 -107.69 140.34 40.88 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.094 -1.004 . . . . 0.0 108.559 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -109.15 155.48 10.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 117.71 -1.596 . . . . 0.0 108.991 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.493 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -52.84 177.87 0.07 OUTLIER Pre-proline 0 C--N 1.289 -2.059 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.383 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -73.1 144.17 37.24 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 O-C-N 124.374 1.723 . . . . 0.0 110.544 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.04 -26.15 14.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 84' ' ' ALA . 29.8 mt-30 -83.32 169.85 15.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -1.157 . . . . 0.0 110.467 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.468 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER 179.71 129.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.302 -0.874 . . . . 0.0 110.476 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.618 ' CD1' ' CE2' ' A' ' 26' ' ' TYR . 6.5 mt -91.16 116.04 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 109.958 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 10.9 pt-20 -78.05 -14.7 59.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.55 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.482 ' CB ' HD21 ' A' ' 92' ' ' LEU . . . -55.82 -29.14 59.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -0.914 . . . . 0.0 110.922 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.582 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -106.04 -23.3 12.67 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.014 -1.054 . . . . 0.0 110.131 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.2 mm-40 -62.6 -39.13 92.78 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.271 -0.893 . . . . 0.0 110.429 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.25 -13.77 59.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -56.8 -17.26 8.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -1.171 . . . . 0.0 110.17 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.616 ' CG1' ' CZ ' ' A' ' 18' ' ' TYR . 61.0 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.184 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.549 ' CG1' HG13 ' A' ' 8' ' ' ILE . 58.6 t . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.077 0.465 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.674 ' CG2' ' CD1' ' A' ' 28' ' ' PHE . 21.4 mt -77.78 82.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 120.96 -1.087 . . . . 0.0 110.854 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.27 -94.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.48 -0.762 . . . . 0.0 111.064 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.21 155.96 39.28 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 0.0 110.985 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 49.5 Cg_endo -76.86 158.37 34.9 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.248 1.657 . . . . 0.0 110.449 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.586 ' HB ' ' CD1' ' A' ' 29' ' ' TRP . 1.6 p -115.15 109.39 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.055 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.582 ' HB3' ' CE2' ' A' ' 18' ' ' TYR . 2.6 mm? -102.06 107.2 18.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 110.446 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -154.25 160.6 41.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.864 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 10.1 pt-20 -40.54 -36.89 0.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 110.291 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -27.83 42.67 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.331 -0.856 . . . . 0.0 110.388 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.0 11.02 37.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.223 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 13' ' ' LEU . 1.5 m-85 -120.93 -33.6 3.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.211 -0.931 . . . . 0.0 109.927 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.19 -8.59 50.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -0.842 . . . . 0.0 109.506 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -110.79 -33.11 2.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -76.38 -17.94 59.12 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.641 -0.917 . . . . 0.0 108.935 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.621 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -59.66 -18.68 43.92 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.717 -0.614 . . . . 0.0 110.499 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.3 17.62 5.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.464 -0.772 . . . . 0.0 109.855 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 92.82 -0.05 69.45 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 18.8 mttt -82.56 143.27 31.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.578 -0.954 . . . . 0.0 109.532 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 89' ' ' ILE . 60.7 m-85 -128.27 101.52 6.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.743 -1.223 . . . . 0.0 111.376 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 4.3 m -74.84 132.28 41.4 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CD1' ' CG2' ' A' ' 8' ' ' ILE . 2.8 m-85 -136.99 164.2 28.92 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.632 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.586 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 68.7 m95 -101.09 122.62 43.91 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 2.8 p -141.4 156.45 21.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 C-N-CA 118.181 -1.408 . . . . 0.0 111.863 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.58 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 2.9 t60 -63.93 151.26 89.87 Favored Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.891 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 47.2 Cg_endo -73.82 72.11 3.94 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.166 1.614 . . . . 0.0 109.961 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.35 -32.0 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.524 -0.735 . . . . 0.0 109.552 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.543 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -47.4 90.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.568 -0.707 . . . . 0.0 109.659 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -41.73 142.04 0.71 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.144 -0.973 . . . . 0.0 110.453 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.509 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -43.58 -42.77 5.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.632 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.495 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 8.7 m -71.13 -26.72 63.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.388 -0.82 . . . . 0.0 109.727 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.4 OUTLIER -66.65 -46.41 75.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.212 179.431 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.512 ' CD1' HG21 ' A' ' 56' ' ' THR . 16.6 mt -57.5 -30.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.507 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 4.3 tttt -62.87 -47.34 83.74 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.501 -0.749 . . . . 0.0 110.007 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.488 ' O ' ' HB ' ' A' ' 45' ' ' THR . 29.5 m-20 -73.01 -35.02 66.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.704 -0.622 . . . . 0.0 111.688 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -58.39 -52.77 64.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.649 -1.282 . . . . 0.0 110.361 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 47' ' ' PHE . 2.7 m -68.37 -36.61 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.673 -1.267 . . . . 0.0 110.45 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.462 ' HG2' HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -65.13 -41.37 94.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.989 -1.07 . . . . 0.0 109.775 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -79.27 -12.91 59.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.936 179.456 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -110.82 -59.47 1.95 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.324 -0.86 . . . . 0.0 110.62 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.567 ' CG ' HG23 ' A' ' 89' ' ' ILE . 10.2 m-85 -71.7 -20.91 61.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.475 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 mttt 63.24 43.01 6.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -118.21 -161.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.638 -0.664 . . . . 0.0 109.831 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.555 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -116.91 109.18 16.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.398 -0.814 . . . . 0.0 109.516 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.507 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 55.4 t -77.32 122.37 31.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.166 -0.959 . . . . 0.0 109.194 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 84' ' ' ALA . 30.1 t -114.94 -11.92 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.496 -0.753 . . . . 0.0 110.881 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -176.35 117.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.118 179.353 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.543 HG23 ' CG1' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -115.73 125.31 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 110.057 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 80' ' ' ILE . 15.8 t-20 -126.81 115.97 20.17 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 109.418 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.22 153.49 31.77 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.93 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -139.42 169.03 18.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.112 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.79 125.75 35.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 110.357 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.582 HG23 ' CZ3' ' A' ' 29' ' ' TRP . 2.4 m . . . . . 0 C--N 1.3 -1.554 0 O-C-N 121.709 -0.62 . . . . 0.0 110.048 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.485 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.273 0.558 . . . . 0.0 110.371 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.514 ' NZ ' ' OG1' ' A' ' 56' ' ' THR . 0.0 OUTLIER -123.5 142.45 51.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.36 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 56' ' ' THR . 13.6 mtpt -100.41 150.97 22.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.419 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -123.25 129.96 52.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.024 -1.048 . . . . 0.0 112.167 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.607 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -109.65 111.35 35.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.201 178.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.543 ' CG1' HG23 ' A' ' 54' ' ' VAL . 3.2 t -100.79 143.9 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.421 -0.799 . . . . 0.0 110.19 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' LYS . 9.2 tp60 -122.54 147.1 46.78 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.354 -0.841 . . . . 0.0 109.39 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.492 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.3 m -125.01 156.8 33.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.178 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 52' ' ' VAL . . . -45.17 175.81 0.03 OUTLIER Pre-proline 0 C--N 1.296 -1.726 0 CA-C-O 121.292 0.568 . . . . 0.0 110.916 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.8 Cg_endo -74.1 142.67 31.25 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 O-C-N 124.221 1.642 . . . . 0.0 110.542 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.82 -15.74 45.77 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.527 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 57.4 mt-30 -93.7 165.05 12.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -1.219 . . . . 0.0 110.629 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 8.2 ptmt 179.63 102.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.47 -0.769 . . . . 0.0 110.241 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 54.8 mt -42.18 98.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 110.189 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.73 -28.47 34.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.089 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . . . -55.8 -23.69 31.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.197 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.525 ' CD2' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -107.73 -23.03 12.25 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.875 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.4 ' OE2' ' CZ ' ' A' ' 21' ' ' PHE . 6.2 mm-40 -84.11 1.72 42.82 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 118.055 -1.458 . . . . 0.0 110.247 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.21 -16.85 8.06 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.46 ' O ' ' OXT' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -60.19 -26.98 66.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.431 -1.041 . . . . 0.0 110.047 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.46 ' OXT' ' O ' ' A' ' 95' ' ' LEU . 10.1 mt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.238 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.588 HG21 ' CD2' ' A' ' 28' ' ' PHE . 2.2 mp -49.94 155.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.362 -0.837 . . . . 0.0 110.519 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.0 mt -139.93 -96.73 0.16 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.179 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.37 140.31 21.62 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.082 -1.011 . . . . 0.0 110.255 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HG3' HD22 ' A' ' 92' ' ' LEU . 45.7 Cg_endo -73.54 162.55 39.67 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.003 1.528 . . . . 0.0 110.204 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.525 HG11 ' NE1' ' A' ' 29' ' ' TRP . 2.5 m -98.35 140.59 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.91 . . . . 0.0 110.335 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.583 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.0 mm? -102.76 113.2 26.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 15' ' ' GLU . 3.7 m -170.67 143.88 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 109.952 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.1 mt-10 -42.74 -49.34 5.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.119 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.6 -17.9 3.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.256 -0.903 . . . . 0.0 110.318 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -106.6 -49.8 3.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.583 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.3 m-85 -56.25 -53.52 56.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.828 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.79 -12.37 34.95 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.185 -0.947 . . . . 0.0 109.209 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -90.86 -48.64 3.33 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 9.4 m-30 -46.83 -27.66 1.3 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.347 -1.09 . . . . 0.0 108.151 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -40.18 -28.14 0.05 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.476 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.552 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 3.5 pm0 -104.62 17.07 24.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.343 -0.848 . . . . 0.0 111.471 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 87.32 7.22 76.82 Favored Glycine 0 N--CA 1.486 1.975 0 O-C-N 120.965 -1.084 . . . . 0.0 110.543 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.559 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 3.2 mptp? -84.94 134.97 34.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -1.195 . . . . 0.0 110.241 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.587 ' CZ ' ' HB ' ' A' ' 89' ' ' ILE . 86.3 m-85 -126.94 110.44 13.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.718 -1.239 . . . . 0.0 111.544 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.4 m -76.0 135.76 39.99 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 121.466 0.65 . . . . 0.0 109.674 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.588 ' CD2' HG21 ' A' ' 8' ' ' ILE . 21.3 m-85 -129.58 165.23 22.14 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.588 -0.695 . . . . 0.0 110.703 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.525 ' NE1' HG11 ' A' ' 12' ' ' VAL . 19.9 m95 -104.43 122.49 45.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.0 p -151.17 165.21 2.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 118.472 -1.291 . . . . 0.0 111.51 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.466 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -59.04 149.42 66.71 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.773 -0.579 . . . . 0.0 110.791 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 47.9 Cg_endo -73.33 69.97 4.01 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.26 1.663 . . . . 0.0 109.88 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.26 -33.71 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 110.273 -178.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -42.11 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.414 -0.804 . . . . 0.0 110.307 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -47.62 142.63 4.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.209 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 12.5 mttt -49.75 -44.59 48.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.308 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -64.75 -49.75 69.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.981 . . . . 0.0 110.545 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.458 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.7 OUTLIER -55.29 -41.93 72.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 0.0 109.73 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.559 ' CA ' HD11 ' A' ' 8' ' ' ILE . 10.1 mt -57.42 -30.8 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.396 -0.815 . . . . 0.0 109.817 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.52 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.6 tttt -60.75 -46.18 91.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.0 111.025 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -58.97 -34.87 72.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 112.415 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.1 -50.28 42.41 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.588 -1.32 . . . . 0.0 111.715 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.523 HG12 ' CE2' ' A' ' 28' ' ' PHE . 15.1 m -68.54 -27.32 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.51 -1.369 . . . . 0.0 110.36 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.503 ' CG ' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -56.43 -53.0 62.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.939 -1.101 . . . . 0.0 109.237 179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.3 p -80.54 -45.11 17.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 109.884 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.61 -63.09 1.31 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 110.848 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.632 ' CD1' ' CG2' ' A' ' 89' ' ' ILE . 35.2 m-85 -71.51 -21.16 61.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.131 -0.98 . . . . 0.0 109.807 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 71.26 50.85 0.28 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.499 -0.751 . . . . 0.0 110.108 179.602 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.554 ' CG2' ' N ' ' A' ' 50' ' ' LYS . 1.5 p -149.3 171.99 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.541 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.554 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -89.97 110.57 21.53 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.534 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.52 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 22.0 t -77.87 138.49 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.786 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.53 ' CG1' ' OE1' ' A' ' 82' ' ' GLN . 11.3 p -110.28 -29.34 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.226 -0.921 . . . . 0.0 110.842 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' HG3' ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -159.12 149.63 19.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.987 -1.07 . . . . 0.0 110.467 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.532 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.4 t -133.0 117.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 110.121 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.508 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.6 m-20 -116.86 114.69 24.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.2 -0.937 . . . . 0.0 109.157 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -119.66 150.66 39.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.99 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 3.0 pp -140.61 170.34 15.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.57 120.98 32.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.33 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.4 -0.813 . . . . 0.0 109.938 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.132 0.492 . . . . 0.0 110.146 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.469 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 8.7 pttt -123.05 141.92 51.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.294 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 3.9 ptpt -100.85 149.18 24.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.671 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -116.89 123.67 47.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.03 -1.044 . . . . 0.0 112.585 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.623 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.7 mp -101.98 111.45 31.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.572 HG21 ' CE2' ' A' ' 28' ' ' PHE . 89.0 t -108.99 133.96 52.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.254 -0.904 . . . . 0.0 110.861 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.554 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 2.7 tm0? -103.22 153.45 20.36 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.332 -0.855 . . . . 0.0 109.345 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 3.7 m -109.39 157.18 9.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 C-N-CA 118.799 -1.16 . . . . 0.0 108.419 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.533 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -70.87 179.97 0.8 Allowed Pre-proline 0 C--N 1.283 -2.284 0 C-N-CA 119.071 -1.051 . . . . 0.0 109.988 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.0 Cg_endo -73.25 137.83 26.65 Favored 'Trans proline' 0 C--N 1.297 -2.136 0 O-C-N 124.242 1.653 . . . . 0.0 110.389 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.23 -36.65 4.26 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.527 ' OE1' ' CB ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -105.95 -178.89 3.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.239 -1.154 . . . . 0.0 110.608 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 90' ' ' GLU . 5.8 ptpt -179.86 104.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 0.0 110.056 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.632 ' CG2' ' CD1' ' A' ' 47' ' ' PHE . 71.3 mt -54.35 86.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.351 -0.843 . . . . 0.0 109.885 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 2.8 pt-20 -71.11 -12.22 61.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.443 -0.785 . . . . 0.0 110.925 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.51 ' O ' ' CD1' ' A' ' 95' ' ' LEU . . . -53.37 -27.35 23.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.992 -1.068 . . . . 0.0 110.562 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.92 -23.67 12.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.98 -1.075 . . . . 0.0 109.683 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.531 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 1.5 pp20? -66.23 -29.67 69.97 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.349 -0.941 . . . . 0.0 109.485 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.52 -22.63 28.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.51 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 0.5 OUTLIER -44.73 -25.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -1.08 . . . . 0.0 109.857 179.665 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.582 HD12 ' CG ' ' A' ' 18' ' ' TYR . 12.5 mm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.188 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.436 ' C ' HG21 ' A' ' 30' ' ' VAL . 3.2 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.349 0.595 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.655 ' CG2' ' CG ' ' A' ' 28' ' ' PHE . 4.5 mt -49.74 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.169 -0.957 . . . . 0.0 110.078 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' TRP . 0.7 OUTLIER -57.88 -106.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 110.664 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.537 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -108.13 162.88 18.33 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.877 -1.139 . . . . 0.0 110.525 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.636 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.8 Cg_endo -73.72 133.47 18.69 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.105 1.582 . . . . 0.0 110.439 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 27' ' ' THR . 2.1 p -93.91 116.78 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.89 . . . . 0.0 109.968 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.4 mm? -100.96 109.24 21.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.399 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -159.13 163.92 35.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.004 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.9 mt-10 -42.88 -52.94 4.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 110.069 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -57.63 -39.5 77.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 110.099 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.493 ' HB3' ' CB ' ' A' ' 27' ' ' THR . . . -91.33 23.72 3.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.875 . . . . 0.0 109.692 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.624 ' CZ ' ' CD1' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -125.51 -63.24 1.15 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.0 109.518 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.05 -12.06 35.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.548 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.38 -40.54 2.21 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -74.01 -29.41 61.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.57 -0.959 . . . . 0.0 108.78 179.128 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -46.13 -23.54 0.34 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.689 -0.632 . . . . 0.0 110.57 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.74 -14.71 34.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 110.508 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 132.42 -1.23 4.83 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 12.5 mmtt -81.69 147.45 29.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -1.153 . . . . 0.0 109.602 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.643 ' CE2' ' CD1' ' A' ' 89' ' ' ILE . 20.6 m-85 -127.2 106.69 9.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.91 -1.119 . . . . 0.0 111.661 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.529 ' O ' ' CG1' ' A' ' 12' ' ' VAL . 2.9 m -75.73 126.75 31.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.655 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.4 OUTLIER -135.32 164.01 28.71 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.177 -0.952 . . . . 0.0 110.46 -178.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.566 ' CZ3' ' HD3' ' A' ' 76' ' ' ARG . 23.3 m95 -101.92 122.28 43.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 13.7 p -146.24 166.49 8.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.06 -1.025 . . . . 0.0 111.488 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.494 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -71.92 169.59 15.6 Favored Pre-proline 0 C--N 1.293 -1.85 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.963 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.494 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 48.6 Cg_endo -75.41 -53.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.043 0 O-C-N 124.245 1.655 . . . . 0.0 109.643 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 31' ' ' HIS 0.256 0.0 OUTLIER -46.54 -22.45 0.28 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.874 179.027 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 102.76 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 110.306 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -67.17 143.27 56.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 110.18 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 54' ' ' VAL . 13.9 mttt -42.45 -38.61 1.96 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -68.33 -52.28 35.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.388 -0.82 . . . . 0.0 110.608 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -55.19 -43.54 74.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.529 HG23 ' CG1' ' A' ' 8' ' ' ILE . 11.4 mt -56.87 -30.3 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.112 -0.993 . . . . 0.0 109.403 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 15.1 ttpt -63.67 -47.02 82.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.461 -0.774 . . . . 0.0 111.039 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -58.73 -34.94 71.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.368 -0.832 . . . . 0.0 112.189 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . -65.34 -50.43 65.62 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.682 -1.262 . . . . 0.0 111.289 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 9.4 m -76.23 -32.22 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.614 -1.304 . . . . 0.0 110.612 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.79 -51.64 68.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.698 -1.251 . . . . 0.0 109.415 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -79.71 -46.23 17.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 110.035 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -59.16 -64.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.389 -0.819 . . . . 0.0 110.404 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.639 ' CE1' ' CB ' ' A' ' 91' ' ' ALA . 7.5 m-85 -72.03 -19.9 61.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.242 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 66.9 41.92 2.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 110.251 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -122.55 -164.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.556 -0.715 . . . . 0.0 109.931 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.575 ' CB ' ' NE2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -119.28 106.79 12.67 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 110.145 179.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.532 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 76.3 t -78.43 119.7 27.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.538 HG13 ' CA ' ' A' ' 83' ' ' VAL . 12.2 p -104.23 4.96 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.919 . . . . 0.0 110.7 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 167.77 119.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.217 -0.927 . . . . 0.0 110.504 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.533 HG23 ' CG1' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -112.16 120.01 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 109.861 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -107.66 115.22 29.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.181 -0.95 . . . . 0.0 109.047 178.623 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.53 ' OG1' ' CE ' ' A' ' 77' ' ' LYS . 2.3 p -116.68 139.07 50.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.101 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.527 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -136.38 144.1 44.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 110.264 -179.569 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -76.34 115.16 15.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.321 -0.862 . . . . 0.0 109.892 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.566 ' HD3' ' CZ3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.267 0.556 . . . . 0.0 110.214 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.53 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 1.8 tttp -117.59 134.77 54.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 109.682 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 6.7 ptpt -102.04 150.3 23.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.022 . . . . 0.0 110.798 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 28' ' ' PHE . . . -117.29 134.14 55.16 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.148 -0.97 . . . . 0.0 111.978 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -110.76 110.86 33.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.533 ' CG1' HG23 ' A' ' 54' ' ' VAL . 2.4 t -104.98 127.72 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.335 -0.853 . . . . 0.0 111.011 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.493 ' O ' HG13 ' A' ' 52' ' ' VAL . 9.9 tp60 -110.02 146.03 36.01 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.066 -1.021 . . . . 0.0 108.761 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.538 ' CA ' HG13 ' A' ' 52' ' ' VAL . 1.6 m -113.26 155.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 118.083 -1.447 . . . . 0.0 109.623 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.523 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -55.83 179.48 0.1 OUTLIER Pre-proline 0 C--N 1.29 -1.996 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.195 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.5 Cg_endo -72.27 141.51 35.76 Favored 'Trans proline' 0 C--N 1.299 -2.048 0 O-C-N 124.193 1.628 . . . . 0.0 110.55 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.57 -19.63 46.52 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.575 ' NE2' ' CB ' ' A' ' 50' ' ' LYS . 49.9 mt-30 -93.11 168.96 10.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -1.141 . . . . 0.0 110.672 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.8 OUTLIER 179.65 122.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.395 -0.815 . . . . 0.0 110.339 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 26' ' ' TYR . 15.2 mt -83.86 106.74 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.146 -0.971 . . . . 0.0 109.958 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -61.94 -13.97 30.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.368 -0.832 . . . . 0.0 110.946 -179.413 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.639 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . -55.03 -34.12 63.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.098 -1.001 . . . . 0.0 110.792 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -105.86 -23.23 12.74 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.011 -1.056 . . . . 0.0 109.592 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.457 ' O ' HG12 ' A' ' 96' ' ' ILE . 6.9 mm-40 -66.49 -37.67 85.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.344 -0.847 . . . . 0.0 109.95 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.07 -8.92 86.82 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 95' ' ' LEU . 4.8 mp -81.34 8.87 8.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -1.153 . . . . 0.0 110.091 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.624 ' CD1' ' CZ ' ' A' ' 18' ' ' TYR . 15.5 mm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.535 HG13 ' CG2' ' A' ' 30' ' ' VAL . 1.7 t . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 121.056 0.455 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.588 HG23 ' CD1' ' A' ' 28' ' ' PHE . 2.6 mm -32.83 126.05 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 121.267 0.556 . . . . 0.0 110.919 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 29' ' ' TRP . 1.3 mt -115.03 -94.54 0.48 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.85 . . . . 0.0 109.751 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.85 153.88 42.14 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.892 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HB3' HD22 ' A' ' 92' ' ' LEU . 48.4 Cg_endo -76.02 158.25 38.25 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.943 1.496 . . . . 0.0 110.314 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.562 HG13 ' CD1' ' A' ' 29' ' ' TRP . 1.4 m -103.69 129.14 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.204 -0.935 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.586 HD13 ' CZ ' ' A' ' 18' ' ' TYR . 2.9 mm? -102.84 113.01 26.09 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.111 -0.993 . . . . 0.0 110.275 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 15' ' ' GLU . 68.8 m -161.58 144.05 11.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 14' ' ' SER . 69.7 mt-10 -42.87 -51.61 5.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 110.043 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -54.86 -34.03 62.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.288 -0.882 . . . . 0.0 110.172 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -86.03 -58.5 2.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.25 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.586 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -46.13 -31.28 2.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.876 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.25 -8.75 50.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.084 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.14 -37.55 1.96 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -71.12 -18.3 62.53 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.698 -0.883 . . . . 0.0 108.843 178.968 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.621 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -58.72 -20.02 45.27 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.676 -0.64 . . . . 0.0 110.474 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -88.62 17.32 5.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.487 -0.758 . . . . 0.0 109.953 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 91.96 3.27 68.2 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 72.9 mttt -82.72 136.94 34.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.563 -0.963 . . . . 0.0 109.382 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.582 ' CD2' HD12 ' A' ' 89' ' ' ILE . 24.6 m-85 -127.95 96.9 4.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.658 -1.277 . . . . 0.0 111.538 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.8 m -75.61 117.57 17.52 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.53 -0.731 . . . . 0.0 109.695 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.679 ' CZ ' ' CZ ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -116.86 162.96 16.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 110.349 -179.663 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.64 ' CZ3' ' CG1' ' A' ' 59' ' ' VAL . 97.7 m95 -92.65 122.77 35.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.535 ' CG2' HG13 ' A' ' 7' ' ' VAL . 8.9 p -147.03 166.97 6.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.038 -177.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.433 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -60.5 141.11 92.0 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.148 179.822 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.512 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.5 Cg_endo -72.2 77.46 2.02 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 124.169 1.615 . . . . 0.0 110.278 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 178.67 -34.71 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.349 -0.844 . . . . 0.0 109.906 -179.264 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.463 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . . . -52.8 92.05 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.493 -0.754 . . . . 0.0 109.917 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -41.98 151.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.335 -0.853 . . . . 0.0 110.319 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' A' ' 54' ' ' VAL . 6.8 mmtp -42.49 -35.07 0.95 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 110.044 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.6 m -75.08 -39.75 60.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 110.096 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.68 -43.52 76.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.061 -1.024 . . . . 0.0 109.536 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.528 HG22 ' CG2' ' A' ' 54' ' ' VAL . 30.0 mt -57.99 -30.32 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.432 -0.792 . . . . 0.0 109.646 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.531 ' HG3' ' CB ' ' A' ' 51' ' ' VAL . 11.5 tttm -60.14 -47.42 85.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.556 -0.715 . . . . 0.0 111.523 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -58.22 -38.87 77.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.379 -0.826 . . . . 0.0 112.108 -178.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . -73.56 -50.87 19.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.7 -1.25 . . . . 0.0 111.818 -178.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.573 HG13 ' CE2' ' A' ' 47' ' ' PHE . 6.1 m -65.59 -44.75 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.711 -1.243 . . . . 0.0 111.054 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.514 ' CG ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -56.91 -48.15 78.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.719 -1.238 . . . . 0.0 110.103 -179.945 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 m -79.0 -47.79 15.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 0.0 110.673 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -68.49 -63.79 0.99 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 110.575 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.679 ' CZ ' ' CZ ' ' A' ' 28' ' ' PHE . 21.3 m-85 -71.72 -4.13 25.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.174 -0.954 . . . . 0.0 110.165 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 12.4 mtmt 46.79 46.15 15.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.432 -0.793 . . . . 0.0 110.25 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -118.13 -163.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.57 -0.706 . . . . 0.0 109.87 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -117.2 112.62 21.07 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.448 -0.782 . . . . 0.0 109.436 179.083 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . 17.3 t -77.67 119.53 26.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.076 -1.015 . . . . 0.0 109.337 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 84' ' ' ALA . 25.6 t -116.06 -10.7 12.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 121.685 0.755 . . . . 0.0 110.149 -178.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 82' ' ' GLN . 0.3 OUTLIER 175.39 116.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.593 -0.692 . . . . 0.0 109.581 179.371 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 1.0 OUTLIER -105.19 136.62 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.996 . . . . 0.0 109.978 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 80' ' ' ILE . 1.1 t-20 -131.39 114.86 15.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.139 -0.975 . . . . 0.0 109.722 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -108.44 150.08 27.89 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.624 -179.662 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.416 ' HG ' ' C ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -128.9 -177.14 4.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.06 -1.025 . . . . 0.0 110.514 -178.934 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.5 119.92 26.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.557 -0.714 . . . . 0.0 109.298 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.64 ' CG1' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.617 0 O-C-N 121.104 -0.998 . . . . 0.0 108.911 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.534 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.282 0.563 . . . . 0.0 110.546 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.512 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 9.3 tttt -123.13 141.13 52.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.47 -0.769 . . . . 0.0 109.604 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.573 ' HE3' ' CH2' ' A' ' 29' ' ' TRP . 6.5 tttt -101.24 134.26 44.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.003 -1.061 . . . . 0.0 109.834 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -124.79 120.35 31.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.924 . . . . 0.0 111.618 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 55' ' ' ASN . 12.0 mt -95.57 111.63 26.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.576 -0.702 . . . . 0.0 109.987 178.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 54' ' ' VAL . 2.9 t -95.41 133.52 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 23' ' ' GLU . 13.9 tp60 -112.26 144.04 42.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 109.6 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.2 m -125.32 156.79 34.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.459 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.525 ' N ' HG23 ' A' ' 52' ' ' VAL . . . -47.97 173.07 0.06 OUTLIER Pre-proline 0 C--N 1.296 -1.73 0 CA-C-O 121.29 0.567 . . . . 0.0 111.035 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -79.88 55.46 5.65 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 124.499 1.789 . . . . 0.0 110.344 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.73 -35.01 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.524 ' OE1' ' CB ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -105.79 177.83 4.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -1.185 . . . . 0.0 109.978 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 90' ' ' GLU . 6.2 ptpt 179.61 115.14 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.31 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.595 HD11 ' CD2' ' A' ' 47' ' ' PHE . 73.7 mt -44.2 94.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.994 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' LYS . 1.9 mt-10 -56.91 -14.33 3.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.384 -0.822 . . . . 0.0 110.977 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.439 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.05 -30.08 58.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 0.0 110.345 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -106.43 -23.23 12.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.176 -0.952 . . . . 0.0 109.495 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 73.7 mm-40 -56.58 -27.58 58.23 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.269 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.2 21.66 28.62 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.457 ' O ' ' OH ' ' A' ' 18' ' ' TYR . 1.4 tp -99.29 2.13 45.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -1.165 . . . . 0.0 110.152 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.235 179.97 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.551 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 98.5 t . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.599 0.714 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.599 HG22 ' CD1' ' A' ' 28' ' ' PHE 0.25 75.1 mt -85.85 104.07 13.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.125 -0.985 . . . . 0.0 110.117 -179.572 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -86.89 -94.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.688 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.498 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -108.09 152.5 41.81 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 110.449 -179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.547 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 47.0 Cg_endo -73.15 174.49 11.95 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.93 1.49 . . . . 0.0 110.197 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.563 HG11 ' CD1' ' A' ' 29' ' ' TRP . 2.5 m -114.98 138.33 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.095 -1.003 . . . . 0.0 110.338 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.576 HD13 ' CZ ' ' A' ' 18' ' ' TYR . 3.2 mm? -102.81 112.66 25.57 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 110.213 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 17' ' ' ALA . 4.1 m -163.87 141.42 7.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -42.83 -54.99 3.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 110.054 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.71 -25.09 25.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.325 -0.859 . . . . 0.0 110.075 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -87.71 -62.02 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.201 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.576 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 1.4 m-85 -46.12 -43.57 15.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.309 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.65 -8.64 57.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.987 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.458 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -105.66 -39.73 2.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -77.5 -20.78 53.76 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.51 -0.994 . . . . 0.0 108.979 179.28 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -57.03 -16.2 6.66 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.553 -0.717 . . . . 0.0 110.192 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 25' ' ' LYS . 4.7 tt0 -96.62 16.39 19.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 110.447 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.68 -2.13 60.29 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.53 ' HG3' ' NE2' ' A' ' 82' ' ' GLN . 23.0 mttt -82.74 143.36 30.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -1.123 . . . . 0.0 109.73 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.637 ' CE2' ' CD1' ' A' ' 89' ' ' ILE . 21.1 m-85 -128.03 97.19 4.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.693 -1.254 . . . . 0.0 111.608 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 8.7 m -76.95 120.68 22.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.708 ' CZ ' ' CZ ' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -120.87 163.73 17.75 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.987 -1.071 . . . . 0.0 111.677 -178.527 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.574 ' CZ3' ' HG3' ' A' ' 76' ' ' ARG . 10.2 m95 -94.4 122.77 37.32 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 178.059 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 7' ' ' VAL 0.259 3.8 p -144.4 160.36 15.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 C-N-CA 118.148 -1.421 . . . . 0.0 111.823 -176.31 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.581 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 2.3 t60 -67.3 152.73 95.85 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.612 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 47.0 Cg_endo -73.19 71.78 3.55 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.071 1.564 . . . . 0.0 109.876 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.37 -33.3 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.782 -179.051 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' HB1' HG21 ' A' ' 30' ' ' VAL . . . -41.31 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.683 -0.636 . . . . 0.0 109.919 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -45.99 137.52 5.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 0.0 110.697 -179.415 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HG3' HG13 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -43.4 -48.82 7.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.345 -0.847 . . . . 0.0 109.763 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.9 m -59.1 -50.15 75.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.728 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 2.2 mm-40 -55.07 -39.38 69.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 0.0 109.487 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.533 ' CA ' HD13 ' A' ' 8' ' ' ILE . 34.8 mt -57.61 -31.83 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.522 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.5 ttmp? -62.97 -45.98 89.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 178.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.484 ' O ' ' HB ' ' A' ' 45' ' ' THR . 32.7 m-80 -72.27 -33.73 67.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.686 -0.634 . . . . 0.0 110.914 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' O ' ' HB1' ' A' ' 46' ' ' ALA . . . -57.44 -46.17 83.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.84 -1.163 . . . . 0.0 110.494 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.643 ' CG1' ' CE2' ' A' ' 47' ' ' PHE . 6.6 m -76.12 -33.13 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.78 -1.2 . . . . 0.0 109.657 178.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.469 ' HG2' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -68.2 -42.83 79.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.119 -0.988 . . . . 0.0 109.861 179.441 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -79.07 -28.56 43.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.879 179.752 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 42' ' ' ALA . . . -95.67 -57.58 2.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 110.967 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.708 ' CZ ' ' CZ ' ' A' ' 28' ' ' PHE . 6.7 m-30 -76.52 -16.54 59.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.908 . . . . 0.0 110.569 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.4 mtpt 57.33 47.7 16.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 110.48 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -123.83 -160.22 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.526 -0.734 . . . . 0.0 110.016 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.554 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 3.8 tmtt? -117.65 105.76 12.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 45.3 t -78.93 119.72 28.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.349 -0.845 . . . . 0.0 110.613 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.575 HG13 ' CA ' ' A' ' 83' ' ' VAL . 7.4 p -107.32 -5.91 10.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.346 -0.846 . . . . 0.0 109.658 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.588 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.96 142.78 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.413 -0.804 . . . . 0.0 109.904 179.353 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.578 ' N ' ' CE ' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -133.48 130.1 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.075 -1.015 . . . . 0.0 109.849 179.698 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.499 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 1.2 t30 -131.18 115.62 16.6 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.863 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.519 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -115.32 164.78 13.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.744 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.3 172.13 15.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.201 -0.937 . . . . 0.0 110.438 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -81.71 118.82 23.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.115 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.564 ' CG2' ' N ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 O-C-N 121.282 -0.886 . . . . 0.0 110.158 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.574 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 6.4 ttm180 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.322 0.582 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.543 ' CA ' HG22 ' A' ' 59' ' ' VAL . 18.1 tttt -122.97 139.59 53.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 109.724 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.564 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 25.1 mttt -101.71 147.81 26.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 110.443 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' PHE . . . -132.89 119.54 20.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.325 -0.859 . . . . 0.0 111.216 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -99.09 112.08 30.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.359 0.6 . . . . 0.0 109.595 179.128 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.522 ' CG1' HG22 ' A' ' 54' ' ' VAL . 2.5 t -104.24 127.38 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.475 -0.765 . . . . 0.0 110.14 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.588 ' CB ' ' CG ' ' A' ' 53' ' ' LYS . 4.2 tp60 -102.54 147.47 26.72 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.027 -1.046 . . . . 0.0 109.334 179.301 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.575 ' CA ' HG13 ' A' ' 52' ' ' VAL . 1.5 m -116.35 156.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.311 -1.356 . . . . 0.0 108.891 177.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.498 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . . . -69.06 176.14 1.71 Allowed Pre-proline 0 C--N 1.287 -2.116 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.125 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 84' ' ' ALA . 43.1 Cg_endo -75.18 136.9 20.63 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 O-C-N 124.204 1.634 . . . . 0.0 110.291 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.25 -21.72 21.65 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -115.35 -179.91 3.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -1.234 . . . . 0.0 110.352 -179.988 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 0.1 OUTLIER 179.5 101.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.827 . . . . 0.0 110.149 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.637 ' CD1' ' CE2' ' A' ' 26' ' ' TYR . 48.5 mt -53.94 101.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -0.971 . . . . 0.0 110.172 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 19.4 pt-20 -60.92 -13.5 16.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.423 -0.798 . . . . 0.0 110.918 -179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 92' ' ' LEU . . . -54.69 -36.14 64.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 110.524 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.601 ' CD1' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.41 -23.11 12.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.022 -1.049 . . . . 0.0 109.8 179.762 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.8 mm-40 -52.15 -45.5 65.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.353 -0.842 . . . . 0.0 110.456 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -83.2 -23.98 53.12 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 1.1 tp -42.13 -27.19 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -1.115 . . . . 0.0 110.268 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 94' ' ' GLY . 17.3 mm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.278 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.542 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 53.7 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.992 0.425 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.62 ' CG2' ' CD2' ' A' ' 28' ' ' PHE . 11.8 mt -81.42 106.31 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.533 -1.354 . . . . 0.0 111.027 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -83.97 -105.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 110.217 179.715 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.65 151.43 41.68 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.948 -1.095 . . . . 0.0 110.415 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.43 175.69 10.68 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.045 1.55 . . . . 0.0 110.154 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.576 HG13 ' CD1' ' A' ' 29' ' ' TRP . 2.4 m -115.06 136.28 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.145 -0.972 . . . . 0.0 110.396 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.573 HD12 ' CE2' ' A' ' 18' ' ' TYR . 3.2 mm? -102.67 107.9 18.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.172 -0.955 . . . . 0.0 110.17 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -163.14 138.54 6.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.201 179.88 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -43.25 -51.07 6.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 110.141 179.908 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -18.17 4.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -103.84 -43.42 5.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.006 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.573 ' CE2' HD12 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -62.72 -39.58 94.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 179.852 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.74 -13.53 44.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.036 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.447 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -105.46 -47.73 1.1 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 178.486 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CE1' HD21 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -51.08 -24.09 3.64 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.897 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.73 -29.93 63.01 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.259 0.552 . . . . 0.0 110.674 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -88.73 16.25 7.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.273 -0.892 . . . . 0.0 110.504 -179.571 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 87.42 13.28 65.84 Favored Glycine 0 N--CA 1.482 1.712 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' CG ' ' OE1' ' A' ' 82' ' ' GLN . 11.3 mttm -82.45 146.33 29.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.183 -1.187 . . . . 0.0 109.505 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.648 ' CE2' ' CD1' ' A' ' 89' ' ' ILE . 28.7 m-85 -127.02 98.3 5.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.911 -1.118 . . . . 0.0 112.146 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.561 ' CG2' ' CD ' ' A' ' 78' ' ' LYS . 2.5 m -79.13 126.42 30.71 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 178.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.62 ' CD2' ' CG2' ' A' ' 8' ' ' ILE . 13.4 m-85 -126.58 164.93 20.13 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.28 -0.888 . . . . 0.0 111.618 -178.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.576 ' CD1' HG13 ' A' ' 12' ' ' VAL . 43.9 m95 -104.24 122.36 45.23 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 176.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 1.2 p -144.28 157.6 15.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 117.708 -1.597 . . . . 0.0 112.259 -176.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.584 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -62.13 151.75 80.15 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.952 -179.109 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.8 Cg_endo -73.67 70.03 4.28 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.211 1.637 . . . . 0.0 109.848 179.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.54 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 109.911 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -44.75 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.639 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -43.22 138.93 2.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.92 . . . . 0.0 110.544 -179.243 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.516 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -43.54 -38.08 2.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.701 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 5.6 m -70.59 -44.45 67.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.469 -0.769 . . . . 0.0 109.685 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.497 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 2.8 mm-40 -55.6 -41.16 73.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.562 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 74.7 mt -57.4 -30.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.903 . . . . 0.0 108.633 179.038 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 17.7 tttm -64.96 -44.46 89.32 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.415 -0.803 . . . . 0.0 109.404 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.479 ' O ' ' HB ' ' A' ' 45' ' ' THR . 40.3 m-80 -73.17 -43.37 61.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.696 -0.627 . . . . 0.0 111.277 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.464 ' HB2' HD11 ' A' ' 8' ' ' ILE . . . -58.23 -51.32 70.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.603 -1.311 . . . . 0.0 110.261 -179.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.602 ' CG2' ' CE2' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -63.98 -47.22 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.056 -1.028 . . . . 0.0 109.968 179.981 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -57.0 -44.88 83.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.027 -1.046 . . . . 0.0 109.41 179.497 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -78.53 -12.58 60.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.4 -0.813 . . . . 0.0 109.446 179.309 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -97.3 -71.71 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.832 . . . . 0.0 110.236 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.579 ' CD1' HG22 ' A' ' 89' ' ' ILE . 43.3 m-85 -72.1 -22.12 61.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.192 -0.942 . . . . 0.0 110.198 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 68.78 44.2 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 110.006 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.467 ' HB ' HG12 ' A' ' 89' ' ' ILE . 1.1 p -118.65 -160.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.541 -0.724 . . . . 0.0 110.383 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -118.11 104.97 11.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.423 -0.798 . . . . 0.0 109.584 179.268 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.518 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 25.1 t -78.23 119.71 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.963 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.2 p -102.98 -8.94 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 110.227 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.618 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 4.9 ptmt -175.39 131.24 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.873 179.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -123.62 127.62 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.974 -1.078 . . . . 0.0 110.332 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 80' ' ' ILE . 37.7 t30 -131.06 115.65 16.72 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.472 -0.767 . . . . 0.0 109.02 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.523 HG23 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.92 157.78 22.9 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 110.239 -179.379 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.94 171.37 14.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.786 . . . . 0.0 110.159 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 128.47 34.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.192 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.576 HG21 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.305 -0.872 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.133 0.492 . . . . 0.0 109.897 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.459 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 20.4 tttt -123.08 127.5 48.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.744 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.561 ' CD ' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -101.81 151.01 22.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.285 179.378 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -127.16 129.34 47.7 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.974 -1.078 . . . . 0.0 111.91 -179.261 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.605 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.5 mp -109.72 111.43 36.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.164 178.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 19.3 t -112.29 128.29 69.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.572 -0.705 . . . . 0.0 110.162 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.618 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 2.5 tp60 -101.55 151.27 22.17 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.037 -1.039 . . . . 0.0 109.012 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.0 m -112.57 155.84 13.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 C-N-CA 118.082 -1.447 . . . . 0.0 108.443 177.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.484 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . . . -58.01 169.98 0.8 Allowed Pre-proline 0 C--N 1.284 -2.244 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.646 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 84' ' ' ALA . 45.4 Cg_endo -79.63 53.48 4.75 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 O-C-N 124.416 1.745 . . . . 0.0 110.733 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.475 ' N ' ' OE1' ' A' ' 87' ' ' GLN . . . -168.72 23.47 0.1 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -150.31 -175.53 5.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.941 -1.329 . . . . 0.0 110.268 -179.965 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER 179.88 113.25 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.455 -0.778 . . . . 0.0 109.998 179.865 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.648 ' CD1' ' CE2' ' A' ' 26' ' ' TYR . 16.8 mt -59.92 100.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.28 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -53.95 -27.99 34.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.72 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.2 73.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.414 -0.804 . . . . 0.0 110.22 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.578 HD21 ' CE1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -107.67 1.23 22.98 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.977 -1.089 . . . . 0.0 112.079 -179.51 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -95.11 3.31 54.91 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 117.958 -1.497 . . . . 0.0 110.118 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -118.54 -17.78 5.09 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.442 ' HB3' ' OH ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -56.31 -33.75 65.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.366 -1.079 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.517 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 4.6 mt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.214 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.493 HG13 ' CG2' ' A' ' 30' ' ' VAL . 9.2 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.052 0.454 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.553 ' CG2' ' HB3' ' A' ' 28' ' ' PHE . 3.2 mt -63.08 156.42 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.224 -0.922 . . . . 0.0 110.032 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -144.61 -81.72 0.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.069 -1.019 . . . . 0.0 110.594 179.483 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.15 145.23 31.03 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.981 -1.074 . . . . 0.0 110.573 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 47.7 Cg_endo -74.53 169.8 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.037 1.546 . . . . 0.0 110.563 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.576 HG13 ' CE2' ' A' ' 29' ' ' TRP . 2.3 m -115.13 136.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.127 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.93 110.26 22.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.136 -0.978 . . . . 0.0 110.435 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -164.0 145.72 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.473 -0.767 . . . . 0.0 109.559 179.821 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 14' ' ' SER . 2.1 mm-40 -43.42 -33.48 1.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 109.986 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -28.23 66.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 110.024 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -91.96 19.36 6.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.296 -0.877 . . . . 0.0 109.807 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.564 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.7 m-85 -138.49 -41.92 0.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.54 -0.725 . . . . 0.0 109.854 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.12 79.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.177 -0.952 . . . . 0.0 108.883 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.85 -31.1 7.93 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 178.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -72.31 -10.83 60.29 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.522 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -66.84 -8.39 28.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.655 -0.653 . . . . 0.0 110.216 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -1.98 19.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 110.385 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.588 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 119.48 4.09 12.23 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 27.4 mttt -84.35 132.71 34.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -1.152 . . . . 0.0 109.772 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.649 ' CB ' ' CZ ' ' A' ' 28' ' ' PHE . 62.7 m-85 -126.94 111.15 13.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.719 -1.238 . . . . 0.0 111.79 -179.328 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 7.5 m -79.27 128.95 33.95 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.458 0.647 . . . . 0.0 109.932 179.09 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.695 ' CE1' ' CZ ' ' A' ' 47' ' ' PHE . 19.0 m-85 -124.76 164.73 19.35 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.519 -0.738 . . . . 0.0 109.879 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.637 ' CH2' ' NE ' ' A' ' 76' ' ' ARG . 4.4 m95 -95.14 122.86 38.25 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.263 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.53 HG21 ' N ' ' A' ' 8' ' ' ILE . 8.1 p -137.1 165.01 28.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.844 -177.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.492 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -61.45 145.31 91.15 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.908 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.39 70.68 2.49 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.1 1.579 . . . . 0.0 109.934 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 178.83 -32.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.413 -0.805 . . . . 0.0 110.12 -178.936 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -56.27 96.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.463 -0.773 . . . . 0.0 110.379 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.446 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 1.3 p -46.17 159.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 109.962 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.531 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 11.0 mttp -47.71 -40.22 19.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.289 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.9 m -75.28 -38.97 60.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.591 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.446 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 2.4 mt-10 -55.6 -43.88 76.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.038 -1.039 . . . . 0.0 109.944 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 13.0 mt -57.5 -30.24 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.774 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 39.8 tttm -57.6 -41.99 82.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 111.537 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -58.29 -49.53 76.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.465 -0.772 . . . . 0.0 112.397 -178.049 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.448 ' HB3' HD13 ' A' ' 8' ' ' ILE . . . -73.49 -39.18 65.06 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.711 -1.243 . . . . 0.0 111.631 -178.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.605 ' CG2' ' CE2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -62.41 -45.54 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.898 -1.126 . . . . 0.0 110.401 -179.343 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.41 -38.75 71.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.012 . . . . 0.0 109.846 -179.818 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -79.38 -45.43 19.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 109.975 179.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.64 -60.58 2.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 110.497 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.695 ' CZ ' ' CE1' ' A' ' 28' ' ' PHE . 44.4 m-85 -71.65 -21.52 61.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.957 . . . . 0.0 110.158 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 56.32 40.75 29.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 110.295 179.734 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -120.99 -165.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.519 -0.738 . . . . 0.0 109.896 179.708 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -106.66 112.17 25.04 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.23 178.812 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.53 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 19.6 t -77.59 135.68 25.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.482 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.517 HG21 ' N ' ' A' ' 84' ' ' ALA . 2.5 t -128.57 -5.87 3.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.48 -0.763 . . . . 0.0 110.573 -178.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.534 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER 170.45 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.424 -0.797 . . . . 0.0 109.118 179.498 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.522 ' CG2' HG23 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -115.47 133.04 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.332 -0.855 . . . . 0.0 110.564 -179.26 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.531 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -131.58 116.09 16.95 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.437 -0.79 . . . . 0.0 109.372 178.515 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -116.6 149.46 39.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 110.436 -179.295 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.443 ' O ' HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -130.11 143.38 50.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.477 -0.765 . . . . 0.0 109.521 179.884 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.21 112.58 7.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.018 -1.051 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.519 HG13 ' CE ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.285 -0.884 . . . . 0.0 110.089 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.637 ' NE ' ' CH2' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.283 0.563 . . . . 0.0 109.859 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.51 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 6.5 ptmt -123.3 141.79 51.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.437 -179.683 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 1.7 ptpt -101.0 151.14 22.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.361 -0.837 . . . . 0.0 109.626 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -115.61 118.77 34.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.019 -1.051 . . . . 0.0 111.992 -179.109 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.515 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 12.1 mt -94.94 110.96 24.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.528 -0.732 . . . . 0.0 109.585 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.588 HG22 ' CE2' ' A' ' 28' ' ' PHE . 6.4 t -102.09 143.22 15.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.09 -1.006 . . . . 0.0 110.458 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.534 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 29.6 tp60 -116.44 150.58 37.6 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.298 -0.876 . . . . 0.0 109.098 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.517 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.5 m -124.91 155.75 33.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 118.324 -1.351 . . . . 0.0 109.973 178.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.517 ' N ' HG21 ' A' ' 52' ' ' VAL . . . -47.76 178.34 0.03 OUTLIER Pre-proline 0 C--N 1.291 -1.969 0 O-C-N 121.839 -0.538 . . . . 0.0 110.73 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.7 Cg_endo -74.23 142.78 30.95 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.386 1.73 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.65 -40.98 2.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.521 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 6.6 mt-30 -70.18 176.88 3.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -1.199 . . . . 0.0 110.387 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 178.42 102.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.18 -179.192 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 8.3 mt -55.99 87.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.914 -1.116 . . . . 0.0 109.597 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' LYS . 11.1 pt-20 -57.99 -13.22 4.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.429 -0.795 . . . . 0.0 110.946 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.523 ' CB ' HD23 ' A' ' 92' ' ' LEU . . . -54.27 -33.53 58.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.108 -0.995 . . . . 0.0 110.777 -179.16 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.557 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.24 -23.04 12.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.927 -1.108 . . . . 0.0 109.929 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.2 mm-40 -52.9 -33.83 52.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.436 -0.79 . . . . 0.0 110.413 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.67 6.06 58.72 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 13' ' ' LEU . 1.3 tp -76.02 -25.43 55.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -1.17 . . . . 0.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.564 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 8.2 mt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.158 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.231 0.538 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.596 HG22 ' CD2' ' A' ' 28' ' ' PHE . 4.8 mt -56.02 148.0 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.02 -100.36 0.44 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 110.663 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.38 161.66 23.13 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.042 -1.037 . . . . 0.0 110.718 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.6 157.99 35.99 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.126 1.593 . . . . 0.0 110.308 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.577 ' CG1' ' NE1' ' A' ' 29' ' ' TRP . 2.4 m -100.03 140.0 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.0 110.272 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.64 113.17 26.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.95 . . . . 0.0 110.19 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 52.7 m -167.01 135.13 2.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.3 mm-40 -42.86 -47.45 5.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.92 . . . . 0.0 110.038 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -54.79 -35.92 64.36 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 19' ' ' ALA . . . -79.91 -63.71 1.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 0.0 110.183 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.614 ' CZ ' ' CG1' ' A' ' 96' ' ' ILE . 1.3 m-85 -42.87 -26.25 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 110.406 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -88.42 -35.32 17.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.691 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -83.23 -38.34 11.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 178.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.69 -15.06 60.35 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.728 -0.866 . . . . 0.0 108.882 178.871 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 18' ' ' TYR . . . -63.97 -17.15 62.99 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.485 0.66 . . . . 0.0 109.916 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.18 -2.76 52.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.412 -0.805 . . . . 0.0 110.203 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 117.78 0.77 17.56 Favored Glycine 0 N--CA 1.478 1.5 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 73.2 mttt -81.96 140.33 34.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -1.108 . . . . 0.0 109.617 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.586 ' CE1' ' HB ' ' A' ' 89' ' ' ILE . 64.4 m-85 -127.85 104.85 8.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.572 -1.33 . . . . 0.0 111.982 -178.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 1.9 m -79.44 140.15 37.45 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.43 0.634 . . . . 0.0 109.291 178.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.596 ' CD2' HG22 ' A' ' 8' ' ' ILE . 17.0 m-85 -140.24 165.18 28.08 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 110.404 -179.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.577 ' NE1' ' CG1' ' A' ' 12' ' ' VAL . 96.3 m95 -105.12 121.8 44.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 176.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.466 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 4.9 p -144.03 165.46 13.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.778 -176.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.472 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -59.62 149.6 70.34 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.75 -179.369 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.472 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 47.1 Cg_endo -73.65 71.66 3.92 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.208 1.636 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.487 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.08 -34.05 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.356 -0.84 . . . . 0.0 110.156 -179.095 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -47.65 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.364 -0.835 . . . . 0.0 110.212 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -43.34 167.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 1.2 mtpt -64.13 -58.06 7.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.925 . . . . 0.0 110.349 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.5 m -58.74 -39.29 80.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.951 . . . . 0.0 110.177 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 6.4 mt-10 -55.89 -45.98 78.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 0.0 109.651 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 17.7 mt -57.13 -30.13 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.493 -0.755 . . . . 0.0 110.015 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.0 ttmm -57.77 -47.51 82.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.414 -0.804 . . . . 0.0 111.799 -179.283 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -58.7 -45.95 88.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 112.63 -177.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.5 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . -58.75 -48.45 81.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.768 -1.207 . . . . 0.0 111.893 -178.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 19.1 m -74.47 -28.89 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.424 -1.422 . . . . 0.0 110.467 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -56.69 -52.61 64.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.836 -1.165 . . . . 0.0 109.219 179.558 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.2 p -80.25 -45.42 17.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.853 179.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -58.44 -65.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.419 -0.801 . . . . 0.0 110.57 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.629 ' CD1' ' CG2' ' A' ' 89' ' ' ILE . 31.8 m-85 -71.48 -19.07 62.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.996 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER 68.08 46.31 1.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 110.517 179.643 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -134.01 -165.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.437 -0.789 . . . . 0.0 110.259 179.907 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.551 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -118.74 111.18 18.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.545 -0.722 . . . . 0.0 109.881 179.274 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.573 ' CG1' ' CG1' ' A' ' 81' ' ' VAL . 89.4 t -78.77 136.32 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 110.134 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 82' ' ' GLN . 8.7 p -118.25 -7.3 11.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.277 -0.889 . . . . 0.0 110.164 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.618 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -176.67 131.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.819 179.41 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 1.2 t -123.68 119.64 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.999 -1.063 . . . . 0.0 110.258 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.48 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 1.6 t-20 -116.74 115.91 26.51 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.218 178.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.505 ' CB ' ' HE3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -109.55 145.44 36.33 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.57 -179.611 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -124.58 160.45 28.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.275 -0.891 . . . . 0.0 110.903 -179.049 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -72.98 115.12 11.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.25 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.586 ' CG2' ' N ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.267 -0.895 . . . . 0.0 110.229 -179.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.56 ' CG ' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.152 0.501 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.523 ' CA ' HG21 ' A' ' 59' ' ' VAL . 13.2 tttt -121.15 137.99 54.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.068 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.586 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -105.44 150.67 25.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 110.001 -179.901 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -128.88 128.64 44.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.091 -1.006 . . . . 0.0 112.347 -179.212 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.619 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -108.69 111.88 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 5.0 t -108.37 137.46 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 111.234 -178.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.618 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 1.4 tp60 -111.17 154.08 24.86 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.265 -0.897 . . . . 0.0 108.742 178.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.47 HG21 ' HB2' ' A' ' 87' ' ' GLN . 2.9 m -116.45 155.82 17.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 C-N-CA 118.257 -1.377 . . . . 0.0 108.643 177.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -56.19 -179.6 0.09 OUTLIER Pre-proline 0 C--N 1.284 -2.244 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.032 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.3 Cg_endo -71.68 140.4 35.73 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 124.103 1.581 . . . . 0.0 110.387 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.05 -23.34 29.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.499 ' OE1' ' N ' ' A' ' 84' ' ' ALA . 35.7 mt-30 -87.1 167.93 13.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.259 -1.142 . . . . 0.0 110.641 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.456 ' HD3' ' OH ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER 179.45 115.49 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.332 -0.855 . . . . 0.0 110.653 179.89 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.629 ' CG2' ' CD1' ' A' ' 47' ' ' PHE . 9.2 mt -78.05 75.53 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.548 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.71 -13.09 1.49 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.508 -0.745 . . . . 0.0 111.479 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 92' ' ' LEU . . . -53.59 -20.6 5.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.933 -1.105 . . . . 0.0 110.629 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.47 -23.21 12.56 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.001 -1.062 . . . . 0.0 109.609 179.506 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -54.61 -35.71 63.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 110.373 -179.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.11 -4.9 71.1 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.468 ' HB3' ' OH ' ' A' ' 18' ' ' TYR . 3.0 tp -69.24 -5.47 23.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.091 -1.24 . . . . 0.0 110.194 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.614 ' CG1' ' CZ ' ' A' ' 18' ' ' TYR . 20.3 mt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.21 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 30' ' ' VAL . 11.3 t . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.625 ' CG2' ' CD2' ' A' ' 28' ' ' PHE . 6.8 mt -74.07 158.13 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.991 -1.068 . . . . 0.0 110.151 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.1 mt -140.71 -99.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 110.251 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.68 155.96 39.69 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 110.346 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 27' ' ' THR . 46.0 Cg_endo -73.71 153.76 48.83 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.978 1.514 . . . . 0.0 110.255 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.618 ' CG1' ' CE2' ' A' ' 29' ' ' TRP . 2.3 m -92.14 141.12 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.271 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.565 HD13 ' CZ ' ' A' ' 18' ' ' TYR . 3.2 mm? -102.83 107.5 18.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.932 . . . . 0.0 110.204 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 15' ' ' GLU . 22.3 m -161.54 143.06 11.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.104 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' SER . 9.8 tm-20 -43.19 -51.31 6.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.004 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -42.67 71.87 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.23 -0.919 . . . . 0.0 110.218 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 18' ' ' TYR . . . -70.83 -65.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 1.6 m-85 -42.55 -27.62 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 110.317 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -90.38 -34.85 15.5 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.24 -0.913 . . . . 0.0 109.562 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -78.58 -44.98 9.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.158 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.04 -22.36 64.96 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.56 -0.964 . . . . 0.0 108.734 178.936 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.427 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -52.6 -19.37 2.28 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.333 0.587 . . . . 0.0 110.661 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.53 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 1.6 tt0 -95.06 15.08 19.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.868 . . . . 0.0 110.498 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 97.61 1.01 59.04 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.512 ' HD2' ' CG2' ' A' ' 80' ' ' ILE . 2.8 mttp -82.5 143.37 31.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -1.089 . . . . 0.0 109.552 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 23.1 m-85 -127.81 103.87 7.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.761 -1.212 . . . . 0.0 111.918 -179.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 1.9 m -75.62 141.28 42.88 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.625 ' CD2' ' CG2' ' A' ' 8' ' ' ILE . 18.4 m-85 -138.0 165.24 27.05 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.353 -0.842 . . . . 0.0 110.48 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.618 ' CE2' ' CG1' ' A' ' 12' ' ' VAL . 22.4 m95 -101.68 120.79 40.89 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.287 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 1.9 p -152.57 165.31 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 118.481 -1.288 . . . . 0.0 111.522 -176.693 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.545 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -70.9 172.55 6.2 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.713 -0.617 . . . . 0.0 110.683 -179.51 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.9 Cg_endo -75.35 -59.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.241 1.653 . . . . 0.0 110.413 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -38.46 -26.0 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.552 179.283 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 32' ' ' PRO . . . -62.95 90.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.82 -1.175 . . . . 0.0 110.051 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -49.49 162.66 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 -179.84 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -57.47 -56.22 24.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.86 . . . . 0.0 110.117 -179.964 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 m -60.49 -34.77 74.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.307 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -55.79 -42.65 75.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 109.642 179.776 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.56 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 9.0 mt -57.65 -30.96 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.145 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 13.3 tttp -62.22 -46.25 89.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 110.52 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -59.12 -49.12 79.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.477 -0.764 . . . . 0.0 112.003 -178.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.65 73.43 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.849 -1.157 . . . . 0.0 111.417 -178.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.603 ' CG1' ' CG2' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -63.7 -39.54 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.864 -1.147 . . . . 0.0 110.395 -179.325 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.24 -47.33 78.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.0 -1.063 . . . . 0.0 109.609 179.939 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.3 p -79.42 -45.07 20.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.357 -0.839 . . . . 0.0 109.883 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.12 -69.61 0.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.418 -0.801 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 77.5 m-85 -71.63 -21.81 61.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.132 -0.98 . . . . 0.0 110.219 -179.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 9.2 mttt 65.2 40.08 5.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -117.88 -162.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.485 0.659 . . . . 0.0 110.313 -179.896 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.498 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -118.2 104.52 10.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.522 -0.736 . . . . 0.0 109.486 178.946 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.603 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 27.0 t -78.81 119.8 28.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.694 -179.223 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 82' ' ' GLN . 8.5 p -103.17 -0.57 10.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.295 -0.878 . . . . 0.0 109.812 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.571 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.97 146.87 0.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 179.385 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.527 HG22 ' CG2' ' A' ' 81' ' ' VAL . 1.2 t -133.37 122.25 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.479 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -121.99 115.8 23.17 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 109.086 178.639 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -120.67 140.84 51.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 110.305 -179.481 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.526 HD13 ' CE ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -148.55 149.93 32.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.634 -0.667 . . . . 0.0 109.345 -179.847 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.597 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 1.7 m80 -86.34 143.51 27.82 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.151 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.289 -2.051 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.529 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.57 ' HG3' ' CD2' ' A' ' 58' ' ' HIS . 3.4 ttpt -96.29 128.99 43.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 111.077 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.526 ' CE ' HD13 ' A' ' 57' ' ' LEU . 28.7 pttt -119.54 151.3 38.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.413 -0.804 . . . . 0.0 109.348 179.147 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -118.06 128.77 55.08 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.89 -1.131 . . . . 0.0 113.03 -178.356 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.601 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.7 mp -107.58 111.24 34.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.527 ' CG2' HG22 ' A' ' 54' ' ' VAL . 23.4 t -107.37 139.0 30.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 111.005 -178.703 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.571 ' CB ' ' CG ' ' A' ' 53' ' ' LYS . 1.6 tp60 -105.59 153.32 21.95 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.341 -0.849 . . . . 0.0 108.789 179.008 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 1.5 m -119.16 156.52 21.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 C-N-CA 118.171 -1.412 . . . . 0.0 109.327 178.343 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.496 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . . . -64.46 177.03 0.61 Allowed Pre-proline 0 C--N 1.287 -2.138 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.223 -179.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 84' ' ' ALA . 43.5 Cg_endo -74.81 138.4 23.46 Favored 'Trans proline' 0 C--N 1.298 -2.093 0 O-C-N 124.296 1.682 . . . . 0.0 110.19 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.68 -31.88 7.0 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -108.45 174.09 6.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.037 -1.272 . . . . 0.0 110.669 -179.917 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 178.99 130.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.487 -0.758 . . . . 0.0 110.081 179.827 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 40.1 mt -83.74 82.5 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 110.118 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -13.83 10.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.522 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.443 ' HB2' HG22 ' A' ' 89' ' ' ILE . . . -55.09 -19.6 7.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 0.0 110.525 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.21 -23.07 12.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.086 -1.009 . . . . 0.0 109.674 179.834 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -58.87 -54.74 43.75 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.426 -0.796 . . . . 0.0 110.442 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -73.9 -21.9 78.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 6.8 tp -42.71 -27.15 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -1.145 . . . . 0.0 110.363 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.495 HG13 ' CE1' ' A' ' 18' ' ' TYR . 40.0 mt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.5 ' O ' HD23 ' A' ' 9' ' ' LEU . 15.5 t . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.237 0.541 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.543 HG21 ' CB ' ' A' ' 28' ' ' PHE . 3.3 mt -69.57 157.62 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 110.83 -178.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -152.13 -93.23 0.05 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 110.723 179.836 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.81 141.63 25.75 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.088 -1.008 . . . . 0.0 110.909 -179.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.2 Cg_endo -77.16 173.49 14.3 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.207 1.635 . . . . 0.0 110.821 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.581 HG11 ' CD1' ' A' ' 29' ' ' TRP . 1.2 m -115.21 127.4 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.339 -0.85 . . . . 0.0 110.032 179.841 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.579 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 3.0 mm? -103.08 113.27 26.62 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 110.351 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.7 m -158.15 161.54 37.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.133 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -58.03 -55.26 37.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -54.66 -21.61 11.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.45 -52.03 3.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.579 ' CZ ' HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -49.5 -34.99 18.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.925 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.41 -8.63 50.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.38 -42.8 1.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.563 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -66.31 -17.05 64.53 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.56 -0.964 . . . . 0.0 108.91 178.879 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.72 -20.13 46.15 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.747 -0.596 . . . . 0.0 110.658 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.468 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 3.2 tt0 -88.54 17.71 5.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.458 -0.776 . . . . 0.0 110.123 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.09 4.12 69.26 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -178.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 48.2 mttm -82.76 134.96 35.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.591 -0.947 . . . . 0.0 109.445 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.643 ' CD2' ' CD1' ' A' ' 89' ' ' ILE . 24.6 m-85 -128.21 98.03 4.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.562 -1.336 . . . . 0.0 111.537 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.4 m -75.02 132.89 41.66 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.638 -0.664 . . . . 0.0 109.915 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.66 ' CE1' ' CZ ' ' A' ' 47' ' ' PHE . 34.8 m-85 -126.72 163.72 22.9 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.244 -179.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.581 ' CD1' HG11 ' A' ' 12' ' ' VAL . 95.8 m95 -95.11 122.61 37.96 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.117 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.7 p -149.02 164.38 4.23 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 C-N-CA 117.649 -1.62 . . . . 0.0 112.224 -176.634 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.42 ' N ' ' CG2' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -56.75 140.78 75.09 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.281 -179.905 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 48.9 Cg_endo -74.83 80.02 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.199 1.631 . . . . 0.0 110.262 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 178.47 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 110.112 -179.133 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' CB ' HG13 ' A' ' 39' ' ' ILE . . . -54.36 97.03 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.406 -0.809 . . . . 0.0 110.282 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.475 ' OG1' ' CG ' ' A' ' 38' ' ' GLU . 2.2 p -42.82 149.52 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 110.168 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.512 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 5.7 mmtp -42.61 -40.72 2.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.183 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 3.5 m -75.12 -39.07 60.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.31 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.475 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 7.8 mt-10 -55.68 -44.25 77.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 109.808 179.825 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.541 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 14.5 mt -57.24 -30.32 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.618 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 24.2 tttt -57.82 -42.98 85.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 0.0 111.258 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -58.19 -49.11 78.2 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.404 -0.81 . . . . 0.0 112.428 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.47 -47.98 65.71 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.711 -1.243 . . . . 0.0 111.759 -178.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.587 HG23 ' CE2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -59.78 -47.09 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.908 -1.12 . . . . 0.0 110.013 -179.431 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.82 -43.38 80.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.095 -1.003 . . . . 0.0 109.831 179.897 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -79.14 -27.39 42.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 109.97 179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.42 -61.64 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.074 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.66 ' CZ ' ' CE1' ' A' ' 28' ' ' PHE . 52.1 m-85 -71.8 -20.88 61.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.961 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 62.86 39.92 10.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.458 -0.776 . . . . 0.0 110.104 179.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -119.32 -164.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.807 179.705 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.565 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 5.4 tmtm? -113.42 106.6 14.78 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.443 -0.786 . . . . 0.0 109.364 179.021 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.552 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 44.7 t -78.22 130.72 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 110.145 -179.397 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 82' ' ' GLN . 13.3 p -114.96 -9.77 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.409 -0.807 . . . . 0.0 110.271 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.595 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 176.75 129.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 109.932 179.696 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.578 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -109.15 141.56 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.104 179.847 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.512 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.6 m-20 -130.04 115.52 17.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.285 -0.884 . . . . 0.0 109.561 178.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -108.85 159.82 16.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.916 -179.459 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 58' ' ' HIS . 1.8 pp -148.47 177.88 9.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.211 -0.931 . . . . 0.0 110.853 -179.37 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CD1' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -74.95 134.53 41.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.967 179.642 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.561 HG12 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.902 . . . . 0.0 109.358 179.677 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.527 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.104 0.478 . . . . 0.0 110.266 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.53 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 6.3 tttp -123.78 142.2 51.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.556 ' CD ' ' CG2' ' A' ' 27' ' ' THR . 0.9 OUTLIER -100.59 138.39 37.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.073 . . . . 0.0 109.792 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -133.22 119.36 19.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.097 -1.002 . . . . 0.0 111.836 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 16.7 mt -99.9 109.91 25.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.857 178.327 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.578 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 52.8 t -96.73 129.46 46.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 110.02 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.595 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 2.5 tp60 -98.86 153.2 18.97 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.013 179.358 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 1.5 m -119.66 156.6 22.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 C-N-CA 118.327 -1.349 . . . . 0.0 108.632 177.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.509 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -69.84 179.29 0.81 Allowed Pre-proline 0 C--N 1.283 -2.309 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.133 -179.71 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.06 140.76 31.76 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 124.263 1.665 . . . . 0.0 110.432 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.45 -37.1 3.95 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.472 ' OE1' ' HB3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -104.31 176.8 5.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.125 -1.221 . . . . 0.0 110.643 -179.897 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.55 115.04 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.488 -0.757 . . . . 0.0 110.001 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.643 ' CD1' ' CD2' ' A' ' 26' ' ' TYR . 14.1 mt -60.94 109.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.23 -0.919 . . . . 0.0 110.464 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 17.8 pt-20 -78.12 -14.33 59.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.318 -0.863 . . . . 0.0 110.745 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.461 ' HB1' HD22 ' A' ' 92' ' ' LEU . . . -55.15 -28.67 54.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.0 110.373 -179.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.02 -23.13 12.71 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.165 -0.959 . . . . 0.0 109.467 179.788 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.468 ' O ' HG12 ' A' ' 96' ' ' ILE . 25.3 mm-40 -54.53 -24.42 20.66 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.43 -0.794 . . . . 0.0 110.165 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.63 -36.35 4.85 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.468 ' HB3' HD12 ' A' ' 13' ' ' LEU . 3.5 mp -49.32 -31.94 10.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.375 -1.073 . . . . 0.0 110.114 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.562 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . 46.4 pt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.181 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 30' ' ' VAL . 8.4 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.369 0.604 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.633 ' CG2' ' CD1' ' A' ' 28' ' ' PHE . 14.7 mm -87.04 102.8 12.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 121.371 -0.83 . . . . 0.0 110.466 -178.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 29' ' ' TRP . 4.5 mp -62.51 -107.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 110.431 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.539 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -108.64 164.22 15.22 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.961 -1.087 . . . . 0.0 110.257 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 45.9 Cg_endo -73.31 153.5 50.79 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.982 1.517 . . . . 0.0 110.176 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 27' ' ' THR . 1.4 p -112.96 114.64 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.939 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.5 mm? -101.49 112.5 25.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 110.345 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -158.31 154.95 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.951 -179.981 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.0 mm-40 -43.08 -58.07 2.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 110.038 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 22.4 ttmt -54.72 -19.17 5.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.491 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -99.84 -54.58 2.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 110.065 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 13' ' ' LEU . 3.1 m-85 -53.82 -50.86 65.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.968 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 15' ' ' GLU . . . -63.8 -12.7 37.93 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.224 -0.922 . . . . 0.0 109.14 179.204 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' N ' ' A' ' 22' ' ' ALA . . . -94.46 -40.47 4.46 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 178.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.574 ' CE2' HD12 ' A' ' 92' ' ' LEU . 3.4 m-30 -51.44 -24.67 5.24 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.601 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 20' ' ' GLY . . . -43.27 -36.3 1.76 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.467 0.651 . . . . 0.0 110.25 -179.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.415 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 2.2 tt0 -95.9 16.48 17.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.412 -0.805 . . . . 0.0 110.515 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 80.64 6.74 89.17 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 49.9 mttt -82.17 132.62 35.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.241 -1.152 . . . . 0.0 109.755 179.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.578 ' CD2' HD11 ' A' ' 89' ' ' ILE . 70.7 m-85 -126.46 111.84 14.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.775 -1.203 . . . . 0.0 111.988 -178.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.598 ' CG2' ' CG ' ' A' ' 78' ' ' LYS . 36.8 m -75.73 141.97 42.53 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.606 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.688 ' CE2' ' CZ ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -141.11 164.72 29.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 -179.221 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.578 ' CZ2' ' HE2' ' A' ' 78' ' ' LYS . 79.6 m95 -93.5 122.4 35.89 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.166 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.516 ' CG1' ' HG2' ' A' ' 77' ' ' LYS . 7.6 p -137.05 164.64 29.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.68 -178.101 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CD2' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.14 150.03 97.9 Favored Pre-proline 0 C--N 1.294 -1.835 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.343 -179.839 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.54 67.3 3.7 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 O-C-N 124.222 1.643 . . . . 0.0 109.769 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.543 ' HE3' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 179.35 -32.38 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.455 -0.778 . . . . 0.0 109.828 -178.886 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HB3' HG13 ' A' ' 39' ' ' ILE . . . -49.54 101.06 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.368 -0.833 . . . . 0.0 110.218 -179.765 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -49.8 141.5 10.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.348 -179.974 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.521 ' CE ' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -43.84 -36.06 2.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 110.209 179.846 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -75.11 -49.04 20.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.854 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 1.6 mm-40 -54.79 -42.29 71.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 0.0 109.859 -179.74 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.462 HG12 HD13 ' A' ' 8' ' ' ILE . 21.3 mt -57.54 -30.69 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.9 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 7.8 tttt -60.94 -44.04 97.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.469 -0.77 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -58.43 -34.35 70.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.767 . . . . 0.0 111.927 -178.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . -72.97 -50.4 23.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.594 -1.316 . . . . 0.0 111.754 -178.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.651 ' CG1' ' CE2' ' A' ' 47' ' ' PHE . 27.7 m -66.53 -31.35 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.578 -1.326 . . . . 0.0 110.557 -179.586 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.465 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.02 -52.93 61.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.057 -1.027 . . . . 0.0 109.97 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -80.18 -24.49 40.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 110.28 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -84.97 -56.38 3.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 0.0 110.812 -179.467 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 8.1 m-30 -71.72 -16.21 62.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.064 -1.022 . . . . 0.0 110.238 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 66.0 46.52 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.473 -0.767 . . . . 0.0 110.724 179.585 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.566 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -136.54 -164.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.365 -0.835 . . . . 0.0 110.253 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.566 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -114.52 105.13 12.73 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.422 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 57.9 t -77.71 119.19 25.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 110.33 -179.029 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.527 HG13 ' CA ' ' A' ' 83' ' ' VAL . 7.3 p -96.2 -20.64 5.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.547 -0.721 . . . . 0.0 109.619 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.535 ' HG3' ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -167.9 146.17 4.53 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.428 -0.795 . . . . 0.0 109.942 179.865 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 1.2 t -132.14 116.78 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.684 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 80' ' ' ILE . 1.1 t-20 -114.1 115.1 27.0 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.0 -1.062 . . . . 0.0 109.614 179.17 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.528 ' CA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -110.75 141.44 44.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.345 -0.847 . . . . 0.0 110.248 -179.249 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.06 148.61 49.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 109.944 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.94 126.56 30.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 110.403 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.518 HG21 ' CE ' ' A' ' 78' ' ' LYS . 1.6 m . . . . . 0 C--N 1.302 -1.492 0 O-C-N 121.585 -0.697 . . . . 0.0 110.168 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.575 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.255 0.55 . . . . 0.0 110.181 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.527 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 81.2 tttt -106.62 136.87 45.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.577 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.598 ' CG ' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.67 151.09 30.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.485 179.555 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 28' ' ' PHE . . . -125.56 120.13 30.03 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.027 -1.045 . . . . 0.0 112.867 -179.169 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 55' ' ' ASN . 10.2 mt -96.68 110.52 24.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.237 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 26' ' ' TYR . 2.2 t -101.3 130.94 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 110.369 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.535 ' HB2' ' HG3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -112.55 153.63 27.21 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.023 -1.048 . . . . 0.0 109.639 179.346 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.527 ' CA ' HG13 ' A' ' 52' ' ' VAL . 1.9 m -115.41 157.21 16.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.065 177.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -61.93 174.81 0.62 Allowed Pre-proline 0 C--N 1.29 -2.019 0 O-C-N 121.238 -0.914 . . . . 0.0 110.827 -179.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.5 Cg_endo -76.73 58.13 5.86 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.465 1.771 . . . . 0.0 110.57 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.19 -33.79 0.02 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.466 ' OE1' ' CB ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -112.38 -179.94 3.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.119 -1.224 . . . . 0.0 110.457 -179.779 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.477 ' HA ' HG22 ' A' ' 83' ' ' VAL . 4.2 ptpt -170.73 125.54 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.578 HD11 ' CD2' ' A' ' 26' ' ' TYR . 59.8 mt -68.43 98.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.152 -0.968 . . . . 0.0 110.161 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 1.9 mt-10 -70.65 -13.52 62.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.415 -0.803 . . . . 0.0 110.81 -179.587 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.455 ' CB ' HD21 ' A' ' 92' ' ' LEU . . . -54.48 -28.88 47.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.067 -1.02 . . . . 0.0 110.407 -179.376 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.574 HD12 ' CE2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -106.19 -22.55 12.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.162 -0.961 . . . . 0.0 109.402 179.605 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' O ' HD12 ' A' ' 96' ' ' ILE . 13.2 mm-40 -56.53 -54.09 49.92 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.494 -0.753 . . . . 0.0 110.33 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.65 -14.71 79.6 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 2.2 tp -67.92 -7.71 30.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.134 -1.216 . . . . 0.0 110.132 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.498 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 45.4 mt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.205 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 30' ' ' VAL . 2.1 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.478 0.656 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.602 ' CG2' ' CD2' ' A' ' 28' ' ' PHE . 5.6 mm -102.83 121.64 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 110.589 -178.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.0 mt -96.41 -107.19 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.507 -0.746 . . . . 0.0 109.867 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.79 158.02 36.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.066 -1.021 . . . . 0.0 110.127 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.474 ' O ' HD21 ' A' ' 13' ' ' LEU . 46.9 Cg_endo -73.62 140.16 29.19 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.915 1.481 . . . . 0.0 109.65 179.38 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 12' ' ' VAL . 1.6 m -85.39 132.21 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.015 -1.053 . . . . 0.0 110.172 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.8 mm? -102.77 112.73 25.66 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.168 -0.958 . . . . 0.0 110.119 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' ALA . 3.1 m -163.54 148.62 11.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 110.045 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 14' ' ' SER . 58.7 mt-10 -42.88 -53.67 4.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 110.004 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -54.9 -21.98 13.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.19 -0.944 . . . . 0.0 110.116 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -100.31 -57.28 2.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 110.272 -179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.565 ' CZ ' HD11 ' A' ' 13' ' ' LEU . 1.4 m-85 -47.03 -34.7 5.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.938 . . . . 0.0 110.303 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.07 -8.88 50.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.994 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -103.61 -34.01 3.97 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -80.24 -18.95 48.01 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.702 -0.881 . . . . 0.0 108.95 179.164 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.21 -21.73 14.98 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.416 0.627 . . . . 0.0 110.732 -179.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.508 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -88.99 17.08 6.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.702 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.519 ' HA2' ' CE ' ' A' ' 88' ' ' LYS . . . 93.17 0.69 67.67 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.233 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 62.4 mttt -82.43 142.23 32.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.479 -1.012 . . . . 0.0 109.293 179.628 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.589 ' CE2' HG13 ' A' ' 89' ' ' ILE . 26.7 m-85 -128.79 111.02 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.662 -1.274 . . . . 0.0 111.511 -179.267 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 26.7 m -82.78 125.29 31.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.612 0.72 . . . . 0.0 110.151 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.619 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 22.0 m-30 -119.3 165.53 14.16 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.706 -0.621 . . . . 0.0 109.662 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.541 ' CZ3' ' CG ' ' A' ' 76' ' ' ARG . 1.9 m95 -103.02 122.84 45.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.062 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 2.5 p -149.01 164.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.571 -1.251 . . . . 0.0 111.596 -176.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.474 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -62.69 151.4 84.36 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.896 -0.503 . . . . 0.0 110.659 -179.346 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 46.7 Cg_endo -73.81 70.1 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.236 1.651 . . . . 0.0 109.906 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.24 -33.75 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 110.324 -178.988 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 35' ' ' THR . . . -41.75 98.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 110.179 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.453 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -41.33 138.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 0.0 110.322 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.505 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 1.4 mttt -42.56 -35.89 1.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.9 m -75.04 -36.07 61.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 110.019 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 0.9 OUTLIER -55.91 -46.21 78.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.998 179.807 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.529 ' CG1' HD13 ' A' ' 8' ' ' ILE . 6.2 mt -57.31 -30.24 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.542 179.585 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 12.5 tttm -62.99 -47.55 82.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.628 -0.67 . . . . 0.0 111.324 -179.433 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.62 -34.65 78.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.311 -0.868 . . . . 0.0 111.76 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -49.49 29.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.981 -1.075 . . . . 0.0 111.705 -178.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.619 ' CG1' ' CE2' ' A' ' 28' ' ' PHE . 26.7 m -71.21 -28.5 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.683 -1.26 . . . . 0.0 110.765 -179.301 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.53 -51.66 67.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.8 -1.188 . . . . 0.0 109.22 179.542 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -79.41 -45.09 20.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.83 . . . . 0.0 109.728 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.17 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.46 -0.775 . . . . 0.0 110.531 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CD1' ' CG2' ' A' ' 89' ' ' ILE . 24.5 m-85 -71.69 -21.09 61.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.026 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.8 mttt 63.76 47.4 3.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.858 . . . . 0.0 110.556 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.556 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -130.33 -162.84 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.514 -0.741 . . . . 0.0 110.017 179.967 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.556 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 2.2 tmtt? -118.1 107.43 13.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.423 -0.798 . . . . 0.0 109.839 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.532 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 49.2 t -78.6 119.84 28.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.216 -0.927 . . . . 0.0 110.166 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.573 HG11 ' CA ' ' A' ' 83' ' ' VAL . 7.5 p -112.59 4.96 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.893 . . . . 0.0 110.035 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER 171.88 120.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.222 179.902 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.585 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 1.2 t -115.87 136.27 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 0.0 110.125 179.664 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.505 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 1.1 t-20 -131.26 116.51 17.72 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.468 -0.77 . . . . 0.0 109.482 179.154 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -113.75 166.3 11.69 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.07 -1.019 . . . . 0.0 109.871 -179.724 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.521 ' CD2' ' HD2' ' A' ' 78' ' ' LYS . 2.8 pp -152.63 146.29 25.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.918 . . . . 0.0 110.64 -179.027 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -81.75 122.13 27.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.05 -1.032 . . . . 0.0 109.759 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.654 HG11 ' HG2' ' A' ' 76' ' ' ARG . 1.2 p . . . . . 0 C--N 1.298 -1.662 0 O-C-N 121.818 -0.551 . . . . 0.0 110.437 -178.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.654 ' HG2' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.516 ' CG ' HG13 ' A' ' 30' ' ' VAL . 7.5 pttt -123.88 131.32 53.56 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.758 -1.214 . . . . 0.0 110.717 -179.013 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 12.5 ptpt -101.7 151.42 22.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.404 -0.81 . . . . 0.0 108.908 179.085 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -116.37 120.1 37.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.773 -1.204 . . . . 0.0 112.712 -178.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.626 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -97.07 112.17 28.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.227 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.585 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 6.4 t -109.53 132.25 58.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 111.14 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.528 ' HG3' ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -103.52 149.89 24.43 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.395 -0.816 . . . . 0.0 108.84 179.078 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.573 ' CA ' HG11 ' A' ' 52' ' ' VAL . 1.3 m -116.11 157.98 16.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.445 -1.302 . . . . 0.0 109.744 179.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.538 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -76.36 -178.37 0.92 Allowed Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.048 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.2 Cg_endo -72.09 135.9 26.03 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 O-C-N 124.087 1.572 . . . . 0.0 109.937 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.79 -50.56 0.76 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.479 ' OE1' ' HB2' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -98.18 174.58 6.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.166 -1.196 . . . . 0.0 110.53 179.889 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.519 ' CE ' ' HA2' ' A' ' 24' ' ' GLY . 0.3 OUTLIER 178.68 115.72 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.478 -0.763 . . . . 0.0 110.315 -179.855 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.635 ' CG2' ' CD1' ' A' ' 47' ' ' PHE . 7.5 mt -68.26 63.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.886 -1.134 . . . . 0.0 109.48 179.347 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 88' ' ' LYS . 2.4 mm-40 -54.3 -12.83 0.72 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.64 -0.663 . . . . 0.0 111.72 -179.558 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.508 ' O ' ' CD1' ' A' ' 95' ' ' LEU . . . -53.42 -16.03 1.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.882 -1.136 . . . . 0.0 110.968 -179.058 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.579 HD11 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -101.76 -23.04 14.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.862 -1.149 . . . . 0.0 109.514 179.43 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -54.19 -29.0 44.34 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.458 -0.776 . . . . 0.0 110.396 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -96.91 -24.64 12.71 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.508 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 3.5 mp -42.42 -28.9 0.24 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -1.144 . . . . 0.0 110.182 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.53 HG12 ' CE1' ' A' ' 18' ' ' TYR . 72.8 mt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 120.764 0.316 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.663 ' HA ' ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -85.61 65.66 9.27 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.19 -1.404 . . . . 0.0 108.08 178.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 13.3 p -108.64 -104.87 0.36 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.519 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -84.13 -5.08 59.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.019 -1.051 . . . . 0.0 109.133 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.663 ' CE2' ' HA ' ' A' ' 2' ' ' LYS 0.25 0.1 OUTLIER -52.83 -139.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.976 0.893 . . . . 0.0 111.178 178.496 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.65 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 31.6 m-20 -30.04 -59.04 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.788 -0.57 . . . . 0.0 112.019 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.649 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 66.3 t -51.41 -109.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.451 -0.78 . . . . 0.0 111.06 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.673 ' CG2' ' CD1' ' A' ' 28' ' ' PHE . 29.0 mt -84.99 104.44 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.657 -1.277 . . . . 0.0 110.749 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 54.2 mt -75.42 -93.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.761 . . . . 0.0 110.987 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.33 157.77 34.18 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.122 -0.986 . . . . 0.0 110.92 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 48.8 Cg_endo -77.01 160.95 33.24 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.149 1.605 . . . . 0.0 110.415 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.516 ' CG1' ' O ' ' A' ' 27' ' ' THR . 1.2 p -115.31 116.56 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 109.831 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.4 mm? -98.85 112.06 24.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.401 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -155.36 157.42 37.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.048 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 5.5 tm-20 -43.52 -61.24 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 110.069 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.74 -17.68 3.76 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.31 -0.869 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.571 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -99.4 -52.16 3.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 109.995 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.605 ' CE1' ' CG1' ' A' ' 96' ' ' ILE . 2.1 m-85 -56.47 -58.1 9.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.157 -0.964 . . . . 0.0 109.931 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.66 -12.82 37.18 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.272 -0.892 . . . . 0.0 109.186 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 21' ' ' PHE . . . -86.31 -47.19 5.02 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 7.7 m-30 -47.88 -28.42 2.63 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -38.31 -38.26 0.35 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.399 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.15 -17.88 23.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.359 -0.838 . . . . 0.0 110.44 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 118.05 4.52 14.32 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 1.7 mmtm -81.69 135.72 35.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -1.123 . . . . 0.0 109.505 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.577 ' CD1' HD13 ' A' ' 92' ' ' LEU . 21.1 m-85 -127.15 111.16 13.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.017 -1.052 . . . . 0.0 112.167 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 24.9 m -77.99 140.05 39.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.673 ' CD1' ' CG2' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -137.5 164.33 28.97 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.066 -1.021 . . . . 0.0 111.349 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.429 ' CZ3' HG21 ' A' ' 59' ' ' VAL . 70.7 m95 -99.31 122.59 42.67 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 2.6 p -144.02 156.71 15.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.787 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.554 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -62.36 151.73 81.58 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.778 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.9 Cg_endo -73.41 71.12 3.87 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.183 1.622 . . . . 0.0 110.047 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.57 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.3 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.57 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -44.27 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.94 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -42.67 144.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 110.338 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -42.53 -52.86 4.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 109.909 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.8 m -62.37 -36.51 82.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.2 OUTLIER -56.47 -44.14 80.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.184 -0.947 . . . . 0.0 109.569 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.524 ' CA ' HD12 ' A' ' 8' ' ' ILE . 1.7 mt -57.61 -32.56 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.315 -0.865 . . . . 0.0 108.805 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 6.4 ttmm -59.25 -45.81 90.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.851 . . . . 0.0 109.621 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.536 ' O ' ' CG2' ' A' ' 45' ' ' THR . 2.8 m-80 -71.83 -34.0 68.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.645 -0.659 . . . . 0.0 111.146 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 3' ' ' THR . . . -57.51 -50.16 73.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.176 . . . . 0.0 110.501 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.63 ' CG1' ' CE2' ' A' ' 47' ' ' PHE . 3.3 m -76.25 -34.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.879 -1.138 . . . . 0.0 110.641 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -60.95 -29.84 69.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.031 -1.043 . . . . 0.0 110.374 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 41' ' ' ASN . 34.4 p -78.52 -46.47 19.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.51 -55.03 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 110.72 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.63 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 6.6 m-30 -71.54 -14.72 62.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.065 -1.022 . . . . 0.0 110.141 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 16.0 mttm 42.48 47.03 4.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.147 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.88 -163.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.569 -0.707 . . . . 0.0 110.008 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.578 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 1.2 tmtp? -118.08 110.27 17.43 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.431 -0.793 . . . . 0.0 109.709 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.53 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 30.0 t -78.63 119.72 28.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.359 -0.838 . . . . 0.0 110.043 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.561 HG11 ' CA ' ' A' ' 83' ' ' VAL . 10.9 p -110.0 7.02 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.309 -0.87 . . . . 0.0 110.025 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER 169.68 119.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 109.987 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.538 HG23 ' CG1' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -121.12 120.83 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.115 -0.99 . . . . 0.0 110.072 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.471 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -121.63 115.95 23.69 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.23 178.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.537 ' CA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.35 150.62 37.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.147 -0.97 . . . . 0.0 110.588 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 pp -141.5 154.88 45.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 109.79 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.612 ' CD2' ' NH1' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -67.43 134.04 50.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.42 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.472 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -120.0 133.22 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.367 -0.833 . . . . 0.0 110.092 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.612 ' NH1' ' CD2' ' A' ' 58' ' ' HIS . 27.9 mmt180 -118.48 151.88 36.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.111 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.31 156.76 0.5 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -45.14 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -1.141 . . . . 0.0 110.202 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -78.53 3.97 14.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -0.83 . . . . 0.0 110.18 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.536 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 8.2 pttm 38.56 32.94 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.535 -0.728 . . . . 0.0 110.558 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -160.56 -49.47 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.221 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.3 OUTLIER 53.56 104.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . 44.75 -169.36 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -51.8 -173.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.392 -1.064 . . . . 0.0 110.344 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ARG . 5.9 t80 -42.26 102.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.272 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.31 40.36 0.31 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 72' ' ' LYS . . . 151.26 -65.0 0.37 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER 65.84 142.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -1.148 . . . . 0.0 110.135 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.465 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 1.6 tmm_? -42.59 103.91 0.33 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.245 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 52.0 Cg_endo -77.16 -166.48 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.051 1.553 . . . . 0.0 110.319 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.27 89.4 3.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.422 -0.799 . . . . 0.0 109.3 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -118.35 145.85 44.82 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.537 -0.727 . . . . 0.0 110.267 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.466 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 12.8 tttt -123.59 140.92 52.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -0.945 . . . . 0.0 110.648 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' THR . 2.1 ttpt -107.97 150.55 26.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.333 -0.855 . . . . 0.0 109.623 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -133.18 121.79 23.06 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.056 -1.027 . . . . 0.0 112.495 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.607 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -101.62 111.95 33.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.538 ' CG1' HG23 ' A' ' 54' ' ' VAL . 3.8 t -107.46 131.24 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.435 -0.791 . . . . 0.0 110.454 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.494 ' HG3' ' N ' ' A' ' 83' ' ' VAL . 2.3 tp60 -111.38 146.63 36.8 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.923 -1.111 . . . . 0.0 108.952 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.561 ' CA ' HG11 ' A' ' 52' ' ' VAL . 1.5 m -114.52 156.08 15.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.654 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.521 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -57.34 178.79 0.15 Allowed Pre-proline 0 C--N 1.29 -1.981 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.525 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.5 Cg_endo -72.7 145.16 40.82 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 O-C-N 124.149 1.605 . . . . 0.0 110.572 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.84 -18.38 47.62 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.516 ' NE2' ' CB ' ' A' ' 50' ' ' LYS . 57.7 mt-30 -94.59 171.58 8.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 110.557 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 3.1 pttt 179.68 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.823 . . . . 0.0 110.303 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.566 HD12 ' CD2' ' A' ' 26' ' ' TYR . 7.5 mt -63.08 118.62 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.95 . . . . 0.0 110.085 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -76.59 -14.74 59.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -0.826 . . . . 0.0 110.678 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.532 ' CB ' HD23 ' A' ' 92' ' ' LEU . . . -56.23 -34.67 66.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 110.946 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.577 HD13 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.23 -23.5 12.56 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.985 -1.072 . . . . 0.0 110.149 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -65.67 -43.24 89.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.259 -0.901 . . . . 0.0 110.289 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.3 8.27 75.31 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.525 ' CD2' HD21 ' A' ' 13' ' ' LEU . 2.3 tp -88.58 24.87 1.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -1.155 . . . . 0.0 110.245 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.605 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 6.9 mt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.248 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.538 ' O ' ' N ' ' A' ' 3' ' ' THR . 5.8 tpt . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.66 ' HA ' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -64.76 76.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.22 -1.392 . . . . 0.0 108.936 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.64 ' N ' ' CE1' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -120.59 -97.41 0.46 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 111.299 -179.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -88.69 -31.0 18.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.975 . . . . 0.0 110.352 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.66 ' CZ ' ' HA ' ' A' ' 2' ' ' LYS . 1.9 p90 -34.04 -28.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.862 -0.524 . . . . 0.0 112.255 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.579 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 3.6 m-20 -164.0 -51.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.8 -1.187 . . . . 0.0 111.165 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.585 HG23 ' CZ ' ' A' ' 5' ' ' TYR . 39.0 t -43.96 -67.97 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 122.128 0.966 . . . . 0.0 109.281 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.581 HG22 ' CG ' ' A' ' 28' ' ' PHE . 8.7 mt -115.05 95.48 3.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.487 -0.758 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.421 HD21 ' O ' ' A' ' 4' ' ' ALA . 97.6 mt -79.04 -97.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.553 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.16 167.28 9.51 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.076 -1.015 . . . . 0.0 110.497 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HG2' ' CD2' ' A' ' 95' ' ' LEU . 46.7 Cg_endo -73.68 171.11 18.47 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.14 1.6 . . . . 0.0 110.529 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.467 HG23 ' HE2' ' A' ' 78' ' ' LYS . 3.0 m -115.36 144.32 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.411 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.3 mm? -102.65 107.49 18.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.212 -0.93 . . . . 0.0 110.328 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 17' ' ' ALA . 5.5 m -164.9 134.79 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.868 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' SER . 7.2 mt-10 -42.88 -59.34 2.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.117 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 -17.44 6.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.958 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.16 17.24 17.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.887 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.641 ' CD1' ' CE1' ' A' ' 21' ' ' PHE . 2.2 m-85 -139.18 -38.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.388 -0.82 . . . . 0.0 109.933 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.35 80.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.05 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 25' ' ' LYS . . . -95.52 -34.95 5.84 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.09 -17.73 64.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 18' ' ' TYR . . . -70.5 -17.05 62.96 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.725 -0.61 . . . . 0.0 110.654 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -88.7 16.37 6.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 110.341 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 102.07 -2.06 51.33 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.48 136.45 34.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.514 -0.992 . . . . 0.0 109.534 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 99.5 m-85 -126.69 116.01 20.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 0.0 111.626 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 3.7 m -83.26 141.29 31.97 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.639 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 26.5 m-85 -134.06 164.37 27.47 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.33 -0.856 . . . . 0.0 110.933 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.57 ' CZ3' HG22 ' A' ' 59' ' ' VAL . 19.6 m95 -97.01 122.35 39.91 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.559 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 11.6 p -138.69 164.91 25.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.059 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.587 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 1.6 t60 -81.13 152.85 71.66 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.304 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 44.5 Cg_endo -70.89 65.7 2.46 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.06 1.558 . . . . 0.0 109.727 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.73 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.665 -179.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.468 ' HB1' HG22 ' A' ' 30' ' ' VAL . . . -42.42 95.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.44 -0.787 . . . . 0.0 109.602 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -39.39 134.27 1.23 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.382 -0.824 . . . . 0.0 110.894 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.499 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 1.9 mttt -46.9 -48.02 21.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.83 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.8 m -62.04 -39.53 92.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 0.0 109.424 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 4.7 mt-10 -55.83 -40.9 73.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 108.937 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.538 ' CA ' HD12 ' A' ' 8' ' ' ILE . 30.6 mt -58.0 -31.03 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.469 -0.77 . . . . 0.0 109.003 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HA ' HG11 ' A' ' 51' ' ' VAL . 3.8 tttt -59.54 -47.3 86.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.777 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.458 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.4 m-80 -72.75 -34.02 66.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.701 -0.624 . . . . 0.0 111.194 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.614 ' HA ' ' CA ' ' A' ' 3' ' ' THR . . . -58.0 -50.43 73.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.786 -1.196 . . . . 0.0 110.553 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 28' ' ' PHE . 3.7 m -67.3 -32.84 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.651 -1.281 . . . . 0.0 109.489 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -69.04 -44.51 72.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 108.812 178.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.551 ' HB ' ' CG2' ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.07 -16.44 56.77 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -104.23 -67.44 0.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.498 -0.751 . . . . 0.0 110.315 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.604 ' CE2' ' CE1' ' A' ' 28' ' ' PHE . 52.4 m-85 -71.95 -21.91 61.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.0 110.343 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 64.94 46.4 2.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -123.56 -158.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.512 -0.743 . . . . 0.0 110.136 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.555 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -116.89 110.4 18.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 109.762 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' A' ' 43' ' ' VAL . 92.3 t -78.73 120.4 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.931 . . . . 0.0 110.321 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.548 HG13 ' CA ' ' A' ' 83' ' ' VAL . 10.1 p -112.83 3.85 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.263 -0.898 . . . . 0.0 109.988 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 1.8 mttp 169.12 119.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.055 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.87 131.39 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.048 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.499 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 13.1 t30 -131.17 115.97 17.07 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.34 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -116.61 161.36 19.29 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.193 -0.942 . . . . 0.0 109.945 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -156.65 170.83 21.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.383 -0.823 . . . . 0.0 110.188 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.461 ' NE2' ' OD2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -80.76 129.77 34.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 110.219 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.583 ' CG1' ' CD ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -120.16 125.94 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.48 -0.762 . . . . 0.0 110.074 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 74' ' ' PRO . 15.7 mmt85 -114.95 131.09 57.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 110.264 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -107.59 138.51 14.59 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -79.47 -2.36 41.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -1.17 . . . . 0.0 110.272 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -117.53 177.58 4.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.213 -0.929 . . . . 0.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.87 25.33 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.269 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 67' ' ' GLY . 36.9 ptt180 -104.58 -29.76 10.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.205 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -41.79 100.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -0.834 . . . . 0.0 110.401 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 65' ' ' ARG . . . -179.23 155.62 16.42 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.573 ' O ' ' CD2' ' A' ' 69' ' ' TYR . 7.5 mtt85 -89.39 179.39 6.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -1.157 . . . . 0.0 110.3 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER 50.72 113.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.851 0.834 . . . . 0.0 111.106 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 42.73 40.22 1.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.069 -1.02 . . . . 0.0 110.15 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 72' ' ' LYS . . . -99.83 -178.12 30.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 71' ' ' GLY . 14.6 mtpt 56.77 111.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -1.168 . . . . 0.0 110.1 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER 44.16 77.27 0.46 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 110.088 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 50.9 Cg_endo -77.4 -165.01 0.3 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.179 1.621 . . . . 0.0 110.393 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.461 ' OD2' ' NE2' ' A' ' 58' ' ' HIS . 0.3 OUTLIER -114.68 89.4 3.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.474 ' HB3' HG23 ' A' ' 59' ' ' VAL . 4.3 mpt_? -101.81 143.11 32.13 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.581 -0.699 . . . . 0.0 110.201 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.534 ' HG2' ' CG1' ' A' ' 30' ' ' VAL . 10.4 tttt -120.87 133.69 55.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.583 ' CD ' ' CG1' ' A' ' 59' ' ' VAL . 3.8 mttt -110.23 151.48 27.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.367 -0.833 . . . . 0.0 109.942 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -123.14 119.77 31.25 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.933 -1.104 . . . . 0.0 112.193 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.627 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.5 mp -102.42 111.88 33.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 24.0 t -111.08 136.09 48.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.486 -0.759 . . . . 0.0 110.433 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 23' ' ' GLU . 1.9 tp60 -111.47 151.32 28.72 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.222 -0.924 . . . . 0.0 108.868 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.548 ' CA ' HG13 ' A' ' 52' ' ' VAL . 2.0 m -112.68 155.71 13.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 C-N-CA 118.069 -1.453 . . . . 0.0 109.531 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -49.16 179.03 0.03 OUTLIER Pre-proline 0 C--N 1.291 -1.936 0 O-C-N 121.543 -0.723 . . . . 0.0 110.482 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.4 Cg_endo -71.79 140.07 34.76 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.22 1.642 . . . . 0.0 110.492 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.19 -24.58 12.97 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.504 ' NE2' ' HB2' ' A' ' 50' ' ' LYS . 87.1 mt-30 -95.82 164.37 12.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -1.148 . . . . 0.0 110.619 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER 179.43 108.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.245 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.58 ' HB ' ' CE1' ' A' ' 26' ' ' TYR . 91.4 mt -51.11 91.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.126 -0.984 . . . . 0.0 109.541 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 88' ' ' LYS . 4.1 mm-40 -63.01 -13.39 34.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 111.206 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.524 ' CB ' HD23 ' A' ' 92' ' ' LEU . . . -54.65 -33.76 61.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 110.804 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.545 ' N ' ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -106.87 -23.67 12.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.952 -1.092 . . . . 0.0 110.507 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -48.95 -30.97 6.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.163 -0.961 . . . . 0.0 110.14 -179.149 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.404 ' N ' ' HG3' ' A' ' 93' ' ' GLU . . . -103.48 -19.89 11.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.502 ' CD2' ' HG2' ' A' ' 11' ' ' PRO . 26.7 tp -53.13 -19.14 2.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -1.114 . . . . 0.0 110.054 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.638 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 32.4 mt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.131 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.774 0.321 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.673 ' HA ' ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -85.22 65.9 9.45 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.017 178.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.555 ' O ' ' CB ' ' A' ' 42' ' ' ALA . 11.7 p -108.87 -105.71 0.35 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -83.51 -5.12 59.07 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.983 -1.073 . . . . 0.0 109.198 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.673 ' CE2' ' HA ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -52.54 -140.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.094 0.95 . . . . 0.0 111.394 178.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.641 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 14.2 m-20 -29.87 -58.43 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.81 -0.556 . . . . 0.0 112.144 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.638 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 58.2 t -52.71 -109.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.497 -0.752 . . . . 0.0 110.994 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.661 ' CG2' ' CG ' ' A' ' 28' ' ' PHE . 24.0 mt -88.28 113.19 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 120.681 -1.262 . . . . 0.0 111.268 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.4 mp -92.06 -88.22 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.291 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.03 150.85 40.91 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.45 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.487 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.8 Cg_endo -74.32 -178.21 3.8 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.065 1.561 . . . . 0.0 110.177 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.469 ' O ' HG21 ' A' ' 12' ' ' VAL . 1.9 m -115.16 133.33 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.149 -0.969 . . . . 0.0 110.347 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.567 HD13 ' CE2' ' A' ' 18' ' ' TYR . 3.2 mm? -103.12 112.83 25.87 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.193 -0.942 . . . . 0.0 110.185 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 17' ' ' ALA . 60.6 m -163.79 128.65 2.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.145 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -42.96 -58.63 2.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.898 . . . . 0.0 110.048 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -17.63 3.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 110.215 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.7 -48.04 5.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 110.149 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.567 ' CE2' HD13 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -52.79 -33.1 47.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 109.772 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.47 -21.6 66.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -100.81 -37.59 3.64 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 105.683 -2.967 . . . . 0.0 105.683 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -64.64 -19.17 65.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' TYR . . . -93.36 4.63 53.66 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.219 0.533 . . . . 0.0 110.629 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -111.87 16.58 20.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.764 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 95.69 -24.82 27.79 Favored Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 39.7 mttm -81.79 140.42 34.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.352 -1.087 . . . . 0.0 109.153 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.585 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 35.4 m-85 -126.92 110.18 12.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.803 -1.186 . . . . 0.0 112.234 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.524 ' CG2' ' HD3' ' A' ' 78' ' ' LYS . 28.3 m -80.57 118.25 21.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.661 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -116.99 164.97 13.9 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 111.638 -178.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.572 ' CH2' HG13 ' A' ' 59' ' ' VAL . 7.4 m95 -97.81 123.0 41.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 2.0 p -145.56 157.45 12.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 C-N-CA 118.195 -1.402 . . . . 0.0 111.712 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.575 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -59.21 149.57 67.3 Favored Pre-proline 0 C--N 1.297 -1.679 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.044 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.575 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 47.7 Cg_endo -73.02 71.57 3.47 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.061 1.558 . . . . 0.0 109.808 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.48 -33.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.417 -0.802 . . . . 0.0 109.932 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HB3' ' CG1' ' A' ' 7' ' ' VAL . . . -42.36 93.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.484 -0.76 . . . . 0.0 109.799 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -42.17 141.68 0.88 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 110.443 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 4.3 mmtp -42.63 -41.13 2.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.372 -0.83 . . . . 0.0 109.778 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 62.1 m -70.97 -35.93 72.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.728 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 5.8 mt-10 -58.54 -42.53 88.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.553 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.53 HG22 ' CG2' ' A' ' 54' ' ' VAL . 0.7 OUTLIER -57.48 -31.68 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HG3' ' CB ' ' A' ' 51' ' ' VAL . 8.1 tttm -62.97 -46.37 88.02 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.552 -0.717 . . . . 0.0 109.627 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.532 ' O ' ' CG2' ' A' ' 45' ' ' THR . 38.4 m-80 -72.97 -34.12 66.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.601 -0.687 . . . . 0.0 110.921 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 3' ' ' THR . . . -57.74 -50.27 73.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.932 -1.105 . . . . 0.0 110.43 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 2.7 m -76.64 -36.61 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.869 -1.144 . . . . 0.0 110.654 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -56.92 -32.31 65.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.942 -1.099 . . . . 0.0 110.256 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 41' ' ' ASN . 35.4 p -77.99 -46.01 22.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.234 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.06 -55.61 4.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 0.0 110.735 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.596 ' CE1' ' CG2' ' A' ' 89' ' ' ILE . 21.0 m-85 -71.67 -21.33 61.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.155 -0.966 . . . . 0.0 110.372 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 51.08 44.52 28.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -115.29 -162.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.633 -0.667 . . . . 0.0 109.923 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.576 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 8.0 tmtt? -117.2 108.32 15.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.893 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.524 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . 33.5 t -78.44 119.64 27.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.242 -0.911 . . . . 0.0 109.769 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.567 HG11 ' CA ' ' A' ' 83' ' ' VAL . 3.3 p -107.26 -12.75 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.43 -0.794 . . . . 0.0 110.167 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -173.15 123.4 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.979 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.53 ' CG2' HG22 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -123.63 131.2 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.192 -0.942 . . . . 0.0 110.085 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.471 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 2.5 m-20 -131.07 115.82 16.95 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.538 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -114.8 146.04 41.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 pp -128.01 153.45 46.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.279 -0.888 . . . . 0.0 110.608 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.566 ' NE2' ' NH2' ' A' ' 60' ' ' ARG . 2.0 t-160 -66.32 118.32 9.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.144 -0.973 . . . . 0.0 109.279 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.572 HG13 ' CH2' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -103.87 121.29 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.246 -0.909 . . . . 0.0 110.013 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.566 ' NH2' ' NE2' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -130.57 122.07 26.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 47.19 -174.04 0.02 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.48 -30.44 3.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -1.097 . . . . 0.0 110.141 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 64' ' ' LYS . 7.7 tptp -160.41 68.65 0.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.173 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 63' ' ' LYS . 7.3 mttt 52.95 171.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.22 -9.01 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.928 . . . . 0.0 110.406 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER 41.29 51.83 3.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.249 -0.907 . . . . 0.0 110.203 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 66' ' ' LEU . . . 41.19 44.67 3.85 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -153.34 -177.55 6.41 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.497 -1.002 . . . . 0.0 110.193 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.423 ' N ' ' HG3' ' A' ' 68' ' ' ARG . 22.3 t80 -93.32 92.63 7.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.0 110.132 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.36 39.91 1.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 110.156 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 72' ' ' LYS . . . 128.6 -38.52 2.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 7.1 mttt 63.11 -176.31 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -1.134 . . . . 0.0 109.984 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.36 78.4 22.63 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 110.453 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HG2' ' NE ' ' A' ' 76' ' ' ARG . 51.5 Cg_endo -77.02 -165.73 0.34 Allowed 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.063 1.56 . . . . 0.0 110.265 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.408 ' HA ' ' NH2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -115.07 89.39 3.09 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.53 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.563 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -124.1 151.45 43.88 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.624 -0.673 . . . . 0.0 110.365 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.526 ' CA ' HG22 ' A' ' 59' ' ' VAL . 19.9 tttt -123.5 137.51 54.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.561 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 6.9 mttt -101.06 147.69 25.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.164 -0.96 . . . . 0.0 109.936 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -133.44 121.87 22.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.0 111.873 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.623 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -98.67 111.7 28.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' TYR . 2.4 t -107.41 122.27 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.505 -0.747 . . . . 0.0 110.659 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.518 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 4.5 tp-100 -104.37 142.81 33.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 109.016 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.567 ' CA ' HG11 ' A' ' 52' ' ' VAL . 1.1 m -109.76 156.99 10.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 C-N-CA 118.15 -1.42 . . . . 0.0 109.896 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.506 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -72.14 178.83 1.19 Allowed Pre-proline 0 C--N 1.291 -1.965 0 O-C-N 121.65 -0.656 . . . . 0.0 110.235 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.1 Cg_endo -73.04 140.4 31.29 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 124.234 1.65 . . . . 0.0 110.345 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.63 -30.36 9.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.452 ' HB2' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -112.19 176.39 5.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.204 -1.174 . . . . 0.0 110.467 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.3 OUTLIER 179.3 115.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 110.331 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.596 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 39.5 mt -67.91 60.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.174 -0.954 . . . . 0.0 109.655 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 88' ' ' LYS . 14.1 pt-20 -58.2 -13.08 4.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.445 -0.785 . . . . 0.0 111.022 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.24 -16.63 2.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.989 -1.07 . . . . 0.0 110.627 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.543 ' N ' ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.21 -23.23 12.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.062 -1.024 . . . . 0.0 109.634 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.4 -19.75 6.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.352 -0.842 . . . . 0.0 110.332 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.08 -20.16 11.67 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.5 tp -46.36 -24.37 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.566 HG13 ' CE2' ' A' ' 18' ' ' TYR . 2.0 mp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.21 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' O ' ' N ' ' A' ' 3' ' ' THR . 4.1 ptm . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 120.585 0.231 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.698 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -61.5 87.8 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.08 -1.448 . . . . 0.0 108.848 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.543 ' HA ' HG21 ' A' ' 45' ' ' THR . 3.2 p -133.72 -19.95 2.04 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.756 0.789 . . . . 0.0 110.984 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.605 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . 178.71 -27.24 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.628 -0.67 . . . . 0.0 109.337 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.698 ' CE1' ' HA ' ' A' ' 2' ' ' LYS 0.277 0.1 OUTLIER -45.97 -135.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.857 0.837 . . . . 0.0 112.059 178.17 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.646 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 5.7 t0 -24.39 -58.62 0.05 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.866 0.841 . . . . 0.0 111.305 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.562 ' CG1' HG13 ' A' ' 8' ' ' ILE . 39.6 t -70.24 156.67 7.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.779 -0.576 . . . . 0.0 110.977 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.641 ' CG2' ' CG ' ' A' ' 28' ' ' PHE . 16.2 mt 24.56 51.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.302 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 29' ' ' TRP . 3.5 mt -44.71 -99.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.307 -0.87 . . . . 0.0 111.262 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -99.56 151.68 37.53 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.924 -1.11 . . . . 0.0 110.816 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.632 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 49.8 Cg_endo -76.33 153.6 35.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.103 1.581 . . . . 0.0 110.519 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.522 HG11 ' CG2' ' A' ' 27' ' ' THR . 1.5 p -115.15 105.21 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.058 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.12 106.75 17.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.57 -178.54 5.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.184 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -57.34 -67.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.251 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -45.66 74.46 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.258 -0.901 . . . . 0.0 110.354 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 21' ' ' PHE . . . -56.21 -48.9 75.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.575 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 1.9 m-85 -57.9 -33.33 68.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.875 . . . . 0.0 110.147 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.37 -8.88 49.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.858 . . . . 0.0 109.865 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -103.33 -38.23 2.88 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -74.94 -18.88 60.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.571 -0.958 . . . . 0.0 108.873 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 18' ' ' TYR . . . -56.92 -20.7 24.79 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.702 -0.624 . . . . 0.0 110.729 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.6 17.27 5.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.38 -0.825 . . . . 0.0 110.059 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.04 0.89 67.74 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 48.8 mttt -82.79 143.47 30.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.567 -0.961 . . . . 0.0 109.545 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.615 ' CD2' ' CD1' ' A' ' 89' ' ' ILE . 22.9 m-85 -128.01 99.41 5.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.611 -1.306 . . . . 0.0 111.083 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.7 m -74.63 127.32 32.83 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.641 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -131.44 165.23 23.98 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.314 -0.866 . . . . 0.0 111.162 -178.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.512 ' O ' ' N ' ' A' ' 9' ' ' LEU . 46.1 m95 -100.0 123.27 44.06 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 7' ' ' VAL . 2.0 p -142.55 164.81 17.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.081 -176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.562 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 2.5 t60 -65.34 149.76 96.64 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.545 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 48.1 Cg_endo -73.18 67.49 4.22 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.088 1.573 . . . . 0.0 109.434 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.72 -32.19 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.405 -0.81 . . . . 0.0 110.062 -178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -41.09 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.692 . . . . 0.0 109.882 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -45.99 142.12 2.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.0 110.388 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -42.81 -38.62 2.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.841 . . . . 0.0 109.675 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.6 m -73.17 -36.24 66.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.556 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -59.32 -43.46 92.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.158 -0.963 . . . . 0.0 109.207 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.539 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 13.4 mt -57.75 -30.46 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.523 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 14.5 tttt -65.29 -45.09 85.82 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.595 0.712 . . . . 0.0 110.127 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.566 ' O ' ' CG2' ' A' ' 45' ' ' THR . 10.1 m-80 -71.27 -49.31 44.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.59 -0.694 . . . . 0.0 111.905 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 3' ' ' THR . . . -57.16 -51.07 70.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.792 -1.192 . . . . 0.0 110.946 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.405 HG21 ' CE2' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -59.45 -40.92 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.84 -1.162 . . . . 0.0 110.249 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -65.6 -29.56 70.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.181 -0.949 . . . . 0.0 110.755 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.566 ' CG2' ' O ' ' A' ' 41' ' ' ASN . 28.1 p -66.17 -47.08 75.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.081 . . . . 0.0 110.979 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.56 -56.67 3.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 111.338 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.571 ' CD2' HD12 ' A' ' 89' ' ' ILE . 8.8 m-85 -71.59 -21.19 61.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.147 -0.971 . . . . 0.0 110.694 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 31.1 mtmt 48.42 41.02 16.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 109.665 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -102.87 -161.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.721 -0.612 . . . . 0.0 109.625 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.551 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 6.0 tmtm? -114.48 112.38 22.9 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.68 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.523 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 48.8 t -77.64 119.79 27.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 84' ' ' ALA . 41.1 t -114.21 -14.5 10.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.487 -0.758 . . . . 0.0 110.554 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.9 OUTLIER -178.75 115.1 0.07 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.463 -0.773 . . . . 0.0 109.998 179.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.522 HG22 ' CG1' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -112.76 130.9 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.808 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 80' ' ' ILE . 17.3 m120 -130.48 115.96 17.54 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.793 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.528 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -114.58 160.27 19.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.6 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 pp -141.71 166.64 24.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.592 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.57 ' CD2' ' HG2' ' A' ' 60' ' ' ARG . 5.7 t-160 -77.47 118.36 19.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.127 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.573 ' CG2' ' N ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -119.6 130.93 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.284 -0.885 . . . . 0.0 110.187 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.57 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 15.7 mmt85 -145.21 137.26 25.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . -50.75 -178.06 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 62' ' ' LYS . 0.7 OUTLIER -139.45 48.96 1.83 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.35 -1.088 . . . . 0.0 110.122 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 64' ' ' LYS . 1.3 tttp -148.42 -90.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -42.31 -71.65 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 0.0 110.249 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -52.21 159.1 1.0 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.262 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER 178.38 107.08 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.396 -0.815 . . . . 0.0 110.145 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.51 ' O ' ' CG ' ' A' ' 68' ' ' ARG . . . -43.35 94.36 0.01 OUTLIER Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 66' ' ' LEU . 28.4 mtt180 -165.39 -172.29 2.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -1.106 . . . . 0.0 110.126 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 18.6 p90 -47.73 135.21 12.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 110.119 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER 40.86 41.22 1.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.424 -0.798 . . . . 0.0 110.358 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.1 147.25 18.37 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.56 160.53 31.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -1.149 . . . . 0.0 110.259 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.456 ' HG3' ' HD2' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -96.42 146.96 32.22 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 0.0 110.17 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HD2' ' HG3' ' A' ' 73' ' ' ARG . 48.4 Cg_endo -73.86 -165.28 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.033 1.544 . . . . 0.0 110.464 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.537 ' CB ' ' HG3' ' A' ' 32' ' ' PRO . 76.6 m-20 -114.71 89.64 3.14 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.475 -0.766 . . . . 0.0 109.261 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.483 ' HG2' ' HB ' ' A' ' 59' ' ' VAL . 6.8 ttm180 -129.35 112.49 13.9 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.625 -0.672 . . . . 0.0 109.961 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.532 ' CA ' HG21 ' A' ' 59' ' ' VAL . 13.7 tttt -123.06 139.21 54.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.912 . . . . 0.0 110.076 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.573 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 15.4 mttt -101.88 147.22 26.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.335 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' PHE . . . -131.49 126.71 35.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.12 -0.987 . . . . 0.0 111.847 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.6 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -105.61 111.77 36.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.522 ' CG1' HG22 ' A' ' 54' ' ' VAL . 1.4 t -96.44 141.47 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.435 -0.791 . . . . 0.0 110.284 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 53' ' ' LYS . 7.5 tp60 -121.13 142.46 49.84 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.376 -0.828 . . . . 0.0 109.507 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 84' ' ' ALA . 2.6 m -125.24 156.65 34.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.437 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 52' ' ' VAL . . . -44.19 171.87 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.798 0 CA-C-O 121.302 0.572 . . . . 0.0 110.854 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.8 53.94 4.6 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 O-C-N 124.39 1.732 . . . . 0.0 110.232 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -167.42 -47.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.519 ' OE1' ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -51.04 -173.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -1.155 . . . . 0.0 110.848 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 3.4 pttt 178.98 80.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.505 -0.747 . . . . 0.0 110.416 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.615 ' CD1' ' CD2' ' A' ' 26' ' ' TYR . 5.2 mt -47.69 109.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.736 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 4.7 mm-40 -67.43 -14.64 63.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 0.0 110.74 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.433 ' HB2' HD21 ' A' ' 92' ' ' LEU . . . -57.47 -36.8 71.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.201 -0.937 . . . . 0.0 110.84 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.99 -23.55 12.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.009 -1.057 . . . . 0.0 110.107 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.0 mm-40 -60.63 -31.9 71.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -0.903 . . . . 0.0 110.239 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.35 -12.8 40.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.425 HD23 HD21 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -80.4 -10.66 59.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.208 -1.172 . . . . 0.0 110.203 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 18' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.03 -0.985 . . . . 0.0 110.216 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.754 0.312 . . . . 0.0 110.583 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.618 ' N ' ' HA ' ' A' ' 6' ' ' ASP . 48.1 mmtt -44.6 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.592 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.4 m 4.45 -71.74 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.636 0 CA-C-O 121.233 0.54 . . . . 0.0 110.865 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 2' ' ' LYS 0.26 . . -55.69 81.02 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 177.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.625 ' CE2' HG23 ' A' ' 7' ' ' VAL . 1.0 OUTLIER 23.56 47.9 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.827 0.822 . . . . 0.0 110.405 -178.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.618 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 4.7 t0 65.77 52.89 1.23 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.0 0.905 . . . . 0.0 111.447 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.625 HG23 ' CE2' ' A' ' 5' ' ' TYR . 3.0 t -134.48 -126.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.239 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.64 ' CG2' ' CD2' ' A' ' 28' ' ' PHE . 2.7 mt -57.55 152.0 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.16 -0.962 . . . . 0.0 110.315 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.533 ' CG ' ' HB3' ' A' ' 2' ' ' LYS . 2.2 mt -132.87 -99.34 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.479 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.58 153.66 42.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.02 . . . . 0.0 110.504 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HG3' ' CD2' ' A' ' 92' ' ' LEU . 47.7 Cg_endo -74.94 161.53 38.76 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.07 1.563 . . . . 0.0 110.354 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.561 HG12 ' CD1' ' A' ' 29' ' ' TRP . 2.7 m -104.86 143.02 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.226 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 18' ' ' TYR . 3.2 mm? -102.41 106.89 17.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -154.78 142.11 19.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.997 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 9.7 tm-20 -42.52 -52.65 4.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.895 . . . . 0.0 110.145 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -54.72 -42.02 71.02 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.107 -0.996 . . . . 0.0 110.094 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.54 ' N ' ' CG ' ' A' ' 16' ' ' LYS . . . -65.97 -63.24 1.13 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.34 -0.85 . . . . 0.0 110.028 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.538 ' CE2' HD11 ' A' ' 13' ' ' LEU . 1.6 m-85 -48.8 -30.66 5.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 110.302 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.21 -9.2 55.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.48 -38.39 1.78 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -73.61 -23.47 59.91 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.533 -0.98 . . . . 0.0 108.974 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -51.39 -21.09 2.06 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.628 -0.67 . . . . 0.0 110.064 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.36 16.37 13.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.266 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.73 2.36 65.08 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 77.0 mttt -82.26 142.53 32.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -1.14 . . . . 0.0 109.544 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 19.9 m-85 -127.7 104.23 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.751 -1.218 . . . . 0.0 112.073 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.8 m -76.01 124.54 27.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.64 ' CD2' ' CG2' ' A' ' 8' ' ' ILE . 14.9 m-85 -124.72 164.92 18.91 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.525 -0.734 . . . . 0.0 110.989 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.572 ' CZ3' HG23 ' A' ' 59' ' ' VAL . 33.4 m95 -102.88 122.24 44.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.462 HG21 HG11 ' A' ' 7' ' ' VAL . 5.2 p -144.49 165.49 12.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.496 -1.282 . . . . 0.0 111.81 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.475 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 1.5 t60 -60.81 148.53 82.65 Favored Pre-proline 0 C--N 1.297 -1.678 0 O-C-N 121.927 -0.483 . . . . 0.0 110.495 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.9 Cg_endo -72.39 71.05 3.14 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.15 1.605 . . . . 0.0 109.915 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.538 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.18 -33.85 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.947 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -50.3 90.63 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.412 -0.805 . . . . 0.0 109.98 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -48.41 176.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -69.01 -28.84 66.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 110.185 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.2 m -75.06 -52.25 11.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.872 . . . . 0.0 110.583 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 35' ' ' THR . 89.4 mt-10 -55.1 -42.82 73.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.919 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CA ' HD11 ' A' ' 8' ' ' ILE . 26.7 mt -57.07 -30.69 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.163 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.545 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 10.1 tttp -62.87 -47.29 83.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.867 . . . . 0.0 111.322 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -62.39 -35.06 78.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.452 -0.78 . . . . 0.0 112.695 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . -69.85 -50.26 44.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.484 -1.385 . . . . 0.0 111.896 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 39' ' ' ILE . 14.4 m -69.87 -32.14 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.575 -1.328 . . . . 0.0 110.787 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.53 ' CG ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -60.33 -52.68 64.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.989 -1.069 . . . . 0.0 109.91 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -79.84 -24.43 41.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 110.251 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -84.8 -64.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.877 . . . . 0.0 110.505 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.515 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 11.3 m-85 -71.69 -21.22 61.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 109.991 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER 66.48 44.12 2.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.377 -0.827 . . . . 0.0 110.335 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.579 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -125.77 -162.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.585 -0.697 . . . . 0.0 109.858 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.579 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -115.01 114.74 25.8 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 109.811 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.545 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 11.7 t -77.95 119.76 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.266 -0.896 . . . . 0.0 109.236 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.527 HG21 ' N ' ' A' ' 84' ' ' ALA . 25.5 t -114.01 -14.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.521 -0.737 . . . . 0.0 110.721 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.15 115.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -0.792 . . . . 0.0 110.091 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 0.9 OUTLIER -113.03 116.77 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.653 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -116.43 116.26 27.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.377 -0.827 . . . . 0.0 109.679 179.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.538 ' OG1' ' CE ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -115.92 155.26 28.3 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.89 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.514 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -144.89 161.02 40.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 109.922 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -82.35 124.36 29.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.0 110.408 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.572 HG23 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -120.28 114.09 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.592 -0.692 . . . . 0.0 110.005 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 74' ' ' PRO . 3.5 mmt85 -99.03 100.57 11.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.43 94.32 0.09 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -169.48 -36.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.131 . . . . 0.0 110.214 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 2.5 mmtt -74.07 148.15 42.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.188 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' LYS . 4.2 mttp -41.83 142.61 0.64 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 110.553 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 5.8 mtm105 -142.02 -46.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 109.954 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.468 ' O ' ' C ' ' A' ' 67' ' ' GLY . 0.9 OUTLIER 58.89 49.29 9.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.812 . . . . 0.0 110.6 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 66' ' ' LEU . . . 37.42 79.84 0.03 OUTLIER Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -135.13 150.4 50.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -1.226 . . . . 0.0 110.325 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 69' ' ' TYR . 34.8 p90 -44.03 118.46 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.04 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER 40.3 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.415 -0.803 . . . . 0.0 110.363 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.17 -167.17 30.26 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.99 79.57 1.27 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -1.161 . . . . 0.0 110.238 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.438 ' CB ' ' HB3' ' A' ' 60' ' ' ARG . 11.3 mtm180 -77.34 141.45 66.2 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.458 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 49.2 Cg_endo -73.22 -165.48 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.092 1.574 . . . . 0.0 110.433 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.73 89.39 3.08 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 109.201 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.4 OUTLIER -125.9 144.89 50.49 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.632 -0.667 . . . . 0.0 110.365 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.538 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 0.3 OUTLIER -124.06 141.96 51.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 110.155 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 1.9 ptpt -100.96 150.2 23.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.004 -1.06 . . . . 0.0 109.518 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -117.95 128.63 54.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.147 -0.971 . . . . 0.0 112.124 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.607 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -105.57 111.74 36.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.413 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.569 HG23 ' CE2' ' A' ' 28' ' ' PHE . 13.5 t -102.83 137.62 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.48 -0.763 . . . . 0.0 110.724 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 39.1 tp60 -117.93 153.47 33.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.866 . . . . 0.0 109.831 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 84' ' ' ALA . 2.4 m -125.34 157.11 34.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.697 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.527 ' N ' HG21 ' A' ' 52' ' ' VAL . . . -45.47 177.2 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.686 0 CA-C-O 121.275 0.559 . . . . 0.0 110.926 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.8 Cg_endo -73.48 140.53 30.16 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.25 1.658 . . . . 0.0 110.299 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.27 -21.71 19.48 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.511 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 49.1 mt-30 -89.28 167.22 13.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -1.16 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HA ' ' OH ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER 179.67 99.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 110.522 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.579 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 24.5 mt -44.12 104.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 109.623 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 15.4 mm-40 -56.34 -13.97 2.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.455 -0.778 . . . . 0.0 111.677 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.508 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . -55.0 -36.46 65.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.861 -1.149 . . . . 0.0 110.732 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.576 HD11 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.56 -23.33 12.5 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.046 -1.034 . . . . 0.0 109.827 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 15.3 mm-40 -49.99 -44.6 51.09 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.444 -0.785 . . . . 0.0 110.555 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.59 1.57 58.5 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.46 ' O ' ' OH ' ' A' ' 18' ' ' TYR . 15.9 tp -77.52 3.06 14.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -1.172 . . . . 0.0 110.196 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.299 -179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.16 0.505 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.647 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -95.9 82.22 3.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.014 -1.054 . . . . 0.0 109.171 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.613 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -133.61 -94.1 0.32 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.37 -0.831 . . . . 0.0 110.254 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.532 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -77.14 -17.57 58.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.106 -0.996 . . . . 0.0 109.808 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.647 ' CZ ' ' HB3' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -54.08 -139.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.779 0.8 . . . . 0.0 110.311 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 62.2 m-20 -31.99 -58.37 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.5 -0.75 . . . . 0.0 112.022 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.626 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 62.0 t -45.64 -101.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.293 -0.88 . . . . 0.0 111.29 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.561 ' HA ' ' CG1' ' A' ' 30' ' ' VAL . 37.3 mt -88.25 104.15 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.852 -1.155 . . . . 0.0 110.925 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 mt -70.39 -98.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.855 . . . . 0.0 110.352 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.46 159.26 31.43 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.024 -1.048 . . . . 0.0 110.467 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 48.3 Cg_endo -75.0 171.09 19.01 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.088 1.572 . . . . 0.0 110.5 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.578 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.19 132.85 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.917 . . . . 0.0 110.315 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.1 mm? -103.23 106.65 17.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.131 -0.98 . . . . 0.0 110.114 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.438 ' OG ' ' C ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -165.72 140.82 4.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.938 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -43.03 -41.03 3.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.121 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -54.64 -24.55 22.08 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.247 -0.908 . . . . 0.0 110.145 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -100.74 -51.4 3.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.521 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.5 m-85 -54.77 -47.33 74.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.71 -9.41 43.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.88 . . . . 0.0 109.012 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 21' ' ' PHE . . . -98.29 -41.27 3.26 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.864 -2.495 . . . . 0.0 106.864 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.609 ' CE1' ' HA ' ' A' ' 26' ' ' TYR . 4.4 m-30 -48.4 -27.36 2.56 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -37.8 -42.91 0.63 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.62 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.45 -18.25 21.69 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.384 -0.823 . . . . 0.0 110.573 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.509 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 123.01 5.15 8.24 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HG2' ' HB2' ' A' ' 82' ' ' GLN . 23.7 mttt -82.67 127.96 33.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 109.596 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.657 ' CB ' ' CZ ' ' A' ' 28' ' ' PHE . 65.9 m-85 -127.11 114.66 18.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.711 -1.243 . . . . 0.0 112.297 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 5.4 m -81.47 123.98 29.06 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.469 0.652 . . . . 0.0 110.61 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 26' ' ' TYR . 61.5 m-85 -122.27 148.67 44.71 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.435 -0.79 . . . . 0.0 110.538 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.578 ' CD1' HG12 ' A' ' 12' ' ' VAL . 96.9 m95 -76.62 122.8 25.16 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.561 ' CG1' ' HA ' ' A' ' 8' ' ' ILE . 1.9 m -135.91 154.65 34.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.866 -1.146 . . . . 0.0 111.412 -177.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.517 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -52.26 130.92 42.42 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 176.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.529 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 38.8 Cg_endo -65.01 72.99 0.23 Allowed 'Trans proline' 0 C--N 1.294 -2.315 0 O-C-N 123.443 1.233 . . . . 0.0 109.361 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 31' ' ' HIS . 0.1 OUTLIER 179.68 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -41.75 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.387 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -38.36 128.11 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.499 -0.751 . . . . 0.0 110.81 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.542 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 1.5 mttt -41.96 -31.79 0.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.417 -0.802 . . . . 0.0 109.674 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.0 m -72.97 -51.06 19.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.84 . . . . 0.0 109.473 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 4.2 mt-10 -55.43 -38.94 69.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.162 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.508 ' CA ' HD12 ' A' ' 8' ' ' ILE . 38.6 mt -58.08 -30.68 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -0.847 . . . . 0.0 108.969 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 37' ' ' THR . 3.5 tttm -62.04 -47.51 84.43 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.716 0.769 . . . . 0.0 110.083 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.42 -33.93 67.47 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.693 -0.629 . . . . 0.0 111.052 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.54 ' HA ' ' CA ' ' A' ' 3' ' ' THR . . . -58.24 -50.89 71.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.861 -1.149 . . . . 0.0 110.643 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.512 HG13 ' CD2' ' A' ' 47' ' ' PHE . 1.1 m -64.72 -33.26 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.517 -1.364 . . . . 0.0 109.783 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -58.48 -29.05 65.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.848 . . . . 0.0 110.326 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.516 ' CG2' ' HB ' ' A' ' 3' ' ' THR . 1.3 p -77.99 -48.94 15.06 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.109 -0.994 . . . . 0.0 110.346 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . -82.94 -56.24 3.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.543 -0.723 . . . . 0.0 110.907 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.512 ' CD2' HG13 ' A' ' 43' ' ' VAL . 14.3 m-85 -71.41 -11.34 60.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.124 -0.985 . . . . 0.0 110.092 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 21.9 mtpt 41.7 47.86 3.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.434 -0.791 . . . . 0.0 110.17 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -122.01 -164.25 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.52 -0.738 . . . . 0.0 109.987 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.568 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -116.64 109.94 17.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.415 -0.803 . . . . 0.0 109.636 179.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.523 ' CG1' HG12 ' A' ' 81' ' ' VAL . 61.0 t -78.23 148.13 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.196 -0.94 . . . . 0.0 109.974 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.543 ' CG1' ' HG3' ' A' ' 82' ' ' GLN . 7.1 p -139.46 9.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 110.082 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.08 117.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 109.948 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.58 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.24 117.26 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 110.116 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.542 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 20.2 m-20 -115.96 115.67 26.58 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.355 -0.841 . . . . 0.0 109.428 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -114.63 167.05 11.09 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 110.024 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.77 160.63 36.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.489 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.516 ' NE2' ' HA ' ' A' ' 75' ' ' ASP . 3.1 t-160 -75.51 130.85 39.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.063 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.576 HG21 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -120.61 138.29 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.452 -0.78 . . . . 0.0 110.486 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 14.8 mmt85 -112.44 157.68 20.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 110.014 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.36 146.85 17.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.75 23.88 12.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -1.144 . . . . 0.0 110.103 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -106.18 26.46 9.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 3.9 tmtt? 172.8 55.24 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.219 -0.925 . . . . 0.0 110.087 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.468 ' HD3' ' HD2' ' A' ' 73' ' ' ARG . 5.9 ttm180 -115.75 -25.94 7.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 68' ' ' ARG . 1.7 mm? 55.8 108.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -55.48 82.57 0.01 OUTLIER Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -136.08 166.54 23.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.25 -1.147 . . . . 0.0 110.338 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -61.98 149.79 39.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.119 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER 42.4 47.88 4.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 0.0 110.325 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 70' ' ' LEU . . . -43.9 169.4 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.09 128.53 55.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.166 -1.196 . . . . 0.0 110.768 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.468 ' HD2' ' HD3' ' A' ' 65' ' ' ARG . 7.3 mtp180 -137.47 129.62 16.64 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.403 -0.811 . . . . 0.0 109.764 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.59 -170.01 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.782 1.412 . . . . 0.0 110.516 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.516 ' HA ' ' NE2' ' A' ' 58' ' ' HIS . 0.6 OUTLIER -116.56 89.29 3.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.4 -0.812 . . . . 0.0 109.809 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 59' ' ' VAL . 1.6 mpt_? -99.5 135.76 40.44 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.405 -0.809 . . . . 0.0 109.828 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.529 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 29.1 tttt -123.06 128.12 49.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.118 -0.989 . . . . 0.0 110.62 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.539 ' HB3' ' CG2' ' A' ' 27' ' ' THR . 13.4 mtmt -101.34 148.25 25.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.376 -0.827 . . . . 0.0 108.99 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.66 118.96 25.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.97 -1.081 . . . . 0.0 112.007 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 17.5 mt -97.15 110.53 25.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.812 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.58 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 21.9 t -105.99 133.07 51.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.759 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.543 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 42.0 tp60 -111.25 153.46 25.84 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.922 -1.111 . . . . 0.0 109.103 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.7 m -114.66 155.76 15.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 118.179 -1.408 . . . . 0.0 109.611 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.519 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -49.92 178.93 0.03 OUTLIER Pre-proline 0 C--N 1.289 -2.023 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.353 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -72.45 142.39 36.72 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.244 1.655 . . . . 0.0 110.546 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.37 -36.83 3.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 11.7 mt-30 -80.53 173.03 13.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.136 . . . . 0.0 110.618 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 179.63 93.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -0.793 . . . . 0.0 110.216 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.572 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 14.8 mt -43.09 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -0.971 . . . . 0.0 110.026 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.456 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 2.9 mt-10 -75.17 -14.19 60.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 0.0 110.744 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.11 -24.03 23.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.096 -1.002 . . . . 0.0 110.506 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -105.86 -23.2 12.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.11 -0.994 . . . . 0.0 109.592 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 40.0 mm-40 -60.66 -23.17 64.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.399 -0.813 . . . . 0.0 110.196 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.97 -19.47 8.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.4 tp -50.47 -21.05 1.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -1.123 . . . . 0.0 110.13 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.521 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 43.8 mt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.141 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HG2' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.869 0.366 . . . . 0.0 110.393 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.654 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -85.83 60.92 6.53 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.152 178.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -104.62 -106.29 0.3 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.524 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -83.96 -3.41 57.96 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.925 -1.109 . . . . 0.0 108.962 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.654 ' CZ ' ' HB3' ' A' ' 2' ' ' LYS 0.258 0.3 OUTLIER -53.92 -141.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.827 0.822 . . . . 0.0 110.529 178.501 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.65 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 40.0 t0 -27.8 -62.31 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.382 0.611 . . . . 0.0 111.692 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.628 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 84.6 t -49.9 -103.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 111.109 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.581 ' CG2' ' HB3' ' A' ' 28' ' ' PHE . 9.8 mt -84.22 88.65 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 0.0 111.143 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -54.97 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.408 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.51 164.78 13.99 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.574 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.3 Cg_endo -80.22 155.04 22.21 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.013 1.533 . . . . 0.0 110.261 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.589 ' HB ' ' CD1' ' A' ' 29' ' ' TRP . 1.8 p -115.24 112.54 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.085 -1.009 . . . . 0.0 110.32 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.563 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 2.6 mm? -102.55 110.72 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.923 . . . . 0.0 110.391 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -144.71 162.46 36.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.981 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' SER . 52.9 mt-10 -42.79 -65.32 0.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -14.61 32.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 110.344 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' PHE . . . -100.51 23.74 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 110.418 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.563 ' CZ ' HD11 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -134.36 -49.67 0.79 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.075 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.75 -35.29 80.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.102 -0.999 . . . . 0.0 109.324 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -88.76 -34.4 9.15 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.596 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -72.47 -8.69 56.38 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -78.2 -16.59 57.72 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.54 -0.725 . . . . 0.0 110.813 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 2.0 mm-40 -88.74 17.36 5.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.527 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.577 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 101.56 -3.35 53.57 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.52 ' CG ' ' OE1' ' A' ' 82' ' ' GLN . 28.3 mttt -82.44 137.04 34.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.603 -0.94 . . . . 0.0 109.516 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 99.3 m-85 -127.15 112.21 14.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.708 -1.245 . . . . 0.0 111.435 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 3.9 m -82.38 127.96 33.76 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.63 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 22.7 m-85 -123.08 147.43 46.74 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.163 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.604 ' CZ3' ' CG ' ' A' ' 76' ' ' ARG . 3.9 m95 -84.35 122.6 29.16 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.516 ' CG1' ' HA ' ' A' ' 8' ' ' ILE . 1.5 m -138.51 164.07 27.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 118.207 -1.397 . . . . 0.0 112.043 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -61.64 134.36 93.76 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 176.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.513 ' CD ' ' HB3' ' A' ' 75' ' ' ASP . 38.3 Cg_endo -64.2 75.9 0.18 Allowed 'Trans proline' 0 C--N 1.293 -2.359 0 O-C-N 123.22 1.116 . . . . 0.0 109.398 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.47 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.529 ' HB3' ' CG1' ' A' ' 7' ' ' VAL . . . -38.46 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.821 -0.55 . . . . 0.0 109.84 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -46.76 140.58 4.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.108 -0.995 . . . . 0.0 110.76 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.487 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 8.6 mttt -43.42 -45.36 6.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.308 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 3.4 m -61.01 -48.53 81.37 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 109.296 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.426 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 2.1 mt-10 -58.43 -44.51 89.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.358 -0.839 . . . . 0.0 109.356 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.524 ' CG2' HD11 ' A' ' 8' ' ' ILE . 15.3 mt -57.3 -30.71 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.535 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 54.9 tttt -66.55 -47.6 72.32 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.425 -0.797 . . . . 0.0 109.366 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.525 ' O ' ' CG2' ' A' ' 45' ' ' THR . 72.2 m-20 -73.65 -34.38 64.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.625 -0.672 . . . . 0.0 110.8 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 3' ' ' THR . . . -57.96 -50.49 73.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.84 -1.163 . . . . 0.0 110.365 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.63 ' CG1' ' CE2' ' A' ' 28' ' ' PHE . 3.2 m -73.47 -36.33 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.837 -1.164 . . . . 0.0 110.022 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -58.0 -34.71 70.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.088 -1.008 . . . . 0.0 109.48 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' A' ' 3' ' ' THR . 39.9 p -79.3 -45.06 20.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.511 -0.743 . . . . 0.0 110.078 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.46 -56.83 3.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.384 -0.822 . . . . 0.0 111.018 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.576 ' CD1' HG23 ' A' ' 89' ' ' ILE . 6.4 m-85 -71.49 -21.39 61.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.018 -1.051 . . . . 0.0 110.245 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.95 44.45 19.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 110.38 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -123.55 -164.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.515 -0.74 . . . . 0.0 109.791 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.573 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.23 107.3 15.1 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 109.489 179.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.535 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 75.6 t -78.07 119.4 26.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.214 -0.929 . . . . 0.0 110.026 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.1 p -103.43 -0.21 10.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 110.086 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.91 141.58 0.11 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.82 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.581 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -134.3 127.73 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.073 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 47.0 t30 -131.27 115.1 15.86 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.406 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.32 149.23 39.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -130.68 170.98 13.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 110.665 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.525 ' CD2' ' HG2' ' A' ' 60' ' ' ARG . 5.0 t-160 -80.23 115.56 19.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 110.007 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.527 ' CG1' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -119.64 137.29 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.349 -0.845 . . . . 0.0 110.042 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 11.7 mmt180 -145.68 151.4 37.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 110.186 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.51 108.78 1.64 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.9 62.5 7.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -1.142 . . . . 0.0 110.196 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -108.2 114.65 28.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.266 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.57 74.19 0.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 110.185 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 3.9 ttm180 -136.36 -50.63 0.69 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.212 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 67' ' ' GLY . 4.8 mp 54.41 57.02 6.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.932 . . . . 0.0 110.265 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 68' ' ' ARG . . . 42.32 52.52 5.14 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 36.5 mtt85 -150.62 -177.54 6.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -1.196 . . . . 0.0 110.199 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.452 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 6.1 t80 -102.2 56.28 0.8 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.24 -0.912 . . . . 0.0 110.214 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.33 41.47 1.36 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.081 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.51 178.88 48.85 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -95.37 158.97 15.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -1.163 . . . . 0.0 110.171 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -114.89 99.09 51.58 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.175 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 60' ' ' ARG . 47.7 Cg_endo -73.23 -164.8 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.053 1.554 . . . . 0.0 110.523 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB3' ' CD ' ' A' ' 32' ' ' PRO . 1.5 m-20 -114.45 89.46 3.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 109.365 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.604 ' CG ' ' CZ3' ' A' ' 29' ' ' TRP . 0.5 OUTLIER -120.83 114.37 21.51 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.703 -0.623 . . . . 0.0 109.646 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.512 ' NZ ' ' OG1' ' A' ' 56' ' ' THR . 4.3 tttp -123.06 140.84 52.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.144 -0.972 . . . . 0.0 110.753 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HD2' ' CG2' ' A' ' 27' ' ' THR . 0.4 OUTLIER -106.96 143.33 35.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.427 -0.796 . . . . 0.0 109.646 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -133.69 118.96 18.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.083 -1.011 . . . . 0.0 111.247 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.62 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -100.83 111.85 31.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.523 0.678 . . . . 0.0 109.911 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.581 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 35.1 t -109.1 136.09 46.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 110.265 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.522 ' HB3' ' CG ' ' A' ' 53' ' ' LYS . 6.6 tp60 -110.33 153.44 24.9 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.102 -0.999 . . . . 0.0 109.0 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.443 ' C ' HG13 ' A' ' 52' ' ' VAL . 2.3 m -116.18 155.44 17.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.832 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.54 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -50.09 179.26 0.03 OUTLIER Pre-proline 0 C--N 1.288 -2.066 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.617 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 41.5 Cg_endo -71.5 141.31 38.13 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.366 1.719 . . . . 0.0 110.499 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.6 -25.48 11.13 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.525 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 60.3 mt-30 -94.05 163.77 13.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -1.164 . . . . 0.0 110.689 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER 179.51 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.457 -0.777 . . . . 0.0 110.113 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.576 HG23 ' CD1' ' A' ' 47' ' ' PHE . 9.4 mt -44.28 95.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.953 . . . . 0.0 109.596 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.529 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -68.53 -13.27 62.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.439 -0.788 . . . . 0.0 111.155 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.502 ' CB ' HD21 ' A' ' 92' ' ' LEU . . . -54.44 -35.08 62.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.087 -1.008 . . . . 0.0 110.969 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.516 ' N ' ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -106.89 -23.67 12.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.889 -1.132 . . . . 0.0 110.773 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 1.9 pp20? -51.1 -22.93 2.73 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.038 -1.039 . . . . 0.0 110.234 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -99.08 -23.77 11.11 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.462 ' HB3' ' OH ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -42.75 -29.58 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -1.128 . . . . 0.0 110.147 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.547 HG13 ' CE1' ' A' ' 18' ' ' TYR . 2.6 mp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptm . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.029 0.442 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.645 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -92.27 84.44 5.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.081 -1.012 . . . . 0.0 109.382 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.622 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.3 p -136.88 -89.45 0.27 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.611 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.565 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -76.3 -22.59 54.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.893 -1.129 . . . . 0.0 110.126 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -52.15 -139.09 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.837 0.827 . . . . 0.0 110.814 178.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.644 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 11.8 t70 -30.56 -56.56 0.2 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.466 -0.771 . . . . 0.0 111.819 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 99.1 t -53.71 -103.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.887 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.609 ' CG2' ' CD2' ' A' ' 28' ' ' PHE . 3.6 mt -86.1 90.55 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.846 -1.159 . . . . 0.0 111.26 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -72.75 -97.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.811 . . . . 0.0 110.198 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.38 162.36 20.21 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.998 . . . . 0.0 110.242 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.96 163.5 36.73 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.994 1.523 . . . . 0.0 110.388 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.626 ' CG1' ' CD1' ' A' ' 29' ' ' TRP . 2.4 m -115.13 139.4 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.942 . . . . 0.0 110.317 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.569 HD11 ' CE2' ' A' ' 18' ' ' TYR . 3.2 mm? -102.67 111.48 23.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -0.958 . . . . 0.0 110.042 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 15' ' ' GLU . 54.3 m -145.66 139.56 26.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 110.183 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 8.7 tm-20 -42.79 -58.71 2.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 110.176 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -42.26 71.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.264 -0.897 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -58.93 -66.0 0.57 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.569 ' CE2' HD11 ' A' ' 13' ' ' LEU . 1.6 m-85 -44.92 -31.08 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 110.58 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.77 -8.77 48.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -110.98 -31.97 2.75 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -76.08 -17.22 59.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.686 -0.891 . . . . 0.0 108.92 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.615 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -57.0 -21.31 29.72 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.791 -0.568 . . . . 0.0 110.725 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -88.99 17.08 6.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.51 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.11 0.18 66.0 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.527 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 1.7 mttp -82.36 137.21 34.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -1.015 . . . . 0.0 109.064 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.619 ' CB ' ' CZ ' ' A' ' 28' ' ' PHE . 27.6 m-85 -128.86 105.52 8.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.34 -1.475 . . . . 0.0 112.244 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 4.3 m -74.88 141.02 44.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.445 0.641 . . . . 0.0 109.37 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.619 ' CZ ' ' CB ' ' A' ' 26' ' ' TYR . 21.7 m-85 -133.3 166.18 23.09 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.434 -0.791 . . . . 0.0 110.032 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.626 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 14.0 m95 -98.28 122.96 42.08 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.537 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 2.0 p -143.9 160.39 16.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 C-N-CA 117.792 -1.563 . . . . 0.0 112.768 -176.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.587 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -62.2 151.99 79.86 Favored Pre-proline 0 C--N 1.3 -1.572 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.69 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.9 Cg_endo -73.06 69.54 3.85 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.082 1.569 . . . . 0.0 109.647 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.2 OUTLIER 179.72 -34.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.399 -0.813 . . . . 0.0 110.017 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB1' ' CG2' ' A' ' 30' ' ' VAL . . . -43.75 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.381 -0.825 . . . . 0.0 109.603 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -41.55 136.04 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.535 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.529 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 7.5 mttt -43.74 -41.34 4.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 109.385 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.5 m -67.66 -40.26 84.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.267 -0.896 . . . . 0.0 108.997 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.517 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 5.1 mt-10 -55.79 -39.46 71.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.899 . . . . 0.0 108.763 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.533 ' CG2' HD11 ' A' ' 8' ' ' ILE . 32.3 mt -57.75 -34.66 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.6 ttmt -57.99 -47.91 81.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.37 -0.831 . . . . 0.0 109.945 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -73.79 -34.82 64.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.696 -0.627 . . . . 0.0 111.345 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.579 ' HA ' ' CA ' ' A' ' 3' ' ' THR . . . -58.77 -50.5 73.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.824 -1.173 . . . . 0.0 110.672 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.563 HG13 ' CE2' ' A' ' 28' ' ' PHE . 2.6 m -65.02 -33.21 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.774 -1.204 . . . . 0.0 109.811 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -60.65 -44.29 96.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 0.0 109.204 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.566 ' CG2' ' CB ' ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.06 -15.28 58.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.0 109.323 179.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' A' ' 4' ' ' ALA . . . -102.66 -68.79 0.81 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.406 -0.809 . . . . 0.0 110.459 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.538 ' CD2' HD12 ' A' ' 89' ' ' ILE . 29.9 m-85 -74.08 -21.56 59.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 4.3 tttp 65.15 47.21 2.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 110.107 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.544 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -125.29 -162.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.498 -0.752 . . . . 0.0 110.413 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.544 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -118.29 114.58 23.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.473 -0.767 . . . . 0.0 109.788 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.534 ' CG2' HG22 ' A' ' 43' ' ' VAL . 90.4 t -78.94 123.31 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.0 110.435 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.482 HG11 ' O ' ' A' ' 82' ' ' GLN . 8.4 p -114.93 9.94 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.924 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.55 120.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.402 -0.811 . . . . 0.0 109.902 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.12 125.51 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.196 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.529 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -125.12 115.6 20.72 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.224 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -119.2 150.46 40.04 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.902 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.528 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 3.3 pp -146.86 145.38 29.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.408 -0.807 . . . . 0.0 110.054 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 132.49 44.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.357 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.489 ' C ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -120.2 125.85 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.366 -0.834 . . . . 0.0 110.106 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -132.77 133.98 44.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 110.188 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . -44.5 166.06 0.04 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -139.28 -54.84 0.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -1.144 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -76.2 -31.39 58.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.227 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 63' ' ' LYS . 6.0 ttpt -43.32 -26.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 110.295 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 4.9 ttp180 -73.78 -19.82 60.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.415 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER 52.24 53.1 12.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 66' ' ' LEU . . . 40.99 42.7 3.04 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HG3' ' N ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -159.88 177.41 10.81 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.468 -1.019 . . . . 0.0 110.114 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.506 ' N ' ' HG3' ' A' ' 68' ' ' ARG . 3.6 t80 -89.51 92.79 9.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 110.102 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD13 ' HD2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -130.33 40.33 3.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 110.2 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' C ' ' HG3' ' A' ' 72' ' ' LYS . . . 144.79 -166.07 27.49 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.42 ' HG3' ' C ' ' A' ' 71' ' ' GLY . 41.7 mtpt -148.73 129.33 14.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -1.171 . . . . 0.0 110.217 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.456 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -43.8 106.55 0.51 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.02 -167.39 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.966 1.509 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.66 89.44 3.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.435 -0.791 . . . . 0.0 109.604 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.557 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 1.8 tpt180 -107.43 112.82 25.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.58 -0.7 . . . . 0.0 109.906 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.443 ' O ' HG11 ' A' ' 30' ' ' VAL . 11.3 tttp -110.03 129.41 55.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 10.4 ptpt -114.65 151.51 33.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.996 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -122.23 125.71 46.64 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.0 112.585 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.527 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 22.7 mt -104.22 110.93 31.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.452 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 97.9 t -104.26 134.55 45.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 110.346 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.519 ' HG3' ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -102.51 150.71 23.12 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.171 -0.956 . . . . 0.0 108.704 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.519 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.4 m -115.33 156.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 118.069 -1.452 . . . . 0.0 109.754 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -67.65 -179.71 0.49 Allowed Pre-proline 0 C--N 1.288 -2.104 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.163 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.0 Cg_endo -73.2 139.53 29.52 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 O-C-N 124.264 1.665 . . . . 0.0 110.195 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.503 ' O ' ' CE ' ' A' ' 88' ' ' LYS . . . 109.09 -48.31 0.95 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.465 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -94.07 176.87 6.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.16 -1.2 . . . . 0.0 110.672 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 86' ' ' GLY . 0.4 OUTLIER 179.56 100.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -0.772 . . . . 0.0 110.088 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.575 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 10.4 mt -44.19 108.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 110.05 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 10.0 mm-40 -75.75 -13.65 60.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -0.803 . . . . 0.0 110.799 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' CB ' HD23 ' A' ' 92' ' ' LEU . . . -54.82 -31.38 59.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.0 110.577 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.575 HD11 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.31 -23.04 12.66 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.19 -0.944 . . . . 0.0 109.715 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 36.1 mm-40 -50.84 -35.25 31.51 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 110.382 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -94.78 -24.22 18.41 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 92' ' ' LEU . 1.3 mp -43.0 -27.22 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -1.181 . . . . 0.0 110.173 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.562 HD12 ' CD1' ' A' ' 18' ' ' TYR . 22.8 mm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.18 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.543 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.686 0.279 . . . . 0.0 110.565 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 4' ' ' ALA . 4.6 mmpt? -45.11 97.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.603 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.4 m 3.86 -70.68 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 CA-C-O 121.407 0.622 . . . . 0.0 110.739 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.634 ' N ' ' O ' ' A' ' 2' ' ' LYS 0.27 . . -55.19 80.46 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.64 ' CE2' ' CG2' ' A' ' 7' ' ' VAL . 1.5 p90 24.37 46.61 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.842 0.829 . . . . 0.0 110.321 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.62 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 5.9 t70 64.67 52.54 1.69 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.925 0.869 . . . . 0.0 111.406 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.64 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 3.3 t -131.98 -125.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.134 -0.978 . . . . 0.0 109.638 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.583 HG23 ' CD1' ' A' ' 28' ' ' PHE . 3.8 mt -57.04 120.33 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.157 -0.965 . . . . 0.0 110.121 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -111.65 -89.59 0.51 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.175 -0.953 . . . . 0.0 110.297 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.25 142.42 24.55 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.095 -1.003 . . . . 0.0 110.212 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.593 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 47.5 Cg_endo -73.69 175.73 10.33 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.058 1.557 . . . . 0.0 110.506 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.61 ' CG1' ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.08 133.15 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.926 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.98 110.23 22.07 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.152 -0.968 . . . . 0.0 110.293 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 71.7 m -166.07 138.39 3.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 110.008 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 14' ' ' SER . 13.2 mt-10 -43.41 -46.36 6.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 110.064 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.72 -18.05 4.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.574 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -101.62 -49.81 3.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.752 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.576 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.4 m-85 -58.64 -44.74 90.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.496 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -12.61 38.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 108.876 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' N ' ' A' ' 22' ' ' ALA . . . -98.95 -39.59 3.53 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CE2' HD12 ' A' ' 92' ' ' LEU . 3.6 m-30 -49.96 -25.43 3.28 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 20' ' ' GLY . . . -40.21 -31.68 0.14 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.724 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 3.6 tp10 -104.05 -1.26 27.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.771 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.543 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 103.52 9.1 39.11 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 15.4 mttt -82.58 131.54 35.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -1.133 . . . . 0.0 109.668 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 89' ' ' ILE . 70.1 m-85 -126.86 108.09 10.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.887 -1.133 . . . . 0.0 112.003 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 27.1 m -75.85 121.9 23.3 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.593 ' CE1' ' N ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER -116.4 164.03 15.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 110.618 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.61 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 68.1 m95 -97.5 123.22 41.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.527 ' HA ' ' CD2' ' A' ' 9' ' ' LEU . 2.6 p -151.4 164.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 C-N-CA 117.827 -1.549 . . . . 0.0 111.997 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.464 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -51.01 140.46 20.89 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.207 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.501 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.4 Cg_endo -72.17 76.57 2.14 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.06 1.558 . . . . 0.0 110.059 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 179.03 -33.81 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.418 -0.801 . . . . 0.0 110.03 -178.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 39' ' ' ILE . . . -48.43 107.5 0.13 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 110.194 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.46 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -59.45 147.51 36.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -0.927 . . . . 0.0 110.012 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.515 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 21.8 mttt -46.56 -34.4 4.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 110.102 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 m -75.18 -51.19 13.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 110.447 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.49 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 1.8 mt-10 -55.19 -42.82 73.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.779 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 20.9 mt -57.19 -30.59 35.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.529 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 ttpm? -62.71 -46.35 88.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 111.046 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.401 ' O ' HG21 ' A' ' 45' ' ' THR . 13.5 m-80 -58.97 -34.89 72.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.421 -0.799 . . . . 0.0 112.336 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 5' ' ' TYR . . . -72.43 -49.27 34.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.666 -1.271 . . . . 0.0 111.652 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.582 HG22 ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -69.52 -37.63 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.888 -1.133 . . . . 0.0 110.84 -178.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.68 -44.12 81.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.072 -1.017 . . . . 0.0 110.424 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 41' ' ' ASN . 34.0 p -78.99 -46.19 18.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 110.295 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.68 -55.93 22.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.311 -0.868 . . . . 0.0 110.554 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.582 ' CD1' HG22 ' A' ' 43' ' ' VAL . 70.6 m-85 -83.2 3.02 32.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.112 -0.992 . . . . 0.0 110.333 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 4.5 pttm 38.23 42.57 0.51 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.735 0.779 . . . . 0.0 110.326 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -115.39 -165.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.599 -0.688 . . . . 0.0 109.792 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 2.8 tmtm? -118.27 103.16 9.56 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.443 -0.785 . . . . 0.0 109.831 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.529 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 97.7 t -78.37 119.63 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.36 -0.838 . . . . 0.0 109.69 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.565 HG11 ' CA ' ' A' ' 83' ' ' VAL . 7.3 p -101.02 -5.61 9.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -0.903 . . . . 0.0 110.381 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER 176.08 119.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.344 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.502 HG21 ' CG1' ' A' ' 81' ' ' VAL . 1.1 t -109.56 124.51 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 109.743 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.515 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 12.9 m120 -122.83 116.32 23.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.219 -0.926 . . . . 0.0 109.818 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.543 ' OG1' ' CE ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -110.17 155.43 21.98 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.36 -0.837 . . . . 0.0 110.185 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.435 ' N ' HD22 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -138.58 156.96 47.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.778 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.32 122.91 25.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.463 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.561 HG21 ' CZ3' ' A' ' 29' ' ' TRP . 4.3 m -120.33 132.78 69.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.701 -0.625 . . . . 0.0 110.21 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.494 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -135.89 109.22 7.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.224 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 60.9 144.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.76 -49.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -1.145 . . . . 0.0 110.243 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 64' ' ' LYS . 18.6 mmtt -105.45 -57.8 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.181 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -41.55 -37.41 1.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.386 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -52.52 -57.46 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 110.236 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER 61.19 135.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.202 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . 44.58 -169.73 0.02 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -42.71 166.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.372 -1.075 . . . . 0.0 110.237 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -44.77 134.5 5.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.242 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.12 41.01 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.078 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.1 -152.75 8.19 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 145.18 50.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -1.18 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 15.6 mtt85 -107.68 99.8 31.4 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.239 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.02 -165.05 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.948 1.499 . . . . 0.0 110.366 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.6 89.47 3.1 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.444 -0.785 . . . . 0.0 109.337 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.512 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -120.95 147.64 45.18 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.681 -0.637 . . . . 0.0 110.116 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.543 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 0.1 OUTLIER -121.92 142.14 50.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 0.0 110.379 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HE2' ' CZ2' ' A' ' 29' ' ' TRP . 1.8 mttt -100.91 151.22 22.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 109.718 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 28' ' ' PHE . . . -119.55 119.24 33.22 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.985 -1.072 . . . . 0.0 111.944 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.533 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 9.1 mt -95.95 110.87 25.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 109.527 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.527 ' CG1' HG13 ' A' ' 43' ' ' VAL . 2.9 t -99.8 125.95 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.14 -0.975 . . . . 0.0 110.263 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER -106.75 143.15 35.27 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.011 -1.056 . . . . 0.0 108.932 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.565 ' CA ' HG11 ' A' ' 52' ' ' VAL . 1.3 m -115.0 156.84 15.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.442 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.502 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . . . -68.18 177.17 1.1 Allowed Pre-proline 0 C--N 1.29 -1.999 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.671 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -73.49 141.91 32.2 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.348 1.709 . . . . 0.0 110.36 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.97 -26.74 14.52 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.451 ' OE1' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -113.72 177.68 4.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -1.132 . . . . 0.0 110.305 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.6 OUTLIER 179.71 122.68 0.06 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -0.933 . . . . 0.0 110.373 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 12.5 mt -73.6 93.94 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 110.101 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 20.0 pt-20 -72.55 -14.66 61.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.855 . . . . 0.0 110.409 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.461 ' HB3' HD23 ' A' ' 92' ' ' LEU . . . -55.7 -23.82 30.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.892 . . . . 0.0 110.495 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.577 HD12 ' CE2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -106.22 -23.01 12.69 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.174 -0.954 . . . . 0.0 109.713 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.3 mm-40 -61.34 -31.06 70.92 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.359 -0.838 . . . . 0.0 110.369 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.68 -6.22 56.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 92' ' ' LEU . 1.1 tp -61.86 -12.07 15.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.167 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.576 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 2.9 mp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.15 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 120.871 0.367 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.644 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -83.89 76.37 10.03 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.784 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.611 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -120.51 -90.72 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.592 -0.693 . . . . 0.0 109.777 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -88.87 -27.63 20.89 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.201 -0.937 . . . . 0.0 109.091 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.644 ' CE1' ' C ' ' A' ' 2' ' ' LYS . 1.1 p90 -35.44 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.593 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 28.3 m-20 -162.16 -58.02 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.912 -1.118 . . . . 0.0 110.311 -177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.555 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 46.4 t -43.02 -73.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 121.807 0.813 . . . . 0.0 109.075 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.582 HG21 ' CD2' ' A' ' 28' ' ' PHE . 6.4 mt -110.59 67.77 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 121.232 -0.918 . . . . 0.0 109.932 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 5' ' ' TYR . 6.7 mt -54.28 -94.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.806 . . . . 0.0 110.742 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.17 150.45 36.73 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 110.61 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.22 162.02 37.22 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.121 1.59 . . . . 0.0 110.276 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.508 HG12 ' CG2' ' A' ' 27' ' ' THR . 1.1 p -115.35 110.33 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.287 -0.883 . . . . 0.0 110.027 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.12 106.92 17.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.245 -0.909 . . . . 0.0 110.234 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.76 174.58 10.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 110.253 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -55.7 -65.58 0.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.317 -0.865 . . . . 0.0 110.243 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -54.69 -34.79 62.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.169 -0.957 . . . . 0.0 110.302 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 21' ' ' PHE . . . -71.98 -49.52 36.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.156 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 13' ' ' LEU . 1.3 m-85 -58.07 -31.53 67.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.39 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.46 -8.52 50.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 110.177 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -107.63 -35.41 2.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.401 -1.879 . . . . 0.0 108.401 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -76.02 -16.6 59.93 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.63 -0.924 . . . . 0.0 109.118 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.622 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -59.09 -20.29 52.09 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.442 0.639 . . . . 0.0 110.75 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -88.86 17.27 5.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.395 -0.816 . . . . 0.0 110.434 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.29 -0.25 65.95 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.518 ' HG3' ' NE2' ' A' ' 82' ' ' GLN . 19.7 mttt -82.4 142.71 31.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.572 -0.958 . . . . 0.0 109.395 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 22.9 m-85 -128.29 110.65 12.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.676 -1.265 . . . . 0.0 111.368 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 3.0 m -81.55 131.18 35.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.478 0.656 . . . . 0.0 109.277 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.648 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 23.3 m-85 -124.65 165.06 18.57 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.488 -0.758 . . . . 0.0 110.672 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.637 ' CE3' ' CG ' ' A' ' 76' ' ' ARG . 3.1 m95 -103.12 122.29 44.38 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 2.6 p -139.42 161.57 27.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 C-N-CA 118.025 -1.47 . . . . 0.0 112.327 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.583 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -74.03 150.26 87.87 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.259 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 44.0 Cg_endo -70.31 67.14 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.986 1.519 . . . . 0.0 109.729 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.88 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.577 -0.702 . . . . 0.0 109.575 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -43.98 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.338 -0.851 . . . . 0.0 109.306 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -38.0 130.86 1.13 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.496 -0.752 . . . . 0.0 110.964 -179.127 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 1.5 mttt -42.84 -43.31 3.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 109.619 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 4.5 m -61.79 -44.52 96.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 19.6 mm-40 -55.36 -38.83 69.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.392 -0.817 . . . . 0.0 109.422 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.542 ' CA ' HD12 ' A' ' 8' ' ' ILE . 25.0 mt -57.38 -30.87 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.527 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 59.9 tttm -67.85 -47.05 70.04 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.444 -0.785 . . . . 0.0 109.582 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.466 ' O ' ' HB ' ' A' ' 45' ' ' THR . 58.0 m-80 -73.6 -34.31 65.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.604 -0.685 . . . . 0.0 111.325 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.57 ' HA ' ' CB ' ' A' ' 3' ' ' THR . . . -58.15 -50.56 73.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.739 -1.226 . . . . 0.0 110.454 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.648 ' CG1' ' CE2' ' A' ' 28' ' ' PHE . 3.6 m -68.31 -32.89 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.854 -1.154 . . . . 0.0 109.372 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CD ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.42 -42.02 79.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.12 -0.987 . . . . 0.0 108.483 178.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.604 ' CG2' ' CB ' ' A' ' 3' ' ' THR . 0.9 OUTLIER -79.52 -12.8 59.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 178.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.8 -62.2 1.57 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 110.678 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.54 ' CD1' HG22 ' A' ' 89' ' ' ILE . 24.0 m-85 -71.59 -22.48 61.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.996 -1.065 . . . . 0.0 110.071 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER 65.88 46.78 2.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.845 . . . . 0.0 110.038 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.427 ' O ' ' CD ' ' A' ' 44' ' ' GLU . 1.2 p -125.28 -164.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.631 -0.668 . . . . 0.0 110.412 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . 1.3 tmtp? -118.46 106.73 13.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.451 -0.781 . . . . 0.0 109.763 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.527 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 40.6 t -78.8 140.54 16.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 110.542 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 82' ' ' GLN . 13.6 p -118.91 -6.46 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.616 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -179.18 131.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.529 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -120.26 129.47 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.918 -1.114 . . . . 0.0 110.117 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.475 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 3.8 m-80 -131.53 115.71 16.49 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.437 -0.789 . . . . 0.0 109.387 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -115.5 159.58 21.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 109.311 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.533 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -148.33 144.71 27.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.11 -0.993 . . . . 0.0 110.968 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.05 103.36 2.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.858 . . . . 0.0 109.034 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.526 ' CG2' ' HG2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -95.86 109.36 22.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.385 -0.822 . . . . 0.0 109.319 -179.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 2.1 mmt180 -114.36 134.29 55.08 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.397 -0.815 . . . . 0.0 110.457 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.548 ' HA3' ' CB ' ' A' ' 73' ' ' ARG . . . -85.25 114.32 3.95 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 61' ' ' GLY . 16.0 mmmt -53.62 -172.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -1.158 . . . . 0.0 110.174 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 64' ' ' LYS . 1.1 ttpt -53.73 -29.24 38.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 63' ' ' LYS . 1.6 mptt -41.61 100.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -159.83 -57.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.28 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 67' ' ' GLY . 23.2 tp -41.95 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 110.435 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 65' ' ' ARG . . . 42.22 87.36 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.2 mtt85 -144.94 131.24 19.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -1.122 . . . . 0.0 110.196 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.431 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 1.8 p90 -44.86 134.04 5.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 43.45 40.37 2.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.871 . . . . 0.0 109.931 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 72' ' ' LYS . . . -89.51 -124.17 2.49 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER 42.95 54.25 4.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -1.121 . . . . 0.0 110.114 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.548 ' CB ' ' HA3' ' A' ' 61' ' ' GLY . 3.5 mtm180 -103.31 103.81 37.28 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 110.166 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 55.3 Cg_endo -77.33 -165.38 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.091 1.574 . . . . 0.0 110.888 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -114.83 90.01 3.24 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.637 ' CG ' ' CE3' ' A' ' 29' ' ' TRP . 0.3 OUTLIER -137.42 153.85 50.07 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.62 -0.675 . . . . 0.0 111.102 -178.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.533 ' CE ' HG12 ' A' ' 30' ' ' VAL . 4.8 ptmt -98.59 141.2 31.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.402 -0.812 . . . . 0.0 110.18 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 19.2 ptpt -109.3 151.41 26.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -0.936 . . . . 0.0 110.483 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -116.9 122.68 45.01 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.234 -0.916 . . . . 0.0 111.931 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.632 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.5 mp -103.18 112.77 37.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.559 -0.713 . . . . 0.0 109.468 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 23.8 t -113.3 128.68 69.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.417 -0.802 . . . . 0.0 110.866 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.616 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 1.5 tp60 -98.82 153.36 18.83 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.193 -0.942 . . . . 0.0 108.679 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 84' ' ' ALA . 1.5 m -116.66 156.69 17.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 C-N-CA 118.264 -1.375 . . . . 0.0 108.679 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.52 ' CB ' ' OE1' ' A' ' 87' ' ' GLN . . . -69.27 178.79 0.85 Allowed Pre-proline 0 C--N 1.285 -2.229 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.002 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.6 138.41 26.68 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 124.243 1.654 . . . . 0.0 110.458 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.42 -30.1 8.52 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.52 ' OE1' ' CB ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -111.69 176.9 4.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.242 . . . . 0.0 110.705 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 90' ' ' GLU . 8.2 ptpt 179.46 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.459 -0.776 . . . . 0.0 110.012 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 14.9 mt -45.07 95.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.002 . . . . 0.0 110.075 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 88' ' ' LYS . 1.1 pt-20 -68.13 -13.89 62.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.384 -0.823 . . . . 0.0 110.666 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.96 -28.68 53.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.125 -0.985 . . . . 0.0 110.347 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.498 ' CD1' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.23 -23.04 12.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.492 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 13.9 mm-40 -51.07 -31.92 20.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.436 -0.79 . . . . 0.0 110.45 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -98.02 -26.63 9.45 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.466 HD21 HD22 ' A' ' 13' ' ' LEU . 1.4 mp -43.56 -26.18 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.227 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 94' ' ' GLY . 40.5 mt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.23 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.514 ' O ' ' N ' ' A' ' 3' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.692 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -60.92 89.97 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.004 -1.478 . . . . 0.0 108.84 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.52 ' HA ' ' CG2' ' A' ' 45' ' ' THR 0.265 12.0 t -134.1 -24.43 1.65 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 122.113 0.958 . . . . 0.0 110.363 -178.038 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.63 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . 179.86 -29.0 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 121.376 0.607 . . . . 0.0 109.525 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.692 ' CE1' ' HA ' ' A' ' 2' ' ' LYS 0.288 0.1 OUTLIER -43.31 -136.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.36 1.076 . . . . 0.0 112.685 177.914 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.633 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 22.9 m-20 -23.06 -62.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.687 0.756 . . . . 0.0 112.293 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 45.7 t -57.33 -111.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.575 -0.703 . . . . 0.0 111.199 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.652 ' CG2' ' CG ' ' A' ' 28' ' ' PHE . 5.7 mt -86.37 100.2 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.861 -1.15 . . . . 0.0 111.109 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -91.63 -86.01 0.23 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.226 -0.921 . . . . 0.0 111.067 179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.544 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -107.99 140.64 21.85 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.9 -1.125 . . . . 0.0 110.592 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.628 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.1 Cg_endo -72.96 170.38 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.079 1.568 . . . . 0.0 110.393 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.579 HG13 ' CD1' ' A' ' 29' ' ' TRP . 1.6 m -115.27 133.16 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.165 -0.959 . . . . 0.0 110.405 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.576 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -102.83 112.66 25.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.163 -0.961 . . . . 0.0 110.215 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 15' ' ' GLU . 40.5 m -159.69 145.62 15.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.007 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' SER . 36.5 mt-10 -42.76 -54.13 4.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 110.165 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -54.61 -28.17 44.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 0.0 110.182 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -87.05 -55.41 3.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.625 ' CE1' ' CG1' ' A' ' 96' ' ' ILE . 1.4 m-85 -53.7 -26.24 21.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.02 -15.65 31.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -101.49 -36.44 3.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -77.67 -23.08 49.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.574 -0.956 . . . . 0.0 108.835 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 18' ' ' TYR . . . -50.61 -20.58 1.24 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.606 -0.684 . . . . 0.0 110.338 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.3 13.63 25.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.53 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.467 ' C ' ' NE2' ' A' ' 82' ' ' GLN . . . 99.94 -0.53 56.34 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 20.7 mttt -82.38 147.45 28.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -1.138 . . . . 0.0 109.396 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.641 ' CE2' ' CD1' ' A' ' 89' ' ' ILE . 22.0 m-85 -128.07 102.88 6.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.693 -1.254 . . . . 0.0 112.209 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.532 ' CG2' ' CD ' ' A' ' 78' ' ' LYS . 3.4 m -75.82 125.92 30.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.652 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -130.28 164.96 23.44 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.934 -1.103 . . . . 0.0 112.085 -177.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.579 ' CD1' HG13 ' A' ' 12' ' ' VAL . 24.9 m95 -101.33 123.31 45.22 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 1.4 p -145.96 158.81 11.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 117.772 -1.571 . . . . 0.0 112.003 -176.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.579 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -59.97 151.17 66.34 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.852 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 49.0 Cg_endo -73.36 70.01 4.03 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.227 1.646 . . . . 0.0 109.763 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.57 -33.42 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 110.071 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.518 ' HB3' ' CG1' ' A' ' 7' ' ' VAL . . . -42.61 93.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.45 -0.781 . . . . 0.0 109.831 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -51.52 140.29 18.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 110.421 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.514 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 8.5 mttt -42.26 -43.27 3.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.88 . . . . 0.0 110.027 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -64.32 -53.36 50.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.865 . . . . 0.0 110.07 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.8 OUTLIER -55.47 -40.43 71.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.549 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 14.9 mt -57.68 -31.4 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.271 -0.893 . . . . 0.0 108.968 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 37' ' ' THR . 6.7 tttt -63.12 -42.54 99.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.371 -0.831 . . . . 0.0 109.833 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.541 ' O ' ' CG2' ' A' ' 45' ' ' THR . 44.1 m-80 -71.39 -44.89 64.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.69 -0.631 . . . . 0.0 111.836 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 3' ' ' THR . . . -57.78 -52.11 66.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.768 -1.208 . . . . 0.0 110.964 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.571 HG23 ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -59.69 -38.64 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.547 -1.346 . . . . 0.0 109.862 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -64.37 -32.73 74.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 41' ' ' ASN . 26.7 p -62.95 -47.47 83.07 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.153 -0.967 . . . . 0.0 110.65 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.88 -52.11 5.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.222 -0.924 . . . . 0.0 110.828 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.598 ' CG ' HD11 ' A' ' 89' ' ' ILE . 78.1 m-85 -71.76 -21.39 61.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.231 -0.918 . . . . 0.0 110.499 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 14.0 mtpt 46.83 42.62 12.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.669 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.39 -162.59 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 121.398 0.618 . . . . 0.0 109.727 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.565 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.21 107.55 15.44 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.881 179.09 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.563 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 22.8 t -78.33 119.5 27.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.261 -0.9 . . . . 0.0 109.316 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 8.4 p -105.9 9.06 9.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.248 -0.908 . . . . 0.0 110.683 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.15 117.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 110.46 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.528 HG22 ' CG1' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -115.28 116.66 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.0 109.519 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.514 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 82.8 m-20 -118.56 115.87 25.46 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 109.409 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.529 ' CA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -115.0 162.45 16.96 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.987 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.79 153.01 30.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 110.469 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.36 130.59 43.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.745 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -116.91 127.21 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.29 -0.881 . . . . 0.0 110.154 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.578 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.4 OUTLIER -107.6 124.06 49.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.271 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.96 174.02 45.49 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -53.56 -44.54 69.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -1.079 . . . . 0.0 110.245 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -43.71 166.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.182 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 63' ' ' LYS . 8.0 pttt 174.28 89.32 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.32 -0.863 . . . . 0.0 110.041 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.529 ' CA ' ' HB2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -153.01 -158.21 0.87 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.181 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.51 ' N ' ' HD3' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 71.28 123.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.204 -0.935 . . . . 0.0 109.915 -179.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 68' ' ' ARG . . . 54.0 79.26 0.09 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.507 ' HA ' ' CE ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -42.38 133.34 3.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.286 -1.126 . . . . 0.0 110.435 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 49.0 t80 -162.87 59.44 0.2 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.364 -0.835 . . . . 0.0 109.863 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER 43.08 40.49 2.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.927 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.1 96.22 1.89 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.529 ' HB2' ' CA ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -92.92 154.71 18.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -1.178 . . . . 0.0 110.47 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.32 142.49 14.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.436 -0.79 . . . . 0.0 109.803 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.09 -168.55 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.828 1.436 . . . . 0.0 110.207 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.473 ' HB3' ' HG3' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -116.06 89.41 3.1 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.414 -0.804 . . . . 0.0 109.501 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -106.59 127.5 53.39 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.481 -0.762 . . . . 0.0 109.899 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.524 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 51.1 tttt -117.86 128.59 54.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.573 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -101.7 151.11 22.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.56 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -129.4 131.41 46.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.915 -1.115 . . . . 0.0 112.053 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -110.63 111.43 36.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.528 ' CG1' HG22 ' A' ' 54' ' ' VAL . 2.6 t -106.16 133.92 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.505 -0.747 . . . . 0.0 110.431 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.541 ' HG3' ' N ' ' A' ' 83' ' ' VAL . 4.7 tp60 -117.14 152.77 34.04 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.005 -1.06 . . . . 0.0 108.674 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.541 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.4 m -118.79 155.76 20.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.142 -1.423 . . . . 0.0 109.711 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -50.85 174.11 0.09 OUTLIER Pre-proline 0 C--N 1.289 -2.024 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.871 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.8 Cg_endo -76.66 55.54 4.85 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.307 1.688 . . . . 0.0 110.609 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -163.81 -50.28 0.02 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.526 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -51.27 -172.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -1.174 . . . . 0.0 111.025 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 179.25 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.63 -0.669 . . . . 0.0 110.172 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.641 ' CD1' ' CE2' ' A' ' 26' ' ' TYR . 5.6 mt -68.72 109.16 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.0 110.146 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 3.3 mt-10 -78.3 -14.49 59.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.585 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -56.29 -33.04 65.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 111.137 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -106.11 -23.44 12.61 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.952 -1.092 . . . . 0.0 110.138 -179.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mm-40 -62.71 -23.02 66.94 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.179 -0.95 . . . . 0.0 110.228 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -113.51 -26.32 3.99 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 8.0 tp -42.87 -27.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -1.132 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.625 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 52.0 mt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.215 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.538 ' O ' ' N ' ' A' ' 3' ' ' THR . 1.3 ptt? . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.751 0.31 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.622 ' N ' ' HA ' ' A' ' 6' ' ' ASP . 22.3 mmtt -44.31 97.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.601 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.4 m 4.29 -71.53 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 121.365 0.602 . . . . 0.0 110.843 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 2' ' ' LYS 0.265 . . -55.41 81.04 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.618 ' CE2' ' CG2' ' A' ' 7' ' ' VAL . 1.7 p90 24.18 47.19 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.819 0.818 . . . . 0.0 110.408 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.622 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 4.3 t0 64.75 52.64 1.63 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.993 0.901 . . . . 0.0 111.333 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.618 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 3.2 t -133.38 -124.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.133 -0.979 . . . . 0.0 109.993 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.598 HG23 ' CB ' ' A' ' 28' ' ' PHE . 4.9 mt -56.12 156.07 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 121.217 -0.927 . . . . 0.0 110.812 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.472 ' HG ' ' HB3' ' A' ' 2' ' ' LYS . 14.2 mt -143.52 -93.78 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 110.155 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.21 149.81 39.68 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.068 -1.02 . . . . 0.0 110.277 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.452 ' HG3' ' CD2' ' A' ' 92' ' ' LEU . 45.9 Cg_endo -73.33 173.57 13.54 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.1 1.579 . . . . 0.0 110.357 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.523 HG12 ' CE2' ' A' ' 29' ' ' TRP . 2.4 m -112.8 139.35 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.206 -0.934 . . . . 0.0 110.152 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.575 HD13 ' CZ ' ' A' ' 18' ' ' TYR . 3.2 mm? -102.77 112.28 24.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.197 -0.939 . . . . 0.0 110.243 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -161.99 138.07 7.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 0.0 110.098 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 2.2 tm-20 -42.87 -50.11 5.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.178 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -46.75 74.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.849 . . . . 0.0 110.23 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -67.86 -60.37 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.187 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.575 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 1.2 m-85 -44.61 -29.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.117 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.75 -19.27 23.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.86 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -96.19 -40.55 3.97 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.244 -1.943 . . . . 0.0 108.244 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.626 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -69.79 -17.08 63.39 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.638 -0.919 . . . . 0.0 108.952 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.626 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -58.34 -21.2 48.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.272 0.558 . . . . 0.0 110.89 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -88.53 16.96 5.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.25 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.67 1.96 65.52 Favored Glycine 0 N--CA 1.48 1.594 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 24.7 mttm -82.24 137.7 34.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.607 -0.937 . . . . 0.0 109.246 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 24.8 m-85 -128.76 103.89 7.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.518 -1.363 . . . . 0.0 112.007 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.561 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 1.4 m -75.03 140.96 43.91 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.619 -0.676 . . . . 0.0 109.339 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.611 ' CZ ' ' CE2' ' A' ' 47' ' ' PHE . 22.0 m-85 -134.56 165.64 24.74 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.453 -0.779 . . . . 0.0 110.438 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.523 ' CE2' HG12 ' A' ' 12' ' ' VAL . 10.0 m95 -98.96 122.33 42.07 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 7.4 p -148.06 165.68 5.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.617 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.474 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -61.14 152.91 69.8 Favored Pre-proline 0 C--N 1.298 -1.669 0 O-C-N 121.851 -0.53 . . . . 0.0 110.383 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.466 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.9 Cg_endo -73.4 71.53 3.77 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.099 1.578 . . . . 0.0 110.349 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.02 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.264 -0.898 . . . . 0.0 110.101 -179.256 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 33' ' ' LYS . . . -42.74 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 110.186 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -48.09 155.81 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 110.26 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.544 ' CD ' ' O ' ' A' ' 54' ' ' VAL . 7.2 mmtp -57.33 -36.25 70.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.88 . . . . 0.0 110.204 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -75.14 -50.21 17.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 23.0 mt-10 -54.97 -37.92 67.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.942 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.535 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 17.8 mt -57.91 -30.83 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 109.401 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.529 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 2.4 ttpt -61.69 -45.89 92.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 111.096 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -58.9 -36.67 75.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 112.314 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.577 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . . . -73.22 -50.49 22.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.603 -1.311 . . . . 0.0 111.685 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.464 HG12 ' CE2' ' A' ' 47' ' ' PHE . 4.7 m -66.01 -30.57 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.518 -1.364 . . . . 0.0 110.583 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -62.76 -52.41 63.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.088 -1.007 . . . . 0.0 109.964 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -79.72 -15.72 56.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.895 . . . . 0.0 110.224 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.25 -62.05 1.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.471 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.611 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 9.7 m-85 -71.73 -15.96 62.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.183 -0.948 . . . . 0.0 110.096 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 5.9 mmtt 61.56 45.36 8.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.48 -0.762 . . . . 0.0 110.235 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -128.28 -162.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.528 -0.733 . . . . 0.0 110.007 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.561 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.06 106.14 12.58 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 109.358 178.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.529 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 97.8 t -78.23 119.77 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.322 -0.861 . . . . 0.0 110.184 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 82' ' ' GLN . 7.6 p -106.01 -3.97 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.545 ' HG3' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 178.34 147.94 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.859 . . . . 0.0 109.875 179.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.566 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 1.1 t -132.79 131.32 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.002 -1.061 . . . . 0.0 109.871 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.508 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -131.61 115.88 16.66 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.39 -0.819 . . . . 0.0 109.22 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -113.83 166.27 11.74 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.39 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 7.0 mt -143.17 179.76 6.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.432 -0.793 . . . . 0.0 109.852 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.496 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 1.4 t-160 -104.15 102.17 11.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.339 -0.85 . . . . 0.0 109.387 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.532 ' CG1' ' HE2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -110.64 134.5 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.271 -0.893 . . . . 0.0 110.095 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.573 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -130.46 168.39 17.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 110.339 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.09 131.09 25.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -96.4 -28.07 14.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -1.121 . . . . 0.0 110.256 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 64' ' ' LYS . 18.0 mttt -122.67 15.29 10.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.295 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 63' ' ' LYS . 14.6 tptt -43.77 -27.73 0.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 110.417 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -74.16 -1.72 21.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 0.0 110.364 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 65' ' ' ARG . 8.2 tp -41.14 143.27 0.42 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 68' ' ' ARG . . . 53.47 -168.59 1.18 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 67' ' ' GLY . 15.5 ptt180 -40.94 155.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.461 -1.023 . . . . 0.0 110.273 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.9 112.61 7.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.46 40.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.055 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -168.88 117.47 0.72 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 1.2 mtpm? -101.58 108.24 19.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -1.152 . . . . 0.0 110.143 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.429 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -40.79 100.25 0.22 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.384 -0.823 . . . . 0.0 110.311 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 54.3 Cg_endo -81.36 -166.18 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.059 1.557 . . . . 0.0 110.449 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.15 89.48 3.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.504 -0.748 . . . . 0.0 108.984 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -106.82 142.88 35.75 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.609 -0.682 . . . . 0.0 110.531 -179.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.516 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 5.9 ptmt -123.15 141.19 52.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.982 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 5.2 ptpt -101.57 151.12 22.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.105 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -115.48 119.96 37.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.217 -0.927 . . . . 0.0 112.25 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 12.8 mt -98.2 110.78 26.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.784 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 50.4 t -103.63 133.04 48.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.91 -1.119 . . . . 0.0 110.257 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.545 ' CB ' ' HG3' ' A' ' 53' ' ' LYS . 1.4 tp60 -102.71 153.28 20.29 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.07 -1.019 . . . . 0.0 109.065 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.1 m -120.94 156.19 24.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 C-N-CA 118.35 -1.34 . . . . 0.0 109.053 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -63.3 177.74 0.44 Allowed Pre-proline 0 C--N 1.286 -2.168 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.194 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.6 Cg_endo -74.23 138.92 25.77 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 124.233 1.649 . . . . 0.0 110.301 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.47 -30.32 10.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.81 176.35 5.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.112 -1.228 . . . . 0.0 110.548 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 7.9 pttt 179.56 104.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.449 -0.782 . . . . 0.0 110.195 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.555 HG21 ' CG ' ' A' ' 47' ' ' PHE . 9.8 mt -42.65 100.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 3.1 mm-40 -63.06 -13.72 39.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.419 -0.801 . . . . 0.0 110.985 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.481 ' CB ' HD21 ' A' ' 92' ' ' LEU . . . -54.75 -32.73 60.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.099 -1.0 . . . . 0.0 110.418 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.574 HD13 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.12 -23.02 12.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.148 -0.97 . . . . 0.0 109.599 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 64.9 mm-40 -48.05 -58.76 4.03 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.38 -0.825 . . . . 0.0 110.423 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -76.5 -33.66 47.22 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 8.0 tp -41.64 -27.34 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.299 -1.118 . . . . 0.0 110.331 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.468 HG23 HD13 ' A' ' 96' ' ' ILE . 50.4 mt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.263 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.86 0.362 . . . . 0.0 110.364 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.636 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 1.2 mttt -79.89 78.2 6.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.692 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.612 ' N ' ' CE1' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -121.12 -88.91 0.62 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.409 0.623 . . . . 0.0 110.157 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -90.21 -30.59 17.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.456 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.636 ' CE1' ' C ' ' A' ' 2' ' ' LYS . 1.8 p90 -34.36 -26.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.564 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 46.2 t0 -160.19 -59.55 0.06 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.891 -1.131 . . . . 0.0 110.727 -176.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.549 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 40.9 t -42.01 -68.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.046 0.926 . . . . 0.0 109.611 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.584 HG23 ' CD2' ' A' ' 28' ' ' PHE . 4.7 mt -114.06 99.04 7.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 O-C-N 121.326 -0.859 . . . . 0.0 110.068 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.451 ' CD2' ' O ' ' A' ' 4' ' ' ALA . 75.0 mt -93.05 -95.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.328 -0.857 . . . . 0.0 110.854 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.95 154.95 41.8 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.7 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.451 ' HB3' HD23 ' A' ' 92' ' ' LEU . 49.3 Cg_endo -75.61 158.17 39.9 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.134 1.597 . . . . 0.0 110.167 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 27' ' ' THR . 1.5 p -115.2 117.24 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.5 mm? -102.07 106.96 17.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 110.174 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -144.72 152.8 40.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.6 tt0 -43.07 -63.78 0.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -25.8 28.46 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.39 -51.19 7.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.143 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.561 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 2.1 m-85 -55.75 -32.47 63.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.17 -8.48 51.09 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.256 -0.903 . . . . 0.0 109.901 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.76 -34.0 3.4 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.584 -1.807 . . . . 0.0 108.584 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -79.37 -19.81 49.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.574 -0.956 . . . . 0.0 109.026 179.244 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -54.6 -17.65 3.55 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.65 -0.656 . . . . 0.0 110.879 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.8 OUTLIER -93.17 17.07 11.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.507 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.53 -2.01 67.07 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 1.7 mttp -82.13 139.51 34.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.524 -0.986 . . . . 0.0 109.376 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 23.8 m-85 -128.42 102.88 6.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.533 -1.354 . . . . 0.0 112.033 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 8.1 m -74.88 141.15 44.2 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.449 0.642 . . . . 0.0 109.659 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.64 ' CZ ' ' CE2' ' A' ' 47' ' ' PHE . 44.8 m-85 -134.22 165.18 25.7 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.49 -0.756 . . . . 0.0 110.056 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.579 ' CZ3' ' HG2' ' A' ' 76' ' ' ARG . 52.9 m95 -89.92 122.0 32.54 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 10.6 p -134.14 165.26 32.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 118.344 -1.342 . . . . 0.0 112.394 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.585 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 1.9 t60 -82.75 152.4 66.22 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.297 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 43.8 Cg_endo -70.61 65.56 2.29 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.173 1.617 . . . . 0.0 109.544 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.87 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.559 -0.713 . . . . 0.0 109.647 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -48.37 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.501 -0.75 . . . . 0.0 109.575 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -40.31 134.35 1.66 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.301 -0.875 . . . . 0.0 110.797 -179.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.521 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 3.5 tttm -42.4 -43.36 3.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.7 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 5.2 m -61.27 -44.32 97.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.92 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 35' ' ' THR . 6.7 mt-10 -55.13 -39.61 69.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.376 -0.827 . . . . 0.0 109.494 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.529 ' CA ' HD12 ' A' ' 8' ' ' ILE . 10.4 mt -57.67 -30.67 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.379 -0.826 . . . . 0.0 108.914 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.507 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 9.6 tttt -61.79 -47.64 84.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.827 . . . . 0.0 109.541 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.468 ' O ' HG22 ' A' ' 3' ' ' THR . 24.3 m-80 -73.48 -34.33 65.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.653 -0.654 . . . . 0.0 110.97 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.578 ' HA ' ' CA ' ' A' ' 3' ' ' THR . . . -58.37 -50.27 74.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.912 -1.118 . . . . 0.0 110.656 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.592 HG13 ' CE2' ' A' ' 28' ' ' PHE . 2.7 m -68.11 -36.94 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.715 -1.241 . . . . 0.0 109.835 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -63.36 -42.6 98.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.092 -1.005 . . . . 0.0 108.886 179.154 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.539 ' HB ' ' CG2' ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.2 -20.43 48.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.578 -0.701 . . . . 0.0 109.315 179.083 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 42' ' ' ALA . . . -100.04 -67.14 0.87 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 110.456 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.64 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 62.6 m-85 -72.58 -21.61 61.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 110.432 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 64.06 47.87 3.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.311 -0.868 . . . . 0.0 110.274 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -122.28 -158.82 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.483 -0.761 . . . . 0.0 110.062 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.551 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -117.16 111.3 19.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.436 179.209 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.507 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 57.7 t -78.3 119.8 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.189 -0.944 . . . . 0.0 110.424 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.554 HG13 ' CA ' ' A' ' 83' ' ' VAL . 12.2 p -113.8 -1.41 9.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.489 -0.757 . . . . 0.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 175.83 119.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.81 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.548 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -113.68 132.04 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 110.304 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 80' ' ' ILE . 2.4 m120 -131.05 115.56 16.61 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.457 -0.777 . . . . 0.0 109.573 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -116.28 144.61 44.01 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 109.982 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.45 162.01 34.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -0.804 . . . . 0.0 109.973 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 127.49 32.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.565 HG23 ' CZ3' ' A' ' 29' ' ' TRP . 1.9 m -118.63 123.37 71.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.607 -0.683 . . . . 0.0 109.979 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.577 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -105.16 142.26 35.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.475 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' O ' ' HE2' ' A' ' 62' ' ' LYS . . . 87.55 153.92 25.94 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -144.05 -65.64 0.36 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -1.122 . . . . 0.0 110.176 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -124.59 -11.76 7.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 0.0 110.18 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 177.64 131.24 0.06 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.31 -0.869 . . . . 0.0 110.427 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.428 ' N ' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -128.96 1.07 5.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -41.32 129.26 3.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.413 -0.805 . . . . 0.0 110.335 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.52 51.62 2.62 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.451 ' HG2' ' HB3' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -125.06 12.54 8.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -1.233 . . . . 0.0 109.463 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.581 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 29.1 t80 -166.25 69.33 0.12 Allowed 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.795 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.3 OUTLIER 43.36 38.84 1.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 109.941 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 72' ' ' LYS . . . -87.53 141.01 17.06 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 71' ' ' GLY . 8.4 mttt -166.07 109.52 0.78 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -1.131 . . . . 0.0 110.236 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -45.33 105.38 0.45 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 110.014 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.467 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 49.0 Cg_endo -72.6 -166.85 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.57 . . . . 0.0 110.388 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.34 89.39 3.09 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.397 -0.814 . . . . 0.0 109.489 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.579 ' HG2' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -105.52 143.22 33.99 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.515 -0.74 . . . . 0.0 110.018 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.539 ' CE ' HG12 ' A' ' 30' ' ' VAL . 10.0 tttt -110.18 141.87 42.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.554 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HE2' ' CG1' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -116.57 151.32 36.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.417 -0.802 . . . . 0.0 109.82 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.98 123.24 36.66 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.997 -1.064 . . . . 0.0 112.63 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 55' ' ' ASN . 14.9 mt -103.29 111.36 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.829 -0.544 . . . . 0.0 110.019 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.548 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 60.2 t -104.29 130.37 55.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.94 -1.1 . . . . 0.0 109.969 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 83' ' ' VAL . 3.6 tp60 -102.64 149.76 24.11 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.143 -0.973 . . . . 0.0 109.205 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.554 ' CA ' HG13 ' A' ' 52' ' ' VAL . 1.5 m -112.89 156.65 13.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 118.45 -1.3 . . . . 0.0 109.405 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.489 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . . . -62.87 175.49 0.64 Allowed Pre-proline 0 C--N 1.291 -1.951 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.916 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 84' ' ' ALA . 44.3 Cg_endo -76.26 55.29 4.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.525 1.803 . . . . 0.0 110.415 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -158.67 -37.08 0.02 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.513 ' NE2' ' HB2' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -110.64 -179.57 3.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.297 -1.12 . . . . 0.0 110.219 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.459 ' HA ' HG22 ' A' ' 83' ' ' VAL . 2.6 pttt -176.17 100.35 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.617 ' CG2' ' CD1' ' A' ' 47' ' ' PHE . 11.2 mt -42.35 113.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.006 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 1.2 pt-20 -77.95 -13.36 59.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 0.0 110.914 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.447 ' HB2' HD21 ' A' ' 92' ' ' LEU . . . -54.52 -28.8 47.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.064 -1.022 . . . . 0.0 110.575 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.26 -23.15 12.64 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.077 -1.014 . . . . 0.0 109.605 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' O ' HD13 ' A' ' 96' ' ' ILE . 20.5 mm-40 -58.14 -37.69 75.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.487 -0.758 . . . . 0.0 110.296 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.42 25.08 29.41 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.457 HD23 HD23 ' A' ' 13' ' ' LEU . 1.2 tp -106.45 -15.1 14.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -1.143 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.453 HG13 ' CE1' ' A' ' 18' ' ' TYR . 2.7 mp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.197 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' HG3' ' A' ' 1' ' ' MET . 6.5 ptp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.087 0.47 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -90.35 84.81 6.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.058 -1.026 . . . . 0.0 109.075 179.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.625 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 28.9 p -136.26 -88.61 0.31 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 110.621 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.558 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -78.15 -20.79 51.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.681 -1.262 . . . . 0.0 110.155 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.658 ' CZ ' ' HB3' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -52.13 -138.46 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.483 0.659 . . . . 0.0 110.802 178.179 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.65 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 55.3 t0 -31.13 -56.42 0.23 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.46 -0.775 . . . . 0.0 110.791 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.629 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 74.7 t -56.35 167.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.659 -0.651 . . . . 0.0 110.374 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.632 HG23 ' CD2' ' A' ' 28' ' ' PHE . 58.0 mt 11.59 86.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.222 0.534 . . . . 0.0 112.283 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.1 mt -68.29 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 110.149 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.41 158.54 33.59 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.956 -1.09 . . . . 0.0 110.359 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.35 161.69 42.07 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.012 1.533 . . . . 0.0 110.344 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.582 ' CG1' ' NE1' ' A' ' 29' ' ' TRP . 2.2 m -104.65 135.13 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.145 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.85 107.18 17.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.118 -0.989 . . . . 0.0 110.334 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 15' ' ' GLU . 14.9 m -162.11 147.16 12.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.947 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.1 tt0 -42.78 -55.48 3.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.917 . . . . 0.0 109.989 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -29.95 54.56 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 110.154 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -82.96 -64.88 1.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 1.6 m-85 -42.95 -51.72 5.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.299 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.74 -24.56 67.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.21 -0.931 . . . . 0.0 109.943 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -87.43 -44.75 5.47 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.52 -23.9 56.74 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.509 -0.995 . . . . 0.0 108.957 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 18' ' ' TYR . . . -50.43 -21.57 1.52 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.657 -0.652 . . . . 0.0 110.204 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.516 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -91.85 16.26 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.235 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.63 0.02 64.9 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 14.6 mttt -82.18 146.95 29.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -1.128 . . . . 0.0 109.694 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.63 ' CE2' ' CD1' ' A' ' 89' ' ' ILE . 22.3 m-85 -127.31 104.69 8.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.773 -1.204 . . . . 0.0 112.0 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 3.9 m -78.27 131.43 37.08 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.632 ' CD2' HG23 ' A' ' 8' ' ' ILE . 24.1 m-85 -136.32 164.42 28.14 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.177 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.582 ' NE1' ' CG1' ' A' ' 12' ' ' VAL . 99.6 m95 -100.43 121.91 42.32 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.547 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.6 p -145.78 164.99 10.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.503 -176.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.595 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -73.46 171.47 10.58 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.767 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 48.4 Cg_endo -75.18 -53.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.927 1.488 . . . . 0.0 109.374 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' THR 0.252 0.0 OUTLIER -47.12 -22.63 0.39 Allowed 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.678 178.927 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . . . -67.02 61.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.363 -0.835 . . . . 0.0 109.617 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -38.33 148.65 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.65 -0.656 . . . . 0.0 110.919 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 54' ' ' VAL . 14.1 mttt -42.67 -46.56 5.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -0.826 . . . . 0.0 109.955 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.463 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -58.78 -53.06 62.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.325 -0.86 . . . . 0.0 110.025 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -55.4 -41.85 73.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.862 . . . . 0.0 109.701 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.536 HG23 ' CD1' ' A' ' 8' ' ' ILE . 21.9 mt -57.63 -31.44 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.182 -0.949 . . . . 0.0 108.87 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.516 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 15.7 tttp -63.27 -45.35 91.9 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.368 -0.832 . . . . 0.0 109.864 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.453 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.3 m-80 -71.22 -34.36 70.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.688 -0.633 . . . . 0.0 111.412 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.609 ' HA ' ' CA ' ' A' ' 3' ' ' THR . . . -58.56 -50.73 72.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.768 -1.208 . . . . 0.0 110.6 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.537 HG13 ' CE2' ' A' ' 47' ' ' PHE . 2.9 m -71.05 -34.19 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.838 -1.163 . . . . 0.0 109.582 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -64.88 -38.06 89.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.28 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.596 ' CG2' ' CB ' ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.22 -33.43 43.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.516 -0.74 . . . . 0.0 109.72 179.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 4' ' ' ALA . . . -90.12 -62.42 1.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.39 -0.819 . . . . 0.0 110.72 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.563 ' CG ' HG23 ' A' ' 89' ' ' ILE . 21.8 m-85 -71.69 -21.45 61.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.415 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 7.4 mttt 60.64 46.89 8.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 0.0 110.272 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -123.19 -162.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.472 -0.768 . . . . 0.0 110.163 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 2.2 tmtm? -118.16 111.41 18.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.411 -0.805 . . . . 0.0 109.845 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.516 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 64.9 t -78.74 119.53 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.579 HG12 ' CA ' ' A' ' 83' ' ' VAL . 12.1 p -107.81 7.54 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.984 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER 169.25 117.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.814 . . . . 0.0 110.07 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.574 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -119.01 117.25 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.948 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 80' ' ' ILE . 2.5 m120 -116.27 116.11 27.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.285 -0.884 . . . . 0.0 109.523 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.547 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -114.82 139.76 49.48 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.356 -0.84 . . . . 0.0 109.809 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 58' ' ' HIS . 1.4 pp -125.36 167.81 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.646 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.446 ' O ' HD12 ' A' ' 57' ' ' LEU . 23.7 t-160 -72.95 128.23 34.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.465 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.566 HG12 ' CZ3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -111.33 138.66 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.576 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -113.59 173.51 6.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 110.152 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.63 92.18 0.38 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -111.8 91.96 3.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -1.137 . . . . 0.0 110.279 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.11 55.14 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.228 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 46.44 59.55 3.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.312 -0.867 . . . . 0.0 110.159 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HD2' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -177.84 -42.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.327 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' A' ' 65' ' ' ARG . 1.6 mp 45.27 94.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.786 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 68' ' ' ARG . . . 75.52 -158.47 50.41 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 67' ' ' GLY . 4.5 ptp85 -51.65 -169.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.599 -0.942 . . . . 0.0 110.657 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.573 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 6.1 t80 -38.3 108.75 0.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.443 -0.786 . . . . 0.0 110.862 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.3 OUTLIER 34.92 41.44 0.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.814 0.816 . . . . 0.0 110.804 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 66' ' ' LEU . . . -88.55 -145.85 11.69 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.57 139.64 47.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -1.14 . . . . 0.0 110.156 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.45 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.95 113.35 8.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.175 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.09 -165.5 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.86 1.452 . . . . 0.0 110.32 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 75' ' ' ASP . 18.7 p-10 -114.05 89.48 3.1 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.415 -0.803 . . . . 0.0 109.42 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.54 ' CG ' ' HB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -95.16 153.6 17.58 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.565 -0.709 . . . . 0.0 110.308 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.529 ' O ' ' CG1' ' A' ' 30' ' ' VAL . 20.9 tttt -123.21 135.06 54.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 109.398 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 56' ' ' THR . 5.2 ttpp -101.36 150.59 22.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.08 -1.012 . . . . 0.0 109.926 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -132.53 130.88 40.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.099 -1.001 . . . . 0.0 112.626 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.599 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -111.93 111.86 37.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.574 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 20.2 t -108.65 130.35 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.312 -0.868 . . . . 0.0 111.189 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.52 ' HG3' ' N ' ' A' ' 83' ' ' VAL . 3.1 tp60 -105.88 148.18 27.89 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.321 -0.862 . . . . 0.0 108.706 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.579 ' CA ' HG12 ' A' ' 52' ' ' VAL . 1.2 m -114.74 156.88 15.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.696 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.493 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -69.13 178.34 0.95 Allowed Pre-proline 0 C--N 1.291 -1.972 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.026 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 44.3 Cg_endo -74.16 139.36 26.54 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 O-C-N 124.23 1.648 . . . . 0.0 110.552 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.94 -40.17 2.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.482 ' OE1' ' HB2' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -96.44 -179.51 4.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.107 -1.231 . . . . 0.0 110.718 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 90' ' ' GLU . 5.6 ptmt 179.39 90.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 110.266 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.63 ' CD1' ' CE2' ' A' ' 26' ' ' TYR . 15.5 mt -46.28 97.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.076 -1.015 . . . . 0.0 109.821 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -58.26 -13.6 5.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.402 -0.811 . . . . 0.0 111.125 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.518 ' CB ' HD22 ' A' ' 92' ' ' LEU . . . -54.99 -36.7 65.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.052 -1.03 . . . . 0.0 110.823 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.599 ' CD1' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.8 -23.07 12.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.936 -1.103 . . . . 0.0 109.921 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 7.5 mm-40 -54.79 -40.1 69.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 110.409 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.81 -6.65 67.2 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 1.3 mp -63.47 -28.72 70.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -1.163 . . . . 0.0 110.126 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.557 HD12 ' CD1' ' A' ' 18' ' ' TYR . 17.4 mm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.16 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' O ' HG23 ' A' ' 3' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 120.659 0.266 . . . . 0.0 110.445 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.669 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -62.59 93.76 0.06 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.071 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 9.3 t -137.49 -38.81 0.59 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.422 1.106 . . . . 0.0 109.198 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.624 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -160.4 -24.5 0.06 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.628 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.669 ' CE1' ' HA ' ' A' ' 2' ' ' LYS 0.267 0.0 OUTLIER -46.85 -135.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.955 0.883 . . . . 0.0 111.891 178.418 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.598 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -24.6 -63.44 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.71 0.767 . . . . 0.0 111.854 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.541 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 60.8 t -56.71 -108.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.672 -0.642 . . . . 0.0 111.657 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.608 HG23 ' CD2' ' A' ' 28' ' ' PHE . 17.1 mt -81.6 93.8 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.775 -1.203 . . . . 0.0 112.118 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 39.4 mt -70.06 -106.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.365 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' TRP . . . -108.51 162.92 18.23 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.786 -1.196 . . . . 0.0 110.769 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -75.05 166.56 28.89 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.0 1.527 . . . . 0.0 110.545 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.584 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.5 m -115.25 137.95 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.565 HD13 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -102.8 113.03 26.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 110.294 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.468 ' OG ' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -152.54 146.64 25.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 110.103 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -42.72 -60.41 1.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 110.283 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -54.63 -42.22 70.95 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 110.371 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.542 ' N ' ' CG ' ' A' ' 16' ' ' LYS . . . -63.11 -60.01 4.01 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 1.3 m-85 -48.69 -36.24 15.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 0.0 110.106 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.37 -8.66 50.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.049 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.57 -34.77 4.02 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -79.06 -20.77 48.01 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.569 -0.959 . . . . 0.0 108.801 179.107 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.33 -21.45 5.71 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.705 -0.622 . . . . 0.0 110.819 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.91 17.19 5.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.35 -0.844 . . . . 0.0 110.48 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.72 -1.2 68.33 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.527 ' HD3' ' CG2' ' A' ' 80' ' ' ILE . 5.3 mttt -82.15 142.43 32.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.496 -1.002 . . . . 0.0 109.229 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 89' ' ' ILE . 21.3 m-85 -128.01 113.09 15.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.611 -1.306 . . . . 0.0 111.743 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 9.2 m -84.25 122.35 28.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.608 ' CD2' HG23 ' A' ' 8' ' ' ILE . 19.8 m-85 -116.8 165.33 13.43 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.562 -0.712 . . . . 0.0 110.991 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.584 ' CD1' HG12 ' A' ' 12' ' ' VAL . 22.8 m95 -99.74 123.1 43.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 177.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 1.4 p -144.22 156.28 15.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 117.407 -1.717 . . . . 0.0 112.463 -176.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.589 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -62.64 151.45 83.93 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.832 -179.359 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.3 Cg_endo -72.13 69.19 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.001 1.527 . . . . 0.0 109.478 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.77 -32.49 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.483 -0.761 . . . . 0.0 109.774 -178.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.524 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -40.29 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.758 -0.589 . . . . 0.0 109.897 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -42.87 137.45 2.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.087 -1.008 . . . . 0.0 110.533 -179.132 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.512 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -42.21 -39.18 1.97 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 0.0 109.737 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 14.3 m -74.79 -33.99 62.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.678 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -60.4 -43.96 96.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.385 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.557 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 10.2 mt -57.36 -30.33 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 37' ' ' THR . 30.0 tttt -66.51 -44.53 82.28 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.518 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.478 ' O ' ' HB ' ' A' ' 45' ' ' THR . 1.7 m-80 -73.35 -45.35 55.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.707 -0.621 . . . . 0.0 112.037 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 3' ' ' THR . . . -58.36 -51.82 68.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.583 -1.323 . . . . 0.0 110.462 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.56 HG21 ' CE2' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -61.3 -47.38 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 110.296 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -58.33 -43.26 88.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.066 -1.021 . . . . 0.0 109.536 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.555 ' CG2' ' CB ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -73.76 -13.57 60.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.521 -0.737 . . . . 0.0 109.737 179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 3' ' ' THR . . . -102.61 -69.03 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.393 -0.817 . . . . 0.0 110.351 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.54 ' CD1' HG23 ' A' ' 89' ' ' ILE . 17.1 m-85 -71.99 -21.56 61.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.893 . . . . 0.0 110.11 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.3 mttt 62.72 43.12 7.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.406 -0.809 . . . . 0.0 109.934 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -113.65 -159.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.635 -0.666 . . . . 0.0 109.952 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.567 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.16 105.06 11.41 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 109.946 179.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.424 HG13 HG23 ' A' ' 54' ' ' VAL . 21.5 t -78.67 119.61 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.898 . . . . 0.0 109.783 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.575 HG13 ' CA ' ' A' ' 83' ' ' VAL . 14.6 p -113.27 11.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 110.244 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 4.1 mttt 169.47 119.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.035 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.566 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 1.1 t -123.62 116.71 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 110.101 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.512 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -119.8 115.86 24.71 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.36 -0.838 . . . . 0.0 109.203 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -117.16 150.2 39.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.973 . . . . 0.0 110.043 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.532 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -148.42 149.0 30.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 110.1 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.481 ' NE2' ' HB3' ' A' ' 32' ' ' PRO . 1.1 m80 -66.63 127.31 31.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.176 -0.953 . . . . 0.0 110.58 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.52 HG22 ' CZ3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -120.42 138.27 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.689 -0.632 . . . . 0.0 110.225 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -160.1 149.78 17.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.115 -0.99 . . . . 0.0 110.593 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.49 103.65 2.76 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -122.21 -66.94 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -1.112 . . . . 0.0 110.076 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -156.78 159.91 38.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 52.86 81.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.097 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' LEU . 18.3 mtm180 -82.65 -85.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 110.351 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 68' ' ' ARG . 5.6 mp 43.34 84.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 0.0 109.952 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.5 57.61 0.19 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -125.01 18.35 8.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.063 -1.257 . . . . 0.0 109.288 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 11.1 t80 -157.81 52.58 0.45 Allowed 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.92 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER 41.17 40.43 1.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.822 0.82 . . . . 0.0 110.199 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 72' ' ' LYS . . . -104.51 -94.47 2.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 71' ' ' GLY . 12.1 pttp 40.06 -165.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.601 -0.94 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -71.43 113.64 21.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.115 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 52.0 Cg_endo -73.37 -169.21 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.877 1.461 . . . . 0.0 110.41 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.83 89.1 3.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.632 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.529 ' CG ' ' CZ3' ' A' ' 29' ' ' TRP . 0.4 OUTLIER -121.41 150.17 41.91 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.375 -0.828 . . . . 0.0 110.11 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.498 ' NZ ' ' OG1' ' A' ' 56' ' ' THR . 8.8 tttp -123.22 125.88 45.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.512 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 5.2 ptpt -101.73 151.51 21.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 109.471 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.82 120.29 28.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.895 -1.128 . . . . 0.0 112.592 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.617 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -96.19 112.53 28.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 40.7 t -113.09 126.34 70.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.378 -0.826 . . . . 0.0 110.661 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.488 ' O ' HG13 ' A' ' 52' ' ' VAL . 34.1 tp60 -102.19 151.41 22.23 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.08 -1.013 . . . . 0.0 108.888 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.575 ' CA ' HG13 ' A' ' 52' ' ' VAL . 1.1 m -118.82 157.04 20.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 118.451 -1.3 . . . . 0.0 109.647 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.511 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -69.29 178.83 0.84 Allowed Pre-proline 0 C--N 1.29 -1.986 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.302 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.3 140.81 31.12 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 O-C-N 124.343 1.707 . . . . 0.0 110.438 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.22 -32.47 6.82 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.491 ' OE1' ' CB ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.94 173.41 6.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -1.155 . . . . 0.0 110.49 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 90' ' ' GLU . 1.1 pttp 178.8 110.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.463 -0.773 . . . . 0.0 110.364 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 13.1 mt -63.44 77.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 109.698 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.83 -14.1 0.88 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.473 -0.767 . . . . 0.0 111.465 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.431 ' HB3' HD21 ' A' ' 92' ' ' LEU . . . -54.49 -21.01 8.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.913 -1.117 . . . . 0.0 110.999 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.84 -24.19 12.14 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.926 -1.109 . . . . 0.0 110.165 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 93' ' ' GLU . 8.4 mp0 -54.04 -26.86 28.78 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.275 -0.89 . . . . 0.0 110.237 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.42 -15.79 31.37 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.462 ' HB3' ' OH ' ' A' ' 18' ' ' TYR . 1.0 OUTLIER -53.36 -31.81 46.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -1.115 . . . . 0.0 110.118 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.564 HG13 ' CE1' ' A' ' 18' ' ' TYR . 71.8 mt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.138 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.506 ' HG2' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.798 0.809 . . . . 0.0 110.497 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' A' ' 4' ' ' ALA . 1.2 mmtt -82.65 109.06 16.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -32.52 -36.1 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.1 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.66 ' C ' ' CD1' ' A' ' 5' ' ' TYR 0.291 . . -63.17 68.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.66 ' CD1' ' C ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER 30.28 37.13 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.388 1.09 . . . . 0.0 108.724 -176.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 4' ' ' ALA . 2.6 t0 63.57 56.02 1.65 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.005 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.646 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 2.8 t -129.12 -128.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.826 -1.171 . . . . 0.0 110.01 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.539 ' CD1' HG22 ' A' ' 39' ' ' ILE . 3.5 mt -50.56 149.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.192 -0.942 . . . . 0.0 109.626 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.491 HD22 ' HG3' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -143.01 -92.75 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.138 -0.976 . . . . 0.0 110.572 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.67 138.15 21.42 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 46.4 Cg_endo -74.18 173.51 14.02 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.011 1.532 . . . . 0.0 110.11 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.578 ' CG1' ' NE1' ' A' ' 29' ' ' TRP . 1.4 m -105.34 129.21 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.234 -0.916 . . . . 0.0 110.17 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.1 mm? -103.37 107.14 17.85 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.241 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -158.87 148.64 19.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.014 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.45 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 13.6 mm-40 -43.25 -52.83 5.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.33 -0.856 . . . . 0.0 109.98 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.6 -41.42 69.92 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.157 -0.964 . . . . 0.0 110.006 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -73.25 -61.77 1.7 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.571 ' CZ ' HD11 ' A' ' 13' ' ' LEU . 1.4 m-85 -46.73 -32.93 3.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.949 . . . . 0.0 110.197 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 15' ' ' GLU . . . -90.39 -8.76 49.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 0.0 110.02 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.438 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -106.63 -38.17 2.27 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.13 -19.0 61.22 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.582 -0.952 . . . . 0.0 108.938 179.112 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -22.08 22.86 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.588 -0.695 . . . . 0.0 110.364 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -88.75 17.01 5.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 110.074 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' C ' ' OE1' ' A' ' 82' ' ' GLN . . . 91.37 3.74 69.06 Favored Glycine 0 N--CA 1.48 1.59 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 41.2 mttt -82.67 139.68 33.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -1.044 . . . . 0.0 109.48 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.59 ' CZ ' ' HB ' ' A' ' 89' ' ' ILE . 21.4 m-85 -127.64 100.1 5.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.67 -1.269 . . . . 0.0 111.481 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 17.7 m -80.64 116.2 20.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' CZ ' ' CZ ' ' A' ' 47' ' ' PHE . 3.5 m-85 -119.24 163.22 17.43 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 109.992 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.578 ' NE1' ' CG1' ' A' ' 12' ' ' VAL . 97.2 m95 -98.9 122.08 41.68 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.492 HG21 ' C ' ' A' ' 7' ' ' VAL . 9.8 p -131.17 165.31 31.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 118.493 -1.283 . . . . 0.0 112.193 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.434 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -60.29 147.65 81.22 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.067 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.79 70.96 3.43 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.22 1.642 . . . . 0.0 109.93 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.94 -33.19 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.368 -0.833 . . . . 0.0 110.076 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HB3' HG13 ' A' ' 39' ' ' ILE . . . -53.39 108.44 0.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.382 -0.824 . . . . 0.0 110.363 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 36.3 p -60.0 -170.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 110.153 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -77.33 -43.67 32.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.918 . . . . 0.0 110.336 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.3 m -71.56 -43.78 65.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.74 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.506 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 9.2 mt-10 -55.59 -46.21 77.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.361 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.539 HG22 ' CD1' ' A' ' 8' ' ' ILE . 27.1 mt -56.77 -30.4 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.911 . . . . 0.0 109.942 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 27.2 tttm -60.01 -44.69 94.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 111.664 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.45 ' O ' HG21 ' A' ' 45' ' ' THR . 54.9 m-80 -58.23 -36.55 73.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.302 -0.874 . . . . 0.0 112.685 -177.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.576 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . . . -73.23 -50.2 23.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.658 -1.276 . . . . 0.0 111.965 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.561 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -67.01 -43.02 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.791 -1.193 . . . . 0.0 110.748 -179.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.7 -42.1 78.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.929 -1.107 . . . . 0.0 110.149 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 41' ' ' ASN . 33.6 p -79.21 -46.68 17.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 0.0 109.98 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.2 -67.81 0.38 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.827 . . . . 0.0 110.494 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.617 ' CZ ' ' CZ ' ' A' ' 28' ' ' PHE . 90.5 m-85 -72.14 -3.84 25.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.89 . . . . 0.0 110.455 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 3.0 mtpp 43.35 42.81 3.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.455 -0.778 . . . . 0.0 110.347 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -112.39 -166.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.53 -0.731 . . . . 0.0 109.681 179.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.558 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -109.31 109.19 20.03 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.286 178.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.53 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 22.7 t -77.34 119.64 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.161 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 84' ' ' ALA . 6.2 t -111.79 -6.81 11.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.493 0.663 . . . . 0.0 110.667 -178.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.506 ' CG ' ' HB3' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 175.87 135.97 0.05 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.526 -0.734 . . . . 0.0 109.069 179.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.524 HG22 ' CG1' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -132.38 118.49 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 1.7 m120 -117.33 115.94 26.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.294 -0.878 . . . . 0.0 109.574 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.1 151.08 36.3 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.528 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 1.2 pp -147.79 143.01 27.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 110.323 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -67.26 127.2 31.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.54 HG22 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -120.22 110.38 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.508 -0.745 . . . . 0.0 110.032 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 74' ' ' PRO . 1.4 mmt85 -97.28 117.38 31.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 110.277 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 164.04 124.29 0.7 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HB3' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -168.82 -53.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 110.189 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -122.81 -177.97 3.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' LYS . 3.2 tttm -41.68 136.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.206 -0.934 . . . . 0.0 110.323 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.432 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -125.93 -161.22 1.03 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.253 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 65' ' ' ARG . 1.4 tp 42.12 51.53 4.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.222 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.85 118.44 0.45 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 68' ' ' ARG . 3.8 ptt180 -61.75 124.39 20.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.172 -1.193 . . . . 0.0 110.22 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.571 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 17.6 t80 -164.91 66.47 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.785 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 42.64 39.19 1.53 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.874 . . . . 0.0 109.975 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 72' ' ' LYS . . . -158.12 -100.67 0.17 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER 67.36 152.61 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.216 -1.167 . . . . 0.0 110.265 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.458 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 7.2 mtm-85 -50.99 109.23 1.27 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.463 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 50.2 Cg_endo -73.63 -166.64 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.915 1.481 . . . . 0.0 110.354 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' OD1' ' NH1' ' A' ' 60' ' ' ARG . 70.5 m-20 -115.53 89.44 3.1 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.418 -0.801 . . . . 0.0 109.352 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.536 ' CG ' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -111.96 140.85 46.29 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.499 -0.75 . . . . 0.0 110.104 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.485 ' CE ' HD11 ' A' ' 39' ' ' ILE . 9.2 tttt -123.29 127.41 48.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.925 . . . . 0.0 110.387 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 13.7 ptpt -102.71 151.11 22.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.038 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -122.88 125.9 46.27 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.023 -1.048 . . . . 0.0 112.258 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.602 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -100.77 111.88 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.612 -0.68 . . . . 0.0 109.204 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.524 ' CG1' HG22 ' A' ' 54' ' ' VAL . 1.6 t -100.01 144.56 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.356 -0.84 . . . . 0.0 110.35 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.506 ' HB3' ' CG ' ' A' ' 53' ' ' LYS . 42.6 tp60 -124.52 147.94 48.07 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.129 -0.982 . . . . 0.0 109.486 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -125.17 156.5 34.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.219 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.536 ' N ' HG22 ' A' ' 52' ' ' VAL . . . -43.83 173.23 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 CA-C-O 121.216 0.532 . . . . 0.0 111.194 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 84' ' ' ALA . 44.4 Cg_endo -76.11 54.42 4.16 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 O-C-N 124.347 1.709 . . . . 0.0 110.459 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -169.22 -50.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.537 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . 5.2 mp0 -50.86 179.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 110.314 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER 179.53 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.889 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 6.9 mt -64.54 77.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.057 -1.027 . . . . 0.0 109.207 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 88' ' ' LYS . 14.0 pt-20 -53.67 -14.36 0.87 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.384 -0.823 . . . . 0.0 111.263 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 95' ' ' LEU . . . -54.43 -22.2 11.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.913 -1.117 . . . . 0.0 110.295 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -106.24 -23.27 12.61 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.219 -0.926 . . . . 0.0 109.629 179.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 90' ' ' GLU . 5.3 mm-40 -61.29 -52.21 65.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.456 -0.778 . . . . 0.0 110.459 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.6 4.57 83.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 18.6 tp -75.13 -17.34 60.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 110.226 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.564 HG12 ' CZ ' ' A' ' 18' ' ' TYR . 52.3 mt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.208 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.73 0.3 . . . . 0.0 110.549 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.615 ' N ' ' HA ' ' A' ' 6' ' ' ASP . 1.9 mmpt? -43.85 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.3 m 4.79 -71.52 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.661 0 CA-C-O 121.074 0.464 . . . . 0.0 111.082 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 2' ' ' LYS 0.251 . . -56.95 79.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.43 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.627 ' CE2' HG23 ' A' ' 7' ' ' VAL . 0.7 OUTLIER 25.09 49.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.901 0.858 . . . . 0.0 110.409 -177.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.615 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 5.5 t70 64.79 53.74 1.44 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.019 0.914 . . . . 0.0 111.398 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.627 HG23 ' CE2' ' A' ' 5' ' ' TYR . 4.7 t -137.58 -121.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -0.848 . . . . 0.0 109.663 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.58 HG21 ' CD2' ' A' ' 28' ' ' PHE . 4.9 mt -61.34 151.86 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 121.127 -0.983 . . . . 0.0 110.004 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.535 ' CG ' ' HB3' ' A' ' 2' ' ' LYS . 15.3 mt -133.69 -99.74 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 110.367 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.83 155.42 40.76 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 110.344 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HG3' ' CD2' ' A' ' 92' ' ' LEU . 47.2 Cg_endo -73.92 155.52 48.25 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.036 1.545 . . . . 0.0 110.113 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.519 HG13 ' CE ' ' A' ' 78' ' ' LYS . 2.7 m -99.58 141.25 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.264 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.3 mm? -102.78 110.51 22.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -162.62 142.29 9.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.901 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.3 mm-40 -42.64 -47.16 5.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 110.106 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -54.81 -48.5 72.7 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.205 -0.934 . . . . 0.0 110.129 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -65.93 -62.45 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.123 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.616 ' CZ ' ' CG1' ' A' ' 96' ' ' ILE . 1.1 m-85 -45.95 -31.45 2.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.87 . . . . 0.0 110.375 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.42 -8.67 49.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.05 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.54 -37.17 1.95 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.53 -19.95 60.78 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 108.953 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.94 -21.31 11.28 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.427 0.632 . . . . 0.0 110.392 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -92.31 16.45 11.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.31 -0.868 . . . . 0.0 110.261 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.91 2.99 64.29 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HG3' ' NE2' ' A' ' 82' ' ' GLN . 17.5 mttm -82.58 142.18 31.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -1.133 . . . . 0.0 109.488 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.618 ' CE2' ' CD1' ' A' ' 89' ' ' ILE . 22.8 m-85 -127.62 103.95 7.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.707 -1.246 . . . . 0.0 111.461 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 4.3 m -76.76 126.78 31.56 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.455 0.645 . . . . 0.0 109.451 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.582 ' CE2' HG22 ' A' ' 43' ' ' VAL . 15.2 m-85 -125.95 164.67 20.28 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.48 -0.762 . . . . 0.0 110.861 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.63 ' CZ3' ' CD ' ' A' ' 76' ' ' ARG . 18.6 m95 -97.74 122.14 40.48 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 77' ' ' LYS . 9.8 p -146.06 166.72 8.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 118.816 -1.154 . . . . 0.0 111.585 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.435 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -69.6 151.86 96.45 Favored Pre-proline 0 C--N 1.297 -1.695 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.557 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.0 69.12 4.75 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.169 1.615 . . . . 0.0 109.988 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.22 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.307 -0.871 . . . . 0.0 110.039 -179.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HB3' ' CG1' ' A' ' 39' ' ' ILE . . . -41.71 101.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.506 -0.746 . . . . 0.0 110.373 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -53.27 135.94 37.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 2.6 mttp -42.21 -46.81 4.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.298 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -60.4 -53.24 59.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.551 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 17.5 mt-10 -55.72 -42.29 75.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 109.688 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.532 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 11.5 mt -57.74 -30.99 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.627 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 22.2 tttt -60.73 -45.51 93.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.623 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -64.32 -46.39 83.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.467 -0.77 . . . . 0.0 111.989 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.571 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -58.76 -40.6 84.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.716 -1.24 . . . . 0.0 111.092 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.582 HG22 ' CE2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -76.3 -44.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.916 -1.115 . . . . 0.0 110.367 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.2 -37.8 70.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.961 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.8 p -79.44 -45.22 19.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.969 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.22 -62.69 1.28 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.449 -0.782 . . . . 0.0 110.734 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 89' ' ' ILE . 46.3 m-85 -71.8 -21.37 61.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 0.0 110.387 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 61.82 40.91 12.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.425 -0.797 . . . . 0.0 110.371 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -118.14 -164.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.512 -0.743 . . . . 0.0 110.034 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.86 101.45 8.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.458 -0.776 . . . . 0.0 109.386 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.582 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 25.6 t -78.3 119.24 26.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.365 -0.834 . . . . 0.0 110.197 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 82' ' ' GLN . 8.1 p -102.3 -2.37 9.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.52 -0.738 . . . . 0.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.579 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.42 143.44 0.14 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.293 -0.88 . . . . 0.0 110.09 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.526 HG23 ' CG1' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -133.96 118.35 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 0.0 110.146 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.479 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 1.7 t-20 -118.85 115.97 25.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.208 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.519 ' OG1' ' CE ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -115.99 165.48 13.06 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.17 -178.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.7 150.2 28.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.797 . . . . 0.0 109.984 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.565 ' CD2' ' HD2' ' A' ' 60' ' ' ARG . 6.6 t-160 -67.17 125.77 27.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.095 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -119.64 137.52 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.355 -0.84 . . . . 0.0 109.889 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.565 ' HD2' ' CD2' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -156.9 -167.26 2.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.181 -0.95 . . . . 0.0 110.53 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.04 50.55 38.56 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.85 -35.95 2.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.344 -1.092 . . . . 0.0 110.089 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 65' ' ' ARG . 2.3 mptp? -61.49 139.02 58.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 110.179 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 69' ' ' TYR . 9.5 mttp -41.28 96.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.324 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 1.1 mtp85 -107.02 -66.05 1.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 110.226 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.1 mp 49.63 -178.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 109.53 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.482 ' C ' ' CG ' ' A' ' 68' ' ' ARG . . . -86.39 38.51 3.09 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.482 ' CG ' ' C ' ' A' ' 67' ' ' GLY . 11.4 mtm180 -147.48 18.97 1.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.403 1.097 . . . . 0.0 109.239 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.528 ' CB ' ' O ' ' A' ' 65' ' ' ARG . 8.2 t80 -138.38 -161.95 1.24 Allowed 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.891 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -165.65 103.05 0.7 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.455 -0.778 . . . . 0.0 109.865 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.15 72.81 0.35 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.461 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -43.75 161.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -1.172 . . . . 0.0 110.17 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 72' ' ' LYS . 3.8 mtm180 -42.48 102.05 0.26 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.127 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 49.5 Cg_endo -73.09 -165.71 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.01 1.531 . . . . 0.0 110.51 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -114.74 89.26 3.05 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.392 -0.818 . . . . 0.0 109.174 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.63 ' CD ' ' CZ3' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -136.2 122.64 20.72 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.729 -0.607 . . . . 0.0 109.441 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.519 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 8.7 tttt -119.84 141.9 49.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 110.456 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.566 ' HE3' ' CZ2' ' A' ' 29' ' ' TRP . 2.1 tptm -101.2 146.84 26.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 109.725 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -128.23 123.53 34.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.201 -0.937 . . . . 0.0 111.382 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.632 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -106.17 113.0 41.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.462 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.526 ' CG1' HG23 ' A' ' 54' ' ' VAL . 5.9 t -104.27 133.28 48.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.479 -0.763 . . . . 0.0 110.428 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.579 ' CB ' ' CG ' ' A' ' 53' ' ' LYS . 3.1 tp60 -107.69 140.34 40.88 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.094 -1.004 . . . . 0.0 108.559 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -109.15 155.48 10.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 117.71 -1.596 . . . . 0.0 108.991 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.493 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -52.84 177.87 0.07 OUTLIER Pre-proline 0 C--N 1.289 -2.059 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.383 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -73.1 144.17 37.24 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 O-C-N 124.374 1.723 . . . . 0.0 110.544 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.04 -26.15 14.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 84' ' ' ALA . 29.8 mt-30 -83.32 169.85 15.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -1.157 . . . . 0.0 110.467 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.468 ' NZ ' ' HB3' ' A' ' 88' ' ' LYS . 0.1 OUTLIER 179.71 129.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.302 -0.874 . . . . 0.0 110.476 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.618 ' CD1' ' CE2' ' A' ' 26' ' ' TYR . 6.5 mt -91.16 116.04 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 109.958 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 10.9 pt-20 -78.05 -14.7 59.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.55 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.482 ' CB ' HD21 ' A' ' 92' ' ' LEU . . . -55.82 -29.14 59.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -0.914 . . . . 0.0 110.922 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.582 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -106.04 -23.3 12.67 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.014 -1.054 . . . . 0.0 110.131 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.2 mm-40 -62.6 -39.13 92.78 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.271 -0.893 . . . . 0.0 110.429 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.25 -13.77 59.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -56.8 -17.26 8.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -1.171 . . . . 0.0 110.17 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.616 ' CG1' ' CZ ' ' A' ' 18' ' ' TYR . 61.0 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.184 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.518 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.695 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 2.3 pttt -58.1 92.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.13 -1.428 . . . . 0.0 108.897 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.554 ' CB ' HG21 ' A' ' 45' ' ' THR 0.264 10.1 t -136.97 -34.89 0.72 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 122.185 0.993 . . . . 0.0 109.741 -178.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -170.41 -26.83 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.799 -0.563 . . . . 0.0 110.459 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.695 ' CE1' ' HA ' ' A' ' 2' ' ' LYS 0.272 0.0 OUTLIER -47.39 -134.55 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.974 0.892 . . . . 0.0 112.033 178.384 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.627 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 27.9 m-20 -24.04 -65.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.539 0.685 . . . . 0.0 112.215 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.549 ' CG1' HG13 ' A' ' 8' ' ' ILE . 58.6 t -53.91 -110.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.583 -0.698 . . . . 0.0 110.971 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.674 ' CG2' ' CD1' ' A' ' 28' ' ' PHE . 21.4 mt -77.78 82.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 120.96 -1.087 . . . . 0.0 110.854 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -52.27 -94.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.48 -0.762 . . . . 0.0 111.064 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.21 155.96 39.28 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 0.0 110.985 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 49.5 Cg_endo -76.86 158.37 34.9 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.248 1.657 . . . . 0.0 110.449 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.586 ' HB ' ' CD1' ' A' ' 29' ' ' TRP . 1.6 p -115.15 109.39 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.055 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.582 ' HB3' ' CE2' ' A' ' 18' ' ' TYR . 2.6 mm? -102.06 107.2 18.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 110.446 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -154.25 160.6 41.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.864 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 10.1 pt-20 -40.54 -36.89 0.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 110.291 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -27.83 42.67 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.331 -0.856 . . . . 0.0 110.388 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.0 11.02 37.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.223 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 13' ' ' LEU . 1.5 m-85 -120.93 -33.6 3.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.211 -0.931 . . . . 0.0 109.927 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.19 -8.59 50.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -0.842 . . . . 0.0 109.506 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -110.79 -33.11 2.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -76.38 -17.94 59.12 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.641 -0.917 . . . . 0.0 108.935 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.621 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -59.66 -18.68 43.92 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.717 -0.614 . . . . 0.0 110.499 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.3 17.62 5.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.464 -0.772 . . . . 0.0 109.855 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 92.82 -0.05 69.45 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 18.8 mttt -82.56 143.27 31.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.578 -0.954 . . . . 0.0 109.532 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 89' ' ' ILE . 60.7 m-85 -128.27 101.52 6.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.743 -1.223 . . . . 0.0 111.376 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 4.3 m -74.84 132.28 41.4 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CD1' ' CG2' ' A' ' 8' ' ' ILE . 2.8 m-85 -136.99 164.2 28.92 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.632 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.586 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 68.7 m95 -101.09 122.62 43.91 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 2.8 p -141.4 156.45 21.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 C-N-CA 118.181 -1.408 . . . . 0.0 111.863 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.58 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 2.9 t60 -63.93 151.26 89.87 Favored Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.891 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 47.2 Cg_endo -73.82 72.11 3.94 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.166 1.614 . . . . 0.0 109.961 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.35 -32.0 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.524 -0.735 . . . . 0.0 109.552 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.543 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -47.4 90.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.568 -0.707 . . . . 0.0 109.659 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -41.73 142.04 0.71 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.144 -0.973 . . . . 0.0 110.453 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.509 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -43.58 -42.77 5.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.632 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.495 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 8.7 m -71.13 -26.72 63.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.388 -0.82 . . . . 0.0 109.727 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.4 OUTLIER -66.65 -46.41 75.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.212 179.431 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.512 ' CD1' HG21 ' A' ' 56' ' ' THR . 16.6 mt -57.5 -30.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.507 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 4.3 tttt -62.87 -47.34 83.74 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.501 -0.749 . . . . 0.0 110.007 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.488 ' O ' ' HB ' ' A' ' 45' ' ' THR . 29.5 m-20 -73.01 -35.02 66.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.704 -0.622 . . . . 0.0 111.688 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 3' ' ' THR . . . -58.39 -52.77 64.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.649 -1.282 . . . . 0.0 110.361 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 47' ' ' PHE . 2.7 m -68.37 -36.61 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.673 -1.267 . . . . 0.0 110.45 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.462 ' HG2' HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -65.13 -41.37 94.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.989 -1.07 . . . . 0.0 109.775 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.554 HG21 ' CB ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -79.27 -12.91 59.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.936 179.456 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.528 ' CB ' ' OG1' ' A' ' 3' ' ' THR . . . -110.82 -59.47 1.95 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.324 -0.86 . . . . 0.0 110.62 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.567 ' CG ' HG23 ' A' ' 89' ' ' ILE . 10.2 m-85 -71.7 -20.91 61.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.475 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 mttt 63.24 43.01 6.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -118.21 -161.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.638 -0.664 . . . . 0.0 109.831 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.555 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -116.91 109.18 16.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.398 -0.814 . . . . 0.0 109.516 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.507 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 55.4 t -77.32 122.37 31.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.166 -0.959 . . . . 0.0 109.194 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 84' ' ' ALA . 30.1 t -114.94 -11.92 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.496 -0.753 . . . . 0.0 110.881 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -176.35 117.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.118 179.353 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.543 HG23 ' CG1' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -115.73 125.31 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 110.057 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 80' ' ' ILE . 15.8 t-20 -126.81 115.97 20.17 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 109.418 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.22 153.49 31.77 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.93 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -139.42 169.03 18.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.112 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.79 125.75 35.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 110.357 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.582 HG23 ' CZ3' ' A' ' 29' ' ' TRP . 2.4 m -120.26 120.58 63.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.709 -0.62 . . . . 0.0 110.048 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.557 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -132.99 117.73 17.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.154 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.39 131.89 3.05 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -96.57 -65.19 0.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -1.138 . . . . 0.0 110.386 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -76.12 57.8 1.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 0.0 110.281 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 54.53 108.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.192 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.533 ' CB ' ' HG3' ' A' ' 73' ' ' ARG . 3.7 ptt85 -56.13 -160.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.378 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 65' ' ' ARG . 7.2 tp 54.91 106.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.154 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.08 -176.03 43.03 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.517 ' O ' ' C ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -61.62 -175.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -1.148 . . . . 0.0 110.268 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 7.9 t80 27.89 70.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.652 0.739 . . . . 0.0 111.018 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER 36.46 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.816 . . . . 0.0 110.875 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 70' ' ' LEU . . . -43.15 165.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -102.84 133.89 47.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -1.17 . . . . 0.0 110.394 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.533 ' HG3' ' CB ' ' A' ' 65' ' ' ARG . 3.8 ttm180 -166.55 79.67 1.05 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.322 -0.861 . . . . 0.0 110.198 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.454 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 52.3 Cg_endo -76.41 -167.0 0.41 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.087 1.572 . . . . 0.0 110.461 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -115.33 89.39 3.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.539 -0.726 . . . . 0.0 109.249 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.485 ' CG ' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -129.67 147.34 51.45 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.587 -0.695 . . . . 0.0 110.371 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.514 ' NZ ' ' OG1' ' A' ' 56' ' ' THR . 0.0 OUTLIER -123.5 142.45 51.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.36 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 56' ' ' THR . 13.6 mtpt -100.41 150.97 22.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.419 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -123.25 129.96 52.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.024 -1.048 . . . . 0.0 112.167 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.607 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -109.65 111.35 35.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.201 178.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.543 ' CG1' HG23 ' A' ' 54' ' ' VAL . 3.2 t -100.79 143.9 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.421 -0.799 . . . . 0.0 110.19 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' LYS . 9.2 tp60 -122.54 147.1 46.78 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.354 -0.841 . . . . 0.0 109.39 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.492 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.3 m -125.01 156.8 33.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.178 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 52' ' ' VAL . . . -45.17 175.81 0.03 OUTLIER Pre-proline 0 C--N 1.296 -1.726 0 CA-C-O 121.292 0.568 . . . . 0.0 110.916 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.8 Cg_endo -74.1 142.67 31.25 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 O-C-N 124.221 1.642 . . . . 0.0 110.542 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.82 -15.74 45.77 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.527 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 57.4 mt-30 -93.7 165.05 12.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -1.219 . . . . 0.0 110.629 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 8.2 ptmt 179.63 102.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.47 -0.769 . . . . 0.0 110.241 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 54.8 mt -42.18 98.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 110.189 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.73 -28.47 34.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.089 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . . . -55.8 -23.69 31.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.197 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.525 ' CD2' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -107.73 -23.03 12.25 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.875 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.4 ' OE2' ' CZ ' ' A' ' 21' ' ' PHE . 6.2 mm-40 -84.11 1.72 42.82 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 118.055 -1.458 . . . . 0.0 110.247 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.21 -16.85 8.06 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.46 ' O ' ' OXT' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -60.19 -26.98 66.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.431 -1.041 . . . . 0.0 110.047 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.46 ' OXT' ' O ' ' A' ' 95' ' ' LEU . 10.1 mt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.238 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.535 ' O ' ' N ' ' A' ' 3' ' ' THR . 2.3 ptp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.684 0.278 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.633 ' N ' ' HA ' ' A' ' 6' ' ' ASP . 13.2 mmtt -43.67 98.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.593 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.5 m 4.51 -71.56 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.7 0 CA-C-O 121.33 0.586 . . . . 0.0 110.829 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 2' ' ' LYS 0.26 . . -55.58 81.44 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.058 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 7' ' ' VAL . 1.5 p90 23.52 47.54 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.74 0.781 . . . . 0.0 110.416 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.633 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 4.4 t70 64.94 52.33 1.58 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.03 0.919 . . . . 0.0 111.505 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.642 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 2.5 t -133.42 -129.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 109.525 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.588 HG21 ' CD2' ' A' ' 28' ' ' PHE . 2.2 mp -49.94 155.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.362 -0.837 . . . . 0.0 110.519 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.528 ' CG ' ' HB3' ' A' ' 2' ' ' LYS . 24.0 mt -139.93 -96.73 0.16 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.179 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.37 140.31 21.62 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.082 -1.011 . . . . 0.0 110.255 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HG3' HD22 ' A' ' 92' ' ' LEU . 45.7 Cg_endo -73.54 162.55 39.67 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.003 1.528 . . . . 0.0 110.204 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.525 HG11 ' NE1' ' A' ' 29' ' ' TRP . 2.5 m -98.35 140.59 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.91 . . . . 0.0 110.335 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.583 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.0 mm? -102.76 113.2 26.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 15' ' ' GLU . 3.7 m -170.67 143.88 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 109.952 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.1 mt-10 -42.74 -49.34 5.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.119 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.6 -17.9 3.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.256 -0.903 . . . . 0.0 110.318 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -106.6 -49.8 3.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.583 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.3 m-85 -56.25 -53.52 56.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.828 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.79 -12.37 34.95 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.185 -0.947 . . . . 0.0 109.209 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -90.86 -48.64 3.33 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 9.4 m-30 -46.83 -27.66 1.3 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.347 -1.09 . . . . 0.0 108.151 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -40.18 -28.14 0.05 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.476 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.552 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 3.5 pm0 -104.62 17.07 24.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.343 -0.848 . . . . 0.0 111.471 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 87.32 7.22 76.82 Favored Glycine 0 N--CA 1.486 1.975 0 O-C-N 120.965 -1.084 . . . . 0.0 110.543 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.559 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 3.2 mptp? -84.94 134.97 34.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -1.195 . . . . 0.0 110.241 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.587 ' CZ ' ' HB ' ' A' ' 89' ' ' ILE . 86.3 m-85 -126.94 110.44 13.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.718 -1.239 . . . . 0.0 111.544 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.4 m -76.0 135.76 39.99 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 121.466 0.65 . . . . 0.0 109.674 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.588 ' CD2' HG21 ' A' ' 8' ' ' ILE . 21.3 m-85 -129.58 165.23 22.14 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.588 -0.695 . . . . 0.0 110.703 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.525 ' NE1' HG11 ' A' ' 12' ' ' VAL . 19.9 m95 -104.43 122.49 45.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.0 p -151.17 165.21 2.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 118.472 -1.291 . . . . 0.0 111.51 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.466 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -59.04 149.42 66.71 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.773 -0.579 . . . . 0.0 110.791 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 47.9 Cg_endo -73.33 69.97 4.01 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.26 1.663 . . . . 0.0 109.88 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.26 -33.71 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 110.273 -178.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -42.11 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.414 -0.804 . . . . 0.0 110.307 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -47.62 142.63 4.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.209 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 12.5 mttt -49.75 -44.59 48.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.308 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -64.75 -49.75 69.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.981 . . . . 0.0 110.545 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.491 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -55.29 -41.93 72.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 0.0 109.73 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.559 ' CA ' HD11 ' A' ' 8' ' ' ILE . 10.1 mt -57.42 -30.8 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.396 -0.815 . . . . 0.0 109.817 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.52 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.6 tttt -60.75 -46.18 91.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.0 111.025 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -58.97 -34.87 72.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 112.415 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.546 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -70.1 -50.28 42.41 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.588 -1.32 . . . . 0.0 111.715 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.523 HG12 ' CE2' ' A' ' 28' ' ' PHE . 15.1 m -68.54 -27.32 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.51 -1.369 . . . . 0.0 110.36 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.503 ' CG ' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -56.43 -53.0 62.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.939 -1.101 . . . . 0.0 109.237 179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.3 p -80.54 -45.11 17.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 109.884 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.61 -63.09 1.31 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 110.848 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.632 ' CD1' ' CG2' ' A' ' 89' ' ' ILE . 35.2 m-85 -71.51 -21.16 61.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.131 -0.98 . . . . 0.0 109.807 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 71.26 50.85 0.28 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.499 -0.751 . . . . 0.0 110.108 179.602 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.554 ' CG2' ' N ' ' A' ' 50' ' ' LYS . 1.5 p -149.3 171.99 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.541 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.554 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -89.97 110.57 21.53 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.534 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.52 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 22.0 t -77.87 138.49 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.786 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.53 ' CG1' ' OE1' ' A' ' 82' ' ' GLN . 11.3 p -110.28 -29.34 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.226 -0.921 . . . . 0.0 110.842 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' HG3' ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -159.12 149.63 19.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.987 -1.07 . . . . 0.0 110.467 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.532 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.4 t -133.0 117.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 110.121 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.508 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.6 m-20 -116.86 114.69 24.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.2 -0.937 . . . . 0.0 109.157 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -119.66 150.66 39.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.99 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 3.0 pp -140.61 170.34 15.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.428 ' ND1' ' NH1' ' A' ' 60' ' ' ARG . 0.4 OUTLIER -90.57 120.98 32.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.33 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -117.51 130.71 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.4 -0.813 . . . . 0.0 109.938 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 4.7 mmt85 -115.66 174.18 6.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 110.136 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -45.17 126.86 7.54 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.479 ' CE ' ' CA ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -99.67 -61.64 1.34 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 110.277 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.98 139.91 57.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.234 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.3 tttm 56.86 76.61 0.3 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 110.186 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -105.02 -81.45 0.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.333 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.4 mm? 43.65 72.3 0.19 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.932 . . . . 0.0 109.904 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.37 57.32 0.18 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -137.25 21.89 2.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.015 -1.285 . . . . 0.0 110.035 179.622 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 9.6 t80 -168.56 58.32 0.06 Allowed 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.838 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER 43.05 41.74 2.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 0.0 109.946 -179.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 70' ' ' LEU . . . -52.93 -169.93 0.02 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.58 109.74 21.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -1.151 . . . . 0.0 110.26 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.466 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 7.7 ttm105 -158.1 79.46 3.23 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.457 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 51.9 Cg_endo -77.89 -165.94 0.36 Allowed 'Trans proline' 0 C--N 1.302 -1.869 0 O-C-N 124.169 1.615 . . . . 0.0 110.377 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.442 ' OD2' ' HG3' ' A' ' 32' ' ' PRO . 11.7 p-10 -114.6 89.36 3.07 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.408 -0.808 . . . . 0.0 109.407 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -126.05 142.13 51.66 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.146 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.469 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 8.7 pttt -123.05 141.92 51.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.294 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 3.9 ptpt -100.85 149.18 24.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.671 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -116.89 123.67 47.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.03 -1.044 . . . . 0.0 112.585 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.623 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.7 mp -101.98 111.45 31.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.572 HG21 ' CE2' ' A' ' 28' ' ' PHE . 89.0 t -108.99 133.96 52.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.254 -0.904 . . . . 0.0 110.861 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.554 ' CG ' ' HD2' ' A' ' 25' ' ' LYS . 2.7 tm0? -103.22 153.45 20.36 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.332 -0.855 . . . . 0.0 109.345 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 3.7 m -109.39 157.18 9.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 C-N-CA 118.799 -1.16 . . . . 0.0 108.419 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.533 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -70.87 179.97 0.8 Allowed Pre-proline 0 C--N 1.283 -2.284 0 C-N-CA 119.071 -1.051 . . . . 0.0 109.988 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.0 Cg_endo -73.25 137.83 26.65 Favored 'Trans proline' 0 C--N 1.297 -2.136 0 O-C-N 124.242 1.653 . . . . 0.0 110.389 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.23 -36.65 4.26 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.527 ' OE1' ' CB ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -105.95 -178.89 3.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.239 -1.154 . . . . 0.0 110.608 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 90' ' ' GLU . 5.8 ptpt -179.86 104.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 0.0 110.056 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.632 ' CG2' ' CD1' ' A' ' 47' ' ' PHE . 71.3 mt -54.35 86.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.351 -0.843 . . . . 0.0 109.885 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 2.8 pt-20 -71.11 -12.22 61.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.443 -0.785 . . . . 0.0 110.925 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.51 ' O ' ' CD1' ' A' ' 95' ' ' LEU . . . -53.37 -27.35 23.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.992 -1.068 . . . . 0.0 110.562 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.92 -23.67 12.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.98 -1.075 . . . . 0.0 109.683 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.531 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 1.5 pp20? -66.23 -29.67 69.97 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.349 -0.941 . . . . 0.0 109.485 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.52 -22.63 28.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.51 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 0.5 OUTLIER -44.73 -25.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -1.08 . . . . 0.0 109.857 179.665 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.582 HD12 ' CG ' ' A' ' 18' ' ' TYR . 12.5 mm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.188 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.801 0.334 . . . . 0.0 110.633 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.623 ' N ' ' HA ' ' A' ' 6' ' ' ASP . 43.1 mmtt -43.91 98.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.605 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.5 m 4.56 -72.07 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.308 0.575 . . . . 0.0 110.704 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.62 ' N ' ' O ' ' A' ' 2' ' ' LYS 0.258 . . -55.51 81.96 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.644 ' CE2' ' CG2' ' A' ' 7' ' ' VAL . 1.4 p90 22.81 48.18 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 121.761 0.791 . . . . 0.0 110.502 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.623 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 5.9 t70 64.07 53.64 1.8 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.002 0.906 . . . . 0.0 111.492 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.644 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 3.2 t -131.42 -125.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.491 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.655 ' CG2' ' CG ' ' A' ' 28' ' ' PHE . 4.5 mt -49.74 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.169 -0.957 . . . . 0.0 110.078 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.523 ' CD2' ' HD2' ' A' ' 2' ' ' LYS . 0.7 OUTLIER -57.88 -106.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 110.664 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.537 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -108.13 162.88 18.33 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.877 -1.139 . . . . 0.0 110.525 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.636 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.8 Cg_endo -73.72 133.47 18.69 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.105 1.582 . . . . 0.0 110.439 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 27' ' ' THR . 2.1 p -93.91 116.78 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.89 . . . . 0.0 109.968 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.4 mm? -100.96 109.24 21.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.399 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -159.13 163.92 35.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.004 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.9 mt-10 -42.88 -52.94 4.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 110.069 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -57.63 -39.5 77.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 110.099 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.493 ' HB3' ' CB ' ' A' ' 27' ' ' THR . . . -91.33 23.72 3.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.875 . . . . 0.0 109.692 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.624 ' CZ ' ' CD1' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -125.51 -63.24 1.15 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.0 109.518 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.05 -12.06 35.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.548 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.38 -40.54 2.21 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -74.01 -29.41 61.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.57 -0.959 . . . . 0.0 108.78 179.128 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 18' ' ' TYR . . . -46.13 -23.54 0.34 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.689 -0.632 . . . . 0.0 110.57 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.74 -14.71 34.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 110.508 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 132.42 -1.23 4.83 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 12.5 mmtt -81.69 147.45 29.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -1.153 . . . . 0.0 109.602 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.643 ' CE2' ' CD1' ' A' ' 89' ' ' ILE . 20.6 m-85 -127.2 106.69 9.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.91 -1.119 . . . . 0.0 111.661 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.529 ' O ' ' CG1' ' A' ' 12' ' ' VAL . 2.9 m -75.73 126.75 31.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.655 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.4 OUTLIER -135.32 164.01 28.71 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.177 -0.952 . . . . 0.0 110.46 -178.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.566 ' CZ3' ' HD3' ' A' ' 76' ' ' ARG . 23.3 m95 -101.92 122.28 43.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 13.7 p -146.24 166.49 8.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.06 -1.025 . . . . 0.0 111.488 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.494 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -71.92 169.59 15.6 Favored Pre-proline 0 C--N 1.293 -1.85 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.963 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.494 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 48.6 Cg_endo -75.41 -53.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.043 0 O-C-N 124.245 1.655 . . . . 0.0 109.643 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 31' ' ' HIS 0.256 0.0 OUTLIER -46.54 -22.45 0.28 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.874 179.027 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 102.76 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 110.306 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -67.17 143.27 56.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 110.18 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 54' ' ' VAL . 13.9 mttt -42.45 -38.61 1.96 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -68.33 -52.28 35.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.388 -0.82 . . . . 0.0 110.608 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 29.5 mm-40 -55.19 -43.54 74.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.529 HG23 ' CG1' ' A' ' 8' ' ' ILE . 11.4 mt -56.87 -30.3 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.112 -0.993 . . . . 0.0 109.403 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 15.1 ttpt -63.67 -47.02 82.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.461 -0.774 . . . . 0.0 111.039 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -58.73 -34.94 71.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.368 -0.832 . . . . 0.0 112.189 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . -65.34 -50.43 65.62 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.682 -1.262 . . . . 0.0 111.289 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 9.4 m -76.23 -32.22 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.614 -1.304 . . . . 0.0 110.612 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.79 -51.64 68.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.698 -1.251 . . . . 0.0 109.415 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -79.71 -46.23 17.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 110.035 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -59.16 -64.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.389 -0.819 . . . . 0.0 110.404 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.639 ' CE1' ' CB ' ' A' ' 91' ' ' ALA . 7.5 m-85 -72.03 -19.9 61.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.242 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 66.9 41.92 2.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 110.251 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -122.55 -164.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.556 -0.715 . . . . 0.0 109.931 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.575 ' CB ' ' NE2' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -119.28 106.79 12.67 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 110.145 179.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.532 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 76.3 t -78.43 119.7 27.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.538 HG13 ' CA ' ' A' ' 83' ' ' VAL . 12.2 p -104.23 4.96 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.919 . . . . 0.0 110.7 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 167.77 119.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.217 -0.927 . . . . 0.0 110.504 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.533 HG23 ' CG1' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -112.16 120.01 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 109.861 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -107.66 115.22 29.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.181 -0.95 . . . . 0.0 109.047 178.623 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.53 ' OG1' ' CE ' ' A' ' 77' ' ' LYS . 2.3 p -116.68 139.07 50.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.101 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.527 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -136.38 144.1 44.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 110.264 -179.569 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.496 ' CG ' ' NE ' ' A' ' 60' ' ' ARG . 2.0 t-160 -76.34 115.16 15.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -109.48 121.14 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.321 -0.862 . . . . 0.0 109.892 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -133.65 167.68 20.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 110.302 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -43.61 147.91 0.94 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.33 29.01 0.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -1.1 . . . . 0.0 110.202 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -110.53 -20.98 12.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.147 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 0.8 OUTLIER 168.31 115.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 110.064 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.439 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -145.75 51.74 1.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 110.435 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.482 HD21 ' CZ ' ' A' ' 68' ' ' ARG . 2.3 mp -42.57 126.0 3.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.051 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.15 52.0 1.72 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.482 ' CZ ' HD21 ' A' ' 66' ' ' LEU . 16.4 ptt180 -154.22 22.95 0.49 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.049 -1.265 . . . . 0.0 110.02 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 40.1 t80 -166.54 55.99 0.09 Allowed 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.751 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER 41.21 94.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.283 -0.885 . . . . 0.0 110.416 -179.728 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.69 153.79 37.1 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 3.2 mppt? -97.29 62.51 1.77 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -1.141 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.14 78.9 1.44 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.284 -0.885 . . . . 0.0 110.335 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 50.3 Cg_endo -76.16 -165.01 0.28 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.021 1.537 . . . . 0.0 110.394 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' OD2' ' O ' ' A' ' 75' ' ' ASP . 6.4 p-10 -114.2 89.47 3.1 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.411 -0.806 . . . . 0.0 109.327 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.566 ' HD3' ' CZ3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -120.2 112.67 19.37 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.627 -0.671 . . . . 0.0 110.214 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.53 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 1.8 tttp -117.59 134.77 54.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 109.682 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 6.7 ptpt -102.04 150.3 23.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.022 . . . . 0.0 110.798 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 28' ' ' PHE . . . -117.29 134.14 55.16 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.148 -0.97 . . . . 0.0 111.978 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.593 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -110.76 110.86 33.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.533 ' CG1' HG23 ' A' ' 54' ' ' VAL . 2.4 t -104.98 127.72 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.335 -0.853 . . . . 0.0 111.011 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.493 ' O ' HG13 ' A' ' 52' ' ' VAL . 9.9 tp60 -110.02 146.03 36.01 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.066 -1.021 . . . . 0.0 108.761 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.538 ' CA ' HG13 ' A' ' 52' ' ' VAL . 1.6 m -113.26 155.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 118.083 -1.447 . . . . 0.0 109.623 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.523 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -55.83 179.48 0.1 OUTLIER Pre-proline 0 C--N 1.29 -1.996 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.195 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.5 Cg_endo -72.27 141.51 35.76 Favored 'Trans proline' 0 C--N 1.299 -2.048 0 O-C-N 124.193 1.628 . . . . 0.0 110.55 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.57 -19.63 46.52 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.575 ' NE2' ' CB ' ' A' ' 50' ' ' LYS . 49.9 mt-30 -93.11 168.96 10.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -1.141 . . . . 0.0 110.672 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.8 OUTLIER 179.65 122.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.395 -0.815 . . . . 0.0 110.339 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 26' ' ' TYR . 15.2 mt -83.86 106.74 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.146 -0.971 . . . . 0.0 109.958 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -61.94 -13.97 30.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.368 -0.832 . . . . 0.0 110.946 -179.413 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.639 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . -55.03 -34.12 63.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.098 -1.001 . . . . 0.0 110.792 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -105.86 -23.23 12.74 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.011 -1.056 . . . . 0.0 109.592 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' O ' HG12 ' A' ' 96' ' ' ILE . 6.9 mm-40 -66.49 -37.67 85.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.344 -0.847 . . . . 0.0 109.95 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.07 -8.92 86.82 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 95' ' ' LEU . 4.8 mp -81.34 8.87 8.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -1.153 . . . . 0.0 110.091 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.624 ' CD1' ' CZ ' ' A' ' 18' ' ' TYR . 15.5 mm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.517 ' HB2' ' CB ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.273 0.558 . . . . 0.0 110.509 . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.615 ' O ' ' N ' ' A' ' 4' ' ' ALA . 5.7 mmtm -47.56 100.11 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.602 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.2 m 3.01 -68.7 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 121.118 0.485 . . . . 0.0 111.337 -179.18 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.638 ' C ' ' CD1' ' A' ' 5' ' ' TYR 0.262 . . -56.7 73.94 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CE2' HG22 ' A' ' 7' ' ' VAL . 5.0 p90 31.08 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.742 0.782 . . . . 0.0 109.674 -178.006 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.605 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER 85.24 39.75 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.877 0.846 . . . . 0.0 111.755 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.639 HG22 ' CE2' ' A' ' 5' ' ' TYR . 1.7 t -134.78 -137.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.134 -0.979 . . . . 0.0 109.987 178.018 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.588 HG23 ' CD1' ' A' ' 28' ' ' PHE . 2.6 mm -32.83 126.05 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 121.267 0.556 . . . . 0.0 110.919 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 2' ' ' LYS . 1.3 mt -115.03 -94.54 0.48 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.85 . . . . 0.0 109.751 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.85 153.88 42.14 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.892 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HB3' HD22 ' A' ' 92' ' ' LEU . 48.4 Cg_endo -76.02 158.25 38.25 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.943 1.496 . . . . 0.0 110.314 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.562 HG13 ' CD1' ' A' ' 29' ' ' TRP . 1.4 m -103.69 129.14 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.204 -0.935 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.586 HD13 ' CZ ' ' A' ' 18' ' ' TYR . 2.9 mm? -102.84 113.01 26.09 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.111 -0.993 . . . . 0.0 110.275 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 15' ' ' GLU . 68.8 m -161.58 144.05 11.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 14' ' ' SER . 69.7 mt-10 -42.87 -51.61 5.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 110.043 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -54.86 -34.03 62.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.288 -0.882 . . . . 0.0 110.172 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -86.03 -58.5 2.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.25 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.586 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -46.13 -31.28 2.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.876 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.25 -8.75 50.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.084 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.14 -37.55 1.96 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -71.12 -18.3 62.53 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.698 -0.883 . . . . 0.0 108.843 178.968 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.621 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -58.72 -20.02 45.27 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.676 -0.64 . . . . 0.0 110.474 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -88.62 17.32 5.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.487 -0.758 . . . . 0.0 109.953 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 91.96 3.27 68.2 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 72.9 mttt -82.72 136.94 34.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.563 -0.963 . . . . 0.0 109.382 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.582 ' CD2' HD12 ' A' ' 89' ' ' ILE . 24.6 m-85 -127.95 96.9 4.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.658 -1.277 . . . . 0.0 111.538 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.8 m -75.61 117.57 17.52 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.53 -0.731 . . . . 0.0 109.695 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.679 ' CZ ' ' CZ ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -116.86 162.96 16.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 110.349 -179.663 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.64 ' CZ3' ' CG1' ' A' ' 59' ' ' VAL . 97.7 m95 -92.65 122.77 35.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.535 ' CG2' HG13 ' A' ' 7' ' ' VAL . 8.9 p -147.03 166.97 6.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.038 -177.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.433 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -60.5 141.11 92.0 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.148 179.822 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.512 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.5 Cg_endo -72.2 77.46 2.02 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 124.169 1.615 . . . . 0.0 110.278 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 178.67 -34.71 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.349 -0.844 . . . . 0.0 109.906 -179.264 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.463 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . . . -52.8 92.05 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.493 -0.754 . . . . 0.0 109.917 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -41.98 151.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.335 -0.853 . . . . 0.0 110.319 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' A' ' 54' ' ' VAL . 6.8 mmtp -42.49 -35.07 0.95 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 110.044 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.6 m -75.08 -39.75 60.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 110.096 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.68 -43.52 76.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.061 -1.024 . . . . 0.0 109.536 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.528 HG22 ' CG2' ' A' ' 54' ' ' VAL . 30.0 mt -57.99 -30.32 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.432 -0.792 . . . . 0.0 109.646 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.531 ' HG3' ' CB ' ' A' ' 51' ' ' VAL . 11.5 tttm -60.14 -47.42 85.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.556 -0.715 . . . . 0.0 111.523 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -58.22 -38.87 77.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.379 -0.826 . . . . 0.0 112.108 -178.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . . . -73.56 -50.87 19.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.7 -1.25 . . . . 0.0 111.818 -178.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.573 HG13 ' CE2' ' A' ' 47' ' ' PHE . 6.1 m -65.59 -44.75 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.711 -1.243 . . . . 0.0 111.054 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.514 ' CG ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -56.91 -48.15 78.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.719 -1.238 . . . . 0.0 110.103 -179.945 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 m -79.0 -47.79 15.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 0.0 110.673 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -68.49 -63.79 0.99 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 110.575 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.679 ' CZ ' ' CZ ' ' A' ' 28' ' ' PHE . 21.3 m-85 -71.72 -4.13 25.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.174 -0.954 . . . . 0.0 110.165 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 12.4 mtmt 46.79 46.15 15.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.432 -0.793 . . . . 0.0 110.25 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -118.13 -163.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.57 -0.706 . . . . 0.0 109.87 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -117.2 112.62 21.07 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.448 -0.782 . . . . 0.0 109.436 179.083 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . 17.3 t -77.67 119.53 26.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.076 -1.015 . . . . 0.0 109.337 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 84' ' ' ALA . 25.6 t -116.06 -10.7 12.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 121.685 0.755 . . . . 0.0 110.149 -178.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 82' ' ' GLN . 0.3 OUTLIER 175.39 116.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.593 -0.692 . . . . 0.0 109.581 179.371 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 1.0 OUTLIER -105.19 136.62 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.996 . . . . 0.0 109.978 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 80' ' ' ILE . 1.1 t-20 -131.39 114.86 15.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.139 -0.975 . . . . 0.0 109.722 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -108.44 150.08 27.89 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.624 -179.662 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.416 ' HG ' ' C ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -128.9 -177.14 4.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.06 -1.025 . . . . 0.0 110.514 -178.934 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.5 119.92 26.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.557 -0.714 . . . . 0.0 109.298 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.64 ' CG1' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -108.98 121.86 62.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.104 -0.998 . . . . 0.0 108.911 179.53 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' O ' ' NE ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -32.69 125.16 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.601 0.715 . . . . 0.0 111.541 -178.422 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 74' ' ' PRO . . . 165.76 77.59 0.03 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -96.47 -179.57 4.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -1.222 . . . . 0.0 110.299 -179.851 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 65' ' ' ARG . 4.1 tttt -72.8 -19.67 61.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.277 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -41.75 99.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 110.293 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -120.88 22.69 11.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.313 -179.861 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 68' ' ' ARG . 10.0 tp -41.98 138.42 1.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 110.164 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -55.15 84.25 0.01 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -126.21 145.25 50.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -1.174 . . . . 0.0 110.225 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.507 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -59.14 147.83 33.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.572 -179.859 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 41.51 42.99 2.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.378 -0.826 . . . . 0.0 110.411 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' HA3' ' CG ' ' A' ' 68' ' ' ARG . . . -114.17 -126.24 4.28 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER 56.57 72.23 0.52 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -1.127 . . . . 0.0 110.256 179.943 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 62' ' ' LYS . 1.8 mtp180 -100.97 108.49 54.58 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.094 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.522 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 48.7 Cg_endo -74.23 -164.66 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.978 1.515 . . . . 0.0 110.653 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 2.1 m-20 -114.14 90.06 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.41 -0.806 . . . . 0.0 108.965 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.534 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -95.55 153.15 17.85 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.645 -0.659 . . . . 0.0 110.546 -179.504 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.512 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 9.3 tttt -123.13 141.13 52.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.47 -0.769 . . . . 0.0 109.604 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.573 ' HE3' ' CH2' ' A' ' 29' ' ' TRP . 6.5 tttt -101.24 134.26 44.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.003 -1.061 . . . . 0.0 109.834 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -124.79 120.35 31.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.924 . . . . 0.0 111.618 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 55' ' ' ASN . 12.0 mt -95.57 111.63 26.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.576 -0.702 . . . . 0.0 109.987 178.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 54' ' ' VAL . 2.9 t -95.41 133.52 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 23' ' ' GLU . 13.9 tp60 -112.26 144.04 42.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 109.6 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.2 m -125.32 156.79 34.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.459 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.525 ' N ' HG23 ' A' ' 52' ' ' VAL . . . -47.97 173.07 0.06 OUTLIER Pre-proline 0 C--N 1.296 -1.73 0 CA-C-O 121.29 0.567 . . . . 0.0 111.035 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -79.88 55.46 5.65 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 124.499 1.789 . . . . 0.0 110.344 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.73 -35.01 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.524 ' OE1' ' CB ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -105.79 177.83 4.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -1.185 . . . . 0.0 109.978 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 90' ' ' GLU . 6.2 ptpt 179.61 115.14 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.31 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.595 HD11 ' CD2' ' A' ' 47' ' ' PHE . 73.7 mt -44.2 94.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.994 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' LYS . 1.9 mt-10 -56.91 -14.33 3.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.384 -0.822 . . . . 0.0 110.977 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.439 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.05 -30.08 58.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 0.0 110.345 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -106.43 -23.23 12.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.176 -0.952 . . . . 0.0 109.495 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 73.7 mm-40 -56.58 -27.58 58.23 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.269 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.2 21.66 28.62 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.457 ' O ' ' OH ' ' A' ' 18' ' ' TYR . 1.4 tp -99.29 2.13 45.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -1.165 . . . . 0.0 110.152 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.235 179.97 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.472 ' HG2' HG23 ' A' ' 3' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.859 0.362 . . . . 0.0 110.325 . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.635 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 1.6 mttt -80.89 76.06 7.83 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.712 -1.195 . . . . 0.0 108.869 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.65 ' CA ' ' HA ' ' A' ' 42' ' ' ALA . 74.0 p -119.79 -87.58 0.63 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.725 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -92.98 -27.41 17.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.99 . . . . 0.0 108.892 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CE1' ' C ' ' A' ' 2' ' ' LYS 0.252 1.2 p90 -34.7 -25.54 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.643 178.299 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ALA . 26.6 t0 -161.84 -58.76 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.829 -1.17 . . . . 0.0 110.589 -176.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.57 HG21 ' OH ' ' A' ' 5' ' ' TYR . 98.5 t -38.81 -97.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.599 0.714 . . . . 0.0 110.427 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.599 HG22 ' CD1' ' A' ' 28' ' ' PHE 0.25 75.1 mt -85.85 104.07 13.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.125 -0.985 . . . . 0.0 110.117 -179.572 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -86.89 -94.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.688 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.498 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -108.09 152.5 41.81 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 110.449 -179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.547 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 47.0 Cg_endo -73.15 174.49 11.95 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.93 1.49 . . . . 0.0 110.197 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.563 HG11 ' CD1' ' A' ' 29' ' ' TRP . 2.5 m -114.98 138.33 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.095 -1.003 . . . . 0.0 110.338 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.576 HD13 ' CZ ' ' A' ' 18' ' ' TYR . 3.2 mm? -102.81 112.66 25.57 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 110.213 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 17' ' ' ALA . 4.1 m -163.87 141.42 7.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -42.83 -54.99 3.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 110.054 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.71 -25.09 25.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.325 -0.859 . . . . 0.0 110.075 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -87.71 -62.02 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.201 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.576 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 1.4 m-85 -46.12 -43.57 15.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.309 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.65 -8.64 57.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.987 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.458 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -105.66 -39.73 2.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -77.5 -20.78 53.76 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.51 -0.994 . . . . 0.0 108.979 179.28 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -57.03 -16.2 6.66 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.553 -0.717 . . . . 0.0 110.192 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 25' ' ' LYS . 4.7 tt0 -96.62 16.39 19.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 110.447 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.68 -2.13 60.29 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.53 ' HG3' ' NE2' ' A' ' 82' ' ' GLN . 23.0 mttt -82.74 143.36 30.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -1.123 . . . . 0.0 109.73 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.637 ' CE2' ' CD1' ' A' ' 89' ' ' ILE . 21.1 m-85 -128.03 97.19 4.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.693 -1.254 . . . . 0.0 111.608 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 8.7 m -76.95 120.68 22.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.708 ' CZ ' ' CZ ' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -120.87 163.73 17.75 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.987 -1.071 . . . . 0.0 111.677 -178.527 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.574 ' CZ3' ' HG3' ' A' ' 76' ' ' ARG . 10.2 m95 -94.4 122.77 37.32 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 178.059 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 7' ' ' VAL 0.259 3.8 p -144.4 160.36 15.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 C-N-CA 118.148 -1.421 . . . . 0.0 111.823 -176.31 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.581 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 2.3 t60 -67.3 152.73 95.85 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.612 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 47.0 Cg_endo -73.19 71.78 3.55 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.071 1.564 . . . . 0.0 109.876 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.37 -33.3 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.782 -179.051 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' HB1' HG21 ' A' ' 30' ' ' VAL . . . -41.31 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.683 -0.636 . . . . 0.0 109.919 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -45.99 137.52 5.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 0.0 110.697 -179.415 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HG3' HG13 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -43.4 -48.82 7.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.345 -0.847 . . . . 0.0 109.763 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.9 m -59.1 -50.15 75.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.728 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 2.2 mm-40 -55.07 -39.38 69.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 0.0 109.487 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.533 ' CA ' HD13 ' A' ' 8' ' ' ILE . 34.8 mt -57.61 -31.83 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.522 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.5 ttmp? -62.97 -45.98 89.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 178.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.484 ' O ' ' HB ' ' A' ' 45' ' ' THR . 32.7 m-80 -72.27 -33.73 67.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.686 -0.634 . . . . 0.0 110.914 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.65 ' HA ' ' CA ' ' A' ' 3' ' ' THR . . . -57.44 -46.17 83.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.84 -1.163 . . . . 0.0 110.494 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.643 ' CG1' ' CE2' ' A' ' 47' ' ' PHE . 6.6 m -76.12 -33.13 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.78 -1.2 . . . . 0.0 109.657 178.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.469 ' HG2' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -68.2 -42.83 79.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.119 -0.988 . . . . 0.0 109.861 179.441 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.589 ' CG2' ' CB ' ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.07 -28.56 43.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.879 179.752 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 42' ' ' ALA . . . -95.67 -57.58 2.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 110.967 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.708 ' CZ ' ' CZ ' ' A' ' 28' ' ' PHE . 6.7 m-30 -76.52 -16.54 59.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.908 . . . . 0.0 110.569 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.4 mtpt 57.33 47.7 16.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 110.48 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -123.83 -160.22 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.526 -0.734 . . . . 0.0 110.016 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.554 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 3.8 tmtt? -117.65 105.76 12.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 45.3 t -78.93 119.72 28.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.349 -0.845 . . . . 0.0 110.613 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.575 HG13 ' CA ' ' A' ' 83' ' ' VAL . 7.4 p -107.32 -5.91 10.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.346 -0.846 . . . . 0.0 109.658 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.588 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.96 142.78 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.413 -0.804 . . . . 0.0 109.904 179.353 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.578 ' N ' ' CE ' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -133.48 130.1 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.075 -1.015 . . . . 0.0 109.849 179.698 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.499 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 1.2 t30 -131.18 115.62 16.6 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.863 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.519 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -115.32 164.78 13.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.744 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.3 172.13 15.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.201 -0.937 . . . . 0.0 110.438 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.582 ' CD2' ' HG2' ' A' ' 60' ' ' ARG . 5.5 t-160 -81.71 118.82 23.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.115 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.564 ' CG2' ' N ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -120.41 123.92 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.282 -0.886 . . . . 0.0 110.158 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.582 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 11.1 mmt85 -141.61 102.3 4.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.97 -1.081 . . . . 0.0 110.665 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 58.88 150.28 0.01 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.469 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -91.44 -16.29 27.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -1.207 . . . . 0.0 109.767 179.685 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 62' ' ' LYS . 8.5 pttm -178.57 176.11 1.04 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.458 -0.776 . . . . 0.0 109.975 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 66.31 44.49 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 110.282 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' LEU . 24.5 ptt85 -144.74 -41.06 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 68' ' ' ARG . 2.4 mp 46.83 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.896 . . . . 0.0 110.086 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' A' ' 68' ' ' ARG . . . -66.98 56.08 0.23 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 66' ' ' LEU . 3.5 mmm180 -130.54 14.07 5.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.092 -1.24 . . . . 0.0 109.209 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.59 ' CG ' ' N ' ' A' ' 70' ' ' LEU . 29.0 t80 -163.17 173.73 13.06 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.909 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.59 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -84.92 45.42 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 110.274 179.85 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.479 ' N ' ' CD2' ' A' ' 69' ' ' TYR . . . -64.44 -113.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 1.2 ptmt -111.95 111.98 23.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -1.159 . . . . 0.0 110.265 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -133.52 80.51 56.94 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.265 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' O ' ' NH1' ' A' ' 60' ' ' ARG . 47.6 Cg_endo -74.96 -163.09 0.17 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.111 1.585 . . . . 0.0 110.544 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' HA ' ' NH2' ' A' ' 60' ' ' ARG . 17.9 p-10 -113.18 89.71 3.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.826 0.822 . . . . 0.0 108.898 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.574 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 6.4 ttm180 -126.42 113.51 16.96 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.718 -0.614 . . . . 0.0 110.124 -179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.543 ' CA ' HG22 ' A' ' 59' ' ' VAL . 18.1 tttt -122.97 139.59 53.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 109.724 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.564 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 25.1 mttt -101.71 147.81 26.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 110.443 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' PHE . . . -132.89 119.54 20.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.325 -0.859 . . . . 0.0 111.216 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.602 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -99.09 112.08 30.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.359 0.6 . . . . 0.0 109.595 179.128 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.522 ' CG1' HG22 ' A' ' 54' ' ' VAL . 2.5 t -104.24 127.38 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.475 -0.765 . . . . 0.0 110.14 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.588 ' CB ' ' CG ' ' A' ' 53' ' ' LYS . 4.2 tp60 -102.54 147.47 26.72 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.027 -1.046 . . . . 0.0 109.334 179.301 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.575 ' CA ' HG13 ' A' ' 52' ' ' VAL . 1.5 m -116.35 156.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.311 -1.356 . . . . 0.0 108.891 177.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.498 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . . . -69.06 176.14 1.71 Allowed Pre-proline 0 C--N 1.287 -2.116 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.125 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 84' ' ' ALA . 43.1 Cg_endo -75.18 136.9 20.63 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 O-C-N 124.204 1.634 . . . . 0.0 110.291 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.25 -21.72 21.65 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -115.35 -179.91 3.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -1.234 . . . . 0.0 110.352 -179.988 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER 179.5 101.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.827 . . . . 0.0 110.149 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.637 ' CD1' ' CE2' ' A' ' 26' ' ' TYR . 48.5 mt -53.94 101.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -0.971 . . . . 0.0 110.172 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 19.4 pt-20 -60.92 -13.5 16.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.423 -0.798 . . . . 0.0 110.918 -179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 92' ' ' LEU . . . -54.69 -36.14 64.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 110.524 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.601 ' CD1' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.41 -23.11 12.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.022 -1.049 . . . . 0.0 109.8 179.762 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.8 mm-40 -52.15 -45.5 65.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.353 -0.842 . . . . 0.0 110.456 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -83.2 -23.98 53.12 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 1.1 tp -42.13 -27.19 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -1.115 . . . . 0.0 110.268 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 94' ' ' GLY . 17.3 mm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.278 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.655 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -59.57 87.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.109 -1.436 . . . . 0.0 109.171 179.934 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.564 ' CB ' ' CG2' ' A' ' 45' ' ' THR . 45.5 p -129.61 -56.68 1.14 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 9' ' ' LEU . . . -138.91 -4.8 1.53 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.88 0.848 . . . . 0.0 109.484 178.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.655 ' CE1' ' HA ' ' A' ' 2' ' ' LYS 0.284 0.1 OUTLIER -56.21 -137.89 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.912 0.863 . . . . 0.0 110.842 177.659 . . . . . . . . 4 4 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.621 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 3.3 m-20 -27.57 -59.78 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.08 178.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.648 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 53.7 t -54.4 -111.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.542 -0.724 . . . . 0.0 110.94 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.62 ' CG2' ' CD2' ' A' ' 28' ' ' PHE . 11.8 mt -81.42 106.31 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.533 -1.354 . . . . 0.0 111.027 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -83.97 -105.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 110.217 179.715 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.65 151.43 41.68 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.948 -1.095 . . . . 0.0 110.415 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.43 175.69 10.68 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.045 1.55 . . . . 0.0 110.154 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.576 HG13 ' CD1' ' A' ' 29' ' ' TRP . 2.4 m -115.06 136.28 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.145 -0.972 . . . . 0.0 110.396 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.573 HD12 ' CE2' ' A' ' 18' ' ' TYR . 3.2 mm? -102.67 107.9 18.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.172 -0.955 . . . . 0.0 110.17 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -163.14 138.54 6.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.201 179.88 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -43.25 -51.07 6.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 110.141 179.908 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -18.17 4.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -103.84 -43.42 5.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.006 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.573 ' CE2' HD12 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -62.72 -39.58 94.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 179.852 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.74 -13.53 44.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.036 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.447 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -105.46 -47.73 1.1 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 178.486 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CE1' HD21 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -51.08 -24.09 3.64 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.897 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.73 -29.93 63.01 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.259 0.552 . . . . 0.0 110.674 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -88.73 16.25 7.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.273 -0.892 . . . . 0.0 110.504 -179.571 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 87.42 13.28 65.84 Favored Glycine 0 N--CA 1.482 1.712 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' CG ' ' OE1' ' A' ' 82' ' ' GLN . 11.3 mttm -82.45 146.33 29.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.183 -1.187 . . . . 0.0 109.505 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.648 ' CE2' ' CD1' ' A' ' 89' ' ' ILE . 28.7 m-85 -127.02 98.3 5.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.911 -1.118 . . . . 0.0 112.146 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.561 ' CG2' ' CD ' ' A' ' 78' ' ' LYS . 2.5 m -79.13 126.42 30.71 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 178.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.62 ' CD2' ' CG2' ' A' ' 8' ' ' ILE . 13.4 m-85 -126.58 164.93 20.13 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.28 -0.888 . . . . 0.0 111.618 -178.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.576 ' CD1' HG13 ' A' ' 12' ' ' VAL . 43.9 m95 -104.24 122.36 45.23 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 176.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 1.2 p -144.28 157.6 15.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 117.708 -1.597 . . . . 0.0 112.259 -176.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.584 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -62.13 151.75 80.15 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.952 -179.109 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.8 Cg_endo -73.67 70.03 4.28 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.211 1.637 . . . . 0.0 109.848 179.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.54 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 109.911 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . . . -44.75 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.639 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -43.22 138.93 2.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.92 . . . . 0.0 110.544 -179.243 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.516 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -43.54 -38.08 2.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.701 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 5.6 m -70.59 -44.45 67.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.469 -0.769 . . . . 0.0 109.685 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.497 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 2.8 mm-40 -55.6 -41.16 73.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.562 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 74.7 mt -57.4 -30.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.903 . . . . 0.0 108.633 179.038 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 17.7 tttm -64.96 -44.46 89.32 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.415 -0.803 . . . . 0.0 109.404 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.479 ' O ' ' HB ' ' A' ' 45' ' ' THR . 40.3 m-80 -73.17 -43.37 61.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.696 -0.627 . . . . 0.0 111.277 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.547 ' CA ' ' O ' ' A' ' 3' ' ' THR . . . -58.23 -51.32 70.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.603 -1.311 . . . . 0.0 110.261 -179.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.602 ' CG2' ' CE2' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -63.98 -47.22 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.056 -1.028 . . . . 0.0 109.968 179.981 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -57.0 -44.88 83.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.027 -1.046 . . . . 0.0 109.41 179.497 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.564 ' CG2' ' CB ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -78.53 -12.58 60.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.4 -0.813 . . . . 0.0 109.446 179.309 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -97.3 -71.71 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.832 . . . . 0.0 110.236 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.579 ' CD1' HG22 ' A' ' 89' ' ' ILE . 43.3 m-85 -72.1 -22.12 61.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.192 -0.942 . . . . 0.0 110.198 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 68.78 44.2 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 110.006 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.467 ' HB ' HG12 ' A' ' 89' ' ' ILE . 1.1 p -118.65 -160.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.541 -0.724 . . . . 0.0 110.383 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -118.11 104.97 11.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.423 -0.798 . . . . 0.0 109.584 179.268 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.518 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 25.1 t -78.23 119.71 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.963 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.2 p -102.98 -8.94 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 110.227 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.618 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 4.9 ptmt -175.39 131.24 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.873 179.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.9 OUTLIER -123.62 127.62 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.974 -1.078 . . . . 0.0 110.332 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 80' ' ' ILE . 37.7 t30 -131.06 115.65 16.72 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.472 -0.767 . . . . 0.0 109.02 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.523 HG23 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.92 157.78 22.9 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 110.239 -179.379 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.94 171.37 14.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.786 . . . . 0.0 110.159 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 128.47 34.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.192 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.576 HG21 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -118.5 130.4 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.305 -0.872 . . . . 0.0 109.962 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' ' 74' ' ' PRO . 7.9 mmt85 -115.42 128.78 56.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 110.277 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.77 154.29 0.92 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -82.63 -22.06 34.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -1.122 . . . . 0.0 110.11 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 64' ' ' LYS . 6.8 mttp -69.68 62.33 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' LYS . 2.9 ptpp? -44.2 169.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -56.34 -16.39 5.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.252 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 67' ' ' GLY . 29.7 tp 55.5 108.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.217 -0.927 . . . . 0.0 109.972 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . 45.34 -169.95 0.02 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.71 127.29 32.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -1.126 . . . . 0.0 109.812 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.572 ' CG ' ' N ' ' A' ' 70' ' ' LEU . 39.7 t80 -167.34 173.89 8.5 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.679 -0.638 . . . . 0.0 109.742 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.572 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 1.4 pp -90.12 70.89 7.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.034 -1.041 . . . . 0.0 109.963 179.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 72' ' ' LYS . . . -163.79 -174.86 34.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER 170.1 -173.15 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.495 -1.003 . . . . 0.0 110.114 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -101.08 120.46 55.16 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.059 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.456 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 47.5 Cg_endo -72.42 -165.98 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.823 1.433 . . . . 0.0 110.386 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.88 89.27 3.06 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.44 -0.787 . . . . 0.0 109.383 179.293 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -95.1 147.28 23.6 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.647 -0.658 . . . . 0.0 109.897 179.842 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 30' ' ' VAL . 20.4 tttt -123.08 127.5 48.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.744 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.561 ' CD ' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -101.81 151.01 22.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.285 179.378 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -127.16 129.34 47.7 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.974 -1.078 . . . . 0.0 111.91 -179.261 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.605 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.5 mp -109.72 111.43 36.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.164 178.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 19.3 t -112.29 128.29 69.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.572 -0.705 . . . . 0.0 110.162 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.618 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 2.5 tp60 -101.55 151.27 22.17 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.037 -1.039 . . . . 0.0 109.012 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.0 m -112.57 155.84 13.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 C-N-CA 118.082 -1.447 . . . . 0.0 108.443 177.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.484 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . . . -58.01 169.98 0.8 Allowed Pre-proline 0 C--N 1.284 -2.244 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.646 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 84' ' ' ALA . 45.4 Cg_endo -79.63 53.48 4.75 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 O-C-N 124.416 1.745 . . . . 0.0 110.733 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.475 ' N ' ' OE1' ' A' ' 87' ' ' GLN . . . -168.72 23.47 0.1 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -150.31 -175.53 5.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.941 -1.329 . . . . 0.0 110.268 -179.965 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER 179.88 113.25 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.455 -0.778 . . . . 0.0 109.998 179.865 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.648 ' CD1' ' CE2' ' A' ' 26' ' ' TYR . 16.8 mt -59.92 100.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.28 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -53.95 -27.99 34.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.72 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.2 73.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.414 -0.804 . . . . 0.0 110.22 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.578 HD21 ' CE1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -107.67 1.23 22.98 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.977 -1.089 . . . . 0.0 112.079 -179.51 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -95.11 3.31 54.91 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 117.958 -1.497 . . . . 0.0 110.118 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -118.54 -17.78 5.09 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.442 ' HB3' ' OH ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -56.31 -33.75 65.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.366 -1.079 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.517 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 4.6 mt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.214 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.524 ' HG3' ' CE ' ' A' ' 2' ' ' LYS . 5.8 tpp . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.781 0.8 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -86.31 112.56 21.53 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.738 -0.601 . . . . 0.0 109.456 179.075 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.616 ' O ' ' N ' ' A' ' 5' ' ' TYR . 6.5 t -35.98 -33.46 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.672 ' C ' ' CD1' ' A' ' 5' ' ' TYR 0.29 . . -60.69 65.67 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 176.804 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.672 ' CD1' ' C ' ' A' ' 4' ' ' ALA . 1.2 p90 30.68 46.38 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.683 1.23 . . . . 0.0 107.857 -176.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.533 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 2.8 p30 47.2 63.41 1.97 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.978 -1.465 . . . . 0.0 111.759 -178.131 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.642 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 9.2 t -128.07 -117.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.574 -0.703 . . . . 0.0 110.348 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.553 ' CG2' ' HB3' ' A' ' 28' ' ' PHE . 3.2 mt -63.08 156.42 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.224 -0.922 . . . . 0.0 110.032 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.505 ' CD2' ' HG2' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -144.61 -81.72 0.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.069 -1.019 . . . . 0.0 110.594 179.483 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.15 145.23 31.03 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.981 -1.074 . . . . 0.0 110.573 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 47.7 Cg_endo -74.53 169.8 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.037 1.546 . . . . 0.0 110.563 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.576 HG13 ' CE2' ' A' ' 29' ' ' TRP . 2.3 m -115.13 136.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.127 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.93 110.26 22.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.136 -0.978 . . . . 0.0 110.435 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -164.0 145.72 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.473 -0.767 . . . . 0.0 109.559 179.821 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 14' ' ' SER . 2.1 mm-40 -43.42 -33.48 1.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 109.986 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -28.23 66.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 110.024 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -91.96 19.36 6.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.296 -0.877 . . . . 0.0 109.807 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.564 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.7 m-85 -138.49 -41.92 0.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.54 -0.725 . . . . 0.0 109.854 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.12 79.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.177 -0.952 . . . . 0.0 108.883 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.85 -31.1 7.93 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 178.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -72.31 -10.83 60.29 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.522 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -66.84 -8.39 28.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.655 -0.653 . . . . 0.0 110.216 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -1.98 19.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 110.385 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.588 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 119.48 4.09 12.23 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 27.4 mttt -84.35 132.71 34.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -1.152 . . . . 0.0 109.772 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.649 ' CB ' ' CZ ' ' A' ' 28' ' ' PHE . 62.7 m-85 -126.94 111.15 13.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.719 -1.238 . . . . 0.0 111.79 -179.328 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 7.5 m -79.27 128.95 33.95 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.458 0.647 . . . . 0.0 109.932 179.09 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.695 ' CE1' ' CZ ' ' A' ' 47' ' ' PHE . 19.0 m-85 -124.76 164.73 19.35 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.519 -0.738 . . . . 0.0 109.879 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.637 ' CH2' ' NE ' ' A' ' 76' ' ' ARG . 4.4 m95 -95.14 122.86 38.25 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.263 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.53 HG21 ' N ' ' A' ' 8' ' ' ILE . 8.1 p -137.1 165.01 28.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.844 -177.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.511 ' NE2' ' HE3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.45 145.31 91.15 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.908 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.39 70.68 2.49 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.1 1.579 . . . . 0.0 109.934 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 178.83 -32.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.413 -0.805 . . . . 0.0 110.12 -178.936 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -56.27 96.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.463 -0.773 . . . . 0.0 110.379 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.446 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 1.3 p -46.17 159.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 109.962 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 11.0 mttp -47.71 -40.22 19.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.289 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.9 m -75.28 -38.97 60.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.591 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.47 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 2.4 mt-10 -55.6 -43.88 76.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.038 -1.039 . . . . 0.0 109.944 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 13.0 mt -57.5 -30.24 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.774 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 39.8 tttm -57.6 -41.99 82.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 111.537 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.47 ' HB2' ' OH ' ' A' ' 5' ' ' TYR . 6.6 m-80 -58.29 -49.53 76.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.465 -0.772 . . . . 0.0 112.397 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.528 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -73.49 -39.18 65.06 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.711 -1.243 . . . . 0.0 111.631 -178.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.605 ' CG2' ' CE2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -62.41 -45.54 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.898 -1.126 . . . . 0.0 110.401 -179.343 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.41 -38.75 71.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.012 . . . . 0.0 109.846 -179.818 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -79.38 -45.43 19.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 109.975 179.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.64 -60.58 2.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 110.497 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.695 ' CZ ' ' CE1' ' A' ' 28' ' ' PHE . 44.4 m-85 -71.65 -21.52 61.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.957 . . . . 0.0 110.158 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 56.32 40.75 29.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 110.295 179.734 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -120.99 -165.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.519 -0.738 . . . . 0.0 109.896 179.708 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -106.66 112.17 25.04 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.23 178.812 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.53 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 19.6 t -77.59 135.68 25.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.482 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.517 HG21 ' N ' ' A' ' 84' ' ' ALA . 2.5 t -128.57 -5.87 3.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.48 -0.763 . . . . 0.0 110.573 -178.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.534 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER 170.45 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.424 -0.797 . . . . 0.0 109.118 179.498 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.522 ' CG2' HG23 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -115.47 133.04 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.332 -0.855 . . . . 0.0 110.564 -179.26 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.531 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -131.58 116.09 16.95 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.437 -0.79 . . . . 0.0 109.372 178.515 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -116.6 149.46 39.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 110.436 -179.295 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.443 ' O ' HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -130.11 143.38 50.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.477 -0.765 . . . . 0.0 109.521 179.884 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.414 ' CD2' ' HE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -71.21 112.58 7.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.018 -1.051 . . . . 0.0 110.054 179.874 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.519 HG13 ' CE ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -113.33 126.28 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.285 -0.884 . . . . 0.0 110.089 -179.778 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.562 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -125.15 155.7 39.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.074 -1.016 . . . . 0.0 110.284 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -43.2 119.08 2.2 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -98.08 -21.87 16.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.275 -1.133 . . . . 0.0 110.202 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 6.3 ptmt -62.74 134.67 56.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 110.113 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 67.14 79.67 0.23 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 0.0 110.151 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' ' 66' ' ' LEU . 2.2 ttp-105 -144.89 -36.44 0.31 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.384 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 65' ' ' ARG . 1.1 mm? -38.9 144.22 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.516 -0.74 . . . . 0.0 110.718 -179.689 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 68' ' ' ARG . . . 71.34 -179.56 32.54 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -48.26 178.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -1.068 . . . . 0.0 110.486 -179.799 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.438 ' O ' HD11 ' A' ' 70' ' ' LEU . 30.5 t80 -47.74 132.59 14.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.362 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.438 HD11 ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -158.43 40.81 0.25 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 110.028 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 72' ' ' LYS . . . -177.59 -118.27 0.54 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 71' ' ' GLY . 24.6 mttt -160.69 161.04 32.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -1.121 . . . . 0.0 110.235 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -152.09 81.92 5.53 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.897 . . . . 0.0 110.212 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.35 -164.59 0.23 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.059 1.557 . . . . 0.0 110.499 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -114.44 89.67 3.15 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.767 0.794 . . . . 0.0 109.134 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.637 ' NE ' ' CH2' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -122.46 122.02 37.98 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.693 -0.629 . . . . 0.0 109.859 -179.892 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.51 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 6.5 ptmt -123.3 141.79 51.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.437 -179.683 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 1.7 ptpt -101.0 151.14 22.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.361 -0.837 . . . . 0.0 109.626 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -115.61 118.77 34.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.019 -1.051 . . . . 0.0 111.992 -179.109 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.515 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 12.1 mt -94.94 110.96 24.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.528 -0.732 . . . . 0.0 109.585 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.588 HG22 ' CE2' ' A' ' 28' ' ' PHE . 6.4 t -102.09 143.22 15.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.09 -1.006 . . . . 0.0 110.458 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.534 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 29.6 tp60 -116.44 150.58 37.6 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.298 -0.876 . . . . 0.0 109.098 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.517 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.5 m -124.91 155.75 33.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 118.324 -1.351 . . . . 0.0 109.973 178.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.517 ' N ' HG21 ' A' ' 52' ' ' VAL . . . -47.76 178.34 0.03 OUTLIER Pre-proline 0 C--N 1.291 -1.969 0 O-C-N 121.839 -0.538 . . . . 0.0 110.73 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.7 Cg_endo -74.23 142.78 30.95 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.386 1.73 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.65 -40.98 2.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.521 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 6.6 mt-30 -70.18 176.88 3.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -1.199 . . . . 0.0 110.387 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 178.42 102.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.18 -179.192 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 8.3 mt -55.99 87.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.914 -1.116 . . . . 0.0 109.597 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' LYS . 11.1 pt-20 -57.99 -13.22 4.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.429 -0.795 . . . . 0.0 110.946 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.523 ' CB ' HD23 ' A' ' 92' ' ' LEU . . . -54.27 -33.53 58.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.108 -0.995 . . . . 0.0 110.777 -179.16 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.557 ' N ' ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.24 -23.04 12.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.927 -1.108 . . . . 0.0 109.929 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.2 mm-40 -52.9 -33.83 52.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.436 -0.79 . . . . 0.0 110.413 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.67 6.06 58.72 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 13' ' ' LEU . 1.3 tp -76.02 -25.43 55.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -1.17 . . . . 0.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.564 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 8.2 mt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.158 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.528 ' CG ' ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.794 0.806 . . . . 0.0 110.564 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -76.24 108.72 9.37 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.59 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.554 ' C ' ' O ' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -30.13 -37.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.408 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.647 ' C ' ' CD1' ' A' ' 5' ' ' TYR 0.291 . . -63.78 68.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.348 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.647 ' CD1' ' C ' ' A' ' 4' ' ' ALA . 0.6 OUTLIER 29.61 38.06 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 122.311 1.053 . . . . 0.0 108.857 -176.886 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 4' ' ' ALA . 2.2 t0 64.92 55.33 1.19 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.976 -179.389 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.632 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 5.4 t -127.96 -120.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.898 -1.126 . . . . 0.0 110.31 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.596 HG22 ' CD2' ' A' ' 28' ' ' PHE . 4.8 mt -56.02 148.0 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.535 ' CD2' ' HD2' ' A' ' 2' ' ' LYS . 0.6 OUTLIER -119.02 -100.36 0.44 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 110.663 -179.572 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.38 161.66 23.13 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.042 -1.037 . . . . 0.0 110.718 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.6 157.99 35.99 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.126 1.593 . . . . 0.0 110.308 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.577 ' CG1' ' NE1' ' A' ' 29' ' ' TRP . 2.4 m -100.03 140.0 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.0 110.272 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.64 113.17 26.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.95 . . . . 0.0 110.19 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 52.7 m -167.01 135.13 2.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.3 mm-40 -42.86 -47.45 5.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.92 . . . . 0.0 110.038 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -54.79 -35.92 64.36 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 19' ' ' ALA . . . -79.91 -63.71 1.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 0.0 110.183 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.614 ' CZ ' ' CG1' ' A' ' 96' ' ' ILE . 1.3 m-85 -42.87 -26.25 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 110.406 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -88.42 -35.32 17.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.691 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -83.23 -38.34 11.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 178.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.69 -15.06 60.35 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.728 -0.866 . . . . 0.0 108.882 178.871 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 18' ' ' TYR . . . -63.97 -17.15 62.99 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.485 0.66 . . . . 0.0 109.916 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.18 -2.76 52.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.412 -0.805 . . . . 0.0 110.203 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 117.78 0.77 17.56 Favored Glycine 0 N--CA 1.478 1.5 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 73.2 mttt -81.96 140.33 34.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -1.108 . . . . 0.0 109.617 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.586 ' CE1' ' HB ' ' A' ' 89' ' ' ILE . 64.4 m-85 -127.85 104.85 8.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.572 -1.33 . . . . 0.0 111.982 -178.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 1.9 m -79.44 140.15 37.45 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.43 0.634 . . . . 0.0 109.291 178.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.596 ' CD2' HG22 ' A' ' 8' ' ' ILE . 17.0 m-85 -140.24 165.18 28.08 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 110.404 -179.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.577 ' NE1' ' CG1' ' A' ' 12' ' ' VAL . 96.3 m95 -105.12 121.8 44.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 176.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.466 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 4.9 p -144.03 165.46 13.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.778 -176.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -59.62 149.6 70.34 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.75 -179.369 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.472 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 47.1 Cg_endo -73.65 71.66 3.92 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.208 1.636 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.487 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.08 -34.05 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.356 -0.84 . . . . 0.0 110.156 -179.095 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -47.65 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.364 -0.835 . . . . 0.0 110.212 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -43.34 167.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 1.2 mtpt -64.13 -58.06 7.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.925 . . . . 0.0 110.349 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.5 m -58.74 -39.29 80.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.951 . . . . 0.0 110.177 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.467 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 6.4 mt-10 -55.89 -45.98 78.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 0.0 109.651 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 17.7 mt -57.13 -30.13 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.493 -0.755 . . . . 0.0 110.015 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.0 ttmm -57.77 -47.51 82.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.414 -0.804 . . . . 0.0 111.799 -179.283 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -58.7 -45.95 88.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 112.63 -177.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.576 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -58.75 -48.45 81.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.768 -1.207 . . . . 0.0 111.893 -178.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 19.1 m -74.47 -28.89 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.424 -1.422 . . . . 0.0 110.467 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -56.69 -52.61 64.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.836 -1.165 . . . . 0.0 109.219 179.558 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.2 p -80.25 -45.42 17.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.853 179.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -58.44 -65.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.419 -0.801 . . . . 0.0 110.57 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.629 ' CD1' ' CG2' ' A' ' 89' ' ' ILE . 31.8 m-85 -71.48 -19.07 62.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.996 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER 68.08 46.31 1.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 110.517 179.643 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -134.01 -165.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.437 -0.789 . . . . 0.0 110.259 179.907 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.551 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -118.74 111.18 18.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.545 -0.722 . . . . 0.0 109.881 179.274 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.573 ' CG1' ' CG1' ' A' ' 81' ' ' VAL . 89.4 t -78.77 136.32 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 110.134 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 82' ' ' GLN . 8.7 p -118.25 -7.3 11.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.277 -0.889 . . . . 0.0 110.164 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.618 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -176.67 131.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.819 179.41 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 1.2 t -123.68 119.64 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.999 -1.063 . . . . 0.0 110.258 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.48 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 1.6 t-20 -116.74 115.91 26.51 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.218 178.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -109.55 145.44 36.33 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.57 -179.611 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -124.58 160.45 28.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.275 -0.891 . . . . 0.0 110.903 -179.049 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.416 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 3.3 t-160 -72.98 115.12 11.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.25 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.586 ' CG2' ' N ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -106.08 139.46 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -0.895 . . . . 0.0 110.229 -179.279 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.605 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -138.64 134.49 33.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.176 -0.953 . . . . 0.0 110.277 -179.279 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . -54.95 -171.14 0.07 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -42.59 165.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -1.124 . . . . 0.0 110.304 -179.982 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -77.18 -142.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 0.0 110.2 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? 51.33 87.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.257 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 67' ' ' GLY . 11.5 tpp180 -88.32 -7.63 56.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.256 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 68' ' ' ARG . 2.6 mp -42.0 93.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 110.371 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 65' ' ' ARG . . . -67.16 58.44 0.25 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -117.11 15.57 15.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.12 -1.223 . . . . 0.0 109.393 179.902 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 8.6 t80 -155.66 53.17 0.59 Allowed 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.137 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER 40.98 41.3 1.21 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.847 0.832 . . . . 0.0 110.283 179.955 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 72' ' ' LYS . . . -105.79 -111.1 3.56 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER 63.13 70.95 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.281 -1.129 . . . . 0.0 110.228 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HG3' ' HA3' ' A' ' 61' ' ' GLY . 2.1 mpt_? -45.7 137.99 5.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 110.146 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.73 -167.24 0.36 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.991 1.522 . . . . 0.0 110.413 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.61 89.47 3.11 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.469 -0.769 . . . . 0.0 109.472 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.56 ' CG ' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -94.91 152.55 18.27 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.577 -0.702 . . . . 0.0 109.908 179.603 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.523 ' CA ' HG21 ' A' ' 59' ' ' VAL . 13.2 tttt -121.15 137.99 54.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.068 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.586 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -105.44 150.67 25.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 110.001 -179.901 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -128.88 128.64 44.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.091 -1.006 . . . . 0.0 112.347 -179.212 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.619 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -108.69 111.88 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 5.0 t -108.37 137.46 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 111.234 -178.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.618 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 1.4 tp60 -111.17 154.08 24.86 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.265 -0.897 . . . . 0.0 108.742 178.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.47 HG21 ' HB2' ' A' ' 87' ' ' GLN . 2.9 m -116.45 155.82 17.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 C-N-CA 118.257 -1.377 . . . . 0.0 108.643 177.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -56.19 -179.6 0.09 OUTLIER Pre-proline 0 C--N 1.284 -2.244 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.032 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.3 Cg_endo -71.68 140.4 35.73 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 124.103 1.581 . . . . 0.0 110.387 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.05 -23.34 29.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.499 ' OE1' ' N ' ' A' ' 84' ' ' ALA . 35.7 mt-30 -87.1 167.93 13.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.259 -1.142 . . . . 0.0 110.641 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.456 ' HD3' ' OH ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER 179.45 115.49 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.332 -0.855 . . . . 0.0 110.653 179.89 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.629 ' CG2' ' CD1' ' A' ' 47' ' ' PHE . 9.2 mt -78.05 75.53 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.548 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.71 -13.09 1.49 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.508 -0.745 . . . . 0.0 111.479 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 92' ' ' LEU . . . -53.59 -20.6 5.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.933 -1.105 . . . . 0.0 110.629 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.47 -23.21 12.56 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.001 -1.062 . . . . 0.0 109.609 179.506 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -54.61 -35.71 63.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 110.373 -179.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.11 -4.9 71.1 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.468 ' HB3' ' OH ' ' A' ' 18' ' ' TYR . 3.0 tp -69.24 -5.47 23.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.091 -1.24 . . . . 0.0 110.194 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.614 ' CG1' ' CZ ' ' A' ' 18' ' ' TYR . 20.3 mt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.21 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.756 0.312 . . . . 0.0 110.609 . . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.617 ' N ' ' HA ' ' A' ' 6' ' ' ASP . 4.8 mttp -44.86 98.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.165 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.589 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.3 m 4.37 -70.93 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.668 0 CA-C-O 121.102 0.477 . . . . 0.0 111.099 -178.448 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 2' ' ' LYS 0.259 . . -56.76 79.04 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.484 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.632 ' CE2' HG21 ' A' ' 7' ' ' VAL . 0.6 OUTLIER 25.38 48.32 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.923 0.868 . . . . 0.0 110.192 -178.019 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.617 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 6.7 t0 64.85 54.42 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.111 0.958 . . . . 0.0 111.288 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.632 HG21 ' CE2' ' A' ' 5' ' ' TYR . 11.3 t -137.45 -110.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.351 -0.843 . . . . 0.0 109.778 179.006 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.625 ' CG2' ' CD2' ' A' ' 28' ' ' PHE . 6.8 mt -74.07 158.13 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.991 -1.068 . . . . 0.0 110.151 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.474 ' CG ' ' HB3' ' A' ' 2' ' ' LYS . 34.1 mt -140.71 -99.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 110.251 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.68 155.96 39.69 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 110.346 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 27' ' ' THR . 46.0 Cg_endo -73.71 153.76 48.83 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.978 1.514 . . . . 0.0 110.255 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.618 ' CG1' ' CE2' ' A' ' 29' ' ' TRP . 2.3 m -92.14 141.12 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.271 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.565 HD13 ' CZ ' ' A' ' 18' ' ' TYR . 3.2 mm? -102.83 107.5 18.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.932 . . . . 0.0 110.204 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 15' ' ' GLU . 22.3 m -161.54 143.06 11.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.104 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' SER . 9.8 tm-20 -43.19 -51.31 6.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.004 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -42.67 71.87 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.23 -0.919 . . . . 0.0 110.218 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 18' ' ' TYR . . . -70.83 -65.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 1.6 m-85 -42.55 -27.62 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 110.317 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -90.38 -34.85 15.5 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.24 -0.913 . . . . 0.0 109.562 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -78.58 -44.98 9.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.158 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.04 -22.36 64.96 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.56 -0.964 . . . . 0.0 108.734 178.936 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.427 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -52.6 -19.37 2.28 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.333 0.587 . . . . 0.0 110.661 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 1.6 tt0 -95.06 15.08 19.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.868 . . . . 0.0 110.498 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 97.61 1.01 59.04 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.512 ' HD2' ' CG2' ' A' ' 80' ' ' ILE . 2.8 mttp -82.5 143.37 31.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -1.089 . . . . 0.0 109.552 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 23.1 m-85 -127.81 103.87 7.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.761 -1.212 . . . . 0.0 111.918 -179.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 1.9 m -75.62 141.28 42.88 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.625 ' CD2' ' CG2' ' A' ' 8' ' ' ILE . 18.4 m-85 -138.0 165.24 27.05 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.353 -0.842 . . . . 0.0 110.48 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.618 ' CE2' ' CG1' ' A' ' 12' ' ' VAL . 22.4 m95 -101.68 120.79 40.89 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.287 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 1.9 p -152.57 165.31 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 118.481 -1.288 . . . . 0.0 111.522 -176.693 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.545 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -70.9 172.55 6.2 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.713 -0.617 . . . . 0.0 110.683 -179.51 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.9 Cg_endo -75.35 -59.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.241 1.653 . . . . 0.0 110.413 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -38.46 -26.0 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.552 179.283 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 32' ' ' PRO . . . -62.95 90.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.82 -1.175 . . . . 0.0 110.051 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -49.49 162.66 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 -179.84 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -57.47 -56.22 24.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.86 . . . . 0.0 110.117 -179.964 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 m -60.49 -34.77 74.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.307 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -55.79 -42.65 75.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 109.642 179.776 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.56 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 9.0 mt -57.65 -30.96 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.145 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 13.3 tttp -62.22 -46.25 89.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 110.52 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -59.12 -49.12 79.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.477 -0.764 . . . . 0.0 112.003 -178.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.553 ' CB ' ' CE1' ' A' ' 5' ' ' TYR . . . -66.12 -47.65 73.43 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.849 -1.157 . . . . 0.0 111.417 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.603 ' CG1' ' CG2' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -63.7 -39.54 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.864 -1.147 . . . . 0.0 110.395 -179.325 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.24 -47.33 78.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.0 -1.063 . . . . 0.0 109.609 179.939 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.3 p -79.42 -45.07 20.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.357 -0.839 . . . . 0.0 109.883 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.12 -69.61 0.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.418 -0.801 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 77.5 m-85 -71.63 -21.81 61.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.132 -0.98 . . . . 0.0 110.219 -179.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 9.2 mttt 65.2 40.08 5.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -117.88 -162.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.485 0.659 . . . . 0.0 110.313 -179.896 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -118.2 104.52 10.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.522 -0.736 . . . . 0.0 109.486 178.946 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.603 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 27.0 t -78.81 119.8 28.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.694 -179.223 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 82' ' ' GLN . 8.5 p -103.17 -0.57 10.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.295 -0.878 . . . . 0.0 109.812 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.571 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.97 146.87 0.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 179.385 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.527 HG22 ' CG2' ' A' ' 81' ' ' VAL . 1.2 t -133.37 122.25 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.479 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -121.99 115.8 23.17 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 109.086 178.639 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -120.67 140.84 51.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 110.305 -179.481 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.526 HD13 ' CE ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -148.55 149.93 32.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.634 -0.667 . . . . 0.0 109.345 -179.847 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.597 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 1.7 m80 -86.34 143.51 27.82 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.151 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 15.9 m -100.88 139.18 22.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.529 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 76' ' ' ARG . 10.7 mtm180 66.18 -166.05 0.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.918 -1.114 . . . . 0.0 110.111 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 44.51 96.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 179.409 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.03 -58.87 1.84 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -1.148 . . . . 0.0 110.098 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 tttm -155.34 140.23 17.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.148 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.4 mttt 57.6 25.21 11.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.468 ' HD3' ' HB3' ' A' ' 72' ' ' LYS . 5.1 mtt180 -101.82 -48.89 4.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.276 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 1.9 mp 63.61 -167.57 0.21 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.422 -0.799 . . . . 0.0 109.611 -179.202 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.73 44.83 0.32 Allowed Glycine 0 N--CA 1.481 1.699 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.56 20.64 5.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.366 1.079 . . . . 0.0 109.076 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.599 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 31.0 t80 -156.9 173.09 17.53 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.965 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.581 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 3.7 mm? -85.93 43.99 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.158 -0.964 . . . . 0.0 110.347 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.599 ' N ' ' CD2' ' A' ' 69' ' ' TYR . . . -100.43 -121.97 4.82 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HB3' ' HD3' ' A' ' 65' ' ' ARG . 1.5 mmpt? -70.78 -174.24 0.89 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -1.151 . . . . 0.0 110.149 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.52 ' CB ' ' HB3' ' A' ' 60' ' ' ARG . 0.5 OUTLIER -93.1 154.6 41.63 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.921 . . . . 0.0 110.417 -179.882 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HG2' ' NH2' ' A' ' 60' ' ' ARG . 49.2 Cg_endo -73.14 -164.21 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.216 1.64 . . . . 0.0 110.848 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.515 ' OD1' ' CB ' ' A' ' 58' ' ' HIS . 2.6 t0 -114.63 90.54 3.37 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.482 -0.761 . . . . 0.0 109.319 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -93.32 128.67 39.44 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.642 -0.661 . . . . 0.0 109.339 179.856 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.57 ' HG3' ' CD2' ' A' ' 58' ' ' HIS . 3.4 ttpt -96.29 128.99 43.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 111.077 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.526 ' CE ' HD13 ' A' ' 57' ' ' LEU . 28.7 pttt -119.54 151.3 38.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.413 -0.804 . . . . 0.0 109.348 179.147 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -118.06 128.77 55.08 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.89 -1.131 . . . . 0.0 113.03 -178.356 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.601 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.7 mp -107.58 111.24 34.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.527 ' CG2' HG22 ' A' ' 54' ' ' VAL . 23.4 t -107.37 139.0 30.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 111.005 -178.703 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.571 ' CB ' ' CG ' ' A' ' 53' ' ' LYS . 1.6 tp60 -105.59 153.32 21.95 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.341 -0.849 . . . . 0.0 108.789 179.008 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 1.5 m -119.16 156.52 21.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 C-N-CA 118.171 -1.412 . . . . 0.0 109.327 178.343 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.496 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . . . -64.46 177.03 0.61 Allowed Pre-proline 0 C--N 1.287 -2.138 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.223 -179.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 84' ' ' ALA . 43.5 Cg_endo -74.81 138.4 23.46 Favored 'Trans proline' 0 C--N 1.298 -2.093 0 O-C-N 124.296 1.682 . . . . 0.0 110.19 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.68 -31.88 7.0 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -108.45 174.09 6.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.037 -1.272 . . . . 0.0 110.669 -179.917 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 178.99 130.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.487 -0.758 . . . . 0.0 110.081 179.827 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 40.1 mt -83.74 82.5 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 110.118 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -13.83 10.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.522 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.443 ' HB2' HG22 ' A' ' 89' ' ' ILE . . . -55.09 -19.6 7.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 0.0 110.525 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.547 ' N ' ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.21 -23.07 12.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.086 -1.009 . . . . 0.0 109.674 179.834 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -58.87 -54.74 43.75 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.426 -0.796 . . . . 0.0 110.442 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -73.9 -21.9 78.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 6.8 tp -42.71 -27.15 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -1.145 . . . . 0.0 110.363 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.495 HG13 ' CE1' ' A' ' 18' ' ' TYR . 40.0 mt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.532 ' HB3' ' CB ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.197 0.522 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 6' ' ' ASP . 10.8 mmpt? -71.17 119.15 14.89 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.258 -0.901 . . . . 0.0 110.473 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.596 ' O ' ' N ' ' A' ' 5' ' ' TYR . 6.1 t -37.33 -32.67 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.702 ' C ' ' CD1' ' A' ' 5' ' ' TYR 0.273 . . -63.01 64.31 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.66 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.702 ' CD1' ' C ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER 32.96 36.16 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 122.667 1.222 . . . . 0.0 108.293 -176.582 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 2' ' ' LYS . 13.4 t0 61.88 59.78 1.67 Allowed 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.072 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.639 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 15.5 t -128.57 -113.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -0.827 . . . . 0.0 111.505 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.543 HG21 ' CB ' ' A' ' 28' ' ' PHE . 3.3 mt -69.57 157.62 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 110.83 -178.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -152.13 -93.23 0.05 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 110.723 179.836 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.81 141.63 25.75 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.088 -1.008 . . . . 0.0 110.909 -179.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.2 Cg_endo -77.16 173.49 14.3 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.207 1.635 . . . . 0.0 110.821 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.581 HG11 ' CD1' ' A' ' 29' ' ' TRP . 1.2 m -115.21 127.4 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.339 -0.85 . . . . 0.0 110.032 179.841 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.579 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 3.0 mm? -103.08 113.27 26.62 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 110.351 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.7 m -158.15 161.54 37.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.133 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -58.03 -55.26 37.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -54.66 -21.61 11.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.45 -52.03 3.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.579 ' CZ ' HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -49.5 -34.99 18.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.925 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.41 -8.63 50.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.38 -42.8 1.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.563 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -66.31 -17.05 64.53 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.56 -0.964 . . . . 0.0 108.91 178.879 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.72 -20.13 46.15 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.747 -0.596 . . . . 0.0 110.658 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.468 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 3.2 tt0 -88.54 17.71 5.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.458 -0.776 . . . . 0.0 110.123 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.09 4.12 69.26 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -178.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 48.2 mttm -82.76 134.96 35.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.591 -0.947 . . . . 0.0 109.445 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.643 ' CD2' ' CD1' ' A' ' 89' ' ' ILE . 24.6 m-85 -128.21 98.03 4.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.562 -1.336 . . . . 0.0 111.537 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.4 m -75.02 132.89 41.66 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.638 -0.664 . . . . 0.0 109.915 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.66 ' CE1' ' CZ ' ' A' ' 47' ' ' PHE . 34.8 m-85 -126.72 163.72 22.9 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.244 -179.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.581 ' CD1' HG11 ' A' ' 12' ' ' VAL . 95.8 m95 -95.11 122.61 37.96 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.117 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.7 p -149.02 164.38 4.23 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 C-N-CA 117.649 -1.62 . . . . 0.0 112.224 -176.634 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.42 ' N ' ' CG2' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -56.75 140.78 75.09 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.281 -179.905 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 48.9 Cg_endo -74.83 80.02 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.199 1.631 . . . . 0.0 110.262 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 178.47 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 110.112 -179.133 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' CB ' HG13 ' A' ' 39' ' ' ILE . . . -54.36 97.03 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.406 -0.809 . . . . 0.0 110.282 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.475 ' OG1' ' CG ' ' A' ' 38' ' ' GLU . 2.2 p -42.82 149.52 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 110.168 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.512 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 5.7 mmtp -42.61 -40.72 2.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.183 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 3.5 m -75.12 -39.07 60.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.31 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.475 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 7.8 mt-10 -55.68 -44.25 77.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 109.808 179.825 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.541 ' O ' ' CD1' ' A' ' 8' ' ' ILE . 14.5 mt -57.24 -30.32 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.618 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 24.2 tttt -57.82 -42.98 85.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 0.0 111.258 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.412 ' HB2' ' OH ' ' A' ' 5' ' ' TYR . 42.6 m-80 -58.19 -49.11 78.2 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.404 -0.81 . . . . 0.0 112.428 -178.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.561 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . . . -68.47 -47.98 65.71 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.711 -1.243 . . . . 0.0 111.759 -178.357 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.587 HG23 ' CE2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -59.78 -47.09 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.908 -1.12 . . . . 0.0 110.013 -179.431 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.82 -43.38 80.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.095 -1.003 . . . . 0.0 109.831 179.897 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -79.14 -27.39 42.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 109.97 179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.42 -61.64 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.074 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.66 ' CZ ' ' CE1' ' A' ' 28' ' ' PHE . 52.1 m-85 -71.8 -20.88 61.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.961 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 62.86 39.92 10.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.458 -0.776 . . . . 0.0 110.104 179.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -119.32 -164.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.807 179.705 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.565 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 5.4 tmtm? -113.42 106.6 14.78 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.443 -0.786 . . . . 0.0 109.364 179.021 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.552 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 44.7 t -78.22 130.72 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 110.145 -179.397 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 82' ' ' GLN . 13.3 p -114.96 -9.77 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.409 -0.807 . . . . 0.0 110.271 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.595 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 176.75 129.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 109.932 179.696 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.578 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -109.15 141.56 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.104 179.847 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.512 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.6 m-20 -130.04 115.52 17.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.285 -0.884 . . . . 0.0 109.561 178.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -108.85 159.82 16.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.916 -179.459 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 58' ' ' HIS . 1.8 pp -148.47 177.88 9.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.211 -0.931 . . . . 0.0 110.853 -179.37 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CD1' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -74.95 134.53 41.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.967 179.642 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.561 HG12 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -120.7 122.12 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.902 . . . . 0.0 109.358 179.677 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.508 ' O ' ' NH2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -37.68 105.31 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.433 0.635 . . . . 0.0 110.81 -179.141 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' HA3' ' NE ' ' A' ' 76' ' ' ARG . . . 150.4 108.56 0.44 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 74' ' ' PRO . 16.9 pttt -118.94 -162.44 0.9 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -1.11 . . . . 0.0 110.201 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -72.74 -160.84 0.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt 61.08 62.62 1.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 66' ' ' LEU . 17.8 ptt180 -111.35 -6.52 14.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.877 . . . . 0.0 110.348 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 65' ' ' ARG . 6.0 mp -42.08 114.28 0.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 110.111 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.77 57.1 0.21 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 9.6 ptt85 -140.14 23.65 2.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.25 . . . . 0.0 110.08 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.559 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 57.4 t80 -161.69 52.3 0.24 Allowed 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.039 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 41.36 39.18 0.95 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -0.841 . . . . 0.0 110.156 -179.905 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 72' ' ' LYS . . . -125.06 165.64 18.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 71' ' ' GLY . 10.4 ptpt 179.33 58.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -1.159 . . . . 0.0 110.331 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -144.18 115.1 5.41 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.241 179.905 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 61' ' ' GLY . 51.5 Cg_endo -80.67 -164.85 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.014 1.534 . . . . 0.0 110.591 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 1.9 t70 -114.66 90.34 3.32 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.446 -0.784 . . . . 0.0 108.886 179.241 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.527 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -96.03 153.72 17.63 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.603 -0.686 . . . . 0.0 110.266 -179.604 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.53 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 6.3 tttp -123.78 142.2 51.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.556 ' CD ' ' CG2' ' A' ' 27' ' ' THR . 0.9 OUTLIER -100.59 138.39 37.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.073 . . . . 0.0 109.792 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -133.22 119.36 19.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.097 -1.002 . . . . 0.0 111.836 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 16.7 mt -99.9 109.91 25.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.857 178.327 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.578 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 52.8 t -96.73 129.46 46.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 110.02 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.595 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 2.5 tp60 -98.86 153.2 18.97 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.013 179.358 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 1.5 m -119.66 156.6 22.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 C-N-CA 118.327 -1.349 . . . . 0.0 108.632 177.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.509 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -69.84 179.29 0.81 Allowed Pre-proline 0 C--N 1.283 -2.309 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.133 -179.71 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.06 140.76 31.76 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 124.263 1.665 . . . . 0.0 110.432 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.45 -37.1 3.95 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.472 ' OE1' ' HB3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -104.31 176.8 5.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.125 -1.221 . . . . 0.0 110.643 -179.897 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.55 115.04 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.488 -0.757 . . . . 0.0 110.001 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.643 ' CD1' ' CD2' ' A' ' 26' ' ' TYR . 14.1 mt -60.94 109.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.23 -0.919 . . . . 0.0 110.464 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 17.8 pt-20 -78.12 -14.33 59.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.318 -0.863 . . . . 0.0 110.745 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.461 ' HB1' HD22 ' A' ' 92' ' ' LEU . . . -55.15 -28.67 54.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.0 110.373 -179.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.02 -23.13 12.71 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.165 -0.959 . . . . 0.0 109.467 179.788 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.468 ' O ' HG12 ' A' ' 96' ' ' ILE . 25.3 mm-40 -54.53 -24.42 20.66 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.43 -0.794 . . . . 0.0 110.165 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.63 -36.35 4.85 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.468 ' HB3' HD12 ' A' ' 13' ' ' LEU . 3.5 mp -49.32 -31.94 10.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.375 -1.073 . . . . 0.0 110.114 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.562 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . 46.4 pt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.181 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 1.7 ptt? . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.921 0.391 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.59 ' HB2' ' N ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -99.43 34.07 2.3 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.801 178.687 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 5' ' ' TYR . 12.1 t -35.51 -34.51 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 177.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.712 ' C ' ' CD1' ' A' ' 5' ' ' TYR 0.268 . . -54.11 74.84 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.769 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.712 ' CD1' ' C ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER 34.52 35.73 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.674 1.226 . . . . 0.0 108.058 -176.179 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 6.0 t0 62.35 62.91 1.1 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.904 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' A' ' 5' ' ' TYR . 8.4 t -132.17 -79.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -0.853 . . . . 0.0 110.573 179.053 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.633 ' CG2' ' CD1' ' A' ' 28' ' ' PHE . 14.7 mm -87.04 102.8 12.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 121.371 -0.83 . . . . 0.0 110.466 -178.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' A' ' 2' ' ' LYS . 4.5 mp -62.51 -107.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 110.431 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.539 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -108.64 164.22 15.22 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.961 -1.087 . . . . 0.0 110.257 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 45.9 Cg_endo -73.31 153.5 50.79 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.982 1.517 . . . . 0.0 110.176 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 27' ' ' THR . 1.4 p -112.96 114.64 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.939 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.5 mm? -101.49 112.5 25.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 110.345 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -158.31 154.95 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.951 -179.981 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.0 mm-40 -43.08 -58.07 2.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 110.038 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 22.4 ttmt -54.72 -19.17 5.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.491 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -99.84 -54.58 2.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 110.065 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 13' ' ' LEU . 3.1 m-85 -53.82 -50.86 65.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.968 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 15' ' ' GLU . . . -63.8 -12.7 37.93 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.224 -0.922 . . . . 0.0 109.14 179.204 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' N ' ' A' ' 22' ' ' ALA . . . -94.46 -40.47 4.46 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 178.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.574 ' CE2' HD12 ' A' ' 92' ' ' LEU . 3.4 m-30 -51.44 -24.67 5.24 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.601 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 20' ' ' GLY . . . -43.27 -36.3 1.76 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.467 0.651 . . . . 0.0 110.25 -179.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.415 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 2.2 tt0 -95.9 16.48 17.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.412 -0.805 . . . . 0.0 110.515 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 80.64 6.74 89.17 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 49.9 mttt -82.17 132.62 35.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.241 -1.152 . . . . 0.0 109.755 179.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.578 ' CD2' HD11 ' A' ' 89' ' ' ILE . 70.7 m-85 -126.46 111.84 14.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.775 -1.203 . . . . 0.0 111.988 -178.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.598 ' CG2' ' CG ' ' A' ' 78' ' ' LYS . 36.8 m -75.73 141.97 42.53 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.606 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.688 ' CE2' ' CZ ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -141.11 164.72 29.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 -179.221 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.578 ' CZ2' ' HE2' ' A' ' 78' ' ' LYS . 79.6 m95 -93.5 122.4 35.89 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.166 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.516 ' CG1' ' HG2' ' A' ' 77' ' ' LYS . 7.6 p -137.05 164.64 29.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.68 -178.101 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CD2' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.14 150.03 97.9 Favored Pre-proline 0 C--N 1.294 -1.835 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.343 -179.839 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.54 67.3 3.7 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 O-C-N 124.222 1.643 . . . . 0.0 109.769 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.543 ' HE3' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 179.35 -32.38 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.455 -0.778 . . . . 0.0 109.828 -178.886 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HB3' HG13 ' A' ' 39' ' ' ILE . . . -49.54 101.06 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.368 -0.833 . . . . 0.0 110.218 -179.765 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -49.8 141.5 10.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.348 -179.974 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.521 ' CE ' ' OD1' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -43.84 -36.06 2.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 110.209 179.846 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -75.11 -49.04 20.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.854 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 1.6 mm-40 -54.79 -42.29 71.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 0.0 109.859 -179.74 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.462 HG12 HD13 ' A' ' 8' ' ' ILE . 21.3 mt -57.54 -30.69 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.9 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 7.8 tttt -60.94 -44.04 97.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.469 -0.77 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -58.43 -34.35 70.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.767 . . . . 0.0 111.927 -178.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.593 ' HB1' ' CE1' ' A' ' 5' ' ' TYR . . . -72.97 -50.4 23.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.594 -1.316 . . . . 0.0 111.754 -178.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.651 ' CG1' ' CE2' ' A' ' 47' ' ' PHE . 27.7 m -66.53 -31.35 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.578 -1.326 . . . . 0.0 110.557 -179.586 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.465 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.02 -52.93 61.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.057 -1.027 . . . . 0.0 109.97 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -80.18 -24.49 40.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 110.28 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -84.97 -56.38 3.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 0.0 110.812 -179.467 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 8.1 m-30 -71.72 -16.21 62.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.064 -1.022 . . . . 0.0 110.238 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 66.0 46.52 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.473 -0.767 . . . . 0.0 110.724 179.585 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.566 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -136.54 -164.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.365 -0.835 . . . . 0.0 110.253 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.566 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -114.52 105.13 12.73 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.422 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 57.9 t -77.71 119.19 25.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 110.33 -179.029 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.527 HG13 ' C ' ' A' ' 82' ' ' GLN . 7.3 p -96.2 -20.64 5.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.547 -0.721 . . . . 0.0 109.619 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.535 ' HG3' ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -167.9 146.17 4.53 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.428 -0.795 . . . . 0.0 109.942 179.865 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 1.2 t -132.14 116.78 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.684 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.521 ' OD1' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -114.1 115.1 27.0 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.0 -1.062 . . . . 0.0 109.614 179.17 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.528 ' CA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -110.75 141.44 44.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.345 -0.847 . . . . 0.0 110.248 -179.249 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.06 148.61 49.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 109.944 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.94 126.56 30.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 110.403 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.518 HG21 ' CE ' ' A' ' 78' ' ' LYS . 1.6 m -120.29 138.14 51.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.585 -0.697 . . . . 0.0 110.168 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.511 ' CB ' ' HG2' ' A' ' 73' ' ' ARG . 11.2 mmt85 -104.99 109.05 20.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 110.298 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.25 178.91 36.52 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.55 179.67 1.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -1.151 . . . . 0.0 110.242 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -58.7 159.34 6.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.234 -0.916 . . . . 0.0 110.169 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mttt 57.26 46.19 19.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 110.21 -180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 67' ' ' GLY . 2.4 mtm180 -158.69 20.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.468 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 3.5 mm? -58.87 78.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.321 -0.862 . . . . 0.0 110.266 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' ARG . . . 50.82 44.06 48.57 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.74 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.542 ' O ' ' C ' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -124.56 20.3 8.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.407 -1.055 . . . . 0.0 109.153 179.671 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER 19.62 77.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.344 179.662 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 tp -140.42 40.39 1.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 110.162 -179.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.2 -103.28 0.17 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.21 175.93 2.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -1.134 . . . . 0.0 110.16 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.511 ' HG2' ' CB ' ' A' ' 60' ' ' ARG . 2.2 mtp180 -118.97 94.46 48.2 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 110.232 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.472 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 47.9 Cg_endo -73.58 -164.55 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.094 1.576 . . . . 0.0 110.355 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -114.21 89.6 3.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.457 -0.777 . . . . 0.0 109.328 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.575 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -100.85 153.24 19.65 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.67 -0.643 . . . . 0.0 110.181 -179.977 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.527 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 81.2 tttt -106.62 136.87 45.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.577 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.598 ' CG ' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.67 151.09 30.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.485 179.555 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 28' ' ' PHE . . . -125.56 120.13 30.03 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.027 -1.045 . . . . 0.0 112.867 -179.169 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 55' ' ' ASN . 10.2 mt -96.68 110.52 24.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.237 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 26' ' ' TYR . 2.2 t -101.3 130.94 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 110.369 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.535 ' HB2' ' HG3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -112.55 153.63 27.21 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.023 -1.048 . . . . 0.0 109.639 179.346 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.527 ' CA ' HG13 ' A' ' 52' ' ' VAL . 1.9 m -115.41 157.21 16.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.065 177.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -61.93 174.81 0.62 Allowed Pre-proline 0 C--N 1.29 -2.019 0 O-C-N 121.238 -0.914 . . . . 0.0 110.827 -179.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.5 Cg_endo -76.73 58.13 5.86 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.465 1.771 . . . . 0.0 110.57 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.19 -33.79 0.02 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.466 ' OE1' ' CB ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -112.38 -179.94 3.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.119 -1.224 . . . . 0.0 110.457 -179.779 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.477 ' HA ' HG22 ' A' ' 83' ' ' VAL . 4.2 ptpt -170.73 125.54 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.578 HD11 ' CD2' ' A' ' 26' ' ' TYR . 59.8 mt -68.43 98.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.152 -0.968 . . . . 0.0 110.161 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 1.9 mt-10 -70.65 -13.52 62.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.415 -0.803 . . . . 0.0 110.81 -179.587 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.455 ' CB ' HD21 ' A' ' 92' ' ' LEU . . . -54.48 -28.88 47.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.067 -1.02 . . . . 0.0 110.407 -179.376 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.574 HD12 ' CE2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -106.19 -22.55 12.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.162 -0.961 . . . . 0.0 109.402 179.605 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' O ' HD12 ' A' ' 96' ' ' ILE . 13.2 mm-40 -56.53 -54.09 49.92 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.494 -0.753 . . . . 0.0 110.33 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.65 -14.71 79.6 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 2.2 tp -67.92 -7.71 30.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.134 -1.216 . . . . 0.0 110.132 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.498 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 45.4 mt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.205 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.578 ' CG ' ' HB2' ' A' ' 6' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.639 ' N ' ' HA ' ' A' ' 6' ' ' ASP . 10.9 mttm -43.45 98.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.603 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.4 m 4.52 -70.97 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.716 0 CA-C-O 121.556 0.693 . . . . 0.0 110.571 -177.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.638 ' N ' ' O ' ' A' ' 2' ' ' LYS 0.281 . . -55.72 80.02 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.772 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.643 ' CE2' ' CG2' ' A' ' 7' ' ' VAL . 1.9 p90 24.62 45.59 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 121.862 0.839 . . . . 0.0 110.496 -178.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.639 ' HA ' ' N ' ' A' ' 2' ' ' LYS . 2.2 t70 65.29 54.34 1.2 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.012 0.91 . . . . 0.0 111.56 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.643 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 2.1 t -135.96 -73.88 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.785 -1.197 . . . . 0.0 110.839 178.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.602 ' CG2' ' CD2' ' A' ' 28' ' ' PHE . 5.6 mm -102.83 121.64 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 110.589 -178.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 2' ' ' LYS . 20.0 mt -96.41 -107.19 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.507 -0.746 . . . . 0.0 109.867 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.79 158.02 36.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.066 -1.021 . . . . 0.0 110.127 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.474 ' O ' HD21 ' A' ' 13' ' ' LEU . 46.9 Cg_endo -73.62 140.16 29.19 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.915 1.481 . . . . 0.0 109.65 179.38 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 12' ' ' VAL . 1.6 m -85.39 132.21 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.015 -1.053 . . . . 0.0 110.172 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.8 mm? -102.77 112.73 25.66 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.168 -0.958 . . . . 0.0 110.119 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' ALA . 3.1 m -163.54 148.62 11.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 110.045 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 14' ' ' SER . 58.7 mt-10 -42.88 -53.67 4.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 110.004 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -54.9 -21.98 13.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.19 -0.944 . . . . 0.0 110.116 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -100.31 -57.28 2.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 110.272 -179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.565 ' CZ ' HD11 ' A' ' 13' ' ' LEU . 1.4 m-85 -47.03 -34.7 5.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.938 . . . . 0.0 110.303 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.07 -8.88 50.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.994 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -103.61 -34.01 3.97 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -80.24 -18.95 48.01 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.702 -0.881 . . . . 0.0 108.95 179.164 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.21 -21.73 14.98 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.416 0.627 . . . . 0.0 110.732 -179.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -88.99 17.08 6.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.702 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.519 ' HA2' ' CE ' ' A' ' 88' ' ' LYS . . . 93.17 0.69 67.67 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.233 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 62.4 mttt -82.43 142.23 32.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.479 -1.012 . . . . 0.0 109.293 179.628 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.589 ' CE2' HG13 ' A' ' 89' ' ' ILE . 26.7 m-85 -128.79 111.02 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.662 -1.274 . . . . 0.0 111.511 -179.267 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 26.7 m -82.78 125.29 31.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.612 0.72 . . . . 0.0 110.151 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.619 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 22.0 m-30 -119.3 165.53 14.16 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.706 -0.621 . . . . 0.0 109.662 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.541 ' CZ3' ' CG ' ' A' ' 76' ' ' ARG . 1.9 m95 -103.02 122.84 45.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.062 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 2.5 p -149.01 164.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.571 -1.251 . . . . 0.0 111.596 -176.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.474 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -62.69 151.4 84.36 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.896 -0.503 . . . . 0.0 110.659 -179.346 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 46.7 Cg_endo -73.81 70.1 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.236 1.651 . . . . 0.0 109.906 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.24 -33.75 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 110.324 -178.988 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 35' ' ' THR . . . -41.75 98.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 110.179 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.453 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -41.33 138.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 0.0 110.322 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.505 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 1.4 mttt -42.56 -35.89 1.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.9 m -75.04 -36.07 61.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 110.019 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.459 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -55.91 -46.21 78.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.998 179.807 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.529 ' CG1' HD13 ' A' ' 8' ' ' ILE . 6.2 mt -57.31 -30.24 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.542 179.585 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 12.5 tttm -62.99 -47.55 82.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.628 -0.67 . . . . 0.0 111.324 -179.433 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.62 -34.65 78.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.311 -0.868 . . . . 0.0 111.76 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.565 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . . . -72.86 -49.49 29.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.981 -1.075 . . . . 0.0 111.705 -178.622 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.619 ' CG1' ' CE2' ' A' ' 28' ' ' PHE . 26.7 m -71.21 -28.5 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.683 -1.26 . . . . 0.0 110.765 -179.301 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.53 -51.66 67.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.8 -1.188 . . . . 0.0 109.22 179.542 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -79.41 -45.09 20.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.83 . . . . 0.0 109.728 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.17 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.46 -0.775 . . . . 0.0 110.531 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CD1' ' CG2' ' A' ' 89' ' ' ILE . 24.5 m-85 -71.69 -21.09 61.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.026 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.8 mttt 63.76 47.4 3.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.858 . . . . 0.0 110.556 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.556 ' CG1' ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -130.33 -162.84 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.514 -0.741 . . . . 0.0 110.017 179.967 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.556 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 2.2 tmtt? -118.1 107.43 13.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.423 -0.798 . . . . 0.0 109.839 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.532 ' CG1' ' HG3' ' A' ' 40' ' ' LYS . 49.2 t -78.6 119.84 28.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.216 -0.927 . . . . 0.0 110.166 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.573 HG11 ' CA ' ' A' ' 83' ' ' VAL . 7.5 p -112.59 4.96 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.893 . . . . 0.0 110.035 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER 171.88 120.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.222 179.902 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.585 ' CG2' ' CG2' ' A' ' 81' ' ' VAL . 1.2 t -115.87 136.27 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 0.0 110.125 179.664 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.505 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 1.1 t-20 -131.26 116.51 17.72 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.468 -0.77 . . . . 0.0 109.482 179.154 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -113.75 166.3 11.69 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.07 -1.019 . . . . 0.0 109.871 -179.724 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.521 ' CD2' ' HD2' ' A' ' 78' ' ' LYS . 2.8 pp -152.63 146.29 25.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.918 . . . . 0.0 110.64 -179.027 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.605 ' CD2' ' NE ' ' A' ' 60' ' ' ARG . 1.3 t-160 -81.75 122.13 27.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.05 -1.032 . . . . 0.0 109.759 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.654 HG11 ' HG2' ' A' ' 76' ' ' ARG . 1.2 p -121.35 135.75 60.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.818 -0.551 . . . . 0.0 110.437 -178.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.605 ' NE ' ' CD2' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -173.53 146.28 1.32 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 110.686 -179.329 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' N ' ' HD2' ' A' ' 74' ' ' PRO . . . 145.44 112.51 0.78 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.545 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.08 157.83 42.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -1.137 . . . . 0.0 110.179 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -46.87 -73.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.316 -179.983 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' LYS . 12.2 mtmt -41.52 138.99 1.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 110.463 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 66' ' ' LEU . 16.0 mmm-85 -138.98 -59.49 0.59 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.6 mp 42.7 91.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 110.149 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.18 54.72 1.09 Allowed Glycine 0 N--CA 1.485 1.907 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -179.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.49 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -138.69 26.69 2.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -1.225 . . . . 0.0 109.844 179.917 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.62 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 27.5 t80 -162.53 173.43 14.0 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.019 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.588 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -86.81 44.08 1.14 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.067 179.86 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.62 ' N ' ' CD2' ' A' ' 69' ' ' TYR . . . -92.89 -114.11 2.21 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 21.0 mtpt 59.22 -176.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.109 . . . . 0.0 110.008 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 60' ' ' ARG . 46.2 mtt180 -43.06 110.71 0.93 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.909 . . . . 0.0 109.878 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 60' ' ' ARG . 49.1 Cg_endo -70.8 -169.18 0.36 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.011 1.532 . . . . 0.0 110.78 -179.604 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HA ' ' NE2' ' A' ' 58' ' ' HIS . 0.9 OUTLIER -117.71 89.67 3.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.392 -0.817 . . . . 0.0 109.57 179.324 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.654 ' HG2' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -123.48 131.0 53.51 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.705 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.516 ' CG ' HG13 ' A' ' 30' ' ' VAL . 7.5 pttt -123.88 131.32 53.56 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.758 -1.214 . . . . 0.0 110.717 -179.013 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 12.5 ptpt -101.7 151.42 22.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.404 -0.81 . . . . 0.0 108.908 179.085 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -116.37 120.1 37.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.773 -1.204 . . . . 0.0 112.712 -178.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.626 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 1.6 mp -97.07 112.17 28.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.227 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.585 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 6.4 t -109.53 132.25 58.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 111.14 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.528 ' HG3' ' N ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -103.52 149.89 24.43 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.395 -0.816 . . . . 0.0 108.84 179.078 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.573 ' CA ' HG11 ' A' ' 52' ' ' VAL . 1.3 m -116.11 157.98 16.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.445 -1.302 . . . . 0.0 109.744 179.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.538 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . . . -76.36 -178.37 0.92 Allowed Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.048 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 84' ' ' ALA . 42.2 Cg_endo -72.09 135.9 26.03 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 O-C-N 124.087 1.572 . . . . 0.0 109.937 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.79 -50.56 0.76 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.479 ' OE1' ' HB2' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -98.18 174.58 6.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.166 -1.196 . . . . 0.0 110.53 179.889 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.519 ' CE ' ' HA2' ' A' ' 24' ' ' GLY . 0.3 OUTLIER 178.68 115.72 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.478 -0.763 . . . . 0.0 110.315 -179.855 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.635 ' CG2' ' CD1' ' A' ' 47' ' ' PHE . 7.5 mt -68.26 63.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.886 -1.134 . . . . 0.0 109.48 179.347 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 88' ' ' LYS . 2.4 mm-40 -54.3 -12.83 0.72 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.64 -0.663 . . . . 0.0 111.72 -179.558 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.508 ' O ' ' CD1' ' A' ' 95' ' ' LEU . . . -53.42 -16.03 1.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.882 -1.136 . . . . 0.0 110.968 -179.058 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.579 HD11 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -101.76 -23.04 14.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.862 -1.149 . . . . 0.0 109.514 179.43 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -54.19 -29.0 44.34 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.458 -0.776 . . . . 0.0 110.396 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -96.91 -24.64 12.71 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.508 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 3.5 mp -42.42 -28.9 0.24 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -1.144 . . . . 0.0 110.182 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.53 HG12 ' CE1' ' A' ' 18' ' ' TYR . 72.8 mt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.04 HG13 ' HB1' ' A' ' 34' ' ' ALA . 66.3 t . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.875 0.369 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.026 HG13 HG12 ' A' ' 7' ' ' VAL . 29.0 mt -84.99 104.44 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.657 -1.277 . . . . 0.0 110.749 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.2 mt -75.42 -93.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.761 . . . . 0.0 110.987 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.33 157.77 34.18 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.122 -0.986 . . . . 0.0 110.92 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 48.8 Cg_endo -77.01 160.95 33.24 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.149 1.605 . . . . 0.0 110.415 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 27' ' ' THR . 1.2 p -115.31 116.56 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 109.831 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.836 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.4 mm? -98.85 112.06 24.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.401 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.637 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -155.36 157.42 37.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.048 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 5.5 tm-20 -43.52 -61.24 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 110.069 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.74 -17.68 3.76 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.31 -0.869 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.637 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -99.4 -52.16 3.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 109.995 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.605 ' CE1' ' CG1' ' A' ' 96' ' ' ILE . 2.1 m-85 -56.47 -58.1 9.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.157 -0.964 . . . . 0.0 109.931 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.66 -12.82 37.18 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.272 -0.892 . . . . 0.0 109.186 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 21' ' ' PHE . . . -86.31 -47.19 5.02 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 7.7 m-30 -47.88 -28.42 2.63 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -38.31 -38.26 0.35 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.399 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.15 -17.88 23.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.359 -0.838 . . . . 0.0 110.44 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 118.05 4.52 14.32 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 1.7 mmtm -81.69 135.72 35.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -1.123 . . . . 0.0 109.505 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.69 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.1 m-85 -127.15 111.16 13.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.017 -1.052 . . . . 0.0 112.167 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.778 HG23 HD11 ' A' ' 80' ' ' ILE . 24.9 m -77.99 140.05 39.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.935 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -137.5 164.33 28.97 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.066 -1.021 . . . . 0.0 111.349 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.507 ' CZ3' HG21 ' A' ' 59' ' ' VAL . 70.7 m95 -99.31 122.59 42.67 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.934 HG23 ' C ' ' A' ' 7' ' ' VAL . 2.6 p -144.02 156.71 15.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.787 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -62.36 151.73 81.58 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.778 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.9 Cg_endo -73.41 71.12 3.87 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.183 1.622 . . . . 0.0 110.047 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.57 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.3 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 1.04 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -44.27 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.94 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -42.67 144.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 110.338 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -42.53 -52.86 4.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 109.909 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.8 m -62.37 -36.51 82.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.475 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.2 OUTLIER -56.47 -44.14 80.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.184 -0.947 . . . . 0.0 109.569 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.978 HG23 HD11 ' A' ' 8' ' ' ILE . 1.7 mt -57.61 -32.56 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.315 -0.865 . . . . 0.0 108.805 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG3' HG11 ' A' ' 51' ' ' VAL . 6.4 ttmm -59.25 -45.81 90.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.851 . . . . 0.0 109.621 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 1.024 ' O ' HG23 ' A' ' 45' ' ' THR . 5.2 m120 -71.83 -34.0 68.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.645 -0.659 . . . . 0.0 111.146 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.903 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.51 -50.16 73.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.176 . . . . 0.0 110.501 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.123 HG12 ' CE2' ' A' ' 47' ' ' PHE . 3.3 m -76.25 -34.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.879 -1.138 . . . . 0.0 110.641 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -60.95 -29.84 69.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.031 -1.043 . . . . 0.0 110.374 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 1.024 HG23 ' O ' ' A' ' 41' ' ' ASN . 34.4 p -78.52 -46.47 19.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.51 -55.03 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 110.72 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 1.123 ' CE2' HG12 ' A' ' 43' ' ' VAL . 6.6 m-30 -71.54 -14.72 62.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.065 -1.022 . . . . 0.0 110.141 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 16.0 mttm 42.48 47.03 4.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.147 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.777 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.88 -163.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.569 -0.707 . . . . 0.0 110.008 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.777 ' N ' HG13 ' A' ' 49' ' ' VAL . 1.2 tmtp? -118.08 110.27 17.43 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.431 -0.793 . . . . 0.0 109.709 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.554 HG11 ' HG3' ' A' ' 40' ' ' LYS . 30.0 t -78.63 119.72 28.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.359 -0.838 . . . . 0.0 110.043 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.79 HG12 ' O ' ' A' ' 82' ' ' GLN . 10.9 p -110.0 7.02 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.309 -0.87 . . . . 0.0 110.025 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER 169.68 119.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 109.987 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.98 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -121.12 120.83 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.115 -0.99 . . . . 0.0 110.072 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.49 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -121.63 115.95 23.69 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.23 178.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.54 HG21 HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -116.35 150.62 37.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.147 -0.97 . . . . 0.0 110.588 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.718 HD21 ' HE2' ' A' ' 78' ' ' LYS . 1.2 pp -141.5 154.88 45.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 109.79 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -67.43 134.04 50.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.42 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.507 HG21 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.367 -0.833 . . . . 0.0 110.092 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.156 0.503 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HG2' HG13 ' A' ' 30' ' ' VAL . 12.8 tttt -123.59 140.92 52.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -0.945 . . . . 0.0 110.648 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.718 ' HE2' HD21 ' A' ' 57' ' ' LEU . 2.1 ttpt -107.97 150.55 26.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.333 -0.855 . . . . 0.0 109.623 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.67 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -133.18 121.79 23.06 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.056 -1.027 . . . . 0.0 112.495 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.778 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -101.62 111.95 33.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.98 HG13 HG23 ' A' ' 54' ' ' VAL . 3.8 t -107.46 131.24 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.435 -0.791 . . . . 0.0 110.454 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.79 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -111.38 146.63 36.8 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.923 -1.111 . . . . 0.0 108.952 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 87' ' ' GLN . 1.5 m -114.52 156.08 15.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.654 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.942 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -57.34 178.79 0.15 Allowed Pre-proline 0 C--N 1.29 -1.981 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.525 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.942 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.5 Cg_endo -72.7 145.16 40.82 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 O-C-N 124.149 1.605 . . . . 0.0 110.572 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.84 -18.38 47.62 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.54 ' HB2' HG23 ' A' ' 83' ' ' VAL . 57.7 mt-30 -94.59 171.58 8.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 110.557 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 3.1 pttt 179.68 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.823 . . . . 0.0 110.303 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.69 HD12 ' CD2' ' A' ' 26' ' ' TYR . 7.5 mt -63.08 118.62 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.95 . . . . 0.0 110.085 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -76.59 -14.74 59.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -0.826 . . . . 0.0 110.678 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.742 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -56.23 -34.67 66.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 110.946 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.23 -23.5 12.56 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.985 -1.072 . . . . 0.0 110.149 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.683 ' O ' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -65.67 -43.24 89.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.259 -0.901 . . . . 0.0 110.289 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.3 8.27 75.31 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.786 HD23 HD21 ' A' ' 13' ' ' LEU . 2.3 tp -88.58 24.87 1.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -1.155 . . . . 0.0 110.245 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 93' ' ' GLU . 6.9 mt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.248 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.993 HG13 ' HB1' ' A' ' 34' ' ' ALA . 39.0 t . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 122.128 0.966 . . . . 0.0 109.281 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.932 HD11 HG23 ' A' ' 39' ' ' ILE . 8.7 mt -115.05 95.48 3.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.487 -0.758 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.6 mt -79.04 -97.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.553 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -108.16 167.28 9.51 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.076 -1.015 . . . . 0.0 110.497 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.716 ' HB3' HD13 ' A' ' 92' ' ' LEU . 46.7 Cg_endo -73.68 171.11 18.47 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.14 1.6 . . . . 0.0 110.529 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.706 HG12 ' CD1' ' A' ' 29' ' ' TRP . 3.0 m -115.36 144.32 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.411 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.3 mm? -102.65 107.49 18.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.212 -0.93 . . . . 0.0 110.328 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 17' ' ' ALA . 5.5 m -164.9 134.79 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.868 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' SER . 7.2 mt-10 -42.88 -59.34 2.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.117 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 -17.44 6.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.958 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.16 17.24 17.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.887 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.721 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 2.2 m-85 -139.18 -38.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.388 -0.82 . . . . 0.0 109.933 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.35 80.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.05 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 25' ' ' LYS . . . -95.52 -34.95 5.84 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.09 -17.73 64.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.352 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -70.5 -17.05 62.96 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.725 -0.61 . . . . 0.0 110.654 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -88.7 16.37 6.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 110.341 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 102.07 -2.06 51.33 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.48 136.45 34.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.514 -0.992 . . . . 0.0 109.534 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.758 ' HD1' HD12 ' A' ' 92' ' ' LEU . 99.5 m-85 -126.69 116.01 20.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 0.0 111.626 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.093 HG23 HD11 ' A' ' 80' ' ' ILE . 3.7 m -83.26 141.29 31.97 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.83 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 26.5 m-85 -134.06 164.37 27.47 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.33 -0.856 . . . . 0.0 110.933 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.706 ' CD1' HG12 ' A' ' 12' ' ' VAL . 19.6 m95 -97.01 122.35 39.91 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 7' ' ' VAL . 11.6 p -138.69 164.91 25.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.059 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.602 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 1.6 t60 -81.13 152.85 71.66 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.304 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 44.5 Cg_endo -70.89 65.7 2.46 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.06 1.558 . . . . 0.0 109.727 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.73 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.665 -179.195 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.993 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -42.42 95.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.44 -0.787 . . . . 0.0 109.602 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -39.39 134.27 1.23 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.382 -0.824 . . . . 0.0 110.894 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.651 ' HA ' HD12 ' A' ' 39' ' ' ILE . 1.9 mttt -46.9 -48.02 21.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.83 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.8 m -62.04 -39.53 92.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 0.0 109.424 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 4.7 mt-10 -55.83 -40.9 73.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 108.937 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.932 HG23 HD11 ' A' ' 8' ' ' ILE . 30.6 mt -58.0 -31.03 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.469 -0.77 . . . . 0.0 109.003 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.611 ' O ' HG21 ' A' ' 51' ' ' VAL . 3.8 tttt -59.54 -47.3 86.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.777 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.4 m-80 -72.75 -34.02 66.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.701 -0.624 . . . . 0.0 111.194 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.696 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.0 -50.43 73.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.786 -1.196 . . . . 0.0 110.553 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.785 HG11 ' CE2' ' A' ' 28' ' ' PHE . 3.7 m -67.3 -32.84 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.651 -1.281 . . . . 0.0 109.489 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -69.04 -44.51 72.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 108.812 178.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -79.07 -16.44 56.77 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -104.23 -67.44 0.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.498 -0.751 . . . . 0.0 110.315 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.752 ' HE1' HD21 ' A' ' 92' ' ' LEU . 52.4 m-85 -71.95 -21.91 61.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.0 110.343 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 64.94 46.4 2.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.789 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -123.56 -158.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.512 -0.743 . . . . 0.0 110.136 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.789 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -116.89 110.4 18.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 109.762 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.611 HG21 ' O ' ' A' ' 40' ' ' LYS . 92.3 t -78.73 120.4 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.931 . . . . 0.0 110.321 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 82' ' ' GLN . 10.1 p -112.83 3.85 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.263 -0.898 . . . . 0.0 109.988 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 1.8 mttp 169.12 119.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.055 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.031 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.87 131.39 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.048 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.513 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 13.1 t30 -131.17 115.97 17.07 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.34 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.57 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -116.61 161.36 19.29 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.193 -0.942 . . . . 0.0 109.945 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -156.65 170.83 21.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.383 -0.823 . . . . 0.0 110.188 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -80.76 129.77 34.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 110.219 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.099 HG11 ' CD ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.48 -0.762 . . . . 0.0 110.074 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.62 ' HB3' HG23 ' A' ' 59' ' ' VAL . 4.3 mpt_? . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.226 0.536 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.598 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.4 tttt -120.87 133.69 55.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 1.099 ' CD ' HG11 ' A' ' 59' ' ' VAL . 3.8 mttt -110.23 151.48 27.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.367 -0.833 . . . . 0.0 109.942 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -123.14 119.77 31.25 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.933 -1.104 . . . . 0.0 112.193 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.093 HD11 HG23 ' A' ' 27' ' ' THR . 1.5 mp -102.42 111.88 33.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.031 HG22 ' CG2' ' A' ' 54' ' ' VAL . 24.0 t -111.08 136.09 48.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.486 -0.759 . . . . 0.0 110.433 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.815 ' O ' HG12 ' A' ' 52' ' ' VAL . 1.9 tp60 -111.47 151.32 28.72 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.222 -0.924 . . . . 0.0 108.868 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.583 HG21 ' C ' ' A' ' 87' ' ' GLN . 2.0 m -112.68 155.71 13.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 C-N-CA 118.069 -1.453 . . . . 0.0 109.531 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.971 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -49.16 179.03 0.03 OUTLIER Pre-proline 0 C--N 1.291 -1.936 0 O-C-N 121.543 -0.723 . . . . 0.0 110.482 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.971 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.4 Cg_endo -71.79 140.07 34.76 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.22 1.642 . . . . 0.0 110.492 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.19 -24.58 12.97 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.684 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 87.1 mt-30 -95.82 164.37 12.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -1.148 . . . . 0.0 110.619 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.525 ' N ' HG21 ' A' ' 83' ' ' VAL . 0.0 OUTLIER 179.43 108.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.245 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.591 ' HB ' ' CE1' ' A' ' 26' ' ' TYR . 91.4 mt -51.11 91.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.126 -0.984 . . . . 0.0 109.541 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 4.1 mm-40 -63.01 -13.39 34.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 111.206 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.768 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.65 -33.76 61.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 110.804 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -106.87 -23.67 12.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.952 -1.092 . . . . 0.0 110.507 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -48.95 -30.97 6.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.163 -0.961 . . . . 0.0 110.14 -179.149 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.48 -19.89 11.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.524 ' CD2' ' HG2' ' A' ' 11' ' ' PRO . 26.7 tp -53.13 -19.14 2.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -1.114 . . . . 0.0 110.054 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.638 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 32.4 mt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.131 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.071 HG13 ' HB1' ' A' ' 34' ' ' ALA . 58.2 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 120.991 0.424 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.034 HD11 HG23 ' A' ' 39' ' ' ILE . 24.0 mt -88.28 113.19 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 120.681 -1.262 . . . . 0.0 111.268 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -92.06 -88.22 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.291 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.03 150.85 40.91 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.45 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.487 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.8 Cg_endo -74.32 -178.21 3.8 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.065 1.561 . . . . 0.0 110.177 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.673 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.16 133.33 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.149 -0.969 . . . . 0.0 110.347 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.746 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -103.12 112.83 25.87 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.193 -0.942 . . . . 0.0 110.185 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 17' ' ' ALA . 60.6 m -163.79 128.65 2.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.145 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -42.96 -58.63 2.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.898 . . . . 0.0 110.048 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -17.63 3.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 110.215 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.7 -48.04 5.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 110.149 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.586 ' CE2' HG13 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -52.79 -33.1 47.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 109.772 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.47 -21.6 66.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -100.81 -37.59 3.64 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 105.683 -2.967 . . . . 0.0 105.683 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.612 ' CD1' ' HA ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -64.64 -19.17 65.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.24 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' TYR . . . -93.36 4.63 53.66 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.219 0.533 . . . . 0.0 110.629 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -111.87 16.58 20.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.764 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 95.69 -24.82 27.79 Favored Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 39.7 mttm -81.79 140.42 34.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.352 -1.087 . . . . 0.0 109.153 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.905 ' CD2' HD12 ' A' ' 89' ' ' ILE . 35.4 m-85 -126.92 110.18 12.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.803 -1.186 . . . . 0.0 112.234 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.668 HG23 HD11 ' A' ' 80' ' ' ILE . 28.3 m -80.57 118.25 21.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.914 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -116.99 164.97 13.9 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 111.638 -178.176 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.673 ' CD1' HG12 ' A' ' 12' ' ' VAL . 7.4 m95 -97.81 123.0 41.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.0 p -145.56 157.45 12.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 C-N-CA 118.195 -1.402 . . . . 0.0 111.712 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.602 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -59.21 149.57 67.3 Favored Pre-proline 0 C--N 1.297 -1.679 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.044 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.602 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 47.7 Cg_endo -73.02 71.57 3.47 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.061 1.558 . . . . 0.0 109.808 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.48 -33.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.417 -0.802 . . . . 0.0 109.932 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 1.071 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -42.36 93.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.484 -0.76 . . . . 0.0 109.799 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -42.17 141.68 0.88 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 110.443 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 4.3 mmtp -42.63 -41.13 2.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.372 -0.83 . . . . 0.0 109.778 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 62.1 m -70.97 -35.93 72.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.728 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 5.8 mt-10 -58.54 -42.53 88.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.553 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.034 HG23 HD11 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -57.48 -31.68 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.57 ' HG3' HG11 ' A' ' 51' ' ' VAL . 8.1 tttm -62.97 -46.37 88.02 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.552 -0.717 . . . . 0.0 109.627 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.982 ' O ' HG23 ' A' ' 45' ' ' THR . 38.4 m-80 -72.97 -34.12 66.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.601 -0.687 . . . . 0.0 110.921 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.74 -50.27 73.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.932 -1.105 . . . . 0.0 110.43 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 39' ' ' ILE . 2.7 m -76.64 -36.61 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.869 -1.144 . . . . 0.0 110.654 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -56.92 -32.31 65.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.942 -1.099 . . . . 0.0 110.256 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.982 HG23 ' O ' ' A' ' 41' ' ' ASN . 35.4 p -77.99 -46.01 22.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.234 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.06 -55.61 4.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 0.0 110.735 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.894 ' CD1' HG23 ' A' ' 89' ' ' ILE . 21.0 m-85 -71.67 -21.33 61.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.155 -0.966 . . . . 0.0 110.372 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 51.08 44.52 28.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.778 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -115.29 -162.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.633 -0.667 . . . . 0.0 109.923 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.778 ' N ' HG13 ' A' ' 49' ' ' VAL . 8.0 tmtt? -117.2 108.32 15.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.893 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.57 HG11 ' HG3' ' A' ' 40' ' ' LYS . 33.5 t -78.44 119.64 27.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.242 -0.911 . . . . 0.0 109.769 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 82' ' ' GLN . 3.3 p -107.26 -12.75 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.43 -0.794 . . . . 0.0 110.167 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -173.15 123.4 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.979 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.945 ' CG2' HG13 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -123.63 131.2 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.192 -0.942 . . . . 0.0 110.085 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 2.5 m-20 -131.07 115.82 16.95 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.645 HG21 HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.8 146.04 41.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 58' ' ' HIS . 2.3 pp -128.01 153.45 46.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.279 -0.888 . . . . 0.0 110.608 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.471 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.0 t-160 -66.32 118.32 9.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.144 -0.973 . . . . 0.0 109.279 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.581 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.246 -0.909 . . . . 0.0 110.013 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.582 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.328 0.585 . . . . 0.0 110.365 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.581 ' HA ' HG23 ' A' ' 59' ' ' VAL . 19.9 tttt -123.5 137.51 54.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.561 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 6.9 mttt -101.06 147.69 25.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.164 -0.96 . . . . 0.0 109.936 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.62 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -133.44 121.87 22.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.0 111.873 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 80' ' ' ILE . 1.6 mp -98.67 111.7 28.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.945 HG13 ' CG2' ' A' ' 54' ' ' VAL . 2.4 t -107.41 122.27 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.505 -0.747 . . . . 0.0 110.659 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.741 ' O ' HG12 ' A' ' 52' ' ' VAL . 4.5 tp-100 -104.37 142.81 33.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 109.016 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.486 ' N ' ' OE1' ' A' ' 82' ' ' GLN . 1.1 m -109.76 156.99 10.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 C-N-CA 118.15 -1.42 . . . . 0.0 109.896 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -72.14 178.83 1.19 Allowed Pre-proline 0 C--N 1.291 -1.965 0 O-C-N 121.65 -0.656 . . . . 0.0 110.235 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.1 Cg_endo -73.04 140.4 31.29 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 124.234 1.65 . . . . 0.0 110.345 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.63 -30.36 9.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.555 ' HB2' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -112.19 176.39 5.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.204 -1.174 . . . . 0.0 110.467 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.3 OUTLIER 179.3 115.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 110.331 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.905 HD12 ' CD2' ' A' ' 26' ' ' TYR . 39.5 mt -67.91 60.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.174 -0.954 . . . . 0.0 109.655 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 88' ' ' LYS . 14.1 pt-20 -58.2 -13.08 4.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.445 -0.785 . . . . 0.0 111.022 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.714 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.24 -16.63 2.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.989 -1.07 . . . . 0.0 110.627 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.811 HD21 ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -106.21 -23.23 12.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.062 -1.024 . . . . 0.0 109.634 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.4 -19.75 6.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.352 -0.842 . . . . 0.0 110.332 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.08 -20.16 11.67 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.631 HD23 HD11 ' A' ' 13' ' ' LEU . 14.5 tp -46.36 -24.37 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.586 HG13 ' CE2' ' A' ' 18' ' ' TYR . 2.0 mp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.21 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.966 HG12 HG13 ' A' ' 8' ' ' ILE . 39.6 t . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.279 0.562 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.966 HG13 HG12 ' A' ' 7' ' ' VAL . 16.2 mt 24.56 51.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.302 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 30' ' ' VAL . 3.5 mt -44.71 -99.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.307 -0.87 . . . . 0.0 111.262 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -99.56 151.68 37.53 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.924 -1.11 . . . . 0.0 110.816 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.632 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 49.8 Cg_endo -76.33 153.6 35.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.103 1.581 . . . . 0.0 110.519 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 27' ' ' THR . 1.5 p -115.15 105.21 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.058 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.818 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.12 106.75 17.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.667 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -135.57 -178.54 5.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.184 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -57.34 -67.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.251 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -45.66 74.46 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.258 -0.901 . . . . 0.0 110.354 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.667 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -56.21 -48.9 75.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.665 ' CE1' HG22 ' A' ' 96' ' ' ILE . 1.9 m-85 -57.9 -33.33 68.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.875 . . . . 0.0 110.147 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.37 -8.88 49.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.858 . . . . 0.0 109.865 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -103.33 -38.23 2.88 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.626 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -74.94 -18.88 60.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.571 -0.958 . . . . 0.0 108.873 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.404 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -56.92 -20.7 24.79 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.702 -0.624 . . . . 0.0 110.729 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.6 17.27 5.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.38 -0.825 . . . . 0.0 110.059 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.04 0.89 67.74 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 48.8 mttt -82.79 143.47 30.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.567 -0.961 . . . . 0.0 109.545 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 1.126 ' CD2' HD12 ' A' ' 89' ' ' ILE . 22.9 m-85 -128.01 99.41 5.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.611 -1.306 . . . . 0.0 111.083 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.79 HG23 HD11 ' A' ' 80' ' ' ILE . 2.7 m -74.63 127.32 32.83 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.641 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -131.44 165.23 23.98 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.314 -0.866 . . . . 0.0 111.162 -178.236 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.515 ' NE1' ' HB ' ' A' ' 12' ' ' VAL . 46.1 m95 -100.0 123.27 44.06 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.807 ' HA ' HD12 ' A' ' 9' ' ' LEU . 2.0 p -142.55 164.81 17.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.081 -176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.656 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 1.1 t-160 -65.34 149.76 96.64 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.545 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.656 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 48.1 Cg_endo -73.18 67.49 4.22 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.088 1.573 . . . . 0.0 109.434 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.72 -32.19 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.405 -0.81 . . . . 0.0 110.062 -178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.717 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.09 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.692 . . . . 0.0 109.882 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -45.99 142.12 2.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.0 110.388 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -42.81 -38.62 2.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.841 . . . . 0.0 109.675 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.6 m -73.17 -36.24 66.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.556 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -59.32 -43.46 92.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.158 -0.963 . . . . 0.0 109.207 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.821 ' O ' HD11 ' A' ' 8' ' ' ILE . 13.4 mt -57.75 -30.46 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.673 ' HG3' HG11 ' A' ' 51' ' ' VAL . 14.5 tttt -65.29 -45.09 85.82 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.595 0.712 . . . . 0.0 110.127 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 1.056 ' O ' HG23 ' A' ' 45' ' ' THR . 10.1 m-80 -71.27 -49.31 44.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.59 -0.694 . . . . 0.0 111.905 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.608 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.16 -51.07 70.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.792 -1.192 . . . . 0.0 110.946 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.792 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -59.45 -40.92 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.84 -1.162 . . . . 0.0 110.249 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -65.6 -29.56 70.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.181 -0.949 . . . . 0.0 110.755 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 1.056 HG23 ' O ' ' A' ' 41' ' ' ASN . 28.1 p -66.17 -47.08 75.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.081 . . . . 0.0 110.979 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.56 -56.67 3.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 111.338 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.792 ' CD2' HG22 ' A' ' 43' ' ' VAL . 8.8 m-85 -71.59 -21.19 61.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.147 -0.971 . . . . 0.0 110.694 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 31.1 mtmt 48.42 41.02 16.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 109.665 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -102.87 -161.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.721 -0.612 . . . . 0.0 109.625 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.788 ' N ' HG13 ' A' ' 49' ' ' VAL . 6.0 tmtm? -114.48 112.38 22.9 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.68 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 40' ' ' LYS . 48.8 t -77.64 119.79 27.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.79 HG21 ' N ' ' A' ' 84' ' ' ALA . 41.1 t -114.21 -14.5 10.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.487 -0.758 . . . . 0.0 110.554 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.9 OUTLIER -178.75 115.1 0.07 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.463 -0.773 . . . . 0.0 109.998 179.365 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.884 ' CG2' HG13 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -112.76 130.9 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.808 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.485 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 17.3 m120 -130.48 115.96 17.54 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.793 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.568 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.58 160.27 19.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.6 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.544 HD11 HG13 ' A' ' 59' ' ' VAL . 1.7 pp -141.71 166.64 24.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.592 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.432 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.6 OUTLIER -77.47 118.36 19.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.127 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.284 -0.885 . . . . 0.0 110.187 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.512 ' HG2' ' HB ' ' A' ' 59' ' ' VAL . 6.8 ttm180 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.264 0.554 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.613 ' HA ' HG23 ' A' ' 59' ' ' VAL . 13.7 tttt -123.06 139.21 54.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.912 . . . . 0.0 110.076 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.663 ' HE2' HG21 ' A' ' 12' ' ' VAL . 15.4 mttt -101.88 147.22 26.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.335 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.716 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -131.49 126.71 35.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.12 -0.987 . . . . 0.0 111.847 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.79 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -105.61 111.77 36.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.884 HG13 ' CG2' ' A' ' 54' ' ' VAL . 1.4 t -96.44 141.47 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.435 -0.791 . . . . 0.0 110.284 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 53' ' ' LYS . 7.5 tp60 -121.13 142.46 49.84 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.376 -0.828 . . . . 0.0 109.507 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.6 m -125.24 156.65 34.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.437 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.79 ' N ' HG21 ' A' ' 52' ' ' VAL . . . -44.19 171.87 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.798 0 CA-C-O 121.302 0.572 . . . . 0.0 110.854 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.4 Cg_endo -77.8 53.94 4.6 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 O-C-N 124.39 1.732 . . . . 0.0 110.232 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -167.42 -47.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.565 ' HB3' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -51.04 -173.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -1.155 . . . . 0.0 110.848 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 3.4 pttt 178.98 80.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.505 -0.747 . . . . 0.0 110.416 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.126 HD12 ' CD2' ' A' ' 26' ' ' TYR . 5.2 mt -47.69 109.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.736 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 4.7 mm-40 -67.43 -14.64 63.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 0.0 110.74 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.728 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -57.47 -36.8 71.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.201 -0.937 . . . . 0.0 110.84 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.861 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.99 -23.55 12.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.009 -1.057 . . . . 0.0 110.107 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.0 mm-40 -60.63 -31.9 71.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -0.903 . . . . 0.0 110.239 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.35 -12.8 40.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -80.4 -10.66 59.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.208 -1.172 . . . . 0.0 110.203 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.74 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.03 -0.985 . . . . 0.0 110.216 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.698 ' C ' HG23 ' A' ' 30' ' ' VAL . 3.0 t . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.897 HD11 ' HA ' ' A' ' 39' ' ' ILE . 2.7 mt -57.55 152.0 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.16 -0.962 . . . . 0.0 110.315 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 29' ' ' TRP . 2.2 mt -132.87 -99.34 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.479 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.58 153.66 42.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.02 . . . . 0.0 110.504 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.616 ' HG3' HD22 ' A' ' 92' ' ' LEU . 47.7 Cg_endo -74.94 161.53 38.76 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.07 1.563 . . . . 0.0 110.354 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.78 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.7 m -104.86 143.02 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.226 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.718 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.41 106.89 17.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -154.78 142.11 19.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.997 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 9.7 tm-20 -42.52 -52.65 4.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.895 . . . . 0.0 110.145 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -54.72 -42.02 71.02 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.107 -0.996 . . . . 0.0 110.094 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.54 ' N ' ' CG ' ' A' ' 16' ' ' LYS . . . -65.97 -63.24 1.13 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.34 -0.85 . . . . 0.0 110.028 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.541 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 1.6 m-85 -48.8 -30.66 5.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 110.302 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.21 -9.2 55.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.48 -38.39 1.78 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -73.61 -23.47 59.91 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.533 -0.98 . . . . 0.0 108.974 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -51.39 -21.09 2.06 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.628 -0.67 . . . . 0.0 110.064 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.36 16.37 13.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.266 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.73 2.36 65.08 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.582 ' HB3' HG23 ' A' ' 80' ' ' ILE . 77.0 mttt -82.26 142.53 32.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -1.14 . . . . 0.0 109.544 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 1.107 ' CD2' HD12 ' A' ' 89' ' ' ILE . 19.9 m-85 -127.7 104.23 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.751 -1.218 . . . . 0.0 112.073 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.86 HG23 HD11 ' A' ' 80' ' ' ILE . 2.8 m -76.01 124.54 27.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.801 ' CB ' HG23 ' A' ' 8' ' ' ILE . 14.9 m-85 -124.72 164.92 18.91 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.525 -0.734 . . . . 0.0 110.989 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.78 ' NE1' HG12 ' A' ' 12' ' ' VAL . 33.4 m95 -102.88 122.24 44.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.698 HG23 ' C ' ' A' ' 7' ' ' VAL . 5.2 p -144.49 165.49 12.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.496 -1.282 . . . . 0.0 111.81 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.479 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -60.81 148.53 82.65 Favored Pre-proline 0 C--N 1.297 -1.678 0 O-C-N 121.927 -0.483 . . . . 0.0 110.495 -179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.9 Cg_endo -72.39 71.05 3.14 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.15 1.605 . . . . 0.0 109.915 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.538 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.18 -33.85 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.947 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -50.3 90.63 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.412 -0.805 . . . . 0.0 109.98 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -48.41 176.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.546 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -69.01 -28.84 66.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 110.185 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.2 m -75.06 -52.25 11.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.872 . . . . 0.0 110.583 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.722 ' H ' HG23 ' A' ' 35' ' ' THR . 89.4 mt-10 -55.1 -42.82 73.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.919 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.897 ' HA ' HD11 ' A' ' 8' ' ' ILE . 26.7 mt -57.07 -30.69 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.163 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.62 ' HG3' HG11 ' A' ' 51' ' ' VAL . 10.1 tttp -62.87 -47.29 83.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.867 . . . . 0.0 111.322 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -62.39 -35.06 78.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.452 -0.78 . . . . 0.0 112.695 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.661 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -69.85 -50.26 44.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.484 -1.385 . . . . 0.0 111.896 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.59 HG13 HD13 ' A' ' 8' ' ' ILE . 14.4 m -69.87 -32.14 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.575 -1.328 . . . . 0.0 110.787 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -60.33 -52.68 64.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.989 -1.069 . . . . 0.0 109.91 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -79.84 -24.43 41.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 110.251 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -84.8 -64.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.877 . . . . 0.0 110.505 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.515 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 11.3 m-85 -71.69 -21.22 61.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 109.991 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER 66.48 44.12 2.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.377 -0.827 . . . . 0.0 110.335 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.796 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -125.77 -162.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.585 -0.697 . . . . 0.0 109.858 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.796 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -115.01 114.74 25.8 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 109.811 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.62 HG11 ' HG3' ' A' ' 40' ' ' LYS . 11.7 t -77.95 119.76 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.266 -0.896 . . . . 0.0 109.236 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.795 HG21 ' N ' ' A' ' 84' ' ' ALA . 25.5 t -114.01 -14.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.521 -0.737 . . . . 0.0 110.721 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.15 115.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -0.792 . . . . 0.0 110.091 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.052 HG22 HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.03 116.77 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.653 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.504 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -116.43 116.26 27.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.377 -0.827 . . . . 0.0 109.679 179.361 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -115.92 155.26 28.3 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.89 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.803 HD11 ' HD2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -144.89 161.02 40.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 109.922 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.35 124.36 29.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.0 110.408 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.903 HG11 ' CE ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.592 -0.692 . . . . 0.0 110.005 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.214 0.531 . . . . 0.0 110.365 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.538 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 0.3 OUTLIER -124.06 141.96 51.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 110.155 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.903 ' CE ' HG11 ' A' ' 59' ' ' VAL . 1.9 ptpt -100.96 150.2 23.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.004 -1.06 . . . . 0.0 109.518 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.735 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -117.95 128.63 54.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.147 -0.971 . . . . 0.0 112.124 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.86 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -105.57 111.74 36.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.413 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.052 HG22 HG22 ' A' ' 54' ' ' VAL . 13.5 t -102.83 137.62 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.48 -0.763 . . . . 0.0 110.724 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 39.1 tp60 -117.93 153.47 33.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.866 . . . . 0.0 109.831 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 84' ' ' ALA . 2.4 m -125.34 157.11 34.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.697 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -45.47 177.2 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.686 0 CA-C-O 121.275 0.559 . . . . 0.0 110.926 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.8 Cg_endo -73.48 140.53 30.16 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.25 1.658 . . . . 0.0 110.299 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.27 -21.71 19.48 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.511 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 49.1 mt-30 -89.28 167.22 13.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -1.16 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.533 ' HA ' ' OH ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER 179.67 99.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 110.522 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.107 HD12 ' CD2' ' A' ' 26' ' ' TYR . 24.5 mt -44.12 104.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 109.623 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 15.4 mm-40 -56.34 -13.97 2.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.455 -0.778 . . . . 0.0 111.677 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.723 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.0 -36.46 65.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.861 -1.149 . . . . 0.0 110.732 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.817 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.56 -23.33 12.5 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.046 -1.034 . . . . 0.0 109.827 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 15.3 mm-40 -49.99 -44.6 51.09 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.444 -0.785 . . . . 0.0 110.555 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.59 1.57 58.5 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 95' ' ' LEU . 15.9 tp -77.52 3.06 14.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -1.172 . . . . 0.0 110.196 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.299 -179.964 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.017 HG12 HG13 ' A' ' 8' ' ' ILE . 62.0 t . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 120.93 0.395 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.017 HG13 HG12 ' A' ' 7' ' ' VAL . 37.3 mt -88.25 104.15 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.852 -1.155 . . . . 0.0 110.925 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 mt -70.39 -98.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.855 . . . . 0.0 110.352 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.46 159.26 31.43 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.024 -1.048 . . . . 0.0 110.467 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 48.3 Cg_endo -75.0 171.09 19.01 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.088 1.572 . . . . 0.0 110.5 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.045 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.19 132.85 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.917 . . . . 0.0 110.315 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.683 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.1 mm? -103.23 106.65 17.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.131 -0.98 . . . . 0.0 110.114 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.438 ' OG ' ' C ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -165.72 140.82 4.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.938 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -43.03 -41.03 3.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.121 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -54.64 -24.55 22.08 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.247 -0.908 . . . . 0.0 110.145 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -100.74 -51.4 3.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.547 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.5 m-85 -54.77 -47.33 74.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.71 -9.41 43.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.88 . . . . 0.0 109.012 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 21' ' ' PHE . . . -98.29 -41.27 3.26 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.864 -2.495 . . . . 0.0 106.864 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.631 ' CE1' ' HA ' ' A' ' 26' ' ' TYR . 4.4 m-30 -48.4 -27.36 2.56 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -37.8 -42.91 0.63 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.62 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.45 -18.25 21.69 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.384 -0.823 . . . . 0.0 110.573 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.509 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 123.01 5.15 8.24 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.498 ' HG2' ' HB2' ' A' ' 82' ' ' GLN . 23.7 mttt -82.67 127.96 33.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 109.596 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 1.064 ' CD1' HD12 ' A' ' 92' ' ' LEU . 65.9 m-85 -127.11 114.66 18.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.711 -1.243 . . . . 0.0 112.297 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 5.4 m -81.47 123.98 29.06 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.469 0.652 . . . . 0.0 110.61 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.666 ' CB ' HG23 ' A' ' 8' ' ' ILE . 61.5 m-85 -122.27 148.67 44.71 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.435 -0.79 . . . . 0.0 110.538 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 1.045 ' CD1' HG12 ' A' ' 12' ' ' VAL . 96.9 m95 -76.62 122.8 25.16 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.785 HG12 ' HA ' ' A' ' 8' ' ' ILE . 1.9 m -135.91 154.65 34.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.866 -1.146 . . . . 0.0 111.412 -177.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.517 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -52.26 130.92 42.42 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 176.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 38.8 Cg_endo -65.01 72.99 0.23 Allowed 'Trans proline' 0 C--N 1.294 -2.315 0 O-C-N 123.443 1.233 . . . . 0.0 109.361 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 31' ' ' HIS . 0.1 OUTLIER 179.68 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.997 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.75 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.387 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -38.36 128.11 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.499 -0.751 . . . . 0.0 110.81 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.567 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 1.5 mttt -41.96 -31.79 0.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.417 -0.802 . . . . 0.0 109.674 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.0 m -72.97 -51.06 19.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.84 . . . . 0.0 109.473 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 4.2 mt-10 -55.43 -38.94 69.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.162 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.918 HG23 HD11 ' A' ' 8' ' ' ILE . 38.6 mt -58.08 -30.68 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -0.847 . . . . 0.0 108.969 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.522 ' O ' HG21 ' A' ' 51' ' ' VAL . 3.5 tttm -62.04 -47.51 84.43 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.716 0.769 . . . . 0.0 110.083 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.658 ' O ' HG23 ' A' ' 45' ' ' THR . 45.9 m-80 -72.42 -33.93 67.47 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.693 -0.629 . . . . 0.0 111.052 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.862 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.24 -50.89 71.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.861 -1.149 . . . . 0.0 110.643 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.802 HG21 HG11 ' A' ' 81' ' ' VAL . 1.1 m -64.72 -33.26 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.517 -1.364 . . . . 0.0 109.783 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -58.48 -29.05 65.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.848 . . . . 0.0 110.326 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 41' ' ' ASN . 1.3 p -77.99 -48.94 15.06 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.109 -0.994 . . . . 0.0 110.346 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . -82.94 -56.24 3.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.543 -0.723 . . . . 0.0 110.907 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.526 ' CE1' HD21 ' A' ' 92' ' ' LEU . 14.3 m-85 -71.41 -11.34 60.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.124 -0.985 . . . . 0.0 110.092 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 21.9 mtpt 41.7 47.86 3.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.434 -0.791 . . . . 0.0 110.17 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.766 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -122.01 -164.25 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.52 -0.738 . . . . 0.0 109.987 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.766 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -116.64 109.94 17.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.415 -0.803 . . . . 0.0 109.636 179.171 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.82 HG13 ' CG1' ' A' ' 81' ' ' VAL . 61.0 t -78.23 148.13 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.196 -0.94 . . . . 0.0 109.974 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.1 p -139.46 9.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 110.082 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.08 117.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 109.948 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.062 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.24 117.26 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 110.116 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.567 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 20.2 m-20 -115.96 115.67 26.58 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.355 -0.841 . . . . 0.0 109.428 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -114.63 167.05 11.09 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 110.024 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 58' ' ' HIS . 2.0 pp -158.77 160.63 36.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.489 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.466 ' O ' HD12 ' A' ' 57' ' ' LEU . 1.5 t-80 -75.51 130.85 39.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.063 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.726 HG21 ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.452 -0.78 . . . . 0.0 110.486 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.71 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.6 mpt_? . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.171 0.51 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.713 ' NZ ' HD11 ' A' ' 39' ' ' ILE . 29.1 tttt -123.06 128.12 49.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.118 -0.989 . . . . 0.0 110.62 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.91 ' HD2' HG11 ' A' ' 12' ' ' VAL . 13.4 mtmt -101.34 148.25 25.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.376 -0.827 . . . . 0.0 108.99 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.66 118.96 25.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.97 -1.081 . . . . 0.0 112.007 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 17.5 mt -97.15 110.53 25.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.812 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.062 HG22 ' CG2' ' A' ' 54' ' ' VAL . 21.9 t -105.99 133.07 51.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.759 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.617 ' O ' HG12 ' A' ' 52' ' ' VAL . 42.0 tp60 -111.25 153.46 25.84 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.922 -1.111 . . . . 0.0 109.103 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.7 m -114.66 155.76 15.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 118.179 -1.408 . . . . 0.0 109.611 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.938 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -49.92 178.93 0.03 OUTLIER Pre-proline 0 C--N 1.289 -2.023 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.353 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.938 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -72.45 142.39 36.72 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.244 1.655 . . . . 0.0 110.546 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.37 -36.83 3.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 11.7 mt-30 -80.53 173.03 13.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.136 . . . . 0.0 110.618 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 179.63 93.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -0.793 . . . . 0.0 110.216 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.716 HD12 ' CD2' ' A' ' 26' ' ' TYR . 14.8 mt -43.09 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -0.971 . . . . 0.0 110.026 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.483 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 2.9 mt-10 -75.17 -14.19 60.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 0.0 110.744 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.752 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.11 -24.03 23.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.096 -1.002 . . . . 0.0 110.506 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.064 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -105.86 -23.2 12.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.11 -0.994 . . . . 0.0 109.592 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 40.0 mm-40 -60.66 -23.17 64.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.399 -0.813 . . . . 0.0 110.196 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.97 -19.47 8.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 95' ' ' LEU . 14.4 tp -50.47 -21.05 1.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -1.123 . . . . 0.0 110.13 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.547 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 43.8 mt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.141 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.922 HG12 HG13 ' A' ' 8' ' ' ILE . 84.6 t . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.951 0.405 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.922 HG13 HG12 ' A' ' 7' ' ' VAL . 9.8 mt -84.22 88.65 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 0.0 111.143 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.97 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.408 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.51 164.78 13.99 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.574 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.3 Cg_endo -80.22 155.04 22.21 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.013 1.533 . . . . 0.0 110.261 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.72 HG11 HG22 ' A' ' 27' ' ' THR . 1.8 p -115.24 112.54 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.085 -1.009 . . . . 0.0 110.32 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.774 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.55 110.72 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.923 . . . . 0.0 110.391 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.812 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -144.71 162.46 36.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.981 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' SER . 52.9 mt-10 -42.79 -65.32 0.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -14.61 32.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 110.344 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.812 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -100.51 23.74 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 110.418 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -134.36 -49.67 0.79 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.075 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.75 -35.29 80.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.102 -0.999 . . . . 0.0 109.324 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -88.76 -34.4 9.15 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.596 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -72.47 -8.69 56.38 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.328 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -78.2 -16.59 57.72 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.54 -0.725 . . . . 0.0 110.813 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 2.0 mm-40 -88.74 17.36 5.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.527 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.577 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 101.56 -3.35 53.57 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 28.3 mttt -82.44 137.04 34.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.603 -0.94 . . . . 0.0 109.516 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.647 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 99.3 m-85 -127.15 112.21 14.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.708 -1.245 . . . . 0.0 111.435 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.033 HG23 HD11 ' A' ' 80' ' ' ILE . 3.9 m -82.38 127.96 33.76 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.059 ' CE2' HG11 ' A' ' 43' ' ' VAL . 22.7 m-85 -123.08 147.43 46.74 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.163 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.604 ' CZ3' ' CG ' ' A' ' 76' ' ' ARG . 3.9 m95 -84.35 122.6 29.16 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 8' ' ' ILE . 1.5 m -138.51 164.07 27.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 118.207 -1.397 . . . . 0.0 112.043 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 33' ' ' LYS . 2.4 t-80 -61.64 134.36 93.76 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.448 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 38.3 Cg_endo -64.2 75.9 0.18 Allowed 'Trans proline' 0 C--N 1.293 -2.359 0 O-C-N 123.22 1.116 . . . . 0.0 109.398 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.551 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.47 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.829 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -38.46 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.821 -0.55 . . . . 0.0 109.84 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -46.76 140.58 4.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.108 -0.995 . . . . 0.0 110.76 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.502 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 8.6 mttt -43.42 -45.36 6.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.308 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 3.4 m -61.01 -48.53 81.37 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 109.296 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 2.1 mt-10 -58.43 -44.51 89.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.358 -0.839 . . . . 0.0 109.356 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.767 ' O ' HG22 ' A' ' 43' ' ' VAL . 15.3 mt -57.3 -30.71 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 54.9 tttt -66.55 -47.6 72.32 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.425 -0.797 . . . . 0.0 109.366 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.971 ' O ' HG23 ' A' ' 45' ' ' THR . 72.2 m-20 -73.65 -34.38 64.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.625 -0.672 . . . . 0.0 110.8 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . . . -57.96 -50.49 73.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.84 -1.163 . . . . 0.0 110.365 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.059 HG11 ' CE2' ' A' ' 28' ' ' PHE . 3.2 m -73.47 -36.33 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.837 -1.164 . . . . 0.0 110.022 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -58.0 -34.71 70.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.088 -1.008 . . . . 0.0 109.48 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.971 HG23 ' O ' ' A' ' 41' ' ' ASN . 39.9 p -79.3 -45.06 20.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.511 -0.743 . . . . 0.0 110.078 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.46 -56.83 3.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.384 -0.822 . . . . 0.0 111.018 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CG ' HD13 ' A' ' 89' ' ' ILE . 6.4 m-85 -71.49 -21.39 61.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.018 -1.051 . . . . 0.0 110.245 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.95 44.45 19.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 110.38 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.786 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -123.55 -164.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.515 -0.74 . . . . 0.0 109.791 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.786 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.23 107.3 15.1 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 109.489 179.043 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.859 HG13 HG13 ' A' ' 81' ' ' VAL . 75.6 t -78.07 119.4 26.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.214 -0.929 . . . . 0.0 110.026 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.658 HG12 ' C ' ' A' ' 82' ' ' GLN . 7.1 p -103.43 -0.21 10.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 110.086 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.555 ' CG ' ' HB3' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 178.91 141.58 0.11 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.82 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.08 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -134.3 127.73 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.073 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.502 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 47.0 t30 -131.27 115.1 15.86 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.406 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.32 149.23 39.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.63 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -130.68 170.98 13.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 110.665 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.23 115.56 19.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 110.007 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.54 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.349 -0.845 . . . . 0.0 110.042 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.604 ' CG ' ' CZ3' ' A' ' 29' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.176 0.512 . . . . 0.0 109.646 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.54 ' HA ' HG23 ' A' ' 59' ' ' VAL . 4.3 tttp -123.06 140.84 52.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.144 -0.972 . . . . 0.0 110.753 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.556 ' HD2' ' CG2' ' A' ' 27' ' ' THR . 0.4 OUTLIER -106.96 143.33 35.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.427 -0.796 . . . . 0.0 109.646 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.656 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -133.69 118.96 18.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.083 -1.011 . . . . 0.0 111.247 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.033 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -100.83 111.85 31.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.523 0.678 . . . . 0.0 109.911 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.08 HG22 ' CG2' ' A' ' 54' ' ' VAL . 35.1 t -109.1 136.09 46.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 110.265 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.658 ' C ' HG12 ' A' ' 52' ' ' VAL . 6.6 tp60 -110.33 153.44 24.9 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.102 -0.999 . . . . 0.0 109.0 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.476 HG21 ' C ' ' A' ' 87' ' ' GLN . 2.3 m -116.18 155.44 17.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.832 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.975 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -50.09 179.26 0.03 OUTLIER Pre-proline 0 C--N 1.288 -2.066 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.617 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.975 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 41.5 Cg_endo -71.5 141.31 38.13 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.366 1.719 . . . . 0.0 110.499 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.6 -25.48 11.13 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.525 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 60.3 mt-30 -94.05 163.77 13.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -1.164 . . . . 0.0 110.689 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER 179.51 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.457 -0.777 . . . . 0.0 110.113 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.635 HD13 ' CG ' ' A' ' 47' ' ' PHE . 9.4 mt -44.28 95.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.953 . . . . 0.0 109.596 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.548 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -68.53 -13.27 62.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.439 -0.788 . . . . 0.0 111.155 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.731 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.44 -35.08 62.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.087 -1.008 . . . . 0.0 110.969 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -106.89 -23.67 12.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.889 -1.132 . . . . 0.0 110.773 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.548 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 1.9 pp20? -51.1 -22.93 2.73 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.038 -1.039 . . . . 0.0 110.234 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -99.08 -23.77 11.11 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.636 HD23 ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -42.75 -29.58 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -1.128 . . . . 0.0 110.147 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.566 HG13 ' CE1' ' A' ' 18' ' ' TYR . 2.6 mp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.882 HG12 HG13 ' A' ' 8' ' ' ILE . 99.1 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.252 0.549 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.882 HG13 HG12 ' A' ' 7' ' ' VAL . 3.6 mt -86.1 90.55 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.846 -1.159 . . . . 0.0 111.26 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -97.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.811 . . . . 0.0 110.198 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -108.38 162.36 20.21 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.998 . . . . 0.0 110.242 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 46.8 Cg_endo -73.96 163.5 36.73 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.994 1.523 . . . . 0.0 110.388 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.157 HG12 ' CD1' ' A' ' 29' ' ' TRP . 2.4 m -115.13 139.4 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.942 . . . . 0.0 110.317 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.67 111.48 23.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -0.958 . . . . 0.0 110.042 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 15' ' ' GLU . 54.3 m -145.66 139.56 26.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 110.183 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 8.7 tm-20 -42.79 -58.71 2.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 110.176 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -42.26 71.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.264 -0.897 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -58.93 -66.0 0.57 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.699 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.6 m-85 -44.92 -31.08 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 110.58 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.77 -8.77 48.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -110.98 -31.97 2.75 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -76.08 -17.22 59.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.686 -0.891 . . . . 0.0 108.92 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.615 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -57.0 -21.31 29.72 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.791 -0.568 . . . . 0.0 110.725 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -88.99 17.08 6.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.51 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.11 0.18 66.0 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 1.7 mttp -82.36 137.21 34.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -1.015 . . . . 0.0 109.064 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 1.006 ' CD1' HD12 ' A' ' 92' ' ' LEU . 27.6 m-85 -128.86 105.52 8.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.34 -1.475 . . . . 0.0 112.244 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 4.3 m -74.88 141.02 44.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.445 0.641 . . . . 0.0 109.37 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.735 ' CB ' HG23 ' A' ' 8' ' ' ILE . 21.7 m-85 -133.3 166.18 23.09 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.434 -0.791 . . . . 0.0 110.032 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 1.157 ' CD1' HG12 ' A' ' 12' ' ' VAL . 14.0 m95 -98.28 122.96 42.08 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.0 p -143.9 160.39 16.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 C-N-CA 117.792 -1.563 . . . . 0.0 112.768 -176.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -62.2 151.99 79.86 Favored Pre-proline 0 C--N 1.3 -1.572 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.69 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.9 Cg_endo -73.06 69.54 3.85 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.082 1.569 . . . . 0.0 109.647 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.2 OUTLIER 179.72 -34.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.399 -0.813 . . . . 0.0 110.017 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.874 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -43.75 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.381 -0.825 . . . . 0.0 109.603 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -41.55 136.04 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.535 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.793 ' HA ' HD12 ' A' ' 39' ' ' ILE . 7.5 mttt -43.74 -41.34 4.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 109.385 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.5 m -67.66 -40.26 84.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.267 -0.896 . . . . 0.0 108.997 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.517 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 5.1 mt-10 -55.79 -39.46 71.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.899 . . . . 0.0 108.763 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.797 HG21 ' HB1' ' A' ' 79' ' ' ALA . 32.3 mt -57.75 -34.66 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.6 ttmt -57.99 -47.91 81.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.37 -0.831 . . . . 0.0 109.945 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -73.79 -34.82 64.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.696 -0.627 . . . . 0.0 111.345 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.614 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . . . -58.77 -50.5 73.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.824 -1.173 . . . . 0.0 110.672 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.727 HG13 ' CD1' ' A' ' 8' ' ' ILE . 2.6 m -65.02 -33.21 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.774 -1.204 . . . . 0.0 109.811 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -60.65 -44.29 96.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 0.0 109.204 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.06 -15.28 58.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.0 109.323 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -102.66 -68.79 0.81 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.406 -0.809 . . . . 0.0 110.459 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD2' HG12 ' A' ' 43' ' ' VAL . 29.9 m-85 -74.08 -21.56 59.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 4.3 tttp 65.15 47.21 2.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 110.107 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.771 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -125.29 -162.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.498 -0.752 . . . . 0.0 110.413 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.771 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -118.29 114.58 23.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.473 -0.767 . . . . 0.0 109.788 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.059 HG13 HG13 ' A' ' 81' ' ' VAL . 90.4 t -78.94 123.31 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.0 110.435 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.682 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.4 p -114.93 9.94 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.924 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.55 120.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.402 -0.811 . . . . 0.0 109.902 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.15 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.12 125.51 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.196 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.554 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -125.12 115.6 20.72 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.224 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.548 ' CG2' ' HG2' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -119.2 150.46 40.04 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.902 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.538 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 3.3 pp -146.86 145.38 29.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.408 -0.807 . . . . 0.0 110.054 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.14 132.49 44.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.357 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.366 -0.834 . . . . 0.0 110.106 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.579 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 1.8 tpt180 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.214 0.53 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -110.03 129.41 55.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 10.4 ptpt -114.65 151.51 33.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.996 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.797 ' HB1' HG21 ' A' ' 39' ' ' ILE . . . -122.23 125.71 46.64 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.0 112.585 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 22.7 mt -104.22 110.93 31.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.452 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.15 HG22 ' CG2' ' A' ' 54' ' ' VAL . 97.9 t -104.26 134.55 45.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 110.346 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.682 ' C ' HG12 ' A' ' 52' ' ' VAL . 3.8 tp60 -102.51 150.71 23.12 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.171 -0.956 . . . . 0.0 108.704 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.515 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.4 m -115.33 156.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 118.069 -1.452 . . . . 0.0 109.754 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.92 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -67.65 -179.71 0.49 Allowed Pre-proline 0 C--N 1.288 -2.104 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.163 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.92 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.0 Cg_endo -73.2 139.53 29.52 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 O-C-N 124.264 1.665 . . . . 0.0 110.195 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.503 ' O ' ' CE ' ' A' ' 88' ' ' LYS . . . 109.09 -48.31 0.95 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.819 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -94.07 176.87 6.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.16 -1.2 . . . . 0.0 110.672 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 86' ' ' GLY . 0.4 OUTLIER 179.56 100.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -0.772 . . . . 0.0 110.088 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.925 HD12 ' CD2' ' A' ' 26' ' ' TYR . 10.4 mt -44.19 108.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 110.05 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 10.0 mm-40 -75.75 -13.65 60.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -0.803 . . . . 0.0 110.799 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.864 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.82 -31.38 59.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.0 110.577 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.006 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.31 -23.04 12.66 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.19 -0.944 . . . . 0.0 109.715 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 36.1 mm-40 -50.84 -35.25 31.51 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 110.382 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -94.78 -24.22 18.41 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.864 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.3 mp -43.0 -27.22 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -1.181 . . . . 0.0 110.173 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.54 ' OXT' HG22 ' A' ' 96' ' ' ILE . 22.8 mm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.18 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.852 ' O ' HD23 ' A' ' 9' ' ' LEU . 3.3 t . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.884 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.8 mt -57.04 120.33 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.157 -0.965 . . . . 0.0 110.121 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -111.65 -89.59 0.51 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.175 -0.953 . . . . 0.0 110.297 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.25 142.42 24.55 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.095 -1.003 . . . . 0.0 110.212 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.593 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 47.5 Cg_endo -73.69 175.73 10.33 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.058 1.557 . . . . 0.0 110.506 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.156 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.08 133.15 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.926 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.738 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.98 110.23 22.07 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.152 -0.968 . . . . 0.0 110.293 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 71.7 m -166.07 138.39 3.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 110.008 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 14' ' ' SER . 13.2 mt-10 -43.41 -46.36 6.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 110.064 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.72 -18.05 4.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.574 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -101.62 -49.81 3.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.752 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.985 ' CE1' HD11 ' A' ' 96' ' ' ILE . 2.4 m-85 -58.64 -44.74 90.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.496 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -12.61 38.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 108.876 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' N ' ' A' ' 22' ' ' ALA . . . -98.95 -39.59 3.53 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 3.6 m-30 -49.96 -25.43 3.28 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 20' ' ' GLY . . . -40.21 -31.68 0.14 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.724 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.526 ' HG2' HE22 ' A' ' 82' ' ' GLN . 3.6 tp10 -104.05 -1.26 27.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.771 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.543 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 103.52 9.1 39.11 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 15.4 mttt -82.58 131.54 35.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -1.133 . . . . 0.0 109.668 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.906 ' CD1' HD12 ' A' ' 92' ' ' LEU . 70.1 m-85 -126.86 108.09 10.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.887 -1.133 . . . . 0.0 112.003 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 27.1 m -75.85 121.9 23.3 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.74 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -116.4 164.03 15.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 110.618 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 1.156 ' CD1' HG12 ' A' ' 12' ' ' VAL . 68.1 m95 -97.5 123.22 41.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.802 ' HA ' HD21 ' A' ' 9' ' ' LEU . 2.6 p -151.4 164.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 C-N-CA 117.827 -1.549 . . . . 0.0 111.997 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.481 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -51.01 140.46 20.89 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.207 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.4 Cg_endo -72.17 76.57 2.14 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.06 1.558 . . . . 0.0 110.059 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 179.03 -33.81 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.418 -0.801 . . . . 0.0 110.03 -178.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.676 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -48.43 107.5 0.13 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 110.194 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -59.45 147.51 36.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -0.927 . . . . 0.0 110.012 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.542 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 21.8 mttt -46.56 -34.4 4.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 110.102 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.3 m -75.18 -51.19 13.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 110.447 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 1.8 mt-10 -55.19 -42.82 73.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.779 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.764 HG23 HD11 ' A' ' 8' ' ' ILE . 20.9 mt -57.19 -30.59 35.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.656 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.2 ttpm? -62.71 -46.35 88.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 111.046 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.405 ' O ' HG23 ' A' ' 45' ' ' THR . 13.5 m-80 -58.97 -34.89 72.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.421 -0.799 . . . . 0.0 112.336 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.884 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -72.43 -49.27 34.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.666 -1.271 . . . . 0.0 111.652 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -69.52 -37.63 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.888 -1.133 . . . . 0.0 110.84 -178.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.68 -44.12 81.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.072 -1.017 . . . . 0.0 110.424 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 41' ' ' ASN . 34.0 p -78.99 -46.19 18.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 110.295 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.68 -55.93 22.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.311 -0.868 . . . . 0.0 110.554 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.67 ' CD1' HG22 ' A' ' 43' ' ' VAL . 70.6 m-85 -83.2 3.02 32.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.112 -0.992 . . . . 0.0 110.333 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 4.5 pttm 38.23 42.57 0.51 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.735 0.779 . . . . 0.0 110.326 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.773 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -115.39 -165.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.599 -0.688 . . . . 0.0 109.792 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.773 ' N ' HG13 ' A' ' 49' ' ' VAL . 2.8 tmtm? -118.27 103.16 9.56 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.443 -0.785 . . . . 0.0 109.831 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.656 HG11 ' HG3' ' A' ' 40' ' ' LYS . 97.7 t -78.37 119.63 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.36 -0.838 . . . . 0.0 109.69 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.3 p -101.02 -5.61 9.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -0.903 . . . . 0.0 110.381 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER 176.08 119.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.344 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.937 HG23 HG13 ' A' ' 81' ' ' VAL . 1.1 t -109.56 124.51 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 109.743 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.542 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 12.9 m120 -122.83 116.32 23.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.219 -0.926 . . . . 0.0 109.818 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.543 ' OG1' ' CE ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -110.17 155.43 21.98 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.36 -0.837 . . . . 0.0 110.185 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.584 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -138.58 156.96 47.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.778 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.32 122.91 25.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.463 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.593 HG21 ' HG3' ' A' ' 78' ' ' LYS . 4.3 m . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.701 -0.625 . . . . 0.0 110.21 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.538 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.098 0.475 . . . . 0.0 110.116 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.543 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 0.1 OUTLIER -121.92 142.14 50.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 0.0 110.379 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.842 ' HD3' HG11 ' A' ' 12' ' ' VAL . 1.8 mttt -100.91 151.22 22.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 109.718 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -119.55 119.24 33.22 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.985 -1.072 . . . . 0.0 111.944 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 9.1 mt -95.95 110.87 25.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 109.527 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 43' ' ' VAL . 2.9 t -99.8 125.95 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.14 -0.975 . . . . 0.0 110.263 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.68 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -106.75 143.15 35.27 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.011 -1.056 . . . . 0.0 108.932 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.47 ' CA ' HG12 ' A' ' 52' ' ' VAL . 1.3 m -115.0 156.84 15.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.442 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.853 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -68.18 177.17 1.1 Allowed Pre-proline 0 C--N 1.29 -1.999 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.671 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.853 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -73.49 141.91 32.2 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.348 1.709 . . . . 0.0 110.36 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.97 -26.74 14.52 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -113.72 177.68 4.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -1.132 . . . . 0.0 110.305 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.6 OUTLIER 179.71 122.68 0.06 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -0.933 . . . . 0.0 110.373 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.684 HG22 ' HG ' ' A' ' 92' ' ' LEU . 12.5 mt -73.6 93.94 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 110.101 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 20.0 pt-20 -72.55 -14.66 61.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.855 . . . . 0.0 110.409 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.756 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.7 -23.82 30.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.892 . . . . 0.0 110.495 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.906 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.22 -23.01 12.69 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.174 -0.954 . . . . 0.0 109.713 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.3 mm-40 -61.34 -31.06 70.92 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.359 -0.838 . . . . 0.0 110.369 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.68 -6.22 56.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.1 tp -61.86 -12.07 15.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.167 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.985 HD11 ' CE1' ' A' ' 18' ' ' TYR . 2.9 mp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.15 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.975 HG13 ' HB1' ' A' ' 34' ' ' ALA . 46.4 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.807 0.813 . . . . 0.0 109.075 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.861 HG23 ' HB3' ' A' ' 28' ' ' PHE . 6.4 mt -110.59 67.77 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 121.232 -0.918 . . . . 0.0 109.932 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 mt -54.28 -94.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.806 . . . . 0.0 110.742 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.17 150.45 36.73 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 110.61 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.22 162.02 37.22 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.121 1.59 . . . . 0.0 110.276 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.724 HG13 ' HB ' ' A' ' 27' ' ' THR . 1.1 p -115.35 110.33 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.287 -0.883 . . . . 0.0 110.027 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.818 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.12 106.92 17.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.245 -0.909 . . . . 0.0 110.234 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.651 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -137.76 174.58 10.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 110.253 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -55.7 -65.58 0.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.317 -0.865 . . . . 0.0 110.243 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -54.69 -34.79 62.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.169 -0.957 . . . . 0.0 110.302 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.651 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -71.98 -49.52 36.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.156 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 13' ' ' LEU . 1.3 m-85 -58.07 -31.53 67.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.39 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.46 -8.52 50.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 110.177 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -107.63 -35.41 2.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.401 -1.879 . . . . 0.0 108.401 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -76.02 -16.6 59.93 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.63 -0.924 . . . . 0.0 109.118 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.622 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -59.09 -20.29 52.09 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.442 0.639 . . . . 0.0 110.75 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -88.86 17.27 5.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.395 -0.816 . . . . 0.0 110.434 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.29 -0.25 65.95 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 19.7 mttt -82.4 142.71 31.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.572 -0.958 . . . . 0.0 109.395 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.954 ' CD1' HD12 ' A' ' 92' ' ' LEU . 22.9 m-85 -128.29 110.65 12.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.676 -1.265 . . . . 0.0 111.368 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.992 HG23 HD11 ' A' ' 80' ' ' ILE . 3.0 m -81.55 131.18 35.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.478 0.656 . . . . 0.0 109.277 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.041 ' CE2' HG11 ' A' ' 43' ' ' VAL . 23.3 m-85 -124.65 165.06 18.57 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.488 -0.758 . . . . 0.0 110.672 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.637 ' CE3' ' CG ' ' A' ' 76' ' ' ARG . 3.1 m95 -103.12 122.29 44.38 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.6 p -139.42 161.57 27.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 C-N-CA 118.025 -1.47 . . . . 0.0 112.327 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.593 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -74.03 150.26 87.87 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.259 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 44.0 Cg_endo -70.31 67.14 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.986 1.519 . . . . 0.0 109.729 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.88 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.577 -0.702 . . . . 0.0 109.575 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.975 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -43.98 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.338 -0.851 . . . . 0.0 109.306 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -38.0 130.86 1.13 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.496 -0.752 . . . . 0.0 110.964 -179.127 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.834 ' HA ' HD12 ' A' ' 39' ' ' ILE . 1.5 mttt -42.84 -43.31 3.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 109.619 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 4.5 m -61.79 -44.52 96.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.485 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 19.6 mm-40 -55.36 -38.83 69.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.392 -0.817 . . . . 0.0 109.422 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 36' ' ' LYS . 25.0 mt -57.38 -30.87 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.706 ' HG3' HG11 ' A' ' 51' ' ' VAL . 59.9 tttm -67.85 -47.05 70.04 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.444 -0.785 . . . . 0.0 109.582 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.476 ' O ' ' HB ' ' A' ' 45' ' ' THR . 58.0 m-80 -73.6 -34.31 65.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.604 -0.685 . . . . 0.0 111.325 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.459 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . . . -58.15 -50.56 73.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.739 -1.226 . . . . 0.0 110.454 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.041 HG11 ' CE2' ' A' ' 28' ' ' PHE . 3.6 m -68.31 -32.89 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.854 -1.154 . . . . 0.0 109.372 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CD ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.42 -42.02 79.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.12 -0.987 . . . . 0.0 108.483 178.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.9 OUTLIER -79.52 -12.8 59.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 178.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.8 -62.2 1.57 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 110.678 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 43' ' ' VAL . 24.0 m-85 -71.59 -22.48 61.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.996 -1.065 . . . . 0.0 110.071 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER 65.88 46.78 2.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.845 . . . . 0.0 110.038 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.676 HG22 ' H ' ' A' ' 50' ' ' LYS . 1.2 p -125.28 -164.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.631 -0.668 . . . . 0.0 110.412 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.676 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.3 tmtp? -118.46 106.73 13.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.451 -0.781 . . . . 0.0 109.763 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.706 HG11 ' HG3' ' A' ' 40' ' ' LYS . 40.6 t -78.8 140.54 16.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 110.542 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.669 HG12 ' C ' ' A' ' 82' ' ' GLN . 13.6 p -118.91 -6.46 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.616 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -179.18 131.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.529 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.041 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -120.26 129.47 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.918 -1.114 . . . . 0.0 110.117 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.487 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 3.8 m-80 -131.53 115.71 16.49 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.437 -0.789 . . . . 0.0 109.387 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.561 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -115.5 159.58 21.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 109.311 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.634 HD11 ' HD2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -148.33 144.71 27.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.11 -0.993 . . . . 0.0 110.968 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 103.36 2.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.858 . . . . 0.0 109.034 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.538 0 O-C-N 121.385 -0.822 . . . . 0.0 109.319 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.637 ' CG ' ' CE3' ' A' ' 29' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.397 0.618 . . . . 0.0 111.102 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 59' ' ' VAL . 4.8 ptmt -98.59 141.2 31.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.402 -0.812 . . . . 0.0 110.18 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.634 ' HD2' HD11 ' A' ' 57' ' ' LEU . 19.2 ptpt -109.3 151.41 26.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -0.936 . . . . 0.0 110.483 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.898 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -116.9 122.68 45.01 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.234 -0.916 . . . . 0.0 111.931 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.992 HD11 HG23 ' A' ' 27' ' ' THR . 1.5 mp -103.18 112.77 37.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.559 -0.713 . . . . 0.0 109.468 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.041 HG22 ' CG2' ' A' ' 54' ' ' VAL . 23.8 t -113.3 128.68 69.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.417 -0.802 . . . . 0.0 110.866 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.669 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.5 tp60 -98.82 153.36 18.83 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.193 -0.942 . . . . 0.0 108.679 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 84' ' ' ALA . 1.5 m -116.66 156.69 17.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 C-N-CA 118.264 -1.375 . . . . 0.0 108.679 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.986 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -69.27 178.79 0.85 Allowed Pre-proline 0 C--N 1.285 -2.229 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.002 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.893 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.6 138.41 26.68 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 124.243 1.654 . . . . 0.0 110.458 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.42 -30.1 8.52 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.986 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -111.69 176.9 4.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.242 . . . . 0.0 110.705 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 90' ' ' GLU . 8.2 ptpt 179.46 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.459 -0.776 . . . . 0.0 110.012 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.827 HD12 ' CD2' ' A' ' 26' ' ' TYR . 14.9 mt -45.07 95.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.002 . . . . 0.0 110.075 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 88' ' ' LYS . 1.1 pt-20 -68.13 -13.89 62.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.384 -0.823 . . . . 0.0 110.666 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.769 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.96 -28.68 53.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.125 -0.985 . . . . 0.0 110.347 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.954 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.23 -23.04 12.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.492 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 13.9 mm-40 -51.07 -31.92 20.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.436 -0.79 . . . . 0.0 110.45 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -98.02 -26.63 9.45 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.769 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.4 mp -43.56 -26.18 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.227 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.412 HG13 ' CE1' ' A' ' 18' ' ' TYR . 40.5 mt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.23 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.025 HG12 HG13 ' A' ' 8' ' ' ILE . 45.7 t . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 121.183 0.516 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.025 HG13 HG12 ' A' ' 7' ' ' VAL . 5.7 mt -86.37 100.2 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.861 -1.15 . . . . 0.0 111.109 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.496 HD21 ' HA ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -91.63 -86.01 0.23 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.226 -0.921 . . . . 0.0 111.067 179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.544 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -107.99 140.64 21.85 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.9 -1.125 . . . . 0.0 110.592 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.628 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.1 Cg_endo -72.96 170.38 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.079 1.568 . . . . 0.0 110.393 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.076 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.6 m -115.27 133.16 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.165 -0.959 . . . . 0.0 110.405 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.838 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -102.83 112.66 25.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.163 -0.961 . . . . 0.0 110.215 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 15' ' ' GLU . 40.5 m -159.69 145.62 15.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.007 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' SER . 36.5 mt-10 -42.76 -54.13 4.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 110.165 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -54.61 -28.17 44.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 0.0 110.182 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -87.05 -55.41 3.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.838 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -53.7 -26.24 21.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.02 -15.65 31.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -101.49 -36.44 3.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -77.67 -23.08 49.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.574 -0.956 . . . . 0.0 108.835 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -50.61 -20.58 1.24 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.606 -0.684 . . . . 0.0 110.338 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.3 13.63 25.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.53 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 99.94 -0.53 56.34 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 20.7 mttt -82.38 147.45 28.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -1.138 . . . . 0.0 109.396 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 1.076 ' CE2' HD12 ' A' ' 89' ' ' ILE . 22.0 m-85 -128.07 102.88 6.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.693 -1.254 . . . . 0.0 112.209 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.799 HG22 ' HD3' ' A' ' 78' ' ' LYS . 3.4 m -75.82 125.92 30.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.652 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -130.28 164.96 23.44 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.934 -1.103 . . . . 0.0 112.085 -177.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 1.076 ' CD1' HG12 ' A' ' 12' ' ' VAL . 24.9 m95 -101.33 123.31 45.22 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 7' ' ' VAL . 1.4 p -145.96 158.81 11.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 117.772 -1.571 . . . . 0.0 112.003 -176.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.593 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -59.97 151.17 66.34 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.852 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 49.0 Cg_endo -73.36 70.01 4.03 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.227 1.646 . . . . 0.0 109.763 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.57 -33.42 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 110.071 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.996 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -42.61 93.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.45 -0.781 . . . . 0.0 109.831 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -51.52 140.29 18.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 110.421 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 8.5 mttt -42.26 -43.27 3.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.88 . . . . 0.0 110.027 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -64.32 -53.36 50.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.865 . . . . 0.0 110.07 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.8 OUTLIER -55.47 -40.43 71.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.769 HG23 HD11 ' A' ' 8' ' ' ILE . 14.9 mt -57.68 -31.4 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.271 -0.893 . . . . 0.0 108.968 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 37' ' ' THR . 6.7 tttt -63.12 -42.54 99.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.371 -0.831 . . . . 0.0 109.833 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 1.045 ' O ' HG23 ' A' ' 45' ' ' THR . 44.1 m-80 -71.39 -44.89 64.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.69 -0.631 . . . . 0.0 111.836 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.856 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.78 -52.11 66.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.768 -1.208 . . . . 0.0 110.964 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.797 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -59.69 -38.64 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.547 -1.346 . . . . 0.0 109.862 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -64.37 -32.73 74.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 1.045 HG23 ' O ' ' A' ' 41' ' ' ASN . 26.7 p -62.95 -47.47 83.07 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.153 -0.967 . . . . 0.0 110.65 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.88 -52.11 5.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.222 -0.924 . . . . 0.0 110.828 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.797 ' CD2' HG22 ' A' ' 43' ' ' VAL . 78.1 m-85 -71.76 -21.39 61.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.231 -0.918 . . . . 0.0 110.499 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 14.0 mtpt 46.83 42.62 12.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.669 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.78 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.39 -162.59 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 121.398 0.618 . . . . 0.0 109.727 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.78 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.21 107.55 15.44 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.881 179.09 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.591 ' CG2' HG11 ' A' ' 43' ' ' VAL . 22.8 t -78.33 119.5 27.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.261 -0.9 . . . . 0.0 109.316 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.625 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.4 p -105.9 9.06 9.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.248 -0.908 . . . . 0.0 110.683 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.15 117.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 110.46 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.96 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -115.28 116.66 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.0 109.519 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 82.8 m-20 -118.56 115.87 25.46 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 109.409 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.545 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -115.0 162.45 16.96 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.987 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -154.79 153.01 30.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 110.469 -179.325 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.36 130.59 43.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.745 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.687 HG11 ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.29 -0.881 . . . . 0.0 110.154 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.226 0.536 . . . . 0.0 109.899 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.524 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 51.1 tttt -117.86 128.59 54.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.573 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.799 ' HD3' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -101.7 151.11 22.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.56 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.812 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -129.4 131.41 46.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.915 -1.115 . . . . 0.0 112.053 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.812 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.6 mp -110.63 111.43 36.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.96 HG13 HG23 ' A' ' 54' ' ' VAL . 2.6 t -106.16 133.92 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.505 -0.747 . . . . 0.0 110.431 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.625 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.1 tp-100 -117.14 152.77 34.04 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.005 -1.06 . . . . 0.0 108.674 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.545 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -118.79 155.76 20.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.142 -1.423 . . . . 0.0 109.711 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.778 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -50.85 174.11 0.09 OUTLIER Pre-proline 0 C--N 1.289 -2.024 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.871 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.778 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.8 Cg_endo -76.66 55.54 4.85 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.307 1.688 . . . . 0.0 110.609 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -163.81 -50.28 0.02 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.546 ' HB3' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -51.27 -172.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -1.174 . . . . 0.0 111.025 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 179.25 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.63 -0.669 . . . . 0.0 110.172 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.076 HD12 ' CE2' ' A' ' 26' ' ' TYR . 5.6 mt -68.72 109.16 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.0 110.146 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 3.3 mt-10 -78.3 -14.49 59.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.585 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.757 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -56.29 -33.04 65.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 111.137 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.757 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.11 -23.44 12.61 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.952 -1.092 . . . . 0.0 110.138 -179.473 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mm-40 -62.71 -23.02 66.94 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.179 -0.95 . . . . 0.0 110.228 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -113.51 -26.32 3.99 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.518 HD23 HD11 ' A' ' 13' ' ' LEU . 8.0 tp -42.87 -27.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -1.132 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.625 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 52.0 mt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.215 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.76 ' C ' HG23 ' A' ' 30' ' ' VAL . 3.2 t . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.234 0.54 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.088 HD13 HG13 ' A' ' 43' ' ' VAL . 4.9 mt -56.12 156.07 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 121.217 -0.927 . . . . 0.0 110.812 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.2 mt -143.52 -93.78 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 110.155 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.21 149.81 39.68 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.068 -1.02 . . . . 0.0 110.277 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.619 ' HG3' HD22 ' A' ' 92' ' ' LEU . 45.9 Cg_endo -73.33 173.57 13.54 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.1 1.579 . . . . 0.0 110.357 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.626 HG12 ' CE2' ' A' ' 29' ' ' TRP . 2.4 m -112.8 139.35 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.206 -0.934 . . . . 0.0 110.152 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.753 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.77 112.28 24.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.197 -0.939 . . . . 0.0 110.243 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -161.99 138.07 7.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 0.0 110.098 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 2.2 tm-20 -42.87 -50.11 5.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.178 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -46.75 74.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.849 . . . . 0.0 110.23 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -67.86 -60.37 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.187 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.717 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.2 m-85 -44.61 -29.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.117 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.75 -19.27 23.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.86 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -96.19 -40.55 3.97 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.244 -1.943 . . . . 0.0 108.244 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.626 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -69.79 -17.08 63.39 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.638 -0.919 . . . . 0.0 108.952 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.626 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -58.34 -21.2 48.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.272 0.558 . . . . 0.0 110.89 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -88.53 16.96 5.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.25 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.67 1.96 65.52 Favored Glycine 0 N--CA 1.48 1.594 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 24.7 mttm -82.24 137.7 34.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.607 -0.937 . . . . 0.0 109.246 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.966 ' CD1' HD12 ' A' ' 92' ' ' LEU . 24.8 m-85 -128.76 103.89 7.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.518 -1.363 . . . . 0.0 112.007 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 78' ' ' LYS . 1.4 m -75.03 140.96 43.91 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.619 -0.676 . . . . 0.0 109.339 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.814 ' CB ' HG23 ' A' ' 8' ' ' ILE . 22.0 m-85 -134.56 165.64 24.74 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.453 -0.779 . . . . 0.0 110.438 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.626 ' CE2' HG12 ' A' ' 12' ' ' VAL . 10.0 m95 -98.96 122.33 42.07 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.76 HG23 ' C ' ' A' ' 7' ' ' VAL . 7.4 p -148.06 165.68 5.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.617 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.483 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -61.14 152.91 69.8 Favored Pre-proline 0 C--N 1.298 -1.669 0 O-C-N 121.851 -0.53 . . . . 0.0 110.383 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.497 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.9 Cg_endo -73.4 71.53 3.77 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.099 1.578 . . . . 0.0 110.349 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.02 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.264 -0.898 . . . . 0.0 110.101 -179.256 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.415 ' CB ' HG13 ' A' ' 7' ' ' VAL . . . -42.74 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 110.186 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -48.09 155.81 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 110.26 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.584 ' O ' HG11 ' A' ' 54' ' ' VAL . 7.2 mmtp -57.33 -36.25 70.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.88 . . . . 0.0 110.204 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -75.14 -50.21 17.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 23.0 mt-10 -54.97 -37.92 67.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.942 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.718 HG23 HD11 ' A' ' 8' ' ' ILE . 17.8 mt -57.91 -30.83 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 109.401 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HG3' HG11 ' A' ' 51' ' ' VAL . 2.4 ttpt -61.69 -45.89 92.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 111.096 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -58.9 -36.67 75.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 112.314 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.942 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -73.22 -50.49 22.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.603 -1.311 . . . . 0.0 111.685 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.088 HG13 HD13 ' A' ' 8' ' ' ILE . 4.7 m -66.01 -30.57 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.518 -1.364 . . . . 0.0 110.583 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -62.76 -52.41 63.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.088 -1.007 . . . . 0.0 109.964 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -79.72 -15.72 56.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.895 . . . . 0.0 110.224 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.25 -62.05 1.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.471 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.611 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 9.7 m-85 -71.73 -15.96 62.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.183 -0.948 . . . . 0.0 110.096 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 5.9 mmtt 61.56 45.36 8.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.48 -0.762 . . . . 0.0 110.235 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.776 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -128.28 -162.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.528 -0.733 . . . . 0.0 110.007 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.776 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.06 106.14 12.58 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 109.358 178.893 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.832 HG13 HG13 ' A' ' 81' ' ' VAL . 97.8 t -78.23 119.77 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.322 -0.861 . . . . 0.0 110.184 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.65 HG12 ' C ' ' A' ' 82' ' ' GLN . 7.6 p -106.01 -3.97 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.569 ' HG3' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 178.34 147.94 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.859 . . . . 0.0 109.875 179.523 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.103 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.1 t -132.79 131.32 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.002 -1.061 . . . . 0.0 109.871 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -131.61 115.88 16.66 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.39 -0.819 . . . . 0.0 109.22 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.761 ' O ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -113.83 166.27 11.74 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.39 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 56' ' ' THR . 7.0 mt -143.17 179.76 6.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.432 -0.793 . . . . 0.0 109.852 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -104.15 102.17 11.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.339 -0.85 . . . . 0.0 109.387 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.548 ' CG1' ' HE2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.271 -0.893 . . . . 0.0 110.095 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.399 0.619 . . . . 0.0 110.531 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.516 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 5.9 ptmt -123.15 141.19 52.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.982 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.676 ' HB2' HG22 ' A' ' 27' ' ' THR . 5.2 ptpt -101.57 151.12 22.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.105 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -115.48 119.96 37.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.217 -0.927 . . . . 0.0 112.25 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.592 HG12 HG23 ' A' ' 27' ' ' THR . 12.8 mt -98.2 110.78 26.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.784 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.103 HG22 ' CG2' ' A' ' 54' ' ' VAL . 50.4 t -103.63 133.04 48.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.91 -1.119 . . . . 0.0 110.257 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.65 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.4 tp60 -102.71 153.28 20.29 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.07 -1.019 . . . . 0.0 109.065 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.1 m -120.94 156.19 24.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 C-N-CA 118.35 -1.34 . . . . 0.0 109.053 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.868 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -63.3 177.74 0.44 Allowed Pre-proline 0 C--N 1.286 -2.168 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.194 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.868 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.6 Cg_endo -74.23 138.92 25.77 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 124.233 1.649 . . . . 0.0 110.301 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.47 -30.32 10.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.81 176.35 5.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.112 -1.228 . . . . 0.0 110.548 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 7.9 pttt 179.56 104.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.449 -0.782 . . . . 0.0 110.195 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 26' ' ' TYR . 9.8 mt -42.65 100.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.54 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 3.1 mm-40 -63.06 -13.72 39.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.419 -0.801 . . . . 0.0 110.985 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.757 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.75 -32.73 60.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.099 -1.0 . . . . 0.0 110.418 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.966 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.12 -23.02 12.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.148 -0.97 . . . . 0.0 109.599 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 64.9 mm-40 -48.05 -58.76 4.03 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.38 -0.825 . . . . 0.0 110.423 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -76.5 -33.66 47.22 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 8.0 tp -41.64 -27.34 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.299 -1.118 . . . . 0.0 110.331 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.451 HG12 ' CE1' ' A' ' 18' ' ' TYR . 50.4 mt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.263 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.994 HG13 ' HB1' ' A' ' 34' ' ' ALA . 40.9 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 122.046 0.926 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.805 HG23 ' CB ' ' A' ' 28' ' ' PHE . 4.7 mt -114.06 99.04 7.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 O-C-N 121.326 -0.859 . . . . 0.0 110.068 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.0 mt -93.05 -95.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.328 -0.857 . . . . 0.0 110.854 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.95 154.95 41.8 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.7 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.61 158.17 39.9 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.134 1.597 . . . . 0.0 110.167 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 27' ' ' THR . 1.5 p -115.2 117.24 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.818 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.5 mm? -102.07 106.96 17.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 110.174 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.592 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -144.72 152.8 40.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.6 tt0 -43.07 -63.78 0.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -25.8 28.46 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.592 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -84.39 -51.19 7.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.143 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.617 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 2.1 m-85 -55.75 -32.47 63.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.17 -8.48 51.09 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.256 -0.903 . . . . 0.0 109.901 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.76 -34.0 3.4 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.584 -1.807 . . . . 0.0 108.584 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -79.37 -19.81 49.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.574 -0.956 . . . . 0.0 109.026 179.244 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -54.6 -17.65 3.55 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.65 -0.656 . . . . 0.0 110.879 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.8 OUTLIER -93.17 17.07 11.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.507 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.53 -2.01 67.07 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 1.7 mttp -82.13 139.51 34.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.524 -0.986 . . . . 0.0 109.376 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 1.001 ' CD1' HD12 ' A' ' 92' ' ' LEU . 23.8 m-85 -128.42 102.88 6.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.533 -1.354 . . . . 0.0 112.033 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.652 HG21 ' NZ ' ' A' ' 78' ' ' LYS . 8.1 m -74.88 141.15 44.2 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.449 0.642 . . . . 0.0 109.659 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.805 ' CB ' HG23 ' A' ' 8' ' ' ILE . 44.8 m-85 -134.22 165.18 25.7 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.49 -0.756 . . . . 0.0 110.056 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.605 ' CZ3' ' HG2' ' A' ' 76' ' ' ARG . 52.9 m95 -89.92 122.0 32.54 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 7' ' ' VAL . 10.6 p -134.14 165.26 32.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 118.344 -1.342 . . . . 0.0 112.394 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.597 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -82.75 152.4 66.22 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.297 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 43.8 Cg_endo -70.61 65.56 2.29 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.173 1.617 . . . . 0.0 109.544 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.87 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.559 -0.713 . . . . 0.0 109.647 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.994 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -48.37 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.501 -0.75 . . . . 0.0 109.575 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -40.31 134.35 1.66 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.301 -0.875 . . . . 0.0 110.797 -179.226 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.643 ' HA ' HD12 ' A' ' 39' ' ' ILE . 3.5 tttm -42.4 -43.36 3.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.7 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 5.2 m -61.27 -44.32 97.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.92 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 35' ' ' THR . 6.7 mt-10 -55.13 -39.61 69.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.376 -0.827 . . . . 0.0 109.494 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.718 HG23 HD11 ' A' ' 8' ' ' ILE . 10.4 mt -57.67 -30.67 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.379 -0.826 . . . . 0.0 108.914 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.591 ' HG3' HG11 ' A' ' 51' ' ' VAL . 9.6 tttt -61.79 -47.64 84.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.827 . . . . 0.0 109.541 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.449 ' O ' ' HB ' ' A' ' 45' ' ' THR . 24.3 m-80 -73.48 -34.33 65.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.653 -0.654 . . . . 0.0 110.97 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.64 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . . . -58.37 -50.27 74.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.912 -1.118 . . . . 0.0 110.656 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.004 HG21 HG11 ' A' ' 81' ' ' VAL . 2.7 m -68.11 -36.94 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.715 -1.241 . . . . 0.0 109.835 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -63.36 -42.6 98.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.092 -1.005 . . . . 0.0 108.886 179.154 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -79.2 -20.43 48.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.578 -0.701 . . . . 0.0 109.315 179.083 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -100.04 -67.14 0.87 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 110.456 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.711 ' CD2' HG12 ' A' ' 43' ' ' VAL . 62.6 m-85 -72.58 -21.61 61.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 110.432 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 64.06 47.87 3.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.311 -0.868 . . . . 0.0 110.274 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -122.28 -158.82 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.483 -0.761 . . . . 0.0 110.062 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.788 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -117.16 111.3 19.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.436 179.209 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.78 HG13 HG13 ' A' ' 81' ' ' VAL . 57.7 t -78.3 119.8 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.189 -0.944 . . . . 0.0 110.424 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 82' ' ' GLN . 12.2 p -113.8 -1.41 9.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.489 -0.757 . . . . 0.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 175.83 119.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.81 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.081 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -113.68 132.04 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 110.304 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.553 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 2.4 m120 -131.05 115.56 16.61 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.457 -0.777 . . . . 0.0 109.573 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -116.28 144.61 44.01 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 109.982 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.45 162.01 34.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -0.804 . . . . 0.0 109.973 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 127.49 32.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.944 HG11 ' HD3' ' A' ' 78' ' ' LYS . 1.9 m . . . . . 0 C--N 1.3 -1.565 0 O-C-N 121.607 -0.683 . . . . 0.0 109.979 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.605 ' HG2' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.286 0.565 . . . . 0.0 110.018 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.0 tttt -110.18 141.87 42.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.554 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.944 ' HD3' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -116.57 151.32 36.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.417 -0.802 . . . . 0.0 109.82 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.98 123.24 36.66 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.997 -1.064 . . . . 0.0 112.63 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 14.9 mt -103.29 111.36 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.829 -0.544 . . . . 0.0 110.019 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.081 HG22 ' CG2' ' A' ' 54' ' ' VAL . 60.2 t -104.29 130.37 55.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.94 -1.1 . . . . 0.0 109.969 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.782 ' O ' HG12 ' A' ' 52' ' ' VAL . 3.6 tp60 -102.64 149.76 24.11 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.143 -0.973 . . . . 0.0 109.205 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.539 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.5 m -112.89 156.65 13.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 118.45 -1.3 . . . . 0.0 109.405 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.895 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -62.87 175.49 0.64 Allowed Pre-proline 0 C--N 1.291 -1.951 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.916 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.846 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.3 Cg_endo -76.26 55.29 4.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.525 1.803 . . . . 0.0 110.415 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -158.67 -37.08 0.02 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.895 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -110.64 -179.57 3.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.297 -1.12 . . . . 0.0 110.219 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.439 ' HA ' HG21 ' A' ' 83' ' ' VAL . 2.6 pttt -176.17 100.35 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.743 HD12 ' CD2' ' A' ' 26' ' ' TYR . 11.2 mt -42.35 113.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.006 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 1.2 pt-20 -77.95 -13.36 59.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 0.0 110.914 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.639 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.52 -28.8 47.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.064 -1.022 . . . . 0.0 110.575 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.001 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.26 -23.15 12.64 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.077 -1.014 . . . . 0.0 109.605 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.549 ' O ' HD12 ' A' ' 96' ' ' ILE . 20.5 mm-40 -58.14 -37.69 75.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.487 -0.758 . . . . 0.0 110.296 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.42 25.08 29.41 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.556 HD23 HD21 ' A' ' 13' ' ' LEU . 1.2 tp -106.45 -15.1 14.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -1.143 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.66 ' O ' HG22 ' A' ' 96' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.197 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.679 HG12 HG13 ' A' ' 8' ' ' ILE . 74.7 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.877 0.37 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.933 HD11 HG23 ' A' ' 39' ' ' ILE . 58.0 mt 11.59 86.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.222 0.534 . . . . 0.0 112.283 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.1 mt -68.29 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 110.149 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.41 158.54 33.59 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.956 -1.09 . . . . 0.0 110.359 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.435 ' HG3' HD22 ' A' ' 92' ' ' LEU . 46.4 Cg_endo -73.35 161.69 42.07 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.012 1.533 . . . . 0.0 110.344 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.073 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.2 m -104.65 135.13 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.145 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.835 HD11 HD23 ' A' ' 95' ' ' LEU . 3.2 mm? -102.85 107.18 17.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.118 -0.989 . . . . 0.0 110.334 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 15' ' ' GLU . 14.9 m -162.11 147.16 12.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.947 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.1 tt0 -42.78 -55.48 3.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.917 . . . . 0.0 109.989 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -29.95 54.56 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 110.154 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -82.96 -64.88 1.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.812 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.6 m-85 -42.95 -51.72 5.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.299 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.74 -24.56 67.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.21 -0.931 . . . . 0.0 109.943 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -87.43 -44.75 5.47 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.52 -23.9 56.74 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.509 -0.995 . . . . 0.0 108.957 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -50.43 -21.57 1.52 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.657 -0.652 . . . . 0.0 110.204 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.516 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -91.85 16.26 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.235 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.63 0.02 64.9 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 14.6 mttt -82.18 146.95 29.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -1.128 . . . . 0.0 109.694 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 1.0 ' CD2' HD12 ' A' ' 89' ' ' ILE . 22.3 m-85 -127.31 104.69 8.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.773 -1.204 . . . . 0.0 112.0 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.857 HG23 HD11 ' A' ' 80' ' ' ILE . 3.9 m -78.27 131.43 37.08 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.858 ' CB ' HG23 ' A' ' 8' ' ' ILE . 24.1 m-85 -136.32 164.42 28.14 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.177 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 1.073 ' NE1' HG12 ' A' ' 12' ' ' VAL . 99.6 m95 -100.43 121.91 42.32 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.6 p -145.78 164.99 10.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.503 -176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.623 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -73.46 171.47 10.58 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.767 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 48.4 Cg_endo -75.18 -53.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.927 1.488 . . . . 0.0 109.374 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' THR 0.252 0.0 OUTLIER -47.12 -22.63 0.39 Allowed 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.678 178.927 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -67.02 61.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.363 -0.835 . . . . 0.0 109.617 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -38.33 148.65 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.65 -0.656 . . . . 0.0 110.919 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 14.1 mttt -42.67 -46.56 5.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -0.826 . . . . 0.0 109.955 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -58.78 -53.06 62.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.325 -0.86 . . . . 0.0 110.025 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -55.4 -41.85 73.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.862 . . . . 0.0 109.701 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.933 HG23 HD11 ' A' ' 8' ' ' ILE . 21.9 mt -57.63 -31.44 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.182 -0.949 . . . . 0.0 108.87 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.596 ' HG3' HG11 ' A' ' 51' ' ' VAL . 15.7 tttp -63.27 -45.35 91.9 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.368 -0.832 . . . . 0.0 109.864 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.462 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.3 m-80 -71.22 -34.36 70.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.688 -0.633 . . . . 0.0 111.412 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.924 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.56 -50.73 72.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.768 -1.208 . . . . 0.0 110.6 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.595 HG12 ' CE2' ' A' ' 47' ' ' PHE . 2.9 m -71.05 -34.19 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.838 -1.163 . . . . 0.0 109.582 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -64.88 -38.06 89.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.28 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -79.22 -33.43 43.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.516 -0.74 . . . . 0.0 109.72 179.426 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.12 -62.42 1.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.39 -0.819 . . . . 0.0 110.72 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.595 ' CE2' HG12 ' A' ' 43' ' ' VAL . 21.8 m-85 -71.69 -21.45 61.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.415 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 7.4 mttt 60.64 46.89 8.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 0.0 110.272 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -123.19 -162.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.472 -0.768 . . . . 0.0 110.163 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.788 ' N ' HG13 ' A' ' 49' ' ' VAL . 2.2 tmtm? -118.16 111.41 18.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.411 -0.805 . . . . 0.0 109.845 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.596 HG11 ' HG3' ' A' ' 40' ' ' LYS . 64.9 t -78.74 119.53 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 82' ' ' GLN . 12.1 p -107.81 7.54 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.984 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER 169.25 117.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.814 . . . . 0.0 110.07 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.02 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -119.01 117.25 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.948 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 80' ' ' ILE . 2.5 m120 -116.27 116.11 27.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.285 -0.884 . . . . 0.0 109.523 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.547 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -114.82 139.76 49.48 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.356 -0.84 . . . . 0.0 109.809 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 58' ' ' HIS . 1.4 pp -125.36 167.81 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.646 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.729 ' O ' HD12 ' A' ' 57' ' ' LEU . 23.7 t-160 -72.95 128.23 34.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.465 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.567 ' HB ' ' CG ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.567 ' CG ' ' HB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.126 0.489 . . . . 0.0 110.308 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.761 ' CE ' HD11 ' A' ' 39' ' ' ILE . 20.9 tttt -123.21 135.06 54.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 109.398 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 5.2 ttpp -101.36 150.59 22.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.08 -1.012 . . . . 0.0 109.926 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.821 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -132.53 130.88 40.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.099 -1.001 . . . . 0.0 112.626 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.857 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -111.93 111.86 37.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.02 HG22 ' CG2' ' A' ' 54' ' ' VAL . 20.2 t -108.65 130.35 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.312 -0.868 . . . . 0.0 111.189 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.739 ' O ' HG12 ' A' ' 52' ' ' VAL . 3.1 tp60 -105.88 148.18 27.89 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.321 -0.862 . . . . 0.0 108.706 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.523 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.2 m -114.74 156.88 15.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.696 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.917 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -69.13 178.34 0.95 Allowed Pre-proline 0 C--N 1.291 -1.972 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.026 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.917 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.3 Cg_endo -74.16 139.36 26.54 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 O-C-N 124.23 1.648 . . . . 0.0 110.552 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.94 -40.17 2.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.666 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -96.44 -179.51 4.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.107 -1.231 . . . . 0.0 110.718 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HE2' ' HG2' ' A' ' 90' ' ' GLU . 5.6 ptmt 179.39 90.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 110.266 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.0 HD12 ' CD2' ' A' ' 26' ' ' TYR . 15.5 mt -46.28 97.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.076 -1.015 . . . . 0.0 109.821 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -58.26 -13.6 5.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.402 -0.811 . . . . 0.0 111.125 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.959 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.99 -36.7 65.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.052 -1.03 . . . . 0.0 110.823 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.95 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.8 -23.07 12.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.936 -1.103 . . . . 0.0 109.921 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 7.5 mm-40 -54.79 -40.1 69.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 110.409 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.81 -6.65 67.2 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.959 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.3 mp -63.47 -28.72 70.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -1.163 . . . . 0.0 110.126 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.425 HD13 ' CE1' ' A' ' 18' ' ' TYR . 17.4 mm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.16 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.029 HG12 HG13 ' A' ' 8' ' ' ILE . 60.8 t . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.847 0.356 . . . . 0.0 111.657 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.029 HG13 HG12 ' A' ' 7' ' ' VAL . 17.1 mt -81.6 93.8 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.775 -1.203 . . . . 0.0 112.118 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 29' ' ' TRP . 39.4 mt -70.06 -106.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.365 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' TRP . . . -108.51 162.92 18.23 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.786 -1.196 . . . . 0.0 110.769 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -75.05 166.56 28.89 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.0 1.527 . . . . 0.0 110.545 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.863 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.5 m -115.25 137.95 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.929 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -102.8 113.03 26.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 110.294 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -152.54 146.64 25.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 110.103 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -42.72 -60.41 1.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 110.283 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -54.63 -42.22 70.95 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 110.371 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.542 ' N ' ' CG ' ' A' ' 16' ' ' LYS . . . -63.11 -60.01 4.01 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.929 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.3 m-85 -48.69 -36.24 15.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 0.0 110.106 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.37 -8.66 50.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.049 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -102.57 -34.77 4.02 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.628 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -79.06 -20.77 48.01 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.569 -0.959 . . . . 0.0 108.801 179.107 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.33 -21.45 5.71 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.705 -0.622 . . . . 0.0 110.819 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.91 17.19 5.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.35 -0.844 . . . . 0.0 110.48 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.72 -1.2 68.33 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.3 mttt -82.15 142.43 32.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.496 -1.002 . . . . 0.0 109.229 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.654 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.3 m-85 -128.01 113.09 15.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.611 -1.306 . . . . 0.0 111.743 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.806 HG23 HD11 ' A' ' 80' ' ' ILE . 9.2 m -84.25 122.35 28.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.766 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 19.8 m-85 -116.8 165.33 13.43 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.562 -0.712 . . . . 0.0 110.991 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.863 ' CD1' HG12 ' A' ' 12' ' ' VAL . 22.8 m95 -99.74 123.1 43.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 177.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 7' ' ' VAL . 1.4 p -144.22 156.28 15.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 117.407 -1.717 . . . . 0.0 112.463 -176.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -62.64 151.45 83.93 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.832 -179.359 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.3 Cg_endo -72.13 69.19 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.001 1.527 . . . . 0.0 109.478 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.77 -32.49 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.483 -0.761 . . . . 0.0 109.774 -178.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.881 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -40.29 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.758 -0.589 . . . . 0.0 109.897 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -42.87 137.45 2.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.087 -1.008 . . . . 0.0 110.533 -179.132 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.525 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -42.21 -39.18 1.97 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 0.0 109.737 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 14.3 m -74.79 -33.99 62.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.678 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -60.4 -43.96 96.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.385 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.86 ' O ' HD11 ' A' ' 8' ' ' ILE . 10.2 mt -57.36 -30.33 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.545 ' HG3' HG11 ' A' ' 51' ' ' VAL . 30.0 tttt -66.51 -44.53 82.28 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.518 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 45' ' ' THR . 1.7 m-80 -73.35 -45.35 55.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.707 -0.621 . . . . 0.0 112.037 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.673 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.36 -51.82 68.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.583 -1.323 . . . . 0.0 110.462 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.735 HG21 ' CE2' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -61.3 -47.38 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 110.296 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.5 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -58.33 -43.26 88.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.066 -1.021 . . . . 0.0 109.536 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -73.76 -13.57 60.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.521 -0.737 . . . . 0.0 109.737 179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.61 -69.03 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.393 -0.817 . . . . 0.0 110.351 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.448 ' O ' ' HB2' ' A' ' 48' ' ' LYS . 17.1 m-85 -71.99 -21.56 61.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.893 . . . . 0.0 110.11 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.3 mttt 62.72 43.12 7.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.406 -0.809 . . . . 0.0 109.934 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.805 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -113.65 -159.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.635 -0.666 . . . . 0.0 109.952 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.805 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.16 105.06 11.41 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 109.946 179.319 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG22 ' CG1' ' A' ' 81' ' ' VAL . 21.5 t -78.67 119.61 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.898 . . . . 0.0 109.783 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 82' ' ' GLN . 14.6 p -113.27 11.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 110.244 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 4.1 mttt 169.47 119.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.035 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.013 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.1 t -123.62 116.71 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 110.101 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.525 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -119.8 115.86 24.71 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.36 -0.838 . . . . 0.0 109.203 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.649 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -117.16 150.2 39.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.973 . . . . 0.0 110.043 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.542 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -148.42 149.0 30.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 110.1 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.516 ' NE2' ' HB3' ' A' ' 32' ' ' PRO . 1.1 m80 -66.63 127.31 31.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.176 -0.953 . . . . 0.0 110.58 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.689 -0.632 . . . . 0.0 110.225 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.535 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.189 0.518 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HG2' HG13 ' A' ' 30' ' ' VAL . 8.8 tttp -123.22 125.88 45.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.512 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.631 ' HD3' HD11 ' A' ' 80' ' ' ILE . 5.2 ptpt -101.73 151.51 21.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 109.471 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -126.82 120.29 28.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.895 -1.128 . . . . 0.0 112.592 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.806 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -96.19 112.53 28.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.013 HG22 ' CG2' ' A' ' 54' ' ' VAL . 40.7 t -113.09 126.34 70.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.378 -0.826 . . . . 0.0 110.661 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.663 ' O ' HG12 ' A' ' 52' ' ' VAL . 34.1 tp60 -102.19 151.41 22.23 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.08 -1.013 . . . . 0.0 108.888 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.482 HG11 ' HE2' ' A' ' 26' ' ' TYR . 1.1 m -118.82 157.04 20.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 118.451 -1.3 . . . . 0.0 109.647 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.962 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -69.29 178.83 0.84 Allowed Pre-proline 0 C--N 1.29 -1.986 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.302 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.928 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.3 140.81 31.12 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 O-C-N 124.343 1.707 . . . . 0.0 110.438 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.22 -32.47 6.82 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.962 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.94 173.41 6.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -1.155 . . . . 0.0 110.49 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 90' ' ' GLU . 1.1 pttp 178.8 110.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.463 -0.773 . . . . 0.0 110.364 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.654 HD12 ' CD2' ' A' ' 26' ' ' TYR . 13.1 mt -63.44 77.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 109.698 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.526 ' HA ' ' OE1' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -53.83 -14.1 0.88 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.473 -0.767 . . . . 0.0 111.465 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.71 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.49 -21.01 8.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.913 -1.117 . . . . 0.0 110.999 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.84 -24.19 12.14 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.926 -1.109 . . . . 0.0 110.165 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.526 ' OE1' ' HA ' ' A' ' 90' ' ' GLU . 8.4 mp0 -54.04 -26.86 28.78 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.275 -0.89 . . . . 0.0 110.237 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.42 -15.79 31.37 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -53.36 -31.81 46.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -1.115 . . . . 0.0 110.118 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.591 HG13 ' CE1' ' A' ' 18' ' ' TYR . 71.8 mt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.138 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.851 ' O ' HD23 ' A' ' 9' ' ' LEU . 2.8 t . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.157 0.503 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.5 mt -50.56 149.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.192 -0.942 . . . . 0.0 109.626 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.851 HD23 ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -143.01 -92.75 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.138 -0.976 . . . . 0.0 110.572 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.608 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -96.67 138.15 21.42 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 46.4 Cg_endo -74.18 173.51 14.02 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.011 1.532 . . . . 0.0 110.11 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.039 HG12 ' NE1' ' A' ' 29' ' ' TRP . 1.4 m -105.34 129.21 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.234 -0.916 . . . . 0.0 110.17 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.851 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -103.37 107.14 17.85 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.241 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -158.87 148.64 19.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.014 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 14' ' ' SER . 13.6 mm-40 -43.25 -52.83 5.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.33 -0.856 . . . . 0.0 109.98 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.6 -41.42 69.92 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.157 -0.964 . . . . 0.0 110.006 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -73.25 -61.77 1.7 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.851 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -46.73 -32.93 3.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.949 . . . . 0.0 110.197 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.39 -8.76 49.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 0.0 110.02 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -106.63 -38.17 2.27 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -73.13 -19.0 61.22 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.582 -0.952 . . . . 0.0 108.938 179.112 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -22.08 22.86 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.588 -0.695 . . . . 0.0 110.364 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.409 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 1.5 tt0 -88.75 17.01 5.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 110.074 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 91.37 3.74 69.06 Favored Glycine 0 N--CA 1.48 1.59 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 41.2 mttt -82.67 139.68 33.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -1.044 . . . . 0.0 109.48 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.982 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.4 m-85 -127.64 100.1 5.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.67 -1.269 . . . . 0.0 111.481 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.864 HG23 HD11 ' A' ' 80' ' ' ILE . 17.7 m -80.64 116.2 20.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.85 ' HB3' HG23 ' A' ' 8' ' ' ILE . 3.5 m-85 -119.24 163.22 17.43 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 109.992 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 1.039 ' NE1' HG12 ' A' ' 12' ' ' VAL . 97.2 m95 -98.9 122.08 41.68 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.511 HG23 ' C ' ' A' ' 7' ' ' VAL . 9.8 p -131.17 165.31 31.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 118.493 -1.283 . . . . 0.0 112.193 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.472 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -60.29 147.65 81.22 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.067 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.79 70.96 3.43 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.22 1.642 . . . . 0.0 109.93 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 178.94 -33.19 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.368 -0.833 . . . . 0.0 110.076 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.546 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -53.39 108.44 0.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.382 -0.824 . . . . 0.0 110.363 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 36.3 p -60.0 -170.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 110.153 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -77.33 -43.67 32.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.918 . . . . 0.0 110.336 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 6.3 m -71.56 -43.78 65.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.74 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.454 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 9.2 mt-10 -55.59 -46.21 77.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.361 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.858 HG23 HD11 ' A' ' 8' ' ' ILE . 27.1 mt -56.77 -30.4 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.911 . . . . 0.0 109.942 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.932 ' HG3' HG11 ' A' ' 51' ' ' VAL . 27.2 tttm -60.01 -44.69 94.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 111.664 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.629 ' O ' HG23 ' A' ' 45' ' ' THR . 54.9 m-80 -58.23 -36.55 73.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.302 -0.874 . . . . 0.0 112.685 -177.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.873 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -73.23 -50.2 23.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.658 -1.276 . . . . 0.0 111.965 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.883 HG11 HG11 ' A' ' 81' ' ' VAL . 0.7 OUTLIER -67.01 -43.02 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.791 -1.193 . . . . 0.0 110.748 -179.032 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.7 -42.1 78.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.929 -1.107 . . . . 0.0 110.149 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 41' ' ' ASN . 33.6 p -79.21 -46.68 17.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 0.0 109.98 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.2 -67.81 0.38 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.827 . . . . 0.0 110.494 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.876 ' CD2' HG22 ' A' ' 43' ' ' VAL . 90.5 m-85 -72.14 -3.84 25.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.89 . . . . 0.0 110.455 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 3.0 mtpp 43.35 42.81 3.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.455 -0.778 . . . . 0.0 110.347 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.754 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -112.39 -166.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.53 -0.731 . . . . 0.0 109.681 179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.754 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -109.31 109.19 20.03 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.286 178.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.932 HG11 ' HG3' ' A' ' 40' ' ' LYS . 22.7 t -77.34 119.64 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.161 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.75 HG21 ' N ' ' A' ' 84' ' ' ALA . 6.2 t -111.79 -6.81 11.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.493 0.663 . . . . 0.0 110.667 -178.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.532 ' CG ' ' HB3' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 175.87 135.97 0.05 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.526 -0.734 . . . . 0.0 109.069 179.647 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.923 ' CG2' HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -132.38 118.49 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.493 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.7 m120 -117.33 115.94 26.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.294 -0.878 . . . . 0.0 109.574 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.1 151.08 36.3 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.657 HD21 ' HD2' ' A' ' 78' ' ' LYS . 1.2 pp -147.79 143.01 27.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 110.323 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -67.26 127.2 31.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.888 HG11 ' HE3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.508 -0.745 . . . . 0.0 110.032 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.547 ' HG2' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.236 0.541 . . . . 0.0 110.104 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.486 ' CE ' HD11 ' A' ' 39' ' ' ILE . 9.2 tttt -123.29 127.41 48.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.925 . . . . 0.0 110.387 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.888 ' HE3' HG11 ' A' ' 59' ' ' VAL . 13.7 ptpt -102.71 151.11 22.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.038 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.642 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -122.88 125.9 46.27 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.023 -1.048 . . . . 0.0 112.258 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.864 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -100.77 111.88 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.612 -0.68 . . . . 0.0 109.204 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.923 HG13 ' CG2' ' A' ' 54' ' ' VAL . 1.6 t -100.01 144.56 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.356 -0.84 . . . . 0.0 110.35 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.532 ' HB3' ' CG ' ' A' ' 53' ' ' LYS . 42.6 tp60 -124.52 147.94 48.07 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.129 -0.982 . . . . 0.0 109.486 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -125.17 156.5 34.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.219 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.778 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -43.83 173.23 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 CA-C-O 121.216 0.532 . . . . 0.0 111.194 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.767 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.4 Cg_endo -76.11 54.42 4.16 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 O-C-N 124.347 1.709 . . . . 0.0 110.459 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -169.22 -50.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.778 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 5.2 mp0 -50.86 179.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 110.314 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER 179.53 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.889 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.982 HD12 ' CD2' ' A' ' 26' ' ' TYR . 6.9 mt -64.54 77.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.057 -1.027 . . . . 0.0 109.207 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 88' ' ' LYS . 14.0 pt-20 -53.67 -14.36 0.87 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.384 -0.823 . . . . 0.0 111.263 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.749 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.43 -22.2 11.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.913 -1.117 . . . . 0.0 110.295 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.749 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.24 -23.27 12.61 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.219 -0.926 . . . . 0.0 109.629 179.565 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' HA ' ' A' ' 90' ' ' GLU . 5.3 mm-40 -61.29 -52.21 65.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.456 -0.778 . . . . 0.0 110.459 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.6 4.57 83.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 18.6 tp -75.13 -17.34 60.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 110.226 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.589 HG12 ' CZ ' ' A' ' 18' ' ' TYR . 52.3 mt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.208 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.709 ' C ' HG23 ' A' ' 30' ' ' VAL . 4.7 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.926 HD12 ' HB3' ' A' ' 42' ' ' ALA . 4.9 mt -61.34 151.86 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 121.127 -0.983 . . . . 0.0 110.004 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 mt -133.69 -99.74 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 110.367 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.83 155.42 40.76 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 110.344 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.673 ' HG3' HD22 ' A' ' 92' ' ' LEU . 47.2 Cg_endo -73.92 155.52 48.25 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.036 1.545 . . . . 0.0 110.113 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.872 HG11 ' CE ' ' A' ' 78' ' ' LYS . 2.7 m -99.58 141.25 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.264 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.731 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.3 mm? -102.78 110.51 22.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -162.62 142.29 9.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.901 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.3 mm-40 -42.64 -47.16 5.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 110.106 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -54.81 -48.5 72.7 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.205 -0.934 . . . . 0.0 110.129 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -65.93 -62.45 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.123 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.616 ' CZ ' ' CG1' ' A' ' 96' ' ' ILE . 1.1 m-85 -45.95 -31.45 2.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.87 . . . . 0.0 110.375 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.42 -8.67 49.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.05 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.54 -37.17 1.95 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.53 -19.95 60.78 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 108.953 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.94 -21.31 11.28 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.427 0.632 . . . . 0.0 110.392 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -92.31 16.45 11.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.31 -0.868 . . . . 0.0 110.261 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.91 2.99 64.29 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HB3' HG23 ' A' ' 80' ' ' ILE . 17.5 mttm -82.58 142.18 31.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -1.133 . . . . 0.0 109.488 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.899 ' CD2' HD12 ' A' ' 89' ' ' ILE . 22.8 m-85 -127.62 103.95 7.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.707 -1.246 . . . . 0.0 111.461 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.78 HG23 HD11 ' A' ' 80' ' ' ILE . 4.3 m -76.76 126.78 31.56 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.455 0.645 . . . . 0.0 109.451 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.824 ' CB ' HG23 ' A' ' 8' ' ' ILE . 15.2 m-85 -125.95 164.67 20.28 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.48 -0.762 . . . . 0.0 110.861 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.723 ' NE1' HG12 ' A' ' 12' ' ' VAL . 18.6 m95 -97.74 122.14 40.48 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.709 HG23 ' C ' ' A' ' 7' ' ' VAL . 9.8 p -146.06 166.72 8.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 118.816 -1.154 . . . . 0.0 111.585 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.483 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -69.6 151.86 96.45 Favored Pre-proline 0 C--N 1.297 -1.695 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.557 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.0 69.12 4.75 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.169 1.615 . . . . 0.0 109.988 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.22 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.307 -0.871 . . . . 0.0 110.039 -179.063 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.71 101.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.506 -0.746 . . . . 0.0 110.373 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -53.27 135.94 37.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.527 ' HE3' HG23 ' A' ' 56' ' ' THR . 2.6 mttp -42.21 -46.81 4.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.298 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -60.4 -53.24 59.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.551 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 17.5 mt-10 -55.72 -42.29 75.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 109.688 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.787 HG23 HD11 ' A' ' 8' ' ' ILE . 11.5 mt -57.74 -30.99 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.627 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.528 ' HG3' HG11 ' A' ' 51' ' ' VAL . 22.2 tttt -60.73 -45.51 93.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.623 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.737 ' O ' HG23 ' A' ' 45' ' ' THR . 31.7 m-80 -64.32 -46.39 83.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.467 -0.77 . . . . 0.0 111.989 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.926 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.76 -40.6 84.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.716 -1.24 . . . . 0.0 111.092 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.752 HG21 ' HE2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -76.3 -44.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.916 -1.115 . . . . 0.0 110.367 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.2 -37.8 70.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.961 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 41' ' ' ASN . 34.8 p -79.44 -45.22 19.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.969 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.22 -62.69 1.28 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.449 -0.782 . . . . 0.0 110.734 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.702 ' CD2' HG22 ' A' ' 43' ' ' VAL . 46.3 m-85 -71.8 -21.37 61.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 0.0 110.387 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 61.82 40.91 12.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.425 -0.797 . . . . 0.0 110.371 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.769 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -118.14 -164.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.512 -0.743 . . . . 0.0 110.034 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.769 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.86 101.45 8.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.458 -0.776 . . . . 0.0 109.386 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.733 HG22 ' CG1' ' A' ' 81' ' ' VAL . 25.6 t -78.3 119.24 26.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.365 -0.834 . . . . 0.0 110.197 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.878 HG12 ' O ' ' A' ' 82' ' ' GLN . 8.1 p -102.3 -2.37 9.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.52 -0.738 . . . . 0.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.579 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.42 143.44 0.14 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.293 -0.88 . . . . 0.0 110.09 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -133.96 118.35 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 0.0 110.146 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.51 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.7 t-20 -118.85 115.97 25.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.208 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.527 HG23 ' HE3' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -115.99 165.48 13.06 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.17 -178.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -153.7 150.2 28.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.797 . . . . 0.0 109.984 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -67.17 125.77 27.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.095 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.355 -0.84 . . . . 0.0 109.889 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.63 ' CD ' ' CZ3' ' A' ' 29' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.526 ' O ' HG12 ' A' ' 30' ' ' VAL . 8.7 tttt -119.84 141.9 49.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 110.456 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.872 ' CE ' HG11 ' A' ' 12' ' ' VAL . 2.1 tptm -101.2 146.84 26.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 109.725 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.757 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -128.23 123.53 34.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.201 -0.937 . . . . 0.0 111.382 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.78 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -106.17 113.0 41.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.462 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 54' ' ' VAL . 5.9 t -104.27 133.28 48.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.479 -0.763 . . . . 0.0 110.428 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.878 ' O ' HG12 ' A' ' 52' ' ' VAL . 3.1 tp60 -107.69 140.34 40.88 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.094 -1.004 . . . . 0.0 108.559 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -109.15 155.48 10.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 117.71 -1.596 . . . . 0.0 108.991 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.927 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -52.84 177.87 0.07 OUTLIER Pre-proline 0 C--N 1.289 -2.059 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.383 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.927 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -73.1 144.17 37.24 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 O-C-N 124.374 1.723 . . . . 0.0 110.544 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.04 -26.15 14.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.568 ' HB2' HG23 ' A' ' 83' ' ' VAL . 29.8 mt-30 -83.32 169.85 15.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -1.157 . . . . 0.0 110.467 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.469 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER 179.71 129.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.302 -0.874 . . . . 0.0 110.476 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.899 HD12 ' CD2' ' A' ' 26' ' ' TYR . 6.5 mt -91.16 116.04 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 109.958 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 10.9 pt-20 -78.05 -14.7 59.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.55 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.837 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -55.82 -29.14 59.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -0.914 . . . . 0.0 110.922 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.755 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.04 -23.3 12.67 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.014 -1.054 . . . . 0.0 110.131 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.2 mm-40 -62.6 -39.13 92.78 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.271 -0.893 . . . . 0.0 110.429 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.25 -13.77 59.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.837 HD13 ' O ' ' A' ' 91' ' ' ALA . 0.9 OUTLIER -56.8 -17.26 8.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -1.171 . . . . 0.0 110.17 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.747 ' OXT' HG22 ' A' ' 96' ' ' ILE . 61.0 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.184 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.033 HG13 ' HB1' ' A' ' 34' ' ' ALA . 58.6 t . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.077 0.465 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.018 HG13 HG12 ' A' ' 7' ' ' VAL . 21.4 mt -77.78 82.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 120.96 -1.087 . . . . 0.0 110.854 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.27 -94.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.48 -0.762 . . . . 0.0 111.064 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.21 155.96 39.28 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 0.0 110.985 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 49.5 Cg_endo -76.86 158.37 34.9 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.248 1.657 . . . . 0.0 110.449 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 27' ' ' THR . 1.6 p -115.15 109.39 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.055 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.06 107.2 18.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 110.446 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.7 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -154.25 160.6 41.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.864 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 10.1 pt-20 -40.54 -36.89 0.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 110.291 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -27.83 42.67 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.331 -0.856 . . . . 0.0 110.388 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.7 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -97.0 11.02 37.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.223 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.618 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 1.5 m-85 -120.93 -33.6 3.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.211 -0.931 . . . . 0.0 109.927 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.19 -8.59 50.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -0.842 . . . . 0.0 109.506 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -110.79 -33.11 2.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -76.38 -17.94 59.12 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.641 -0.917 . . . . 0.0 108.935 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.621 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -59.66 -18.68 43.92 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.717 -0.614 . . . . 0.0 110.499 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.3 17.62 5.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.464 -0.772 . . . . 0.0 109.855 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 92.82 -0.05 69.45 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 18.8 mttt -82.56 143.27 31.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.578 -0.954 . . . . 0.0 109.532 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.843 ' HD1' HD13 ' A' ' 92' ' ' LEU . 60.7 m-85 -128.27 101.52 6.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.743 -1.223 . . . . 0.0 111.376 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.673 ' O ' HG12 ' A' ' 12' ' ' VAL . 4.3 m -74.84 132.28 41.4 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.824 ' HB3' HG23 ' A' ' 8' ' ' ILE . 2.8 m-85 -136.99 164.2 28.92 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.632 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.597 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 68.7 m95 -101.09 122.62 43.91 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.957 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.8 p -141.4 156.45 21.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 C-N-CA 118.181 -1.408 . . . . 0.0 111.863 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.591 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -63.93 151.26 89.87 Favored Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.891 -179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.591 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 47.2 Cg_endo -73.82 72.11 3.94 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.166 1.614 . . . . 0.0 109.961 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.35 -32.0 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.524 -0.735 . . . . 0.0 109.552 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 1.033 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -47.4 90.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.568 -0.707 . . . . 0.0 109.659 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -41.73 142.04 0.71 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.144 -0.973 . . . . 0.0 110.453 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.511 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -43.58 -42.77 5.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.632 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 8.7 m -71.13 -26.72 63.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.388 -0.82 . . . . 0.0 109.727 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.4 OUTLIER -66.65 -46.41 75.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.212 179.431 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.787 HG23 HD11 ' A' ' 8' ' ' ILE . 16.6 mt -57.5 -30.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.587 ' HG3' HG11 ' A' ' 51' ' ' VAL . 4.3 tttt -62.87 -47.34 83.74 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.501 -0.749 . . . . 0.0 110.007 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.511 ' O ' ' HB ' ' A' ' 45' ' ' THR . 29.5 m-20 -73.01 -35.02 66.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.704 -0.622 . . . . 0.0 111.688 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.763 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.39 -52.77 64.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.649 -1.282 . . . . 0.0 110.361 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.673 HG13 HD13 ' A' ' 8' ' ' ILE . 2.7 m -68.37 -36.61 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.673 -1.267 . . . . 0.0 110.45 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.657 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -65.13 -41.37 94.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.989 -1.07 . . . . 0.0 109.775 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -79.27 -12.91 59.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.936 179.456 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.82 -59.47 1.95 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.324 -0.86 . . . . 0.0 110.62 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CD2' HG12 ' A' ' 43' ' ' VAL . 10.2 m-85 -71.7 -20.91 61.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.475 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 mttt 63.24 43.01 6.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.793 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -118.21 -161.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.638 -0.664 . . . . 0.0 109.831 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.793 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -116.91 109.18 16.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.398 -0.814 . . . . 0.0 109.516 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.657 HG23 ' HG2' ' A' ' 44' ' ' GLU . 55.4 t -77.32 122.37 31.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.166 -0.959 . . . . 0.0 109.194 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.736 HG21 ' N ' ' A' ' 84' ' ' ALA . 30.1 t -114.94 -11.92 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.496 -0.753 . . . . 0.0 110.881 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -176.35 117.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.118 179.353 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.98 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -115.73 125.31 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 110.057 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.511 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 15.8 t-20 -126.81 115.97 20.17 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 109.418 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.599 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -116.22 153.49 31.77 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.93 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -139.42 169.03 18.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.112 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.79 125.75 35.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 110.357 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.939 HG11 ' CD ' ' A' ' 78' ' ' LYS . 2.4 m . . . . . 0 C--N 1.3 -1.554 0 O-C-N 121.709 -0.62 . . . . 0.0 110.048 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.506 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.273 0.558 . . . . 0.0 110.371 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.699 ' CG ' HG13 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -123.5 142.45 51.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.36 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.939 ' CD ' HG11 ' A' ' 59' ' ' VAL . 13.6 mtpt -100.41 150.97 22.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.419 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.799 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -123.25 129.96 52.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.024 -1.048 . . . . 0.0 112.167 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.799 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.6 mp -109.65 111.35 35.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.201 178.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.98 HG13 HG23 ' A' ' 54' ' ' VAL . 3.2 t -100.79 143.9 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.421 -0.799 . . . . 0.0 110.19 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' LYS . 9.2 tp60 -122.54 147.1 46.78 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.354 -0.841 . . . . 0.0 109.39 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.491 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.3 m -125.01 156.8 33.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.178 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.847 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -45.17 175.81 0.03 OUTLIER Pre-proline 0 C--N 1.296 -1.726 0 CA-C-O 121.292 0.568 . . . . 0.0 110.916 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.847 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.8 Cg_endo -74.1 142.67 31.25 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 O-C-N 124.221 1.642 . . . . 0.0 110.542 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.82 -15.74 45.77 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.527 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 57.4 mt-30 -93.7 165.05 12.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -1.219 . . . . 0.0 110.629 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 90' ' ' GLU . 8.2 ptmt 179.63 102.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.47 -0.769 . . . . 0.0 110.241 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 54.8 mt -42.18 98.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 110.189 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.73 -28.47 34.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.089 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.462 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . -55.8 -23.69 31.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.197 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.843 HD13 ' HD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -107.73 -23.03 12.25 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.875 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.4 ' OE2' ' CZ ' ' A' ' 21' ' ' PHE . 6.2 mm-40 -84.11 1.72 42.82 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 118.055 -1.458 . . . . 0.0 110.247 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.21 -16.85 8.06 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.46 ' O ' ' OXT' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -60.19 -26.98 66.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.431 -1.041 . . . . 0.0 110.047 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.46 ' OXT' ' O ' ' A' ' 95' ' ' LEU . 10.1 mt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.238 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 8' ' ' ILE . 2.5 t . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.882 HG23 ' HB3' ' A' ' 28' ' ' PHE . 2.2 mp -49.94 155.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.362 -0.837 . . . . 0.0 110.519 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 9' ' ' LEU . 24.0 mt -139.93 -96.73 0.16 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.179 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.37 140.31 21.62 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.082 -1.011 . . . . 0.0 110.255 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.778 ' HG3' HD22 ' A' ' 92' ' ' LEU . 45.7 Cg_endo -73.54 162.55 39.67 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.003 1.528 . . . . 0.0 110.204 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.911 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.5 m -98.35 140.59 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.91 . . . . 0.0 110.335 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.863 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.0 mm? -102.76 113.2 26.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 15' ' ' GLU . 3.7 m -170.67 143.88 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 109.952 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.1 mt-10 -42.74 -49.34 5.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.119 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.6 -17.9 3.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.256 -0.903 . . . . 0.0 110.318 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.481 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -106.6 -49.8 3.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.863 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.3 m-85 -56.25 -53.52 56.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.828 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.79 -12.37 34.95 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.185 -0.947 . . . . 0.0 109.209 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -90.86 -48.64 3.33 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 9.4 m-30 -46.83 -27.66 1.3 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.347 -1.09 . . . . 0.0 108.151 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -40.18 -28.14 0.05 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.476 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.547 ' HG3' ' CE ' ' A' ' 25' ' ' LYS . 3.5 pm0 -104.62 17.07 24.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.343 -0.848 . . . . 0.0 111.471 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 87.32 7.22 76.82 Favored Glycine 0 N--CA 1.486 1.975 0 O-C-N 120.965 -1.084 . . . . 0.0 110.543 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.56 ' HD2' ' CG ' ' A' ' 82' ' ' GLN . 3.2 mptp? -84.94 134.97 34.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -1.195 . . . . 0.0 110.241 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.866 ' HD1' HD12 ' A' ' 92' ' ' LEU . 86.3 m-85 -126.94 110.44 13.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.718 -1.239 . . . . 0.0 111.544 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.827 HG23 HD11 ' A' ' 80' ' ' ILE . 2.4 m -76.0 135.76 39.99 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 121.466 0.65 . . . . 0.0 109.674 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.882 ' HB3' HG23 ' A' ' 8' ' ' ILE . 21.3 m-85 -129.58 165.23 22.14 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.588 -0.695 . . . . 0.0 110.703 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.911 ' NE1' HG12 ' A' ' 12' ' ' VAL . 19.9 m95 -104.43 122.49 45.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.0 p -151.17 165.21 2.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 118.472 -1.291 . . . . 0.0 111.51 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.45 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -59.04 149.42 66.71 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.773 -0.579 . . . . 0.0 110.791 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 47.9 Cg_endo -73.33 69.97 4.01 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.26 1.663 . . . . 0.0 109.88 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.26 -33.71 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 110.273 -178.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' LYS . . . -42.11 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.414 -0.804 . . . . 0.0 110.307 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -47.62 142.63 4.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.209 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 12.5 mttt -49.75 -44.59 48.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.308 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -64.75 -49.75 69.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.981 . . . . 0.0 110.545 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.7 OUTLIER -55.29 -41.93 72.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 0.0 109.73 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.687 ' HA ' HD11 ' A' ' 8' ' ' ILE . 10.1 mt -57.42 -30.8 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.396 -0.815 . . . . 0.0 109.817 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.522 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.6 tttt -60.75 -46.18 91.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.0 111.025 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -58.97 -34.87 72.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 112.415 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.65 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . . . -70.1 -50.28 42.41 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.588 -1.32 . . . . 0.0 111.715 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.879 HG23 HG21 ' A' ' 51' ' ' VAL . 15.1 m -68.54 -27.32 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.51 -1.369 . . . . 0.0 110.36 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.83 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -56.43 -53.0 62.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.939 -1.101 . . . . 0.0 109.237 179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.3 p -80.54 -45.11 17.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 109.884 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -56.61 -63.09 1.31 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 110.848 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.722 ' CD1' HG23 ' A' ' 89' ' ' ILE . 35.2 m-85 -71.51 -21.16 61.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.131 -0.98 . . . . 0.0 109.807 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 71.26 50.85 0.28 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.499 -0.751 . . . . 0.0 110.108 179.602 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.701 HG11 HG12 ' A' ' 89' ' ' ILE . 1.5 p -149.3 171.99 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.541 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.57 ' N ' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -89.97 110.57 21.53 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.534 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 43' ' ' VAL . 22.0 t -77.87 138.49 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.786 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.787 HG11 ' OE1' ' A' ' 82' ' ' GLN . 11.3 p -110.28 -29.34 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.226 -0.921 . . . . 0.0 110.842 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.558 ' HG3' ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -159.12 149.63 19.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.987 -1.07 . . . . 0.0 110.467 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.009 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.4 t -133.0 117.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 110.121 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.554 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.6 m-20 -116.86 114.69 24.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.2 -0.937 . . . . 0.0 109.157 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.656 HG21 HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -119.66 150.66 39.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.99 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.938 HD21 ' HD2' ' A' ' 78' ' ' LYS . 3.0 pp -140.61 170.34 15.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.57 120.98 32.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.33 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.823 HG13 HD11 ' A' ' 57' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.4 -0.813 . . . . 0.0 109.938 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.132 0.492 . . . . 0.0 110.146 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 32' ' ' PRO . 8.7 pttt -123.05 141.92 51.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.294 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.938 ' HD2' HD21 ' A' ' 57' ' ' LEU . 3.9 ptpt -100.85 149.18 24.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.671 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.828 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -116.89 123.67 47.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.03 -1.044 . . . . 0.0 112.585 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.827 HD11 HG23 ' A' ' 27' ' ' THR . 1.7 mp -101.98 111.45 31.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.009 HG22 ' CG2' ' A' ' 54' ' ' VAL . 89.0 t -108.99 133.96 52.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.254 -0.904 . . . . 0.0 110.861 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.787 ' OE1' HG11 ' A' ' 52' ' ' VAL . 2.7 tm0? -103.22 153.45 20.36 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.332 -0.855 . . . . 0.0 109.345 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 89' ' ' ILE . 3.7 m -109.39 157.18 9.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 C-N-CA 118.799 -1.16 . . . . 0.0 108.419 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 1.029 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -70.87 179.97 0.8 Allowed Pre-proline 0 C--N 1.283 -2.284 0 C-N-CA 119.071 -1.051 . . . . 0.0 109.988 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.922 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.0 Cg_endo -73.25 137.83 26.65 Favored 'Trans proline' 0 C--N 1.297 -2.136 0 O-C-N 124.242 1.653 . . . . 0.0 110.389 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.23 -36.65 4.26 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 1.029 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -105.95 -178.89 3.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.239 -1.154 . . . . 0.0 110.608 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 90' ' ' GLU . 5.8 ptpt -179.86 104.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 0.0 110.056 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.722 HG23 ' CD1' ' A' ' 47' ' ' PHE . 71.3 mt -54.35 86.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.351 -0.843 . . . . 0.0 109.885 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.557 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 2.8 pt-20 -71.11 -12.22 61.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.443 -0.785 . . . . 0.0 110.925 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.989 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -53.37 -27.35 23.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.992 -1.068 . . . . 0.0 110.562 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.866 HD12 ' HD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.92 -23.67 12.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.98 -1.075 . . . . 0.0 109.683 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 1.5 pp20? -66.23 -29.67 69.97 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.349 -0.941 . . . . 0.0 109.485 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.52 -22.63 28.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.989 HD13 ' O ' ' A' ' 91' ' ' ALA . 0.5 OUTLIER -44.73 -25.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -1.08 . . . . 0.0 109.857 179.665 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.556 HD13 ' CE2' ' A' ' 18' ' ' TYR . 12.5 mm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.188 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.573 ' C ' HG23 ' A' ' 30' ' ' VAL . 3.2 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.349 0.595 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.908 HG23 ' HB3' ' A' ' 28' ' ' PHE . 4.5 mt -49.74 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.169 -0.957 . . . . 0.0 110.078 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' TRP . 0.7 OUTLIER -57.88 -106.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 110.664 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.537 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -108.13 162.88 18.33 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.877 -1.139 . . . . 0.0 110.525 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.636 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.8 Cg_endo -73.72 133.47 18.69 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.105 1.582 . . . . 0.0 110.439 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 27' ' ' THR . 2.1 p -93.91 116.78 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.89 . . . . 0.0 109.968 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.841 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.4 mm? -100.96 109.24 21.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.399 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -159.13 163.92 35.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.004 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.9 mt-10 -42.88 -52.94 4.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 110.069 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -57.63 -39.5 77.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 110.099 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 21' ' ' PHE . . . -91.33 23.72 3.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.875 . . . . 0.0 109.692 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.947 ' OH ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -125.51 -63.24 1.15 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.0 109.518 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.05 -12.06 35.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.548 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.38 -40.54 2.21 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -74.01 -29.41 61.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.57 -0.959 . . . . 0.0 108.78 179.128 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -46.13 -23.54 0.34 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.689 -0.632 . . . . 0.0 110.57 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.74 -14.71 34.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 110.508 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 132.42 -1.23 4.83 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 12.5 mmtt -81.69 147.45 29.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -1.153 . . . . 0.0 109.602 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 1.017 ' CD2' HD12 ' A' ' 89' ' ' ILE . 20.6 m-85 -127.2 106.69 9.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.91 -1.119 . . . . 0.0 111.661 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.788 ' O ' HG12 ' A' ' 12' ' ' VAL . 2.9 m -75.73 126.75 31.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.908 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -135.32 164.01 28.71 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.177 -0.952 . . . . 0.0 110.46 -178.679 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.537 ' CZ3' ' HD3' ' A' ' 76' ' ' ARG . 23.3 m95 -101.92 122.28 43.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.573 HG23 ' C ' ' A' ' 7' ' ' VAL . 13.7 p -146.24 166.49 8.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.06 -1.025 . . . . 0.0 111.488 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.517 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -71.92 169.59 15.6 Favored Pre-proline 0 C--N 1.293 -1.85 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.963 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.492 ' HA ' ' HD2' ' A' ' 77' ' ' LYS . 48.6 Cg_endo -75.41 -53.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.043 0 O-C-N 124.245 1.655 . . . . 0.0 109.643 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HG3' ' HB3' ' A' ' 31' ' ' HIS 0.256 0.0 OUTLIER -46.54 -22.45 0.28 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.874 179.027 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -66.05 102.76 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 110.306 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -67.17 143.27 56.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 110.18 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 13.9 mttt -42.45 -38.61 1.96 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -68.33 -52.28 35.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.388 -0.82 . . . . 0.0 110.608 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -55.19 -43.54 74.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.678 HG23 HD11 ' A' ' 8' ' ' ILE . 11.4 mt -56.87 -30.3 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.112 -0.993 . . . . 0.0 109.403 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.565 ' HG3' HG11 ' A' ' 51' ' ' VAL . 15.1 ttpt -63.67 -47.02 82.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.461 -0.774 . . . . 0.0 111.039 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -58.73 -34.94 71.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.368 -0.832 . . . . 0.0 112.189 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.68 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -65.34 -50.43 65.62 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.682 -1.262 . . . . 0.0 111.289 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.508 HG23 HG21 ' A' ' 51' ' ' VAL . 9.4 m -76.23 -32.22 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.614 -1.304 . . . . 0.0 110.612 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.79 -51.64 68.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.698 -1.251 . . . . 0.0 109.415 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -79.71 -46.23 17.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 110.035 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -59.16 -64.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.389 -0.819 . . . . 0.0 110.404 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.639 ' CE1' ' CB ' ' A' ' 91' ' ' ALA . 7.5 m-85 -72.03 -19.9 61.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.242 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 66.9 41.92 2.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 110.251 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.777 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -122.55 -164.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.556 -0.715 . . . . 0.0 109.931 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.777 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -119.28 106.79 12.67 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 110.145 179.259 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.58 HG13 ' CG1' ' A' ' 81' ' ' VAL . 76.3 t -78.43 119.7 27.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.796 HG12 ' O ' ' A' ' 82' ' ' GLN . 12.2 p -104.23 4.96 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.919 . . . . 0.0 110.7 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 167.77 119.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.217 -0.927 . . . . 0.0 110.504 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.062 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -112.16 120.01 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 109.861 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -107.66 115.22 29.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.181 -0.95 . . . . 0.0 109.047 178.623 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.55 HG21 HD12 ' A' ' 39' ' ' ILE . 2.3 p -116.68 139.07 50.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.101 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.822 HD11 ' HD2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -136.38 144.1 44.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 110.264 -179.569 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -76.34 115.16 15.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.321 -0.862 . . . . 0.0 109.892 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.537 ' HD3' ' CZ3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.267 0.556 . . . . 0.0 110.214 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.53 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 1.8 tttp -117.59 134.77 54.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 109.682 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.822 ' HD2' HD11 ' A' ' 57' ' ' LEU . 6.7 ptpt -102.04 150.3 23.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.022 . . . . 0.0 110.798 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.806 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -117.29 134.14 55.16 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.148 -0.97 . . . . 0.0 111.978 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.806 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.6 mp -110.76 110.86 33.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.062 HG13 HG23 ' A' ' 54' ' ' VAL . 2.4 t -104.98 127.72 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.335 -0.853 . . . . 0.0 111.011 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.796 ' O ' HG12 ' A' ' 52' ' ' VAL . 9.9 tp60 -110.02 146.03 36.01 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.066 -1.021 . . . . 0.0 108.761 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 87' ' ' GLN . 1.6 m -113.26 155.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 118.083 -1.447 . . . . 0.0 109.623 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.951 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -55.83 179.48 0.1 OUTLIER Pre-proline 0 C--N 1.29 -1.996 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.195 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.951 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.5 Cg_endo -72.27 141.51 35.76 Favored 'Trans proline' 0 C--N 1.299 -2.048 0 O-C-N 124.193 1.628 . . . . 0.0 110.55 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.57 -19.63 46.52 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.575 ' NE2' ' CB ' ' A' ' 50' ' ' LYS . 49.9 mt-30 -93.11 168.96 10.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -1.141 . . . . 0.0 110.672 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.8 OUTLIER 179.65 122.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.395 -0.815 . . . . 0.0 110.339 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.017 HD12 ' CD2' ' A' ' 26' ' ' TYR . 15.2 mt -83.86 106.74 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.146 -0.971 . . . . 0.0 109.958 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -61.94 -13.97 30.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.368 -0.832 . . . . 0.0 110.946 -179.413 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.639 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . -55.03 -34.12 63.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.098 -1.001 . . . . 0.0 110.792 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.776 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -105.86 -23.23 12.74 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.011 -1.056 . . . . 0.0 109.592 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.9 mm-40 -66.49 -37.67 85.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.344 -0.847 . . . . 0.0 109.95 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.07 -8.92 86.82 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 92' ' ' LEU . 4.8 mp -81.34 8.87 8.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -1.153 . . . . 0.0 110.091 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.947 HD13 ' OH ' ' A' ' 18' ' ' TYR . 15.5 mm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.92 ' C ' HG23 ' A' ' 30' ' ' VAL . 1.7 t . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 121.056 0.455 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.926 ' CD1' HG23 ' A' ' 39' ' ' ILE . 2.6 mm -32.83 126.05 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 121.267 0.556 . . . . 0.0 110.919 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 29' ' ' TRP . 1.3 mt -115.03 -94.54 0.48 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.85 . . . . 0.0 109.751 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.85 153.88 42.14 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.892 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.643 ' CB ' HD22 ' A' ' 92' ' ' LEU . 48.4 Cg_endo -76.02 158.25 38.25 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.943 1.496 . . . . 0.0 110.314 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.045 HG12 ' NE1' ' A' ' 29' ' ' TRP . 1.4 m -103.69 129.14 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.204 -0.935 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.906 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 2.9 mm? -102.84 113.01 26.09 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.111 -0.993 . . . . 0.0 110.275 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 15' ' ' GLU . 68.8 m -161.58 144.05 11.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 14' ' ' SER . 69.7 mt-10 -42.87 -51.61 5.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 110.043 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -54.86 -34.03 62.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.288 -0.882 . . . . 0.0 110.172 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -86.03 -58.5 2.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.25 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.906 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -46.13 -31.28 2.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.876 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.25 -8.75 50.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.084 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.14 -37.55 1.96 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -71.12 -18.3 62.53 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.698 -0.883 . . . . 0.0 108.843 178.968 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.621 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -58.72 -20.02 45.27 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.676 -0.64 . . . . 0.0 110.474 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -88.62 17.32 5.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.487 -0.758 . . . . 0.0 109.953 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 91.96 3.27 68.2 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 72.9 mttt -82.72 136.94 34.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.563 -0.963 . . . . 0.0 109.382 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.946 ' CD2' HD12 ' A' ' 89' ' ' ILE . 24.6 m-85 -127.95 96.9 4.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.658 -1.277 . . . . 0.0 111.538 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.837 HG22 ' HG2' ' A' ' 78' ' ' LYS . 2.8 m -75.61 117.57 17.52 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.53 -0.731 . . . . 0.0 109.695 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.679 ' CZ ' ' CZ ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -116.86 162.96 16.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 110.349 -179.663 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 1.045 ' NE1' HG12 ' A' ' 12' ' ' VAL . 97.7 m95 -92.65 122.77 35.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.92 HG23 ' C ' ' A' ' 7' ' ' VAL . 8.9 p -147.03 166.97 6.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.038 -177.407 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.502 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -60.5 141.11 92.0 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.148 179.822 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.546 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.5 Cg_endo -72.2 77.46 2.02 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 124.169 1.615 . . . . 0.0 110.278 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 178.67 -34.71 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.349 -0.844 . . . . 0.0 109.906 -179.264 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.49 ' CB ' HG13 ' A' ' 7' ' ' VAL . . . -52.8 92.05 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.493 -0.754 . . . . 0.0 109.917 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -41.98 151.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.335 -0.853 . . . . 0.0 110.319 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.619 ' O ' HG11 ' A' ' 54' ' ' VAL . 6.8 mmtp -42.49 -35.07 0.95 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 110.044 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.6 m -75.08 -39.75 60.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 110.096 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.68 -43.52 76.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.061 -1.024 . . . . 0.0 109.536 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.926 HG23 ' CD1' ' A' ' 8' ' ' ILE . 30.0 mt -57.99 -30.32 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.432 -0.792 . . . . 0.0 109.646 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.685 ' HG3' HG21 ' A' ' 51' ' ' VAL . 11.5 tttm -60.14 -47.42 85.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.556 -0.715 . . . . 0.0 111.523 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -58.22 -38.87 77.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.379 -0.826 . . . . 0.0 112.108 -178.056 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.605 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -73.56 -50.87 19.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.7 -1.25 . . . . 0.0 111.818 -178.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.116 HG12 ' CE2' ' A' ' 47' ' ' PHE . 6.1 m -65.59 -44.75 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.711 -1.243 . . . . 0.0 111.054 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.623 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -56.91 -48.15 78.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.719 -1.238 . . . . 0.0 110.103 -179.945 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 m -79.0 -47.79 15.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 0.0 110.673 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -68.49 -63.79 0.99 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 110.575 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 1.116 ' CE2' HG12 ' A' ' 43' ' ' VAL . 21.3 m-85 -71.72 -4.13 25.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.174 -0.954 . . . . 0.0 110.165 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 12.4 mtmt 46.79 46.15 15.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.432 -0.793 . . . . 0.0 110.25 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.778 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -118.13 -163.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.57 -0.706 . . . . 0.0 109.87 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.778 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -117.2 112.62 21.07 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.448 -0.782 . . . . 0.0 109.436 179.083 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.685 HG21 ' HG3' ' A' ' 40' ' ' LYS . 17.3 t -77.67 119.53 26.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.076 -1.015 . . . . 0.0 109.337 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.808 HG21 ' N ' ' A' ' 84' ' ' ALA . 25.6 t -116.06 -10.7 12.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 121.685 0.755 . . . . 0.0 110.149 -178.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 82' ' ' GLN . 0.3 OUTLIER 175.39 116.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.593 -0.692 . . . . 0.0 109.581 179.371 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -105.19 136.62 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.996 . . . . 0.0 109.978 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.543 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.1 t-20 -131.39 114.86 15.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.139 -0.975 . . . . 0.0 109.722 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -108.44 150.08 27.89 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.624 -179.662 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.612 HD12 ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -128.9 -177.14 4.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.06 -1.025 . . . . 0.0 110.514 -178.934 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.5 119.92 26.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.557 -0.714 . . . . 0.0 109.298 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.795 HG11 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.617 0 O-C-N 121.104 -0.998 . . . . 0.0 108.911 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.562 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.282 0.563 . . . . 0.0 110.546 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.546 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 9.3 tttt -123.13 141.13 52.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.47 -0.769 . . . . 0.0 109.604 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.837 ' HG2' HG22 ' A' ' 27' ' ' THR . 6.5 tttt -101.24 134.26 44.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.003 -1.061 . . . . 0.0 109.834 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -124.79 120.35 31.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.924 . . . . 0.0 111.618 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.0 mt -95.57 111.63 26.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.576 -0.702 . . . . 0.0 109.987 178.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.939 HG21 HG11 ' A' ' 43' ' ' VAL . 2.9 t -95.41 133.52 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 23' ' ' GLU . 13.9 tp60 -112.26 144.04 42.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 109.6 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.2 m -125.32 156.79 34.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.459 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 1.018 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -47.97 173.07 0.06 OUTLIER Pre-proline 0 C--N 1.296 -1.73 0 CA-C-O 121.29 0.567 . . . . 0.0 111.035 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 47.3 Cg_endo -79.88 55.46 5.65 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 124.499 1.789 . . . . 0.0 110.344 179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.73 -35.01 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 1.018 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -105.79 177.83 4.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -1.185 . . . . 0.0 109.978 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 90' ' ' GLU . 6.2 ptpt 179.61 115.14 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.31 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.946 HD12 ' CD2' ' A' ' 26' ' ' TYR . 73.7 mt -44.2 94.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.994 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' LYS . 1.9 mt-10 -56.91 -14.33 3.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.384 -0.822 . . . . 0.0 110.977 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.56 ' HB3' HG22 ' A' ' 89' ' ' ILE . . . -55.05 -30.08 58.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 0.0 110.345 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.901 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -106.43 -23.23 12.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.176 -0.952 . . . . 0.0 109.495 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 73.7 mm-40 -56.58 -27.58 58.23 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.269 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.2 21.66 28.62 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.837 HD23 HD11 ' A' ' 13' ' ' LEU . 1.4 tp -99.29 2.13 45.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -1.165 . . . . 0.0 110.152 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.463 HD11 ' HZ ' ' A' ' 21' ' ' PHE . 1.5 mp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.235 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.036 HG13 ' HB1' ' A' ' 34' ' ' ALA . 98.5 t . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.599 0.714 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.046 HD11 HG23 ' A' ' 39' ' ' ILE 0.25 75.1 mt -85.85 104.07 13.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.125 -0.985 . . . . 0.0 110.117 -179.572 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -86.89 -94.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.688 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.498 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -108.09 152.5 41.81 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 110.449 -179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.547 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 47.0 Cg_endo -73.15 174.49 11.95 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.93 1.49 . . . . 0.0 110.197 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.841 HG12 ' CD1' ' A' ' 29' ' ' TRP . 2.5 m -114.98 138.33 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.095 -1.003 . . . . 0.0 110.338 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.81 112.66 25.57 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 110.213 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 17' ' ' ALA . 4.1 m -163.87 141.42 7.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -42.83 -54.99 3.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 110.054 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.71 -25.09 25.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.325 -0.859 . . . . 0.0 110.075 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -87.71 -62.02 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.201 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.755 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -46.12 -43.57 15.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.309 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.65 -8.64 57.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.987 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -105.66 -39.73 2.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -77.5 -20.78 53.76 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.51 -0.994 . . . . 0.0 108.979 179.28 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -57.03 -16.2 6.66 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.553 -0.717 . . . . 0.0 110.192 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 25' ' ' LYS . 4.7 tt0 -96.62 16.39 19.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 110.447 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.68 -2.13 60.29 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 23.0 mttt -82.74 143.36 30.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -1.123 . . . . 0.0 109.73 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 1.146 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.1 m-85 -128.03 97.19 4.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.693 -1.254 . . . . 0.0 111.608 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.965 HG23 HD11 ' A' ' 80' ' ' ILE . 8.7 m -76.95 120.68 22.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.233 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.755 ' CB ' HG23 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -120.87 163.73 17.75 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.987 -1.071 . . . . 0.0 111.677 -178.527 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.841 ' CD1' HG12 ' A' ' 12' ' ' VAL . 10.2 m95 -94.4 122.77 37.32 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 178.059 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 7' ' ' VAL 0.259 3.8 p -144.4 160.36 15.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 C-N-CA 118.148 -1.421 . . . . 0.0 111.823 -176.31 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.598 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -67.3 152.73 95.85 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.612 -179.346 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.598 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 47.0 Cg_endo -73.19 71.78 3.55 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.071 1.564 . . . . 0.0 109.876 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.37 -33.3 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.782 -179.051 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 1.036 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.31 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.683 -0.636 . . . . 0.0 109.919 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -45.99 137.52 5.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 0.0 110.697 -179.415 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.553 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -43.4 -48.82 7.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.345 -0.847 . . . . 0.0 109.763 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.9 m -59.1 -50.15 75.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.728 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 2.2 mm-40 -55.07 -39.38 69.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 0.0 109.487 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.046 HG23 HD11 ' A' ' 8' ' ' ILE . 34.8 mt -57.61 -31.83 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.543 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.5 ttmp? -62.97 -45.98 89.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 178.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 45' ' ' THR . 32.7 m-80 -72.27 -33.73 67.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.686 -0.634 . . . . 0.0 110.914 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.857 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.44 -46.17 83.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.84 -1.163 . . . . 0.0 110.494 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.19 HG12 ' CE2' ' A' ' 47' ' ' PHE . 6.6 m -76.12 -33.13 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.78 -1.2 . . . . 0.0 109.657 178.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.52 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -68.2 -42.83 79.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.119 -0.988 . . . . 0.0 109.861 179.441 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -79.07 -28.56 43.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.879 179.752 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -95.67 -57.58 2.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 110.967 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 1.19 ' CE2' HG12 ' A' ' 43' ' ' VAL . 6.7 m-30 -76.52 -16.54 59.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.908 . . . . 0.0 110.569 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.4 mtpt 57.33 47.7 16.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 110.48 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.782 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -123.83 -160.22 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.526 -0.734 . . . . 0.0 110.016 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.782 ' N ' HG13 ' A' ' 49' ' ' VAL . 3.8 tmtt? -117.65 105.76 12.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.645 HG21 HG23 ' A' ' 43' ' ' VAL . 45.3 t -78.93 119.72 28.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.349 -0.845 . . . . 0.0 110.613 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.4 p -107.32 -5.91 10.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.346 -0.846 . . . . 0.0 109.658 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.588 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.96 142.78 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.413 -0.804 . . . . 0.0 109.904 179.353 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.96 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -133.48 130.1 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.075 -1.015 . . . . 0.0 109.849 179.698 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.499 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 1.2 t30 -131.18 115.62 16.6 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.863 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.539 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -115.32 164.78 13.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.744 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -149.3 172.13 15.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.201 -0.937 . . . . 0.0 110.438 -179.423 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -81.71 118.82 23.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.115 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 O-C-N 121.282 -0.886 . . . . 0.0 110.158 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.596 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 6.4 ttm180 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.322 0.582 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.688 ' NZ ' ' HB3' ' A' ' 34' ' ' ALA . 18.1 tttt -122.97 139.59 53.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 109.724 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HE2' HG11 ' A' ' 12' ' ' VAL . 25.1 mttt -101.71 147.81 26.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 110.443 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.605 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -132.89 119.54 20.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.325 -0.859 . . . . 0.0 111.216 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.965 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -99.09 112.08 30.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.359 0.6 . . . . 0.0 109.595 179.128 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.049 HG11 HG21 ' A' ' 43' ' ' VAL . 2.5 t -104.24 127.38 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.475 -0.765 . . . . 0.0 110.14 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.691 ' O ' HG12 ' A' ' 52' ' ' VAL . 4.2 tp60 -102.54 147.47 26.72 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.027 -1.046 . . . . 0.0 109.334 179.301 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 1.5 m -116.35 156.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.311 -1.356 . . . . 0.0 108.891 177.591 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.789 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -69.06 176.14 1.71 Allowed Pre-proline 0 C--N 1.287 -2.116 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.125 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.789 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.1 Cg_endo -75.18 136.9 20.63 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 O-C-N 124.204 1.634 . . . . 0.0 110.291 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.25 -21.72 21.65 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -115.35 -179.91 3.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -1.234 . . . . 0.0 110.352 -179.988 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER 179.5 101.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.827 . . . . 0.0 110.149 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.146 HD12 ' CD2' ' A' ' 26' ' ' TYR . 48.5 mt -53.94 101.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -0.971 . . . . 0.0 110.172 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 19.4 pt-20 -60.92 -13.5 16.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.423 -0.798 . . . . 0.0 110.918 -179.542 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.71 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.69 -36.14 64.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 110.524 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.97 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.41 -23.11 12.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.022 -1.049 . . . . 0.0 109.8 179.762 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.8 mm-40 -52.15 -45.5 65.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.353 -0.842 . . . . 0.0 110.456 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -83.2 -23.98 53.12 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.1 tp -42.13 -27.19 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -1.115 . . . . 0.0 110.268 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 94' ' ' GLY . 17.3 mm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.278 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.006 HG13 ' HB1' ' A' ' 34' ' ' ALA . 53.7 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.992 0.425 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.954 HG13 HG12 ' A' ' 7' ' ' VAL . 11.8 mt -81.42 106.31 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.533 -1.354 . . . . 0.0 111.027 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -83.97 -105.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 110.217 179.715 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.65 151.43 41.68 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.948 -1.095 . . . . 0.0 110.415 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.505 ' CB ' HD11 ' A' ' 92' ' ' LEU . 47.3 Cg_endo -74.43 175.69 10.68 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.045 1.55 . . . . 0.0 110.154 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.988 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.4 m -115.06 136.28 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.145 -0.972 . . . . 0.0 110.396 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.741 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.67 107.9 18.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.172 -0.955 . . . . 0.0 110.17 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -163.14 138.54 6.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.201 179.88 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -43.25 -51.07 6.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 110.141 179.908 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -18.17 4.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -103.84 -43.42 5.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.006 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.588 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -62.72 -39.58 94.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 179.852 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.74 -13.53 44.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.036 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -105.46 -47.73 1.1 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 178.486 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.88 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -51.08 -24.09 3.64 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.897 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.73 -29.93 63.01 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.259 0.552 . . . . 0.0 110.674 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -88.73 16.25 7.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.273 -0.892 . . . . 0.0 110.504 -179.571 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 87.42 13.28 65.84 Favored Glycine 0 N--CA 1.482 1.712 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' CG ' ' OE1' ' A' ' 82' ' ' GLN . 11.3 mttm -82.45 146.33 29.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.183 -1.187 . . . . 0.0 109.505 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 1.131 ' CE2' HD12 ' A' ' 89' ' ' ILE . 28.7 m-85 -127.02 98.3 5.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.911 -1.118 . . . . 0.0 112.146 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.849 HG22 ' HD3' ' A' ' 78' ' ' LYS . 2.5 m -79.13 126.42 30.71 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 178.249 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.808 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 13.4 m-85 -126.58 164.93 20.13 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.28 -0.888 . . . . 0.0 111.618 -178.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.988 ' NE1' HG12 ' A' ' 12' ' ' VAL . 43.9 m95 -104.24 122.36 45.23 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 176.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 7' ' ' VAL . 1.2 p -144.28 157.6 15.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 117.708 -1.597 . . . . 0.0 112.259 -176.169 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -62.13 151.75 80.15 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.952 -179.109 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.8 Cg_endo -73.67 70.03 4.28 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.211 1.637 . . . . 0.0 109.848 179.471 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.54 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 109.911 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 1.006 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -44.75 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.639 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -43.22 138.93 2.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.92 . . . . 0.0 110.544 -179.243 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.543 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -43.54 -38.08 2.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.701 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 5.6 m -70.59 -44.45 67.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.469 -0.769 . . . . 0.0 109.685 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.497 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 2.8 mm-40 -55.6 -41.16 73.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.562 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.815 ' O ' HD11 ' A' ' 8' ' ' ILE . 74.7 mt -57.4 -30.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.903 . . . . 0.0 108.633 179.038 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 37' ' ' THR . 17.7 tttm -64.96 -44.46 89.32 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.415 -0.803 . . . . 0.0 109.404 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.5 ' O ' ' HB ' ' A' ' 45' ' ' THR . 40.3 m-80 -73.17 -43.37 61.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.696 -0.627 . . . . 0.0 111.277 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.854 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.23 -51.32 70.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.603 -1.311 . . . . 0.0 110.261 -179.142 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.767 HG21 ' HE2' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -63.98 -47.22 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.056 -1.028 . . . . 0.0 109.968 179.981 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.481 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -57.0 -44.88 83.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.027 -1.046 . . . . 0.0 109.41 179.497 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -78.53 -12.58 60.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.4 -0.813 . . . . 0.0 109.446 179.309 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -97.3 -71.71 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.832 . . . . 0.0 110.236 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.812 ' CG ' HD13 ' A' ' 89' ' ' ILE . 43.3 m-85 -72.1 -22.12 61.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.192 -0.942 . . . . 0.0 110.198 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 68.78 44.2 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 110.006 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.67 HG22 ' H ' ' A' ' 50' ' ' LYS . 1.1 p -118.65 -160.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.541 -0.724 . . . . 0.0 110.383 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.67 ' H ' HG22 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.11 104.97 11.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.423 -0.798 . . . . 0.0 109.584 179.268 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.735 HG22 ' CG1' ' A' ' 81' ' ' VAL . 25.1 t -78.23 119.71 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.963 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.2 p -102.98 -8.94 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 110.227 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 4.9 ptmt -175.39 131.24 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.873 179.196 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.038 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -123.62 127.62 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.974 -1.078 . . . . 0.0 110.332 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.543 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 37.7 t30 -131.06 115.65 16.72 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.472 -0.767 . . . . 0.0 109.02 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.598 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.92 157.78 22.9 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 110.239 -179.379 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -145.94 171.37 14.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.786 . . . . 0.0 110.159 -179.67 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -85.26 128.47 34.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.192 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.538 HG21 ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.305 -0.872 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.133 0.492 . . . . 0.0 109.897 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 20.4 tttt -123.08 127.5 48.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.744 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.849 ' HD3' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -101.81 151.01 22.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.285 179.378 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.808 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -127.16 129.34 47.7 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.974 -1.078 . . . . 0.0 111.91 -179.261 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.79 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.5 mp -109.72 111.43 36.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.164 178.294 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.038 HG13 HG23 ' A' ' 54' ' ' VAL . 19.3 t -112.29 128.29 69.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.572 -0.705 . . . . 0.0 110.162 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.713 ' O ' HG12 ' A' ' 52' ' ' VAL . 2.5 tp60 -101.55 151.27 22.17 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.037 -1.039 . . . . 0.0 109.012 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.0 m -112.57 155.84 13.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 C-N-CA 118.082 -1.447 . . . . 0.0 108.443 177.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.713 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -58.01 169.98 0.8 Allowed Pre-proline 0 C--N 1.284 -2.244 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.646 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.615 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 45.4 Cg_endo -79.63 53.48 4.75 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 O-C-N 124.416 1.745 . . . . 0.0 110.733 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.475 ' N ' ' OE1' ' A' ' 87' ' ' GLN . . . -168.72 23.47 0.1 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.713 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -150.31 -175.53 5.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.941 -1.329 . . . . 0.0 110.268 -179.965 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER 179.88 113.25 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.455 -0.778 . . . . 0.0 109.998 179.865 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.131 HD12 ' CE2' ' A' ' 26' ' ' TYR . 16.8 mt -59.92 100.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.28 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -53.95 -27.99 34.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.72 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.2 73.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.414 -0.804 . . . . 0.0 110.22 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.88 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -107.67 1.23 22.98 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.977 -1.089 . . . . 0.0 112.079 -179.51 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -95.11 3.31 54.91 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 117.958 -1.497 . . . . 0.0 110.118 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -118.54 -17.78 5.09 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -56.31 -33.75 65.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.366 -1.079 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.517 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 4.6 mt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.214 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.596 HG12 HG13 ' A' ' 8' ' ' ILE . 9.2 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.052 0.454 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.101 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.2 mt -63.08 156.42 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.224 -0.922 . . . . 0.0 110.032 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.557 HD12 ' H ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -144.61 -81.72 0.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.069 -1.019 . . . . 0.0 110.594 179.483 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.557 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -108.15 145.23 31.03 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.981 -1.074 . . . . 0.0 110.573 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 47.7 Cg_endo -74.53 169.8 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.037 1.546 . . . . 0.0 110.563 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.8 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.3 m -115.13 136.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.127 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.007 HD11 HD23 ' A' ' 95' ' ' LEU . 3.2 mm? -102.93 110.26 22.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.136 -0.978 . . . . 0.0 110.435 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -164.0 145.72 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.473 -0.767 . . . . 0.0 109.559 179.821 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 14' ' ' SER . 2.1 mm-40 -43.42 -33.48 1.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 109.986 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -28.23 66.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 110.024 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -91.96 19.36 6.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.296 -0.877 . . . . 0.0 109.807 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.584 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.7 m-85 -138.49 -41.92 0.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.54 -0.725 . . . . 0.0 109.854 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.12 79.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.177 -0.952 . . . . 0.0 108.883 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.85 -31.1 7.93 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 178.318 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -72.31 -10.83 60.29 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.522 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -66.84 -8.39 28.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.655 -0.653 . . . . 0.0 110.216 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -1.98 19.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 110.385 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.588 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 119.48 4.09 12.23 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 27.4 mttt -84.35 132.71 34.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -1.152 . . . . 0.0 109.772 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.859 ' CD2' HD12 ' A' ' 89' ' ' ILE . 62.7 m-85 -126.94 111.15 13.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.719 -1.238 . . . . 0.0 111.79 -179.328 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.728 HG22 ' HB2' ' A' ' 78' ' ' LYS . 7.5 m -79.27 128.95 33.95 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.458 0.647 . . . . 0.0 109.932 179.09 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.695 ' CE1' ' CZ ' ' A' ' 47' ' ' PHE . 19.0 m-85 -124.76 164.73 19.35 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.519 -0.738 . . . . 0.0 109.879 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.8 ' NE1' HG12 ' A' ' 12' ' ' VAL . 4.4 m95 -95.14 122.86 38.25 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.263 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.536 HG23 ' N ' ' A' ' 8' ' ' ILE . 8.1 p -137.1 165.01 28.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.844 -177.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.479 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -61.45 145.31 91.15 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.908 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.39 70.68 2.49 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.1 1.579 . . . . 0.0 109.934 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 178.83 -32.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.413 -0.805 . . . . 0.0 110.12 -178.936 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -56.27 96.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.463 -0.773 . . . . 0.0 110.379 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.439 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 1.3 p -46.17 159.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 109.962 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.773 ' O ' HG11 ' A' ' 54' ' ' VAL . 11.0 mttp -47.71 -40.22 19.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.289 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.9 m -75.28 -38.97 60.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.591 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.439 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 2.4 mt-10 -55.6 -43.88 76.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.038 -1.039 . . . . 0.0 109.944 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.776 ' O ' HD11 ' A' ' 8' ' ' ILE . 13.0 mt -57.5 -30.24 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.774 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.916 ' HG3' HG11 ' A' ' 51' ' ' VAL . 39.8 tttm -57.6 -41.99 82.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 111.537 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.425 ' O ' HG23 ' A' ' 45' ' ' THR . 6.6 m-80 -58.29 -49.53 76.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.465 -0.772 . . . . 0.0 112.397 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.101 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -73.49 -39.18 65.06 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.711 -1.243 . . . . 0.0 111.631 -178.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.843 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -62.41 -45.54 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.898 -1.126 . . . . 0.0 110.401 -179.343 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.477 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -56.41 -38.75 71.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.012 . . . . 0.0 109.846 -179.818 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 41' ' ' ASN . 43.0 p -79.38 -45.43 19.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 109.975 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.64 -60.58 2.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 110.497 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.843 ' CD2' HG22 ' A' ' 43' ' ' VAL . 44.4 m-85 -71.65 -21.52 61.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.957 . . . . 0.0 110.158 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 56.32 40.75 29.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 110.295 179.734 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.77 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -120.99 -165.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.519 -0.738 . . . . 0.0 109.896 179.708 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.77 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -106.66 112.17 25.04 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.23 178.812 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.916 HG11 ' HG3' ' A' ' 40' ' ' LYS . 19.6 t -77.59 135.68 25.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.482 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.765 HG21 ' N ' ' A' ' 84' ' ' ALA . 2.5 t -128.57 -5.87 3.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.48 -0.763 . . . . 0.0 110.573 -178.336 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.537 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER 170.45 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.424 -0.797 . . . . 0.0 109.118 179.498 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.863 HG22 HG22 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -115.47 133.04 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.332 -0.855 . . . . 0.0 110.564 -179.26 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.557 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -131.58 116.09 16.95 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.437 -0.79 . . . . 0.0 109.372 178.515 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -116.6 149.46 39.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 110.436 -179.295 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.531 HD12 ' HG3' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -130.11 143.38 50.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.477 -0.765 . . . . 0.0 109.521 179.884 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.21 112.58 7.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.018 -1.051 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.285 -0.884 . . . . 0.0 110.089 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.637 ' NE ' ' CH2' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.283 0.563 . . . . 0.0 109.859 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.51 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 6.5 ptmt -123.3 141.79 51.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.437 -179.683 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.728 ' HB2' HG22 ' A' ' 27' ' ' THR . 1.7 ptpt -101.0 151.14 22.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.361 -0.837 . . . . 0.0 109.626 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -115.61 118.77 34.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.019 -1.051 . . . . 0.0 111.992 -179.109 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 12.1 mt -94.94 110.96 24.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.528 -0.732 . . . . 0.0 109.585 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.863 HG22 HG22 ' A' ' 54' ' ' VAL . 6.4 t -102.09 143.22 15.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.09 -1.006 . . . . 0.0 110.458 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.537 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 29.6 tp60 -116.44 150.58 37.6 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.298 -0.876 . . . . 0.0 109.098 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.511 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.5 m -124.91 155.75 33.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 118.324 -1.351 . . . . 0.0 109.973 178.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.939 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -47.76 178.34 0.03 OUTLIER Pre-proline 0 C--N 1.291 -1.969 0 O-C-N 121.839 -0.538 . . . . 0.0 110.73 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.939 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.7 Cg_endo -74.23 142.78 30.95 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.386 1.73 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.65 -40.98 2.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.521 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 6.6 mt-30 -70.18 176.88 3.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -1.199 . . . . 0.0 110.387 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 178.42 102.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.18 -179.192 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.859 HD12 ' CD2' ' A' ' 26' ' ' TYR . 8.3 mt -55.99 87.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.914 -1.116 . . . . 0.0 109.597 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' LYS . 11.1 pt-20 -57.99 -13.22 4.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.429 -0.795 . . . . 0.0 110.946 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.757 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.27 -33.53 58.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.108 -0.995 . . . . 0.0 110.777 -179.16 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.757 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.24 -23.04 12.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.927 -1.108 . . . . 0.0 109.929 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.2 mm-40 -52.9 -33.83 52.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.436 -0.79 . . . . 0.0 110.413 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.67 6.06 58.72 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.007 HD23 HD11 ' A' ' 13' ' ' LEU . 1.3 tp -76.02 -25.43 55.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -1.17 . . . . 0.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.584 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 8.2 mt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.158 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.535 ' C ' HG23 ' A' ' 30' ' ' VAL . 5.4 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.231 0.538 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.973 HD12 ' HB3' ' A' ' 42' ' ' ALA . 4.8 mt -56.02 148.0 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.02 -100.36 0.44 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 110.663 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.38 161.66 23.13 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.042 -1.037 . . . . 0.0 110.718 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HG3' HD22 ' A' ' 92' ' ' LEU . 49.8 Cg_endo -76.6 157.99 35.99 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.126 1.593 . . . . 0.0 110.308 179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.017 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.4 m -100.03 140.0 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.0 110.272 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.759 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.64 113.17 26.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.95 . . . . 0.0 110.19 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 52.7 m -167.01 135.13 2.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.3 mm-40 -42.86 -47.45 5.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.92 . . . . 0.0 110.038 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -54.79 -35.92 64.36 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 19' ' ' ALA . . . -79.91 -63.71 1.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 0.0 110.183 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.854 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 1.3 m-85 -42.87 -26.25 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 110.406 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -88.42 -35.32 17.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.691 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -83.23 -38.34 11.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 178.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.69 -15.06 60.35 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.728 -0.866 . . . . 0.0 108.882 178.871 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -63.97 -17.15 62.99 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.485 0.66 . . . . 0.0 109.916 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.18 -2.76 52.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.412 -0.805 . . . . 0.0 110.203 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 117.78 0.77 17.56 Favored Glycine 0 N--CA 1.478 1.5 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 73.2 mttt -81.96 140.33 34.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -1.108 . . . . 0.0 109.617 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 64.4 m-85 -127.85 104.85 8.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.572 -1.33 . . . . 0.0 111.982 -178.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.002 HG23 HD11 ' A' ' 80' ' ' ILE . 1.9 m -79.44 140.15 37.45 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.43 0.634 . . . . 0.0 109.291 178.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.859 ' HB3' HG23 ' A' ' 8' ' ' ILE . 17.0 m-85 -140.24 165.18 28.08 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 110.404 -179.196 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 1.017 ' NE1' HG12 ' A' ' 12' ' ' VAL . 96.3 m95 -105.12 121.8 44.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 176.897 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 7' ' ' VAL . 4.9 p -144.03 165.46 13.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.778 -176.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.461 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -59.62 149.6 70.34 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.75 -179.369 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . 47.1 Cg_endo -73.65 71.66 3.92 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.208 1.636 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.487 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.08 -34.05 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.356 -0.84 . . . . 0.0 110.156 -179.095 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -47.65 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.364 -0.835 . . . . 0.0 110.212 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -43.34 167.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.545 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.2 mtpt -64.13 -58.06 7.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.925 . . . . 0.0 110.349 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.495 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.5 m -58.74 -39.29 80.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.951 . . . . 0.0 110.177 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 6.4 mt-10 -55.89 -45.98 78.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 0.0 109.651 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.711 ' O ' HD11 ' A' ' 8' ' ' ILE . 17.7 mt -57.13 -30.13 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.493 -0.755 . . . . 0.0 110.015 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.552 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.0 ttmm -57.77 -47.51 82.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.414 -0.804 . . . . 0.0 111.799 -179.283 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -58.7 -45.95 88.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 112.63 -177.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.973 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.75 -48.45 81.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.768 -1.207 . . . . 0.0 111.893 -178.266 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.959 HG13 HD13 ' A' ' 8' ' ' ILE . 19.1 m -74.47 -28.89 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.424 -1.422 . . . . 0.0 110.467 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -52.61 64.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.836 -1.165 . . . . 0.0 109.219 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.2 p -80.25 -45.42 17.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.853 179.011 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -58.44 -65.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.419 -0.801 . . . . 0.0 110.57 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.663 ' HE1' HD21 ' A' ' 92' ' ' LEU . 31.8 m-85 -71.48 -19.07 62.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.996 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER 68.08 46.31 1.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 110.517 179.643 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.753 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -134.01 -165.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.437 -0.789 . . . . 0.0 110.259 179.907 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.753 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -118.74 111.18 18.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.545 -0.722 . . . . 0.0 109.881 179.274 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.898 HG13 ' CG1' ' A' ' 81' ' ' VAL . 89.4 t -78.77 136.32 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 110.134 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.673 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.7 p -118.25 -7.3 11.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.277 -0.889 . . . . 0.0 110.164 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -176.67 131.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.819 179.41 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.087 HG23 HG13 ' A' ' 81' ' ' VAL . 1.2 t -123.68 119.64 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.999 -1.063 . . . . 0.0 110.258 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.488 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 1.6 t30 -116.74 115.91 26.51 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.218 178.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -109.55 145.44 36.33 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.57 -179.611 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.58 160.45 28.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.275 -0.891 . . . . 0.0 110.903 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -72.98 115.12 11.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.25 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.745 HG11 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.267 -0.895 . . . . 0.0 110.229 -179.279 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.587 ' CG ' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.152 0.501 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HA ' HG23 ' A' ' 59' ' ' VAL . 13.2 tttt -121.15 137.99 54.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.068 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.69 ' HD3' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -105.44 150.67 25.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 110.001 -179.901 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.785 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -128.88 128.64 44.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.091 -1.006 . . . . 0.0 112.347 -179.212 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.002 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -108.69 111.88 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.087 HG13 HG23 ' A' ' 54' ' ' VAL . 5.0 t -108.37 137.46 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 111.234 -178.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.673 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.4 tp60 -111.17 154.08 24.86 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.265 -0.897 . . . . 0.0 108.742 178.403 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 87' ' ' GLN . 2.9 m -116.45 155.82 17.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 C-N-CA 118.257 -1.377 . . . . 0.0 108.643 177.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.966 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -56.19 -179.6 0.09 OUTLIER Pre-proline 0 C--N 1.284 -2.244 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.032 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.966 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.3 Cg_endo -71.68 140.4 35.73 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 124.103 1.581 . . . . 0.0 110.387 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.05 -23.34 29.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.534 ' HB2' HG23 ' A' ' 83' ' ' VAL . 35.7 mt-30 -87.1 167.93 13.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.259 -1.142 . . . . 0.0 110.641 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HD3' ' OH ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER 179.45 115.49 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.332 -0.855 . . . . 0.0 110.653 179.89 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.629 ' CG2' ' CD1' ' A' ' 47' ' ' PHE . 9.2 mt -78.05 75.53 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.548 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.71 -13.09 1.49 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.508 -0.745 . . . . 0.0 111.479 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.748 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -53.59 -20.6 5.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.933 -1.105 . . . . 0.0 110.629 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.748 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.47 -23.21 12.56 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.001 -1.062 . . . . 0.0 109.609 179.506 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -54.61 -35.71 63.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 110.373 -179.581 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.11 -4.9 71.1 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 95' ' ' LEU . 3.0 tp -69.24 -5.47 23.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.091 -1.24 . . . . 0.0 110.194 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.614 ' CG1' ' CZ ' ' A' ' 18' ' ' TYR . 20.3 mt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.21 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 8' ' ' ILE . 11.3 t . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.973 HD12 ' HB3' ' A' ' 42' ' ' ALA . 6.8 mt -74.07 158.13 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.991 -1.068 . . . . 0.0 110.151 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 9' ' ' LEU . 34.1 mt -140.71 -99.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 110.251 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.68 155.96 39.69 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 110.346 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.957 ' HG3' HD22 ' A' ' 92' ' ' LEU . 46.0 Cg_endo -73.71 153.76 48.83 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.978 1.514 . . . . 0.0 110.255 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.941 HG12 ' CE2' ' A' ' 29' ' ' TRP . 2.3 m -92.14 141.12 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.271 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.766 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.83 107.5 18.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.932 . . . . 0.0 110.204 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 15' ' ' GLU . 22.3 m -161.54 143.06 11.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.104 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' SER . 9.8 tm-20 -43.19 -51.31 6.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.004 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -42.67 71.87 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.23 -0.919 . . . . 0.0 110.218 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 18' ' ' TYR . . . -70.83 -65.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.703 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.6 m-85 -42.55 -27.62 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 110.317 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -90.38 -34.85 15.5 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.24 -0.913 . . . . 0.0 109.562 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -78.58 -44.98 9.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.158 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.629 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.04 -22.36 64.96 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.56 -0.964 . . . . 0.0 108.734 178.936 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -52.6 -19.37 2.28 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.333 0.587 . . . . 0.0 110.661 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.06 15.08 19.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.868 . . . . 0.0 110.498 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 97.61 1.01 59.04 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HD2' HG21 ' A' ' 80' ' ' ILE . 2.8 mttp -82.5 143.37 31.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -1.089 . . . . 0.0 109.552 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 1.079 ' CD2' HD12 ' A' ' 89' ' ' ILE . 23.1 m-85 -127.81 103.87 7.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.761 -1.212 . . . . 0.0 111.918 -179.338 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.058 HG23 HD11 ' A' ' 80' ' ' ILE . 1.9 m -75.62 141.28 42.88 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.785 ' CB ' HG23 ' A' ' 8' ' ' ILE . 18.4 m-85 -138.0 165.24 27.05 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.353 -0.842 . . . . 0.0 110.48 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.941 ' CE2' HG12 ' A' ' 12' ' ' VAL . 22.4 m95 -101.68 120.79 40.89 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.287 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.785 HG13 ' HE2' ' A' ' 77' ' ' LYS . 1.9 p -152.57 165.31 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 118.481 -1.288 . . . . 0.0 111.522 -176.693 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.566 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -70.9 172.55 6.2 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.713 -0.617 . . . . 0.0 110.683 -179.51 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.9 Cg_endo -75.35 -59.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.241 1.653 . . . . 0.0 110.413 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -38.46 -26.0 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.552 179.283 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.725 ' HB3' ' NZ ' ' A' ' 77' ' ' LYS . . . -62.95 90.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.82 -1.175 . . . . 0.0 110.051 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -49.49 162.66 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 -179.84 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -57.47 -56.22 24.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.86 . . . . 0.0 110.117 -179.964 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.6 m -60.49 -34.77 74.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.307 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -55.79 -42.65 75.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 109.642 179.776 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.775 ' O ' HD11 ' A' ' 8' ' ' ILE . 9.0 mt -57.65 -30.96 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.145 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HG3' HG11 ' A' ' 51' ' ' VAL . 13.3 tttp -62.22 -46.25 89.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 110.52 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -59.12 -49.12 79.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.477 -0.764 . . . . 0.0 112.003 -178.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.973 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -66.12 -47.65 73.43 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.849 -1.157 . . . . 0.0 111.417 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.907 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -63.7 -39.54 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.864 -1.147 . . . . 0.0 110.395 -179.325 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.24 -47.33 78.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.0 -1.063 . . . . 0.0 109.609 179.939 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.3 p -79.42 -45.07 20.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.357 -0.839 . . . . 0.0 109.883 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.12 -69.61 0.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.418 -0.801 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.907 ' CD2' HG22 ' A' ' 43' ' ' VAL . 77.5 m-85 -71.63 -21.81 61.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.132 -0.98 . . . . 0.0 110.219 -179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 9.2 mttt 65.2 40.08 5.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.744 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -117.88 -162.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.485 0.659 . . . . 0.0 110.313 -179.896 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.744 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -118.2 104.52 10.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.522 -0.736 . . . . 0.0 109.486 178.946 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.817 HG22 HG11 ' A' ' 81' ' ' VAL . 27.0 t -78.81 119.8 28.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.694 -179.223 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.652 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.5 p -103.17 -0.57 10.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.295 -0.878 . . . . 0.0 109.812 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.571 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.97 146.87 0.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 179.385 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.924 HG22 HG22 ' A' ' 81' ' ' VAL . 1.2 t -133.37 122.25 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.516 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -121.99 115.8 23.17 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 109.086 178.639 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.641 ' C ' HD23 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -120.67 140.84 51.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 110.305 -179.481 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.677 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -148.55 149.93 32.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.634 -0.667 . . . . 0.0 109.345 -179.847 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.616 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 5.5 m-70 -86.34 143.51 27.82 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.151 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.461 ' H ' HG22 ' A' ' 59' ' ' VAL . 15.9 m . . . . . 0 C--N 1.289 -2.051 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.785 ' HE2' HG13 ' A' ' 30' ' ' VAL . 3.4 ttpt -96.29 128.99 43.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 111.077 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 28.7 pttt -119.54 151.3 38.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.413 -0.804 . . . . 0.0 109.348 179.147 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.761 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -118.06 128.77 55.08 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.89 -1.131 . . . . 0.0 113.03 -178.356 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.058 HD11 HG23 ' A' ' 27' ' ' THR . 1.7 mp -107.58 111.24 34.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.546 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.924 HG22 HG22 ' A' ' 54' ' ' VAL . 23.4 t -107.37 139.0 30.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 111.005 -178.703 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.652 ' C ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -105.59 153.32 21.95 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.341 -0.849 . . . . 0.0 108.789 179.008 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.53 HG11 ' HE2' ' A' ' 26' ' ' TYR . 1.5 m -119.16 156.52 21.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 C-N-CA 118.171 -1.412 . . . . 0.0 109.327 178.343 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -64.46 177.03 0.61 Allowed Pre-proline 0 C--N 1.287 -2.138 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.223 -179.711 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.5 Cg_endo -74.81 138.4 23.46 Favored 'Trans proline' 0 C--N 1.298 -2.093 0 O-C-N 124.296 1.682 . . . . 0.0 110.19 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.68 -31.88 7.0 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.531 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -108.45 174.09 6.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.037 -1.272 . . . . 0.0 110.669 -179.917 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 178.99 130.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.487 -0.758 . . . . 0.0 110.081 179.827 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.079 HD12 ' CD2' ' A' ' 26' ' ' TYR . 40.1 mt -83.74 82.5 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 110.118 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -13.83 10.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.522 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.766 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.09 -19.6 7.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 0.0 110.525 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.957 HD22 ' HG3' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -106.21 -23.07 12.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.086 -1.009 . . . . 0.0 109.674 179.834 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -58.87 -54.74 43.75 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.426 -0.796 . . . . 0.0 110.442 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -73.9 -21.9 78.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.688 HD23 HD11 ' A' ' 13' ' ' LEU . 6.8 tp -42.71 -27.15 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -1.145 . . . . 0.0 110.363 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.516 HG13 ' CE1' ' A' ' 18' ' ' TYR . 40.0 mt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.779 HG12 HG13 ' A' ' 8' ' ' ILE . 15.5 t . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.237 0.541 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.059 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.3 mt -69.57 157.62 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 110.83 -178.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -152.13 -93.23 0.05 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 110.723 179.836 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -91.81 141.63 25.75 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.088 -1.008 . . . . 0.0 110.909 -179.455 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.2 Cg_endo -77.16 173.49 14.3 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.207 1.635 . . . . 0.0 110.821 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.978 HG12 ' NE1' ' A' ' 29' ' ' TRP . 1.2 m -115.21 127.4 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.339 -0.85 . . . . 0.0 110.032 179.841 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.802 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.0 mm? -103.08 113.27 26.62 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 110.351 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.7 m -158.15 161.54 37.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.133 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -58.03 -55.26 37.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -54.66 -21.61 11.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.45 -52.03 3.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.802 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -49.5 -34.99 18.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.925 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.41 -8.63 50.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.38 -42.8 1.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -66.31 -17.05 64.53 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.56 -0.964 . . . . 0.0 108.91 178.879 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.72 -20.13 46.15 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.747 -0.596 . . . . 0.0 110.658 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.468 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 3.2 tt0 -88.54 17.71 5.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.458 -0.776 . . . . 0.0 110.123 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.09 4.12 69.26 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -178.582 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 48.2 mttm -82.76 134.96 35.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.591 -0.947 . . . . 0.0 109.445 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 1.032 ' CD2' HD12 ' A' ' 89' ' ' ILE . 24.6 m-85 -128.21 98.03 4.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.562 -1.336 . . . . 0.0 111.537 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.4 m -75.02 132.89 41.66 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.638 -0.664 . . . . 0.0 109.915 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.67 ' CB ' HG23 ' A' ' 8' ' ' ILE . 34.8 m-85 -126.72 163.72 22.9 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.244 -179.651 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.978 ' NE1' HG12 ' A' ' 12' ' ' VAL . 95.8 m95 -95.11 122.61 37.96 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.117 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.628 HG23 ' C ' ' A' ' 7' ' ' VAL . 2.7 p -149.02 164.38 4.23 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 C-N-CA 117.649 -1.62 . . . . 0.0 112.224 -176.634 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.453 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -56.75 140.78 75.09 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.281 -179.905 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 48.9 Cg_endo -74.83 80.02 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.199 1.631 . . . . 0.0 110.262 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 178.47 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 110.112 -179.133 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -54.36 97.03 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.406 -0.809 . . . . 0.0 110.282 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.475 ' OG1' ' CG ' ' A' ' 38' ' ' GLU . 2.2 p -42.82 149.52 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 110.168 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.631 ' O ' HG11 ' A' ' 54' ' ' VAL . 5.7 mmtp -42.61 -40.72 2.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.183 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 3.5 m -75.12 -39.07 60.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.31 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.475 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 7.8 mt-10 -55.68 -44.25 77.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 109.808 179.825 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.685 ' O ' HD11 ' A' ' 8' ' ' ILE . 14.5 mt -57.24 -30.32 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.618 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.672 ' HG3' HG11 ' A' ' 51' ' ' VAL . 24.2 tttt -57.82 -42.98 85.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 0.0 111.258 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -58.19 -49.11 78.2 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.404 -0.81 . . . . 0.0 112.428 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.059 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -68.47 -47.98 65.71 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.711 -1.243 . . . . 0.0 111.759 -178.357 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.034 HG11 HG11 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -59.78 -47.09 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.908 -1.12 . . . . 0.0 110.013 -179.431 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.503 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -56.82 -43.38 80.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.095 -1.003 . . . . 0.0 109.831 179.897 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -79.14 -27.39 42.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 109.97 179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.42 -61.64 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.074 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.842 ' CD2' HG22 ' A' ' 43' ' ' VAL . 52.1 m-85 -71.8 -20.88 61.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.961 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 62.86 39.92 10.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.458 -0.776 . . . . 0.0 110.104 179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.771 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -119.32 -164.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.807 179.705 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.771 ' N ' HG13 ' A' ' 49' ' ' VAL . 5.4 tmtm? -113.42 106.6 14.78 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.443 -0.786 . . . . 0.0 109.364 179.021 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.799 HG22 ' CG1' ' A' ' 81' ' ' VAL . 44.7 t -78.22 130.72 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 110.145 -179.397 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.665 HG12 ' C ' ' A' ' 82' ' ' GLN . 13.3 p -114.96 -9.77 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.409 -0.807 . . . . 0.0 110.271 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.615 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 176.75 129.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 109.932 179.696 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.1 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.6 OUTLIER -109.15 141.56 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.104 179.847 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.56 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.6 m-20 -130.04 115.52 17.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.285 -0.884 . . . . 0.0 109.561 178.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -108.85 159.82 16.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.916 -179.459 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.903 HD11 ' HE3' ' A' ' 78' ' ' LYS . 1.8 pp -148.47 177.88 9.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.211 -0.931 . . . . 0.0 110.853 -179.37 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.83 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -74.95 134.53 41.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.967 179.642 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.902 . . . . 0.0 109.358 179.677 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.104 0.478 . . . . 0.0 110.266 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.562 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 6.3 tttp -123.78 142.2 51.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.903 ' HE3' HD11 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -100.59 138.39 37.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.073 . . . . 0.0 109.792 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -133.22 119.36 19.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.097 -1.002 . . . . 0.0 111.836 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.626 HG12 HG23 ' A' ' 27' ' ' THR . 16.7 mt -99.9 109.91 25.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.857 178.327 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.1 HG22 ' CG2' ' A' ' 54' ' ' VAL . 52.8 t -96.73 129.46 46.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 110.02 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.665 ' C ' HG12 ' A' ' 52' ' ' VAL . 2.5 tp60 -98.86 153.2 18.97 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.013 179.358 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 1.5 m -119.66 156.6 22.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 C-N-CA 118.327 -1.349 . . . . 0.0 108.632 177.769 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.907 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -69.84 179.29 0.81 Allowed Pre-proline 0 C--N 1.283 -2.309 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.133 -179.71 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.907 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.06 140.76 31.76 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 124.263 1.665 . . . . 0.0 110.432 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.45 -37.1 3.95 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.887 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -104.31 176.8 5.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.125 -1.221 . . . . 0.0 110.643 -179.897 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.55 115.04 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.488 -0.757 . . . . 0.0 110.001 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.032 HD12 ' CD2' ' A' ' 26' ' ' TYR . 14.1 mt -60.94 109.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.23 -0.919 . . . . 0.0 110.464 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 17.8 pt-20 -78.12 -14.33 59.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.318 -0.863 . . . . 0.0 110.745 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.705 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.15 -28.67 54.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.0 110.373 -179.638 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.764 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.02 -23.13 12.71 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.165 -0.959 . . . . 0.0 109.467 179.788 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 25.3 mm-40 -54.53 -24.42 20.66 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.43 -0.794 . . . . 0.0 110.165 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.63 -36.35 4.85 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.433 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 3.5 mp -49.32 -31.94 10.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.375 -1.073 . . . . 0.0 110.114 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.783 HG22 ' CD1' ' A' ' 18' ' ' TYR . 46.4 pt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.181 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 30' ' ' VAL . 8.4 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.369 0.604 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.048 HD11 HG23 ' A' ' 39' ' ' ILE . 14.7 mm -87.04 102.8 12.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 121.371 -0.83 . . . . 0.0 110.466 -178.564 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.607 ' H ' HD12 ' A' ' 9' ' ' LEU . 4.5 mp -62.51 -107.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 110.431 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.539 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -108.64 164.22 15.22 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.961 -1.087 . . . . 0.0 110.257 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 45.9 Cg_endo -73.31 153.5 50.79 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.982 1.517 . . . . 0.0 110.176 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.749 HG12 ' O ' ' A' ' 27' ' ' THR . 1.4 p -112.96 114.64 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.939 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.84 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.5 mm? -101.49 112.5 25.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 110.345 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.526 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -158.31 154.95 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.951 -179.981 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.0 mm-40 -43.08 -58.07 2.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 110.038 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 22.4 ttmt -54.72 -19.17 5.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.526 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -99.84 -54.58 2.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 110.065 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.567 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 3.1 m-85 -53.82 -50.86 65.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.968 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -12.7 37.93 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.224 -0.922 . . . . 0.0 109.14 179.204 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' N ' ' A' ' 22' ' ' ALA . . . -94.46 -40.47 4.46 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 178.384 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 3.4 m-30 -51.44 -24.67 5.24 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.601 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 20' ' ' GLY . . . -43.27 -36.3 1.76 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.467 0.651 . . . . 0.0 110.25 -179.718 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.449 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 2.2 tt0 -95.9 16.48 17.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.412 -0.805 . . . . 0.0 110.515 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 80.64 6.74 89.17 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HG2' ' HG3' ' A' ' 82' ' ' GLN . 49.9 mttt -82.17 132.62 35.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.241 -1.152 . . . . 0.0 109.755 179.812 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.861 ' CD2' HD12 ' A' ' 89' ' ' ILE . 70.7 m-85 -126.46 111.84 14.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.775 -1.203 . . . . 0.0 111.988 -178.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.749 ' O ' HG12 ' A' ' 12' ' ' VAL . 36.8 m -75.73 141.97 42.53 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.606 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.896 ' CD1' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -141.11 164.72 29.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 -179.221 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.6 ' CE3' ' HG2' ' A' ' 76' ' ' ARG . 79.6 m95 -93.5 122.4 35.89 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.166 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 7' ' ' VAL . 7.6 p -137.05 164.64 29.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.68 -178.101 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.431 ' HB3' ' CG ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.14 150.03 97.9 Favored Pre-proline 0 C--N 1.294 -1.835 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.343 -179.839 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.54 67.3 3.7 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 O-C-N 124.222 1.643 . . . . 0.0 109.769 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 179.35 -32.38 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.455 -0.778 . . . . 0.0 109.828 -178.886 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.619 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -49.54 101.06 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.368 -0.833 . . . . 0.0 110.218 -179.765 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.468 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -49.8 141.5 10.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.348 -179.974 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.539 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -43.84 -36.06 2.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 110.209 179.846 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.0 m -75.11 -49.04 20.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.468 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 1.6 mm-40 -54.79 -42.29 71.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 0.0 109.859 -179.74 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.048 HG23 HD11 ' A' ' 8' ' ' ILE . 21.3 mt -57.54 -30.69 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.9 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.737 ' HG3' HG11 ' A' ' 51' ' ' VAL . 7.8 tttt -60.94 -44.04 97.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.469 -0.77 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -58.43 -34.35 70.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.767 . . . . 0.0 111.927 -178.636 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . -72.97 -50.4 23.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.594 -1.316 . . . . 0.0 111.754 -178.66 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.08 HG21 HG11 ' A' ' 81' ' ' VAL . 27.7 m -66.53 -31.35 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.578 -1.326 . . . . 0.0 110.557 -179.586 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.781 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.02 -52.93 61.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.057 -1.027 . . . . 0.0 109.97 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -80.18 -24.49 40.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 110.28 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -84.97 -56.38 3.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 0.0 110.812 -179.467 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.843 ' CE2' HG12 ' A' ' 43' ' ' VAL . 8.1 m-30 -71.72 -16.21 62.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.064 -1.022 . . . . 0.0 110.238 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 66.0 46.52 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.473 -0.767 . . . . 0.0 110.724 179.585 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.799 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -136.54 -164.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.365 -0.835 . . . . 0.0 110.253 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.799 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -114.52 105.13 12.73 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.422 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.798 HG21 HG23 ' A' ' 43' ' ' VAL . 57.9 t -77.71 119.19 25.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 110.33 -179.029 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.612 HG12 ' C ' ' A' ' 82' ' ' GLN . 7.3 p -96.2 -20.64 5.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.547 -0.721 . . . . 0.0 109.619 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.581 ' HG3' ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -167.9 146.17 4.53 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.428 -0.795 . . . . 0.0 109.942 179.865 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.874 HG23 HG13 ' A' ' 81' ' ' VAL . 1.2 t -132.14 116.78 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.684 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.523 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -114.1 115.1 27.0 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.0 -1.062 . . . . 0.0 109.614 179.17 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.678 HG21 HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -110.75 141.44 44.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.345 -0.847 . . . . 0.0 110.248 -179.249 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.06 148.61 49.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 109.944 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.94 126.56 30.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 110.403 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.556 HG21 ' CE ' ' A' ' 78' ' ' LYS . 1.6 m . . . . . 0 C--N 1.302 -1.492 0 O-C-N 121.585 -0.697 . . . . 0.0 110.168 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.6 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.255 0.55 . . . . 0.0 110.181 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.527 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 81.2 tttt -106.62 136.87 45.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.577 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.613 ' HG3' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.67 151.09 30.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.485 179.555 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -125.56 120.13 30.03 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.027 -1.045 . . . . 0.0 112.867 -179.169 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 10.2 mt -96.68 110.52 24.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.237 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.08 HG11 HG21 ' A' ' 43' ' ' VAL . 2.2 t -101.3 130.94 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 110.369 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.612 ' C ' HG12 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -112.55 153.63 27.21 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.023 -1.048 . . . . 0.0 109.639 179.346 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 1.9 m -115.41 157.21 16.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.065 177.898 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.937 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -61.93 174.81 0.62 Allowed Pre-proline 0 C--N 1.29 -2.019 0 O-C-N 121.238 -0.914 . . . . 0.0 110.827 -179.527 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.5 Cg_endo -76.73 58.13 5.86 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.465 1.771 . . . . 0.0 110.57 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.19 -33.79 0.02 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.937 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -112.38 -179.94 3.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.119 -1.224 . . . . 0.0 110.457 -179.779 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HA ' HG21 ' A' ' 83' ' ' VAL . 4.2 ptpt -170.73 125.54 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.861 HD12 ' CD2' ' A' ' 26' ' ' TYR . 59.8 mt -68.43 98.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.152 -0.968 . . . . 0.0 110.161 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 1.9 mt-10 -70.65 -13.52 62.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.415 -0.803 . . . . 0.0 110.81 -179.587 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.722 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.48 -28.88 47.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.067 -1.02 . . . . 0.0 110.407 -179.376 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.85 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.19 -22.55 12.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.162 -0.961 . . . . 0.0 109.402 179.605 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.624 ' O ' HD12 ' A' ' 96' ' ' ILE . 13.2 mm-40 -56.53 -54.09 49.92 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.494 -0.753 . . . . 0.0 110.33 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.65 -14.71 79.6 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.581 HD23 HD21 ' A' ' 13' ' ' LEU . 2.2 tp -67.92 -7.71 30.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.134 -1.216 . . . . 0.0 110.132 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 93' ' ' GLU . 45.4 mt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.205 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.675 ' O ' HG23 ' A' ' 30' ' ' VAL . 2.1 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.478 0.656 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.675 ' CD1' HG23 ' A' ' 39' ' ' ILE . 5.6 mm -102.83 121.64 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 110.589 -178.484 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 9' ' ' LEU . 20.0 mt -96.41 -107.19 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.507 -0.746 . . . . 0.0 109.867 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.79 158.02 36.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.066 -1.021 . . . . 0.0 110.127 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.685 ' HG3' HD22 ' A' ' 92' ' ' LEU . 46.9 Cg_endo -73.62 140.16 29.19 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.915 1.481 . . . . 0.0 109.65 179.38 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.676 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.6 m -85.39 132.21 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.015 -1.053 . . . . 0.0 110.172 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.848 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 2.8 mm? -102.77 112.73 25.66 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.168 -0.958 . . . . 0.0 110.119 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' ALA . 3.1 m -163.54 148.62 11.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 110.045 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 14' ' ' SER . 58.7 mt-10 -42.88 -53.67 4.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 110.004 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -54.9 -21.98 13.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.19 -0.944 . . . . 0.0 110.116 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -100.31 -57.28 2.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 110.272 -179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.848 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -47.03 -34.7 5.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.938 . . . . 0.0 110.303 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.07 -8.88 50.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.994 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -103.61 -34.01 3.97 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -80.24 -18.95 48.01 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.702 -0.881 . . . . 0.0 108.95 179.164 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -55.21 -21.73 14.98 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.416 0.627 . . . . 0.0 110.732 -179.522 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.99 17.08 6.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.533 ' HA2' ' CE ' ' A' ' 88' ' ' LYS . . . 93.17 0.69 67.67 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.233 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 62.4 mttt -82.43 142.23 32.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.479 -1.012 . . . . 0.0 109.293 179.628 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.722 ' CD1' HD12 ' A' ' 92' ' ' LEU . 26.7 m-85 -128.79 111.02 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.662 -1.274 . . . . 0.0 111.511 -179.267 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.8 HG23 HD11 ' A' ' 80' ' ' ILE . 26.7 m -82.78 125.29 31.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.612 0.72 . . . . 0.0 110.151 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.983 ' CE2' HG11 ' A' ' 43' ' ' VAL . 22.0 m-30 -119.3 165.53 14.16 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.706 -0.621 . . . . 0.0 109.662 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.676 ' CD1' HG12 ' A' ' 12' ' ' VAL . 1.9 m95 -103.02 122.84 45.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.062 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.5 p -149.01 164.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.571 -1.251 . . . . 0.0 111.596 -176.814 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -62.69 151.4 84.36 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.896 -0.503 . . . . 0.0 110.659 -179.346 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.537 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 46.7 Cg_endo -73.81 70.1 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.236 1.651 . . . . 0.0 109.906 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.24 -33.75 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 110.324 -178.988 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . . . -41.75 98.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 110.179 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -41.33 138.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 0.0 110.322 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.527 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 1.4 mttt -42.56 -35.89 1.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.9 m -75.04 -36.07 61.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 110.019 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.441 ' OE1' ' HA ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -55.91 -46.21 78.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.998 179.807 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.703 ' O ' HG22 ' A' ' 43' ' ' VAL . 6.2 mt -57.31 -30.24 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.542 179.585 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.534 ' HG3' HG11 ' A' ' 51' ' ' VAL . 12.5 tttm -62.99 -47.55 82.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.628 -0.67 . . . . 0.0 111.324 -179.433 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.62 -34.65 78.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.311 -0.868 . . . . 0.0 111.76 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -49.49 29.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.981 -1.075 . . . . 0.0 111.705 -178.622 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.983 HG11 ' CE2' ' A' ' 28' ' ' PHE . 26.7 m -71.21 -28.5 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.683 -1.26 . . . . 0.0 110.765 -179.301 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.53 -51.66 67.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.8 -1.188 . . . . 0.0 109.22 179.542 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -79.41 -45.09 20.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.83 . . . . 0.0 109.728 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -61.17 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.46 -0.775 . . . . 0.0 110.531 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CD1' ' CG2' ' A' ' 89' ' ' ILE . 24.5 m-85 -71.69 -21.09 61.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.026 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.8 mttt 63.76 47.4 3.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.858 . . . . 0.0 110.556 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.769 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -130.33 -162.84 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.514 -0.741 . . . . 0.0 110.017 179.967 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.769 ' N ' HG13 ' A' ' 49' ' ' VAL . 2.2 tmtt? -118.1 107.43 13.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.423 -0.798 . . . . 0.0 109.839 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.663 HG22 HG11 ' A' ' 81' ' ' VAL . 49.2 t -78.6 119.84 28.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.216 -0.927 . . . . 0.0 110.166 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.5 p -112.59 4.96 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.893 . . . . 0.0 110.035 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER 171.88 120.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.222 179.902 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.086 HG23 HG13 ' A' ' 81' ' ' VAL . 1.2 t -115.87 136.27 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 0.0 110.125 179.664 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.527 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 1.1 t-20 -131.26 116.51 17.72 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.468 -0.77 . . . . 0.0 109.482 179.154 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -113.75 166.3 11.69 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.07 -1.019 . . . . 0.0 109.871 -179.724 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.717 ' C ' HD12 ' A' ' 57' ' ' LEU . 2.8 pp -152.63 146.29 25.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.918 . . . . 0.0 110.64 -179.027 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -81.75 122.13 27.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.05 -1.032 . . . . 0.0 109.759 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.731 HG13 ' CG ' ' A' ' 76' ' ' ARG . 1.2 p . . . . . 0 C--N 1.298 -1.662 0 O-C-N 121.818 -0.551 . . . . 0.0 110.437 -178.928 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.731 ' CG ' HG13 ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.622 ' CG ' HG13 ' A' ' 30' ' ' VAL . 7.5 pttt -123.88 131.32 53.56 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.758 -1.214 . . . . 0.0 110.717 -179.013 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 12.5 ptpt -101.7 151.42 22.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.404 -0.81 . . . . 0.0 108.908 179.085 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -116.37 120.1 37.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.773 -1.204 . . . . 0.0 112.712 -178.601 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.8 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -97.07 112.17 28.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.227 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.086 HG13 HG23 ' A' ' 54' ' ' VAL . 6.4 t -109.53 132.25 58.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 111.14 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.69 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -103.52 149.89 24.43 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.395 -0.816 . . . . 0.0 108.84 179.078 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.529 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.3 m -116.11 157.98 16.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.445 -1.302 . . . . 0.0 109.744 179.008 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.915 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -76.36 -178.37 0.92 Allowed Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.048 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.915 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.2 Cg_endo -72.09 135.9 26.03 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 O-C-N 124.087 1.572 . . . . 0.0 109.937 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.79 -50.56 0.76 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.719 ' HB2' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.18 174.58 6.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.166 -1.196 . . . . 0.0 110.53 179.889 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.533 ' CE ' ' HA2' ' A' ' 24' ' ' GLY . 0.3 OUTLIER 178.68 115.72 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.478 -0.763 . . . . 0.0 110.315 -179.855 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' CD2' ' A' ' 26' ' ' TYR . 7.5 mt -68.26 63.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.886 -1.134 . . . . 0.0 109.48 179.347 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 88' ' ' LYS . 2.4 mm-40 -54.3 -12.83 0.72 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.64 -0.663 . . . . 0.0 111.72 -179.558 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.917 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -53.42 -16.03 1.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.882 -1.136 . . . . 0.0 110.968 -179.058 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.754 HD23 ' N ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -101.76 -23.04 14.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.862 -1.149 . . . . 0.0 109.514 179.43 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -54.19 -29.0 44.34 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.458 -0.776 . . . . 0.0 110.396 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -96.91 -24.64 12.71 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.917 HD13 ' O ' ' A' ' 91' ' ' ALA . 3.5 mp -42.42 -28.9 0.24 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -1.144 . . . . 0.0 110.182 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.556 HG12 ' CE1' ' A' ' 18' ' ' TYR . 72.8 mt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 120.764 0.316 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.7 ' HA ' ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -85.61 65.66 9.27 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.19 -1.404 . . . . 0.0 108.08 178.249 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.813 HG22 ' CB ' ' A' ' 45' ' ' THR . 13.3 p -108.64 -104.87 0.36 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.519 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -84.13 -5.08 59.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.019 -1.051 . . . . 0.0 109.133 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.896 ' CZ ' HG23 ' A' ' 7' ' ' VAL 0.25 0.1 OUTLIER -52.83 -139.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.976 0.893 . . . . 0.0 111.178 178.496 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.661 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 31.6 m-20 -30.04 -59.04 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.788 -0.57 . . . . 0.0 112.019 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.04 HG13 ' HB1' ' A' ' 34' ' ' ALA . 66.3 t -51.41 -109.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.451 -0.78 . . . . 0.0 111.06 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.026 HG13 HG12 ' A' ' 7' ' ' VAL . 29.0 mt -84.99 104.44 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.657 -1.277 . . . . 0.0 110.749 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 54.2 mt -75.42 -93.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.761 . . . . 0.0 110.987 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.33 157.77 34.18 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.122 -0.986 . . . . 0.0 110.92 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 48.8 Cg_endo -77.01 160.95 33.24 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.149 1.605 . . . . 0.0 110.415 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 27' ' ' THR . 1.2 p -115.31 116.56 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 109.831 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.836 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.4 mm? -98.85 112.06 24.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.401 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.637 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -155.36 157.42 37.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.048 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 5.5 tm-20 -43.52 -61.24 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 110.069 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.74 -17.68 3.76 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.31 -0.869 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.637 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -99.4 -52.16 3.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 109.995 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.605 ' CE1' ' CG1' ' A' ' 96' ' ' ILE . 2.1 m-85 -56.47 -58.1 9.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.157 -0.964 . . . . 0.0 109.931 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.66 -12.82 37.18 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.272 -0.892 . . . . 0.0 109.186 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 21' ' ' PHE . . . -86.31 -47.19 5.02 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 7.7 m-30 -47.88 -28.42 2.63 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -38.31 -38.26 0.35 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.399 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.15 -17.88 23.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.359 -0.838 . . . . 0.0 110.44 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 118.05 4.52 14.32 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 1.7 mmtm -81.69 135.72 35.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -1.123 . . . . 0.0 109.505 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.69 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.1 m-85 -127.15 111.16 13.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.017 -1.052 . . . . 0.0 112.167 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.778 HG23 HD11 ' A' ' 80' ' ' ILE . 24.9 m -77.99 140.05 39.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.935 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -137.5 164.33 28.97 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.066 -1.021 . . . . 0.0 111.349 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.507 ' CZ3' HG21 ' A' ' 59' ' ' VAL . 70.7 m95 -99.31 122.59 42.67 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.934 HG23 ' C ' ' A' ' 7' ' ' VAL . 2.6 p -144.02 156.71 15.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.787 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -62.36 151.73 81.58 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.778 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.9 Cg_endo -73.41 71.12 3.87 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.183 1.622 . . . . 0.0 110.047 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.57 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.3 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 1.04 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -44.27 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.94 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -42.67 144.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 110.338 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -42.53 -52.86 4.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 109.909 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.8 m -62.37 -36.51 82.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.475 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.2 OUTLIER -56.47 -44.14 80.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.184 -0.947 . . . . 0.0 109.569 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.978 HG23 HD11 ' A' ' 8' ' ' ILE . 1.7 mt -57.61 -32.56 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.315 -0.865 . . . . 0.0 108.805 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG3' HG11 ' A' ' 51' ' ' VAL . 6.4 ttmm -59.25 -45.81 90.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.851 . . . . 0.0 109.621 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 1.024 ' O ' HG23 ' A' ' 45' ' ' THR . 5.2 m120 -71.83 -34.0 68.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.645 -0.659 . . . . 0.0 111.146 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.903 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.51 -50.16 73.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.176 . . . . 0.0 110.501 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.123 HG12 ' CE2' ' A' ' 47' ' ' PHE . 3.3 m -76.25 -34.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.879 -1.138 . . . . 0.0 110.641 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -60.95 -29.84 69.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.031 -1.043 . . . . 0.0 110.374 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 1.024 HG23 ' O ' ' A' ' 41' ' ' ASN . 34.4 p -78.52 -46.47 19.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.51 -55.03 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 110.72 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 1.123 ' CE2' HG12 ' A' ' 43' ' ' VAL . 6.6 m-30 -71.54 -14.72 62.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.065 -1.022 . . . . 0.0 110.141 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 16.0 mttm 42.48 47.03 4.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.147 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.777 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.88 -163.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.569 -0.707 . . . . 0.0 110.008 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.777 ' N ' HG13 ' A' ' 49' ' ' VAL . 1.2 tmtp? -118.08 110.27 17.43 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.431 -0.793 . . . . 0.0 109.709 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.554 HG11 ' HG3' ' A' ' 40' ' ' LYS . 30.0 t -78.63 119.72 28.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.359 -0.838 . . . . 0.0 110.043 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.79 HG12 ' O ' ' A' ' 82' ' ' GLN . 10.9 p -110.0 7.02 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.309 -0.87 . . . . 0.0 110.025 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER 169.68 119.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 109.987 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.98 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -121.12 120.83 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.115 -0.99 . . . . 0.0 110.072 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.49 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -121.63 115.95 23.69 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.23 178.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.54 HG21 HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -116.35 150.62 37.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.147 -0.97 . . . . 0.0 110.588 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.718 HD21 ' HE2' ' A' ' 78' ' ' LYS . 1.2 pp -141.5 154.88 45.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 109.79 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.441 ' HE1' ' HB3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -67.43 134.04 50.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.42 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.507 HG21 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -120.0 133.22 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.367 -0.833 . . . . 0.0 110.092 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 27.9 mmt180 -118.48 151.88 36.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.111 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.31 156.76 0.5 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -45.14 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -1.141 . . . . 0.0 110.202 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -78.53 3.97 14.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -0.83 . . . . 0.0 110.18 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.536 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 8.2 pttm 38.56 32.94 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.535 -0.728 . . . . 0.0 110.558 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -160.56 -49.47 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.221 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.3 OUTLIER 53.56 104.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . 44.75 -169.36 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -51.8 -173.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.392 -1.064 . . . . 0.0 110.344 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ARG . 5.9 t80 -42.26 102.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.272 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.31 40.36 0.31 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 72' ' ' LYS . . . 151.26 -65.0 0.37 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER 65.84 142.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -1.148 . . . . 0.0 110.135 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 1.6 tmm_? -42.59 103.91 0.33 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.245 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.16 -166.48 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.051 1.553 . . . . 0.0 110.319 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.27 89.4 3.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.422 -0.799 . . . . 0.0 109.3 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -118.35 145.85 44.82 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.537 -0.727 . . . . 0.0 110.267 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HG2' HG13 ' A' ' 30' ' ' VAL . 12.8 tttt -123.59 140.92 52.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -0.945 . . . . 0.0 110.648 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.718 ' HE2' HD21 ' A' ' 57' ' ' LEU . 2.1 ttpt -107.97 150.55 26.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.333 -0.855 . . . . 0.0 109.623 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.67 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -133.18 121.79 23.06 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.056 -1.027 . . . . 0.0 112.495 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.778 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -101.62 111.95 33.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.98 HG13 HG23 ' A' ' 54' ' ' VAL . 3.8 t -107.46 131.24 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.435 -0.791 . . . . 0.0 110.454 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.79 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -111.38 146.63 36.8 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.923 -1.111 . . . . 0.0 108.952 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 87' ' ' GLN . 1.5 m -114.52 156.08 15.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.654 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.942 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -57.34 178.79 0.15 Allowed Pre-proline 0 C--N 1.29 -1.981 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.525 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.942 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.5 Cg_endo -72.7 145.16 40.82 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 O-C-N 124.149 1.605 . . . . 0.0 110.572 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.84 -18.38 47.62 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.54 ' HB2' HG23 ' A' ' 83' ' ' VAL . 57.7 mt-30 -94.59 171.58 8.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 110.557 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 3.1 pttt 179.68 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.823 . . . . 0.0 110.303 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.69 HD12 ' CD2' ' A' ' 26' ' ' TYR . 7.5 mt -63.08 118.62 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.95 . . . . 0.0 110.085 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -76.59 -14.74 59.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -0.826 . . . . 0.0 110.678 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.742 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -56.23 -34.67 66.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 110.946 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.23 -23.5 12.56 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.985 -1.072 . . . . 0.0 110.149 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.683 ' O ' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -65.67 -43.24 89.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.259 -0.901 . . . . 0.0 110.289 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.3 8.27 75.31 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.786 HD23 HD21 ' A' ' 13' ' ' LEU . 2.3 tp -88.58 24.87 1.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -1.155 . . . . 0.0 110.245 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 93' ' ' GLU . 6.9 mt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.248 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.538 ' O ' ' N ' ' A' ' 3' ' ' THR . 5.8 tpt . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.688 ' HA ' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -64.76 76.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.22 -1.392 . . . . 0.0 108.936 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.741 HG21 ' CB ' ' A' ' 45' ' ' THR . 0.9 OUTLIER -120.59 -97.41 0.46 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 111.299 -179.011 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.868 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -88.69 -31.0 18.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.975 . . . . 0.0 110.352 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.917 ' CE1' HG23 ' A' ' 7' ' ' VAL . 1.9 p90 -34.04 -28.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.862 -0.524 . . . . 0.0 112.255 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.585 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 3.6 m-20 -164.0 -51.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.8 -1.187 . . . . 0.0 111.165 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.993 HG13 ' HB1' ' A' ' 34' ' ' ALA . 39.0 t -43.96 -67.97 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 122.128 0.966 . . . . 0.0 109.281 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.932 HD11 HG23 ' A' ' 39' ' ' ILE . 8.7 mt -115.05 95.48 3.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.487 -0.758 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.6 mt -79.04 -97.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.553 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -108.16 167.28 9.51 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.076 -1.015 . . . . 0.0 110.497 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.716 ' HB3' HD13 ' A' ' 92' ' ' LEU . 46.7 Cg_endo -73.68 171.11 18.47 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.14 1.6 . . . . 0.0 110.529 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.706 HG12 ' CD1' ' A' ' 29' ' ' TRP . 3.0 m -115.36 144.32 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.411 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.3 mm? -102.65 107.49 18.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.212 -0.93 . . . . 0.0 110.328 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 17' ' ' ALA . 5.5 m -164.9 134.79 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.868 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' SER . 7.2 mt-10 -42.88 -59.34 2.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.117 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 -17.44 6.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.958 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.16 17.24 17.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.887 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.721 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 2.2 m-85 -139.18 -38.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.388 -0.82 . . . . 0.0 109.933 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.35 80.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.05 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 25' ' ' LYS . . . -95.52 -34.95 5.84 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.09 -17.73 64.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -70.5 -17.05 62.96 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.725 -0.61 . . . . 0.0 110.654 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -88.7 16.37 6.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 110.341 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 102.07 -2.06 51.33 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.48 136.45 34.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.514 -0.992 . . . . 0.0 109.534 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.758 ' HD1' HD12 ' A' ' 92' ' ' LEU . 99.5 m-85 -126.69 116.01 20.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 0.0 111.626 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.093 HG23 HD11 ' A' ' 80' ' ' ILE . 3.7 m -83.26 141.29 31.97 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.83 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 26.5 m-85 -134.06 164.37 27.47 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.33 -0.856 . . . . 0.0 110.933 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.706 ' CD1' HG12 ' A' ' 12' ' ' VAL . 19.6 m95 -97.01 122.35 39.91 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 7' ' ' VAL . 11.6 p -138.69 164.91 25.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.059 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.602 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 1.6 t60 -81.13 152.85 71.66 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.304 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 44.5 Cg_endo -70.89 65.7 2.46 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.06 1.558 . . . . 0.0 109.727 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.73 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.665 -179.195 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.993 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -42.42 95.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.44 -0.787 . . . . 0.0 109.602 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -39.39 134.27 1.23 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.382 -0.824 . . . . 0.0 110.894 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.651 ' HA ' HD12 ' A' ' 39' ' ' ILE . 1.9 mttt -46.9 -48.02 21.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.83 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.8 m -62.04 -39.53 92.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 0.0 109.424 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 4.7 mt-10 -55.83 -40.9 73.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 108.937 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.932 HG23 HD11 ' A' ' 8' ' ' ILE . 30.6 mt -58.0 -31.03 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.469 -0.77 . . . . 0.0 109.003 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.611 ' O ' HG21 ' A' ' 51' ' ' VAL . 3.8 tttt -59.54 -47.3 86.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.777 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.4 m-80 -72.75 -34.02 66.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.701 -0.624 . . . . 0.0 111.194 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.696 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.0 -50.43 73.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.786 -1.196 . . . . 0.0 110.553 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.785 HG11 ' CE2' ' A' ' 28' ' ' PHE . 3.7 m -67.3 -32.84 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.651 -1.281 . . . . 0.0 109.489 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -69.04 -44.51 72.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 108.812 178.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.741 ' CB ' HG21 ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.07 -16.44 56.77 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.868 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -104.23 -67.44 0.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.498 -0.751 . . . . 0.0 110.315 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.752 ' HE1' HD21 ' A' ' 92' ' ' LEU . 52.4 m-85 -71.95 -21.91 61.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.0 110.343 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 64.94 46.4 2.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.789 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -123.56 -158.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.512 -0.743 . . . . 0.0 110.136 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.789 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -116.89 110.4 18.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 109.762 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.611 HG21 ' O ' ' A' ' 40' ' ' LYS . 92.3 t -78.73 120.4 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.931 . . . . 0.0 110.321 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 82' ' ' GLN . 10.1 p -112.83 3.85 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.263 -0.898 . . . . 0.0 109.988 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 1.8 mttp 169.12 119.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.055 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.031 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.87 131.39 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.048 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.513 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 13.1 t30 -131.17 115.97 17.07 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.34 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.57 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -116.61 161.36 19.29 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.193 -0.942 . . . . 0.0 109.945 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -156.65 170.83 21.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.383 -0.823 . . . . 0.0 110.188 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.461 ' NE2' ' OD2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -80.76 129.77 34.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 110.219 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.099 HG11 ' CD ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -120.16 125.94 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.48 -0.762 . . . . 0.0 110.074 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' A' ' 74' ' ' PRO . 15.7 mmt85 -114.95 131.09 57.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 110.264 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -107.59 138.51 14.59 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -79.47 -2.36 41.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -1.17 . . . . 0.0 110.272 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -117.53 177.58 4.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.213 -0.929 . . . . 0.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.87 25.33 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.269 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 67' ' ' GLY . 36.9 ptt180 -104.58 -29.76 10.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.205 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -41.79 100.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -0.834 . . . . 0.0 110.401 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 65' ' ' ARG . . . -179.23 155.62 16.42 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.573 ' O ' ' CD2' ' A' ' 69' ' ' TYR . 7.5 mtt85 -89.39 179.39 6.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -1.157 . . . . 0.0 110.3 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER 50.72 113.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.851 0.834 . . . . 0.0 111.106 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 42.73 40.22 1.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.069 -1.02 . . . . 0.0 110.15 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 72' ' ' LYS . . . -99.83 -178.12 30.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 71' ' ' GLY . 14.6 mtpt 56.77 111.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -1.168 . . . . 0.0 110.1 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER 44.16 77.27 0.46 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 110.088 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 50.9 Cg_endo -77.4 -165.01 0.3 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.179 1.621 . . . . 0.0 110.393 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.461 ' OD2' ' NE2' ' A' ' 58' ' ' HIS . 0.3 OUTLIER -114.68 89.4 3.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.62 ' HB3' HG23 ' A' ' 59' ' ' VAL . 4.3 mpt_? -101.81 143.11 32.13 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.581 -0.699 . . . . 0.0 110.201 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.598 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.4 tttt -120.87 133.69 55.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 1.099 ' CD ' HG11 ' A' ' 59' ' ' VAL . 3.8 mttt -110.23 151.48 27.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.367 -0.833 . . . . 0.0 109.942 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -123.14 119.77 31.25 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.933 -1.104 . . . . 0.0 112.193 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.093 HD11 HG23 ' A' ' 27' ' ' THR . 1.5 mp -102.42 111.88 33.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.031 HG22 ' CG2' ' A' ' 54' ' ' VAL . 24.0 t -111.08 136.09 48.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.486 -0.759 . . . . 0.0 110.433 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.815 ' O ' HG12 ' A' ' 52' ' ' VAL . 1.9 tp60 -111.47 151.32 28.72 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.222 -0.924 . . . . 0.0 108.868 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.583 HG21 ' C ' ' A' ' 87' ' ' GLN . 2.0 m -112.68 155.71 13.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 C-N-CA 118.069 -1.453 . . . . 0.0 109.531 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.971 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -49.16 179.03 0.03 OUTLIER Pre-proline 0 C--N 1.291 -1.936 0 O-C-N 121.543 -0.723 . . . . 0.0 110.482 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.971 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.4 Cg_endo -71.79 140.07 34.76 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.22 1.642 . . . . 0.0 110.492 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.19 -24.58 12.97 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.684 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 87.1 mt-30 -95.82 164.37 12.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -1.148 . . . . 0.0 110.619 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.525 ' N ' HG21 ' A' ' 83' ' ' VAL . 0.0 OUTLIER 179.43 108.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.245 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.591 ' HB ' ' CE1' ' A' ' 26' ' ' TYR . 91.4 mt -51.11 91.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.126 -0.984 . . . . 0.0 109.541 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 4.1 mm-40 -63.01 -13.39 34.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 111.206 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.768 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.65 -33.76 61.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 110.804 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -106.87 -23.67 12.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.952 -1.092 . . . . 0.0 110.507 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -48.95 -30.97 6.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.163 -0.961 . . . . 0.0 110.14 -179.149 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.48 -19.89 11.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.524 ' CD2' ' HG2' ' A' ' 11' ' ' PRO . 26.7 tp -53.13 -19.14 2.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -1.114 . . . . 0.0 110.054 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.638 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 32.4 mt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.131 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.774 0.321 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.708 ' HA ' ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -85.22 65.9 9.45 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.017 178.324 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.767 HG22 HG21 ' A' ' 45' ' ' THR . 11.7 p -108.87 -105.71 0.35 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 8' ' ' ILE . . . -83.51 -5.12 59.07 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.983 -1.073 . . . . 0.0 109.198 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.911 ' CZ ' HG23 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -52.54 -140.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.094 0.95 . . . . 0.0 111.394 178.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.648 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 14.2 m-20 -29.87 -58.43 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.81 -0.556 . . . . 0.0 112.144 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.071 HG13 ' HB1' ' A' ' 34' ' ' ALA . 58.2 t -52.71 -109.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.497 -0.752 . . . . 0.0 110.994 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.034 HD11 HG23 ' A' ' 39' ' ' ILE . 24.0 mt -88.28 113.19 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 120.681 -1.262 . . . . 0.0 111.268 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.4 mp -92.06 -88.22 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.291 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.03 150.85 40.91 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.45 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.487 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.8 Cg_endo -74.32 -178.21 3.8 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.065 1.561 . . . . 0.0 110.177 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.673 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.16 133.33 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.149 -0.969 . . . . 0.0 110.347 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.746 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -103.12 112.83 25.87 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.193 -0.942 . . . . 0.0 110.185 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 17' ' ' ALA . 60.6 m -163.79 128.65 2.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.145 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -42.96 -58.63 2.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.898 . . . . 0.0 110.048 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -17.63 3.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 110.215 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.7 -48.04 5.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 110.149 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.586 ' CE2' HG13 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -52.79 -33.1 47.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 109.772 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.47 -21.6 66.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -100.81 -37.59 3.64 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 105.683 -2.967 . . . . 0.0 105.683 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.612 ' CD1' ' HA ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -64.64 -19.17 65.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.24 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' TYR . . . -93.36 4.63 53.66 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.219 0.533 . . . . 0.0 110.629 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -111.87 16.58 20.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.764 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 95.69 -24.82 27.79 Favored Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 39.7 mttm -81.79 140.42 34.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.352 -1.087 . . . . 0.0 109.153 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.905 ' CD2' HD12 ' A' ' 89' ' ' ILE . 35.4 m-85 -126.92 110.18 12.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.803 -1.186 . . . . 0.0 112.234 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.668 HG23 HD11 ' A' ' 80' ' ' ILE . 28.3 m -80.57 118.25 21.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.914 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -116.99 164.97 13.9 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 111.638 -178.176 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.673 ' CD1' HG12 ' A' ' 12' ' ' VAL . 7.4 m95 -97.81 123.0 41.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.0 p -145.56 157.45 12.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 C-N-CA 118.195 -1.402 . . . . 0.0 111.712 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.602 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -59.21 149.57 67.3 Favored Pre-proline 0 C--N 1.297 -1.679 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.044 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.602 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 47.7 Cg_endo -73.02 71.57 3.47 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.061 1.558 . . . . 0.0 109.808 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.48 -33.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.417 -0.802 . . . . 0.0 109.932 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 1.071 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -42.36 93.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.484 -0.76 . . . . 0.0 109.799 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -42.17 141.68 0.88 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 110.443 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 4.3 mmtp -42.63 -41.13 2.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.372 -0.83 . . . . 0.0 109.778 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 62.1 m -70.97 -35.93 72.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.728 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 5.8 mt-10 -58.54 -42.53 88.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.553 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.034 HG23 HD11 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -57.48 -31.68 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.57 ' HG3' HG11 ' A' ' 51' ' ' VAL . 8.1 tttm -62.97 -46.37 88.02 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.552 -0.717 . . . . 0.0 109.627 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.982 ' O ' HG23 ' A' ' 45' ' ' THR . 38.4 m-80 -72.97 -34.12 66.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.601 -0.687 . . . . 0.0 110.921 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 3' ' ' THR . . . -57.74 -50.27 73.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.932 -1.105 . . . . 0.0 110.43 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 39' ' ' ILE . 2.7 m -76.64 -36.61 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.869 -1.144 . . . . 0.0 110.654 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -56.92 -32.31 65.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.942 -1.099 . . . . 0.0 110.256 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.982 HG23 ' O ' ' A' ' 41' ' ' ASN . 35.4 p -77.99 -46.01 22.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.234 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.06 -55.61 4.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 0.0 110.735 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.894 ' CD1' HG23 ' A' ' 89' ' ' ILE . 21.0 m-85 -71.67 -21.33 61.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.155 -0.966 . . . . 0.0 110.372 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 51.08 44.52 28.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.778 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -115.29 -162.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.633 -0.667 . . . . 0.0 109.923 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.778 ' N ' HG13 ' A' ' 49' ' ' VAL . 8.0 tmtt? -117.2 108.32 15.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.893 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.57 HG11 ' HG3' ' A' ' 40' ' ' LYS . 33.5 t -78.44 119.64 27.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.242 -0.911 . . . . 0.0 109.769 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 82' ' ' GLN . 3.3 p -107.26 -12.75 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.43 -0.794 . . . . 0.0 110.167 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -173.15 123.4 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.979 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.945 ' CG2' HG13 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -123.63 131.2 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.192 -0.942 . . . . 0.0 110.085 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 2.5 m-20 -131.07 115.82 16.95 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.645 HG21 HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.8 146.04 41.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 58' ' ' HIS . 2.3 pp -128.01 153.45 46.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.279 -0.888 . . . . 0.0 110.608 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.566 ' NE2' ' NH2' ' A' ' 60' ' ' ARG . 2.0 t-160 -66.32 118.32 9.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.144 -0.973 . . . . 0.0 109.279 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.581 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -103.87 121.29 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.246 -0.909 . . . . 0.0 110.013 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.566 ' NH2' ' NE2' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -130.57 122.07 26.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 47.19 -174.04 0.02 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.48 -30.44 3.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -1.097 . . . . 0.0 110.141 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 64' ' ' LYS . 7.7 tptp -160.41 68.65 0.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.173 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 63' ' ' LYS . 7.3 mttt 52.95 171.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.22 -9.01 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.928 . . . . 0.0 110.406 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER 41.29 51.83 3.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.249 -0.907 . . . . 0.0 110.203 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 66' ' ' LEU . . . 41.19 44.67 3.85 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -153.34 -177.55 6.41 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.497 -1.002 . . . . 0.0 110.193 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.419 ' N ' ' HG3' ' A' ' 68' ' ' ARG . 22.3 t80 -93.32 92.63 7.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.0 110.132 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.36 39.91 1.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 110.156 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 72' ' ' LYS . . . 128.6 -38.52 2.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 7.1 mttt 63.11 -176.31 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -1.134 . . . . 0.0 109.984 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.36 78.4 22.63 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 110.453 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HG2' ' NE ' ' A' ' 76' ' ' ARG . 51.5 Cg_endo -77.02 -165.73 0.34 Allowed 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.063 1.56 . . . . 0.0 110.265 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' HA ' ' NH2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -115.07 89.39 3.09 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.53 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.582 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -124.1 151.45 43.88 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.624 -0.673 . . . . 0.0 110.365 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.581 ' HA ' HG23 ' A' ' 59' ' ' VAL . 19.9 tttt -123.5 137.51 54.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.561 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 6.9 mttt -101.06 147.69 25.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.164 -0.96 . . . . 0.0 109.936 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.62 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -133.44 121.87 22.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.0 111.873 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 80' ' ' ILE . 1.6 mp -98.67 111.7 28.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.945 HG13 ' CG2' ' A' ' 54' ' ' VAL . 2.4 t -107.41 122.27 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.505 -0.747 . . . . 0.0 110.659 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.741 ' O ' HG12 ' A' ' 52' ' ' VAL . 4.5 tp-100 -104.37 142.81 33.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 109.016 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.486 ' N ' ' OE1' ' A' ' 82' ' ' GLN . 1.1 m -109.76 156.99 10.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 C-N-CA 118.15 -1.42 . . . . 0.0 109.896 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -72.14 178.83 1.19 Allowed Pre-proline 0 C--N 1.291 -1.965 0 O-C-N 121.65 -0.656 . . . . 0.0 110.235 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.1 Cg_endo -73.04 140.4 31.29 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 124.234 1.65 . . . . 0.0 110.345 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.63 -30.36 9.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.555 ' HB2' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -112.19 176.39 5.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.204 -1.174 . . . . 0.0 110.467 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.3 OUTLIER 179.3 115.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 110.331 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.905 HD12 ' CD2' ' A' ' 26' ' ' TYR . 39.5 mt -67.91 60.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.174 -0.954 . . . . 0.0 109.655 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 88' ' ' LYS . 14.1 pt-20 -58.2 -13.08 4.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.445 -0.785 . . . . 0.0 111.022 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.714 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.24 -16.63 2.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.989 -1.07 . . . . 0.0 110.627 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.811 HD21 ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -106.21 -23.23 12.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.062 -1.024 . . . . 0.0 109.634 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.4 -19.75 6.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.352 -0.842 . . . . 0.0 110.332 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.08 -20.16 11.67 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.631 HD23 HD11 ' A' ' 13' ' ' LEU . 14.5 tp -46.36 -24.37 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.586 HG13 ' CE2' ' A' ' 18' ' ' TYR . 2.0 mp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.21 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.516 ' O ' ' N ' ' A' ' 3' ' ' THR . 4.1 ptm . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 120.585 0.231 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.735 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -61.5 87.8 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.08 -1.448 . . . . 0.0 108.848 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.769 HG22 ' HB ' ' A' ' 45' ' ' THR . 3.2 p -133.72 -19.95 2.04 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.756 0.789 . . . . 0.0 110.984 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.605 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . 178.71 -27.24 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.628 -0.67 . . . . 0.0 109.337 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.735 ' CE1' ' HA ' ' A' ' 2' ' ' LYS 0.277 0.1 OUTLIER -45.97 -135.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.857 0.837 . . . . 0.0 112.059 178.17 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.646 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 5.7 t0 -24.39 -58.62 0.05 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.866 0.841 . . . . 0.0 111.305 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.966 HG12 HG13 ' A' ' 8' ' ' ILE . 39.6 t -70.24 156.67 7.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.779 -0.576 . . . . 0.0 110.977 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.966 HG13 HG12 ' A' ' 7' ' ' VAL . 16.2 mt 24.56 51.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.302 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 30' ' ' VAL . 3.5 mt -44.71 -99.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.307 -0.87 . . . . 0.0 111.262 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -99.56 151.68 37.53 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.924 -1.11 . . . . 0.0 110.816 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.632 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 49.8 Cg_endo -76.33 153.6 35.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.103 1.581 . . . . 0.0 110.519 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 27' ' ' THR . 1.5 p -115.15 105.21 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.058 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.818 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.12 106.75 17.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.667 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -135.57 -178.54 5.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.184 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -57.34 -67.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.251 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -45.66 74.46 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.258 -0.901 . . . . 0.0 110.354 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.667 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -56.21 -48.9 75.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.665 ' CE1' HG22 ' A' ' 96' ' ' ILE . 1.9 m-85 -57.9 -33.33 68.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.875 . . . . 0.0 110.147 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.37 -8.88 49.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.858 . . . . 0.0 109.865 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -103.33 -38.23 2.88 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.626 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -74.94 -18.88 60.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.571 -0.958 . . . . 0.0 108.873 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.404 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -56.92 -20.7 24.79 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.702 -0.624 . . . . 0.0 110.729 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.6 17.27 5.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.38 -0.825 . . . . 0.0 110.059 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.04 0.89 67.74 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 48.8 mttt -82.79 143.47 30.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.567 -0.961 . . . . 0.0 109.545 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 1.126 ' CD2' HD12 ' A' ' 89' ' ' ILE . 22.9 m-85 -128.01 99.41 5.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.611 -1.306 . . . . 0.0 111.083 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.79 HG23 HD11 ' A' ' 80' ' ' ILE . 2.7 m -74.63 127.32 32.83 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.641 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -131.44 165.23 23.98 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.314 -0.866 . . . . 0.0 111.162 -178.236 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.515 ' NE1' ' HB ' ' A' ' 12' ' ' VAL . 46.1 m95 -100.0 123.27 44.06 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.807 ' HA ' HD12 ' A' ' 9' ' ' LEU . 2.0 p -142.55 164.81 17.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.081 -176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.656 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 1.1 t-160 -65.34 149.76 96.64 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.545 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.656 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 48.1 Cg_endo -73.18 67.49 4.22 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.088 1.573 . . . . 0.0 109.434 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.72 -32.19 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.405 -0.81 . . . . 0.0 110.062 -178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.717 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.09 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.692 . . . . 0.0 109.882 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -45.99 142.12 2.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.0 110.388 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -42.81 -38.62 2.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.841 . . . . 0.0 109.675 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.6 m -73.17 -36.24 66.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.556 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -59.32 -43.46 92.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.158 -0.963 . . . . 0.0 109.207 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.821 ' O ' HD11 ' A' ' 8' ' ' ILE . 13.4 mt -57.75 -30.46 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.673 ' HG3' HG11 ' A' ' 51' ' ' VAL . 14.5 tttt -65.29 -45.09 85.82 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.595 0.712 . . . . 0.0 110.127 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 1.056 ' O ' HG23 ' A' ' 45' ' ' THR . 10.1 m-80 -71.27 -49.31 44.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.59 -0.694 . . . . 0.0 111.905 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.608 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.16 -51.07 70.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.792 -1.192 . . . . 0.0 110.946 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.792 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -59.45 -40.92 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.84 -1.162 . . . . 0.0 110.249 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -65.6 -29.56 70.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.181 -0.949 . . . . 0.0 110.755 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 1.056 HG23 ' O ' ' A' ' 41' ' ' ASN . 28.1 p -66.17 -47.08 75.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.081 . . . . 0.0 110.979 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.56 -56.67 3.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 111.338 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.792 ' CD2' HG22 ' A' ' 43' ' ' VAL . 8.8 m-85 -71.59 -21.19 61.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.147 -0.971 . . . . 0.0 110.694 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 31.1 mtmt 48.42 41.02 16.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 109.665 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -102.87 -161.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.721 -0.612 . . . . 0.0 109.625 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.788 ' N ' HG13 ' A' ' 49' ' ' VAL . 6.0 tmtm? -114.48 112.38 22.9 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.68 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 40' ' ' LYS . 48.8 t -77.64 119.79 27.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.79 HG21 ' N ' ' A' ' 84' ' ' ALA . 41.1 t -114.21 -14.5 10.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.487 -0.758 . . . . 0.0 110.554 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.9 OUTLIER -178.75 115.1 0.07 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.463 -0.773 . . . . 0.0 109.998 179.365 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.884 ' CG2' HG13 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -112.76 130.9 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.808 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.485 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 17.3 m120 -130.48 115.96 17.54 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.793 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.568 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.58 160.27 19.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.6 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.544 HD11 HG13 ' A' ' 59' ' ' VAL . 1.7 pp -141.71 166.64 24.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.592 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.591 ' CD2' ' HG2' ' A' ' 60' ' ' ARG . 5.7 t-160 -77.47 118.36 19.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.127 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -119.6 130.93 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.284 -0.885 . . . . 0.0 110.187 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.591 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 15.7 mmt85 -145.21 137.26 25.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . -50.75 -178.06 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 62' ' ' LYS . 0.7 OUTLIER -139.45 48.96 1.83 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.35 -1.088 . . . . 0.0 110.122 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 64' ' ' LYS . 1.3 tttp -148.42 -90.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -42.31 -71.65 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 0.0 110.249 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -52.21 159.1 1.0 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.262 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER 178.38 107.08 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.396 -0.815 . . . . 0.0 110.145 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.51 ' O ' ' CG ' ' A' ' 68' ' ' ARG . . . -43.35 94.36 0.01 OUTLIER Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 66' ' ' LEU . 28.4 mtt180 -165.39 -172.29 2.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -1.106 . . . . 0.0 110.126 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 18.6 p90 -47.73 135.21 12.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 110.119 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER 40.86 41.22 1.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.424 -0.798 . . . . 0.0 110.358 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.1 147.25 18.37 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.56 160.53 31.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -1.149 . . . . 0.0 110.259 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.501 ' HG3' ' HD2' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -96.42 146.96 32.22 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 0.0 110.17 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HD2' ' HG3' ' A' ' 73' ' ' ARG . 48.4 Cg_endo -73.86 -165.28 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.033 1.544 . . . . 0.0 110.464 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.543 ' CB ' ' HG3' ' A' ' 32' ' ' PRO . 76.6 m-20 -114.71 89.64 3.14 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.475 -0.766 . . . . 0.0 109.261 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.512 ' HG2' ' HB ' ' A' ' 59' ' ' VAL . 6.8 ttm180 -129.35 112.49 13.9 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.625 -0.672 . . . . 0.0 109.961 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.613 ' HA ' HG23 ' A' ' 59' ' ' VAL . 13.7 tttt -123.06 139.21 54.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.912 . . . . 0.0 110.076 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.663 ' HE2' HG21 ' A' ' 12' ' ' VAL . 15.4 mttt -101.88 147.22 26.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.335 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.716 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -131.49 126.71 35.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.12 -0.987 . . . . 0.0 111.847 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.79 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -105.61 111.77 36.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.884 HG13 ' CG2' ' A' ' 54' ' ' VAL . 1.4 t -96.44 141.47 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.435 -0.791 . . . . 0.0 110.284 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 53' ' ' LYS . 7.5 tp60 -121.13 142.46 49.84 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.376 -0.828 . . . . 0.0 109.507 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.6 m -125.24 156.65 34.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.437 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.79 ' N ' HG21 ' A' ' 52' ' ' VAL . . . -44.19 171.87 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.798 0 CA-C-O 121.302 0.572 . . . . 0.0 110.854 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.4 Cg_endo -77.8 53.94 4.6 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 O-C-N 124.39 1.732 . . . . 0.0 110.232 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -167.42 -47.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.565 ' HB3' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -51.04 -173.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -1.155 . . . . 0.0 110.848 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 3.4 pttt 178.98 80.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.505 -0.747 . . . . 0.0 110.416 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.126 HD12 ' CD2' ' A' ' 26' ' ' TYR . 5.2 mt -47.69 109.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.736 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 4.7 mm-40 -67.43 -14.64 63.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 0.0 110.74 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.728 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -57.47 -36.8 71.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.201 -0.937 . . . . 0.0 110.84 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.861 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.99 -23.55 12.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.009 -1.057 . . . . 0.0 110.107 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.0 mm-40 -60.63 -31.9 71.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -0.903 . . . . 0.0 110.239 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.35 -12.8 40.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -80.4 -10.66 59.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.208 -1.172 . . . . 0.0 110.203 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.74 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.03 -0.985 . . . . 0.0 110.216 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.561 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.754 0.312 . . . . 0.0 110.583 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.768 ' HA ' HD21 ' A' ' 9' ' ' LEU . 48.1 mmtt -44.6 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.616 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.4 m 4.45 -71.74 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.636 0 CA-C-O 121.233 0.54 . . . . 0.0 110.865 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.002 ' O ' HG23 ' A' ' 7' ' ' VAL 0.26 . . -55.69 81.02 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 177.158 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.906 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER 23.56 47.9 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.827 0.822 . . . . 0.0 110.405 -178.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.619 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 4.7 t0 65.77 52.89 1.23 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.0 0.905 . . . . 0.0 111.447 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 4' ' ' ALA . 3.0 t -134.48 -126.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.239 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.897 HD11 ' HA ' ' A' ' 39' ' ' ILE . 2.7 mt -57.55 152.0 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.16 -0.962 . . . . 0.0 110.315 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 2' ' ' LYS . 2.2 mt -132.87 -99.34 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.479 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.58 153.66 42.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.02 . . . . 0.0 110.504 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.616 ' HG3' HD22 ' A' ' 92' ' ' LEU . 47.7 Cg_endo -74.94 161.53 38.76 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.07 1.563 . . . . 0.0 110.354 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.78 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.7 m -104.86 143.02 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.226 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.718 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.41 106.89 17.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -154.78 142.11 19.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.997 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 9.7 tm-20 -42.52 -52.65 4.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.895 . . . . 0.0 110.145 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -54.72 -42.02 71.02 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.107 -0.996 . . . . 0.0 110.094 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.54 ' N ' ' CG ' ' A' ' 16' ' ' LYS . . . -65.97 -63.24 1.13 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.34 -0.85 . . . . 0.0 110.028 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.541 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 1.6 m-85 -48.8 -30.66 5.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 110.302 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.21 -9.2 55.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.48 -38.39 1.78 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -73.61 -23.47 59.91 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.533 -0.98 . . . . 0.0 108.974 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -51.39 -21.09 2.06 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.628 -0.67 . . . . 0.0 110.064 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.36 16.37 13.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.266 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.73 2.36 65.08 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.582 ' HB3' HG23 ' A' ' 80' ' ' ILE . 77.0 mttt -82.26 142.53 32.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -1.14 . . . . 0.0 109.544 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 1.107 ' CD2' HD12 ' A' ' 89' ' ' ILE . 19.9 m-85 -127.7 104.23 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.751 -1.218 . . . . 0.0 112.073 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.86 HG23 HD11 ' A' ' 80' ' ' ILE . 2.8 m -76.01 124.54 27.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.801 ' CB ' HG23 ' A' ' 8' ' ' ILE . 14.9 m-85 -124.72 164.92 18.91 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.525 -0.734 . . . . 0.0 110.989 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.78 ' NE1' HG12 ' A' ' 12' ' ' VAL . 33.4 m95 -102.88 122.24 44.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.698 HG23 ' C ' ' A' ' 7' ' ' VAL . 5.2 p -144.49 165.49 12.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.496 -1.282 . . . . 0.0 111.81 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.479 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -60.81 148.53 82.65 Favored Pre-proline 0 C--N 1.297 -1.678 0 O-C-N 121.927 -0.483 . . . . 0.0 110.495 -179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.9 Cg_endo -72.39 71.05 3.14 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.15 1.605 . . . . 0.0 109.915 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.538 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.18 -33.85 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.947 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -50.3 90.63 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.412 -0.805 . . . . 0.0 109.98 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -48.41 176.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.546 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -69.01 -28.84 66.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 110.185 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.2 m -75.06 -52.25 11.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.872 . . . . 0.0 110.583 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.722 ' H ' HG23 ' A' ' 35' ' ' THR . 89.4 mt-10 -55.1 -42.82 73.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.919 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.897 ' HA ' HD11 ' A' ' 8' ' ' ILE . 26.7 mt -57.07 -30.69 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.163 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.62 ' HG3' HG11 ' A' ' 51' ' ' VAL . 10.1 tttp -62.87 -47.29 83.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.867 . . . . 0.0 111.322 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -62.39 -35.06 78.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.452 -0.78 . . . . 0.0 112.695 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.784 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -69.85 -50.26 44.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.484 -1.385 . . . . 0.0 111.896 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.59 HG13 HD13 ' A' ' 8' ' ' ILE . 14.4 m -69.87 -32.14 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.575 -1.328 . . . . 0.0 110.787 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -60.33 -52.68 64.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.989 -1.069 . . . . 0.0 109.91 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -79.84 -24.43 41.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 110.251 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -84.8 -64.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.877 . . . . 0.0 110.505 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.515 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 11.3 m-85 -71.69 -21.22 61.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 109.991 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER 66.48 44.12 2.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.377 -0.827 . . . . 0.0 110.335 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.796 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -125.77 -162.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.585 -0.697 . . . . 0.0 109.858 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.796 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -115.01 114.74 25.8 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 109.811 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.62 HG11 ' HG3' ' A' ' 40' ' ' LYS . 11.7 t -77.95 119.76 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.266 -0.896 . . . . 0.0 109.236 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.795 HG21 ' N ' ' A' ' 84' ' ' ALA . 25.5 t -114.01 -14.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.521 -0.737 . . . . 0.0 110.721 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.15 115.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -0.792 . . . . 0.0 110.091 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.052 HG22 HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.03 116.77 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.653 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.504 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -116.43 116.26 27.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.377 -0.827 . . . . 0.0 109.679 179.361 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -115.92 155.26 28.3 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.89 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.803 HD11 ' HD2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -144.89 161.02 40.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 109.922 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -82.35 124.36 29.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.0 110.408 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.903 HG11 ' CE ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -120.28 114.09 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.592 -0.692 . . . . 0.0 110.005 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 74' ' ' PRO . 3.5 mmt85 -99.03 100.57 11.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.43 94.32 0.09 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -169.48 -36.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.131 . . . . 0.0 110.214 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 2.5 mmtt -74.07 148.15 42.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.188 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 4.2 mttp -41.83 142.61 0.64 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 110.553 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 5.8 mtm105 -142.02 -46.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 109.954 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.468 ' O ' ' C ' ' A' ' 67' ' ' GLY . 0.9 OUTLIER 58.89 49.29 9.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.812 . . . . 0.0 110.6 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 66' ' ' LEU . . . 37.42 79.84 0.03 OUTLIER Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -135.13 150.4 50.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -1.226 . . . . 0.0 110.325 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 69' ' ' TYR . 34.8 p90 -44.03 118.46 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.04 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER 40.3 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.415 -0.803 . . . . 0.0 110.363 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.17 -167.17 30.26 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.99 79.57 1.27 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -1.161 . . . . 0.0 110.238 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.455 ' CB ' ' HB3' ' A' ' 60' ' ' ARG . 11.3 mtm180 -77.34 141.45 66.2 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.459 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 49.2 Cg_endo -73.22 -165.48 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.092 1.574 . . . . 0.0 110.433 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.73 89.39 3.08 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 109.201 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.4 OUTLIER -125.9 144.89 50.49 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.632 -0.667 . . . . 0.0 110.365 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.538 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 0.3 OUTLIER -124.06 141.96 51.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 110.155 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.903 ' CE ' HG11 ' A' ' 59' ' ' VAL . 1.9 ptpt -100.96 150.2 23.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.004 -1.06 . . . . 0.0 109.518 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.735 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -117.95 128.63 54.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.147 -0.971 . . . . 0.0 112.124 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.86 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -105.57 111.74 36.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.413 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.052 HG22 HG22 ' A' ' 54' ' ' VAL . 13.5 t -102.83 137.62 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.48 -0.763 . . . . 0.0 110.724 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 39.1 tp60 -117.93 153.47 33.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.866 . . . . 0.0 109.831 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 84' ' ' ALA . 2.4 m -125.34 157.11 34.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.697 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -45.47 177.2 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.686 0 CA-C-O 121.275 0.559 . . . . 0.0 110.926 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.8 Cg_endo -73.48 140.53 30.16 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.25 1.658 . . . . 0.0 110.299 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.27 -21.71 19.48 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.511 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 49.1 mt-30 -89.28 167.22 13.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -1.16 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.533 ' HA ' ' OH ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER 179.67 99.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 110.522 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.107 HD12 ' CD2' ' A' ' 26' ' ' TYR . 24.5 mt -44.12 104.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 109.623 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 15.4 mm-40 -56.34 -13.97 2.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.455 -0.778 . . . . 0.0 111.677 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.723 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.0 -36.46 65.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.861 -1.149 . . . . 0.0 110.732 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.817 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.56 -23.33 12.5 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.046 -1.034 . . . . 0.0 109.827 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 15.3 mm-40 -49.99 -44.6 51.09 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.444 -0.785 . . . . 0.0 110.555 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.59 1.57 58.5 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.479 ' HA ' HD12 ' A' ' 95' ' ' LEU . 15.9 tp -77.52 3.06 14.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -1.172 . . . . 0.0 110.196 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.299 -179.964 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.16 0.505 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -95.9 82.22 3.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.014 -1.054 . . . . 0.0 109.171 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.968 ' HB ' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -133.61 -94.1 0.32 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.37 -0.831 . . . . 0.0 110.254 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.532 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -77.14 -17.57 58.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.106 -0.996 . . . . 0.0 109.808 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.803 ' CZ ' HG23 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -54.08 -139.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.779 0.8 . . . . 0.0 110.311 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 62.2 m-20 -31.99 -58.37 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.5 -0.75 . . . . 0.0 112.022 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.017 HG12 HG13 ' A' ' 8' ' ' ILE . 62.0 t -45.64 -101.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.293 -0.88 . . . . 0.0 111.29 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.017 HG13 HG12 ' A' ' 7' ' ' VAL . 37.3 mt -88.25 104.15 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.852 -1.155 . . . . 0.0 110.925 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 mt -70.39 -98.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.855 . . . . 0.0 110.352 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.46 159.26 31.43 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.024 -1.048 . . . . 0.0 110.467 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 48.3 Cg_endo -75.0 171.09 19.01 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.088 1.572 . . . . 0.0 110.5 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.045 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.19 132.85 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.917 . . . . 0.0 110.315 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.683 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.1 mm? -103.23 106.65 17.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.131 -0.98 . . . . 0.0 110.114 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.438 ' OG ' ' C ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -165.72 140.82 4.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.938 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -43.03 -41.03 3.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.121 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -54.64 -24.55 22.08 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.247 -0.908 . . . . 0.0 110.145 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -100.74 -51.4 3.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.547 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.5 m-85 -54.77 -47.33 74.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.71 -9.41 43.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.88 . . . . 0.0 109.012 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 21' ' ' PHE . . . -98.29 -41.27 3.26 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.864 -2.495 . . . . 0.0 106.864 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.631 ' CE1' ' HA ' ' A' ' 26' ' ' TYR . 4.4 m-30 -48.4 -27.36 2.56 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -37.8 -42.91 0.63 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.62 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.45 -18.25 21.69 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.384 -0.823 . . . . 0.0 110.573 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.509 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 123.01 5.15 8.24 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.498 ' HG2' ' HB2' ' A' ' 82' ' ' GLN . 23.7 mttt -82.67 127.96 33.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 109.596 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 1.064 ' CD1' HD12 ' A' ' 92' ' ' LEU . 65.9 m-85 -127.11 114.66 18.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.711 -1.243 . . . . 0.0 112.297 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 5.4 m -81.47 123.98 29.06 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.469 0.652 . . . . 0.0 110.61 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.666 ' CB ' HG23 ' A' ' 8' ' ' ILE . 61.5 m-85 -122.27 148.67 44.71 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.435 -0.79 . . . . 0.0 110.538 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 1.045 ' CD1' HG12 ' A' ' 12' ' ' VAL . 96.9 m95 -76.62 122.8 25.16 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.785 HG12 ' HA ' ' A' ' 8' ' ' ILE . 1.9 m -135.91 154.65 34.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.866 -1.146 . . . . 0.0 111.412 -177.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.518 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 0.6 OUTLIER -52.26 130.92 42.42 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 176.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 38.8 Cg_endo -65.01 72.99 0.23 Allowed 'Trans proline' 0 C--N 1.294 -2.315 0 O-C-N 123.443 1.233 . . . . 0.0 109.361 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 31' ' ' HIS . 0.1 OUTLIER 179.68 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.997 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.75 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.387 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -38.36 128.11 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.499 -0.751 . . . . 0.0 110.81 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.567 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 1.5 mttt -41.96 -31.79 0.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.417 -0.802 . . . . 0.0 109.674 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.0 m -72.97 -51.06 19.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.84 . . . . 0.0 109.473 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 4.2 mt-10 -55.43 -38.94 69.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.162 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.918 HG23 HD11 ' A' ' 8' ' ' ILE . 38.6 mt -58.08 -30.68 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -0.847 . . . . 0.0 108.969 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.522 ' O ' HG21 ' A' ' 51' ' ' VAL . 3.5 tttm -62.04 -47.51 84.43 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.716 0.769 . . . . 0.0 110.083 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.658 ' O ' HG23 ' A' ' 45' ' ' THR . 45.9 m-80 -72.42 -33.93 67.47 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.693 -0.629 . . . . 0.0 111.052 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.862 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.24 -50.89 71.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.861 -1.149 . . . . 0.0 110.643 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.802 HG21 HG11 ' A' ' 81' ' ' VAL . 1.1 m -64.72 -33.26 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.517 -1.364 . . . . 0.0 109.783 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -58.48 -29.05 65.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.848 . . . . 0.0 110.326 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.968 HG21 ' HB ' ' A' ' 3' ' ' THR . 1.3 p -77.99 -48.94 15.06 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.109 -0.994 . . . . 0.0 110.346 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . -82.94 -56.24 3.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.543 -0.723 . . . . 0.0 110.907 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.526 ' CE1' HD21 ' A' ' 92' ' ' LEU . 14.3 m-85 -71.41 -11.34 60.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.124 -0.985 . . . . 0.0 110.092 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 21.9 mtpt 41.7 47.86 3.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.434 -0.791 . . . . 0.0 110.17 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.766 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -122.01 -164.25 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.52 -0.738 . . . . 0.0 109.987 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.766 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -116.64 109.94 17.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.415 -0.803 . . . . 0.0 109.636 179.171 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.82 HG13 ' CG1' ' A' ' 81' ' ' VAL . 61.0 t -78.23 148.13 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.196 -0.94 . . . . 0.0 109.974 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.1 p -139.46 9.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 110.082 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.08 117.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 109.948 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.062 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.24 117.26 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 110.116 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.567 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 20.2 m-20 -115.96 115.67 26.58 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.355 -0.841 . . . . 0.0 109.428 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -114.63 167.05 11.09 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 110.024 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 58' ' ' HIS . 2.0 pp -158.77 160.63 36.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.489 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.545 ' NE2' ' HA ' ' A' ' 75' ' ' ASP . 3.1 t-160 -75.51 130.85 39.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.063 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.726 HG21 ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -120.61 138.29 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.452 -0.78 . . . . 0.0 110.486 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.453 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 14.8 mmt85 -112.44 157.68 20.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 110.014 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.36 146.85 17.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.75 23.88 12.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -1.144 . . . . 0.0 110.103 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -106.18 26.46 9.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 3.9 tmtt? 172.8 55.24 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.219 -0.925 . . . . 0.0 110.087 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 66' ' ' LEU . 5.9 ttm180 -115.75 -25.94 7.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 68' ' ' ARG . 1.7 mm? 55.8 108.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -55.48 82.57 0.01 OUTLIER Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -136.08 166.54 23.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.25 -1.147 . . . . 0.0 110.338 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -61.98 149.79 39.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.119 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER 42.4 47.88 4.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 0.0 110.325 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 70' ' ' LEU . . . -43.9 169.4 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.09 128.53 55.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.166 -1.196 . . . . 0.0 110.768 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HD2' ' HD3' ' A' ' 65' ' ' ARG . 7.3 mtp180 -137.47 129.62 16.64 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.403 -0.811 . . . . 0.0 109.764 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.59 -170.01 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.782 1.412 . . . . 0.0 110.516 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.545 ' HA ' ' NE2' ' A' ' 58' ' ' HIS . 0.6 OUTLIER -116.56 89.29 3.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.4 -0.812 . . . . 0.0 109.809 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.71 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.6 mpt_? -99.5 135.76 40.44 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.405 -0.809 . . . . 0.0 109.828 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.713 ' NZ ' HD11 ' A' ' 39' ' ' ILE . 29.1 tttt -123.06 128.12 49.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.118 -0.989 . . . . 0.0 110.62 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.91 ' HD2' HG11 ' A' ' 12' ' ' VAL . 13.4 mtmt -101.34 148.25 25.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.376 -0.827 . . . . 0.0 108.99 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.66 118.96 25.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.97 -1.081 . . . . 0.0 112.007 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 17.5 mt -97.15 110.53 25.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.812 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.062 HG22 ' CG2' ' A' ' 54' ' ' VAL . 21.9 t -105.99 133.07 51.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.759 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.617 ' O ' HG12 ' A' ' 52' ' ' VAL . 42.0 tp60 -111.25 153.46 25.84 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.922 -1.111 . . . . 0.0 109.103 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.7 m -114.66 155.76 15.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 118.179 -1.408 . . . . 0.0 109.611 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.938 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -49.92 178.93 0.03 OUTLIER Pre-proline 0 C--N 1.289 -2.023 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.353 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.938 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -72.45 142.39 36.72 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.244 1.655 . . . . 0.0 110.546 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.37 -36.83 3.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 11.7 mt-30 -80.53 173.03 13.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.136 . . . . 0.0 110.618 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 179.63 93.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -0.793 . . . . 0.0 110.216 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.716 HD12 ' CD2' ' A' ' 26' ' ' TYR . 14.8 mt -43.09 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -0.971 . . . . 0.0 110.026 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.483 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 2.9 mt-10 -75.17 -14.19 60.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 0.0 110.744 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.752 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.11 -24.03 23.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.096 -1.002 . . . . 0.0 110.506 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.064 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -105.86 -23.2 12.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.11 -0.994 . . . . 0.0 109.592 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 40.0 mm-40 -60.66 -23.17 64.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.399 -0.813 . . . . 0.0 110.196 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.97 -19.47 8.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 95' ' ' LEU . 14.4 tp -50.47 -21.05 1.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -1.123 . . . . 0.0 110.13 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.547 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 43.8 mt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.141 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.869 0.366 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -85.83 60.92 6.53 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.152 178.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.685 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -104.62 -106.29 0.3 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.524 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -83.96 -3.41 57.96 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.925 -1.109 . . . . 0.0 108.962 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.891 ' CZ ' HG23 ' A' ' 7' ' ' VAL 0.258 0.3 OUTLIER -53.92 -141.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.827 0.822 . . . . 0.0 110.529 178.501 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.65 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 40.0 t0 -27.8 -62.31 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.382 0.611 . . . . 0.0 111.692 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.922 HG12 HG13 ' A' ' 8' ' ' ILE . 84.6 t -49.9 -103.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 111.109 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.922 HG13 HG12 ' A' ' 7' ' ' VAL . 9.8 mt -84.22 88.65 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 0.0 111.143 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -54.97 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.408 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.51 164.78 13.99 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.574 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.3 Cg_endo -80.22 155.04 22.21 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.013 1.533 . . . . 0.0 110.261 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.72 HG11 HG22 ' A' ' 27' ' ' THR . 1.8 p -115.24 112.54 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.085 -1.009 . . . . 0.0 110.32 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.774 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.55 110.72 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.923 . . . . 0.0 110.391 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.812 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -144.71 162.46 36.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.981 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' SER . 52.9 mt-10 -42.79 -65.32 0.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -14.61 32.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 110.344 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.812 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -100.51 23.74 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 110.418 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -134.36 -49.67 0.79 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.075 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.75 -35.29 80.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.102 -0.999 . . . . 0.0 109.324 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -88.76 -34.4 9.15 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.596 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -72.47 -8.69 56.38 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.328 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -78.2 -16.59 57.72 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.54 -0.725 . . . . 0.0 110.813 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 2.0 mm-40 -88.74 17.36 5.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.527 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.577 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 101.56 -3.35 53.57 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 28.3 mttt -82.44 137.04 34.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.603 -0.94 . . . . 0.0 109.516 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.647 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 99.3 m-85 -127.15 112.21 14.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.708 -1.245 . . . . 0.0 111.435 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.033 HG23 HD11 ' A' ' 80' ' ' ILE . 3.9 m -82.38 127.96 33.76 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.059 ' CE2' HG11 ' A' ' 43' ' ' VAL . 22.7 m-85 -123.08 147.43 46.74 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.163 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.604 ' CZ3' ' CG ' ' A' ' 76' ' ' ARG . 3.9 m95 -84.35 122.6 29.16 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 8' ' ' ILE . 1.5 m -138.51 164.07 27.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 118.207 -1.397 . . . . 0.0 112.043 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 33' ' ' LYS . 2.4 t-80 -61.64 134.36 93.76 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.502 ' CD ' ' HB3' ' A' ' 75' ' ' ASP . 38.3 Cg_endo -64.2 75.9 0.18 Allowed 'Trans proline' 0 C--N 1.293 -2.359 0 O-C-N 123.22 1.116 . . . . 0.0 109.398 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.551 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.47 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.829 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -38.46 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.821 -0.55 . . . . 0.0 109.84 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -46.76 140.58 4.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.108 -0.995 . . . . 0.0 110.76 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.502 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 8.6 mttt -43.42 -45.36 6.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.308 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 3.4 m -61.01 -48.53 81.37 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 109.296 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 2.1 mt-10 -58.43 -44.51 89.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.358 -0.839 . . . . 0.0 109.356 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.767 ' O ' HG22 ' A' ' 43' ' ' VAL . 15.3 mt -57.3 -30.71 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 54.9 tttt -66.55 -47.6 72.32 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.425 -0.797 . . . . 0.0 109.366 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.971 ' O ' HG23 ' A' ' 45' ' ' THR . 72.2 m-20 -73.65 -34.38 64.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.625 -0.672 . . . . 0.0 110.8 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.685 ' HB1' ' O ' ' A' ' 3' ' ' THR . . . -57.96 -50.49 73.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.84 -1.163 . . . . 0.0 110.365 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.059 HG11 ' CE2' ' A' ' 28' ' ' PHE . 3.2 m -73.47 -36.33 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.837 -1.164 . . . . 0.0 110.022 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -58.0 -34.71 70.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.088 -1.008 . . . . 0.0 109.48 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.971 HG23 ' O ' ' A' ' 41' ' ' ASN . 39.9 p -79.3 -45.06 20.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.511 -0.743 . . . . 0.0 110.078 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HB2' ' OG1' ' A' ' 3' ' ' THR . . . -80.46 -56.83 3.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.384 -0.822 . . . . 0.0 111.018 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CG ' HD13 ' A' ' 89' ' ' ILE . 6.4 m-85 -71.49 -21.39 61.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.018 -1.051 . . . . 0.0 110.245 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.95 44.45 19.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 110.38 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.786 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -123.55 -164.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.515 -0.74 . . . . 0.0 109.791 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.786 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.23 107.3 15.1 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 109.489 179.043 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.859 HG13 HG13 ' A' ' 81' ' ' VAL . 75.6 t -78.07 119.4 26.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.214 -0.929 . . . . 0.0 110.026 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.658 HG12 ' C ' ' A' ' 82' ' ' GLN . 7.1 p -103.43 -0.21 10.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 110.086 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.555 ' CG ' ' HB3' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 178.91 141.58 0.11 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.82 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.08 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -134.3 127.73 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.073 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.502 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 47.0 t30 -131.27 115.1 15.86 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.406 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.32 149.23 39.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.63 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -130.68 170.98 13.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 110.665 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.544 ' CD2' ' HG2' ' A' ' 60' ' ' ARG . 5.0 t-160 -80.23 115.56 19.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 110.007 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.54 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -119.64 137.29 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.349 -0.845 . . . . 0.0 110.042 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.544 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 11.7 mmt180 -145.68 151.4 37.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 110.186 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.51 108.78 1.64 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.9 62.5 7.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -1.142 . . . . 0.0 110.196 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -108.2 114.65 28.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.266 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.57 74.19 0.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 110.185 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 3.9 ttm180 -136.36 -50.63 0.69 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.212 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 67' ' ' GLY . 4.8 mp 54.41 57.02 6.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.932 . . . . 0.0 110.265 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' A' ' 68' ' ' ARG . . . 42.32 52.52 5.14 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 36.5 mtt85 -150.62 -177.54 6.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -1.196 . . . . 0.0 110.199 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.452 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 6.1 t80 -102.2 56.28 0.8 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.24 -0.912 . . . . 0.0 110.214 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.33 41.47 1.36 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.081 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.51 178.88 48.85 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -95.37 158.97 15.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -1.163 . . . . 0.0 110.171 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -114.89 99.09 51.58 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.175 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 60' ' ' ARG . 47.7 Cg_endo -73.23 -164.8 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.053 1.554 . . . . 0.0 110.523 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.502 ' HB3' ' CD ' ' A' ' 32' ' ' PRO . 1.5 m-20 -114.45 89.46 3.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 109.365 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.604 ' CG ' ' CZ3' ' A' ' 29' ' ' TRP . 0.5 OUTLIER -120.83 114.37 21.51 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.703 -0.623 . . . . 0.0 109.646 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.54 ' HA ' HG23 ' A' ' 59' ' ' VAL . 4.3 tttp -123.06 140.84 52.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.144 -0.972 . . . . 0.0 110.753 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.556 ' HD2' ' CG2' ' A' ' 27' ' ' THR . 0.4 OUTLIER -106.96 143.33 35.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.427 -0.796 . . . . 0.0 109.646 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.656 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -133.69 118.96 18.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.083 -1.011 . . . . 0.0 111.247 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.033 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -100.83 111.85 31.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.523 0.678 . . . . 0.0 109.911 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.08 HG22 ' CG2' ' A' ' 54' ' ' VAL . 35.1 t -109.1 136.09 46.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 110.265 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.658 ' C ' HG12 ' A' ' 52' ' ' VAL . 6.6 tp60 -110.33 153.44 24.9 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.102 -0.999 . . . . 0.0 109.0 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.476 HG21 ' C ' ' A' ' 87' ' ' GLN . 2.3 m -116.18 155.44 17.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.832 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.975 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -50.09 179.26 0.03 OUTLIER Pre-proline 0 C--N 1.288 -2.066 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.617 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.975 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 41.5 Cg_endo -71.5 141.31 38.13 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.366 1.719 . . . . 0.0 110.499 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.6 -25.48 11.13 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.525 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 60.3 mt-30 -94.05 163.77 13.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -1.164 . . . . 0.0 110.689 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER 179.51 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.457 -0.777 . . . . 0.0 110.113 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.635 HD13 ' CG ' ' A' ' 47' ' ' PHE . 9.4 mt -44.28 95.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.953 . . . . 0.0 109.596 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.548 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -68.53 -13.27 62.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.439 -0.788 . . . . 0.0 111.155 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.731 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.44 -35.08 62.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.087 -1.008 . . . . 0.0 110.969 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -106.89 -23.67 12.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.889 -1.132 . . . . 0.0 110.773 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.548 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 1.9 pp20? -51.1 -22.93 2.73 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.038 -1.039 . . . . 0.0 110.234 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -99.08 -23.77 11.11 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.636 HD23 ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -42.75 -29.58 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -1.128 . . . . 0.0 110.147 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.566 HG13 ' CE1' ' A' ' 18' ' ' TYR . 2.6 mp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptm . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.029 0.442 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.649 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -92.27 84.44 5.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.081 -1.012 . . . . 0.0 109.382 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.837 HG21 ' CB ' ' A' ' 45' ' ' THR . 1.3 p -136.88 -89.45 0.27 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.611 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.888 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -76.3 -22.59 54.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.893 -1.129 . . . . 0.0 110.126 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.883 ' CZ ' HG23 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -52.15 -139.09 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.837 0.827 . . . . 0.0 110.814 178.188 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.644 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 11.8 t70 -30.56 -56.56 0.2 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.466 -0.771 . . . . 0.0 111.819 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.883 HG23 ' CZ ' ' A' ' 5' ' ' TYR . 99.1 t -53.71 -103.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.887 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.882 HG13 HG12 ' A' ' 7' ' ' VAL . 3.6 mt -86.1 90.55 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.846 -1.159 . . . . 0.0 111.26 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -72.75 -97.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.811 . . . . 0.0 110.198 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -108.38 162.36 20.21 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.998 . . . . 0.0 110.242 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 46.8 Cg_endo -73.96 163.5 36.73 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.994 1.523 . . . . 0.0 110.388 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.157 HG12 ' CD1' ' A' ' 29' ' ' TRP . 2.4 m -115.13 139.4 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.942 . . . . 0.0 110.317 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.67 111.48 23.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -0.958 . . . . 0.0 110.042 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 15' ' ' GLU . 54.3 m -145.66 139.56 26.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 110.183 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 8.7 tm-20 -42.79 -58.71 2.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 110.176 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -42.26 71.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.264 -0.897 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -58.93 -66.0 0.57 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.699 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.6 m-85 -44.92 -31.08 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 110.58 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.77 -8.77 48.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -110.98 -31.97 2.75 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -76.08 -17.22 59.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.686 -0.891 . . . . 0.0 108.92 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.615 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -57.0 -21.31 29.72 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.791 -0.568 . . . . 0.0 110.725 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -88.99 17.08 6.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.51 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.11 0.18 66.0 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 1.7 mttp -82.36 137.21 34.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -1.015 . . . . 0.0 109.064 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 1.006 ' CD1' HD12 ' A' ' 92' ' ' LEU . 27.6 m-85 -128.86 105.52 8.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.34 -1.475 . . . . 0.0 112.244 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 4.3 m -74.88 141.02 44.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.445 0.641 . . . . 0.0 109.37 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.735 ' CB ' HG23 ' A' ' 8' ' ' ILE . 21.7 m-85 -133.3 166.18 23.09 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.434 -0.791 . . . . 0.0 110.032 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 1.157 ' CD1' HG12 ' A' ' 12' ' ' VAL . 14.0 m95 -98.28 122.96 42.08 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.0 p -143.9 160.39 16.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 C-N-CA 117.792 -1.563 . . . . 0.0 112.768 -176.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -62.2 151.99 79.86 Favored Pre-proline 0 C--N 1.3 -1.572 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.69 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.9 Cg_endo -73.06 69.54 3.85 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.082 1.569 . . . . 0.0 109.647 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.2 OUTLIER 179.72 -34.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.399 -0.813 . . . . 0.0 110.017 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.874 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -43.75 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.381 -0.825 . . . . 0.0 109.603 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -41.55 136.04 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.535 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.793 ' HA ' HD12 ' A' ' 39' ' ' ILE . 7.5 mttt -43.74 -41.34 4.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 109.385 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.5 m -67.66 -40.26 84.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.267 -0.896 . . . . 0.0 108.997 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.517 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 5.1 mt-10 -55.79 -39.46 71.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.899 . . . . 0.0 108.763 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.797 HG21 ' HB1' ' A' ' 79' ' ' ALA . 32.3 mt -57.75 -34.66 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.6 ttmt -57.99 -47.91 81.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.37 -0.831 . . . . 0.0 109.945 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -73.79 -34.82 64.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.696 -0.627 . . . . 0.0 111.345 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 3' ' ' THR . . . -58.77 -50.5 73.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.824 -1.173 . . . . 0.0 110.672 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.727 HG13 ' CD1' ' A' ' 8' ' ' ILE . 2.6 m -65.02 -33.21 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.774 -1.204 . . . . 0.0 109.811 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -60.65 -44.29 96.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 0.0 109.204 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.837 ' CB ' HG21 ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.06 -15.28 58.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.0 109.323 179.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.888 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -102.66 -68.79 0.81 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.406 -0.809 . . . . 0.0 110.459 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD2' HG12 ' A' ' 43' ' ' VAL . 29.9 m-85 -74.08 -21.56 59.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 4.3 tttp 65.15 47.21 2.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 110.107 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.771 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -125.29 -162.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.498 -0.752 . . . . 0.0 110.413 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.771 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -118.29 114.58 23.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.473 -0.767 . . . . 0.0 109.788 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.059 HG13 HG13 ' A' ' 81' ' ' VAL . 90.4 t -78.94 123.31 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.0 110.435 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.682 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.4 p -114.93 9.94 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.924 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.55 120.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.402 -0.811 . . . . 0.0 109.902 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.15 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.12 125.51 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.196 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.554 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -125.12 115.6 20.72 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.224 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.548 ' CG2' ' HG2' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -119.2 150.46 40.04 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.902 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.538 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 3.3 pp -146.86 145.38 29.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.408 -0.807 . . . . 0.0 110.054 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 132.49 44.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.357 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -120.2 125.85 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.366 -0.834 . . . . 0.0 110.106 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -132.77 133.98 44.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 110.188 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . -44.5 166.06 0.04 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -139.28 -54.84 0.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -1.144 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -76.2 -31.39 58.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.227 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 63' ' ' LYS . 6.0 ttpt -43.32 -26.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 110.295 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 4.9 ttp180 -73.78 -19.82 60.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.415 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER 52.24 53.1 12.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 66' ' ' LEU . . . 40.99 42.7 3.04 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.512 ' HG3' ' N ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -159.88 177.41 10.81 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.468 -1.019 . . . . 0.0 110.114 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.512 ' N ' ' HG3' ' A' ' 68' ' ' ARG . 3.6 t80 -89.51 92.79 9.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 110.102 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.468 HD13 ' HD2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -130.33 40.33 3.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 110.2 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.433 ' C ' ' HG3' ' A' ' 72' ' ' LYS . . . 144.79 -166.07 27.49 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HG3' ' C ' ' A' ' 71' ' ' GLY . 41.7 mtpt -148.73 129.33 14.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -1.171 . . . . 0.0 110.217 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.5 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -43.8 106.55 0.51 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.02 -167.39 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.966 1.509 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.66 89.44 3.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.435 -0.791 . . . . 0.0 109.604 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.579 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 1.8 tpt180 -107.43 112.82 25.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.58 -0.7 . . . . 0.0 109.906 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -110.03 129.41 55.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 10.4 ptpt -114.65 151.51 33.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.996 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.797 ' HB1' HG21 ' A' ' 39' ' ' ILE . . . -122.23 125.71 46.64 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.0 112.585 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 22.7 mt -104.22 110.93 31.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.452 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.15 HG22 ' CG2' ' A' ' 54' ' ' VAL . 97.9 t -104.26 134.55 45.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 110.346 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.682 ' C ' HG12 ' A' ' 52' ' ' VAL . 3.8 tp60 -102.51 150.71 23.12 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.171 -0.956 . . . . 0.0 108.704 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.515 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.4 m -115.33 156.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 118.069 -1.452 . . . . 0.0 109.754 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.92 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -67.65 -179.71 0.49 Allowed Pre-proline 0 C--N 1.288 -2.104 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.163 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.92 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.0 Cg_endo -73.2 139.53 29.52 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 O-C-N 124.264 1.665 . . . . 0.0 110.195 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.503 ' O ' ' CE ' ' A' ' 88' ' ' LYS . . . 109.09 -48.31 0.95 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.819 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -94.07 176.87 6.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.16 -1.2 . . . . 0.0 110.672 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 86' ' ' GLY . 0.4 OUTLIER 179.56 100.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -0.772 . . . . 0.0 110.088 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.925 HD12 ' CD2' ' A' ' 26' ' ' TYR . 10.4 mt -44.19 108.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 110.05 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 10.0 mm-40 -75.75 -13.65 60.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -0.803 . . . . 0.0 110.799 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.864 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.82 -31.38 59.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.0 110.577 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.006 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.31 -23.04 12.66 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.19 -0.944 . . . . 0.0 109.715 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 36.1 mm-40 -50.84 -35.25 31.51 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 110.382 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -94.78 -24.22 18.41 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.864 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.3 mp -43.0 -27.22 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -1.181 . . . . 0.0 110.173 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.54 HG22 ' OXT' ' A' ' 96' ' ' ILE . 22.8 mm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.18 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.564 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.686 0.279 . . . . 0.0 110.565 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 4' ' ' ALA . 4.6 mmpt? -45.11 97.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.629 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.4 m 3.86 -70.68 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 CA-C-O 121.407 0.622 . . . . 0.0 110.739 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.982 ' O ' HG23 ' A' ' 7' ' ' VAL 0.27 . . -55.19 80.46 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.083 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.095 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.5 p90 24.37 46.61 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.842 0.829 . . . . 0.0 110.321 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.604 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 5.9 t70 64.67 52.54 1.69 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.925 0.869 . . . . 0.0 111.406 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.095 HG21 ' CE2' ' A' ' 5' ' ' TYR . 3.3 t -131.98 -125.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.134 -0.978 . . . . 0.0 109.638 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.884 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.8 mt -57.04 120.33 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.157 -0.965 . . . . 0.0 110.121 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -111.65 -89.59 0.51 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.175 -0.953 . . . . 0.0 110.297 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.25 142.42 24.55 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.095 -1.003 . . . . 0.0 110.212 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.593 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 47.5 Cg_endo -73.69 175.73 10.33 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.058 1.557 . . . . 0.0 110.506 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.156 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.08 133.15 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.926 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.738 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.98 110.23 22.07 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.152 -0.968 . . . . 0.0 110.293 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 71.7 m -166.07 138.39 3.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 110.008 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 14' ' ' SER . 13.2 mt-10 -43.41 -46.36 6.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 110.064 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.72 -18.05 4.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.574 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -101.62 -49.81 3.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.752 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.985 ' CE1' HD11 ' A' ' 96' ' ' ILE . 2.4 m-85 -58.64 -44.74 90.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.496 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -12.61 38.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 108.876 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' N ' ' A' ' 22' ' ' ALA . . . -98.95 -39.59 3.53 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 3.6 m-30 -49.96 -25.43 3.28 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 20' ' ' GLY . . . -40.21 -31.68 0.14 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.724 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.526 ' HG2' HE22 ' A' ' 82' ' ' GLN . 3.6 tp10 -104.05 -1.26 27.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.771 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.543 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 103.52 9.1 39.11 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 15.4 mttt -82.58 131.54 35.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -1.133 . . . . 0.0 109.668 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.906 ' CD1' HD12 ' A' ' 92' ' ' LEU . 70.1 m-85 -126.86 108.09 10.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.887 -1.133 . . . . 0.0 112.003 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 27.1 m -75.85 121.9 23.3 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.74 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -116.4 164.03 15.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 110.618 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 1.156 ' CD1' HG12 ' A' ' 12' ' ' VAL . 68.1 m95 -97.5 123.22 41.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.802 ' HA ' HD21 ' A' ' 9' ' ' LEU . 2.6 p -151.4 164.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 C-N-CA 117.827 -1.549 . . . . 0.0 111.997 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.481 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -51.01 140.46 20.89 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.207 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.4 Cg_endo -72.17 76.57 2.14 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.06 1.558 . . . . 0.0 110.059 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 179.03 -33.81 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.418 -0.801 . . . . 0.0 110.03 -178.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.676 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -48.43 107.5 0.13 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 110.194 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -59.45 147.51 36.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -0.927 . . . . 0.0 110.012 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.542 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 21.8 mttt -46.56 -34.4 4.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 110.102 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.3 m -75.18 -51.19 13.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 110.447 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.49 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 1.8 mt-10 -55.19 -42.82 73.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.779 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.764 HG23 HD11 ' A' ' 8' ' ' ILE . 20.9 mt -57.19 -30.59 35.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.656 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.2 ttpm? -62.71 -46.35 88.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 111.046 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.405 ' O ' HG23 ' A' ' 45' ' ' THR . 13.5 m-80 -58.97 -34.89 72.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.421 -0.799 . . . . 0.0 112.336 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.884 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -72.43 -49.27 34.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.666 -1.271 . . . . 0.0 111.652 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -69.52 -37.63 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.888 -1.133 . . . . 0.0 110.84 -178.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.68 -44.12 81.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.072 -1.017 . . . . 0.0 110.424 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 41' ' ' ASN . 34.0 p -78.99 -46.19 18.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 110.295 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.68 -55.93 22.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.311 -0.868 . . . . 0.0 110.554 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.67 ' CD1' HG22 ' A' ' 43' ' ' VAL . 70.6 m-85 -83.2 3.02 32.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.112 -0.992 . . . . 0.0 110.333 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 4.5 pttm 38.23 42.57 0.51 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.735 0.779 . . . . 0.0 110.326 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.773 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -115.39 -165.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.599 -0.688 . . . . 0.0 109.792 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.773 ' N ' HG13 ' A' ' 49' ' ' VAL . 2.8 tmtm? -118.27 103.16 9.56 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.443 -0.785 . . . . 0.0 109.831 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.656 HG11 ' HG3' ' A' ' 40' ' ' LYS . 97.7 t -78.37 119.63 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.36 -0.838 . . . . 0.0 109.69 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.3 p -101.02 -5.61 9.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -0.903 . . . . 0.0 110.381 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER 176.08 119.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.344 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.937 HG23 HG13 ' A' ' 81' ' ' VAL . 1.1 t -109.56 124.51 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 109.743 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.542 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 12.9 m120 -122.83 116.32 23.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.219 -0.926 . . . . 0.0 109.818 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.543 ' OG1' ' CE ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -110.17 155.43 21.98 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.36 -0.837 . . . . 0.0 110.185 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.584 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -138.58 156.96 47.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.778 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.32 122.91 25.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.463 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.593 HG21 ' HG3' ' A' ' 78' ' ' LYS . 4.3 m -120.33 132.78 69.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.701 -0.625 . . . . 0.0 110.21 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.494 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -135.89 109.22 7.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.224 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 60.9 144.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.76 -49.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -1.145 . . . . 0.0 110.243 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 64' ' ' LYS . 18.6 mmtt -105.45 -57.8 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.181 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -41.55 -37.41 1.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.386 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -52.52 -57.46 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 110.236 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER 61.19 135.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.202 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . 44.58 -169.73 0.02 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -42.71 166.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.372 -1.075 . . . . 0.0 110.237 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -44.77 134.5 5.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.242 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.12 41.01 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.078 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.1 -152.75 8.19 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 145.18 50.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -1.18 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 15.6 mtt85 -107.68 99.8 31.4 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.239 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 73' ' ' ARG . 47.9 Cg_endo -73.02 -165.05 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.948 1.499 . . . . 0.0 110.366 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.6 89.47 3.1 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.444 -0.785 . . . . 0.0 109.337 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.538 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -120.95 147.64 45.18 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.681 -0.637 . . . . 0.0 110.116 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.543 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 0.1 OUTLIER -121.92 142.14 50.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 0.0 110.379 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.842 ' HD3' HG11 ' A' ' 12' ' ' VAL . 1.8 mttt -100.91 151.22 22.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 109.718 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -119.55 119.24 33.22 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.985 -1.072 . . . . 0.0 111.944 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 9.1 mt -95.95 110.87 25.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 109.527 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 43' ' ' VAL . 2.9 t -99.8 125.95 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.14 -0.975 . . . . 0.0 110.263 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.68 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -106.75 143.15 35.27 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.011 -1.056 . . . . 0.0 108.932 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.47 ' CA ' HG12 ' A' ' 52' ' ' VAL . 1.3 m -115.0 156.84 15.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.442 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.853 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -68.18 177.17 1.1 Allowed Pre-proline 0 C--N 1.29 -1.999 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.671 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.853 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -73.49 141.91 32.2 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.348 1.709 . . . . 0.0 110.36 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.97 -26.74 14.52 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -113.72 177.68 4.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -1.132 . . . . 0.0 110.305 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.6 OUTLIER 179.71 122.68 0.06 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -0.933 . . . . 0.0 110.373 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.684 HG22 ' HG ' ' A' ' 92' ' ' LEU . 12.5 mt -73.6 93.94 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 110.101 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 20.0 pt-20 -72.55 -14.66 61.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.855 . . . . 0.0 110.409 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.756 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.7 -23.82 30.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.892 . . . . 0.0 110.495 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.906 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.22 -23.01 12.69 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.174 -0.954 . . . . 0.0 109.713 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.3 mm-40 -61.34 -31.06 70.92 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.359 -0.838 . . . . 0.0 110.369 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.68 -6.22 56.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.1 tp -61.86 -12.07 15.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.167 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.985 HD11 ' CE1' ' A' ' 18' ' ' TYR . 2.9 mp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.15 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 120.871 0.367 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.644 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -83.89 76.37 10.03 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.784 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.718 HG21 ' CG2' ' A' ' 45' ' ' THR . 0.0 OUTLIER -120.51 -90.72 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.592 -0.693 . . . . 0.0 109.777 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -88.87 -27.63 20.89 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.201 -0.937 . . . . 0.0 109.091 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.799 ' CE1' HG23 ' A' ' 7' ' ' VAL . 1.1 p90 -35.44 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.597 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 28.3 m-20 -162.16 -58.02 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.912 -1.118 . . . . 0.0 110.311 -177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.975 HG13 ' HB1' ' A' ' 34' ' ' ALA . 46.4 t -43.02 -73.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 121.807 0.813 . . . . 0.0 109.075 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.861 HG23 ' HB3' ' A' ' 28' ' ' PHE . 6.4 mt -110.59 67.77 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 121.232 -0.918 . . . . 0.0 109.932 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 mt -54.28 -94.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.806 . . . . 0.0 110.742 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.17 150.45 36.73 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 110.61 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.22 162.02 37.22 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.121 1.59 . . . . 0.0 110.276 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.724 HG13 ' HB ' ' A' ' 27' ' ' THR . 1.1 p -115.35 110.33 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.287 -0.883 . . . . 0.0 110.027 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.818 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.12 106.92 17.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.245 -0.909 . . . . 0.0 110.234 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.651 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -137.76 174.58 10.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 110.253 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -55.7 -65.58 0.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.317 -0.865 . . . . 0.0 110.243 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -54.69 -34.79 62.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.169 -0.957 . . . . 0.0 110.302 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.651 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -71.98 -49.52 36.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.156 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 13' ' ' LEU . 1.3 m-85 -58.07 -31.53 67.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.39 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.46 -8.52 50.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 110.177 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -107.63 -35.41 2.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.401 -1.879 . . . . 0.0 108.401 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -76.02 -16.6 59.93 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.63 -0.924 . . . . 0.0 109.118 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.622 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -59.09 -20.29 52.09 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.442 0.639 . . . . 0.0 110.75 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -88.86 17.27 5.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.395 -0.816 . . . . 0.0 110.434 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.29 -0.25 65.95 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 19.7 mttt -82.4 142.71 31.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.572 -0.958 . . . . 0.0 109.395 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.954 ' CD1' HD12 ' A' ' 92' ' ' LEU . 22.9 m-85 -128.29 110.65 12.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.676 -1.265 . . . . 0.0 111.368 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.992 HG23 HD11 ' A' ' 80' ' ' ILE . 3.0 m -81.55 131.18 35.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.478 0.656 . . . . 0.0 109.277 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.041 ' CE2' HG11 ' A' ' 43' ' ' VAL . 23.3 m-85 -124.65 165.06 18.57 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.488 -0.758 . . . . 0.0 110.672 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.637 ' CE3' ' CG ' ' A' ' 76' ' ' ARG . 3.1 m95 -103.12 122.29 44.38 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.6 p -139.42 161.57 27.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 C-N-CA 118.025 -1.47 . . . . 0.0 112.327 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.593 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -74.03 150.26 87.87 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.259 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 44.0 Cg_endo -70.31 67.14 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.986 1.519 . . . . 0.0 109.729 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.88 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.577 -0.702 . . . . 0.0 109.575 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.975 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -43.98 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.338 -0.851 . . . . 0.0 109.306 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -38.0 130.86 1.13 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.496 -0.752 . . . . 0.0 110.964 -179.127 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.834 ' HA ' HD12 ' A' ' 39' ' ' ILE . 1.5 mttt -42.84 -43.31 3.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 109.619 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 4.5 m -61.79 -44.52 96.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 19.6 mm-40 -55.36 -38.83 69.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.392 -0.817 . . . . 0.0 109.422 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 36' ' ' LYS . 25.0 mt -57.38 -30.87 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.706 ' HG3' HG11 ' A' ' 51' ' ' VAL . 59.9 tttm -67.85 -47.05 70.04 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.444 -0.785 . . . . 0.0 109.582 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.476 ' O ' ' HB ' ' A' ' 45' ' ' THR . 58.0 m-80 -73.6 -34.31 65.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.604 -0.685 . . . . 0.0 111.325 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 3' ' ' THR . . . -58.15 -50.56 73.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.739 -1.226 . . . . 0.0 110.454 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.041 HG11 ' CE2' ' A' ' 28' ' ' PHE . 3.6 m -68.31 -32.89 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.854 -1.154 . . . . 0.0 109.372 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CD ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.42 -42.02 79.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.12 -0.987 . . . . 0.0 108.483 178.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.718 ' CG2' HG21 ' A' ' 3' ' ' THR . 0.9 OUTLIER -79.52 -12.8 59.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 178.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.8 -62.2 1.57 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 110.678 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 43' ' ' VAL . 24.0 m-85 -71.59 -22.48 61.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.996 -1.065 . . . . 0.0 110.071 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER 65.88 46.78 2.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.845 . . . . 0.0 110.038 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.676 HG22 ' H ' ' A' ' 50' ' ' LYS . 1.2 p -125.28 -164.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.631 -0.668 . . . . 0.0 110.412 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.676 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.3 tmtp? -118.46 106.73 13.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.451 -0.781 . . . . 0.0 109.763 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.706 HG11 ' HG3' ' A' ' 40' ' ' LYS . 40.6 t -78.8 140.54 16.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 110.542 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.669 HG12 ' C ' ' A' ' 82' ' ' GLN . 13.6 p -118.91 -6.46 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.616 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -179.18 131.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.529 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.041 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -120.26 129.47 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.918 -1.114 . . . . 0.0 110.117 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 3.8 m-80 -131.53 115.71 16.49 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.437 -0.789 . . . . 0.0 109.387 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.561 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -115.5 159.58 21.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 109.311 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.634 HD11 ' HD2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -148.33 144.71 27.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.11 -0.993 . . . . 0.0 110.968 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.05 103.36 2.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.858 . . . . 0.0 109.034 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -95.86 109.36 22.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.385 -0.822 . . . . 0.0 109.319 -179.317 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 2.1 mmt180 -114.36 134.29 55.08 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.397 -0.815 . . . . 0.0 110.457 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.577 ' HA3' ' CB ' ' A' ' 73' ' ' ARG . . . -85.25 114.32 3.95 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 61' ' ' GLY . 16.0 mmmt -53.62 -172.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -1.158 . . . . 0.0 110.174 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 64' ' ' LYS . 1.1 ttpt -53.73 -29.24 38.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 63' ' ' LYS . 1.6 mptt -41.61 100.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -159.83 -57.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.28 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 67' ' ' GLY . 23.2 tp -41.95 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 110.435 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 65' ' ' ARG . . . 42.22 87.36 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 64' ' ' LYS . 23.2 mtt85 -144.94 131.24 19.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -1.122 . . . . 0.0 110.196 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.431 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 1.8 p90 -44.86 134.04 5.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 43.45 40.37 2.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.871 . . . . 0.0 109.931 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 72' ' ' LYS . . . -89.51 -124.17 2.49 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.428 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 0.1 OUTLIER 42.95 54.25 4.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -1.121 . . . . 0.0 110.114 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.577 ' CB ' ' HA3' ' A' ' 61' ' ' GLY . 3.5 mtm180 -103.31 103.81 37.28 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 110.166 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 55.3 Cg_endo -77.33 -165.38 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.091 1.574 . . . . 0.0 110.888 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -114.83 90.01 3.24 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.637 ' CG ' ' CE3' ' A' ' 29' ' ' TRP . 0.3 OUTLIER -137.42 153.85 50.07 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.62 -0.675 . . . . 0.0 111.102 -178.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 59' ' ' VAL . 4.8 ptmt -98.59 141.2 31.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.402 -0.812 . . . . 0.0 110.18 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.634 ' HD2' HD11 ' A' ' 57' ' ' LEU . 19.2 ptpt -109.3 151.41 26.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -0.936 . . . . 0.0 110.483 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.898 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -116.9 122.68 45.01 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.234 -0.916 . . . . 0.0 111.931 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.992 HD11 HG23 ' A' ' 27' ' ' THR . 1.5 mp -103.18 112.77 37.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.559 -0.713 . . . . 0.0 109.468 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.041 HG22 ' CG2' ' A' ' 54' ' ' VAL . 23.8 t -113.3 128.68 69.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.417 -0.802 . . . . 0.0 110.866 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.669 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.5 tp60 -98.82 153.36 18.83 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.193 -0.942 . . . . 0.0 108.679 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 84' ' ' ALA . 1.5 m -116.66 156.69 17.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 C-N-CA 118.264 -1.375 . . . . 0.0 108.679 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.986 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -69.27 178.79 0.85 Allowed Pre-proline 0 C--N 1.285 -2.229 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.002 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.893 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.6 138.41 26.68 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 124.243 1.654 . . . . 0.0 110.458 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.42 -30.1 8.52 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.986 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -111.69 176.9 4.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.242 . . . . 0.0 110.705 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 90' ' ' GLU . 8.2 ptpt 179.46 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.459 -0.776 . . . . 0.0 110.012 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.827 HD12 ' CD2' ' A' ' 26' ' ' TYR . 14.9 mt -45.07 95.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.002 . . . . 0.0 110.075 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 88' ' ' LYS . 1.1 pt-20 -68.13 -13.89 62.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.384 -0.823 . . . . 0.0 110.666 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.769 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.96 -28.68 53.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.125 -0.985 . . . . 0.0 110.347 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.954 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.23 -23.04 12.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.492 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 13.9 mm-40 -51.07 -31.92 20.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.436 -0.79 . . . . 0.0 110.45 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -98.02 -26.63 9.45 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.769 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.4 mp -43.56 -26.18 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.227 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.412 HG13 ' CE1' ' A' ' 18' ' ' TYR . 40.5 mt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.23 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.548 ' O ' HG22 ' A' ' 3' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.727 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -60.92 89.97 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.004 -1.478 . . . . 0.0 108.84 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.602 ' HA ' HG21 ' A' ' 45' ' ' THR 0.265 12.0 t -134.1 -24.43 1.65 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 122.113 0.958 . . . . 0.0 110.363 -178.038 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.63 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . 179.86 -29.0 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 121.376 0.607 . . . . 0.0 109.525 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.727 ' CE1' ' HA ' ' A' ' 2' ' ' LYS 0.288 0.1 OUTLIER -43.31 -136.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.36 1.076 . . . . 0.0 112.685 177.914 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.633 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 22.9 m-20 -23.06 -62.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.687 0.756 . . . . 0.0 112.293 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.025 HG12 HG13 ' A' ' 8' ' ' ILE . 45.7 t -57.33 -111.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.575 -0.703 . . . . 0.0 111.199 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.025 HG13 HG12 ' A' ' 7' ' ' VAL . 5.7 mt -86.37 100.2 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.861 -1.15 . . . . 0.0 111.109 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.496 HD21 ' HA ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -91.63 -86.01 0.23 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.226 -0.921 . . . . 0.0 111.067 179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.544 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -107.99 140.64 21.85 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.9 -1.125 . . . . 0.0 110.592 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.628 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.1 Cg_endo -72.96 170.38 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.079 1.568 . . . . 0.0 110.393 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.076 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.6 m -115.27 133.16 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.165 -0.959 . . . . 0.0 110.405 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.838 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -102.83 112.66 25.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.163 -0.961 . . . . 0.0 110.215 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 15' ' ' GLU . 40.5 m -159.69 145.62 15.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.007 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' SER . 36.5 mt-10 -42.76 -54.13 4.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 110.165 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -54.61 -28.17 44.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 0.0 110.182 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -87.05 -55.41 3.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.838 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -53.7 -26.24 21.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.02 -15.65 31.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -101.49 -36.44 3.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -77.67 -23.08 49.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.574 -0.956 . . . . 0.0 108.835 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -50.61 -20.58 1.24 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.606 -0.684 . . . . 0.0 110.338 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.3 13.63 25.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.53 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 99.94 -0.53 56.34 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 20.7 mttt -82.38 147.45 28.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -1.138 . . . . 0.0 109.396 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 1.076 ' CE2' HD12 ' A' ' 89' ' ' ILE . 22.0 m-85 -128.07 102.88 6.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.693 -1.254 . . . . 0.0 112.209 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.799 HG22 ' HD3' ' A' ' 78' ' ' LYS . 3.4 m -75.82 125.92 30.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.652 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -130.28 164.96 23.44 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.934 -1.103 . . . . 0.0 112.085 -177.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 1.076 ' CD1' HG12 ' A' ' 12' ' ' VAL . 24.9 m95 -101.33 123.31 45.22 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 7' ' ' VAL . 1.4 p -145.96 158.81 11.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 117.772 -1.571 . . . . 0.0 112.003 -176.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.593 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -59.97 151.17 66.34 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.852 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 49.0 Cg_endo -73.36 70.01 4.03 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.227 1.646 . . . . 0.0 109.763 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.57 -33.42 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 110.071 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.996 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -42.61 93.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.45 -0.781 . . . . 0.0 109.831 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -51.52 140.29 18.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 110.421 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 8.5 mttt -42.26 -43.27 3.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.88 . . . . 0.0 110.027 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -64.32 -53.36 50.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.865 . . . . 0.0 110.07 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.8 OUTLIER -55.47 -40.43 71.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.769 HG23 HD11 ' A' ' 8' ' ' ILE . 14.9 mt -57.68 -31.4 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.271 -0.893 . . . . 0.0 108.968 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 37' ' ' THR . 6.7 tttt -63.12 -42.54 99.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.371 -0.831 . . . . 0.0 109.833 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 1.045 ' O ' HG23 ' A' ' 45' ' ' THR . 44.1 m-80 -71.39 -44.89 64.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.69 -0.631 . . . . 0.0 111.836 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.856 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.78 -52.11 66.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.768 -1.208 . . . . 0.0 110.964 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.797 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -59.69 -38.64 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.547 -1.346 . . . . 0.0 109.862 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -64.37 -32.73 74.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 1.045 HG23 ' O ' ' A' ' 41' ' ' ASN . 26.7 p -62.95 -47.47 83.07 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.153 -0.967 . . . . 0.0 110.65 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.88 -52.11 5.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.222 -0.924 . . . . 0.0 110.828 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.797 ' CD2' HG22 ' A' ' 43' ' ' VAL . 78.1 m-85 -71.76 -21.39 61.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.231 -0.918 . . . . 0.0 110.499 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 14.0 mtpt 46.83 42.62 12.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.669 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.78 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.39 -162.59 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 121.398 0.618 . . . . 0.0 109.727 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.78 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.21 107.55 15.44 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.881 179.09 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.591 ' CG2' HG11 ' A' ' 43' ' ' VAL . 22.8 t -78.33 119.5 27.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.261 -0.9 . . . . 0.0 109.316 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.625 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.4 p -105.9 9.06 9.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.248 -0.908 . . . . 0.0 110.683 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.15 117.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 110.46 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.96 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -115.28 116.66 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.0 109.519 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 82.8 m-20 -118.56 115.87 25.46 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 109.409 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.545 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -115.0 162.45 16.96 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.987 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -154.79 153.01 30.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 110.469 -179.325 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.423 ' NE2' ' HA ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -66.36 130.59 43.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.745 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.687 HG11 ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.91 127.21 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.29 -0.881 . . . . 0.0 110.154 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.578 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.4 OUTLIER -107.6 124.06 49.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.271 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.96 174.02 45.49 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -53.56 -44.54 69.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -1.079 . . . . 0.0 110.245 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -43.71 166.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.182 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 63' ' ' LYS . 8.0 pttt 174.28 89.32 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.32 -0.863 . . . . 0.0 110.041 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.544 ' CA ' ' HB2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -153.01 -158.21 0.87 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.181 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' HD3' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 71.28 123.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.204 -0.935 . . . . 0.0 109.915 -179.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 68' ' ' ARG . . . 54.0 79.26 0.09 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' HA ' ' CE ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -42.38 133.34 3.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.286 -1.126 . . . . 0.0 110.435 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 49.0 t80 -162.87 59.44 0.2 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.364 -0.835 . . . . 0.0 109.863 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER 43.08 40.49 2.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.927 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.1 96.22 1.89 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.544 ' HB2' ' CA ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -92.92 154.71 18.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -1.178 . . . . 0.0 110.47 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.32 142.49 14.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.436 -0.79 . . . . 0.0 109.803 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.09 -168.55 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.828 1.436 . . . . 0.0 110.207 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.498 ' HB3' ' HG3' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -116.06 89.41 3.1 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.414 -0.804 . . . . 0.0 109.501 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -106.59 127.5 53.39 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.481 -0.762 . . . . 0.0 109.899 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.524 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 51.1 tttt -117.86 128.59 54.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.573 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.799 ' HD3' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -101.7 151.11 22.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.56 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.812 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -129.4 131.41 46.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.915 -1.115 . . . . 0.0 112.053 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.812 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.6 mp -110.63 111.43 36.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.96 HG13 HG23 ' A' ' 54' ' ' VAL . 2.6 t -106.16 133.92 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.505 -0.747 . . . . 0.0 110.431 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.625 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.1 tp-100 -117.14 152.77 34.04 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.005 -1.06 . . . . 0.0 108.674 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.545 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -118.79 155.76 20.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.142 -1.423 . . . . 0.0 109.711 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.778 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -50.85 174.11 0.09 OUTLIER Pre-proline 0 C--N 1.289 -2.024 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.871 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.778 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.8 Cg_endo -76.66 55.54 4.85 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.307 1.688 . . . . 0.0 110.609 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -163.81 -50.28 0.02 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.546 ' HB3' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -51.27 -172.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -1.174 . . . . 0.0 111.025 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 179.25 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.63 -0.669 . . . . 0.0 110.172 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.076 HD12 ' CE2' ' A' ' 26' ' ' TYR . 5.6 mt -68.72 109.16 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.0 110.146 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 3.3 mt-10 -78.3 -14.49 59.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.585 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.757 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -56.29 -33.04 65.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 111.137 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.757 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.11 -23.44 12.61 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.952 -1.092 . . . . 0.0 110.138 -179.473 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mm-40 -62.71 -23.02 66.94 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.179 -0.95 . . . . 0.0 110.228 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -113.51 -26.32 3.99 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.518 HD23 HD11 ' A' ' 13' ' ' LEU . 8.0 tp -42.87 -27.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -1.132 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.625 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 52.0 mt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.215 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.579 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 1.3 ptt? . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.751 0.31 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.886 ' HD2' HD11 ' A' ' 9' ' ' LEU . 22.3 mmtt -44.31 97.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.4 m 4.29 -71.53 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 121.365 0.602 . . . . 0.0 110.843 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.968 ' O ' HG23 ' A' ' 7' ' ' VAL 0.265 . . -55.41 81.04 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.233 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.087 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.7 p90 24.18 47.19 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.819 0.818 . . . . 0.0 110.408 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.615 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 4.3 t0 64.75 52.64 1.63 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.993 0.901 . . . . 0.0 111.333 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.087 HG21 ' CE2' ' A' ' 5' ' ' TYR . 3.2 t -133.38 -124.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.133 -0.979 . . . . 0.0 109.993 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.088 HD13 HG13 ' A' ' 43' ' ' VAL . 4.9 mt -56.12 156.07 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 121.217 -0.927 . . . . 0.0 110.812 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.886 HD11 ' HD2' ' A' ' 2' ' ' LYS . 14.2 mt -143.52 -93.78 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 110.155 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.21 149.81 39.68 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.068 -1.02 . . . . 0.0 110.277 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.619 ' HG3' HD22 ' A' ' 92' ' ' LEU . 45.9 Cg_endo -73.33 173.57 13.54 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.1 1.579 . . . . 0.0 110.357 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.626 HG12 ' CE2' ' A' ' 29' ' ' TRP . 2.4 m -112.8 139.35 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.206 -0.934 . . . . 0.0 110.152 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.753 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.77 112.28 24.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.197 -0.939 . . . . 0.0 110.243 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -161.99 138.07 7.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 0.0 110.098 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 2.2 tm-20 -42.87 -50.11 5.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.178 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -46.75 74.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.849 . . . . 0.0 110.23 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -67.86 -60.37 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.187 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.717 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.2 m-85 -44.61 -29.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.117 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.75 -19.27 23.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.86 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -96.19 -40.55 3.97 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.244 -1.943 . . . . 0.0 108.244 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.626 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -69.79 -17.08 63.39 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.638 -0.919 . . . . 0.0 108.952 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.626 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -58.34 -21.2 48.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.272 0.558 . . . . 0.0 110.89 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -88.53 16.96 5.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.25 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.67 1.96 65.52 Favored Glycine 0 N--CA 1.48 1.594 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 24.7 mttm -82.24 137.7 34.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.607 -0.937 . . . . 0.0 109.246 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.966 ' CD1' HD12 ' A' ' 92' ' ' LEU . 24.8 m-85 -128.76 103.89 7.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.518 -1.363 . . . . 0.0 112.007 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 78' ' ' LYS . 1.4 m -75.03 140.96 43.91 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.619 -0.676 . . . . 0.0 109.339 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.814 ' CB ' HG23 ' A' ' 8' ' ' ILE . 22.0 m-85 -134.56 165.64 24.74 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.453 -0.779 . . . . 0.0 110.438 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.626 ' CE2' HG12 ' A' ' 12' ' ' VAL . 10.0 m95 -98.96 122.33 42.07 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.76 HG23 ' C ' ' A' ' 7' ' ' VAL . 7.4 p -148.06 165.68 5.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.617 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.483 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -61.14 152.91 69.8 Favored Pre-proline 0 C--N 1.298 -1.669 0 O-C-N 121.851 -0.53 . . . . 0.0 110.383 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.497 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.9 Cg_endo -73.4 71.53 3.77 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.099 1.578 . . . . 0.0 110.349 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.02 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.264 -0.898 . . . . 0.0 110.101 -179.256 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.415 ' CB ' HG13 ' A' ' 7' ' ' VAL . . . -42.74 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 110.186 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -48.09 155.81 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 110.26 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.584 ' O ' HG11 ' A' ' 54' ' ' VAL . 7.2 mmtp -57.33 -36.25 70.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.88 . . . . 0.0 110.204 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -75.14 -50.21 17.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 23.0 mt-10 -54.97 -37.92 67.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.942 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.718 HG23 HD11 ' A' ' 8' ' ' ILE . 17.8 mt -57.91 -30.83 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 109.401 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HG3' HG11 ' A' ' 51' ' ' VAL . 2.4 ttpt -61.69 -45.89 92.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 111.096 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -58.9 -36.67 75.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 112.314 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.942 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -73.22 -50.49 22.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.603 -1.311 . . . . 0.0 111.685 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.088 HG13 HD13 ' A' ' 8' ' ' ILE . 4.7 m -66.01 -30.57 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.518 -1.364 . . . . 0.0 110.583 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -62.76 -52.41 63.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.088 -1.007 . . . . 0.0 109.964 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -79.72 -15.72 56.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.895 . . . . 0.0 110.224 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.25 -62.05 1.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.471 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.611 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 9.7 m-85 -71.73 -15.96 62.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.183 -0.948 . . . . 0.0 110.096 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 5.9 mmtt 61.56 45.36 8.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.48 -0.762 . . . . 0.0 110.235 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.776 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -128.28 -162.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.528 -0.733 . . . . 0.0 110.007 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.776 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.06 106.14 12.58 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 109.358 178.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.832 HG13 HG13 ' A' ' 81' ' ' VAL . 97.8 t -78.23 119.77 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.322 -0.861 . . . . 0.0 110.184 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.65 HG12 ' C ' ' A' ' 82' ' ' GLN . 7.6 p -106.01 -3.97 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.569 ' HG3' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 178.34 147.94 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.859 . . . . 0.0 109.875 179.523 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.103 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.1 t -132.79 131.32 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.002 -1.061 . . . . 0.0 109.871 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -131.61 115.88 16.66 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.39 -0.819 . . . . 0.0 109.22 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.761 ' O ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -113.83 166.27 11.74 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.39 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 56' ' ' THR . 7.0 mt -143.17 179.76 6.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.432 -0.793 . . . . 0.0 109.852 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.499 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 1.4 t-160 -104.15 102.17 11.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.339 -0.85 . . . . 0.0 109.387 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.548 ' CG1' ' HE2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -110.64 134.5 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.271 -0.893 . . . . 0.0 110.095 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.573 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -130.46 168.39 17.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 110.339 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.09 131.09 25.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -96.4 -28.07 14.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -1.121 . . . . 0.0 110.256 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 64' ' ' LYS . 18.0 mttt -122.67 15.29 10.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.295 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 63' ' ' LYS . 14.6 tptt -43.77 -27.73 0.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 110.417 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -74.16 -1.72 21.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 0.0 110.364 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 65' ' ' ARG . 8.2 tp -41.14 143.27 0.42 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 68' ' ' ARG . . . 53.47 -168.59 1.18 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 67' ' ' GLY . 15.5 ptt180 -40.94 155.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.461 -1.023 . . . . 0.0 110.273 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.9 112.61 7.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.46 40.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.055 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -168.88 117.47 0.72 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 1.2 mtpm? -101.58 108.24 19.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -1.152 . . . . 0.0 110.143 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -40.79 100.25 0.22 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.384 -0.823 . . . . 0.0 110.311 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 54.3 Cg_endo -81.36 -166.18 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.059 1.557 . . . . 0.0 110.449 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.15 89.48 3.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.504 -0.748 . . . . 0.0 108.984 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -106.82 142.88 35.75 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.609 -0.682 . . . . 0.0 110.531 -179.693 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.516 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 5.9 ptmt -123.15 141.19 52.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.982 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.676 ' HB2' HG22 ' A' ' 27' ' ' THR . 5.2 ptpt -101.57 151.12 22.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.105 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -115.48 119.96 37.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.217 -0.927 . . . . 0.0 112.25 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.592 HG12 HG23 ' A' ' 27' ' ' THR . 12.8 mt -98.2 110.78 26.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.784 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.103 HG22 ' CG2' ' A' ' 54' ' ' VAL . 50.4 t -103.63 133.04 48.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.91 -1.119 . . . . 0.0 110.257 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.65 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.4 tp60 -102.71 153.28 20.29 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.07 -1.019 . . . . 0.0 109.065 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.1 m -120.94 156.19 24.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 C-N-CA 118.35 -1.34 . . . . 0.0 109.053 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.868 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -63.3 177.74 0.44 Allowed Pre-proline 0 C--N 1.286 -2.168 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.194 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.868 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.6 Cg_endo -74.23 138.92 25.77 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 124.233 1.649 . . . . 0.0 110.301 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.47 -30.32 10.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.81 176.35 5.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.112 -1.228 . . . . 0.0 110.548 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 7.9 pttt 179.56 104.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.449 -0.782 . . . . 0.0 110.195 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 26' ' ' TYR . 9.8 mt -42.65 100.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.54 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 3.1 mm-40 -63.06 -13.72 39.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.419 -0.801 . . . . 0.0 110.985 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.757 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.75 -32.73 60.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.099 -1.0 . . . . 0.0 110.418 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.966 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.12 -23.02 12.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.148 -0.97 . . . . 0.0 109.599 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 64.9 mm-40 -48.05 -58.76 4.03 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.38 -0.825 . . . . 0.0 110.423 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -76.5 -33.66 47.22 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 8.0 tp -41.64 -27.34 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.299 -1.118 . . . . 0.0 110.331 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.451 HG12 ' CE1' ' A' ' 18' ' ' TYR . 50.4 mt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.263 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.86 0.362 . . . . 0.0 110.364 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.636 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 1.2 mttt -79.89 78.2 6.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.692 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.808 HG21 ' CB ' ' A' ' 45' ' ' THR . 0.6 OUTLIER -121.12 -88.91 0.62 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.409 0.623 . . . . 0.0 110.157 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.824 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -90.21 -30.59 17.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.456 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.748 ' CE1' HG23 ' A' ' 7' ' ' VAL . 1.8 p90 -34.36 -26.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.583 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 46.2 t0 -160.19 -59.55 0.06 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.891 -1.131 . . . . 0.0 110.727 -176.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.994 HG13 ' HB1' ' A' ' 34' ' ' ALA . 40.9 t -42.01 -68.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.046 0.926 . . . . 0.0 109.611 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.805 HG23 ' CB ' ' A' ' 28' ' ' PHE . 4.7 mt -114.06 99.04 7.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 O-C-N 121.326 -0.859 . . . . 0.0 110.068 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 4' ' ' ALA . 75.0 mt -93.05 -95.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.328 -0.857 . . . . 0.0 110.854 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.95 154.95 41.8 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.7 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.61 158.17 39.9 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.134 1.597 . . . . 0.0 110.167 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 27' ' ' THR . 1.5 p -115.2 117.24 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.818 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.5 mm? -102.07 106.96 17.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 110.174 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.592 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -144.72 152.8 40.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.6 tt0 -43.07 -63.78 0.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -25.8 28.46 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.592 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -84.39 -51.19 7.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.143 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.617 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 2.1 m-85 -55.75 -32.47 63.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.17 -8.48 51.09 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.256 -0.903 . . . . 0.0 109.901 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.76 -34.0 3.4 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.584 -1.807 . . . . 0.0 108.584 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -79.37 -19.81 49.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.574 -0.956 . . . . 0.0 109.026 179.244 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -54.6 -17.65 3.55 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.65 -0.656 . . . . 0.0 110.879 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.8 OUTLIER -93.17 17.07 11.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.507 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.53 -2.01 67.07 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 1.7 mttp -82.13 139.51 34.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.524 -0.986 . . . . 0.0 109.376 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 1.001 ' CD1' HD12 ' A' ' 92' ' ' LEU . 23.8 m-85 -128.42 102.88 6.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.533 -1.354 . . . . 0.0 112.033 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.652 HG21 ' NZ ' ' A' ' 78' ' ' LYS . 8.1 m -74.88 141.15 44.2 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.449 0.642 . . . . 0.0 109.659 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.805 ' CB ' HG23 ' A' ' 8' ' ' ILE . 44.8 m-85 -134.22 165.18 25.7 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.49 -0.756 . . . . 0.0 110.056 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.605 ' CZ3' ' HG2' ' A' ' 76' ' ' ARG . 52.9 m95 -89.92 122.0 32.54 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 7' ' ' VAL . 10.6 p -134.14 165.26 32.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 118.344 -1.342 . . . . 0.0 112.394 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.597 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -82.75 152.4 66.22 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.297 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 43.8 Cg_endo -70.61 65.56 2.29 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.173 1.617 . . . . 0.0 109.544 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.87 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.559 -0.713 . . . . 0.0 109.647 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.994 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -48.37 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.501 -0.75 . . . . 0.0 109.575 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -40.31 134.35 1.66 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.301 -0.875 . . . . 0.0 110.797 -179.226 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.643 ' HA ' HD12 ' A' ' 39' ' ' ILE . 3.5 tttm -42.4 -43.36 3.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.7 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 5.2 m -61.27 -44.32 97.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.92 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 35' ' ' THR . 6.7 mt-10 -55.13 -39.61 69.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.376 -0.827 . . . . 0.0 109.494 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.718 HG23 HD11 ' A' ' 8' ' ' ILE . 10.4 mt -57.67 -30.67 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.379 -0.826 . . . . 0.0 108.914 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.591 ' HG3' HG11 ' A' ' 51' ' ' VAL . 9.6 tttt -61.79 -47.64 84.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.827 . . . . 0.0 109.541 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.449 ' O ' ' HB ' ' A' ' 45' ' ' THR . 24.3 m-80 -73.48 -34.33 65.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.653 -0.654 . . . . 0.0 110.97 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.64 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . . . -58.37 -50.27 74.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.912 -1.118 . . . . 0.0 110.656 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.004 HG21 HG11 ' A' ' 81' ' ' VAL . 2.7 m -68.11 -36.94 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.715 -1.241 . . . . 0.0 109.835 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -63.36 -42.6 98.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.092 -1.005 . . . . 0.0 108.886 179.154 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.808 ' CB ' HG21 ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.2 -20.43 48.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.578 -0.701 . . . . 0.0 109.315 179.083 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.824 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -100.04 -67.14 0.87 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 110.456 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.711 ' CD2' HG12 ' A' ' 43' ' ' VAL . 62.6 m-85 -72.58 -21.61 61.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 110.432 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 64.06 47.87 3.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.311 -0.868 . . . . 0.0 110.274 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -122.28 -158.82 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.483 -0.761 . . . . 0.0 110.062 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.788 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -117.16 111.3 19.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.436 179.209 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.78 HG13 HG13 ' A' ' 81' ' ' VAL . 57.7 t -78.3 119.8 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.189 -0.944 . . . . 0.0 110.424 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 82' ' ' GLN . 12.2 p -113.8 -1.41 9.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.489 -0.757 . . . . 0.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 175.83 119.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.81 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.081 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -113.68 132.04 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 110.304 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.553 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 2.4 m120 -131.05 115.56 16.61 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.457 -0.777 . . . . 0.0 109.573 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -116.28 144.61 44.01 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 109.982 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.45 162.01 34.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -0.804 . . . . 0.0 109.973 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 127.49 32.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.944 HG11 ' HD3' ' A' ' 78' ' ' LYS . 1.9 m -118.63 123.37 71.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.607 -0.683 . . . . 0.0 109.979 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.577 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -105.16 142.26 35.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.475 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' O ' ' HE2' ' A' ' 62' ' ' LYS . . . 87.55 153.92 25.94 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -144.05 -65.64 0.36 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -1.122 . . . . 0.0 110.176 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -124.59 -11.76 7.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 0.0 110.18 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 177.64 131.24 0.06 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.31 -0.869 . . . . 0.0 110.427 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -128.96 1.07 5.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -41.32 129.26 3.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.413 -0.805 . . . . 0.0 110.335 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.52 51.62 2.62 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HG2' ' HB3' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -125.06 12.54 8.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -1.233 . . . . 0.0 109.463 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.581 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 29.1 t80 -166.25 69.33 0.12 Allowed 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.795 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.3 OUTLIER 43.36 38.84 1.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 109.941 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 72' ' ' LYS . . . -87.53 141.01 17.06 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 71' ' ' GLY . 8.4 mttt -166.07 109.52 0.78 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -1.131 . . . . 0.0 110.236 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -45.33 105.38 0.45 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 110.014 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 49.0 Cg_endo -72.6 -166.85 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.57 . . . . 0.0 110.388 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.34 89.39 3.09 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.397 -0.814 . . . . 0.0 109.489 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.605 ' HG2' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -105.52 143.22 33.99 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.515 -0.74 . . . . 0.0 110.018 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.0 tttt -110.18 141.87 42.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.554 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.944 ' HD3' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -116.57 151.32 36.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.417 -0.802 . . . . 0.0 109.82 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.98 123.24 36.66 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.997 -1.064 . . . . 0.0 112.63 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 14.9 mt -103.29 111.36 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.829 -0.544 . . . . 0.0 110.019 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.081 HG22 ' CG2' ' A' ' 54' ' ' VAL . 60.2 t -104.29 130.37 55.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.94 -1.1 . . . . 0.0 109.969 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.782 ' O ' HG12 ' A' ' 52' ' ' VAL . 3.6 tp60 -102.64 149.76 24.11 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.143 -0.973 . . . . 0.0 109.205 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.539 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.5 m -112.89 156.65 13.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 118.45 -1.3 . . . . 0.0 109.405 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.895 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -62.87 175.49 0.64 Allowed Pre-proline 0 C--N 1.291 -1.951 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.916 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.846 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.3 Cg_endo -76.26 55.29 4.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.525 1.803 . . . . 0.0 110.415 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -158.67 -37.08 0.02 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.895 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -110.64 -179.57 3.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.297 -1.12 . . . . 0.0 110.219 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.439 ' HA ' HG21 ' A' ' 83' ' ' VAL . 2.6 pttt -176.17 100.35 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.743 HD12 ' CD2' ' A' ' 26' ' ' TYR . 11.2 mt -42.35 113.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.006 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 1.2 pt-20 -77.95 -13.36 59.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 0.0 110.914 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.639 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.52 -28.8 47.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.064 -1.022 . . . . 0.0 110.575 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.001 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.26 -23.15 12.64 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.077 -1.014 . . . . 0.0 109.605 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.549 ' O ' HD12 ' A' ' 96' ' ' ILE . 20.5 mm-40 -58.14 -37.69 75.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.487 -0.758 . . . . 0.0 110.296 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.42 25.08 29.41 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.556 HD23 HD21 ' A' ' 13' ' ' LEU . 1.2 tp -106.45 -15.1 14.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -1.143 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 96' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.197 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' A' ' 1' ' ' MET . 6.5 ptp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.087 0.47 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -90.35 84.81 6.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.058 -1.026 . . . . 0.0 109.075 179.15 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.963 HG21 HG21 ' A' ' 45' ' ' THR . 28.9 p -136.26 -88.61 0.31 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 110.621 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.019 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -78.15 -20.79 51.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.681 -1.262 . . . . 0.0 110.155 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.818 ' CZ ' HG23 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -52.13 -138.46 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.483 0.659 . . . . 0.0 110.802 178.179 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.65 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 55.3 t0 -31.13 -56.42 0.23 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.46 -0.775 . . . . 0.0 110.791 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.818 HG23 ' CZ ' ' A' ' 5' ' ' TYR . 74.7 t -56.35 167.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.659 -0.651 . . . . 0.0 110.374 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.933 HD11 HG23 ' A' ' 39' ' ' ILE . 58.0 mt 11.59 86.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.222 0.534 . . . . 0.0 112.283 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.1 mt -68.29 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 110.149 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.41 158.54 33.59 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.956 -1.09 . . . . 0.0 110.359 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.435 ' HG3' HD22 ' A' ' 92' ' ' LEU . 46.4 Cg_endo -73.35 161.69 42.07 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.012 1.533 . . . . 0.0 110.344 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.073 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.2 m -104.65 135.13 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.145 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.835 HD11 HD23 ' A' ' 95' ' ' LEU . 3.2 mm? -102.85 107.18 17.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.118 -0.989 . . . . 0.0 110.334 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 15' ' ' GLU . 14.9 m -162.11 147.16 12.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.947 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.1 tt0 -42.78 -55.48 3.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.917 . . . . 0.0 109.989 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -29.95 54.56 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 110.154 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -82.96 -64.88 1.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.812 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.6 m-85 -42.95 -51.72 5.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.299 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.74 -24.56 67.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.21 -0.931 . . . . 0.0 109.943 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -87.43 -44.75 5.47 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.52 -23.9 56.74 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.509 -0.995 . . . . 0.0 108.957 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -50.43 -21.57 1.52 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.657 -0.652 . . . . 0.0 110.204 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.516 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -91.85 16.26 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.235 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.63 0.02 64.9 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 14.6 mttt -82.18 146.95 29.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -1.128 . . . . 0.0 109.694 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 1.0 ' CD2' HD12 ' A' ' 89' ' ' ILE . 22.3 m-85 -127.31 104.69 8.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.773 -1.204 . . . . 0.0 112.0 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.857 HG23 HD11 ' A' ' 80' ' ' ILE . 3.9 m -78.27 131.43 37.08 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.858 ' CB ' HG23 ' A' ' 8' ' ' ILE . 24.1 m-85 -136.32 164.42 28.14 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.177 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 1.073 ' NE1' HG12 ' A' ' 12' ' ' VAL . 99.6 m95 -100.43 121.91 42.32 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.6 p -145.78 164.99 10.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.503 -176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.623 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -73.46 171.47 10.58 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.767 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 48.4 Cg_endo -75.18 -53.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.927 1.488 . . . . 0.0 109.374 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' THR 0.252 0.0 OUTLIER -47.12 -22.63 0.39 Allowed 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.678 178.927 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -67.02 61.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.363 -0.835 . . . . 0.0 109.617 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -38.33 148.65 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.65 -0.656 . . . . 0.0 110.919 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 14.1 mttt -42.67 -46.56 5.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -0.826 . . . . 0.0 109.955 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -58.78 -53.06 62.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.325 -0.86 . . . . 0.0 110.025 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -55.4 -41.85 73.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.862 . . . . 0.0 109.701 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.933 HG23 HD11 ' A' ' 8' ' ' ILE . 21.9 mt -57.63 -31.44 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.182 -0.949 . . . . 0.0 108.87 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.596 ' HG3' HG11 ' A' ' 51' ' ' VAL . 15.7 tttp -63.27 -45.35 91.9 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.368 -0.832 . . . . 0.0 109.864 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.462 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.3 m-80 -71.22 -34.36 70.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.688 -0.633 . . . . 0.0 111.412 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.924 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.56 -50.73 72.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.768 -1.208 . . . . 0.0 110.6 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.595 HG12 ' CE2' ' A' ' 47' ' ' PHE . 2.9 m -71.05 -34.19 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.838 -1.163 . . . . 0.0 109.582 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -64.88 -38.06 89.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.28 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.963 HG21 HG21 ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.22 -33.43 43.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.516 -0.74 . . . . 0.0 109.72 179.426 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 1.019 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -90.12 -62.42 1.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.39 -0.819 . . . . 0.0 110.72 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.595 ' CE2' HG12 ' A' ' 43' ' ' VAL . 21.8 m-85 -71.69 -21.45 61.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.415 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 7.4 mttt 60.64 46.89 8.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 0.0 110.272 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -123.19 -162.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.472 -0.768 . . . . 0.0 110.163 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.788 ' N ' HG13 ' A' ' 49' ' ' VAL . 2.2 tmtm? -118.16 111.41 18.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.411 -0.805 . . . . 0.0 109.845 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.596 HG11 ' HG3' ' A' ' 40' ' ' LYS . 64.9 t -78.74 119.53 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 82' ' ' GLN . 12.1 p -107.81 7.54 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.984 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER 169.25 117.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.814 . . . . 0.0 110.07 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.02 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -119.01 117.25 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.948 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 80' ' ' ILE . 2.5 m120 -116.27 116.11 27.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.285 -0.884 . . . . 0.0 109.523 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.547 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -114.82 139.76 49.48 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.356 -0.84 . . . . 0.0 109.809 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 58' ' ' HIS . 1.4 pp -125.36 167.81 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.646 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.729 ' O ' HD12 ' A' ' 57' ' ' LEU . 23.7 t-160 -72.95 128.23 34.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.465 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.567 ' HB ' ' CG ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -111.33 138.66 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.576 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -113.59 173.51 6.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 110.152 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.63 92.18 0.38 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -111.8 91.96 3.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -1.137 . . . . 0.0 110.279 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.11 55.14 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.228 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 46.44 59.55 3.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.312 -0.867 . . . . 0.0 110.159 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.622 ' HA ' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -177.84 -42.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.327 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.49 ' N ' ' HD2' ' A' ' 65' ' ' ARG . 1.6 mp 45.27 94.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.786 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 68' ' ' ARG . . . 75.52 -158.47 50.41 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 67' ' ' GLY . 4.5 ptp85 -51.65 -169.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.599 -0.942 . . . . 0.0 110.657 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.573 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 6.1 t80 -38.3 108.75 0.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.443 -0.786 . . . . 0.0 110.862 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER 34.92 41.44 0.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.814 0.816 . . . . 0.0 110.804 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 66' ' ' LEU . . . -88.55 -145.85 11.69 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.57 139.64 47.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -1.14 . . . . 0.0 110.156 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.95 113.35 8.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.175 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.09 -165.5 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.86 1.452 . . . . 0.0 110.32 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 75' ' ' ASP . 18.7 p-10 -114.05 89.48 3.1 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.415 -0.803 . . . . 0.0 109.42 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.567 ' CG ' ' HB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -95.16 153.6 17.58 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.565 -0.709 . . . . 0.0 110.308 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.761 ' CE ' HD11 ' A' ' 39' ' ' ILE . 20.9 tttt -123.21 135.06 54.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 109.398 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 5.2 ttpp -101.36 150.59 22.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.08 -1.012 . . . . 0.0 109.926 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.821 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -132.53 130.88 40.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.099 -1.001 . . . . 0.0 112.626 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.857 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -111.93 111.86 37.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.02 HG22 ' CG2' ' A' ' 54' ' ' VAL . 20.2 t -108.65 130.35 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.312 -0.868 . . . . 0.0 111.189 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.739 ' O ' HG12 ' A' ' 52' ' ' VAL . 3.1 tp60 -105.88 148.18 27.89 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.321 -0.862 . . . . 0.0 108.706 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.523 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.2 m -114.74 156.88 15.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.696 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.917 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -69.13 178.34 0.95 Allowed Pre-proline 0 C--N 1.291 -1.972 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.026 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.917 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.3 Cg_endo -74.16 139.36 26.54 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 O-C-N 124.23 1.648 . . . . 0.0 110.552 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.94 -40.17 2.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.666 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -96.44 -179.51 4.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.107 -1.231 . . . . 0.0 110.718 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HE2' ' HG2' ' A' ' 90' ' ' GLU . 5.6 ptmt 179.39 90.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 110.266 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.0 HD12 ' CD2' ' A' ' 26' ' ' TYR . 15.5 mt -46.28 97.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.076 -1.015 . . . . 0.0 109.821 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -58.26 -13.6 5.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.402 -0.811 . . . . 0.0 111.125 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.959 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.99 -36.7 65.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.052 -1.03 . . . . 0.0 110.823 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.95 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.8 -23.07 12.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.936 -1.103 . . . . 0.0 109.921 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 7.5 mm-40 -54.79 -40.1 69.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 110.409 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.81 -6.65 67.2 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.959 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.3 mp -63.47 -28.72 70.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -1.163 . . . . 0.0 110.126 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.425 HD13 ' CE1' ' A' ' 18' ' ' TYR . 17.4 mm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.16 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.612 ' O ' HG22 ' A' ' 3' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 120.659 0.266 . . . . 0.0 110.445 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.707 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -62.59 93.76 0.06 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.071 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.704 ' HA ' HG22 ' A' ' 45' ' ' THR . 9.3 t -137.49 -38.81 0.59 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.422 1.106 . . . . 0.0 109.198 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.624 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -160.4 -24.5 0.06 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.628 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.707 ' CE1' ' HA ' ' A' ' 2' ' ' LYS 0.267 0.0 OUTLIER -46.85 -135.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.955 0.883 . . . . 0.0 111.891 178.418 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.598 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -24.6 -63.44 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.71 0.767 . . . . 0.0 111.854 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.029 HG12 HG13 ' A' ' 8' ' ' ILE . 60.8 t -56.71 -108.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.672 -0.642 . . . . 0.0 111.657 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.029 HG13 HG12 ' A' ' 7' ' ' VAL . 17.1 mt -81.6 93.8 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.775 -1.203 . . . . 0.0 112.118 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 29' ' ' TRP . 39.4 mt -70.06 -106.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.365 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' TRP . . . -108.51 162.92 18.23 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.786 -1.196 . . . . 0.0 110.769 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -75.05 166.56 28.89 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.0 1.527 . . . . 0.0 110.545 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.863 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.5 m -115.25 137.95 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.929 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -102.8 113.03 26.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 110.294 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -152.54 146.64 25.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 110.103 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -42.72 -60.41 1.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 110.283 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -54.63 -42.22 70.95 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 110.371 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.542 ' N ' ' CG ' ' A' ' 16' ' ' LYS . . . -63.11 -60.01 4.01 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.929 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.3 m-85 -48.69 -36.24 15.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 0.0 110.106 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.37 -8.66 50.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.049 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -102.57 -34.77 4.02 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.628 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -79.06 -20.77 48.01 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.569 -0.959 . . . . 0.0 108.801 179.107 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.33 -21.45 5.71 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.705 -0.622 . . . . 0.0 110.819 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.91 17.19 5.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.35 -0.844 . . . . 0.0 110.48 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.72 -1.2 68.33 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.3 mttt -82.15 142.43 32.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.496 -1.002 . . . . 0.0 109.229 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.654 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.3 m-85 -128.01 113.09 15.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.611 -1.306 . . . . 0.0 111.743 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.806 HG23 HD11 ' A' ' 80' ' ' ILE . 9.2 m -84.25 122.35 28.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.766 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 19.8 m-85 -116.8 165.33 13.43 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.562 -0.712 . . . . 0.0 110.991 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.863 ' CD1' HG12 ' A' ' 12' ' ' VAL . 22.8 m95 -99.74 123.1 43.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 177.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 7' ' ' VAL . 1.4 p -144.22 156.28 15.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 117.407 -1.717 . . . . 0.0 112.463 -176.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -62.64 151.45 83.93 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.832 -179.359 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.3 Cg_endo -72.13 69.19 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.001 1.527 . . . . 0.0 109.478 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.77 -32.49 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.483 -0.761 . . . . 0.0 109.774 -178.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.881 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -40.29 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.758 -0.589 . . . . 0.0 109.897 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -42.87 137.45 2.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.087 -1.008 . . . . 0.0 110.533 -179.132 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.525 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -42.21 -39.18 1.97 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 0.0 109.737 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 14.3 m -74.79 -33.99 62.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.678 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -60.4 -43.96 96.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.385 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.86 ' O ' HD11 ' A' ' 8' ' ' ILE . 10.2 mt -57.36 -30.33 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.545 ' HG3' HG11 ' A' ' 51' ' ' VAL . 30.0 tttt -66.51 -44.53 82.28 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.518 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 45' ' ' THR . 1.7 m-80 -73.35 -45.35 55.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.707 -0.621 . . . . 0.0 112.037 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.673 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.36 -51.82 68.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.583 -1.323 . . . . 0.0 110.462 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.735 HG21 ' CE2' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -61.3 -47.38 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 110.296 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.5 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -58.33 -43.26 88.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.066 -1.021 . . . . 0.0 109.536 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -73.76 -13.57 60.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.521 -0.737 . . . . 0.0 109.737 179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.597 ' HB2' ' OG1' ' A' ' 3' ' ' THR . . . -102.61 -69.03 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.393 -0.817 . . . . 0.0 110.351 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.448 ' O ' ' HB2' ' A' ' 48' ' ' LYS . 17.1 m-85 -71.99 -21.56 61.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.893 . . . . 0.0 110.11 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.3 mttt 62.72 43.12 7.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.406 -0.809 . . . . 0.0 109.934 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.805 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -113.65 -159.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.635 -0.666 . . . . 0.0 109.952 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.805 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.16 105.06 11.41 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 109.946 179.319 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG22 ' CG1' ' A' ' 81' ' ' VAL . 21.5 t -78.67 119.61 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.898 . . . . 0.0 109.783 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 82' ' ' GLN . 14.6 p -113.27 11.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 110.244 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 4.1 mttt 169.47 119.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.035 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.013 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.1 t -123.62 116.71 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 110.101 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.525 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -119.8 115.86 24.71 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.36 -0.838 . . . . 0.0 109.203 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.649 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -117.16 150.2 39.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.973 . . . . 0.0 110.043 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.542 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -148.42 149.0 30.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 110.1 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.516 ' NE2' ' HB3' ' A' ' 32' ' ' PRO . 1.1 m80 -66.63 127.31 31.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.176 -0.953 . . . . 0.0 110.58 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -120.42 138.27 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.689 -0.632 . . . . 0.0 110.225 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -160.1 149.78 17.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.115 -0.99 . . . . 0.0 110.593 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.49 103.65 2.76 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -122.21 -66.94 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -1.112 . . . . 0.0 110.076 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -156.78 159.91 38.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 52.86 81.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.097 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' LEU . 18.3 mtm180 -82.65 -85.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 110.351 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 68' ' ' ARG . 5.6 mp 43.34 84.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 0.0 109.952 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.5 57.61 0.19 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -125.01 18.35 8.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.063 -1.257 . . . . 0.0 109.288 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 11.1 t80 -157.81 52.58 0.45 Allowed 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.92 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER 41.17 40.43 1.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.822 0.82 . . . . 0.0 110.199 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 72' ' ' LYS . . . -104.51 -94.47 2.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 71' ' ' GLY . 12.1 pttp 40.06 -165.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.601 -0.94 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -71.43 113.64 21.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.115 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 52.0 Cg_endo -73.37 -169.21 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.877 1.461 . . . . 0.0 110.41 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.83 89.1 3.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.632 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.535 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.4 OUTLIER -121.41 150.17 41.91 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.375 -0.828 . . . . 0.0 110.11 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HG2' HG13 ' A' ' 30' ' ' VAL . 8.8 tttp -123.22 125.88 45.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.512 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.631 ' HD3' HD11 ' A' ' 80' ' ' ILE . 5.2 ptpt -101.73 151.51 21.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 109.471 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -126.82 120.29 28.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.895 -1.128 . . . . 0.0 112.592 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.806 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -96.19 112.53 28.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.013 HG22 ' CG2' ' A' ' 54' ' ' VAL . 40.7 t -113.09 126.34 70.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.378 -0.826 . . . . 0.0 110.661 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.663 ' O ' HG12 ' A' ' 52' ' ' VAL . 34.1 tp60 -102.19 151.41 22.23 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.08 -1.013 . . . . 0.0 108.888 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.482 HG11 ' HE2' ' A' ' 26' ' ' TYR . 1.1 m -118.82 157.04 20.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 118.451 -1.3 . . . . 0.0 109.647 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.962 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -69.29 178.83 0.84 Allowed Pre-proline 0 C--N 1.29 -1.986 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.302 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.928 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.3 140.81 31.12 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 O-C-N 124.343 1.707 . . . . 0.0 110.438 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.22 -32.47 6.82 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.962 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.94 173.41 6.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -1.155 . . . . 0.0 110.49 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 90' ' ' GLU . 1.1 pttp 178.8 110.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.463 -0.773 . . . . 0.0 110.364 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.654 HD12 ' CD2' ' A' ' 26' ' ' TYR . 13.1 mt -63.44 77.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 109.698 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.526 ' HA ' ' OE1' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -53.83 -14.1 0.88 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.473 -0.767 . . . . 0.0 111.465 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.71 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.49 -21.01 8.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.913 -1.117 . . . . 0.0 110.999 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.84 -24.19 12.14 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.926 -1.109 . . . . 0.0 110.165 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.526 ' OE1' ' HA ' ' A' ' 90' ' ' GLU . 8.4 mp0 -54.04 -26.86 28.78 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.275 -0.89 . . . . 0.0 110.237 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.42 -15.79 31.37 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -53.36 -31.81 46.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -1.115 . . . . 0.0 110.118 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.591 HG13 ' CE1' ' A' ' 18' ' ' TYR . 71.8 mt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.138 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.514 ' HG2' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.798 0.809 . . . . 0.0 110.497 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.907 ' HD2' HD22 ' A' ' 9' ' ' LEU . 1.2 mmtt -82.65 109.06 16.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -32.52 -36.1 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.1 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.054 ' O ' HG23 ' A' ' 7' ' ' VAL 0.291 . . -63.17 68.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.147 ' CE2' HG21 ' A' ' 7' ' ' VAL . 0.4 OUTLIER 30.28 37.13 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.388 1.09 . . . . 0.0 108.724 -176.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 4' ' ' ALA . 2.6 t0 63.57 56.02 1.65 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.005 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.147 HG21 ' CE2' ' A' ' 5' ' ' TYR . 2.8 t -129.12 -128.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.826 -1.171 . . . . 0.0 110.01 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.5 mt -50.56 149.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.192 -0.942 . . . . 0.0 109.626 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.907 HD22 ' HD2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -143.01 -92.75 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.138 -0.976 . . . . 0.0 110.572 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.608 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -96.67 138.15 21.42 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 46.4 Cg_endo -74.18 173.51 14.02 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.011 1.532 . . . . 0.0 110.11 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.039 HG12 ' NE1' ' A' ' 29' ' ' TRP . 1.4 m -105.34 129.21 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.234 -0.916 . . . . 0.0 110.17 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.851 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -103.37 107.14 17.85 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.241 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -158.87 148.64 19.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.014 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 14' ' ' SER . 13.6 mm-40 -43.25 -52.83 5.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.33 -0.856 . . . . 0.0 109.98 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.6 -41.42 69.92 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.157 -0.964 . . . . 0.0 110.006 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -73.25 -61.77 1.7 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.851 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -46.73 -32.93 3.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.949 . . . . 0.0 110.197 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.39 -8.76 49.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 0.0 110.02 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -106.63 -38.17 2.27 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -73.13 -19.0 61.22 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.582 -0.952 . . . . 0.0 108.938 179.112 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -22.08 22.86 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.588 -0.695 . . . . 0.0 110.364 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.409 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 1.5 tt0 -88.75 17.01 5.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 110.074 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 91.37 3.74 69.06 Favored Glycine 0 N--CA 1.48 1.59 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 41.2 mttt -82.67 139.68 33.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -1.044 . . . . 0.0 109.48 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.982 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.4 m-85 -127.64 100.1 5.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.67 -1.269 . . . . 0.0 111.481 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.864 HG23 HD11 ' A' ' 80' ' ' ILE . 17.7 m -80.64 116.2 20.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.85 ' HB3' HG23 ' A' ' 8' ' ' ILE . 3.5 m-85 -119.24 163.22 17.43 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 109.992 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 1.039 ' NE1' HG12 ' A' ' 12' ' ' VAL . 97.2 m95 -98.9 122.08 41.68 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG23 ' C ' ' A' ' 7' ' ' VAL . 9.8 p -131.17 165.31 31.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 118.493 -1.283 . . . . 0.0 112.193 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -60.29 147.65 81.22 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.067 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.79 70.96 3.43 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.22 1.642 . . . . 0.0 109.93 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 178.94 -33.19 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.368 -0.833 . . . . 0.0 110.076 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -53.39 108.44 0.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.382 -0.824 . . . . 0.0 110.363 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 36.3 p -60.0 -170.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 110.153 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -77.33 -43.67 32.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.918 . . . . 0.0 110.336 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 6.3 m -71.56 -43.78 65.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.74 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 9.2 mt-10 -55.59 -46.21 77.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.361 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.858 HG23 HD11 ' A' ' 8' ' ' ILE . 27.1 mt -56.77 -30.4 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.911 . . . . 0.0 109.942 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.932 ' HG3' HG11 ' A' ' 51' ' ' VAL . 27.2 tttm -60.01 -44.69 94.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 111.664 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.629 ' O ' HG23 ' A' ' 45' ' ' THR . 54.9 m-80 -58.23 -36.55 73.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.302 -0.874 . . . . 0.0 112.685 -177.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.917 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -73.23 -50.2 23.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.658 -1.276 . . . . 0.0 111.965 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.883 HG11 HG11 ' A' ' 81' ' ' VAL . 0.7 OUTLIER -67.01 -43.02 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.791 -1.193 . . . . 0.0 110.748 -179.032 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.7 -42.1 78.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.929 -1.107 . . . . 0.0 110.149 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 41' ' ' ASN . 33.6 p -79.21 -46.68 17.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 0.0 109.98 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.2 -67.81 0.38 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.827 . . . . 0.0 110.494 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.876 ' CD2' HG22 ' A' ' 43' ' ' VAL . 90.5 m-85 -72.14 -3.84 25.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.89 . . . . 0.0 110.455 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 3.0 mtpp 43.35 42.81 3.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.455 -0.778 . . . . 0.0 110.347 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.754 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -112.39 -166.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.53 -0.731 . . . . 0.0 109.681 179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.754 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -109.31 109.19 20.03 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.286 178.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.932 HG11 ' HG3' ' A' ' 40' ' ' LYS . 22.7 t -77.34 119.64 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.161 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.75 HG21 ' N ' ' A' ' 84' ' ' ALA . 6.2 t -111.79 -6.81 11.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.493 0.663 . . . . 0.0 110.667 -178.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.532 ' CG ' ' HB3' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 175.87 135.97 0.05 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.526 -0.734 . . . . 0.0 109.069 179.647 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.923 ' CG2' HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -132.38 118.49 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.493 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.7 m120 -117.33 115.94 26.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.294 -0.878 . . . . 0.0 109.574 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.1 151.08 36.3 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.657 HD21 ' HD2' ' A' ' 78' ' ' LYS . 1.2 pp -147.79 143.01 27.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 110.323 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -67.26 127.2 31.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.888 HG11 ' HE3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -120.22 110.38 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.508 -0.745 . . . . 0.0 110.032 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 73' ' ' ARG . 1.4 mmt85 -97.28 117.38 31.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 110.277 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 164.04 124.29 0.7 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HB3' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -168.82 -53.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 110.189 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -122.81 -177.97 3.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' LYS . 3.2 tttm -41.68 136.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.206 -0.934 . . . . 0.0 110.323 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.432 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -125.93 -161.22 1.03 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.253 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 65' ' ' ARG . 1.4 tp 42.12 51.53 4.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.222 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.85 118.44 0.45 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 68' ' ' ARG . 3.8 ptt180 -61.75 124.39 20.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.172 -1.193 . . . . 0.0 110.22 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.571 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 17.6 t80 -164.91 66.47 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.785 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 42.64 39.19 1.53 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.874 . . . . 0.0 109.975 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 72' ' ' LYS . . . -158.12 -100.67 0.17 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER 67.36 152.61 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.216 -1.167 . . . . 0.0 110.265 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 7.2 mtm-85 -50.99 109.23 1.27 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.458 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 50.2 Cg_endo -73.63 -166.64 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.915 1.481 . . . . 0.0 110.354 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' OD1' ' NH1' ' A' ' 60' ' ' ARG . 70.5 m-20 -115.53 89.44 3.1 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.418 -0.801 . . . . 0.0 109.352 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.547 ' HG2' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -111.96 140.85 46.29 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.499 -0.75 . . . . 0.0 110.104 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.486 ' CE ' HD11 ' A' ' 39' ' ' ILE . 9.2 tttt -123.29 127.41 48.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.925 . . . . 0.0 110.387 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.888 ' HE3' HG11 ' A' ' 59' ' ' VAL . 13.7 ptpt -102.71 151.11 22.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.038 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.642 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -122.88 125.9 46.27 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.023 -1.048 . . . . 0.0 112.258 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.864 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -100.77 111.88 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.612 -0.68 . . . . 0.0 109.204 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.923 HG13 ' CG2' ' A' ' 54' ' ' VAL . 1.6 t -100.01 144.56 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.356 -0.84 . . . . 0.0 110.35 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.532 ' HB3' ' CG ' ' A' ' 53' ' ' LYS . 42.6 tp60 -124.52 147.94 48.07 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.129 -0.982 . . . . 0.0 109.486 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -125.17 156.5 34.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.219 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.778 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -43.83 173.23 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 CA-C-O 121.216 0.532 . . . . 0.0 111.194 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.767 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.4 Cg_endo -76.11 54.42 4.16 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 O-C-N 124.347 1.709 . . . . 0.0 110.459 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -169.22 -50.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.778 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 5.2 mp0 -50.86 179.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 110.314 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER 179.53 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.889 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.982 HD12 ' CD2' ' A' ' 26' ' ' TYR . 6.9 mt -64.54 77.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.057 -1.027 . . . . 0.0 109.207 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 88' ' ' LYS . 14.0 pt-20 -53.67 -14.36 0.87 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.384 -0.823 . . . . 0.0 111.263 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.749 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.43 -22.2 11.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.913 -1.117 . . . . 0.0 110.295 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.749 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.24 -23.27 12.61 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.219 -0.926 . . . . 0.0 109.629 179.565 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' HA ' ' A' ' 90' ' ' GLU . 5.3 mm-40 -61.29 -52.21 65.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.456 -0.778 . . . . 0.0 110.459 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.6 4.57 83.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 18.6 tp -75.13 -17.34 60.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 110.226 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.589 HG12 ' CZ ' ' A' ' 18' ' ' TYR . 52.3 mt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.208 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.571 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.73 0.3 . . . . 0.0 110.549 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.713 ' HA ' HD21 ' A' ' 9' ' ' LEU . 1.9 mmpt? -43.85 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.636 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.3 m 4.79 -71.52 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.661 0 CA-C-O 121.074 0.464 . . . . 0.0 111.082 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.922 ' HB1' ' HB1' ' A' ' 42' ' ' ALA 0.251 . . -56.95 79.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.43 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.891 ' CE1' ' HB2' ' A' ' 42' ' ' ALA . 0.7 OUTLIER 25.09 49.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.901 0.858 . . . . 0.0 110.409 -177.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.611 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 5.5 t70 64.79 53.74 1.44 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.019 0.914 . . . . 0.0 111.398 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 4' ' ' ALA . 4.7 t -137.58 -121.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -0.848 . . . . 0.0 109.663 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.926 HD12 ' HB3' ' A' ' 42' ' ' ALA . 4.9 mt -61.34 151.86 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 121.127 -0.983 . . . . 0.0 110.004 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.713 HD21 ' HA ' ' A' ' 2' ' ' LYS . 15.3 mt -133.69 -99.74 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 110.367 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.83 155.42 40.76 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 110.344 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.673 ' HG3' HD22 ' A' ' 92' ' ' LEU . 47.2 Cg_endo -73.92 155.52 48.25 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.036 1.545 . . . . 0.0 110.113 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.872 HG11 ' CE ' ' A' ' 78' ' ' LYS . 2.7 m -99.58 141.25 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.264 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.731 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.3 mm? -102.78 110.51 22.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -162.62 142.29 9.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.901 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.3 mm-40 -42.64 -47.16 5.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 110.106 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -54.81 -48.5 72.7 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.205 -0.934 . . . . 0.0 110.129 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -65.93 -62.45 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.123 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.616 ' CZ ' ' CG1' ' A' ' 96' ' ' ILE . 1.1 m-85 -45.95 -31.45 2.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.87 . . . . 0.0 110.375 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.42 -8.67 49.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.05 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.54 -37.17 1.95 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.53 -19.95 60.78 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 108.953 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.94 -21.31 11.28 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.427 0.632 . . . . 0.0 110.392 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -92.31 16.45 11.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.31 -0.868 . . . . 0.0 110.261 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.91 2.99 64.29 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HB3' HG23 ' A' ' 80' ' ' ILE . 17.5 mttm -82.58 142.18 31.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -1.133 . . . . 0.0 109.488 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.899 ' CD2' HD12 ' A' ' 89' ' ' ILE . 22.8 m-85 -127.62 103.95 7.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.707 -1.246 . . . . 0.0 111.461 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.78 HG23 HD11 ' A' ' 80' ' ' ILE . 4.3 m -76.76 126.78 31.56 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.455 0.645 . . . . 0.0 109.451 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.824 ' CB ' HG23 ' A' ' 8' ' ' ILE . 15.2 m-85 -125.95 164.67 20.28 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.48 -0.762 . . . . 0.0 110.861 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.723 ' NE1' HG12 ' A' ' 12' ' ' VAL . 18.6 m95 -97.74 122.14 40.48 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.709 HG23 ' C ' ' A' ' 7' ' ' VAL . 9.8 p -146.06 166.72 8.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 118.816 -1.154 . . . . 0.0 111.585 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.483 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -69.6 151.86 96.45 Favored Pre-proline 0 C--N 1.297 -1.695 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.557 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.0 69.12 4.75 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.169 1.615 . . . . 0.0 109.988 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.22 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.307 -0.871 . . . . 0.0 110.039 -179.063 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.71 101.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.506 -0.746 . . . . 0.0 110.373 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -53.27 135.94 37.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.527 ' HE3' HG23 ' A' ' 56' ' ' THR . 2.6 mttp -42.21 -46.81 4.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.298 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -60.4 -53.24 59.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.551 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 17.5 mt-10 -55.72 -42.29 75.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 109.688 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.787 HG23 HD11 ' A' ' 8' ' ' ILE . 11.5 mt -57.74 -30.99 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.627 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.528 ' HG3' HG11 ' A' ' 51' ' ' VAL . 22.2 tttt -60.73 -45.51 93.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.623 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.737 ' O ' HG23 ' A' ' 45' ' ' THR . 31.7 m-80 -64.32 -46.39 83.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.467 -0.77 . . . . 0.0 111.989 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.926 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.76 -40.6 84.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.716 -1.24 . . . . 0.0 111.092 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.752 HG21 ' HE2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -76.3 -44.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.916 -1.115 . . . . 0.0 110.367 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.2 -37.8 70.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.961 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 41' ' ' ASN . 34.8 p -79.44 -45.22 19.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.969 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.22 -62.69 1.28 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.449 -0.782 . . . . 0.0 110.734 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.702 ' CD2' HG22 ' A' ' 43' ' ' VAL . 46.3 m-85 -71.8 -21.37 61.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 0.0 110.387 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 61.82 40.91 12.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.425 -0.797 . . . . 0.0 110.371 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.769 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -118.14 -164.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.512 -0.743 . . . . 0.0 110.034 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.769 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.86 101.45 8.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.458 -0.776 . . . . 0.0 109.386 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.733 HG22 ' CG1' ' A' ' 81' ' ' VAL . 25.6 t -78.3 119.24 26.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.365 -0.834 . . . . 0.0 110.197 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.878 HG12 ' O ' ' A' ' 82' ' ' GLN . 8.1 p -102.3 -2.37 9.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.52 -0.738 . . . . 0.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.579 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.42 143.44 0.14 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.293 -0.88 . . . . 0.0 110.09 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -133.96 118.35 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 0.0 110.146 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.51 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.7 t-20 -118.85 115.97 25.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.208 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.527 HG23 ' HE3' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -115.99 165.48 13.06 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.17 -178.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -153.7 150.2 28.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.797 . . . . 0.0 109.984 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.757 ' CE1' ' NH1' ' A' ' 60' ' ' ARG . 1.1 t-80 -67.17 125.77 27.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.095 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -119.64 137.52 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.355 -0.84 . . . . 0.0 109.889 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.757 ' NH1' ' CE1' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -156.9 -167.26 2.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.181 -0.95 . . . . 0.0 110.53 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.04 50.55 38.56 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.85 -35.95 2.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.344 -1.092 . . . . 0.0 110.089 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 65' ' ' ARG . 2.3 mptp? -61.49 139.02 58.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 110.179 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 69' ' ' TYR . 9.5 mttp -41.28 96.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.324 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.568 ' HA ' ' HB3' ' A' ' 69' ' ' TYR . 1.1 mtp85 -107.02 -66.05 1.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 110.226 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.53 HD23 ' HE ' ' A' ' 68' ' ' ARG . 1.1 mp 49.63 -178.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 109.53 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.482 ' C ' ' CG ' ' A' ' 68' ' ' ARG . . . -86.39 38.51 3.09 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.53 ' HE ' HD23 ' A' ' 66' ' ' LEU . 11.4 mtm180 -147.48 18.97 1.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.403 1.097 . . . . 0.0 109.239 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.635 ' O ' HD12 ' A' ' 70' ' ' LEU . 8.2 t80 -138.38 -161.95 1.24 Allowed 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.891 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -165.65 103.05 0.7 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.455 -0.778 . . . . 0.0 109.865 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.15 72.81 0.35 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -43.75 161.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -1.172 . . . . 0.0 110.17 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 72' ' ' LYS . 3.8 mtm180 -42.48 102.05 0.26 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.127 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 49.5 Cg_endo -73.09 -165.71 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.01 1.531 . . . . 0.0 110.51 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -114.74 89.26 3.05 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.392 -0.818 . . . . 0.0 109.174 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.63 ' CD ' ' CZ3' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -136.2 122.64 20.72 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.729 -0.607 . . . . 0.0 109.441 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.526 ' O ' HG12 ' A' ' 30' ' ' VAL . 8.7 tttt -119.84 141.9 49.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 110.456 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.872 ' CE ' HG11 ' A' ' 12' ' ' VAL . 2.1 tptm -101.2 146.84 26.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 109.725 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.757 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -128.23 123.53 34.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.201 -0.937 . . . . 0.0 111.382 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.78 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -106.17 113.0 41.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.462 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 54' ' ' VAL . 5.9 t -104.27 133.28 48.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.479 -0.763 . . . . 0.0 110.428 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.878 ' O ' HG12 ' A' ' 52' ' ' VAL . 3.1 tp60 -107.69 140.34 40.88 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.094 -1.004 . . . . 0.0 108.559 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -109.15 155.48 10.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 117.71 -1.596 . . . . 0.0 108.991 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.927 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -52.84 177.87 0.07 OUTLIER Pre-proline 0 C--N 1.289 -2.059 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.383 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.927 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -73.1 144.17 37.24 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 O-C-N 124.374 1.723 . . . . 0.0 110.544 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.04 -26.15 14.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.568 ' HB2' HG23 ' A' ' 83' ' ' VAL . 29.8 mt-30 -83.32 169.85 15.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -1.157 . . . . 0.0 110.467 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' A' ' 88' ' ' LYS . 0.1 OUTLIER 179.71 129.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.302 -0.874 . . . . 0.0 110.476 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.899 HD12 ' CD2' ' A' ' 26' ' ' TYR . 6.5 mt -91.16 116.04 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 109.958 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 10.9 pt-20 -78.05 -14.7 59.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.55 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.837 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -55.82 -29.14 59.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -0.914 . . . . 0.0 110.922 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.755 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.04 -23.3 12.67 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.014 -1.054 . . . . 0.0 110.131 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.2 mm-40 -62.6 -39.13 92.78 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.271 -0.893 . . . . 0.0 110.429 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.25 -13.77 59.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.837 HD13 ' O ' ' A' ' 91' ' ' ALA . 0.9 OUTLIER -56.8 -17.26 8.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -1.171 . . . . 0.0 110.17 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.747 HG22 ' OXT' ' A' ' 96' ' ' ILE . 61.0 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.184 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.594 ' O ' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.721 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 2.3 pttt -58.1 92.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.13 -1.428 . . . . 0.0 108.897 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.908 ' OG1' ' HB2' ' A' ' 46' ' ' ALA 0.264 10.1 t -136.97 -34.89 0.72 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 122.185 0.993 . . . . 0.0 109.741 -178.317 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -170.41 -26.83 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.799 -0.563 . . . . 0.0 110.459 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.721 ' CE1' ' HA ' ' A' ' 2' ' ' LYS 0.272 0.0 OUTLIER -47.39 -134.55 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.974 0.892 . . . . 0.0 112.033 178.384 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.627 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 27.9 m-20 -24.04 -65.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.539 0.685 . . . . 0.0 112.215 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.033 HG13 ' HB1' ' A' ' 34' ' ' ALA . 58.6 t -53.91 -110.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.583 -0.698 . . . . 0.0 110.971 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.018 HG13 HG12 ' A' ' 7' ' ' VAL . 21.4 mt -77.78 82.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 120.96 -1.087 . . . . 0.0 110.854 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -52.27 -94.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.48 -0.762 . . . . 0.0 111.064 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.21 155.96 39.28 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 0.0 110.985 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 49.5 Cg_endo -76.86 158.37 34.9 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.248 1.657 . . . . 0.0 110.449 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 27' ' ' THR . 1.6 p -115.15 109.39 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.055 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.06 107.2 18.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 110.446 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.7 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -154.25 160.6 41.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.864 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 10.1 pt-20 -40.54 -36.89 0.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 110.291 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -27.83 42.67 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.331 -0.856 . . . . 0.0 110.388 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.7 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -97.0 11.02 37.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.223 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.618 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 1.5 m-85 -120.93 -33.6 3.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.211 -0.931 . . . . 0.0 109.927 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.19 -8.59 50.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -0.842 . . . . 0.0 109.506 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -110.79 -33.11 2.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -76.38 -17.94 59.12 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.641 -0.917 . . . . 0.0 108.935 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.621 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -59.66 -18.68 43.92 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.717 -0.614 . . . . 0.0 110.499 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.3 17.62 5.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.464 -0.772 . . . . 0.0 109.855 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 92.82 -0.05 69.45 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 18.8 mttt -82.56 143.27 31.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.578 -0.954 . . . . 0.0 109.532 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.843 ' HD1' HD13 ' A' ' 92' ' ' LEU . 60.7 m-85 -128.27 101.52 6.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.743 -1.223 . . . . 0.0 111.376 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.673 ' O ' HG12 ' A' ' 12' ' ' VAL . 4.3 m -74.84 132.28 41.4 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.824 ' HB3' HG23 ' A' ' 8' ' ' ILE . 2.8 m-85 -136.99 164.2 28.92 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.632 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.597 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 68.7 m95 -101.09 122.62 43.91 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.957 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.8 p -141.4 156.45 21.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 C-N-CA 118.181 -1.408 . . . . 0.0 111.863 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.591 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -63.93 151.26 89.87 Favored Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.891 -179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.591 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 47.2 Cg_endo -73.82 72.11 3.94 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.166 1.614 . . . . 0.0 109.961 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.35 -32.0 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.524 -0.735 . . . . 0.0 109.552 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 1.033 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -47.4 90.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.568 -0.707 . . . . 0.0 109.659 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -41.73 142.04 0.71 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.144 -0.973 . . . . 0.0 110.453 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.511 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -43.58 -42.77 5.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.632 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 8.7 m -71.13 -26.72 63.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.388 -0.82 . . . . 0.0 109.727 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.4 OUTLIER -66.65 -46.41 75.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.212 179.431 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.787 HG23 HD11 ' A' ' 8' ' ' ILE . 16.6 mt -57.5 -30.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.587 ' HG3' HG11 ' A' ' 51' ' ' VAL . 4.3 tttt -62.87 -47.34 83.74 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.501 -0.749 . . . . 0.0 110.007 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.511 ' O ' ' HB ' ' A' ' 45' ' ' THR . 29.5 m-20 -73.01 -35.02 66.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.704 -0.622 . . . . 0.0 111.688 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.763 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.39 -52.77 64.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.649 -1.282 . . . . 0.0 110.361 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.673 HG13 HD13 ' A' ' 8' ' ' ILE . 2.7 m -68.37 -36.61 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.673 -1.267 . . . . 0.0 110.45 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.657 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -65.13 -41.37 94.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.989 -1.07 . . . . 0.0 109.775 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -79.27 -12.91 59.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.936 179.456 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.908 ' HB2' ' OG1' ' A' ' 3' ' ' THR . . . -110.82 -59.47 1.95 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.324 -0.86 . . . . 0.0 110.62 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CD2' HG12 ' A' ' 43' ' ' VAL . 10.2 m-85 -71.7 -20.91 61.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.475 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 mttt 63.24 43.01 6.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.793 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -118.21 -161.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.638 -0.664 . . . . 0.0 109.831 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.793 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -116.91 109.18 16.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.398 -0.814 . . . . 0.0 109.516 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.657 HG23 ' HG2' ' A' ' 44' ' ' GLU . 55.4 t -77.32 122.37 31.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.166 -0.959 . . . . 0.0 109.194 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.736 HG21 ' N ' ' A' ' 84' ' ' ALA . 30.1 t -114.94 -11.92 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.496 -0.753 . . . . 0.0 110.881 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -176.35 117.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.118 179.353 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.98 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -115.73 125.31 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 110.057 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.511 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 15.8 t-20 -126.81 115.97 20.17 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 109.418 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.599 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -116.22 153.49 31.77 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.93 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -139.42 169.03 18.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.112 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.43 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -88.79 125.75 35.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 110.357 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.939 HG11 ' CD ' ' A' ' 78' ' ' LYS . 2.4 m -120.26 120.58 63.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.709 -0.62 . . . . 0.0 110.048 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.557 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -132.99 117.73 17.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.154 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.39 131.89 3.05 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -96.57 -65.19 0.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -1.138 . . . . 0.0 110.386 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -76.12 57.8 1.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 0.0 110.281 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 54.53 108.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.192 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.542 ' CB ' ' HG3' ' A' ' 73' ' ' ARG . 3.7 ptt85 -56.13 -160.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.378 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 66' ' ' LEU . 7.2 tp 54.91 106.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.154 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.08 -176.03 43.03 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.517 ' O ' ' C ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -61.62 -175.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -1.148 . . . . 0.0 110.268 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 7.9 t80 27.89 70.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.652 0.739 . . . . 0.0 111.018 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER 36.46 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.816 . . . . 0.0 110.875 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 70' ' ' LEU . . . -43.15 165.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -102.84 133.89 47.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -1.17 . . . . 0.0 110.394 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.542 ' HG3' ' CB ' ' A' ' 65' ' ' ARG . 3.8 ttm180 -166.55 79.67 1.05 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.322 -0.861 . . . . 0.0 110.198 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 52.3 Cg_endo -76.41 -167.0 0.41 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.087 1.572 . . . . 0.0 110.461 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -115.33 89.39 3.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.539 -0.726 . . . . 0.0 109.249 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.506 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -129.67 147.34 51.45 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.587 -0.695 . . . . 0.0 110.371 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.699 ' CG ' HG13 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -123.5 142.45 51.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.36 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.939 ' CD ' HG11 ' A' ' 59' ' ' VAL . 13.6 mtpt -100.41 150.97 22.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.419 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.799 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -123.25 129.96 52.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.024 -1.048 . . . . 0.0 112.167 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.799 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.6 mp -109.65 111.35 35.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.201 178.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.98 HG13 HG23 ' A' ' 54' ' ' VAL . 3.2 t -100.79 143.9 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.421 -0.799 . . . . 0.0 110.19 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' LYS . 9.2 tp60 -122.54 147.1 46.78 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.354 -0.841 . . . . 0.0 109.39 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.491 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.3 m -125.01 156.8 33.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.178 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.847 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -45.17 175.81 0.03 OUTLIER Pre-proline 0 C--N 1.296 -1.726 0 CA-C-O 121.292 0.568 . . . . 0.0 110.916 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.847 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.8 Cg_endo -74.1 142.67 31.25 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 O-C-N 124.221 1.642 . . . . 0.0 110.542 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.82 -15.74 45.77 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.527 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 57.4 mt-30 -93.7 165.05 12.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -1.219 . . . . 0.0 110.629 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 90' ' ' GLU . 8.2 ptmt 179.63 102.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.47 -0.769 . . . . 0.0 110.241 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 54.8 mt -42.18 98.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 110.189 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.73 -28.47 34.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.089 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . -55.8 -23.69 31.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.197 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.843 HD13 ' HD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -107.73 -23.03 12.25 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.875 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.4 ' OE2' ' CZ ' ' A' ' 21' ' ' PHE . 6.2 mm-40 -84.11 1.72 42.82 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 118.055 -1.458 . . . . 0.0 110.247 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.21 -16.85 8.06 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.46 ' O ' ' OXT' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -60.19 -26.98 66.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.431 -1.041 . . . . 0.0 110.047 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.46 ' OXT' ' O ' ' A' ' 95' ' ' LEU . 10.1 mt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.238 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 2.3 ptp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.684 0.278 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.791 ' HD2' HD11 ' A' ' 9' ' ' LEU . 13.2 mmtt -43.67 98.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.613 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.5 m 4.51 -71.56 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.7 0 CA-C-O 121.33 0.586 . . . . 0.0 110.829 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.01 ' O ' HG23 ' A' ' 7' ' ' VAL 0.26 . . -55.58 81.44 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.058 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.097 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.5 p90 23.52 47.54 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.74 0.781 . . . . 0.0 110.416 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.619 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 4.4 t70 64.94 52.33 1.58 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.03 0.919 . . . . 0.0 111.505 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.097 HG21 ' CE2' ' A' ' 5' ' ' TYR . 2.5 t -133.42 -129.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 109.525 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.882 HG23 ' HB3' ' A' ' 28' ' ' PHE . 2.2 mp -49.94 155.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.362 -0.837 . . . . 0.0 110.519 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.791 HD11 ' HD2' ' A' ' 2' ' ' LYS . 24.0 mt -139.93 -96.73 0.16 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.179 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.37 140.31 21.62 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.082 -1.011 . . . . 0.0 110.255 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.778 ' HG3' HD22 ' A' ' 92' ' ' LEU . 45.7 Cg_endo -73.54 162.55 39.67 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.003 1.528 . . . . 0.0 110.204 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.911 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.5 m -98.35 140.59 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.91 . . . . 0.0 110.335 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.863 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.0 mm? -102.76 113.2 26.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 15' ' ' GLU . 3.7 m -170.67 143.88 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 109.952 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.1 mt-10 -42.74 -49.34 5.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.119 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.6 -17.9 3.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.256 -0.903 . . . . 0.0 110.318 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.481 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -106.6 -49.8 3.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.863 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.3 m-85 -56.25 -53.52 56.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.828 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.79 -12.37 34.95 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.185 -0.947 . . . . 0.0 109.209 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -90.86 -48.64 3.33 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 9.4 m-30 -46.83 -27.66 1.3 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.347 -1.09 . . . . 0.0 108.151 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -40.18 -28.14 0.05 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.476 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.547 ' HG3' ' CE ' ' A' ' 25' ' ' LYS . 3.5 pm0 -104.62 17.07 24.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.343 -0.848 . . . . 0.0 111.471 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 87.32 7.22 76.82 Favored Glycine 0 N--CA 1.486 1.975 0 O-C-N 120.965 -1.084 . . . . 0.0 110.543 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.56 ' HD2' ' CG ' ' A' ' 82' ' ' GLN . 3.2 mptp? -84.94 134.97 34.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -1.195 . . . . 0.0 110.241 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.866 ' HD1' HD12 ' A' ' 92' ' ' LEU . 86.3 m-85 -126.94 110.44 13.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.718 -1.239 . . . . 0.0 111.544 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.827 HG23 HD11 ' A' ' 80' ' ' ILE . 2.4 m -76.0 135.76 39.99 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 121.466 0.65 . . . . 0.0 109.674 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.882 ' HB3' HG23 ' A' ' 8' ' ' ILE . 21.3 m-85 -129.58 165.23 22.14 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.588 -0.695 . . . . 0.0 110.703 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.911 ' NE1' HG12 ' A' ' 12' ' ' VAL . 19.9 m95 -104.43 122.49 45.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.0 p -151.17 165.21 2.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 118.472 -1.291 . . . . 0.0 111.51 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.45 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -59.04 149.42 66.71 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.773 -0.579 . . . . 0.0 110.791 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 47.9 Cg_endo -73.33 69.97 4.01 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.26 1.663 . . . . 0.0 109.88 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.26 -33.71 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 110.273 -178.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' LYS . . . -42.11 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.414 -0.804 . . . . 0.0 110.307 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -47.62 142.63 4.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.209 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 12.5 mttt -49.75 -44.59 48.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.308 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -64.75 -49.75 69.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.981 . . . . 0.0 110.545 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.7 OUTLIER -55.29 -41.93 72.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 0.0 109.73 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.687 ' HA ' HD11 ' A' ' 8' ' ' ILE . 10.1 mt -57.42 -30.8 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.396 -0.815 . . . . 0.0 109.817 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.522 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.6 tttt -60.75 -46.18 91.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.0 111.025 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -58.97 -34.87 72.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 112.415 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.836 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -70.1 -50.28 42.41 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.588 -1.32 . . . . 0.0 111.715 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.879 HG23 HG21 ' A' ' 51' ' ' VAL . 15.1 m -68.54 -27.32 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.51 -1.369 . . . . 0.0 110.36 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.83 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -56.43 -53.0 62.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.939 -1.101 . . . . 0.0 109.237 179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.3 p -80.54 -45.11 17.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 109.884 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -56.61 -63.09 1.31 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 110.848 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.722 ' CD1' HG23 ' A' ' 89' ' ' ILE . 35.2 m-85 -71.51 -21.16 61.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.131 -0.98 . . . . 0.0 109.807 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 71.26 50.85 0.28 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.499 -0.751 . . . . 0.0 110.108 179.602 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.701 HG11 HG12 ' A' ' 89' ' ' ILE . 1.5 p -149.3 171.99 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.541 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.57 ' N ' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -89.97 110.57 21.53 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.534 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 43' ' ' VAL . 22.0 t -77.87 138.49 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.786 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.787 HG11 ' OE1' ' A' ' 82' ' ' GLN . 11.3 p -110.28 -29.34 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.226 -0.921 . . . . 0.0 110.842 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.558 ' HG3' ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -159.12 149.63 19.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.987 -1.07 . . . . 0.0 110.467 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.009 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.4 t -133.0 117.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 110.121 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.554 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.6 m-20 -116.86 114.69 24.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.2 -0.937 . . . . 0.0 109.157 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.656 HG21 HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -119.66 150.66 39.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.99 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.938 HD21 ' HD2' ' A' ' 78' ' ' LYS . 3.0 pp -140.61 170.34 15.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.428 ' ND1' ' NH1' ' A' ' 60' ' ' ARG . 0.4 OUTLIER -90.57 120.98 32.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.33 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.823 HG13 HD11 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -117.51 130.71 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.4 -0.813 . . . . 0.0 109.938 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.502 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 4.7 mmt85 -115.66 174.18 6.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 110.136 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -45.17 126.86 7.54 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.495 ' CA ' ' HE2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -99.67 -61.64 1.34 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 110.277 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.98 139.91 57.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.234 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.3 tttm 56.86 76.61 0.3 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 110.186 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -105.02 -81.45 0.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.333 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 68' ' ' ARG . 4.4 mm? 43.65 72.3 0.19 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.932 . . . . 0.0 109.904 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.37 57.32 0.18 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -137.25 21.89 2.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.015 -1.285 . . . . 0.0 110.035 179.622 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 9.6 t80 -168.56 58.32 0.06 Allowed 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.838 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER 43.05 41.74 2.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 0.0 109.946 -179.664 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 70' ' ' LEU . . . -52.93 -169.93 0.02 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.58 109.74 21.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -1.151 . . . . 0.0 110.26 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 7.7 ttm105 -158.1 79.46 3.23 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.481 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 51.9 Cg_endo -77.89 -165.94 0.36 Allowed 'Trans proline' 0 C--N 1.302 -1.869 0 O-C-N 124.169 1.615 . . . . 0.0 110.377 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.468 ' OD2' ' HG3' ' A' ' 32' ' ' PRO . 11.7 p-10 -114.6 89.36 3.07 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.408 -0.808 . . . . 0.0 109.407 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -126.05 142.13 51.66 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.146 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 32' ' ' PRO . 8.7 pttt -123.05 141.92 51.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.294 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.938 ' HD2' HD21 ' A' ' 57' ' ' LEU . 3.9 ptpt -100.85 149.18 24.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.671 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.828 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -116.89 123.67 47.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.03 -1.044 . . . . 0.0 112.585 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.827 HD11 HG23 ' A' ' 27' ' ' THR . 1.7 mp -101.98 111.45 31.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.009 HG22 ' CG2' ' A' ' 54' ' ' VAL . 89.0 t -108.99 133.96 52.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.254 -0.904 . . . . 0.0 110.861 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.787 ' OE1' HG11 ' A' ' 52' ' ' VAL . 2.7 tm0? -103.22 153.45 20.36 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.332 -0.855 . . . . 0.0 109.345 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 89' ' ' ILE . 3.7 m -109.39 157.18 9.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 C-N-CA 118.799 -1.16 . . . . 0.0 108.419 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 1.029 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -70.87 179.97 0.8 Allowed Pre-proline 0 C--N 1.283 -2.284 0 C-N-CA 119.071 -1.051 . . . . 0.0 109.988 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.922 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.0 Cg_endo -73.25 137.83 26.65 Favored 'Trans proline' 0 C--N 1.297 -2.136 0 O-C-N 124.242 1.653 . . . . 0.0 110.389 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.23 -36.65 4.26 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 1.029 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -105.95 -178.89 3.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.239 -1.154 . . . . 0.0 110.608 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 90' ' ' GLU . 5.8 ptpt -179.86 104.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 0.0 110.056 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.722 HG23 ' CD1' ' A' ' 47' ' ' PHE . 71.3 mt -54.35 86.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.351 -0.843 . . . . 0.0 109.885 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.557 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 2.8 pt-20 -71.11 -12.22 61.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.443 -0.785 . . . . 0.0 110.925 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.989 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -53.37 -27.35 23.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.992 -1.068 . . . . 0.0 110.562 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.866 HD12 ' HD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.92 -23.67 12.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.98 -1.075 . . . . 0.0 109.683 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 1.5 pp20? -66.23 -29.67 69.97 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.349 -0.941 . . . . 0.0 109.485 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.52 -22.63 28.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.989 HD13 ' O ' ' A' ' 91' ' ' ALA . 0.5 OUTLIER -44.73 -25.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -1.08 . . . . 0.0 109.857 179.665 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.556 HD13 ' CE2' ' A' ' 18' ' ' TYR . 12.5 mm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.188 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.566 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.801 0.334 . . . . 0.0 110.633 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.621 ' CB ' ' HA ' ' A' ' 6' ' ' ASP . 43.1 mmtt -43.91 98.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.638 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.5 m 4.56 -72.07 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.308 0.575 . . . . 0.0 110.704 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.039 ' O ' HG23 ' A' ' 7' ' ' VAL 0.258 . . -55.51 81.96 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.036 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.4 p90 22.81 48.18 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 121.761 0.791 . . . . 0.0 110.502 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.621 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 5.9 t70 64.07 53.64 1.8 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.002 0.906 . . . . 0.0 111.492 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.039 HG23 ' O ' ' A' ' 4' ' ' ALA . 3.2 t -131.42 -125.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.491 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.908 HG23 ' HB3' ' A' ' 28' ' ' PHE . 4.5 mt -49.74 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.169 -0.957 . . . . 0.0 110.078 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.52 HD21 ' HE3' ' A' ' 2' ' ' LYS . 0.7 OUTLIER -57.88 -106.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 110.664 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.537 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -108.13 162.88 18.33 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.877 -1.139 . . . . 0.0 110.525 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.636 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.8 Cg_endo -73.72 133.47 18.69 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.105 1.582 . . . . 0.0 110.439 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 27' ' ' THR . 2.1 p -93.91 116.78 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.89 . . . . 0.0 109.968 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.841 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.4 mm? -100.96 109.24 21.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.399 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -159.13 163.92 35.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.004 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.9 mt-10 -42.88 -52.94 4.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 110.069 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -57.63 -39.5 77.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 110.099 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 21' ' ' PHE . . . -91.33 23.72 3.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.875 . . . . 0.0 109.692 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.947 ' OH ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -125.51 -63.24 1.15 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.0 109.518 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.05 -12.06 35.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.548 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.38 -40.54 2.21 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -74.01 -29.41 61.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.57 -0.959 . . . . 0.0 108.78 179.128 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -46.13 -23.54 0.34 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.689 -0.632 . . . . 0.0 110.57 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.74 -14.71 34.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 110.508 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 132.42 -1.23 4.83 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 12.5 mmtt -81.69 147.45 29.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -1.153 . . . . 0.0 109.602 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 1.017 ' CD2' HD12 ' A' ' 89' ' ' ILE . 20.6 m-85 -127.2 106.69 9.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.91 -1.119 . . . . 0.0 111.661 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.788 ' O ' HG12 ' A' ' 12' ' ' VAL . 2.9 m -75.73 126.75 31.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.908 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -135.32 164.01 28.71 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.177 -0.952 . . . . 0.0 110.46 -178.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.537 ' CZ3' ' HD3' ' A' ' 76' ' ' ARG . 23.3 m95 -101.92 122.28 43.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.573 HG23 ' C ' ' A' ' 7' ' ' VAL . 13.7 p -146.24 166.49 8.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.06 -1.025 . . . . 0.0 111.488 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.517 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -71.92 169.59 15.6 Favored Pre-proline 0 C--N 1.293 -1.85 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.963 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.492 ' HA ' ' HD2' ' A' ' 77' ' ' LYS . 48.6 Cg_endo -75.41 -53.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.043 0 O-C-N 124.245 1.655 . . . . 0.0 109.643 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HG3' ' HB3' ' A' ' 31' ' ' HIS 0.256 0.0 OUTLIER -46.54 -22.45 0.28 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.874 179.027 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -66.05 102.76 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 110.306 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -67.17 143.27 56.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 110.18 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 13.9 mttt -42.45 -38.61 1.96 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -68.33 -52.28 35.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.388 -0.82 . . . . 0.0 110.608 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 29.5 mm-40 -55.19 -43.54 74.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.678 HG23 HD11 ' A' ' 8' ' ' ILE . 11.4 mt -56.87 -30.3 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.112 -0.993 . . . . 0.0 109.403 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.565 ' HG3' HG11 ' A' ' 51' ' ' VAL . 15.1 ttpt -63.67 -47.02 82.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.461 -0.774 . . . . 0.0 111.039 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -58.73 -34.94 71.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.368 -0.832 . . . . 0.0 112.189 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.728 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -65.34 -50.43 65.62 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.682 -1.262 . . . . 0.0 111.289 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.508 HG23 HG21 ' A' ' 51' ' ' VAL . 9.4 m -76.23 -32.22 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.614 -1.304 . . . . 0.0 110.612 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.79 -51.64 68.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.698 -1.251 . . . . 0.0 109.415 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -79.71 -46.23 17.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 110.035 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -59.16 -64.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.389 -0.819 . . . . 0.0 110.404 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.639 ' CE1' ' CB ' ' A' ' 91' ' ' ALA . 7.5 m-85 -72.03 -19.9 61.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.242 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 66.9 41.92 2.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 110.251 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.777 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -122.55 -164.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.556 -0.715 . . . . 0.0 109.931 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.777 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -119.28 106.79 12.67 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 110.145 179.259 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.58 HG13 ' CG1' ' A' ' 81' ' ' VAL . 76.3 t -78.43 119.7 27.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.796 HG12 ' O ' ' A' ' 82' ' ' GLN . 12.2 p -104.23 4.96 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.919 . . . . 0.0 110.7 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 167.77 119.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.217 -0.927 . . . . 0.0 110.504 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.062 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -112.16 120.01 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 109.861 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -107.66 115.22 29.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.181 -0.95 . . . . 0.0 109.047 178.623 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.55 HG21 HD12 ' A' ' 39' ' ' ILE . 2.3 p -116.68 139.07 50.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.101 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.822 HD11 ' HD2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -136.38 144.1 44.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 110.264 -179.569 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.496 ' CG ' ' NE ' ' A' ' 60' ' ' ARG . 2.0 t-160 -76.34 115.16 15.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -109.48 121.14 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.321 -0.862 . . . . 0.0 109.892 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.532 ' N ' ' HD3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -133.65 167.68 20.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 110.302 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -43.61 147.91 0.94 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.33 29.01 0.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -1.1 . . . . 0.0 110.202 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -110.53 -20.98 12.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.147 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 0.8 OUTLIER 168.31 115.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 110.064 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.439 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -145.75 51.74 1.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 110.435 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.504 HD23 ' CZ ' ' A' ' 68' ' ' ARG . 2.3 mp -42.57 126.0 3.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.051 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.15 52.0 1.72 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.504 ' CZ ' HD23 ' A' ' 66' ' ' LEU . 16.4 ptt180 -154.22 22.95 0.49 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.049 -1.265 . . . . 0.0 110.02 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 40.1 t80 -166.54 55.99 0.09 Allowed 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.751 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER 41.21 94.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.283 -0.885 . . . . 0.0 110.416 -179.728 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.69 153.79 37.1 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 3.2 mppt? -97.29 62.51 1.77 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -1.141 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.14 78.9 1.44 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.284 -0.885 . . . . 0.0 110.335 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 50.3 Cg_endo -76.16 -165.01 0.28 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.021 1.537 . . . . 0.0 110.394 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' OD2' ' O ' ' A' ' 75' ' ' ASP . 6.4 p-10 -114.2 89.47 3.1 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.411 -0.806 . . . . 0.0 109.327 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.537 ' HD3' ' CZ3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -120.2 112.67 19.37 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.627 -0.671 . . . . 0.0 110.214 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.53 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 1.8 tttp -117.59 134.77 54.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 109.682 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.822 ' HD2' HD11 ' A' ' 57' ' ' LEU . 6.7 ptpt -102.04 150.3 23.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.022 . . . . 0.0 110.798 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.806 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -117.29 134.14 55.16 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.148 -0.97 . . . . 0.0 111.978 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.806 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.6 mp -110.76 110.86 33.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.062 HG13 HG23 ' A' ' 54' ' ' VAL . 2.4 t -104.98 127.72 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.335 -0.853 . . . . 0.0 111.011 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.796 ' O ' HG12 ' A' ' 52' ' ' VAL . 9.9 tp60 -110.02 146.03 36.01 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.066 -1.021 . . . . 0.0 108.761 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 87' ' ' GLN . 1.6 m -113.26 155.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 118.083 -1.447 . . . . 0.0 109.623 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.951 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -55.83 179.48 0.1 OUTLIER Pre-proline 0 C--N 1.29 -1.996 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.195 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.951 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.5 Cg_endo -72.27 141.51 35.76 Favored 'Trans proline' 0 C--N 1.299 -2.048 0 O-C-N 124.193 1.628 . . . . 0.0 110.55 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.57 -19.63 46.52 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.575 ' NE2' ' CB ' ' A' ' 50' ' ' LYS . 49.9 mt-30 -93.11 168.96 10.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -1.141 . . . . 0.0 110.672 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.8 OUTLIER 179.65 122.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.395 -0.815 . . . . 0.0 110.339 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.017 HD12 ' CD2' ' A' ' 26' ' ' TYR . 15.2 mt -83.86 106.74 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.146 -0.971 . . . . 0.0 109.958 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -61.94 -13.97 30.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.368 -0.832 . . . . 0.0 110.946 -179.413 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.639 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . -55.03 -34.12 63.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.098 -1.001 . . . . 0.0 110.792 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.776 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -105.86 -23.23 12.74 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.011 -1.056 . . . . 0.0 109.592 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.9 mm-40 -66.49 -37.67 85.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.344 -0.847 . . . . 0.0 109.95 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.07 -8.92 86.82 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 92' ' ' LEU . 4.8 mp -81.34 8.87 8.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -1.153 . . . . 0.0 110.091 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.947 HD13 ' OH ' ' A' ' 18' ' ' TYR . 15.5 mm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.538 ' HB2' ' CB ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.273 0.558 . . . . 0.0 110.509 . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.615 ' O ' ' N ' ' A' ' 4' ' ' ALA . 5.7 mmtm -47.56 100.11 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.624 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.2 m 3.01 -68.7 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 121.118 0.485 . . . . 0.0 111.337 -179.18 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.053 ' O ' HG23 ' A' ' 7' ' ' VAL 0.262 . . -56.7 73.94 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.976 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.945 ' CE2' HG21 ' A' ' 7' ' ' VAL . 5.0 p90 31.08 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.742 0.782 . . . . 0.0 109.674 -178.006 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.597 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER 85.24 39.75 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.877 0.846 . . . . 0.0 111.755 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 4' ' ' ALA . 1.7 t -134.78 -137.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.134 -0.979 . . . . 0.0 109.987 178.018 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.926 ' CD1' HG23 ' A' ' 39' ' ' ILE . 2.6 mm -32.83 126.05 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 121.267 0.556 . . . . 0.0 110.919 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.608 HD21 ' HA ' ' A' ' 2' ' ' LYS . 1.3 mt -115.03 -94.54 0.48 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.85 . . . . 0.0 109.751 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.85 153.88 42.14 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.892 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.643 ' CB ' HD22 ' A' ' 92' ' ' LEU . 48.4 Cg_endo -76.02 158.25 38.25 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.943 1.496 . . . . 0.0 110.314 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.045 HG12 ' NE1' ' A' ' 29' ' ' TRP . 1.4 m -103.69 129.14 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.204 -0.935 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.906 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 2.9 mm? -102.84 113.01 26.09 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.111 -0.993 . . . . 0.0 110.275 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 15' ' ' GLU . 68.8 m -161.58 144.05 11.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 14' ' ' SER . 69.7 mt-10 -42.87 -51.61 5.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 110.043 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -54.86 -34.03 62.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.288 -0.882 . . . . 0.0 110.172 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -86.03 -58.5 2.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.25 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.906 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -46.13 -31.28 2.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.876 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.25 -8.75 50.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.084 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.14 -37.55 1.96 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -71.12 -18.3 62.53 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.698 -0.883 . . . . 0.0 108.843 178.968 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.621 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -58.72 -20.02 45.27 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.676 -0.64 . . . . 0.0 110.474 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -88.62 17.32 5.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.487 -0.758 . . . . 0.0 109.953 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 91.96 3.27 68.2 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 72.9 mttt -82.72 136.94 34.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.563 -0.963 . . . . 0.0 109.382 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.946 ' CD2' HD12 ' A' ' 89' ' ' ILE . 24.6 m-85 -127.95 96.9 4.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.658 -1.277 . . . . 0.0 111.538 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.837 HG22 ' HG2' ' A' ' 78' ' ' LYS . 2.8 m -75.61 117.57 17.52 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.53 -0.731 . . . . 0.0 109.695 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.679 ' CZ ' ' CZ ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -116.86 162.96 16.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 110.349 -179.663 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 1.045 ' NE1' HG12 ' A' ' 12' ' ' VAL . 97.7 m95 -92.65 122.77 35.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.92 HG23 ' C ' ' A' ' 7' ' ' VAL . 8.9 p -147.03 166.97 6.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.038 -177.407 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.502 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -60.5 141.11 92.0 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.148 179.822 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.546 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.5 Cg_endo -72.2 77.46 2.02 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 124.169 1.615 . . . . 0.0 110.278 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 178.67 -34.71 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.349 -0.844 . . . . 0.0 109.906 -179.264 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.49 ' CB ' HG13 ' A' ' 7' ' ' VAL . . . -52.8 92.05 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.493 -0.754 . . . . 0.0 109.917 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -41.98 151.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.335 -0.853 . . . . 0.0 110.319 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.619 ' O ' HG11 ' A' ' 54' ' ' VAL . 6.8 mmtp -42.49 -35.07 0.95 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 110.044 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.6 m -75.08 -39.75 60.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 110.096 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.68 -43.52 76.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.061 -1.024 . . . . 0.0 109.536 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.926 HG23 ' CD1' ' A' ' 8' ' ' ILE . 30.0 mt -57.99 -30.32 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.432 -0.792 . . . . 0.0 109.646 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.685 ' HG3' HG21 ' A' ' 51' ' ' VAL . 11.5 tttm -60.14 -47.42 85.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.556 -0.715 . . . . 0.0 111.523 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -58.22 -38.87 77.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.379 -0.826 . . . . 0.0 112.108 -178.056 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.765 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -73.56 -50.87 19.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.7 -1.25 . . . . 0.0 111.818 -178.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.116 HG12 ' CE2' ' A' ' 47' ' ' PHE . 6.1 m -65.59 -44.75 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.711 -1.243 . . . . 0.0 111.054 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.623 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -56.91 -48.15 78.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.719 -1.238 . . . . 0.0 110.103 -179.945 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 m -79.0 -47.79 15.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 0.0 110.673 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -68.49 -63.79 0.99 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 110.575 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 1.116 ' CE2' HG12 ' A' ' 43' ' ' VAL . 21.3 m-85 -71.72 -4.13 25.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.174 -0.954 . . . . 0.0 110.165 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 12.4 mtmt 46.79 46.15 15.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.432 -0.793 . . . . 0.0 110.25 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.778 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -118.13 -163.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.57 -0.706 . . . . 0.0 109.87 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.778 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -117.2 112.62 21.07 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.448 -0.782 . . . . 0.0 109.436 179.083 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.685 HG21 ' HG3' ' A' ' 40' ' ' LYS . 17.3 t -77.67 119.53 26.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.076 -1.015 . . . . 0.0 109.337 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.808 HG21 ' N ' ' A' ' 84' ' ' ALA . 25.6 t -116.06 -10.7 12.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 121.685 0.755 . . . . 0.0 110.149 -178.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 82' ' ' GLN . 0.3 OUTLIER 175.39 116.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.593 -0.692 . . . . 0.0 109.581 179.371 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -105.19 136.62 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.996 . . . . 0.0 109.978 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.543 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.1 t-20 -131.39 114.86 15.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.139 -0.975 . . . . 0.0 109.722 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -108.44 150.08 27.89 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.624 -179.662 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.612 HD12 ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -128.9 -177.14 4.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.06 -1.025 . . . . 0.0 110.514 -178.934 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.5 119.92 26.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.557 -0.714 . . . . 0.0 109.298 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.795 HG11 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -108.98 121.86 62.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.104 -0.998 . . . . 0.0 108.911 179.53 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' O ' ' NE ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -32.69 125.16 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.601 0.715 . . . . 0.0 111.541 -178.422 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 74' ' ' PRO . . . 165.76 77.59 0.03 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -96.47 -179.57 4.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -1.222 . . . . 0.0 110.299 -179.851 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 65' ' ' ARG . 4.1 tttt -72.8 -19.67 61.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.277 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -41.75 99.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 110.293 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -120.88 22.69 11.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.313 -179.861 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 68' ' ' ARG . 10.0 tp -41.98 138.42 1.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 110.164 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -55.15 84.25 0.01 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.541 ' CG ' ' HA3' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -126.21 145.25 50.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -1.174 . . . . 0.0 110.225 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.507 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -59.14 147.83 33.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.572 -179.859 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 41.51 42.99 2.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.378 -0.826 . . . . 0.0 110.411 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.541 ' HA3' ' CG ' ' A' ' 68' ' ' ARG . . . -114.17 -126.24 4.28 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER 56.57 72.23 0.52 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -1.127 . . . . 0.0 110.256 179.943 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 62' ' ' LYS . 1.8 mtp180 -100.97 108.49 54.58 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.094 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.522 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 48.7 Cg_endo -74.23 -164.66 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.978 1.515 . . . . 0.0 110.653 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 2.1 m-20 -114.14 90.06 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.41 -0.806 . . . . 0.0 108.965 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.562 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -95.55 153.15 17.85 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.645 -0.659 . . . . 0.0 110.546 -179.504 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.546 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 9.3 tttt -123.13 141.13 52.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.47 -0.769 . . . . 0.0 109.604 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.837 ' HG2' HG22 ' A' ' 27' ' ' THR . 6.5 tttt -101.24 134.26 44.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.003 -1.061 . . . . 0.0 109.834 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -124.79 120.35 31.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.924 . . . . 0.0 111.618 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.0 mt -95.57 111.63 26.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.576 -0.702 . . . . 0.0 109.987 178.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.939 HG21 HG11 ' A' ' 43' ' ' VAL . 2.9 t -95.41 133.52 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 23' ' ' GLU . 13.9 tp60 -112.26 144.04 42.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 109.6 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.2 m -125.32 156.79 34.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.459 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 1.018 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -47.97 173.07 0.06 OUTLIER Pre-proline 0 C--N 1.296 -1.73 0 CA-C-O 121.29 0.567 . . . . 0.0 111.035 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 47.3 Cg_endo -79.88 55.46 5.65 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 124.499 1.789 . . . . 0.0 110.344 179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.73 -35.01 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 1.018 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -105.79 177.83 4.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -1.185 . . . . 0.0 109.978 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 90' ' ' GLU . 6.2 ptpt 179.61 115.14 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.31 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.946 HD12 ' CD2' ' A' ' 26' ' ' TYR . 73.7 mt -44.2 94.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.994 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' LYS . 1.9 mt-10 -56.91 -14.33 3.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.384 -0.822 . . . . 0.0 110.977 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.56 ' HB3' HG22 ' A' ' 89' ' ' ILE . . . -55.05 -30.08 58.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 0.0 110.345 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.901 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -106.43 -23.23 12.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.176 -0.952 . . . . 0.0 109.495 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 73.7 mm-40 -56.58 -27.58 58.23 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.269 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.2 21.66 28.62 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.837 HD23 HD11 ' A' ' 13' ' ' LEU . 1.4 tp -99.29 2.13 45.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -1.165 . . . . 0.0 110.152 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.463 HD11 ' HZ ' ' A' ' 21' ' ' PHE . 1.5 mp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.235 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.859 0.362 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.635 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 1.6 mttt -80.89 76.06 7.83 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.712 -1.195 . . . . 0.0 108.869 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.911 HG21 HG21 ' A' ' 45' ' ' THR . 74.0 p -119.79 -87.58 0.63 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.725 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.902 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -92.98 -27.41 17.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.99 . . . . 0.0 108.892 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.75 ' CE1' HG23 ' A' ' 7' ' ' VAL 0.252 1.2 p90 -34.7 -25.54 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.643 178.299 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ALA . 26.6 t0 -161.84 -58.76 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.829 -1.17 . . . . 0.0 110.589 -176.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.036 HG13 ' HB1' ' A' ' 34' ' ' ALA . 98.5 t -38.81 -97.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.599 0.714 . . . . 0.0 110.427 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.046 HD11 HG23 ' A' ' 39' ' ' ILE 0.25 75.1 mt -85.85 104.07 13.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.125 -0.985 . . . . 0.0 110.117 -179.572 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -86.89 -94.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.688 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.498 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -108.09 152.5 41.81 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 110.449 -179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.547 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 47.0 Cg_endo -73.15 174.49 11.95 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.93 1.49 . . . . 0.0 110.197 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.841 HG12 ' CD1' ' A' ' 29' ' ' TRP . 2.5 m -114.98 138.33 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.095 -1.003 . . . . 0.0 110.338 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.81 112.66 25.57 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 110.213 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 17' ' ' ALA . 4.1 m -163.87 141.42 7.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -42.83 -54.99 3.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 110.054 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.71 -25.09 25.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.325 -0.859 . . . . 0.0 110.075 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -87.71 -62.02 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.201 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.755 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -46.12 -43.57 15.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.309 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.65 -8.64 57.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.987 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -105.66 -39.73 2.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -77.5 -20.78 53.76 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.51 -0.994 . . . . 0.0 108.979 179.28 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -57.03 -16.2 6.66 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.553 -0.717 . . . . 0.0 110.192 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 25' ' ' LYS . 4.7 tt0 -96.62 16.39 19.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 110.447 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.68 -2.13 60.29 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 23.0 mttt -82.74 143.36 30.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -1.123 . . . . 0.0 109.73 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 1.146 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.1 m-85 -128.03 97.19 4.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.693 -1.254 . . . . 0.0 111.608 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.965 HG23 HD11 ' A' ' 80' ' ' ILE . 8.7 m -76.95 120.68 22.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.233 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.755 ' CB ' HG23 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -120.87 163.73 17.75 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.987 -1.071 . . . . 0.0 111.677 -178.527 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.841 ' CD1' HG12 ' A' ' 12' ' ' VAL . 10.2 m95 -94.4 122.77 37.32 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 178.059 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 7' ' ' VAL 0.259 3.8 p -144.4 160.36 15.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 C-N-CA 118.148 -1.421 . . . . 0.0 111.823 -176.31 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.598 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -67.3 152.73 95.85 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.612 -179.346 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.598 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 47.0 Cg_endo -73.19 71.78 3.55 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.071 1.564 . . . . 0.0 109.876 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.37 -33.3 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.782 -179.051 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 1.036 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.31 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.683 -0.636 . . . . 0.0 109.919 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -45.99 137.52 5.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 0.0 110.697 -179.415 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.553 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -43.4 -48.82 7.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.345 -0.847 . . . . 0.0 109.763 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.9 m -59.1 -50.15 75.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.728 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 2.2 mm-40 -55.07 -39.38 69.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 0.0 109.487 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.046 HG23 HD11 ' A' ' 8' ' ' ILE . 34.8 mt -57.61 -31.83 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.543 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.5 ttmp? -62.97 -45.98 89.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 178.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 45' ' ' THR . 32.7 m-80 -72.27 -33.73 67.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.686 -0.634 . . . . 0.0 110.914 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.857 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.44 -46.17 83.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.84 -1.163 . . . . 0.0 110.494 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.19 HG12 ' CE2' ' A' ' 47' ' ' PHE . 6.6 m -76.12 -33.13 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.78 -1.2 . . . . 0.0 109.657 178.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.52 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -68.2 -42.83 79.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.119 -0.988 . . . . 0.0 109.861 179.441 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.911 HG21 HG21 ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.07 -28.56 43.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.879 179.752 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.902 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -95.67 -57.58 2.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 110.967 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 1.19 ' CE2' HG12 ' A' ' 43' ' ' VAL . 6.7 m-30 -76.52 -16.54 59.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.908 . . . . 0.0 110.569 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.4 mtpt 57.33 47.7 16.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 110.48 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.782 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -123.83 -160.22 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.526 -0.734 . . . . 0.0 110.016 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.782 ' N ' HG13 ' A' ' 49' ' ' VAL . 3.8 tmtt? -117.65 105.76 12.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.645 HG21 HG23 ' A' ' 43' ' ' VAL . 45.3 t -78.93 119.72 28.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.349 -0.845 . . . . 0.0 110.613 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.4 p -107.32 -5.91 10.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.346 -0.846 . . . . 0.0 109.658 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.588 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.96 142.78 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.413 -0.804 . . . . 0.0 109.904 179.353 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.96 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -133.48 130.1 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.075 -1.015 . . . . 0.0 109.849 179.698 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.499 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 1.2 t30 -131.18 115.62 16.6 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.863 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.539 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -115.32 164.78 13.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.744 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -149.3 172.13 15.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.201 -0.937 . . . . 0.0 110.438 -179.423 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.605 ' CD2' ' HG2' ' A' ' 60' ' ' ARG . 5.5 t-160 -81.71 118.82 23.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.115 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -120.41 123.92 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.282 -0.886 . . . . 0.0 110.158 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.605 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 11.1 mmt85 -141.61 102.3 4.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.97 -1.081 . . . . 0.0 110.665 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 58.88 150.28 0.01 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.469 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -91.44 -16.29 27.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -1.207 . . . . 0.0 109.767 179.685 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 62' ' ' LYS . 8.5 pttm -178.57 176.11 1.04 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.458 -0.776 . . . . 0.0 109.975 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 66.31 44.49 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 110.282 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' LEU . 24.5 ptt85 -144.74 -41.06 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 68' ' ' ARG . 2.4 mp 46.83 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.896 . . . . 0.0 110.086 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' A' ' 68' ' ' ARG . . . -66.98 56.08 0.23 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 66' ' ' LEU . 3.5 mmm180 -130.54 14.07 5.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.092 -1.24 . . . . 0.0 109.209 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.59 ' CG ' ' N ' ' A' ' 70' ' ' LEU . 29.0 t80 -163.17 173.73 13.06 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.909 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.59 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -84.92 45.42 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 110.274 179.85 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.479 ' N ' ' CD2' ' A' ' 69' ' ' TYR . . . -64.44 -113.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 1.2 ptmt -111.95 111.98 23.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -1.159 . . . . 0.0 110.265 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -133.52 80.51 56.94 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.265 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' O ' ' NH1' ' A' ' 60' ' ' ARG . 47.6 Cg_endo -74.96 -163.09 0.17 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.111 1.585 . . . . 0.0 110.544 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.556 ' HA ' ' NH2' ' A' ' 60' ' ' ARG . 17.9 p-10 -113.18 89.71 3.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.826 0.822 . . . . 0.0 108.898 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.596 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 6.4 ttm180 -126.42 113.51 16.96 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.718 -0.614 . . . . 0.0 110.124 -179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.688 ' NZ ' ' HB3' ' A' ' 34' ' ' ALA . 18.1 tttt -122.97 139.59 53.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 109.724 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HE2' HG11 ' A' ' 12' ' ' VAL . 25.1 mttt -101.71 147.81 26.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 110.443 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.605 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -132.89 119.54 20.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.325 -0.859 . . . . 0.0 111.216 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.965 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -99.09 112.08 30.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.359 0.6 . . . . 0.0 109.595 179.128 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.049 HG11 HG21 ' A' ' 43' ' ' VAL . 2.5 t -104.24 127.38 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.475 -0.765 . . . . 0.0 110.14 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.691 ' O ' HG12 ' A' ' 52' ' ' VAL . 4.2 tp60 -102.54 147.47 26.72 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.027 -1.046 . . . . 0.0 109.334 179.301 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 1.5 m -116.35 156.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.311 -1.356 . . . . 0.0 108.891 177.591 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.789 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -69.06 176.14 1.71 Allowed Pre-proline 0 C--N 1.287 -2.116 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.125 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.789 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.1 Cg_endo -75.18 136.9 20.63 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 O-C-N 124.204 1.634 . . . . 0.0 110.291 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.25 -21.72 21.65 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -115.35 -179.91 3.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -1.234 . . . . 0.0 110.352 -179.988 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER 179.5 101.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.827 . . . . 0.0 110.149 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.146 HD12 ' CD2' ' A' ' 26' ' ' TYR . 48.5 mt -53.94 101.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -0.971 . . . . 0.0 110.172 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 19.4 pt-20 -60.92 -13.5 16.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.423 -0.798 . . . . 0.0 110.918 -179.542 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.71 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.69 -36.14 64.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 110.524 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.97 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.41 -23.11 12.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.022 -1.049 . . . . 0.0 109.8 179.762 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.8 mm-40 -52.15 -45.5 65.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.353 -0.842 . . . . 0.0 110.456 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -83.2 -23.98 53.12 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.1 tp -42.13 -27.19 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -1.115 . . . . 0.0 110.268 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 94' ' ' GLY . 17.3 mm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.278 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.691 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -59.57 87.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.109 -1.436 . . . . 0.0 109.171 179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.911 HG22 HG21 ' A' ' 45' ' ' THR . 45.5 p -129.61 -56.68 1.14 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 8' ' ' ILE . . . -138.91 -4.8 1.53 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.88 0.848 . . . . 0.0 109.484 178.352 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.775 ' CZ ' HG23 ' A' ' 7' ' ' VAL 0.284 0.1 OUTLIER -56.21 -137.89 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.912 0.863 . . . . 0.0 110.842 177.659 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.621 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 3.3 m-20 -27.57 -59.78 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.08 178.511 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.006 HG13 ' HB1' ' A' ' 34' ' ' ALA . 53.7 t -54.4 -111.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.542 -0.724 . . . . 0.0 110.94 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.954 HG13 HG12 ' A' ' 7' ' ' VAL . 11.8 mt -81.42 106.31 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.533 -1.354 . . . . 0.0 111.027 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -83.97 -105.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 110.217 179.715 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.65 151.43 41.68 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.948 -1.095 . . . . 0.0 110.415 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.505 ' CB ' HD11 ' A' ' 92' ' ' LEU . 47.3 Cg_endo -74.43 175.69 10.68 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.045 1.55 . . . . 0.0 110.154 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.988 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.4 m -115.06 136.28 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.145 -0.972 . . . . 0.0 110.396 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.741 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.67 107.9 18.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.172 -0.955 . . . . 0.0 110.17 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -163.14 138.54 6.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.201 179.88 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -43.25 -51.07 6.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 110.141 179.908 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -18.17 4.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -103.84 -43.42 5.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.006 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.588 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -62.72 -39.58 94.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 179.852 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.74 -13.53 44.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.036 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -105.46 -47.73 1.1 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 178.486 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.88 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -51.08 -24.09 3.64 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.897 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.73 -29.93 63.01 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.259 0.552 . . . . 0.0 110.674 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -88.73 16.25 7.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.273 -0.892 . . . . 0.0 110.504 -179.571 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 87.42 13.28 65.84 Favored Glycine 0 N--CA 1.482 1.712 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' CG ' ' OE1' ' A' ' 82' ' ' GLN . 11.3 mttm -82.45 146.33 29.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.183 -1.187 . . . . 0.0 109.505 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 1.131 ' CE2' HD12 ' A' ' 89' ' ' ILE . 28.7 m-85 -127.02 98.3 5.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.911 -1.118 . . . . 0.0 112.146 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.849 HG22 ' HD3' ' A' ' 78' ' ' LYS . 2.5 m -79.13 126.42 30.71 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 178.249 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.808 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 13.4 m-85 -126.58 164.93 20.13 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.28 -0.888 . . . . 0.0 111.618 -178.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.988 ' NE1' HG12 ' A' ' 12' ' ' VAL . 43.9 m95 -104.24 122.36 45.23 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 176.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 7' ' ' VAL . 1.2 p -144.28 157.6 15.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 117.708 -1.597 . . . . 0.0 112.259 -176.169 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -62.13 151.75 80.15 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.952 -179.109 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.8 Cg_endo -73.67 70.03 4.28 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.211 1.637 . . . . 0.0 109.848 179.471 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.54 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 109.911 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 1.006 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -44.75 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.639 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -43.22 138.93 2.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.92 . . . . 0.0 110.544 -179.243 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.543 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -43.54 -38.08 2.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.701 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 5.6 m -70.59 -44.45 67.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.469 -0.769 . . . . 0.0 109.685 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.497 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 2.8 mm-40 -55.6 -41.16 73.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.562 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.815 ' O ' HD11 ' A' ' 8' ' ' ILE . 74.7 mt -57.4 -30.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.903 . . . . 0.0 108.633 179.038 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 37' ' ' THR . 17.7 tttm -64.96 -44.46 89.32 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.415 -0.803 . . . . 0.0 109.404 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.5 ' O ' ' HB ' ' A' ' 45' ' ' THR . 40.3 m-80 -73.17 -43.37 61.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.696 -0.627 . . . . 0.0 111.277 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.854 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.23 -51.32 70.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.603 -1.311 . . . . 0.0 110.261 -179.142 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.767 HG21 ' HE2' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -63.98 -47.22 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.056 -1.028 . . . . 0.0 109.968 179.981 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.481 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -57.0 -44.88 83.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.027 -1.046 . . . . 0.0 109.41 179.497 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.911 HG21 HG22 ' A' ' 3' ' ' THR . 0.3 OUTLIER -78.53 -12.58 60.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.4 -0.813 . . . . 0.0 109.446 179.309 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -97.3 -71.71 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.832 . . . . 0.0 110.236 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.812 ' CG ' HD13 ' A' ' 89' ' ' ILE . 43.3 m-85 -72.1 -22.12 61.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.192 -0.942 . . . . 0.0 110.198 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 68.78 44.2 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 110.006 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.67 HG22 ' H ' ' A' ' 50' ' ' LYS . 1.1 p -118.65 -160.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.541 -0.724 . . . . 0.0 110.383 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.67 ' H ' HG22 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.11 104.97 11.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.423 -0.798 . . . . 0.0 109.584 179.268 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.735 HG22 ' CG1' ' A' ' 81' ' ' VAL . 25.1 t -78.23 119.71 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.963 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.2 p -102.98 -8.94 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 110.227 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 4.9 ptmt -175.39 131.24 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.873 179.196 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.038 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -123.62 127.62 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.974 -1.078 . . . . 0.0 110.332 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.543 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 37.7 t30 -131.06 115.65 16.72 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.472 -0.767 . . . . 0.0 109.02 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.598 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.92 157.78 22.9 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 110.239 -179.379 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -145.94 171.37 14.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.786 . . . . 0.0 110.159 -179.67 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -85.26 128.47 34.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.192 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.538 HG21 ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -118.5 130.4 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.305 -0.872 . . . . 0.0 109.962 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 74' ' ' PRO . 7.9 mmt85 -115.42 128.78 56.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 110.277 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.77 154.29 0.92 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -82.63 -22.06 34.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -1.122 . . . . 0.0 110.11 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 64' ' ' LYS . 6.8 mttp -69.68 62.33 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' LYS . 2.9 ptpp? -44.2 169.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -56.34 -16.39 5.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.252 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 67' ' ' GLY . 29.7 tp 55.5 108.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.217 -0.927 . . . . 0.0 109.972 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . 45.34 -169.95 0.02 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.71 127.29 32.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -1.126 . . . . 0.0 109.812 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.572 ' CG ' ' N ' ' A' ' 70' ' ' LEU . 39.7 t80 -167.34 173.89 8.5 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.679 -0.638 . . . . 0.0 109.742 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 70' ' ' LEU . 1.4 pp -90.12 70.89 7.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.034 -1.041 . . . . 0.0 109.963 179.691 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 72' ' ' LYS . . . -163.79 -174.86 34.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER 170.1 -173.15 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.495 -1.003 . . . . 0.0 110.114 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -101.08 120.46 55.16 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.059 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 47.5 Cg_endo -72.42 -165.98 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.823 1.433 . . . . 0.0 110.386 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.88 89.27 3.06 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.44 -0.787 . . . . 0.0 109.383 179.293 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -95.1 147.28 23.6 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.647 -0.658 . . . . 0.0 109.897 179.842 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 20.4 tttt -123.08 127.5 48.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.744 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.849 ' HD3' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -101.81 151.01 22.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.285 179.378 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.808 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -127.16 129.34 47.7 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.974 -1.078 . . . . 0.0 111.91 -179.261 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.79 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.5 mp -109.72 111.43 36.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.164 178.294 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.038 HG13 HG23 ' A' ' 54' ' ' VAL . 19.3 t -112.29 128.29 69.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.572 -0.705 . . . . 0.0 110.162 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.713 ' O ' HG12 ' A' ' 52' ' ' VAL . 2.5 tp60 -101.55 151.27 22.17 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.037 -1.039 . . . . 0.0 109.012 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.0 m -112.57 155.84 13.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 C-N-CA 118.082 -1.447 . . . . 0.0 108.443 177.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.713 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -58.01 169.98 0.8 Allowed Pre-proline 0 C--N 1.284 -2.244 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.646 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.615 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 45.4 Cg_endo -79.63 53.48 4.75 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 O-C-N 124.416 1.745 . . . . 0.0 110.733 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.475 ' N ' ' OE1' ' A' ' 87' ' ' GLN . . . -168.72 23.47 0.1 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.713 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -150.31 -175.53 5.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.941 -1.329 . . . . 0.0 110.268 -179.965 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER 179.88 113.25 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.455 -0.778 . . . . 0.0 109.998 179.865 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.131 HD12 ' CE2' ' A' ' 26' ' ' TYR . 16.8 mt -59.92 100.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.28 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -53.95 -27.99 34.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.72 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.2 73.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.414 -0.804 . . . . 0.0 110.22 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.88 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -107.67 1.23 22.98 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.977 -1.089 . . . . 0.0 112.079 -179.51 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -95.11 3.31 54.91 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 117.958 -1.497 . . . . 0.0 110.118 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -118.54 -17.78 5.09 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.486 ' HA ' HD12 ' A' ' 95' ' ' LEU . 0.7 OUTLIER -56.31 -33.75 65.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.366 -1.079 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.517 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 4.6 mt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.214 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.57 ' HG2' ' HB2' ' A' ' 6' ' ' ASP . 5.8 tpp . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.781 0.8 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -86.31 112.56 21.53 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.738 -0.601 . . . . 0.0 109.456 179.075 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.616 ' O ' ' N ' ' A' ' 5' ' ' TYR . 6.5 t -35.98 -33.46 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.82 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.959 ' O ' HG23 ' A' ' 7' ' ' VAL 0.29 . . -60.69 65.67 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 176.804 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.151 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.2 p90 30.68 46.38 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.683 1.23 . . . . 0.0 107.857 -176.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 2.8 p30 47.2 63.41 1.97 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.978 -1.465 . . . . 0.0 111.759 -178.131 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.151 HG21 ' CE2' ' A' ' 5' ' ' TYR . 9.2 t -128.07 -117.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.574 -0.703 . . . . 0.0 110.348 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.101 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.2 mt -63.08 156.42 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.224 -0.922 . . . . 0.0 110.032 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.557 HD12 ' H ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -144.61 -81.72 0.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.069 -1.019 . . . . 0.0 110.594 179.483 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.557 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -108.15 145.23 31.03 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.981 -1.074 . . . . 0.0 110.573 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 47.7 Cg_endo -74.53 169.8 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.037 1.546 . . . . 0.0 110.563 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.8 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.3 m -115.13 136.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.127 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.007 HD11 HD23 ' A' ' 95' ' ' LEU . 3.2 mm? -102.93 110.26 22.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.136 -0.978 . . . . 0.0 110.435 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -164.0 145.72 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.473 -0.767 . . . . 0.0 109.559 179.821 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 14' ' ' SER . 2.1 mm-40 -43.42 -33.48 1.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 109.986 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -28.23 66.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 110.024 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -91.96 19.36 6.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.296 -0.877 . . . . 0.0 109.807 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.584 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.7 m-85 -138.49 -41.92 0.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.54 -0.725 . . . . 0.0 109.854 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.12 79.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.177 -0.952 . . . . 0.0 108.883 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.85 -31.1 7.93 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 178.318 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -72.31 -10.83 60.29 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.522 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -66.84 -8.39 28.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.655 -0.653 . . . . 0.0 110.216 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -1.98 19.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 110.385 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.588 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 119.48 4.09 12.23 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 27.4 mttt -84.35 132.71 34.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -1.152 . . . . 0.0 109.772 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.859 ' CD2' HD12 ' A' ' 89' ' ' ILE . 62.7 m-85 -126.94 111.15 13.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.719 -1.238 . . . . 0.0 111.79 -179.328 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.728 HG22 ' HB2' ' A' ' 78' ' ' LYS . 7.5 m -79.27 128.95 33.95 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.458 0.647 . . . . 0.0 109.932 179.09 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.695 ' CE1' ' CZ ' ' A' ' 47' ' ' PHE . 19.0 m-85 -124.76 164.73 19.35 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.519 -0.738 . . . . 0.0 109.879 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.8 ' NE1' HG12 ' A' ' 12' ' ' VAL . 4.4 m95 -95.14 122.86 38.25 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.263 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.536 HG23 ' N ' ' A' ' 8' ' ' ILE . 8.1 p -137.1 165.01 28.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.844 -177.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.498 ' CE1' ' HE3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.45 145.31 91.15 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.908 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.39 70.68 2.49 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.1 1.579 . . . . 0.0 109.934 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 178.83 -32.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.413 -0.805 . . . . 0.0 110.12 -178.936 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -56.27 96.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.463 -0.773 . . . . 0.0 110.379 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.439 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 1.3 p -46.17 159.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 109.962 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.773 ' O ' HG11 ' A' ' 54' ' ' VAL . 11.0 mttp -47.71 -40.22 19.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.289 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.9 m -75.28 -38.97 60.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.591 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.439 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 2.4 mt-10 -55.6 -43.88 76.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.038 -1.039 . . . . 0.0 109.944 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.776 ' O ' HD11 ' A' ' 8' ' ' ILE . 13.0 mt -57.5 -30.24 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.774 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.916 ' HG3' HG11 ' A' ' 51' ' ' VAL . 39.8 tttm -57.6 -41.99 82.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 111.537 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.489 ' HB2' ' OH ' ' A' ' 5' ' ' TYR . 6.6 m-80 -58.29 -49.53 76.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.465 -0.772 . . . . 0.0 112.397 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.101 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -73.49 -39.18 65.06 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.711 -1.243 . . . . 0.0 111.631 -178.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.843 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -62.41 -45.54 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.898 -1.126 . . . . 0.0 110.401 -179.343 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.477 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -56.41 -38.75 71.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.012 . . . . 0.0 109.846 -179.818 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 41' ' ' ASN . 43.0 p -79.38 -45.43 19.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 109.975 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.64 -60.58 2.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 110.497 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.843 ' CD2' HG22 ' A' ' 43' ' ' VAL . 44.4 m-85 -71.65 -21.52 61.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.957 . . . . 0.0 110.158 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 56.32 40.75 29.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 110.295 179.734 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.77 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -120.99 -165.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.519 -0.738 . . . . 0.0 109.896 179.708 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.77 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -106.66 112.17 25.04 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.23 178.812 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.916 HG11 ' HG3' ' A' ' 40' ' ' LYS . 19.6 t -77.59 135.68 25.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.482 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.765 HG21 ' N ' ' A' ' 84' ' ' ALA . 2.5 t -128.57 -5.87 3.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.48 -0.763 . . . . 0.0 110.573 -178.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.537 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER 170.45 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.424 -0.797 . . . . 0.0 109.118 179.498 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.863 HG22 HG22 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -115.47 133.04 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.332 -0.855 . . . . 0.0 110.564 -179.26 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.557 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -131.58 116.09 16.95 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.437 -0.79 . . . . 0.0 109.372 178.515 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -116.6 149.46 39.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 110.436 -179.295 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.531 HD12 ' HG3' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -130.11 143.38 50.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.477 -0.765 . . . . 0.0 109.521 179.884 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.21 112.58 7.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.018 -1.051 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -113.33 126.28 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.285 -0.884 . . . . 0.0 110.089 -179.778 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.562 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -125.15 155.7 39.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.074 -1.016 . . . . 0.0 110.284 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -43.2 119.08 2.2 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -98.08 -21.87 16.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.275 -1.133 . . . . 0.0 110.202 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 6.3 ptmt -62.74 134.67 56.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 110.113 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 67.14 79.67 0.23 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 0.0 110.151 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' ' 66' ' ' LEU . 2.2 ttp-105 -144.89 -36.44 0.31 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.384 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 65' ' ' ARG . 1.1 mm? -38.9 144.22 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.516 -0.74 . . . . 0.0 110.718 -179.689 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 68' ' ' ARG . . . 71.34 -179.56 32.54 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -48.26 178.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -1.068 . . . . 0.0 110.486 -179.799 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.47 ' O ' HD12 ' A' ' 70' ' ' LEU . 30.5 t80 -47.74 132.59 14.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.362 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -158.43 40.81 0.25 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 110.028 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 72' ' ' LYS . . . -177.59 -118.27 0.54 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 71' ' ' GLY . 24.6 mttt -160.69 161.04 32.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -1.121 . . . . 0.0 110.235 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -152.09 81.92 5.53 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.897 . . . . 0.0 110.212 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.35 -164.59 0.23 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.059 1.557 . . . . 0.0 110.499 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -114.44 89.67 3.15 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.767 0.794 . . . . 0.0 109.134 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.637 ' NE ' ' CH2' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -122.46 122.02 37.98 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.693 -0.629 . . . . 0.0 109.859 -179.892 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.51 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 6.5 ptmt -123.3 141.79 51.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.437 -179.683 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.728 ' HB2' HG22 ' A' ' 27' ' ' THR . 1.7 ptpt -101.0 151.14 22.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.361 -0.837 . . . . 0.0 109.626 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -115.61 118.77 34.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.019 -1.051 . . . . 0.0 111.992 -179.109 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 12.1 mt -94.94 110.96 24.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.528 -0.732 . . . . 0.0 109.585 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.863 HG22 HG22 ' A' ' 54' ' ' VAL . 6.4 t -102.09 143.22 15.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.09 -1.006 . . . . 0.0 110.458 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.537 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 29.6 tp60 -116.44 150.58 37.6 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.298 -0.876 . . . . 0.0 109.098 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.511 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.5 m -124.91 155.75 33.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 118.324 -1.351 . . . . 0.0 109.973 178.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.939 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -47.76 178.34 0.03 OUTLIER Pre-proline 0 C--N 1.291 -1.969 0 O-C-N 121.839 -0.538 . . . . 0.0 110.73 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.939 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.7 Cg_endo -74.23 142.78 30.95 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.386 1.73 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.65 -40.98 2.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.521 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 6.6 mt-30 -70.18 176.88 3.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -1.199 . . . . 0.0 110.387 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 178.42 102.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.18 -179.192 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.859 HD12 ' CD2' ' A' ' 26' ' ' TYR . 8.3 mt -55.99 87.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.914 -1.116 . . . . 0.0 109.597 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' LYS . 11.1 pt-20 -57.99 -13.22 4.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.429 -0.795 . . . . 0.0 110.946 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.757 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.27 -33.53 58.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.108 -0.995 . . . . 0.0 110.777 -179.16 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.757 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.24 -23.04 12.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.927 -1.108 . . . . 0.0 109.929 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.2 mm-40 -52.9 -33.83 52.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.436 -0.79 . . . . 0.0 110.413 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.67 6.06 58.72 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.007 HD23 HD11 ' A' ' 13' ' ' LEU . 1.3 tp -76.02 -25.43 55.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -1.17 . . . . 0.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.584 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 8.2 mt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.158 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' HG3' ' HE3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.794 0.806 . . . . 0.0 110.564 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.888 ' CD ' HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -76.24 108.72 9.37 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.59 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.554 ' C ' ' O ' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -30.13 -37.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.408 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.024 ' O ' HG23 ' A' ' 7' ' ' VAL 0.291 . . -63.78 68.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.348 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.121 ' CE2' HG21 ' A' ' 7' ' ' VAL . 0.6 OUTLIER 29.61 38.06 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 122.311 1.053 . . . . 0.0 108.857 -176.886 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 4' ' ' ALA . 2.2 t0 64.92 55.33 1.19 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.976 -179.389 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.121 HG21 ' CE2' ' A' ' 5' ' ' TYR . 5.4 t -127.96 -120.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.898 -1.126 . . . . 0.0 110.31 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.973 HD12 ' HB3' ' A' ' 42' ' ' ALA . 4.8 mt -56.02 148.0 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.888 HD21 ' CD ' ' A' ' 2' ' ' LYS . 0.6 OUTLIER -119.02 -100.36 0.44 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 110.663 -179.572 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.38 161.66 23.13 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.042 -1.037 . . . . 0.0 110.718 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HG3' HD22 ' A' ' 92' ' ' LEU . 49.8 Cg_endo -76.6 157.99 35.99 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.126 1.593 . . . . 0.0 110.308 179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.017 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.4 m -100.03 140.0 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.0 110.272 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.759 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.64 113.17 26.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.95 . . . . 0.0 110.19 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 52.7 m -167.01 135.13 2.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.3 mm-40 -42.86 -47.45 5.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.92 . . . . 0.0 110.038 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -54.79 -35.92 64.36 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 19' ' ' ALA . . . -79.91 -63.71 1.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 0.0 110.183 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.854 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 1.3 m-85 -42.87 -26.25 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 110.406 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -88.42 -35.32 17.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.691 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -83.23 -38.34 11.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 178.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.69 -15.06 60.35 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.728 -0.866 . . . . 0.0 108.882 178.871 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -63.97 -17.15 62.99 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.485 0.66 . . . . 0.0 109.916 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.18 -2.76 52.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.412 -0.805 . . . . 0.0 110.203 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 117.78 0.77 17.56 Favored Glycine 0 N--CA 1.478 1.5 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 73.2 mttt -81.96 140.33 34.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -1.108 . . . . 0.0 109.617 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 64.4 m-85 -127.85 104.85 8.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.572 -1.33 . . . . 0.0 111.982 -178.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.002 HG23 HD11 ' A' ' 80' ' ' ILE . 1.9 m -79.44 140.15 37.45 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.43 0.634 . . . . 0.0 109.291 178.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.859 ' HB3' HG23 ' A' ' 8' ' ' ILE . 17.0 m-85 -140.24 165.18 28.08 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 110.404 -179.196 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 1.017 ' NE1' HG12 ' A' ' 12' ' ' VAL . 96.3 m95 -105.12 121.8 44.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 176.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 7' ' ' VAL . 4.9 p -144.03 165.46 13.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.778 -176.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.461 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -59.62 149.6 70.34 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.75 -179.369 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . 47.1 Cg_endo -73.65 71.66 3.92 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.208 1.636 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.487 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.08 -34.05 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.356 -0.84 . . . . 0.0 110.156 -179.095 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -47.65 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.364 -0.835 . . . . 0.0 110.212 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -43.34 167.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.545 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.2 mtpt -64.13 -58.06 7.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.925 . . . . 0.0 110.349 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.495 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.5 m -58.74 -39.29 80.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.951 . . . . 0.0 110.177 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.467 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 6.4 mt-10 -55.89 -45.98 78.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 0.0 109.651 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.711 ' O ' HD11 ' A' ' 8' ' ' ILE . 17.7 mt -57.13 -30.13 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.493 -0.755 . . . . 0.0 110.015 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.552 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.0 ttmm -57.77 -47.51 82.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.414 -0.804 . . . . 0.0 111.799 -179.283 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -58.7 -45.95 88.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 112.63 -177.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.973 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.75 -48.45 81.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.768 -1.207 . . . . 0.0 111.893 -178.266 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.959 HG13 HD13 ' A' ' 8' ' ' ILE . 19.1 m -74.47 -28.89 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.424 -1.422 . . . . 0.0 110.467 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -52.61 64.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.836 -1.165 . . . . 0.0 109.219 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.2 p -80.25 -45.42 17.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.853 179.011 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -58.44 -65.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.419 -0.801 . . . . 0.0 110.57 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.663 ' HE1' HD21 ' A' ' 92' ' ' LEU . 31.8 m-85 -71.48 -19.07 62.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.996 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER 68.08 46.31 1.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 110.517 179.643 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.753 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -134.01 -165.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.437 -0.789 . . . . 0.0 110.259 179.907 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.753 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -118.74 111.18 18.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.545 -0.722 . . . . 0.0 109.881 179.274 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.898 HG13 ' CG1' ' A' ' 81' ' ' VAL . 89.4 t -78.77 136.32 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 110.134 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.673 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.7 p -118.25 -7.3 11.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.277 -0.889 . . . . 0.0 110.164 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -176.67 131.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.819 179.41 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.087 HG23 HG13 ' A' ' 81' ' ' VAL . 1.2 t -123.68 119.64 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.999 -1.063 . . . . 0.0 110.258 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.488 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 1.6 t30 -116.74 115.91 26.51 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.218 178.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -109.55 145.44 36.33 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.57 -179.611 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.58 160.45 28.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.275 -0.891 . . . . 0.0 110.903 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.429 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 3.3 t-160 -72.98 115.12 11.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.25 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.745 HG11 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -106.08 139.46 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -0.895 . . . . 0.0 110.229 -179.279 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.605 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -138.64 134.49 33.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.176 -0.953 . . . . 0.0 110.277 -179.279 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.475 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . -54.95 -171.14 0.07 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -42.59 165.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -1.124 . . . . 0.0 110.304 -179.982 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -77.18 -142.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 0.0 110.2 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? 51.33 87.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.257 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 67' ' ' GLY . 11.5 tpp180 -88.32 -7.63 56.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.256 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' ARG . 2.6 mp -42.0 93.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 110.371 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 65' ' ' ARG . . . -67.16 58.44 0.25 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -117.11 15.57 15.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.12 -1.223 . . . . 0.0 109.393 179.902 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 8.6 t80 -155.66 53.17 0.59 Allowed 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.137 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER 40.98 41.3 1.21 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.847 0.832 . . . . 0.0 110.283 179.955 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 72' ' ' LYS . . . -105.79 -111.1 3.56 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER 63.13 70.95 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.281 -1.129 . . . . 0.0 110.228 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.475 ' HG3' ' HA3' ' A' ' 61' ' ' GLY . 2.1 mpt_? -45.7 137.99 5.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 110.146 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.73 -167.24 0.36 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.991 1.522 . . . . 0.0 110.413 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.61 89.47 3.11 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.469 -0.769 . . . . 0.0 109.472 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.587 ' CG ' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -94.91 152.55 18.27 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.577 -0.702 . . . . 0.0 109.908 179.603 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HA ' HG23 ' A' ' 59' ' ' VAL . 13.2 tttt -121.15 137.99 54.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.068 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.69 ' HD3' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -105.44 150.67 25.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 110.001 -179.901 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.785 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -128.88 128.64 44.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.091 -1.006 . . . . 0.0 112.347 -179.212 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.002 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -108.69 111.88 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.087 HG13 HG23 ' A' ' 54' ' ' VAL . 5.0 t -108.37 137.46 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 111.234 -178.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.673 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.4 tp60 -111.17 154.08 24.86 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.265 -0.897 . . . . 0.0 108.742 178.403 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 87' ' ' GLN . 2.9 m -116.45 155.82 17.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 C-N-CA 118.257 -1.377 . . . . 0.0 108.643 177.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.966 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -56.19 -179.6 0.09 OUTLIER Pre-proline 0 C--N 1.284 -2.244 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.032 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.966 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.3 Cg_endo -71.68 140.4 35.73 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 124.103 1.581 . . . . 0.0 110.387 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.05 -23.34 29.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.534 ' HB2' HG23 ' A' ' 83' ' ' VAL . 35.7 mt-30 -87.1 167.93 13.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.259 -1.142 . . . . 0.0 110.641 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HD3' ' OH ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER 179.45 115.49 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.332 -0.855 . . . . 0.0 110.653 179.89 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.629 ' CG2' ' CD1' ' A' ' 47' ' ' PHE . 9.2 mt -78.05 75.53 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.548 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.71 -13.09 1.49 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.508 -0.745 . . . . 0.0 111.479 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.748 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -53.59 -20.6 5.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.933 -1.105 . . . . 0.0 110.629 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.748 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.47 -23.21 12.56 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.001 -1.062 . . . . 0.0 109.609 179.506 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -54.61 -35.71 63.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 110.373 -179.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.11 -4.9 71.1 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.497 ' HA ' HD12 ' A' ' 95' ' ' LEU . 3.0 tp -69.24 -5.47 23.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.091 -1.24 . . . . 0.0 110.194 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.614 ' CG1' ' CZ ' ' A' ' 18' ' ' TYR . 20.3 mt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.21 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.756 0.312 . . . . 0.0 110.609 . . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.611 ' O ' ' N ' ' A' ' 4' ' ' ALA . 4.8 mttp -44.86 98.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.165 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.615 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.3 m 4.37 -70.93 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.668 0 CA-C-O 121.102 0.477 . . . . 0.0 111.099 -178.448 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.801 ' HB1' ' HB1' ' A' ' 42' ' ' ALA 0.259 . . -56.76 79.04 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.484 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.868 ' CE1' ' HB2' ' A' ' 42' ' ' ALA . 0.6 OUTLIER 25.38 48.32 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.923 0.868 . . . . 0.0 110.192 -178.019 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.608 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 6.7 t0 64.85 54.42 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.111 0.958 . . . . 0.0 111.288 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 4' ' ' ALA . 11.3 t -137.45 -110.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.351 -0.843 . . . . 0.0 109.778 179.006 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.973 HD12 ' HB3' ' A' ' 42' ' ' ALA . 6.8 mt -74.07 158.13 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.991 -1.068 . . . . 0.0 110.151 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.598 HD21 ' CA ' ' A' ' 2' ' ' LYS . 34.1 mt -140.71 -99.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 110.251 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.68 155.96 39.69 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 110.346 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.957 ' HG3' HD22 ' A' ' 92' ' ' LEU . 46.0 Cg_endo -73.71 153.76 48.83 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.978 1.514 . . . . 0.0 110.255 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.941 HG12 ' CE2' ' A' ' 29' ' ' TRP . 2.3 m -92.14 141.12 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.271 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.766 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.83 107.5 18.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.932 . . . . 0.0 110.204 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 15' ' ' GLU . 22.3 m -161.54 143.06 11.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.104 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' SER . 9.8 tm-20 -43.19 -51.31 6.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.004 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -42.67 71.87 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.23 -0.919 . . . . 0.0 110.218 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 18' ' ' TYR . . . -70.83 -65.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.703 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.6 m-85 -42.55 -27.62 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 110.317 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -90.38 -34.85 15.5 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.24 -0.913 . . . . 0.0 109.562 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -78.58 -44.98 9.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.158 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.629 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.04 -22.36 64.96 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.56 -0.964 . . . . 0.0 108.734 178.936 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -52.6 -19.37 2.28 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.333 0.587 . . . . 0.0 110.661 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.06 15.08 19.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.868 . . . . 0.0 110.498 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 97.61 1.01 59.04 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HD2' HG21 ' A' ' 80' ' ' ILE . 2.8 mttp -82.5 143.37 31.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -1.089 . . . . 0.0 109.552 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 1.079 ' CD2' HD12 ' A' ' 89' ' ' ILE . 23.1 m-85 -127.81 103.87 7.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.761 -1.212 . . . . 0.0 111.918 -179.338 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.058 HG23 HD11 ' A' ' 80' ' ' ILE . 1.9 m -75.62 141.28 42.88 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.785 ' CB ' HG23 ' A' ' 8' ' ' ILE . 18.4 m-85 -138.0 165.24 27.05 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.353 -0.842 . . . . 0.0 110.48 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.941 ' CE2' HG12 ' A' ' 12' ' ' VAL . 22.4 m95 -101.68 120.79 40.89 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.287 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.785 HG13 ' HE2' ' A' ' 77' ' ' LYS . 1.9 p -152.57 165.31 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 118.481 -1.288 . . . . 0.0 111.522 -176.693 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.566 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -70.9 172.55 6.2 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.713 -0.617 . . . . 0.0 110.683 -179.51 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.9 Cg_endo -75.35 -59.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.241 1.653 . . . . 0.0 110.413 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -38.46 -26.0 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.552 179.283 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.725 ' HB3' ' NZ ' ' A' ' 77' ' ' LYS . . . -62.95 90.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.82 -1.175 . . . . 0.0 110.051 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -49.49 162.66 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 -179.84 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -57.47 -56.22 24.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.86 . . . . 0.0 110.117 -179.964 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.6 m -60.49 -34.77 74.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.307 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -55.79 -42.65 75.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 109.642 179.776 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.775 ' O ' HD11 ' A' ' 8' ' ' ILE . 9.0 mt -57.65 -30.96 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.145 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HG3' HG11 ' A' ' 51' ' ' VAL . 13.3 tttp -62.22 -46.25 89.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 110.52 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -59.12 -49.12 79.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.477 -0.764 . . . . 0.0 112.003 -178.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.973 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -66.12 -47.65 73.43 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.849 -1.157 . . . . 0.0 111.417 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.907 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -63.7 -39.54 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.864 -1.147 . . . . 0.0 110.395 -179.325 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.24 -47.33 78.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.0 -1.063 . . . . 0.0 109.609 179.939 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.3 p -79.42 -45.07 20.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.357 -0.839 . . . . 0.0 109.883 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.12 -69.61 0.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.418 -0.801 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.907 ' CD2' HG22 ' A' ' 43' ' ' VAL . 77.5 m-85 -71.63 -21.81 61.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.132 -0.98 . . . . 0.0 110.219 -179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 9.2 mttt 65.2 40.08 5.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.744 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -117.88 -162.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.485 0.659 . . . . 0.0 110.313 -179.896 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.744 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -118.2 104.52 10.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.522 -0.736 . . . . 0.0 109.486 178.946 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.817 HG22 HG11 ' A' ' 81' ' ' VAL . 27.0 t -78.81 119.8 28.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.694 -179.223 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.652 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.5 p -103.17 -0.57 10.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.295 -0.878 . . . . 0.0 109.812 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.571 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.97 146.87 0.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 179.385 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.924 HG22 HG22 ' A' ' 81' ' ' VAL . 1.2 t -133.37 122.25 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.516 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -121.99 115.8 23.17 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 109.086 178.639 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.641 ' C ' HD23 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -120.67 140.84 51.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 110.305 -179.481 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.677 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -148.55 149.93 32.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.634 -0.667 . . . . 0.0 109.345 -179.847 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.616 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 5.5 m-70 -86.34 143.51 27.82 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.151 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.733 HG23 ' NE ' ' A' ' 60' ' ' ARG . 15.9 m -100.88 139.18 22.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.529 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.733 ' NE ' HG23 ' A' ' 59' ' ' VAL . 10.7 mtm180 66.18 -166.05 0.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.918 -1.114 . . . . 0.0 110.111 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 44.51 96.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 179.409 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.03 -58.87 1.84 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -1.148 . . . . 0.0 110.098 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 tttm -155.34 140.23 17.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.148 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.4 mttt 57.6 25.21 11.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.511 ' HD3' ' HB3' ' A' ' 72' ' ' LYS . 5.1 mtt180 -101.82 -48.89 4.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.276 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 1.9 mp 63.61 -167.57 0.21 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.422 -0.799 . . . . 0.0 109.611 -179.202 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.73 44.83 0.32 Allowed Glycine 0 N--CA 1.481 1.699 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.56 20.64 5.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.366 1.079 . . . . 0.0 109.076 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.599 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 31.0 t80 -156.9 173.09 17.53 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.965 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.581 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 3.7 mm? -85.93 43.99 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.158 -0.964 . . . . 0.0 110.347 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.599 ' N ' ' CD2' ' A' ' 69' ' ' TYR . . . -100.43 -121.97 4.82 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.511 ' HB3' ' HD3' ' A' ' 65' ' ' ARG . 1.5 mmpt? -70.78 -174.24 0.89 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -1.151 . . . . 0.0 110.149 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.544 ' CB ' ' HB3' ' A' ' 60' ' ' ARG . 0.5 OUTLIER -93.1 154.6 41.63 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.921 . . . . 0.0 110.417 -179.882 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.407 ' HG2' ' NH2' ' A' ' 60' ' ' ARG . 49.2 Cg_endo -73.14 -164.21 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.216 1.64 . . . . 0.0 110.848 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.515 ' OD1' ' CB ' ' A' ' 58' ' ' HIS . 2.6 t0 -114.63 90.54 3.37 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.482 -0.761 . . . . 0.0 109.319 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -93.32 128.67 39.44 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.642 -0.661 . . . . 0.0 109.339 179.856 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.785 ' HE2' HG13 ' A' ' 30' ' ' VAL . 3.4 ttpt -96.29 128.99 43.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 111.077 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 28.7 pttt -119.54 151.3 38.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.413 -0.804 . . . . 0.0 109.348 179.147 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.761 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -118.06 128.77 55.08 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.89 -1.131 . . . . 0.0 113.03 -178.356 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.058 HD11 HG23 ' A' ' 27' ' ' THR . 1.7 mp -107.58 111.24 34.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.546 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.924 HG22 HG22 ' A' ' 54' ' ' VAL . 23.4 t -107.37 139.0 30.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 111.005 -178.703 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.652 ' C ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -105.59 153.32 21.95 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.341 -0.849 . . . . 0.0 108.789 179.008 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.53 HG11 ' HE2' ' A' ' 26' ' ' TYR . 1.5 m -119.16 156.52 21.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 C-N-CA 118.171 -1.412 . . . . 0.0 109.327 178.343 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -64.46 177.03 0.61 Allowed Pre-proline 0 C--N 1.287 -2.138 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.223 -179.711 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.5 Cg_endo -74.81 138.4 23.46 Favored 'Trans proline' 0 C--N 1.298 -2.093 0 O-C-N 124.296 1.682 . . . . 0.0 110.19 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.68 -31.88 7.0 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.531 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -108.45 174.09 6.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.037 -1.272 . . . . 0.0 110.669 -179.917 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 178.99 130.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.487 -0.758 . . . . 0.0 110.081 179.827 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.079 HD12 ' CD2' ' A' ' 26' ' ' TYR . 40.1 mt -83.74 82.5 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 110.118 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -13.83 10.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.522 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.766 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.09 -19.6 7.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 0.0 110.525 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.957 HD22 ' HG3' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -106.21 -23.07 12.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.086 -1.009 . . . . 0.0 109.674 179.834 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -58.87 -54.74 43.75 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.426 -0.796 . . . . 0.0 110.442 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -73.9 -21.9 78.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.688 HD23 HD11 ' A' ' 13' ' ' LEU . 6.8 tp -42.71 -27.15 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -1.145 . . . . 0.0 110.363 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.516 HG13 ' CE1' ' A' ' 18' ' ' TYR . 40.0 mt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.549 ' HB3' ' CB ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.197 0.522 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.7 ' HD2' HD22 ' A' ' 9' ' ' LEU . 10.8 mmpt? -71.17 119.15 14.89 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.258 -0.901 . . . . 0.0 110.473 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.596 ' O ' ' N ' ' A' ' 5' ' ' TYR . 6.1 t -37.33 -32.67 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.173 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.94 ' O ' HG23 ' A' ' 7' ' ' VAL 0.273 . . -63.01 64.31 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.66 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.14 ' CE2' HG21 ' A' ' 7' ' ' VAL . 0.5 OUTLIER 32.96 36.16 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 122.667 1.222 . . . . 0.0 108.293 -176.582 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 13.4 t0 61.88 59.78 1.67 Allowed 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.072 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.14 HG21 ' CE2' ' A' ' 5' ' ' TYR . 15.5 t -128.57 -113.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -0.827 . . . . 0.0 111.505 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.059 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.3 mt -69.57 157.62 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 110.83 -178.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.7 HD22 ' HD2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -152.13 -93.23 0.05 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 110.723 179.836 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -91.81 141.63 25.75 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.088 -1.008 . . . . 0.0 110.909 -179.455 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.2 Cg_endo -77.16 173.49 14.3 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.207 1.635 . . . . 0.0 110.821 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.978 HG12 ' NE1' ' A' ' 29' ' ' TRP . 1.2 m -115.21 127.4 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.339 -0.85 . . . . 0.0 110.032 179.841 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.802 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.0 mm? -103.08 113.27 26.62 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 110.351 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.7 m -158.15 161.54 37.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.133 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -58.03 -55.26 37.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -54.66 -21.61 11.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.45 -52.03 3.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.802 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -49.5 -34.99 18.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.925 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.41 -8.63 50.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.38 -42.8 1.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -66.31 -17.05 64.53 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.56 -0.964 . . . . 0.0 108.91 178.879 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.72 -20.13 46.15 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.747 -0.596 . . . . 0.0 110.658 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.468 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 3.2 tt0 -88.54 17.71 5.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.458 -0.776 . . . . 0.0 110.123 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.09 4.12 69.26 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -178.582 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 48.2 mttm -82.76 134.96 35.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.591 -0.947 . . . . 0.0 109.445 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 1.032 ' CD2' HD12 ' A' ' 89' ' ' ILE . 24.6 m-85 -128.21 98.03 4.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.562 -1.336 . . . . 0.0 111.537 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.4 m -75.02 132.89 41.66 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.638 -0.664 . . . . 0.0 109.915 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.67 ' CB ' HG23 ' A' ' 8' ' ' ILE . 34.8 m-85 -126.72 163.72 22.9 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.244 -179.651 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.978 ' NE1' HG12 ' A' ' 12' ' ' VAL . 95.8 m95 -95.11 122.61 37.96 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.117 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.628 HG23 ' C ' ' A' ' 7' ' ' VAL . 2.7 p -149.02 164.38 4.23 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 C-N-CA 117.649 -1.62 . . . . 0.0 112.224 -176.634 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.453 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -56.75 140.78 75.09 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.281 -179.905 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 48.9 Cg_endo -74.83 80.02 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.199 1.631 . . . . 0.0 110.262 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 178.47 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 110.112 -179.133 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -54.36 97.03 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.406 -0.809 . . . . 0.0 110.282 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.475 ' OG1' ' CG ' ' A' ' 38' ' ' GLU . 2.2 p -42.82 149.52 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 110.168 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.631 ' O ' HG11 ' A' ' 54' ' ' VAL . 5.7 mmtp -42.61 -40.72 2.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.183 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 3.5 m -75.12 -39.07 60.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.31 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.475 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 7.8 mt-10 -55.68 -44.25 77.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 109.808 179.825 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.685 ' O ' HD11 ' A' ' 8' ' ' ILE . 14.5 mt -57.24 -30.32 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.618 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.672 ' HG3' HG11 ' A' ' 51' ' ' VAL . 24.2 tttt -57.82 -42.98 85.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 0.0 111.258 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.423 ' HB2' ' OH ' ' A' ' 5' ' ' TYR . 42.6 m-80 -58.19 -49.11 78.2 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.404 -0.81 . . . . 0.0 112.428 -178.212 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.059 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -68.47 -47.98 65.71 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.711 -1.243 . . . . 0.0 111.759 -178.357 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.034 HG11 HG11 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -59.78 -47.09 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.908 -1.12 . . . . 0.0 110.013 -179.431 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.503 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -56.82 -43.38 80.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.095 -1.003 . . . . 0.0 109.831 179.897 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -79.14 -27.39 42.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 109.97 179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.42 -61.64 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.074 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.842 ' CD2' HG22 ' A' ' 43' ' ' VAL . 52.1 m-85 -71.8 -20.88 61.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.961 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 62.86 39.92 10.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.458 -0.776 . . . . 0.0 110.104 179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.771 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -119.32 -164.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.807 179.705 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.771 ' N ' HG13 ' A' ' 49' ' ' VAL . 5.4 tmtm? -113.42 106.6 14.78 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.443 -0.786 . . . . 0.0 109.364 179.021 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.799 HG22 ' CG1' ' A' ' 81' ' ' VAL . 44.7 t -78.22 130.72 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 110.145 -179.397 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.665 HG12 ' C ' ' A' ' 82' ' ' GLN . 13.3 p -114.96 -9.77 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.409 -0.807 . . . . 0.0 110.271 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.615 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 176.75 129.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 109.932 179.696 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.1 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.6 OUTLIER -109.15 141.56 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.104 179.847 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.56 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.6 m-20 -130.04 115.52 17.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.285 -0.884 . . . . 0.0 109.561 178.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -108.85 159.82 16.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.916 -179.459 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.903 HD11 ' HE3' ' A' ' 78' ' ' LYS . 1.8 pp -148.47 177.88 9.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.211 -0.931 . . . . 0.0 110.853 -179.37 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.83 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -74.95 134.53 41.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.967 179.642 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -120.7 122.12 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.902 . . . . 0.0 109.358 179.677 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.508 ' O ' ' NH2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -37.68 105.31 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.433 0.635 . . . . 0.0 110.81 -179.141 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.527 ' HA3' ' NE ' ' A' ' 76' ' ' ARG . . . 150.4 108.56 0.44 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 74' ' ' PRO . 16.9 pttt -118.94 -162.44 0.9 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -1.11 . . . . 0.0 110.201 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -72.74 -160.84 0.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt 61.08 62.62 1.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 66' ' ' LEU . 17.8 ptt180 -111.35 -6.52 14.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.877 . . . . 0.0 110.348 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 68' ' ' ARG . 6.0 mp -42.08 114.28 0.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 110.111 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.77 57.1 0.21 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.537 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 66' ' ' LEU . 9.6 ptt85 -140.14 23.65 2.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.25 . . . . 0.0 110.08 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.559 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 57.4 t80 -161.69 52.3 0.24 Allowed 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.039 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 41.36 39.18 0.95 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -0.841 . . . . 0.0 110.156 -179.905 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 72' ' ' LYS . . . -125.06 165.64 18.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 71' ' ' GLY . 10.4 ptpt 179.33 58.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -1.159 . . . . 0.0 110.331 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -144.18 115.1 5.41 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.241 179.905 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 61' ' ' GLY . 51.5 Cg_endo -80.67 -164.85 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.014 1.534 . . . . 0.0 110.591 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 1.9 t70 -114.66 90.34 3.32 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.446 -0.784 . . . . 0.0 108.886 179.241 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -96.03 153.72 17.63 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.603 -0.686 . . . . 0.0 110.266 -179.604 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.562 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 6.3 tttp -123.78 142.2 51.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.903 ' HE3' HD11 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -100.59 138.39 37.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.073 . . . . 0.0 109.792 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -133.22 119.36 19.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.097 -1.002 . . . . 0.0 111.836 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.626 HG12 HG23 ' A' ' 27' ' ' THR . 16.7 mt -99.9 109.91 25.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.857 178.327 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.1 HG22 ' CG2' ' A' ' 54' ' ' VAL . 52.8 t -96.73 129.46 46.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 110.02 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.665 ' C ' HG12 ' A' ' 52' ' ' VAL . 2.5 tp60 -98.86 153.2 18.97 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.013 179.358 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 1.5 m -119.66 156.6 22.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 C-N-CA 118.327 -1.349 . . . . 0.0 108.632 177.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.907 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -69.84 179.29 0.81 Allowed Pre-proline 0 C--N 1.283 -2.309 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.133 -179.71 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.907 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.06 140.76 31.76 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 124.263 1.665 . . . . 0.0 110.432 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.45 -37.1 3.95 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.887 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -104.31 176.8 5.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.125 -1.221 . . . . 0.0 110.643 -179.897 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.55 115.04 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.488 -0.757 . . . . 0.0 110.001 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.032 HD12 ' CD2' ' A' ' 26' ' ' TYR . 14.1 mt -60.94 109.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.23 -0.919 . . . . 0.0 110.464 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 17.8 pt-20 -78.12 -14.33 59.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.318 -0.863 . . . . 0.0 110.745 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.705 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.15 -28.67 54.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.0 110.373 -179.638 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.764 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.02 -23.13 12.71 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.165 -0.959 . . . . 0.0 109.467 179.788 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 25.3 mm-40 -54.53 -24.42 20.66 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.43 -0.794 . . . . 0.0 110.165 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.63 -36.35 4.85 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.433 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 3.5 mp -49.32 -31.94 10.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.375 -1.073 . . . . 0.0 110.114 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.783 HG22 ' CD1' ' A' ' 18' ' ' TYR . 46.4 pt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.181 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 1.7 ptt? . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.921 0.391 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -99.43 34.07 2.3 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.801 178.687 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 5' ' ' TYR . 12.1 t -35.51 -34.51 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 177.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.973 ' O ' HG23 ' A' ' 7' ' ' VAL 0.268 . . -54.11 74.84 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.769 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.042 ' CE2' HG21 ' A' ' 7' ' ' VAL . 0.3 OUTLIER 34.52 35.73 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.674 1.226 . . . . 0.0 108.058 -176.179 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.65 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 6.0 t0 62.35 62.91 1.1 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.904 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.042 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.4 t -132.17 -79.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -0.853 . . . . 0.0 110.573 179.053 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.048 HD11 HG23 ' A' ' 39' ' ' ILE . 14.7 mm -87.04 102.8 12.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 121.371 -0.83 . . . . 0.0 110.466 -178.564 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.607 ' H ' HD12 ' A' ' 9' ' ' LEU . 4.5 mp -62.51 -107.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 110.431 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.539 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -108.64 164.22 15.22 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.961 -1.087 . . . . 0.0 110.257 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 45.9 Cg_endo -73.31 153.5 50.79 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.982 1.517 . . . . 0.0 110.176 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.749 HG12 ' O ' ' A' ' 27' ' ' THR . 1.4 p -112.96 114.64 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.939 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.84 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.5 mm? -101.49 112.5 25.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 110.345 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.526 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -158.31 154.95 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.951 -179.981 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.0 mm-40 -43.08 -58.07 2.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 110.038 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 22.4 ttmt -54.72 -19.17 5.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.526 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -99.84 -54.58 2.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 110.065 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.567 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 3.1 m-85 -53.82 -50.86 65.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.968 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -12.7 37.93 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.224 -0.922 . . . . 0.0 109.14 179.204 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' N ' ' A' ' 22' ' ' ALA . . . -94.46 -40.47 4.46 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 178.384 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 3.4 m-30 -51.44 -24.67 5.24 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.601 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 20' ' ' GLY . . . -43.27 -36.3 1.76 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.467 0.651 . . . . 0.0 110.25 -179.718 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.449 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 2.2 tt0 -95.9 16.48 17.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.412 -0.805 . . . . 0.0 110.515 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 80.64 6.74 89.17 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HG2' ' HG3' ' A' ' 82' ' ' GLN . 49.9 mttt -82.17 132.62 35.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.241 -1.152 . . . . 0.0 109.755 179.812 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.861 ' CD2' HD12 ' A' ' 89' ' ' ILE . 70.7 m-85 -126.46 111.84 14.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.775 -1.203 . . . . 0.0 111.988 -178.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.749 ' O ' HG12 ' A' ' 12' ' ' VAL . 36.8 m -75.73 141.97 42.53 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.606 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.896 ' CD1' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -141.11 164.72 29.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 -179.221 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.6 ' CE3' ' HG2' ' A' ' 76' ' ' ARG . 79.6 m95 -93.5 122.4 35.89 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.166 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 7' ' ' VAL . 7.6 p -137.05 164.64 29.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.68 -178.101 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.431 ' HB3' ' CG ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.14 150.03 97.9 Favored Pre-proline 0 C--N 1.294 -1.835 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.343 -179.839 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.54 67.3 3.7 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 O-C-N 124.222 1.643 . . . . 0.0 109.769 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 179.35 -32.38 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.455 -0.778 . . . . 0.0 109.828 -178.886 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.619 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -49.54 101.06 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.368 -0.833 . . . . 0.0 110.218 -179.765 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.468 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -49.8 141.5 10.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.348 -179.974 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.539 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -43.84 -36.06 2.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 110.209 179.846 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.0 m -75.11 -49.04 20.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.477 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 1.6 mm-40 -54.79 -42.29 71.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 0.0 109.859 -179.74 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.048 HG23 HD11 ' A' ' 8' ' ' ILE . 21.3 mt -57.54 -30.69 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.9 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.737 ' HG3' HG11 ' A' ' 51' ' ' VAL . 7.8 tttt -60.94 -44.04 97.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.469 -0.77 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -58.43 -34.35 70.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.767 . . . . 0.0 111.927 -178.636 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.957 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -72.97 -50.4 23.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.594 -1.316 . . . . 0.0 111.754 -178.66 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.08 HG21 HG11 ' A' ' 81' ' ' VAL . 27.7 m -66.53 -31.35 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.578 -1.326 . . . . 0.0 110.557 -179.586 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.781 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.02 -52.93 61.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.057 -1.027 . . . . 0.0 109.97 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -80.18 -24.49 40.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 110.28 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -84.97 -56.38 3.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 0.0 110.812 -179.467 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.843 ' CE2' HG12 ' A' ' 43' ' ' VAL . 8.1 m-30 -71.72 -16.21 62.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.064 -1.022 . . . . 0.0 110.238 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 66.0 46.52 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.473 -0.767 . . . . 0.0 110.724 179.585 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.799 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -136.54 -164.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.365 -0.835 . . . . 0.0 110.253 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.799 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -114.52 105.13 12.73 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.422 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.798 HG21 HG23 ' A' ' 43' ' ' VAL . 57.9 t -77.71 119.19 25.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 110.33 -179.029 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.612 HG12 ' C ' ' A' ' 82' ' ' GLN . 7.3 p -96.2 -20.64 5.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.547 -0.721 . . . . 0.0 109.619 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.581 ' HG3' ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -167.9 146.17 4.53 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.428 -0.795 . . . . 0.0 109.942 179.865 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.874 HG23 HG13 ' A' ' 81' ' ' VAL . 1.2 t -132.14 116.78 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.684 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.523 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -114.1 115.1 27.0 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.0 -1.062 . . . . 0.0 109.614 179.17 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.678 HG21 HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -110.75 141.44 44.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.345 -0.847 . . . . 0.0 110.248 -179.249 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.06 148.61 49.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 109.944 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.94 126.56 30.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 110.403 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.556 HG21 ' CE ' ' A' ' 78' ' ' LYS . 1.6 m -120.29 138.14 51.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.585 -0.697 . . . . 0.0 110.168 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.519 ' CB ' ' HG2' ' A' ' 73' ' ' ARG . 11.2 mmt85 -104.99 109.05 20.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 110.298 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.25 178.91 36.52 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.55 179.67 1.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -1.151 . . . . 0.0 110.242 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -58.7 159.34 6.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.234 -0.916 . . . . 0.0 110.169 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mttt 57.26 46.19 19.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 110.21 -180.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 67' ' ' GLY . 2.4 mtm180 -158.69 20.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.5 mm? -58.87 78.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.321 -0.862 . . . . 0.0 110.266 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' ARG . . . 50.82 44.06 48.57 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.74 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.542 ' O ' ' C ' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -124.56 20.3 8.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.407 -1.055 . . . . 0.0 109.153 179.671 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER 19.62 77.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.344 179.662 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 tp -140.42 40.39 1.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 110.162 -179.702 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.2 -103.28 0.17 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.21 175.93 2.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -1.134 . . . . 0.0 110.16 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.519 ' HG2' ' CB ' ' A' ' 60' ' ' ARG . 2.2 mtp180 -118.97 94.46 48.2 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 110.232 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.5 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 47.9 Cg_endo -73.58 -164.55 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.094 1.576 . . . . 0.0 110.355 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -114.21 89.6 3.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.457 -0.777 . . . . 0.0 109.328 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.6 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -100.85 153.24 19.65 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.67 -0.643 . . . . 0.0 110.181 -179.977 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.527 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 81.2 tttt -106.62 136.87 45.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.577 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.613 ' HG3' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.67 151.09 30.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.485 179.555 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -125.56 120.13 30.03 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.027 -1.045 . . . . 0.0 112.867 -179.169 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 10.2 mt -96.68 110.52 24.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.237 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.08 HG11 HG21 ' A' ' 43' ' ' VAL . 2.2 t -101.3 130.94 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 110.369 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.612 ' C ' HG12 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -112.55 153.63 27.21 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.023 -1.048 . . . . 0.0 109.639 179.346 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 1.9 m -115.41 157.21 16.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.065 177.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.937 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -61.93 174.81 0.62 Allowed Pre-proline 0 C--N 1.29 -2.019 0 O-C-N 121.238 -0.914 . . . . 0.0 110.827 -179.527 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.5 Cg_endo -76.73 58.13 5.86 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.465 1.771 . . . . 0.0 110.57 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.19 -33.79 0.02 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.937 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -112.38 -179.94 3.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.119 -1.224 . . . . 0.0 110.457 -179.779 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HA ' HG21 ' A' ' 83' ' ' VAL . 4.2 ptpt -170.73 125.54 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.861 HD12 ' CD2' ' A' ' 26' ' ' TYR . 59.8 mt -68.43 98.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.152 -0.968 . . . . 0.0 110.161 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 1.9 mt-10 -70.65 -13.52 62.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.415 -0.803 . . . . 0.0 110.81 -179.587 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.722 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.48 -28.88 47.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.067 -1.02 . . . . 0.0 110.407 -179.376 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.85 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.19 -22.55 12.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.162 -0.961 . . . . 0.0 109.402 179.605 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.624 ' O ' HD12 ' A' ' 96' ' ' ILE . 13.2 mm-40 -56.53 -54.09 49.92 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.494 -0.753 . . . . 0.0 110.33 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.65 -14.71 79.6 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.581 HD23 HD21 ' A' ' 13' ' ' LEU . 2.2 tp -67.92 -7.71 30.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.134 -1.216 . . . . 0.0 110.132 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 93' ' ' GLU . 45.4 mt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.205 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.624 ' CG ' ' HB2' ' A' ' 6' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.916 ' HA ' HD21 ' A' ' 9' ' ' LEU . 10.9 mttm -43.45 98.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.774 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.4 m 4.52 -70.97 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.716 0 CA-C-O 121.556 0.693 . . . . 0.0 110.571 -177.868 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.034 ' O ' HG23 ' A' ' 7' ' ' VAL 0.281 . . -55.72 80.02 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.772 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.109 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.9 p90 24.62 45.59 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 121.862 0.839 . . . . 0.0 110.496 -178.669 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.658 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 2.2 t70 65.29 54.34 1.2 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.012 0.91 . . . . 0.0 111.56 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.109 HG21 ' CE2' ' A' ' 5' ' ' TYR . 2.1 t -135.96 -73.88 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.785 -1.197 . . . . 0.0 110.839 178.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.675 ' CD1' HG23 ' A' ' 39' ' ' ILE . 5.6 mm -102.83 121.64 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 110.589 -178.484 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 2' ' ' LYS . 20.0 mt -96.41 -107.19 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.507 -0.746 . . . . 0.0 109.867 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.79 158.02 36.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.066 -1.021 . . . . 0.0 110.127 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.685 ' HG3' HD22 ' A' ' 92' ' ' LEU . 46.9 Cg_endo -73.62 140.16 29.19 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.915 1.481 . . . . 0.0 109.65 179.38 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.676 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.6 m -85.39 132.21 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.015 -1.053 . . . . 0.0 110.172 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.848 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 2.8 mm? -102.77 112.73 25.66 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.168 -0.958 . . . . 0.0 110.119 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' ALA . 3.1 m -163.54 148.62 11.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 110.045 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 14' ' ' SER . 58.7 mt-10 -42.88 -53.67 4.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 110.004 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -54.9 -21.98 13.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.19 -0.944 . . . . 0.0 110.116 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -100.31 -57.28 2.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 110.272 -179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.848 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -47.03 -34.7 5.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.938 . . . . 0.0 110.303 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.07 -8.88 50.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.994 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -103.61 -34.01 3.97 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -80.24 -18.95 48.01 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.702 -0.881 . . . . 0.0 108.95 179.164 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -55.21 -21.73 14.98 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.416 0.627 . . . . 0.0 110.732 -179.522 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.99 17.08 6.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.533 ' HA2' ' CE ' ' A' ' 88' ' ' LYS . . . 93.17 0.69 67.67 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.233 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 62.4 mttt -82.43 142.23 32.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.479 -1.012 . . . . 0.0 109.293 179.628 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.722 ' CD1' HD12 ' A' ' 92' ' ' LEU . 26.7 m-85 -128.79 111.02 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.662 -1.274 . . . . 0.0 111.511 -179.267 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.8 HG23 HD11 ' A' ' 80' ' ' ILE . 26.7 m -82.78 125.29 31.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.612 0.72 . . . . 0.0 110.151 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.983 ' CE2' HG11 ' A' ' 43' ' ' VAL . 22.0 m-30 -119.3 165.53 14.16 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.706 -0.621 . . . . 0.0 109.662 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.676 ' CD1' HG12 ' A' ' 12' ' ' VAL . 1.9 m95 -103.02 122.84 45.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.062 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.5 p -149.01 164.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.571 -1.251 . . . . 0.0 111.596 -176.814 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -62.69 151.4 84.36 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.896 -0.503 . . . . 0.0 110.659 -179.346 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.537 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 46.7 Cg_endo -73.81 70.1 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.236 1.651 . . . . 0.0 109.906 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.24 -33.75 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 110.324 -178.988 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . . . -41.75 98.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 110.179 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -41.33 138.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 0.0 110.322 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.527 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 1.4 mttt -42.56 -35.89 1.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.9 m -75.04 -36.07 61.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 110.019 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.459 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -55.91 -46.21 78.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.998 179.807 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.703 ' O ' HG22 ' A' ' 43' ' ' VAL . 6.2 mt -57.31 -30.24 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.542 179.585 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.534 ' HG3' HG11 ' A' ' 51' ' ' VAL . 12.5 tttm -62.99 -47.55 82.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.628 -0.67 . . . . 0.0 111.324 -179.433 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.62 -34.65 78.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.311 -0.868 . . . . 0.0 111.76 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.904 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -72.86 -49.49 29.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.981 -1.075 . . . . 0.0 111.705 -178.622 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.983 HG11 ' CE2' ' A' ' 28' ' ' PHE . 26.7 m -71.21 -28.5 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.683 -1.26 . . . . 0.0 110.765 -179.301 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.53 -51.66 67.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.8 -1.188 . . . . 0.0 109.22 179.542 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -79.41 -45.09 20.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.83 . . . . 0.0 109.728 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -61.17 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.46 -0.775 . . . . 0.0 110.531 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CD1' ' CG2' ' A' ' 89' ' ' ILE . 24.5 m-85 -71.69 -21.09 61.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.026 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.8 mttt 63.76 47.4 3.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.858 . . . . 0.0 110.556 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.769 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -130.33 -162.84 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.514 -0.741 . . . . 0.0 110.017 179.967 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.769 ' N ' HG13 ' A' ' 49' ' ' VAL . 2.2 tmtt? -118.1 107.43 13.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.423 -0.798 . . . . 0.0 109.839 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.663 HG22 HG11 ' A' ' 81' ' ' VAL . 49.2 t -78.6 119.84 28.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.216 -0.927 . . . . 0.0 110.166 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.5 p -112.59 4.96 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.893 . . . . 0.0 110.035 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER 171.88 120.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.222 179.902 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.086 HG23 HG13 ' A' ' 81' ' ' VAL . 1.2 t -115.87 136.27 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 0.0 110.125 179.664 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.527 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 1.1 t-20 -131.26 116.51 17.72 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.468 -0.77 . . . . 0.0 109.482 179.154 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -113.75 166.3 11.69 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.07 -1.019 . . . . 0.0 109.871 -179.724 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.717 ' C ' HD12 ' A' ' 57' ' ' LEU . 2.8 pp -152.63 146.29 25.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.918 . . . . 0.0 110.64 -179.027 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.605 ' CD2' ' NE ' ' A' ' 60' ' ' ARG . 1.3 t-160 -81.75 122.13 27.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.05 -1.032 . . . . 0.0 109.759 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.731 HG13 ' CG ' ' A' ' 76' ' ' ARG . 1.2 p -121.35 135.75 60.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.818 -0.551 . . . . 0.0 110.437 -178.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.605 ' NE ' ' CD2' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -173.53 146.28 1.32 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 110.686 -179.329 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 74' ' ' PRO . . . 145.44 112.51 0.78 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.545 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.08 157.83 42.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -1.137 . . . . 0.0 110.179 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -46.87 -73.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.316 -179.983 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' LYS . 12.2 mtmt -41.52 138.99 1.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 110.463 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 66' ' ' LEU . 16.0 mmm-85 -138.98 -59.49 0.59 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.6 mp 42.7 91.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 110.149 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.18 54.72 1.09 Allowed Glycine 0 N--CA 1.485 1.907 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -179.723 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.49 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -138.69 26.69 2.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -1.225 . . . . 0.0 109.844 179.917 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.62 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 27.5 t80 -162.53 173.43 14.0 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.019 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.588 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -86.81 44.08 1.14 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.067 179.86 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.62 ' N ' ' CD2' ' A' ' 69' ' ' TYR . . . -92.89 -114.11 2.21 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 21.0 mtpt 59.22 -176.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.109 . . . . 0.0 110.008 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 60' ' ' ARG . 46.2 mtt180 -43.06 110.71 0.93 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.909 . . . . 0.0 109.878 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 60' ' ' ARG . 49.1 Cg_endo -70.8 -169.18 0.36 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.011 1.532 . . . . 0.0 110.78 -179.604 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.586 ' HA ' ' NE2' ' A' ' 58' ' ' HIS . 0.9 OUTLIER -117.71 89.67 3.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.392 -0.817 . . . . 0.0 109.57 179.324 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.731 ' CG ' HG13 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -123.48 131.0 53.51 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.705 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.622 ' CG ' HG13 ' A' ' 30' ' ' VAL . 7.5 pttt -123.88 131.32 53.56 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.758 -1.214 . . . . 0.0 110.717 -179.013 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 12.5 ptpt -101.7 151.42 22.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.404 -0.81 . . . . 0.0 108.908 179.085 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -116.37 120.1 37.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.773 -1.204 . . . . 0.0 112.712 -178.601 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.8 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -97.07 112.17 28.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.227 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.086 HG13 HG23 ' A' ' 54' ' ' VAL . 6.4 t -109.53 132.25 58.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 111.14 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.69 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -103.52 149.89 24.43 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.395 -0.816 . . . . 0.0 108.84 179.078 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.529 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.3 m -116.11 157.98 16.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.445 -1.302 . . . . 0.0 109.744 179.008 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.915 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -76.36 -178.37 0.92 Allowed Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.048 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.915 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.2 Cg_endo -72.09 135.9 26.03 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 O-C-N 124.087 1.572 . . . . 0.0 109.937 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.79 -50.56 0.76 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.719 ' HB2' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.18 174.58 6.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.166 -1.196 . . . . 0.0 110.53 179.889 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.533 ' CE ' ' HA2' ' A' ' 24' ' ' GLY . 0.3 OUTLIER 178.68 115.72 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.478 -0.763 . . . . 0.0 110.315 -179.855 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' CD2' ' A' ' 26' ' ' TYR . 7.5 mt -68.26 63.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.886 -1.134 . . . . 0.0 109.48 179.347 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 88' ' ' LYS . 2.4 mm-40 -54.3 -12.83 0.72 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.64 -0.663 . . . . 0.0 111.72 -179.558 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.917 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -53.42 -16.03 1.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.882 -1.136 . . . . 0.0 110.968 -179.058 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.754 HD23 ' N ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -101.76 -23.04 14.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.862 -1.149 . . . . 0.0 109.514 179.43 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -54.19 -29.0 44.34 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.458 -0.776 . . . . 0.0 110.396 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -96.91 -24.64 12.71 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.917 HD13 ' O ' ' A' ' 91' ' ' ALA . 3.5 mp -42.42 -28.9 0.24 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -1.144 . . . . 0.0 110.182 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.556 HG12 ' CE1' ' A' ' 18' ' ' TYR . 72.8 mt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.04 HG13 ' HB1' ' A' ' 34' ' ' ALA . 66.3 t . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.875 0.369 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.026 HG13 HG12 ' A' ' 7' ' ' VAL . 29.0 mt -84.99 104.44 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.657 -1.277 . . . . 0.0 110.749 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.2 mt -75.42 -93.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.761 . . . . 0.0 110.987 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.33 157.77 34.18 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.122 -0.986 . . . . 0.0 110.92 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 48.8 Cg_endo -77.01 160.95 33.24 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.149 1.605 . . . . 0.0 110.415 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 27' ' ' THR . 1.2 p -115.31 116.56 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 109.831 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.836 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.4 mm? -98.85 112.06 24.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.401 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.637 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -155.36 157.42 37.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.048 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 5.5 tm-20 -43.52 -61.24 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 110.069 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.74 -17.68 3.76 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.31 -0.869 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.637 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -99.4 -52.16 3.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 109.995 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.605 ' CE1' ' CG1' ' A' ' 96' ' ' ILE . 2.1 m-85 -56.47 -58.1 9.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.157 -0.964 . . . . 0.0 109.931 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.66 -12.82 37.18 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.272 -0.892 . . . . 0.0 109.186 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 21' ' ' PHE . . . -86.31 -47.19 5.02 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 7.7 m-30 -47.88 -28.42 2.63 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -38.31 -38.26 0.35 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.399 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.15 -17.88 23.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.359 -0.838 . . . . 0.0 110.44 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 118.05 4.52 14.32 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 1.7 mmtm -81.69 135.72 35.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -1.123 . . . . 0.0 109.505 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.69 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.1 m-85 -127.15 111.16 13.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.017 -1.052 . . . . 0.0 112.167 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.778 HG23 HD11 ' A' ' 80' ' ' ILE . 24.9 m -77.99 140.05 39.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.935 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -137.5 164.33 28.97 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.066 -1.021 . . . . 0.0 111.349 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.507 ' CZ3' HG21 ' A' ' 59' ' ' VAL . 70.7 m95 -99.31 122.59 42.67 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.934 HG23 ' C ' ' A' ' 7' ' ' VAL . 2.6 p -144.02 156.71 15.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.787 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -62.36 151.73 81.58 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.778 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.9 Cg_endo -73.41 71.12 3.87 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.183 1.622 . . . . 0.0 110.047 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.57 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.3 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 1.04 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -44.27 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.94 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -42.67 144.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 110.338 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -42.53 -52.86 4.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 109.909 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.8 m -62.37 -36.51 82.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.475 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.2 OUTLIER -56.47 -44.14 80.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.184 -0.947 . . . . 0.0 109.569 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.978 HG23 HD11 ' A' ' 8' ' ' ILE . 1.7 mt -57.61 -32.56 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.315 -0.865 . . . . 0.0 108.805 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG3' HG11 ' A' ' 51' ' ' VAL . 6.4 ttmm -59.25 -45.81 90.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.851 . . . . 0.0 109.621 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 1.024 ' O ' HG23 ' A' ' 45' ' ' THR . 2.8 m-80 -71.83 -34.0 68.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.645 -0.659 . . . . 0.0 111.146 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.903 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.51 -50.16 73.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.176 . . . . 0.0 110.501 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.123 HG12 ' CE2' ' A' ' 47' ' ' PHE . 3.3 m -76.25 -34.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.879 -1.138 . . . . 0.0 110.641 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -60.95 -29.84 69.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.031 -1.043 . . . . 0.0 110.374 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 1.024 HG23 ' O ' ' A' ' 41' ' ' ASN . 34.4 p -78.52 -46.47 19.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.51 -55.03 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 110.72 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 1.123 ' CE2' HG12 ' A' ' 43' ' ' VAL . 6.6 m-30 -71.54 -14.72 62.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.065 -1.022 . . . . 0.0 110.141 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 16.0 mttm 42.48 47.03 4.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.147 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.777 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.88 -163.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.569 -0.707 . . . . 0.0 110.008 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.777 ' N ' HG13 ' A' ' 49' ' ' VAL . 1.2 tmtp? -118.08 110.27 17.43 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.431 -0.793 . . . . 0.0 109.709 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.554 HG11 ' HG3' ' A' ' 40' ' ' LYS . 30.0 t -78.63 119.72 28.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.359 -0.838 . . . . 0.0 110.043 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.79 HG12 ' O ' ' A' ' 82' ' ' GLN . 10.9 p -110.0 7.02 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.309 -0.87 . . . . 0.0 110.025 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER 169.68 119.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 109.987 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.98 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -121.12 120.83 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.115 -0.99 . . . . 0.0 110.072 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.49 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -121.63 115.95 23.69 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.23 178.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.54 HG21 HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -116.35 150.62 37.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.147 -0.97 . . . . 0.0 110.588 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.718 HD21 ' HE2' ' A' ' 78' ' ' LYS . 1.2 pp -141.5 154.88 45.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 109.79 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -67.43 134.04 50.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.42 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.507 HG21 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.367 -0.833 . . . . 0.0 110.092 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.156 0.503 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HG2' HG13 ' A' ' 30' ' ' VAL . 12.8 tttt -123.59 140.92 52.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -0.945 . . . . 0.0 110.648 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.718 ' HE2' HD21 ' A' ' 57' ' ' LEU . 2.1 ttpt -107.97 150.55 26.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.333 -0.855 . . . . 0.0 109.623 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.67 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -133.18 121.79 23.06 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.056 -1.027 . . . . 0.0 112.495 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.778 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -101.62 111.95 33.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.98 HG13 HG23 ' A' ' 54' ' ' VAL . 3.8 t -107.46 131.24 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.435 -0.791 . . . . 0.0 110.454 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.79 ' O ' HG12 ' A' ' 52' ' ' VAL . 2.3 tp60 -111.38 146.63 36.8 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.923 -1.111 . . . . 0.0 108.952 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 87' ' ' GLN . 1.5 m -114.52 156.08 15.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.654 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.942 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -57.34 178.79 0.15 Allowed Pre-proline 0 C--N 1.29 -1.981 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.525 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.942 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.5 Cg_endo -72.7 145.16 40.82 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 O-C-N 124.149 1.605 . . . . 0.0 110.572 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.84 -18.38 47.62 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.54 ' HB2' HG23 ' A' ' 83' ' ' VAL . 57.7 mt-30 -94.59 171.58 8.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 110.557 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 3.1 pttt 179.68 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.823 . . . . 0.0 110.303 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.69 HD12 ' CD2' ' A' ' 26' ' ' TYR . 7.5 mt -63.08 118.62 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.95 . . . . 0.0 110.085 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -76.59 -14.74 59.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -0.826 . . . . 0.0 110.678 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.742 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -56.23 -34.67 66.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 110.946 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.23 -23.5 12.56 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.985 -1.072 . . . . 0.0 110.149 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.683 ' O ' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -65.67 -43.24 89.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.259 -0.901 . . . . 0.0 110.289 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.3 8.27 75.31 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.786 HD23 HD21 ' A' ' 13' ' ' LEU . 2.3 tp -88.58 24.87 1.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -1.155 . . . . 0.0 110.245 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 93' ' ' GLU . 6.9 mt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.248 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.993 HG13 ' HB1' ' A' ' 34' ' ' ALA . 39.0 t . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 122.128 0.966 . . . . 0.0 109.281 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.932 HD11 HG23 ' A' ' 39' ' ' ILE . 8.7 mt -115.05 95.48 3.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.487 -0.758 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.6 mt -79.04 -97.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.553 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -108.16 167.28 9.51 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.076 -1.015 . . . . 0.0 110.497 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.716 ' HB3' HD13 ' A' ' 92' ' ' LEU . 46.7 Cg_endo -73.68 171.11 18.47 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.14 1.6 . . . . 0.0 110.529 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.706 HG12 ' CD1' ' A' ' 29' ' ' TRP . 3.0 m -115.36 144.32 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.411 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.3 mm? -102.65 107.49 18.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.212 -0.93 . . . . 0.0 110.328 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 17' ' ' ALA . 5.5 m -164.9 134.79 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.868 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' SER . 7.2 mt-10 -42.88 -59.34 2.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.117 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 -17.44 6.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.958 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.16 17.24 17.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.887 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.721 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 2.2 m-85 -139.18 -38.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.388 -0.82 . . . . 0.0 109.933 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.35 80.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.05 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 25' ' ' LYS . . . -95.52 -34.95 5.84 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.09 -17.73 64.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -70.5 -17.05 62.96 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.725 -0.61 . . . . 0.0 110.654 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -88.7 16.37 6.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 110.341 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 102.07 -2.06 51.33 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.48 136.45 34.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.514 -0.992 . . . . 0.0 109.534 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.758 ' HD1' HD12 ' A' ' 92' ' ' LEU . 99.5 m-85 -126.69 116.01 20.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 0.0 111.626 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.093 HG23 HD11 ' A' ' 80' ' ' ILE . 3.7 m -83.26 141.29 31.97 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.83 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 26.5 m-85 -134.06 164.37 27.47 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.33 -0.856 . . . . 0.0 110.933 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.706 ' CD1' HG12 ' A' ' 12' ' ' VAL . 19.6 m95 -97.01 122.35 39.91 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 7' ' ' VAL . 11.6 p -138.69 164.91 25.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.059 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.602 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 1.6 t60 -81.13 152.85 71.66 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.304 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 44.5 Cg_endo -70.89 65.7 2.46 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.06 1.558 . . . . 0.0 109.727 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.73 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.665 -179.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.993 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -42.42 95.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.44 -0.787 . . . . 0.0 109.602 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -39.39 134.27 1.23 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.382 -0.824 . . . . 0.0 110.894 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.651 ' HA ' HD12 ' A' ' 39' ' ' ILE . 1.9 mttt -46.9 -48.02 21.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.83 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.8 m -62.04 -39.53 92.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 0.0 109.424 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 4.7 mt-10 -55.83 -40.9 73.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 108.937 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.932 HG23 HD11 ' A' ' 8' ' ' ILE . 30.6 mt -58.0 -31.03 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.469 -0.77 . . . . 0.0 109.003 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.611 ' O ' HG21 ' A' ' 51' ' ' VAL . 3.8 tttt -59.54 -47.3 86.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.777 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.4 m-80 -72.75 -34.02 66.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.701 -0.624 . . . . 0.0 111.194 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.696 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.0 -50.43 73.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.786 -1.196 . . . . 0.0 110.553 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.785 HG11 ' CE2' ' A' ' 28' ' ' PHE . 3.7 m -67.3 -32.84 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.651 -1.281 . . . . 0.0 109.489 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -69.04 -44.51 72.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 108.812 178.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -79.07 -16.44 56.77 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -104.23 -67.44 0.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.498 -0.751 . . . . 0.0 110.315 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.752 ' HE1' HD21 ' A' ' 92' ' ' LEU . 52.4 m-85 -71.95 -21.91 61.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.0 110.343 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 64.94 46.4 2.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.789 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -123.56 -158.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.512 -0.743 . . . . 0.0 110.136 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.789 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -116.89 110.4 18.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 109.762 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.611 HG21 ' O ' ' A' ' 40' ' ' LYS . 92.3 t -78.73 120.4 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.931 . . . . 0.0 110.321 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 82' ' ' GLN . 10.1 p -112.83 3.85 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.263 -0.898 . . . . 0.0 109.988 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 1.8 mttp 169.12 119.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.055 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.031 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.87 131.39 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.048 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.513 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 13.1 t30 -131.17 115.97 17.07 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.34 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.57 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -116.61 161.36 19.29 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.193 -0.942 . . . . 0.0 109.945 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -156.65 170.83 21.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.383 -0.823 . . . . 0.0 110.188 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -80.76 129.77 34.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 110.219 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.099 HG11 ' CD ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.48 -0.762 . . . . 0.0 110.074 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.62 ' HB3' HG23 ' A' ' 59' ' ' VAL . 4.3 mpt_? . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.226 0.536 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.598 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.4 tttt -120.87 133.69 55.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 1.099 ' CD ' HG11 ' A' ' 59' ' ' VAL . 3.8 mttt -110.23 151.48 27.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.367 -0.833 . . . . 0.0 109.942 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -123.14 119.77 31.25 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.933 -1.104 . . . . 0.0 112.193 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.093 HD11 HG23 ' A' ' 27' ' ' THR . 1.5 mp -102.42 111.88 33.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.031 HG22 ' CG2' ' A' ' 54' ' ' VAL . 24.0 t -111.08 136.09 48.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.486 -0.759 . . . . 0.0 110.433 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.815 ' O ' HG12 ' A' ' 52' ' ' VAL . 1.9 tp60 -111.47 151.32 28.72 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.222 -0.924 . . . . 0.0 108.868 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.583 HG21 ' C ' ' A' ' 87' ' ' GLN . 2.0 m -112.68 155.71 13.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 C-N-CA 118.069 -1.453 . . . . 0.0 109.531 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.971 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -49.16 179.03 0.03 OUTLIER Pre-proline 0 C--N 1.291 -1.936 0 O-C-N 121.543 -0.723 . . . . 0.0 110.482 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.971 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.4 Cg_endo -71.79 140.07 34.76 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.22 1.642 . . . . 0.0 110.492 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.19 -24.58 12.97 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.684 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 87.1 mt-30 -95.82 164.37 12.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -1.148 . . . . 0.0 110.619 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.525 ' N ' HG21 ' A' ' 83' ' ' VAL . 0.0 OUTLIER 179.43 108.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.245 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.591 ' HB ' ' CE1' ' A' ' 26' ' ' TYR . 91.4 mt -51.11 91.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.126 -0.984 . . . . 0.0 109.541 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 4.1 mm-40 -63.01 -13.39 34.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 111.206 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.768 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.65 -33.76 61.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 110.804 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -106.87 -23.67 12.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.952 -1.092 . . . . 0.0 110.507 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -48.95 -30.97 6.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.163 -0.961 . . . . 0.0 110.14 -179.149 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.48 -19.89 11.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.524 ' CD2' ' HG2' ' A' ' 11' ' ' PRO . 26.7 tp -53.13 -19.14 2.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -1.114 . . . . 0.0 110.054 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.638 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 32.4 mt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.131 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.071 HG13 ' HB1' ' A' ' 34' ' ' ALA . 58.2 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 120.991 0.424 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.034 HD11 HG23 ' A' ' 39' ' ' ILE . 24.0 mt -88.28 113.19 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 120.681 -1.262 . . . . 0.0 111.268 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -92.06 -88.22 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.291 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.03 150.85 40.91 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.45 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.487 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.8 Cg_endo -74.32 -178.21 3.8 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.065 1.561 . . . . 0.0 110.177 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.673 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.16 133.33 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.149 -0.969 . . . . 0.0 110.347 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.746 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -103.12 112.83 25.87 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.193 -0.942 . . . . 0.0 110.185 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 17' ' ' ALA . 60.6 m -163.79 128.65 2.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.145 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -42.96 -58.63 2.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.898 . . . . 0.0 110.048 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -17.63 3.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 110.215 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.7 -48.04 5.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 110.149 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.586 ' CE2' HG13 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -52.79 -33.1 47.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 109.772 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.47 -21.6 66.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -100.81 -37.59 3.64 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 105.683 -2.967 . . . . 0.0 105.683 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.612 ' CD1' ' HA ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -64.64 -19.17 65.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' TYR . . . -93.36 4.63 53.66 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.219 0.533 . . . . 0.0 110.629 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -111.87 16.58 20.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.764 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 95.69 -24.82 27.79 Favored Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 39.7 mttm -81.79 140.42 34.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.352 -1.087 . . . . 0.0 109.153 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.905 ' CD2' HD12 ' A' ' 89' ' ' ILE . 35.4 m-85 -126.92 110.18 12.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.803 -1.186 . . . . 0.0 112.234 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.668 HG23 HD11 ' A' ' 80' ' ' ILE . 28.3 m -80.57 118.25 21.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.914 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -116.99 164.97 13.9 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 111.638 -178.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.673 ' CD1' HG12 ' A' ' 12' ' ' VAL . 7.4 m95 -97.81 123.0 41.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.0 p -145.56 157.45 12.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 C-N-CA 118.195 -1.402 . . . . 0.0 111.712 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.602 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -59.21 149.57 67.3 Favored Pre-proline 0 C--N 1.297 -1.679 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.044 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.602 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 47.7 Cg_endo -73.02 71.57 3.47 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.061 1.558 . . . . 0.0 109.808 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.48 -33.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.417 -0.802 . . . . 0.0 109.932 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 1.071 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -42.36 93.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.484 -0.76 . . . . 0.0 109.799 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -42.17 141.68 0.88 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 110.443 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 4.3 mmtp -42.63 -41.13 2.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.372 -0.83 . . . . 0.0 109.778 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 62.1 m -70.97 -35.93 72.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.728 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 5.8 mt-10 -58.54 -42.53 88.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.553 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.034 HG23 HD11 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -57.48 -31.68 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.57 ' HG3' HG11 ' A' ' 51' ' ' VAL . 8.1 tttm -62.97 -46.37 88.02 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.552 -0.717 . . . . 0.0 109.627 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.982 ' O ' HG23 ' A' ' 45' ' ' THR . 38.4 m-80 -72.97 -34.12 66.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.601 -0.687 . . . . 0.0 110.921 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.74 -50.27 73.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.932 -1.105 . . . . 0.0 110.43 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 39' ' ' ILE . 2.7 m -76.64 -36.61 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.869 -1.144 . . . . 0.0 110.654 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -56.92 -32.31 65.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.942 -1.099 . . . . 0.0 110.256 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.982 HG23 ' O ' ' A' ' 41' ' ' ASN . 35.4 p -77.99 -46.01 22.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.234 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.06 -55.61 4.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 0.0 110.735 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.894 ' CD1' HG23 ' A' ' 89' ' ' ILE . 21.0 m-85 -71.67 -21.33 61.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.155 -0.966 . . . . 0.0 110.372 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 51.08 44.52 28.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.778 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -115.29 -162.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.633 -0.667 . . . . 0.0 109.923 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.778 ' N ' HG13 ' A' ' 49' ' ' VAL . 8.0 tmtt? -117.2 108.32 15.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.893 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.57 HG11 ' HG3' ' A' ' 40' ' ' LYS . 33.5 t -78.44 119.64 27.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.242 -0.911 . . . . 0.0 109.769 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 82' ' ' GLN . 3.3 p -107.26 -12.75 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.43 -0.794 . . . . 0.0 110.167 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -173.15 123.4 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.979 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.945 ' CG2' HG13 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -123.63 131.2 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.192 -0.942 . . . . 0.0 110.085 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 2.5 m-20 -131.07 115.82 16.95 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.645 HG21 HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.8 146.04 41.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 58' ' ' HIS . 2.3 pp -128.01 153.45 46.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.279 -0.888 . . . . 0.0 110.608 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.471 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.0 t-160 -66.32 118.32 9.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.144 -0.973 . . . . 0.0 109.279 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.581 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.246 -0.909 . . . . 0.0 110.013 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.582 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.328 0.585 . . . . 0.0 110.365 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.581 ' HA ' HG23 ' A' ' 59' ' ' VAL . 19.9 tttt -123.5 137.51 54.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.561 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 6.9 mttt -101.06 147.69 25.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.164 -0.96 . . . . 0.0 109.936 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.62 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -133.44 121.87 22.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.0 111.873 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 80' ' ' ILE . 1.6 mp -98.67 111.7 28.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.945 HG13 ' CG2' ' A' ' 54' ' ' VAL . 2.4 t -107.41 122.27 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.505 -0.747 . . . . 0.0 110.659 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.741 ' O ' HG12 ' A' ' 52' ' ' VAL . 4.5 tp-100 -104.37 142.81 33.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 109.016 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.486 ' N ' ' OE1' ' A' ' 82' ' ' GLN . 1.1 m -109.76 156.99 10.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 C-N-CA 118.15 -1.42 . . . . 0.0 109.896 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -72.14 178.83 1.19 Allowed Pre-proline 0 C--N 1.291 -1.965 0 O-C-N 121.65 -0.656 . . . . 0.0 110.235 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.1 Cg_endo -73.04 140.4 31.29 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 124.234 1.65 . . . . 0.0 110.345 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.63 -30.36 9.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.555 ' HB2' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -112.19 176.39 5.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.204 -1.174 . . . . 0.0 110.467 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.3 OUTLIER 179.3 115.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 110.331 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.905 HD12 ' CD2' ' A' ' 26' ' ' TYR . 39.5 mt -67.91 60.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.174 -0.954 . . . . 0.0 109.655 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 88' ' ' LYS . 14.1 pt-20 -58.2 -13.08 4.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.445 -0.785 . . . . 0.0 111.022 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.714 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.24 -16.63 2.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.989 -1.07 . . . . 0.0 110.627 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.811 HD21 ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -106.21 -23.23 12.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.062 -1.024 . . . . 0.0 109.634 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.4 -19.75 6.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.352 -0.842 . . . . 0.0 110.332 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.08 -20.16 11.67 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.631 HD23 HD11 ' A' ' 13' ' ' LEU . 14.5 tp -46.36 -24.37 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.586 HG13 ' CE2' ' A' ' 18' ' ' TYR . 2.0 mp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.21 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.966 HG12 HG13 ' A' ' 8' ' ' ILE . 39.6 t . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.279 0.562 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.966 HG13 HG12 ' A' ' 7' ' ' VAL . 16.2 mt 24.56 51.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.302 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 30' ' ' VAL . 3.5 mt -44.71 -99.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.307 -0.87 . . . . 0.0 111.262 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -99.56 151.68 37.53 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.924 -1.11 . . . . 0.0 110.816 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.632 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 49.8 Cg_endo -76.33 153.6 35.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.103 1.581 . . . . 0.0 110.519 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 27' ' ' THR . 1.5 p -115.15 105.21 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.058 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.818 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.12 106.75 17.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.667 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -135.57 -178.54 5.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.184 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -57.34 -67.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.251 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -45.66 74.46 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.258 -0.901 . . . . 0.0 110.354 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.667 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -56.21 -48.9 75.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.665 ' CE1' HG22 ' A' ' 96' ' ' ILE . 1.9 m-85 -57.9 -33.33 68.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.875 . . . . 0.0 110.147 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.37 -8.88 49.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.858 . . . . 0.0 109.865 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -103.33 -38.23 2.88 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.626 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -74.94 -18.88 60.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.571 -0.958 . . . . 0.0 108.873 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.404 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -56.92 -20.7 24.79 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.702 -0.624 . . . . 0.0 110.729 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.6 17.27 5.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.38 -0.825 . . . . 0.0 110.059 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.04 0.89 67.74 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 48.8 mttt -82.79 143.47 30.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.567 -0.961 . . . . 0.0 109.545 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 1.126 ' CD2' HD12 ' A' ' 89' ' ' ILE . 22.9 m-85 -128.01 99.41 5.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.611 -1.306 . . . . 0.0 111.083 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.79 HG23 HD11 ' A' ' 80' ' ' ILE . 2.7 m -74.63 127.32 32.83 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.641 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -131.44 165.23 23.98 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.314 -0.866 . . . . 0.0 111.162 -178.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.515 ' NE1' ' HB ' ' A' ' 12' ' ' VAL . 46.1 m95 -100.0 123.27 44.06 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.807 ' HA ' HD12 ' A' ' 9' ' ' LEU . 2.0 p -142.55 164.81 17.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.081 -176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 2.5 t60 -65.34 149.76 96.64 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.545 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 48.1 Cg_endo -73.18 67.49 4.22 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.088 1.573 . . . . 0.0 109.434 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.72 -32.19 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.405 -0.81 . . . . 0.0 110.062 -178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.717 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.09 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.692 . . . . 0.0 109.882 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -45.99 142.12 2.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.0 110.388 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -42.81 -38.62 2.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.841 . . . . 0.0 109.675 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.6 m -73.17 -36.24 66.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.556 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -59.32 -43.46 92.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.158 -0.963 . . . . 0.0 109.207 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.821 ' O ' HD11 ' A' ' 8' ' ' ILE . 13.4 mt -57.75 -30.46 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.673 ' HG3' HG11 ' A' ' 51' ' ' VAL . 14.5 tttt -65.29 -45.09 85.82 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.595 0.712 . . . . 0.0 110.127 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 1.056 ' O ' HG23 ' A' ' 45' ' ' THR . 10.1 m-80 -71.27 -49.31 44.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.59 -0.694 . . . . 0.0 111.905 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.608 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.16 -51.07 70.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.792 -1.192 . . . . 0.0 110.946 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.792 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -59.45 -40.92 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.84 -1.162 . . . . 0.0 110.249 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -65.6 -29.56 70.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.181 -0.949 . . . . 0.0 110.755 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 1.056 HG23 ' O ' ' A' ' 41' ' ' ASN . 28.1 p -66.17 -47.08 75.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.081 . . . . 0.0 110.979 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.56 -56.67 3.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 111.338 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.792 ' CD2' HG22 ' A' ' 43' ' ' VAL . 8.8 m-85 -71.59 -21.19 61.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.147 -0.971 . . . . 0.0 110.694 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 31.1 mtmt 48.42 41.02 16.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 109.665 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -102.87 -161.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.721 -0.612 . . . . 0.0 109.625 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.788 ' N ' HG13 ' A' ' 49' ' ' VAL . 6.0 tmtm? -114.48 112.38 22.9 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.68 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 40' ' ' LYS . 48.8 t -77.64 119.79 27.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.79 HG21 ' N ' ' A' ' 84' ' ' ALA . 41.1 t -114.21 -14.5 10.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.487 -0.758 . . . . 0.0 110.554 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.9 OUTLIER -178.75 115.1 0.07 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.463 -0.773 . . . . 0.0 109.998 179.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.884 ' CG2' HG13 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -112.76 130.9 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.808 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.485 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 17.3 m120 -130.48 115.96 17.54 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.793 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.568 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.58 160.27 19.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.6 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.544 HD11 HG13 ' A' ' 59' ' ' VAL . 1.7 pp -141.71 166.64 24.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.592 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.432 ' O ' HD12 ' A' ' 57' ' ' LEU . 5.7 t-160 -77.47 118.36 19.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.127 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.284 -0.885 . . . . 0.0 110.187 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.512 ' HG2' ' HB ' ' A' ' 59' ' ' VAL . 6.8 ttm180 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.264 0.554 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.613 ' HA ' HG23 ' A' ' 59' ' ' VAL . 13.7 tttt -123.06 139.21 54.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.912 . . . . 0.0 110.076 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.663 ' HE2' HG21 ' A' ' 12' ' ' VAL . 15.4 mttt -101.88 147.22 26.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.335 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.716 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -131.49 126.71 35.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.12 -0.987 . . . . 0.0 111.847 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.79 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -105.61 111.77 36.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.884 HG13 ' CG2' ' A' ' 54' ' ' VAL . 1.4 t -96.44 141.47 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.435 -0.791 . . . . 0.0 110.284 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 53' ' ' LYS . 7.5 tp60 -121.13 142.46 49.84 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.376 -0.828 . . . . 0.0 109.507 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.6 m -125.24 156.65 34.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.437 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.79 ' N ' HG21 ' A' ' 52' ' ' VAL . . . -44.19 171.87 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.798 0 CA-C-O 121.302 0.572 . . . . 0.0 110.854 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.4 Cg_endo -77.8 53.94 4.6 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 O-C-N 124.39 1.732 . . . . 0.0 110.232 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -167.42 -47.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.565 ' HB3' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -51.04 -173.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -1.155 . . . . 0.0 110.848 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 3.4 pttt 178.98 80.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.505 -0.747 . . . . 0.0 110.416 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.126 HD12 ' CD2' ' A' ' 26' ' ' TYR . 5.2 mt -47.69 109.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.736 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 4.7 mm-40 -67.43 -14.64 63.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 0.0 110.74 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.728 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -57.47 -36.8 71.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.201 -0.937 . . . . 0.0 110.84 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.861 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.99 -23.55 12.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.009 -1.057 . . . . 0.0 110.107 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.0 mm-40 -60.63 -31.9 71.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -0.903 . . . . 0.0 110.239 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.35 -12.8 40.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -80.4 -10.66 59.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.208 -1.172 . . . . 0.0 110.203 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.74 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.03 -0.985 . . . . 0.0 110.216 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.698 ' C ' HG23 ' A' ' 30' ' ' VAL . 3.0 t . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.897 HD11 ' HA ' ' A' ' 39' ' ' ILE . 2.7 mt -57.55 152.0 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.16 -0.962 . . . . 0.0 110.315 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 29' ' ' TRP . 2.2 mt -132.87 -99.34 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.479 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.58 153.66 42.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.02 . . . . 0.0 110.504 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.616 ' HG3' HD22 ' A' ' 92' ' ' LEU . 47.7 Cg_endo -74.94 161.53 38.76 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.07 1.563 . . . . 0.0 110.354 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.78 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.7 m -104.86 143.02 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.226 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.718 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.41 106.89 17.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -154.78 142.11 19.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.997 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 9.7 tm-20 -42.52 -52.65 4.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.895 . . . . 0.0 110.145 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -54.72 -42.02 71.02 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.107 -0.996 . . . . 0.0 110.094 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.54 ' N ' ' CG ' ' A' ' 16' ' ' LYS . . . -65.97 -63.24 1.13 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.34 -0.85 . . . . 0.0 110.028 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.541 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 1.6 m-85 -48.8 -30.66 5.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 110.302 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.21 -9.2 55.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.48 -38.39 1.78 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -73.61 -23.47 59.91 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.533 -0.98 . . . . 0.0 108.974 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -51.39 -21.09 2.06 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.628 -0.67 . . . . 0.0 110.064 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.36 16.37 13.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.266 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.73 2.36 65.08 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.582 ' HB3' HG23 ' A' ' 80' ' ' ILE . 77.0 mttt -82.26 142.53 32.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -1.14 . . . . 0.0 109.544 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 1.107 ' CD2' HD12 ' A' ' 89' ' ' ILE . 19.9 m-85 -127.7 104.23 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.751 -1.218 . . . . 0.0 112.073 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.86 HG23 HD11 ' A' ' 80' ' ' ILE . 2.8 m -76.01 124.54 27.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.801 ' CB ' HG23 ' A' ' 8' ' ' ILE . 14.9 m-85 -124.72 164.92 18.91 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.525 -0.734 . . . . 0.0 110.989 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.78 ' NE1' HG12 ' A' ' 12' ' ' VAL . 33.4 m95 -102.88 122.24 44.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.698 HG23 ' C ' ' A' ' 7' ' ' VAL . 5.2 p -144.49 165.49 12.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.496 -1.282 . . . . 0.0 111.81 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.479 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 1.5 t60 -60.81 148.53 82.65 Favored Pre-proline 0 C--N 1.297 -1.678 0 O-C-N 121.927 -0.483 . . . . 0.0 110.495 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.9 Cg_endo -72.39 71.05 3.14 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.15 1.605 . . . . 0.0 109.915 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.538 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.18 -33.85 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.947 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -50.3 90.63 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.412 -0.805 . . . . 0.0 109.98 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -48.41 176.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.546 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -69.01 -28.84 66.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 110.185 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.2 m -75.06 -52.25 11.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.872 . . . . 0.0 110.583 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.722 ' H ' HG23 ' A' ' 35' ' ' THR . 89.4 mt-10 -55.1 -42.82 73.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.919 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.897 ' HA ' HD11 ' A' ' 8' ' ' ILE . 26.7 mt -57.07 -30.69 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.163 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.62 ' HG3' HG11 ' A' ' 51' ' ' VAL . 10.1 tttp -62.87 -47.29 83.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.867 . . . . 0.0 111.322 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -62.39 -35.06 78.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.452 -0.78 . . . . 0.0 112.695 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.661 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -69.85 -50.26 44.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.484 -1.385 . . . . 0.0 111.896 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.59 HG13 HD13 ' A' ' 8' ' ' ILE . 14.4 m -69.87 -32.14 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.575 -1.328 . . . . 0.0 110.787 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -60.33 -52.68 64.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.989 -1.069 . . . . 0.0 109.91 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -79.84 -24.43 41.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 110.251 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -84.8 -64.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.877 . . . . 0.0 110.505 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.515 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 11.3 m-85 -71.69 -21.22 61.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 109.991 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER 66.48 44.12 2.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.377 -0.827 . . . . 0.0 110.335 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.796 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -125.77 -162.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.585 -0.697 . . . . 0.0 109.858 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.796 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -115.01 114.74 25.8 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 109.811 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.62 HG11 ' HG3' ' A' ' 40' ' ' LYS . 11.7 t -77.95 119.76 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.266 -0.896 . . . . 0.0 109.236 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.795 HG21 ' N ' ' A' ' 84' ' ' ALA . 25.5 t -114.01 -14.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.521 -0.737 . . . . 0.0 110.721 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.15 115.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -0.792 . . . . 0.0 110.091 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.052 HG22 HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.03 116.77 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.653 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.504 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -116.43 116.26 27.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.377 -0.827 . . . . 0.0 109.679 179.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -115.92 155.26 28.3 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.89 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.803 HD11 ' HD2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -144.89 161.02 40.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 109.922 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -82.35 124.36 29.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.0 110.408 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.903 HG11 ' CE ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.592 -0.692 . . . . 0.0 110.005 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.214 0.531 . . . . 0.0 110.365 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.538 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 0.3 OUTLIER -124.06 141.96 51.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 110.155 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.903 ' CE ' HG11 ' A' ' 59' ' ' VAL . 1.9 ptpt -100.96 150.2 23.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.004 -1.06 . . . . 0.0 109.518 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.735 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -117.95 128.63 54.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.147 -0.971 . . . . 0.0 112.124 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.86 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -105.57 111.74 36.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.413 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.052 HG22 HG22 ' A' ' 54' ' ' VAL . 13.5 t -102.83 137.62 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.48 -0.763 . . . . 0.0 110.724 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 39.1 tp60 -117.93 153.47 33.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.866 . . . . 0.0 109.831 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 84' ' ' ALA . 2.4 m -125.34 157.11 34.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.697 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -45.47 177.2 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.686 0 CA-C-O 121.275 0.559 . . . . 0.0 110.926 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.8 Cg_endo -73.48 140.53 30.16 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.25 1.658 . . . . 0.0 110.299 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.27 -21.71 19.48 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.511 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 49.1 mt-30 -89.28 167.22 13.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -1.16 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.533 ' HA ' ' OH ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER 179.67 99.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 110.522 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.107 HD12 ' CD2' ' A' ' 26' ' ' TYR . 24.5 mt -44.12 104.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 109.623 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 15.4 mm-40 -56.34 -13.97 2.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.455 -0.778 . . . . 0.0 111.677 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.723 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.0 -36.46 65.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.861 -1.149 . . . . 0.0 110.732 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.817 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.56 -23.33 12.5 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.046 -1.034 . . . . 0.0 109.827 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 15.3 mm-40 -49.99 -44.6 51.09 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.444 -0.785 . . . . 0.0 110.555 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.59 1.57 58.5 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 95' ' ' LEU . 15.9 tp -77.52 3.06 14.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -1.172 . . . . 0.0 110.196 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.299 -179.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.017 HG12 HG13 ' A' ' 8' ' ' ILE . 62.0 t . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 120.93 0.395 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.017 HG13 HG12 ' A' ' 7' ' ' VAL . 37.3 mt -88.25 104.15 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.852 -1.155 . . . . 0.0 110.925 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 mt -70.39 -98.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.855 . . . . 0.0 110.352 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.46 159.26 31.43 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.024 -1.048 . . . . 0.0 110.467 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 48.3 Cg_endo -75.0 171.09 19.01 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.088 1.572 . . . . 0.0 110.5 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.045 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.19 132.85 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.917 . . . . 0.0 110.315 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.683 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.1 mm? -103.23 106.65 17.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.131 -0.98 . . . . 0.0 110.114 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.438 ' OG ' ' C ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -165.72 140.82 4.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.938 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -43.03 -41.03 3.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.121 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -54.64 -24.55 22.08 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.247 -0.908 . . . . 0.0 110.145 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -100.74 -51.4 3.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.547 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.5 m-85 -54.77 -47.33 74.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.71 -9.41 43.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.88 . . . . 0.0 109.012 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 21' ' ' PHE . . . -98.29 -41.27 3.26 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.864 -2.495 . . . . 0.0 106.864 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.631 ' CE1' ' HA ' ' A' ' 26' ' ' TYR . 4.4 m-30 -48.4 -27.36 2.56 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -37.8 -42.91 0.63 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.62 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.45 -18.25 21.69 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.384 -0.823 . . . . 0.0 110.573 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.509 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 123.01 5.15 8.24 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.498 ' HG2' ' HB2' ' A' ' 82' ' ' GLN . 23.7 mttt -82.67 127.96 33.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 109.596 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 1.064 ' CD1' HD12 ' A' ' 92' ' ' LEU . 65.9 m-85 -127.11 114.66 18.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.711 -1.243 . . . . 0.0 112.297 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 5.4 m -81.47 123.98 29.06 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.469 0.652 . . . . 0.0 110.61 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.666 ' CB ' HG23 ' A' ' 8' ' ' ILE . 61.5 m-85 -122.27 148.67 44.71 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.435 -0.79 . . . . 0.0 110.538 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 1.045 ' CD1' HG12 ' A' ' 12' ' ' VAL . 96.9 m95 -76.62 122.8 25.16 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.785 HG12 ' HA ' ' A' ' 8' ' ' ILE . 1.9 m -135.91 154.65 34.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.866 -1.146 . . . . 0.0 111.412 -177.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.517 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -52.26 130.92 42.42 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 176.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 38.8 Cg_endo -65.01 72.99 0.23 Allowed 'Trans proline' 0 C--N 1.294 -2.315 0 O-C-N 123.443 1.233 . . . . 0.0 109.361 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 31' ' ' HIS . 0.1 OUTLIER 179.68 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.997 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.75 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.387 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -38.36 128.11 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.499 -0.751 . . . . 0.0 110.81 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.567 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 1.5 mttt -41.96 -31.79 0.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.417 -0.802 . . . . 0.0 109.674 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.0 m -72.97 -51.06 19.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.84 . . . . 0.0 109.473 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 4.2 mt-10 -55.43 -38.94 69.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.162 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.918 HG23 HD11 ' A' ' 8' ' ' ILE . 38.6 mt -58.08 -30.68 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -0.847 . . . . 0.0 108.969 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.522 ' O ' HG21 ' A' ' 51' ' ' VAL . 3.5 tttm -62.04 -47.51 84.43 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.716 0.769 . . . . 0.0 110.083 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.658 ' O ' HG23 ' A' ' 45' ' ' THR . 45.9 m-80 -72.42 -33.93 67.47 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.693 -0.629 . . . . 0.0 111.052 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.862 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.24 -50.89 71.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.861 -1.149 . . . . 0.0 110.643 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.802 HG21 HG11 ' A' ' 81' ' ' VAL . 1.1 m -64.72 -33.26 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.517 -1.364 . . . . 0.0 109.783 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -58.48 -29.05 65.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.848 . . . . 0.0 110.326 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 41' ' ' ASN . 1.3 p -77.99 -48.94 15.06 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.109 -0.994 . . . . 0.0 110.346 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . -82.94 -56.24 3.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.543 -0.723 . . . . 0.0 110.907 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.526 ' CE1' HD21 ' A' ' 92' ' ' LEU . 14.3 m-85 -71.41 -11.34 60.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.124 -0.985 . . . . 0.0 110.092 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 21.9 mtpt 41.7 47.86 3.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.434 -0.791 . . . . 0.0 110.17 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.766 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -122.01 -164.25 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.52 -0.738 . . . . 0.0 109.987 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.766 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -116.64 109.94 17.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.415 -0.803 . . . . 0.0 109.636 179.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.82 HG13 ' CG1' ' A' ' 81' ' ' VAL . 61.0 t -78.23 148.13 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.196 -0.94 . . . . 0.0 109.974 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.1 p -139.46 9.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 110.082 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.08 117.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 109.948 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.062 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.24 117.26 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 110.116 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.567 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 20.2 m-20 -115.96 115.67 26.58 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.355 -0.841 . . . . 0.0 109.428 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -114.63 167.05 11.09 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 110.024 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 58' ' ' HIS . 2.0 pp -158.77 160.63 36.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.489 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.466 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.1 t-160 -75.51 130.85 39.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.063 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.726 HG21 ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.452 -0.78 . . . . 0.0 110.486 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.71 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.6 mpt_? . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.171 0.51 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.713 ' NZ ' HD11 ' A' ' 39' ' ' ILE . 29.1 tttt -123.06 128.12 49.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.118 -0.989 . . . . 0.0 110.62 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.91 ' HD2' HG11 ' A' ' 12' ' ' VAL . 13.4 mtmt -101.34 148.25 25.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.376 -0.827 . . . . 0.0 108.99 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.66 118.96 25.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.97 -1.081 . . . . 0.0 112.007 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 17.5 mt -97.15 110.53 25.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.812 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.062 HG22 ' CG2' ' A' ' 54' ' ' VAL . 21.9 t -105.99 133.07 51.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.759 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.617 ' O ' HG12 ' A' ' 52' ' ' VAL . 42.0 tp60 -111.25 153.46 25.84 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.922 -1.111 . . . . 0.0 109.103 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.7 m -114.66 155.76 15.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 118.179 -1.408 . . . . 0.0 109.611 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.938 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -49.92 178.93 0.03 OUTLIER Pre-proline 0 C--N 1.289 -2.023 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.353 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.938 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -72.45 142.39 36.72 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.244 1.655 . . . . 0.0 110.546 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.37 -36.83 3.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 11.7 mt-30 -80.53 173.03 13.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.136 . . . . 0.0 110.618 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 179.63 93.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -0.793 . . . . 0.0 110.216 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.716 HD12 ' CD2' ' A' ' 26' ' ' TYR . 14.8 mt -43.09 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -0.971 . . . . 0.0 110.026 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.483 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 2.9 mt-10 -75.17 -14.19 60.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 0.0 110.744 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.752 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.11 -24.03 23.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.096 -1.002 . . . . 0.0 110.506 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.064 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -105.86 -23.2 12.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.11 -0.994 . . . . 0.0 109.592 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 40.0 mm-40 -60.66 -23.17 64.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.399 -0.813 . . . . 0.0 110.196 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.97 -19.47 8.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 95' ' ' LEU . 14.4 tp -50.47 -21.05 1.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -1.123 . . . . 0.0 110.13 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.547 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 43.8 mt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.141 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.922 HG12 HG13 ' A' ' 8' ' ' ILE . 84.6 t . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.951 0.405 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.922 HG13 HG12 ' A' ' 7' ' ' VAL . 9.8 mt -84.22 88.65 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 0.0 111.143 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.97 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.408 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.51 164.78 13.99 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.574 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.3 Cg_endo -80.22 155.04 22.21 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.013 1.533 . . . . 0.0 110.261 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.72 HG11 HG22 ' A' ' 27' ' ' THR . 1.8 p -115.24 112.54 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.085 -1.009 . . . . 0.0 110.32 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.774 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.55 110.72 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.923 . . . . 0.0 110.391 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.812 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -144.71 162.46 36.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.981 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' SER . 52.9 mt-10 -42.79 -65.32 0.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -14.61 32.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 110.344 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.812 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -100.51 23.74 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 110.418 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -134.36 -49.67 0.79 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.075 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.75 -35.29 80.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.102 -0.999 . . . . 0.0 109.324 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -88.76 -34.4 9.15 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.596 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -72.47 -8.69 56.38 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -78.2 -16.59 57.72 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.54 -0.725 . . . . 0.0 110.813 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 2.0 mm-40 -88.74 17.36 5.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.527 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.577 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 101.56 -3.35 53.57 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 28.3 mttt -82.44 137.04 34.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.603 -0.94 . . . . 0.0 109.516 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.647 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 99.3 m-85 -127.15 112.21 14.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.708 -1.245 . . . . 0.0 111.435 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.033 HG23 HD11 ' A' ' 80' ' ' ILE . 3.9 m -82.38 127.96 33.76 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.059 ' CE2' HG11 ' A' ' 43' ' ' VAL . 22.7 m-85 -123.08 147.43 46.74 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.163 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.604 ' CZ3' ' CG ' ' A' ' 76' ' ' ARG . 3.9 m95 -84.35 122.6 29.16 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 8' ' ' ILE . 1.5 m -138.51 164.07 27.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 118.207 -1.397 . . . . 0.0 112.043 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -61.64 134.36 93.76 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 176.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.448 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 38.3 Cg_endo -64.2 75.9 0.18 Allowed 'Trans proline' 0 C--N 1.293 -2.359 0 O-C-N 123.22 1.116 . . . . 0.0 109.398 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.551 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.47 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.829 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -38.46 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.821 -0.55 . . . . 0.0 109.84 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -46.76 140.58 4.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.108 -0.995 . . . . 0.0 110.76 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.502 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 8.6 mttt -43.42 -45.36 6.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.308 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 3.4 m -61.01 -48.53 81.37 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 109.296 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 2.1 mt-10 -58.43 -44.51 89.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.358 -0.839 . . . . 0.0 109.356 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.767 ' O ' HG22 ' A' ' 43' ' ' VAL . 15.3 mt -57.3 -30.71 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 54.9 tttt -66.55 -47.6 72.32 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.425 -0.797 . . . . 0.0 109.366 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.971 ' O ' HG23 ' A' ' 45' ' ' THR . 72.2 m-20 -73.65 -34.38 64.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.625 -0.672 . . . . 0.0 110.8 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . . . -57.96 -50.49 73.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.84 -1.163 . . . . 0.0 110.365 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.059 HG11 ' CE2' ' A' ' 28' ' ' PHE . 3.2 m -73.47 -36.33 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.837 -1.164 . . . . 0.0 110.022 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -58.0 -34.71 70.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.088 -1.008 . . . . 0.0 109.48 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.971 HG23 ' O ' ' A' ' 41' ' ' ASN . 39.9 p -79.3 -45.06 20.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.511 -0.743 . . . . 0.0 110.078 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.46 -56.83 3.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.384 -0.822 . . . . 0.0 111.018 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CG ' HD13 ' A' ' 89' ' ' ILE . 6.4 m-85 -71.49 -21.39 61.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.018 -1.051 . . . . 0.0 110.245 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.95 44.45 19.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 110.38 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.786 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -123.55 -164.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.515 -0.74 . . . . 0.0 109.791 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.786 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.23 107.3 15.1 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 109.489 179.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.859 HG13 HG13 ' A' ' 81' ' ' VAL . 75.6 t -78.07 119.4 26.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.214 -0.929 . . . . 0.0 110.026 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.658 HG12 ' C ' ' A' ' 82' ' ' GLN . 7.1 p -103.43 -0.21 10.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 110.086 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.555 ' CG ' ' HB3' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 178.91 141.58 0.11 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.82 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.08 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -134.3 127.73 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.073 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.502 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 47.0 t30 -131.27 115.1 15.86 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.406 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.32 149.23 39.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.63 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -130.68 170.98 13.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 110.665 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.425 ' CD2' ' C ' ' A' ' 58' ' ' HIS . 5.0 t-160 -80.23 115.56 19.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 110.007 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.54 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.349 -0.845 . . . . 0.0 110.042 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.604 ' CG ' ' CZ3' ' A' ' 29' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.176 0.512 . . . . 0.0 109.646 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.54 ' HA ' HG23 ' A' ' 59' ' ' VAL . 4.3 tttp -123.06 140.84 52.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.144 -0.972 . . . . 0.0 110.753 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.556 ' HD2' ' CG2' ' A' ' 27' ' ' THR . 0.4 OUTLIER -106.96 143.33 35.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.427 -0.796 . . . . 0.0 109.646 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.656 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -133.69 118.96 18.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.083 -1.011 . . . . 0.0 111.247 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.033 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -100.83 111.85 31.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.523 0.678 . . . . 0.0 109.911 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.08 HG22 ' CG2' ' A' ' 54' ' ' VAL . 35.1 t -109.1 136.09 46.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 110.265 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.658 ' C ' HG12 ' A' ' 52' ' ' VAL . 6.6 tp60 -110.33 153.44 24.9 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.102 -0.999 . . . . 0.0 109.0 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.476 HG21 ' C ' ' A' ' 87' ' ' GLN . 2.3 m -116.18 155.44 17.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.832 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.975 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -50.09 179.26 0.03 OUTLIER Pre-proline 0 C--N 1.288 -2.066 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.617 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.975 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 41.5 Cg_endo -71.5 141.31 38.13 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.366 1.719 . . . . 0.0 110.499 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.6 -25.48 11.13 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.525 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 60.3 mt-30 -94.05 163.77 13.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -1.164 . . . . 0.0 110.689 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER 179.51 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.457 -0.777 . . . . 0.0 110.113 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.635 HD13 ' CG ' ' A' ' 47' ' ' PHE . 9.4 mt -44.28 95.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.953 . . . . 0.0 109.596 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.548 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -68.53 -13.27 62.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.439 -0.788 . . . . 0.0 111.155 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.731 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.44 -35.08 62.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.087 -1.008 . . . . 0.0 110.969 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -106.89 -23.67 12.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.889 -1.132 . . . . 0.0 110.773 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.548 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 1.9 pp20? -51.1 -22.93 2.73 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.038 -1.039 . . . . 0.0 110.234 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -99.08 -23.77 11.11 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.636 HD23 ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -42.75 -29.58 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -1.128 . . . . 0.0 110.147 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.566 HG13 ' CE1' ' A' ' 18' ' ' TYR . 2.6 mp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.882 HG12 HG13 ' A' ' 8' ' ' ILE . 99.1 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.252 0.549 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.882 HG13 HG12 ' A' ' 7' ' ' VAL . 3.6 mt -86.1 90.55 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.846 -1.159 . . . . 0.0 111.26 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -97.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.811 . . . . 0.0 110.198 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -108.38 162.36 20.21 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.998 . . . . 0.0 110.242 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 46.8 Cg_endo -73.96 163.5 36.73 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.994 1.523 . . . . 0.0 110.388 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.157 HG12 ' CD1' ' A' ' 29' ' ' TRP . 2.4 m -115.13 139.4 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.942 . . . . 0.0 110.317 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.67 111.48 23.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -0.958 . . . . 0.0 110.042 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 15' ' ' GLU . 54.3 m -145.66 139.56 26.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 110.183 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 8.7 tm-20 -42.79 -58.71 2.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 110.176 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -42.26 71.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.264 -0.897 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -58.93 -66.0 0.57 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.699 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.6 m-85 -44.92 -31.08 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 110.58 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.77 -8.77 48.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -110.98 -31.97 2.75 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -76.08 -17.22 59.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.686 -0.891 . . . . 0.0 108.92 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.615 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -57.0 -21.31 29.72 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.791 -0.568 . . . . 0.0 110.725 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -88.99 17.08 6.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.51 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.11 0.18 66.0 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 1.7 mttp -82.36 137.21 34.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -1.015 . . . . 0.0 109.064 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 1.006 ' CD1' HD12 ' A' ' 92' ' ' LEU . 27.6 m-85 -128.86 105.52 8.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.34 -1.475 . . . . 0.0 112.244 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 4.3 m -74.88 141.02 44.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.445 0.641 . . . . 0.0 109.37 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.735 ' CB ' HG23 ' A' ' 8' ' ' ILE . 21.7 m-85 -133.3 166.18 23.09 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.434 -0.791 . . . . 0.0 110.032 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 1.157 ' CD1' HG12 ' A' ' 12' ' ' VAL . 14.0 m95 -98.28 122.96 42.08 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.0 p -143.9 160.39 16.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 C-N-CA 117.792 -1.563 . . . . 0.0 112.768 -176.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -62.2 151.99 79.86 Favored Pre-proline 0 C--N 1.3 -1.572 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.69 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.9 Cg_endo -73.06 69.54 3.85 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.082 1.569 . . . . 0.0 109.647 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.2 OUTLIER 179.72 -34.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.399 -0.813 . . . . 0.0 110.017 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.874 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -43.75 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.381 -0.825 . . . . 0.0 109.603 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -41.55 136.04 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.535 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.793 ' HA ' HD12 ' A' ' 39' ' ' ILE . 7.5 mttt -43.74 -41.34 4.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 109.385 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.5 m -67.66 -40.26 84.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.267 -0.896 . . . . 0.0 108.997 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.517 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 5.1 mt-10 -55.79 -39.46 71.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.899 . . . . 0.0 108.763 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.797 HG21 ' HB1' ' A' ' 79' ' ' ALA . 32.3 mt -57.75 -34.66 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.6 ttmt -57.99 -47.91 81.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.37 -0.831 . . . . 0.0 109.945 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -73.79 -34.82 64.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.696 -0.627 . . . . 0.0 111.345 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.614 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . . . -58.77 -50.5 73.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.824 -1.173 . . . . 0.0 110.672 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.727 HG13 ' CD1' ' A' ' 8' ' ' ILE . 2.6 m -65.02 -33.21 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.774 -1.204 . . . . 0.0 109.811 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -60.65 -44.29 96.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 0.0 109.204 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.06 -15.28 58.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.0 109.323 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -102.66 -68.79 0.81 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.406 -0.809 . . . . 0.0 110.459 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD2' HG12 ' A' ' 43' ' ' VAL . 29.9 m-85 -74.08 -21.56 59.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 4.3 tttp 65.15 47.21 2.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 110.107 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.771 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -125.29 -162.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.498 -0.752 . . . . 0.0 110.413 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.771 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -118.29 114.58 23.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.473 -0.767 . . . . 0.0 109.788 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.059 HG13 HG13 ' A' ' 81' ' ' VAL . 90.4 t -78.94 123.31 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.0 110.435 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.682 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.4 p -114.93 9.94 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.924 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.55 120.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.402 -0.811 . . . . 0.0 109.902 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.15 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.12 125.51 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.196 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.554 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -125.12 115.6 20.72 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.224 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.548 ' CG2' ' HG2' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -119.2 150.46 40.04 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.902 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.538 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 3.3 pp -146.86 145.38 29.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.408 -0.807 . . . . 0.0 110.054 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 132.49 44.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.357 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.366 -0.834 . . . . 0.0 110.106 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.579 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 1.8 tpt180 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.214 0.53 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -110.03 129.41 55.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 10.4 ptpt -114.65 151.51 33.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.996 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.797 ' HB1' HG21 ' A' ' 39' ' ' ILE . . . -122.23 125.71 46.64 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.0 112.585 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 22.7 mt -104.22 110.93 31.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.452 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.15 HG22 ' CG2' ' A' ' 54' ' ' VAL . 97.9 t -104.26 134.55 45.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 110.346 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.682 ' C ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -102.51 150.71 23.12 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.171 -0.956 . . . . 0.0 108.704 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.515 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.4 m -115.33 156.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 118.069 -1.452 . . . . 0.0 109.754 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.92 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -67.65 -179.71 0.49 Allowed Pre-proline 0 C--N 1.288 -2.104 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.163 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.92 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.0 Cg_endo -73.2 139.53 29.52 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 O-C-N 124.264 1.665 . . . . 0.0 110.195 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.503 ' O ' ' CE ' ' A' ' 88' ' ' LYS . . . 109.09 -48.31 0.95 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.819 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -94.07 176.87 6.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.16 -1.2 . . . . 0.0 110.672 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 86' ' ' GLY . 0.4 OUTLIER 179.56 100.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -0.772 . . . . 0.0 110.088 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.925 HD12 ' CD2' ' A' ' 26' ' ' TYR . 10.4 mt -44.19 108.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 110.05 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 10.0 mm-40 -75.75 -13.65 60.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -0.803 . . . . 0.0 110.799 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.864 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.82 -31.38 59.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.0 110.577 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.006 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.31 -23.04 12.66 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.19 -0.944 . . . . 0.0 109.715 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 36.1 mm-40 -50.84 -35.25 31.51 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 110.382 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -94.78 -24.22 18.41 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.864 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.3 mp -43.0 -27.22 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -1.181 . . . . 0.0 110.173 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.54 ' OXT' HG22 ' A' ' 96' ' ' ILE . 22.8 mm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.18 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.852 ' O ' HD23 ' A' ' 9' ' ' LEU . 3.3 t . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.884 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.8 mt -57.04 120.33 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.157 -0.965 . . . . 0.0 110.121 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -111.65 -89.59 0.51 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.175 -0.953 . . . . 0.0 110.297 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.25 142.42 24.55 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.095 -1.003 . . . . 0.0 110.212 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.593 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 47.5 Cg_endo -73.69 175.73 10.33 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.058 1.557 . . . . 0.0 110.506 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.156 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.08 133.15 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.926 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.738 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.98 110.23 22.07 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.152 -0.968 . . . . 0.0 110.293 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 71.7 m -166.07 138.39 3.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 110.008 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 14' ' ' SER . 13.2 mt-10 -43.41 -46.36 6.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 110.064 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.72 -18.05 4.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.574 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -101.62 -49.81 3.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.752 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.985 ' CE1' HD11 ' A' ' 96' ' ' ILE . 2.4 m-85 -58.64 -44.74 90.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.496 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -12.61 38.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 108.876 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' N ' ' A' ' 22' ' ' ALA . . . -98.95 -39.59 3.53 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 3.6 m-30 -49.96 -25.43 3.28 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 20' ' ' GLY . . . -40.21 -31.68 0.14 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.724 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 3.6 tp10 -104.05 -1.26 27.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.771 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.543 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 103.52 9.1 39.11 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 15.4 mttt -82.58 131.54 35.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -1.133 . . . . 0.0 109.668 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.906 ' CD1' HD12 ' A' ' 92' ' ' LEU . 70.1 m-85 -126.86 108.09 10.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.887 -1.133 . . . . 0.0 112.003 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 27.1 m -75.85 121.9 23.3 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.74 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -116.4 164.03 15.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 110.618 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 1.156 ' CD1' HG12 ' A' ' 12' ' ' VAL . 68.1 m95 -97.5 123.22 41.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.802 ' HA ' HD21 ' A' ' 9' ' ' LEU . 2.6 p -151.4 164.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 C-N-CA 117.827 -1.549 . . . . 0.0 111.997 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.481 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -51.01 140.46 20.89 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.207 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.4 Cg_endo -72.17 76.57 2.14 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.06 1.558 . . . . 0.0 110.059 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 179.03 -33.81 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.418 -0.801 . . . . 0.0 110.03 -178.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.676 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -48.43 107.5 0.13 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 110.194 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -59.45 147.51 36.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -0.927 . . . . 0.0 110.012 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.542 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 21.8 mttt -46.56 -34.4 4.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 110.102 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.3 m -75.18 -51.19 13.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 110.447 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 1.8 mt-10 -55.19 -42.82 73.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.779 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.764 HG23 HD11 ' A' ' 8' ' ' ILE . 20.9 mt -57.19 -30.59 35.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.656 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.2 ttpm? -62.71 -46.35 88.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 111.046 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.405 ' O ' HG23 ' A' ' 45' ' ' THR . 13.5 m-80 -58.97 -34.89 72.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.421 -0.799 . . . . 0.0 112.336 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.884 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -72.43 -49.27 34.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.666 -1.271 . . . . 0.0 111.652 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -69.52 -37.63 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.888 -1.133 . . . . 0.0 110.84 -178.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.68 -44.12 81.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.072 -1.017 . . . . 0.0 110.424 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 41' ' ' ASN . 34.0 p -78.99 -46.19 18.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 110.295 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.68 -55.93 22.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.311 -0.868 . . . . 0.0 110.554 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.67 ' CD1' HG22 ' A' ' 43' ' ' VAL . 70.6 m-85 -83.2 3.02 32.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.112 -0.992 . . . . 0.0 110.333 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 4.5 pttm 38.23 42.57 0.51 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.735 0.779 . . . . 0.0 110.326 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.773 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -115.39 -165.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.599 -0.688 . . . . 0.0 109.792 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.773 ' N ' HG13 ' A' ' 49' ' ' VAL . 2.8 tmtm? -118.27 103.16 9.56 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.443 -0.785 . . . . 0.0 109.831 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.656 HG11 ' HG3' ' A' ' 40' ' ' LYS . 97.7 t -78.37 119.63 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.36 -0.838 . . . . 0.0 109.69 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.3 p -101.02 -5.61 9.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -0.903 . . . . 0.0 110.381 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER 176.08 119.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.344 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.937 HG23 HG13 ' A' ' 81' ' ' VAL . 1.1 t -109.56 124.51 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 109.743 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.542 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 12.9 m120 -122.83 116.32 23.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.219 -0.926 . . . . 0.0 109.818 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.543 ' OG1' ' CE ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -110.17 155.43 21.98 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.36 -0.837 . . . . 0.0 110.185 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.584 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -138.58 156.96 47.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.778 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.32 122.91 25.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.463 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.593 HG21 ' HG3' ' A' ' 78' ' ' LYS . 4.3 m . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.701 -0.625 . . . . 0.0 110.21 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.538 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.098 0.475 . . . . 0.0 110.116 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.543 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 0.1 OUTLIER -121.92 142.14 50.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 0.0 110.379 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.842 ' HD3' HG11 ' A' ' 12' ' ' VAL . 1.8 mttt -100.91 151.22 22.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 109.718 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -119.55 119.24 33.22 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.985 -1.072 . . . . 0.0 111.944 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 9.1 mt -95.95 110.87 25.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 109.527 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 43' ' ' VAL . 2.9 t -99.8 125.95 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.14 -0.975 . . . . 0.0 110.263 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.68 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -106.75 143.15 35.27 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.011 -1.056 . . . . 0.0 108.932 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.47 ' CA ' HG12 ' A' ' 52' ' ' VAL . 1.3 m -115.0 156.84 15.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.442 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.853 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -68.18 177.17 1.1 Allowed Pre-proline 0 C--N 1.29 -1.999 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.671 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.853 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -73.49 141.91 32.2 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.348 1.709 . . . . 0.0 110.36 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.97 -26.74 14.52 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -113.72 177.68 4.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -1.132 . . . . 0.0 110.305 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.6 OUTLIER 179.71 122.68 0.06 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -0.933 . . . . 0.0 110.373 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.684 HG22 ' HG ' ' A' ' 92' ' ' LEU . 12.5 mt -73.6 93.94 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 110.101 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 20.0 pt-20 -72.55 -14.66 61.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.855 . . . . 0.0 110.409 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.756 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.7 -23.82 30.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.892 . . . . 0.0 110.495 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.906 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.22 -23.01 12.69 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.174 -0.954 . . . . 0.0 109.713 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.3 mm-40 -61.34 -31.06 70.92 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.359 -0.838 . . . . 0.0 110.369 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.68 -6.22 56.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.1 tp -61.86 -12.07 15.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.167 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.985 HD11 ' CE1' ' A' ' 18' ' ' TYR . 2.9 mp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.15 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.975 HG13 ' HB1' ' A' ' 34' ' ' ALA . 46.4 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.807 0.813 . . . . 0.0 109.075 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.861 HG23 ' HB3' ' A' ' 28' ' ' PHE . 6.4 mt -110.59 67.77 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 121.232 -0.918 . . . . 0.0 109.932 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 mt -54.28 -94.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.806 . . . . 0.0 110.742 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.17 150.45 36.73 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 110.61 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.22 162.02 37.22 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.121 1.59 . . . . 0.0 110.276 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.724 HG13 ' HB ' ' A' ' 27' ' ' THR . 1.1 p -115.35 110.33 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.287 -0.883 . . . . 0.0 110.027 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.818 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.12 106.92 17.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.245 -0.909 . . . . 0.0 110.234 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.651 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -137.76 174.58 10.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 110.253 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -55.7 -65.58 0.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.317 -0.865 . . . . 0.0 110.243 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -54.69 -34.79 62.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.169 -0.957 . . . . 0.0 110.302 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.651 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -71.98 -49.52 36.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.156 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 13' ' ' LEU . 1.3 m-85 -58.07 -31.53 67.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.39 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.46 -8.52 50.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 110.177 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -107.63 -35.41 2.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.401 -1.879 . . . . 0.0 108.401 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -76.02 -16.6 59.93 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.63 -0.924 . . . . 0.0 109.118 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.622 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -59.09 -20.29 52.09 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.442 0.639 . . . . 0.0 110.75 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -88.86 17.27 5.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.395 -0.816 . . . . 0.0 110.434 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.29 -0.25 65.95 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 19.7 mttt -82.4 142.71 31.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.572 -0.958 . . . . 0.0 109.395 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.954 ' CD1' HD12 ' A' ' 92' ' ' LEU . 22.9 m-85 -128.29 110.65 12.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.676 -1.265 . . . . 0.0 111.368 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.992 HG23 HD11 ' A' ' 80' ' ' ILE . 3.0 m -81.55 131.18 35.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.478 0.656 . . . . 0.0 109.277 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.041 ' CE2' HG11 ' A' ' 43' ' ' VAL . 23.3 m-85 -124.65 165.06 18.57 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.488 -0.758 . . . . 0.0 110.672 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.637 ' CE3' ' CG ' ' A' ' 76' ' ' ARG . 3.1 m95 -103.12 122.29 44.38 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.6 p -139.42 161.57 27.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 C-N-CA 118.025 -1.47 . . . . 0.0 112.327 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.593 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -74.03 150.26 87.87 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.259 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 44.0 Cg_endo -70.31 67.14 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.986 1.519 . . . . 0.0 109.729 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.88 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.577 -0.702 . . . . 0.0 109.575 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.975 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -43.98 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.338 -0.851 . . . . 0.0 109.306 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -38.0 130.86 1.13 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.496 -0.752 . . . . 0.0 110.964 -179.127 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.834 ' HA ' HD12 ' A' ' 39' ' ' ILE . 1.5 mttt -42.84 -43.31 3.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 109.619 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 4.5 m -61.79 -44.52 96.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.485 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 19.6 mm-40 -55.36 -38.83 69.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.392 -0.817 . . . . 0.0 109.422 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 36' ' ' LYS . 25.0 mt -57.38 -30.87 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.706 ' HG3' HG11 ' A' ' 51' ' ' VAL . 59.9 tttm -67.85 -47.05 70.04 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.444 -0.785 . . . . 0.0 109.582 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.476 ' O ' ' HB ' ' A' ' 45' ' ' THR . 58.0 m-80 -73.6 -34.31 65.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.604 -0.685 . . . . 0.0 111.325 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.459 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . . . -58.15 -50.56 73.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.739 -1.226 . . . . 0.0 110.454 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.041 HG11 ' CE2' ' A' ' 28' ' ' PHE . 3.6 m -68.31 -32.89 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.854 -1.154 . . . . 0.0 109.372 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CD ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.42 -42.02 79.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.12 -0.987 . . . . 0.0 108.483 178.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.9 OUTLIER -79.52 -12.8 59.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 178.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.8 -62.2 1.57 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 110.678 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 43' ' ' VAL . 24.0 m-85 -71.59 -22.48 61.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.996 -1.065 . . . . 0.0 110.071 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER 65.88 46.78 2.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.845 . . . . 0.0 110.038 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.676 HG22 ' H ' ' A' ' 50' ' ' LYS . 1.2 p -125.28 -164.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.631 -0.668 . . . . 0.0 110.412 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.676 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.3 tmtp? -118.46 106.73 13.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.451 -0.781 . . . . 0.0 109.763 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.706 HG11 ' HG3' ' A' ' 40' ' ' LYS . 40.6 t -78.8 140.54 16.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 110.542 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.669 HG12 ' C ' ' A' ' 82' ' ' GLN . 13.6 p -118.91 -6.46 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.616 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -179.18 131.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.041 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -120.26 129.47 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.918 -1.114 . . . . 0.0 110.117 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.487 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 3.8 m-80 -131.53 115.71 16.49 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.437 -0.789 . . . . 0.0 109.387 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.561 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -115.5 159.58 21.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 109.311 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.634 HD11 ' HD2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -148.33 144.71 27.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.11 -0.993 . . . . 0.0 110.968 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.05 103.36 2.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.858 . . . . 0.0 109.034 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.538 0 O-C-N 121.385 -0.822 . . . . 0.0 109.319 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.637 ' CG ' ' CE3' ' A' ' 29' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.397 0.618 . . . . 0.0 111.102 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 59' ' ' VAL . 4.8 ptmt -98.59 141.2 31.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.402 -0.812 . . . . 0.0 110.18 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.634 ' HD2' HD11 ' A' ' 57' ' ' LEU . 19.2 ptpt -109.3 151.41 26.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -0.936 . . . . 0.0 110.483 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.898 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -116.9 122.68 45.01 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.234 -0.916 . . . . 0.0 111.931 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.992 HD11 HG23 ' A' ' 27' ' ' THR . 1.5 mp -103.18 112.77 37.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.559 -0.713 . . . . 0.0 109.468 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.041 HG22 ' CG2' ' A' ' 54' ' ' VAL . 23.8 t -113.3 128.68 69.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.417 -0.802 . . . . 0.0 110.866 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.669 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.5 tp60 -98.82 153.36 18.83 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.193 -0.942 . . . . 0.0 108.679 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 84' ' ' ALA . 1.5 m -116.66 156.69 17.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 C-N-CA 118.264 -1.375 . . . . 0.0 108.679 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.986 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -69.27 178.79 0.85 Allowed Pre-proline 0 C--N 1.285 -2.229 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.002 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.893 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.6 138.41 26.68 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 124.243 1.654 . . . . 0.0 110.458 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.42 -30.1 8.52 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.986 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -111.69 176.9 4.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.242 . . . . 0.0 110.705 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 90' ' ' GLU . 8.2 ptpt 179.46 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.459 -0.776 . . . . 0.0 110.012 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.827 HD12 ' CD2' ' A' ' 26' ' ' TYR . 14.9 mt -45.07 95.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.002 . . . . 0.0 110.075 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 88' ' ' LYS . 1.1 pt-20 -68.13 -13.89 62.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.384 -0.823 . . . . 0.0 110.666 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.769 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.96 -28.68 53.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.125 -0.985 . . . . 0.0 110.347 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.954 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.23 -23.04 12.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.492 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 13.9 mm-40 -51.07 -31.92 20.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.436 -0.79 . . . . 0.0 110.45 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -98.02 -26.63 9.45 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.769 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.4 mp -43.56 -26.18 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.227 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.412 HG13 ' CE1' ' A' ' 18' ' ' TYR . 40.5 mt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.23 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.025 HG12 HG13 ' A' ' 8' ' ' ILE . 45.7 t . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 121.183 0.516 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.025 HG13 HG12 ' A' ' 7' ' ' VAL . 5.7 mt -86.37 100.2 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.861 -1.15 . . . . 0.0 111.109 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.496 HD21 ' HA ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -91.63 -86.01 0.23 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.226 -0.921 . . . . 0.0 111.067 179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.544 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -107.99 140.64 21.85 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.9 -1.125 . . . . 0.0 110.592 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.628 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.1 Cg_endo -72.96 170.38 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.079 1.568 . . . . 0.0 110.393 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.076 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.6 m -115.27 133.16 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.165 -0.959 . . . . 0.0 110.405 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.838 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -102.83 112.66 25.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.163 -0.961 . . . . 0.0 110.215 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 15' ' ' GLU . 40.5 m -159.69 145.62 15.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.007 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' SER . 36.5 mt-10 -42.76 -54.13 4.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 110.165 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -54.61 -28.17 44.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 0.0 110.182 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -87.05 -55.41 3.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.838 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -53.7 -26.24 21.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.02 -15.65 31.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -101.49 -36.44 3.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -77.67 -23.08 49.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.574 -0.956 . . . . 0.0 108.835 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -50.61 -20.58 1.24 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.606 -0.684 . . . . 0.0 110.338 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.3 13.63 25.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.53 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 99.94 -0.53 56.34 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 20.7 mttt -82.38 147.45 28.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -1.138 . . . . 0.0 109.396 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 1.076 ' CE2' HD12 ' A' ' 89' ' ' ILE . 22.0 m-85 -128.07 102.88 6.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.693 -1.254 . . . . 0.0 112.209 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.799 HG22 ' HD3' ' A' ' 78' ' ' LYS . 3.4 m -75.82 125.92 30.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.652 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -130.28 164.96 23.44 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.934 -1.103 . . . . 0.0 112.085 -177.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 1.076 ' CD1' HG12 ' A' ' 12' ' ' VAL . 24.9 m95 -101.33 123.31 45.22 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 7' ' ' VAL . 1.4 p -145.96 158.81 11.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 117.772 -1.571 . . . . 0.0 112.003 -176.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.593 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -59.97 151.17 66.34 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.852 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 49.0 Cg_endo -73.36 70.01 4.03 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.227 1.646 . . . . 0.0 109.763 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.57 -33.42 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 110.071 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.996 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -42.61 93.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.45 -0.781 . . . . 0.0 109.831 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -51.52 140.29 18.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 110.421 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 8.5 mttt -42.26 -43.27 3.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.88 . . . . 0.0 110.027 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -64.32 -53.36 50.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.865 . . . . 0.0 110.07 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.8 OUTLIER -55.47 -40.43 71.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.769 HG23 HD11 ' A' ' 8' ' ' ILE . 14.9 mt -57.68 -31.4 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.271 -0.893 . . . . 0.0 108.968 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 37' ' ' THR . 6.7 tttt -63.12 -42.54 99.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.371 -0.831 . . . . 0.0 109.833 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 1.045 ' O ' HG23 ' A' ' 45' ' ' THR . 44.1 m-80 -71.39 -44.89 64.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.69 -0.631 . . . . 0.0 111.836 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.856 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.78 -52.11 66.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.768 -1.208 . . . . 0.0 110.964 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.797 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -59.69 -38.64 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.547 -1.346 . . . . 0.0 109.862 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -64.37 -32.73 74.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 1.045 HG23 ' O ' ' A' ' 41' ' ' ASN . 26.7 p -62.95 -47.47 83.07 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.153 -0.967 . . . . 0.0 110.65 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.88 -52.11 5.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.222 -0.924 . . . . 0.0 110.828 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.797 ' CD2' HG22 ' A' ' 43' ' ' VAL . 78.1 m-85 -71.76 -21.39 61.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.231 -0.918 . . . . 0.0 110.499 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 14.0 mtpt 46.83 42.62 12.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.669 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.78 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.39 -162.59 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 121.398 0.618 . . . . 0.0 109.727 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.78 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.21 107.55 15.44 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.881 179.09 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.591 ' CG2' HG11 ' A' ' 43' ' ' VAL . 22.8 t -78.33 119.5 27.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.261 -0.9 . . . . 0.0 109.316 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.625 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.4 p -105.9 9.06 9.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.248 -0.908 . . . . 0.0 110.683 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.15 117.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 110.46 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.96 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -115.28 116.66 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.0 109.519 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 82.8 m-20 -118.56 115.87 25.46 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 109.409 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.545 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -115.0 162.45 16.96 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.987 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -154.79 153.01 30.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 110.469 -179.325 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.36 130.59 43.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.745 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.687 HG11 ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.29 -0.881 . . . . 0.0 110.154 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.226 0.536 . . . . 0.0 109.899 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.524 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 51.1 tttt -117.86 128.59 54.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.573 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.799 ' HD3' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -101.7 151.11 22.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.56 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.812 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -129.4 131.41 46.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.915 -1.115 . . . . 0.0 112.053 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.812 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.6 mp -110.63 111.43 36.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.96 HG13 HG23 ' A' ' 54' ' ' VAL . 2.6 t -106.16 133.92 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.505 -0.747 . . . . 0.0 110.431 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.625 ' C ' HG12 ' A' ' 52' ' ' VAL . 4.7 tp60 -117.14 152.77 34.04 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.005 -1.06 . . . . 0.0 108.674 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.545 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -118.79 155.76 20.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.142 -1.423 . . . . 0.0 109.711 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.778 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -50.85 174.11 0.09 OUTLIER Pre-proline 0 C--N 1.289 -2.024 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.871 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.778 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.8 Cg_endo -76.66 55.54 4.85 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.307 1.688 . . . . 0.0 110.609 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -163.81 -50.28 0.02 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.546 ' HB3' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -51.27 -172.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -1.174 . . . . 0.0 111.025 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 179.25 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.63 -0.669 . . . . 0.0 110.172 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.076 HD12 ' CE2' ' A' ' 26' ' ' TYR . 5.6 mt -68.72 109.16 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.0 110.146 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 3.3 mt-10 -78.3 -14.49 59.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.585 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.757 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -56.29 -33.04 65.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 111.137 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.757 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.11 -23.44 12.61 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.952 -1.092 . . . . 0.0 110.138 -179.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mm-40 -62.71 -23.02 66.94 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.179 -0.95 . . . . 0.0 110.228 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -113.51 -26.32 3.99 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.518 HD23 HD11 ' A' ' 13' ' ' LEU . 8.0 tp -42.87 -27.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -1.132 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.625 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 52.0 mt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.215 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.76 ' C ' HG23 ' A' ' 30' ' ' VAL . 3.2 t . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.234 0.54 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.088 HD13 HG13 ' A' ' 43' ' ' VAL . 4.9 mt -56.12 156.07 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 121.217 -0.927 . . . . 0.0 110.812 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.2 mt -143.52 -93.78 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 110.155 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.21 149.81 39.68 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.068 -1.02 . . . . 0.0 110.277 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.619 ' HG3' HD22 ' A' ' 92' ' ' LEU . 45.9 Cg_endo -73.33 173.57 13.54 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.1 1.579 . . . . 0.0 110.357 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.626 HG12 ' CE2' ' A' ' 29' ' ' TRP . 2.4 m -112.8 139.35 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.206 -0.934 . . . . 0.0 110.152 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.753 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.77 112.28 24.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.197 -0.939 . . . . 0.0 110.243 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -161.99 138.07 7.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 0.0 110.098 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 2.2 tm-20 -42.87 -50.11 5.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.178 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -46.75 74.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.849 . . . . 0.0 110.23 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -67.86 -60.37 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.187 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.717 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.2 m-85 -44.61 -29.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.117 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.75 -19.27 23.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.86 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -96.19 -40.55 3.97 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.244 -1.943 . . . . 0.0 108.244 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.626 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -69.79 -17.08 63.39 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.638 -0.919 . . . . 0.0 108.952 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.626 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -58.34 -21.2 48.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.272 0.558 . . . . 0.0 110.89 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -88.53 16.96 5.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.25 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.67 1.96 65.52 Favored Glycine 0 N--CA 1.48 1.594 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 24.7 mttm -82.24 137.7 34.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.607 -0.937 . . . . 0.0 109.246 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.966 ' CD1' HD12 ' A' ' 92' ' ' LEU . 24.8 m-85 -128.76 103.89 7.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.518 -1.363 . . . . 0.0 112.007 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 78' ' ' LYS . 1.4 m -75.03 140.96 43.91 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.619 -0.676 . . . . 0.0 109.339 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.814 ' CB ' HG23 ' A' ' 8' ' ' ILE . 22.0 m-85 -134.56 165.64 24.74 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.453 -0.779 . . . . 0.0 110.438 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.626 ' CE2' HG12 ' A' ' 12' ' ' VAL . 10.0 m95 -98.96 122.33 42.07 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.76 HG23 ' C ' ' A' ' 7' ' ' VAL . 7.4 p -148.06 165.68 5.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.617 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.483 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -61.14 152.91 69.8 Favored Pre-proline 0 C--N 1.298 -1.669 0 O-C-N 121.851 -0.53 . . . . 0.0 110.383 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.497 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.9 Cg_endo -73.4 71.53 3.77 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.099 1.578 . . . . 0.0 110.349 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.02 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.264 -0.898 . . . . 0.0 110.101 -179.256 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.415 ' CB ' HG13 ' A' ' 7' ' ' VAL . . . -42.74 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 110.186 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -48.09 155.81 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 110.26 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.584 ' O ' HG11 ' A' ' 54' ' ' VAL . 7.2 mmtp -57.33 -36.25 70.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.88 . . . . 0.0 110.204 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -75.14 -50.21 17.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 23.0 mt-10 -54.97 -37.92 67.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.942 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.718 HG23 HD11 ' A' ' 8' ' ' ILE . 17.8 mt -57.91 -30.83 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 109.401 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HG3' HG11 ' A' ' 51' ' ' VAL . 2.4 ttpt -61.69 -45.89 92.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 111.096 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -58.9 -36.67 75.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 112.314 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.942 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -73.22 -50.49 22.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.603 -1.311 . . . . 0.0 111.685 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.088 HG13 HD13 ' A' ' 8' ' ' ILE . 4.7 m -66.01 -30.57 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.518 -1.364 . . . . 0.0 110.583 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -62.76 -52.41 63.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.088 -1.007 . . . . 0.0 109.964 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -79.72 -15.72 56.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.895 . . . . 0.0 110.224 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.25 -62.05 1.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.471 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.611 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 9.7 m-85 -71.73 -15.96 62.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.183 -0.948 . . . . 0.0 110.096 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 5.9 mmtt 61.56 45.36 8.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.48 -0.762 . . . . 0.0 110.235 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.776 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -128.28 -162.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.528 -0.733 . . . . 0.0 110.007 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.776 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.06 106.14 12.58 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 109.358 178.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.832 HG13 HG13 ' A' ' 81' ' ' VAL . 97.8 t -78.23 119.77 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.322 -0.861 . . . . 0.0 110.184 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.65 HG12 ' C ' ' A' ' 82' ' ' GLN . 7.6 p -106.01 -3.97 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.569 ' HG3' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 178.34 147.94 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.859 . . . . 0.0 109.875 179.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.103 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.1 t -132.79 131.32 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.002 -1.061 . . . . 0.0 109.871 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -131.61 115.88 16.66 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.39 -0.819 . . . . 0.0 109.22 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.761 ' O ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -113.83 166.27 11.74 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.39 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 56' ' ' THR . 7.0 mt -143.17 179.76 6.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.432 -0.793 . . . . 0.0 109.852 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -104.15 102.17 11.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.339 -0.85 . . . . 0.0 109.387 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.548 ' CG1' ' HE2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.271 -0.893 . . . . 0.0 110.095 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.399 0.619 . . . . 0.0 110.531 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.516 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 5.9 ptmt -123.15 141.19 52.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.982 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.676 ' HB2' HG22 ' A' ' 27' ' ' THR . 5.2 ptpt -101.57 151.12 22.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.105 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -115.48 119.96 37.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.217 -0.927 . . . . 0.0 112.25 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.592 HG12 HG23 ' A' ' 27' ' ' THR . 12.8 mt -98.2 110.78 26.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.784 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.103 HG22 ' CG2' ' A' ' 54' ' ' VAL . 50.4 t -103.63 133.04 48.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.91 -1.119 . . . . 0.0 110.257 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.65 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.4 tp60 -102.71 153.28 20.29 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.07 -1.019 . . . . 0.0 109.065 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.1 m -120.94 156.19 24.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 C-N-CA 118.35 -1.34 . . . . 0.0 109.053 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.868 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -63.3 177.74 0.44 Allowed Pre-proline 0 C--N 1.286 -2.168 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.194 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.868 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.6 Cg_endo -74.23 138.92 25.77 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 124.233 1.649 . . . . 0.0 110.301 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.47 -30.32 10.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.81 176.35 5.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.112 -1.228 . . . . 0.0 110.548 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 7.9 pttt 179.56 104.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.449 -0.782 . . . . 0.0 110.195 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 26' ' ' TYR . 9.8 mt -42.65 100.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.54 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 3.1 mm-40 -63.06 -13.72 39.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.419 -0.801 . . . . 0.0 110.985 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.757 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.75 -32.73 60.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.099 -1.0 . . . . 0.0 110.418 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.966 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.12 -23.02 12.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.148 -0.97 . . . . 0.0 109.599 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 64.9 mm-40 -48.05 -58.76 4.03 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.38 -0.825 . . . . 0.0 110.423 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -76.5 -33.66 47.22 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 8.0 tp -41.64 -27.34 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.299 -1.118 . . . . 0.0 110.331 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.451 HG12 ' CE1' ' A' ' 18' ' ' TYR . 50.4 mt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.263 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.994 HG13 ' HB1' ' A' ' 34' ' ' ALA . 40.9 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 122.046 0.926 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.805 HG23 ' CB ' ' A' ' 28' ' ' PHE . 4.7 mt -114.06 99.04 7.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 O-C-N 121.326 -0.859 . . . . 0.0 110.068 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.0 mt -93.05 -95.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.328 -0.857 . . . . 0.0 110.854 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.95 154.95 41.8 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.7 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.61 158.17 39.9 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.134 1.597 . . . . 0.0 110.167 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 27' ' ' THR . 1.5 p -115.2 117.24 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.818 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.5 mm? -102.07 106.96 17.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 110.174 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.592 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -144.72 152.8 40.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.6 tt0 -43.07 -63.78 0.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -25.8 28.46 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.592 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -84.39 -51.19 7.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.143 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.617 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 2.1 m-85 -55.75 -32.47 63.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.17 -8.48 51.09 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.256 -0.903 . . . . 0.0 109.901 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.76 -34.0 3.4 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.584 -1.807 . . . . 0.0 108.584 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -79.37 -19.81 49.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.574 -0.956 . . . . 0.0 109.026 179.244 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -54.6 -17.65 3.55 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.65 -0.656 . . . . 0.0 110.879 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.8 OUTLIER -93.17 17.07 11.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.507 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.53 -2.01 67.07 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 1.7 mttp -82.13 139.51 34.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.524 -0.986 . . . . 0.0 109.376 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 1.001 ' CD1' HD12 ' A' ' 92' ' ' LEU . 23.8 m-85 -128.42 102.88 6.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.533 -1.354 . . . . 0.0 112.033 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.652 HG21 ' NZ ' ' A' ' 78' ' ' LYS . 8.1 m -74.88 141.15 44.2 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.449 0.642 . . . . 0.0 109.659 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.805 ' CB ' HG23 ' A' ' 8' ' ' ILE . 44.8 m-85 -134.22 165.18 25.7 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.49 -0.756 . . . . 0.0 110.056 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.605 ' CZ3' ' HG2' ' A' ' 76' ' ' ARG . 52.9 m95 -89.92 122.0 32.54 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 7' ' ' VAL . 10.6 p -134.14 165.26 32.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 118.344 -1.342 . . . . 0.0 112.394 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.597 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 1.9 t60 -82.75 152.4 66.22 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.297 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 43.8 Cg_endo -70.61 65.56 2.29 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.173 1.617 . . . . 0.0 109.544 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.87 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.559 -0.713 . . . . 0.0 109.647 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.994 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -48.37 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.501 -0.75 . . . . 0.0 109.575 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -40.31 134.35 1.66 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.301 -0.875 . . . . 0.0 110.797 -179.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.643 ' HA ' HD12 ' A' ' 39' ' ' ILE . 3.5 tttm -42.4 -43.36 3.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.7 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 5.2 m -61.27 -44.32 97.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.92 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 35' ' ' THR . 6.7 mt-10 -55.13 -39.61 69.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.376 -0.827 . . . . 0.0 109.494 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.718 HG23 HD11 ' A' ' 8' ' ' ILE . 10.4 mt -57.67 -30.67 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.379 -0.826 . . . . 0.0 108.914 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.591 ' HG3' HG11 ' A' ' 51' ' ' VAL . 9.6 tttt -61.79 -47.64 84.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.827 . . . . 0.0 109.541 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.449 ' O ' ' HB ' ' A' ' 45' ' ' THR . 24.3 m-80 -73.48 -34.33 65.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.653 -0.654 . . . . 0.0 110.97 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.64 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . . . -58.37 -50.27 74.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.912 -1.118 . . . . 0.0 110.656 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.004 HG21 HG11 ' A' ' 81' ' ' VAL . 2.7 m -68.11 -36.94 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.715 -1.241 . . . . 0.0 109.835 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -63.36 -42.6 98.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.092 -1.005 . . . . 0.0 108.886 179.154 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -79.2 -20.43 48.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.578 -0.701 . . . . 0.0 109.315 179.083 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -100.04 -67.14 0.87 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 110.456 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.711 ' CD2' HG12 ' A' ' 43' ' ' VAL . 62.6 m-85 -72.58 -21.61 61.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 110.432 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 64.06 47.87 3.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.311 -0.868 . . . . 0.0 110.274 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -122.28 -158.82 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.483 -0.761 . . . . 0.0 110.062 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.788 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -117.16 111.3 19.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.436 179.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.78 HG13 HG13 ' A' ' 81' ' ' VAL . 57.7 t -78.3 119.8 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.189 -0.944 . . . . 0.0 110.424 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 82' ' ' GLN . 12.2 p -113.8 -1.41 9.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.489 -0.757 . . . . 0.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 175.83 119.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.81 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.081 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -113.68 132.04 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 110.304 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.553 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 2.4 m120 -131.05 115.56 16.61 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.457 -0.777 . . . . 0.0 109.573 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -116.28 144.61 44.01 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 109.982 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.45 162.01 34.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -0.804 . . . . 0.0 109.973 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 127.49 32.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.944 HG11 ' HD3' ' A' ' 78' ' ' LYS . 1.9 m . . . . . 0 C--N 1.3 -1.565 0 O-C-N 121.607 -0.683 . . . . 0.0 109.979 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.605 ' HG2' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.286 0.565 . . . . 0.0 110.018 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.0 tttt -110.18 141.87 42.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.554 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.944 ' HD3' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -116.57 151.32 36.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.417 -0.802 . . . . 0.0 109.82 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.98 123.24 36.66 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.997 -1.064 . . . . 0.0 112.63 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 14.9 mt -103.29 111.36 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.829 -0.544 . . . . 0.0 110.019 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.081 HG22 ' CG2' ' A' ' 54' ' ' VAL . 60.2 t -104.29 130.37 55.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.94 -1.1 . . . . 0.0 109.969 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.782 ' O ' HG12 ' A' ' 52' ' ' VAL . 3.6 tp60 -102.64 149.76 24.11 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.143 -0.973 . . . . 0.0 109.205 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.539 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.5 m -112.89 156.65 13.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 118.45 -1.3 . . . . 0.0 109.405 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.895 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -62.87 175.49 0.64 Allowed Pre-proline 0 C--N 1.291 -1.951 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.916 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.846 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.3 Cg_endo -76.26 55.29 4.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.525 1.803 . . . . 0.0 110.415 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -158.67 -37.08 0.02 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.895 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -110.64 -179.57 3.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.297 -1.12 . . . . 0.0 110.219 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.439 ' HA ' HG21 ' A' ' 83' ' ' VAL . 2.6 pttt -176.17 100.35 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.743 HD12 ' CD2' ' A' ' 26' ' ' TYR . 11.2 mt -42.35 113.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.006 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 1.2 pt-20 -77.95 -13.36 59.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 0.0 110.914 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.639 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.52 -28.8 47.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.064 -1.022 . . . . 0.0 110.575 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.001 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.26 -23.15 12.64 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.077 -1.014 . . . . 0.0 109.605 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.549 ' O ' HD12 ' A' ' 96' ' ' ILE . 20.5 mm-40 -58.14 -37.69 75.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.487 -0.758 . . . . 0.0 110.296 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.42 25.08 29.41 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.556 HD23 HD21 ' A' ' 13' ' ' LEU . 1.2 tp -106.45 -15.1 14.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -1.143 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.66 ' O ' HG22 ' A' ' 96' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.197 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.679 HG12 HG13 ' A' ' 8' ' ' ILE . 74.7 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.877 0.37 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.933 HD11 HG23 ' A' ' 39' ' ' ILE . 58.0 mt 11.59 86.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.222 0.534 . . . . 0.0 112.283 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.1 mt -68.29 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 110.149 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.41 158.54 33.59 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.956 -1.09 . . . . 0.0 110.359 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.435 ' HG3' HD22 ' A' ' 92' ' ' LEU . 46.4 Cg_endo -73.35 161.69 42.07 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.012 1.533 . . . . 0.0 110.344 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.073 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.2 m -104.65 135.13 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.145 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.835 HD11 HD23 ' A' ' 95' ' ' LEU . 3.2 mm? -102.85 107.18 17.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.118 -0.989 . . . . 0.0 110.334 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 15' ' ' GLU . 14.9 m -162.11 147.16 12.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.947 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.1 tt0 -42.78 -55.48 3.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.917 . . . . 0.0 109.989 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -29.95 54.56 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 110.154 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -82.96 -64.88 1.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.812 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.6 m-85 -42.95 -51.72 5.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.299 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.74 -24.56 67.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.21 -0.931 . . . . 0.0 109.943 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -87.43 -44.75 5.47 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.52 -23.9 56.74 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.509 -0.995 . . . . 0.0 108.957 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -50.43 -21.57 1.52 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.657 -0.652 . . . . 0.0 110.204 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.516 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -91.85 16.26 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.235 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.63 0.02 64.9 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 14.6 mttt -82.18 146.95 29.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -1.128 . . . . 0.0 109.694 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 1.0 ' CD2' HD12 ' A' ' 89' ' ' ILE . 22.3 m-85 -127.31 104.69 8.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.773 -1.204 . . . . 0.0 112.0 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.857 HG23 HD11 ' A' ' 80' ' ' ILE . 3.9 m -78.27 131.43 37.08 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.858 ' CB ' HG23 ' A' ' 8' ' ' ILE . 24.1 m-85 -136.32 164.42 28.14 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.177 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 1.073 ' NE1' HG12 ' A' ' 12' ' ' VAL . 99.6 m95 -100.43 121.91 42.32 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.6 p -145.78 164.99 10.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.503 -176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.623 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -73.46 171.47 10.58 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.767 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 48.4 Cg_endo -75.18 -53.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.927 1.488 . . . . 0.0 109.374 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' THR 0.252 0.0 OUTLIER -47.12 -22.63 0.39 Allowed 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.678 178.927 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -67.02 61.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.363 -0.835 . . . . 0.0 109.617 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -38.33 148.65 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.65 -0.656 . . . . 0.0 110.919 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 14.1 mttt -42.67 -46.56 5.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -0.826 . . . . 0.0 109.955 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -58.78 -53.06 62.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.325 -0.86 . . . . 0.0 110.025 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -55.4 -41.85 73.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.862 . . . . 0.0 109.701 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.933 HG23 HD11 ' A' ' 8' ' ' ILE . 21.9 mt -57.63 -31.44 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.182 -0.949 . . . . 0.0 108.87 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.596 ' HG3' HG11 ' A' ' 51' ' ' VAL . 15.7 tttp -63.27 -45.35 91.9 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.368 -0.832 . . . . 0.0 109.864 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.462 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.3 m-80 -71.22 -34.36 70.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.688 -0.633 . . . . 0.0 111.412 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.924 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.56 -50.73 72.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.768 -1.208 . . . . 0.0 110.6 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.595 HG12 ' CE2' ' A' ' 47' ' ' PHE . 2.9 m -71.05 -34.19 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.838 -1.163 . . . . 0.0 109.582 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -64.88 -38.06 89.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.28 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -79.22 -33.43 43.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.516 -0.74 . . . . 0.0 109.72 179.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.12 -62.42 1.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.39 -0.819 . . . . 0.0 110.72 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.595 ' CE2' HG12 ' A' ' 43' ' ' VAL . 21.8 m-85 -71.69 -21.45 61.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.415 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 7.4 mttt 60.64 46.89 8.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 0.0 110.272 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -123.19 -162.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.472 -0.768 . . . . 0.0 110.163 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.788 ' N ' HG13 ' A' ' 49' ' ' VAL . 2.2 tmtm? -118.16 111.41 18.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.411 -0.805 . . . . 0.0 109.845 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.596 HG11 ' HG3' ' A' ' 40' ' ' LYS . 64.9 t -78.74 119.53 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 82' ' ' GLN . 12.1 p -107.81 7.54 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.984 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER 169.25 117.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.814 . . . . 0.0 110.07 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.02 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -119.01 117.25 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.948 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 80' ' ' ILE . 2.5 m120 -116.27 116.11 27.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.285 -0.884 . . . . 0.0 109.523 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.547 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -114.82 139.76 49.48 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.356 -0.84 . . . . 0.0 109.809 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 58' ' ' HIS . 1.4 pp -125.36 167.81 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.646 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.729 ' O ' HD12 ' A' ' 57' ' ' LEU . 23.7 t-160 -72.95 128.23 34.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.465 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.567 ' HB ' ' CG ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.567 ' CG ' ' HB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.126 0.489 . . . . 0.0 110.308 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.761 ' CE ' HD11 ' A' ' 39' ' ' ILE . 20.9 tttt -123.21 135.06 54.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 109.398 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 5.2 ttpp -101.36 150.59 22.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.08 -1.012 . . . . 0.0 109.926 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.821 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -132.53 130.88 40.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.099 -1.001 . . . . 0.0 112.626 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.857 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -111.93 111.86 37.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.02 HG22 ' CG2' ' A' ' 54' ' ' VAL . 20.2 t -108.65 130.35 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.312 -0.868 . . . . 0.0 111.189 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.739 ' O ' HG12 ' A' ' 52' ' ' VAL . 3.1 tp60 -105.88 148.18 27.89 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.321 -0.862 . . . . 0.0 108.706 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.523 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.2 m -114.74 156.88 15.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.696 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.917 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -69.13 178.34 0.95 Allowed Pre-proline 0 C--N 1.291 -1.972 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.026 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.917 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.3 Cg_endo -74.16 139.36 26.54 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 O-C-N 124.23 1.648 . . . . 0.0 110.552 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.94 -40.17 2.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.666 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -96.44 -179.51 4.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.107 -1.231 . . . . 0.0 110.718 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HE2' ' HG2' ' A' ' 90' ' ' GLU . 5.6 ptmt 179.39 90.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 110.266 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.0 HD12 ' CD2' ' A' ' 26' ' ' TYR . 15.5 mt -46.28 97.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.076 -1.015 . . . . 0.0 109.821 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -58.26 -13.6 5.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.402 -0.811 . . . . 0.0 111.125 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.959 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.99 -36.7 65.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.052 -1.03 . . . . 0.0 110.823 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.95 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.8 -23.07 12.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.936 -1.103 . . . . 0.0 109.921 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 7.5 mm-40 -54.79 -40.1 69.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 110.409 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.81 -6.65 67.2 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.959 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.3 mp -63.47 -28.72 70.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -1.163 . . . . 0.0 110.126 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.425 HD13 ' CE1' ' A' ' 18' ' ' TYR . 17.4 mm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.16 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.029 HG12 HG13 ' A' ' 8' ' ' ILE . 60.8 t . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.847 0.356 . . . . 0.0 111.657 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.029 HG13 HG12 ' A' ' 7' ' ' VAL . 17.1 mt -81.6 93.8 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.775 -1.203 . . . . 0.0 112.118 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 29' ' ' TRP . 39.4 mt -70.06 -106.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.365 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' TRP . . . -108.51 162.92 18.23 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.786 -1.196 . . . . 0.0 110.769 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -75.05 166.56 28.89 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.0 1.527 . . . . 0.0 110.545 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.863 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.5 m -115.25 137.95 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.929 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -102.8 113.03 26.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 110.294 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -152.54 146.64 25.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 110.103 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -42.72 -60.41 1.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 110.283 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -54.63 -42.22 70.95 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 110.371 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.542 ' N ' ' CG ' ' A' ' 16' ' ' LYS . . . -63.11 -60.01 4.01 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.929 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.3 m-85 -48.69 -36.24 15.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 0.0 110.106 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.37 -8.66 50.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.049 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -102.57 -34.77 4.02 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.628 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -79.06 -20.77 48.01 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.569 -0.959 . . . . 0.0 108.801 179.107 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.33 -21.45 5.71 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.705 -0.622 . . . . 0.0 110.819 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.91 17.19 5.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.35 -0.844 . . . . 0.0 110.48 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.72 -1.2 68.33 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.3 mttt -82.15 142.43 32.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.496 -1.002 . . . . 0.0 109.229 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.654 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.3 m-85 -128.01 113.09 15.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.611 -1.306 . . . . 0.0 111.743 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.806 HG23 HD11 ' A' ' 80' ' ' ILE . 9.2 m -84.25 122.35 28.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.766 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 19.8 m-85 -116.8 165.33 13.43 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.562 -0.712 . . . . 0.0 110.991 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.863 ' CD1' HG12 ' A' ' 12' ' ' VAL . 22.8 m95 -99.74 123.1 43.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 177.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 7' ' ' VAL . 1.4 p -144.22 156.28 15.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 117.407 -1.717 . . . . 0.0 112.463 -176.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -62.64 151.45 83.93 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.832 -179.359 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.3 Cg_endo -72.13 69.19 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.001 1.527 . . . . 0.0 109.478 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.77 -32.49 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.483 -0.761 . . . . 0.0 109.774 -178.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.881 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -40.29 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.758 -0.589 . . . . 0.0 109.897 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -42.87 137.45 2.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.087 -1.008 . . . . 0.0 110.533 -179.132 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.525 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -42.21 -39.18 1.97 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 0.0 109.737 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 14.3 m -74.79 -33.99 62.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.678 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -60.4 -43.96 96.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.385 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.86 ' O ' HD11 ' A' ' 8' ' ' ILE . 10.2 mt -57.36 -30.33 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.545 ' HG3' HG11 ' A' ' 51' ' ' VAL . 30.0 tttt -66.51 -44.53 82.28 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.518 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 45' ' ' THR . 1.7 m-80 -73.35 -45.35 55.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.707 -0.621 . . . . 0.0 112.037 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.673 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.36 -51.82 68.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.583 -1.323 . . . . 0.0 110.462 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.735 HG21 ' CE2' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -61.3 -47.38 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 110.296 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.5 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -58.33 -43.26 88.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.066 -1.021 . . . . 0.0 109.536 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -73.76 -13.57 60.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.521 -0.737 . . . . 0.0 109.737 179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.61 -69.03 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.393 -0.817 . . . . 0.0 110.351 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.448 ' O ' ' HB2' ' A' ' 48' ' ' LYS . 17.1 m-85 -71.99 -21.56 61.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.893 . . . . 0.0 110.11 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.3 mttt 62.72 43.12 7.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.406 -0.809 . . . . 0.0 109.934 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.805 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -113.65 -159.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.635 -0.666 . . . . 0.0 109.952 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.805 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.16 105.06 11.41 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 109.946 179.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG22 ' CG1' ' A' ' 81' ' ' VAL . 21.5 t -78.67 119.61 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.898 . . . . 0.0 109.783 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 82' ' ' GLN . 14.6 p -113.27 11.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 110.244 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 4.1 mttt 169.47 119.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.035 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.013 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.1 t -123.62 116.71 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 110.101 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.525 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -119.8 115.86 24.71 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.36 -0.838 . . . . 0.0 109.203 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.649 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -117.16 150.2 39.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.973 . . . . 0.0 110.043 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.542 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -148.42 149.0 30.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 110.1 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.516 ' NE2' ' HB3' ' A' ' 32' ' ' PRO . 1.1 m80 -66.63 127.31 31.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.176 -0.953 . . . . 0.0 110.58 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.689 -0.632 . . . . 0.0 110.225 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.535 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.189 0.518 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HG2' HG13 ' A' ' 30' ' ' VAL . 8.8 tttp -123.22 125.88 45.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.512 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.631 ' HD3' HD11 ' A' ' 80' ' ' ILE . 5.2 ptpt -101.73 151.51 21.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 109.471 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -126.82 120.29 28.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.895 -1.128 . . . . 0.0 112.592 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.806 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -96.19 112.53 28.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.013 HG22 ' CG2' ' A' ' 54' ' ' VAL . 40.7 t -113.09 126.34 70.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.378 -0.826 . . . . 0.0 110.661 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.663 ' O ' HG12 ' A' ' 52' ' ' VAL . 34.1 tp60 -102.19 151.41 22.23 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.08 -1.013 . . . . 0.0 108.888 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.482 HG11 ' HE2' ' A' ' 26' ' ' TYR . 1.1 m -118.82 157.04 20.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 118.451 -1.3 . . . . 0.0 109.647 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.962 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -69.29 178.83 0.84 Allowed Pre-proline 0 C--N 1.29 -1.986 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.302 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.928 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.3 140.81 31.12 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 O-C-N 124.343 1.707 . . . . 0.0 110.438 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.22 -32.47 6.82 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.962 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.94 173.41 6.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -1.155 . . . . 0.0 110.49 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 90' ' ' GLU . 1.1 pttp 178.8 110.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.463 -0.773 . . . . 0.0 110.364 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.654 HD12 ' CD2' ' A' ' 26' ' ' TYR . 13.1 mt -63.44 77.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 109.698 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.526 ' HA ' ' OE1' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -53.83 -14.1 0.88 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.473 -0.767 . . . . 0.0 111.465 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.71 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.49 -21.01 8.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.913 -1.117 . . . . 0.0 110.999 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.84 -24.19 12.14 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.926 -1.109 . . . . 0.0 110.165 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.526 ' OE1' ' HA ' ' A' ' 90' ' ' GLU . 8.4 mp0 -54.04 -26.86 28.78 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.275 -0.89 . . . . 0.0 110.237 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.42 -15.79 31.37 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -53.36 -31.81 46.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -1.115 . . . . 0.0 110.118 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.591 HG13 ' CE1' ' A' ' 18' ' ' TYR . 71.8 mt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.138 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.851 ' O ' HD23 ' A' ' 9' ' ' LEU . 2.8 t . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.157 0.503 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.5 mt -50.56 149.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.192 -0.942 . . . . 0.0 109.626 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.851 HD23 ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -143.01 -92.75 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.138 -0.976 . . . . 0.0 110.572 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.608 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -96.67 138.15 21.42 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 46.4 Cg_endo -74.18 173.51 14.02 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.011 1.532 . . . . 0.0 110.11 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.039 HG12 ' NE1' ' A' ' 29' ' ' TRP . 1.4 m -105.34 129.21 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.234 -0.916 . . . . 0.0 110.17 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.851 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -103.37 107.14 17.85 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.241 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -158.87 148.64 19.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.014 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 14' ' ' SER . 13.6 mm-40 -43.25 -52.83 5.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.33 -0.856 . . . . 0.0 109.98 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.6 -41.42 69.92 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.157 -0.964 . . . . 0.0 110.006 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -73.25 -61.77 1.7 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.851 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -46.73 -32.93 3.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.949 . . . . 0.0 110.197 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.39 -8.76 49.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 0.0 110.02 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -106.63 -38.17 2.27 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -73.13 -19.0 61.22 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.582 -0.952 . . . . 0.0 108.938 179.112 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -22.08 22.86 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.588 -0.695 . . . . 0.0 110.364 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.409 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 1.5 tt0 -88.75 17.01 5.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 110.074 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 91.37 3.74 69.06 Favored Glycine 0 N--CA 1.48 1.59 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 41.2 mttt -82.67 139.68 33.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -1.044 . . . . 0.0 109.48 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.982 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.4 m-85 -127.64 100.1 5.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.67 -1.269 . . . . 0.0 111.481 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.864 HG23 HD11 ' A' ' 80' ' ' ILE . 17.7 m -80.64 116.2 20.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.85 ' HB3' HG23 ' A' ' 8' ' ' ILE . 3.5 m-85 -119.24 163.22 17.43 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 109.992 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 1.039 ' NE1' HG12 ' A' ' 12' ' ' VAL . 97.2 m95 -98.9 122.08 41.68 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.511 HG23 ' C ' ' A' ' 7' ' ' VAL . 9.8 p -131.17 165.31 31.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 118.493 -1.283 . . . . 0.0 112.193 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.472 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -60.29 147.65 81.22 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.067 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.79 70.96 3.43 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.22 1.642 . . . . 0.0 109.93 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 178.94 -33.19 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.368 -0.833 . . . . 0.0 110.076 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.546 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -53.39 108.44 0.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.382 -0.824 . . . . 0.0 110.363 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 36.3 p -60.0 -170.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 110.153 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -77.33 -43.67 32.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.918 . . . . 0.0 110.336 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 6.3 m -71.56 -43.78 65.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.74 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.454 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 9.2 mt-10 -55.59 -46.21 77.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.361 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.858 HG23 HD11 ' A' ' 8' ' ' ILE . 27.1 mt -56.77 -30.4 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.911 . . . . 0.0 109.942 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.932 ' HG3' HG11 ' A' ' 51' ' ' VAL . 27.2 tttm -60.01 -44.69 94.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 111.664 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.629 ' O ' HG23 ' A' ' 45' ' ' THR . 54.9 m-80 -58.23 -36.55 73.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.302 -0.874 . . . . 0.0 112.685 -177.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.873 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -73.23 -50.2 23.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.658 -1.276 . . . . 0.0 111.965 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.883 HG11 HG11 ' A' ' 81' ' ' VAL . 0.7 OUTLIER -67.01 -43.02 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.791 -1.193 . . . . 0.0 110.748 -179.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.7 -42.1 78.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.929 -1.107 . . . . 0.0 110.149 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 41' ' ' ASN . 33.6 p -79.21 -46.68 17.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 0.0 109.98 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.2 -67.81 0.38 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.827 . . . . 0.0 110.494 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.876 ' CD2' HG22 ' A' ' 43' ' ' VAL . 90.5 m-85 -72.14 -3.84 25.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.89 . . . . 0.0 110.455 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 3.0 mtpp 43.35 42.81 3.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.455 -0.778 . . . . 0.0 110.347 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.754 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -112.39 -166.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.53 -0.731 . . . . 0.0 109.681 179.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.754 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -109.31 109.19 20.03 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.286 178.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.932 HG11 ' HG3' ' A' ' 40' ' ' LYS . 22.7 t -77.34 119.64 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.161 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.75 HG21 ' N ' ' A' ' 84' ' ' ALA . 6.2 t -111.79 -6.81 11.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.493 0.663 . . . . 0.0 110.667 -178.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.532 ' CG ' ' HB3' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 175.87 135.97 0.05 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.526 -0.734 . . . . 0.0 109.069 179.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.923 ' CG2' HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -132.38 118.49 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.493 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.7 m120 -117.33 115.94 26.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.294 -0.878 . . . . 0.0 109.574 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.1 151.08 36.3 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.657 HD21 ' HD2' ' A' ' 78' ' ' LYS . 1.2 pp -147.79 143.01 27.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 110.323 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -67.26 127.2 31.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.888 HG11 ' HE3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.508 -0.745 . . . . 0.0 110.032 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.547 ' HG2' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.236 0.541 . . . . 0.0 110.104 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.486 ' CE ' HD11 ' A' ' 39' ' ' ILE . 9.2 tttt -123.29 127.41 48.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.925 . . . . 0.0 110.387 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.888 ' HE3' HG11 ' A' ' 59' ' ' VAL . 13.7 ptpt -102.71 151.11 22.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.038 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.642 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -122.88 125.9 46.27 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.023 -1.048 . . . . 0.0 112.258 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.864 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -100.77 111.88 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.612 -0.68 . . . . 0.0 109.204 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.923 HG13 ' CG2' ' A' ' 54' ' ' VAL . 1.6 t -100.01 144.56 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.356 -0.84 . . . . 0.0 110.35 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.532 ' HB3' ' CG ' ' A' ' 53' ' ' LYS . 42.6 tp60 -124.52 147.94 48.07 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.129 -0.982 . . . . 0.0 109.486 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -125.17 156.5 34.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.219 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.778 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -43.83 173.23 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 CA-C-O 121.216 0.532 . . . . 0.0 111.194 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.767 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.4 Cg_endo -76.11 54.42 4.16 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 O-C-N 124.347 1.709 . . . . 0.0 110.459 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -169.22 -50.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.778 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 5.2 mp0 -50.86 179.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 110.314 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER 179.53 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.889 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.982 HD12 ' CD2' ' A' ' 26' ' ' TYR . 6.9 mt -64.54 77.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.057 -1.027 . . . . 0.0 109.207 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 88' ' ' LYS . 14.0 pt-20 -53.67 -14.36 0.87 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.384 -0.823 . . . . 0.0 111.263 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.749 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.43 -22.2 11.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.913 -1.117 . . . . 0.0 110.295 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.749 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.24 -23.27 12.61 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.219 -0.926 . . . . 0.0 109.629 179.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' HA ' ' A' ' 90' ' ' GLU . 5.3 mm-40 -61.29 -52.21 65.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.456 -0.778 . . . . 0.0 110.459 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.6 4.57 83.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 18.6 tp -75.13 -17.34 60.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 110.226 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.589 HG12 ' CZ ' ' A' ' 18' ' ' TYR . 52.3 mt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.208 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.709 ' C ' HG23 ' A' ' 30' ' ' VAL . 4.7 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.926 HD12 ' HB3' ' A' ' 42' ' ' ALA . 4.9 mt -61.34 151.86 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 121.127 -0.983 . . . . 0.0 110.004 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 mt -133.69 -99.74 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 110.367 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.83 155.42 40.76 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 110.344 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.673 ' HG3' HD22 ' A' ' 92' ' ' LEU . 47.2 Cg_endo -73.92 155.52 48.25 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.036 1.545 . . . . 0.0 110.113 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.872 HG11 ' CE ' ' A' ' 78' ' ' LYS . 2.7 m -99.58 141.25 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.264 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.731 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.3 mm? -102.78 110.51 22.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -162.62 142.29 9.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.901 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.3 mm-40 -42.64 -47.16 5.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 110.106 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -54.81 -48.5 72.7 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.205 -0.934 . . . . 0.0 110.129 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -65.93 -62.45 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.123 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.616 ' CZ ' ' CG1' ' A' ' 96' ' ' ILE . 1.1 m-85 -45.95 -31.45 2.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.87 . . . . 0.0 110.375 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.42 -8.67 49.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.05 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.54 -37.17 1.95 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.53 -19.95 60.78 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 108.953 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.94 -21.31 11.28 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.427 0.632 . . . . 0.0 110.392 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -92.31 16.45 11.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.31 -0.868 . . . . 0.0 110.261 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.91 2.99 64.29 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HB3' HG23 ' A' ' 80' ' ' ILE . 17.5 mttm -82.58 142.18 31.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -1.133 . . . . 0.0 109.488 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.899 ' CD2' HD12 ' A' ' 89' ' ' ILE . 22.8 m-85 -127.62 103.95 7.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.707 -1.246 . . . . 0.0 111.461 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.78 HG23 HD11 ' A' ' 80' ' ' ILE . 4.3 m -76.76 126.78 31.56 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.455 0.645 . . . . 0.0 109.451 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.824 ' CB ' HG23 ' A' ' 8' ' ' ILE . 15.2 m-85 -125.95 164.67 20.28 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.48 -0.762 . . . . 0.0 110.861 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.723 ' NE1' HG12 ' A' ' 12' ' ' VAL . 18.6 m95 -97.74 122.14 40.48 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.709 HG23 ' C ' ' A' ' 7' ' ' VAL . 9.8 p -146.06 166.72 8.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 118.816 -1.154 . . . . 0.0 111.585 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.483 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -69.6 151.86 96.45 Favored Pre-proline 0 C--N 1.297 -1.695 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.557 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.0 69.12 4.75 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.169 1.615 . . . . 0.0 109.988 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.22 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.307 -0.871 . . . . 0.0 110.039 -179.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.71 101.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.506 -0.746 . . . . 0.0 110.373 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -53.27 135.94 37.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.527 ' HE3' HG23 ' A' ' 56' ' ' THR . 2.6 mttp -42.21 -46.81 4.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.298 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -60.4 -53.24 59.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.551 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 17.5 mt-10 -55.72 -42.29 75.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 109.688 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.787 HG23 HD11 ' A' ' 8' ' ' ILE . 11.5 mt -57.74 -30.99 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.627 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.528 ' HG3' HG11 ' A' ' 51' ' ' VAL . 22.2 tttt -60.73 -45.51 93.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.623 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.737 ' O ' HG23 ' A' ' 45' ' ' THR . 31.7 m-80 -64.32 -46.39 83.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.467 -0.77 . . . . 0.0 111.989 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.926 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.76 -40.6 84.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.716 -1.24 . . . . 0.0 111.092 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.752 HG21 ' HE2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -76.3 -44.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.916 -1.115 . . . . 0.0 110.367 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.2 -37.8 70.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.961 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 41' ' ' ASN . 34.8 p -79.44 -45.22 19.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.969 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.22 -62.69 1.28 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.449 -0.782 . . . . 0.0 110.734 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.702 ' CD2' HG22 ' A' ' 43' ' ' VAL . 46.3 m-85 -71.8 -21.37 61.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 0.0 110.387 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 61.82 40.91 12.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.425 -0.797 . . . . 0.0 110.371 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.769 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -118.14 -164.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.512 -0.743 . . . . 0.0 110.034 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.769 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.86 101.45 8.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.458 -0.776 . . . . 0.0 109.386 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.733 HG22 ' CG1' ' A' ' 81' ' ' VAL . 25.6 t -78.3 119.24 26.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.365 -0.834 . . . . 0.0 110.197 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.878 HG12 ' O ' ' A' ' 82' ' ' GLN . 8.1 p -102.3 -2.37 9.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.52 -0.738 . . . . 0.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.579 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.42 143.44 0.14 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.293 -0.88 . . . . 0.0 110.09 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -133.96 118.35 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 0.0 110.146 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.51 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.7 t-20 -118.85 115.97 25.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.208 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.527 HG23 ' HE3' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -115.99 165.48 13.06 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.17 -178.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -153.7 150.2 28.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.797 . . . . 0.0 109.984 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -67.17 125.77 27.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.095 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.355 -0.84 . . . . 0.0 109.889 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.63 ' CD ' ' CZ3' ' A' ' 29' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.526 ' O ' HG12 ' A' ' 30' ' ' VAL . 8.7 tttt -119.84 141.9 49.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 110.456 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.872 ' CE ' HG11 ' A' ' 12' ' ' VAL . 2.1 tptm -101.2 146.84 26.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 109.725 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.757 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -128.23 123.53 34.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.201 -0.937 . . . . 0.0 111.382 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.78 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -106.17 113.0 41.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.462 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 54' ' ' VAL . 5.9 t -104.27 133.28 48.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.479 -0.763 . . . . 0.0 110.428 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.878 ' O ' HG12 ' A' ' 52' ' ' VAL . 3.1 tp60 -107.69 140.34 40.88 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.094 -1.004 . . . . 0.0 108.559 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -109.15 155.48 10.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 117.71 -1.596 . . . . 0.0 108.991 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.927 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -52.84 177.87 0.07 OUTLIER Pre-proline 0 C--N 1.289 -2.059 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.383 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.927 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -73.1 144.17 37.24 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 O-C-N 124.374 1.723 . . . . 0.0 110.544 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.04 -26.15 14.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.568 ' HB2' HG23 ' A' ' 83' ' ' VAL . 29.8 mt-30 -83.32 169.85 15.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -1.157 . . . . 0.0 110.467 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.469 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER 179.71 129.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.302 -0.874 . . . . 0.0 110.476 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.899 HD12 ' CD2' ' A' ' 26' ' ' TYR . 6.5 mt -91.16 116.04 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 109.958 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 10.9 pt-20 -78.05 -14.7 59.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.55 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.837 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -55.82 -29.14 59.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -0.914 . . . . 0.0 110.922 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.755 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.04 -23.3 12.67 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.014 -1.054 . . . . 0.0 110.131 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.2 mm-40 -62.6 -39.13 92.78 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.271 -0.893 . . . . 0.0 110.429 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.25 -13.77 59.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.837 HD13 ' O ' ' A' ' 91' ' ' ALA . 0.9 OUTLIER -56.8 -17.26 8.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -1.171 . . . . 0.0 110.17 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.747 ' OXT' HG22 ' A' ' 96' ' ' ILE . 61.0 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.184 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.033 HG13 ' HB1' ' A' ' 34' ' ' ALA . 58.6 t . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.077 0.465 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.018 HG13 HG12 ' A' ' 7' ' ' VAL . 21.4 mt -77.78 82.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 120.96 -1.087 . . . . 0.0 110.854 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.27 -94.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.48 -0.762 . . . . 0.0 111.064 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.21 155.96 39.28 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 0.0 110.985 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 49.5 Cg_endo -76.86 158.37 34.9 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.248 1.657 . . . . 0.0 110.449 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 27' ' ' THR . 1.6 p -115.15 109.39 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.055 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.06 107.2 18.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 110.446 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.7 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -154.25 160.6 41.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.864 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 10.1 pt-20 -40.54 -36.89 0.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 110.291 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -27.83 42.67 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.331 -0.856 . . . . 0.0 110.388 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.7 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -97.0 11.02 37.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.223 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.618 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 1.5 m-85 -120.93 -33.6 3.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.211 -0.931 . . . . 0.0 109.927 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.19 -8.59 50.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -0.842 . . . . 0.0 109.506 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -110.79 -33.11 2.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -76.38 -17.94 59.12 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.641 -0.917 . . . . 0.0 108.935 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.621 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -59.66 -18.68 43.92 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.717 -0.614 . . . . 0.0 110.499 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.3 17.62 5.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.464 -0.772 . . . . 0.0 109.855 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 92.82 -0.05 69.45 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 18.8 mttt -82.56 143.27 31.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.578 -0.954 . . . . 0.0 109.532 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.843 ' HD1' HD13 ' A' ' 92' ' ' LEU . 60.7 m-85 -128.27 101.52 6.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.743 -1.223 . . . . 0.0 111.376 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.673 ' O ' HG12 ' A' ' 12' ' ' VAL . 4.3 m -74.84 132.28 41.4 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.824 ' HB3' HG23 ' A' ' 8' ' ' ILE . 2.8 m-85 -136.99 164.2 28.92 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.632 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.597 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 68.7 m95 -101.09 122.62 43.91 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.957 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.8 p -141.4 156.45 21.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 C-N-CA 118.181 -1.408 . . . . 0.0 111.863 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.591 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 2.9 t60 -63.93 151.26 89.87 Favored Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.891 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.591 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 47.2 Cg_endo -73.82 72.11 3.94 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.166 1.614 . . . . 0.0 109.961 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.35 -32.0 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.524 -0.735 . . . . 0.0 109.552 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 1.033 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -47.4 90.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.568 -0.707 . . . . 0.0 109.659 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -41.73 142.04 0.71 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.144 -0.973 . . . . 0.0 110.453 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.511 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -43.58 -42.77 5.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.632 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 8.7 m -71.13 -26.72 63.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.388 -0.82 . . . . 0.0 109.727 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.4 OUTLIER -66.65 -46.41 75.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.212 179.431 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.787 HG23 HD11 ' A' ' 8' ' ' ILE . 16.6 mt -57.5 -30.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.587 ' HG3' HG11 ' A' ' 51' ' ' VAL . 4.3 tttt -62.87 -47.34 83.74 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.501 -0.749 . . . . 0.0 110.007 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.511 ' O ' ' HB ' ' A' ' 45' ' ' THR . 29.5 m-20 -73.01 -35.02 66.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.704 -0.622 . . . . 0.0 111.688 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.763 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.39 -52.77 64.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.649 -1.282 . . . . 0.0 110.361 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.673 HG13 HD13 ' A' ' 8' ' ' ILE . 2.7 m -68.37 -36.61 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.673 -1.267 . . . . 0.0 110.45 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.657 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -65.13 -41.37 94.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.989 -1.07 . . . . 0.0 109.775 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -79.27 -12.91 59.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.936 179.456 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.82 -59.47 1.95 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.324 -0.86 . . . . 0.0 110.62 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CD2' HG12 ' A' ' 43' ' ' VAL . 10.2 m-85 -71.7 -20.91 61.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.475 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 mttt 63.24 43.01 6.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.793 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -118.21 -161.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.638 -0.664 . . . . 0.0 109.831 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.793 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -116.91 109.18 16.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.398 -0.814 . . . . 0.0 109.516 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.657 HG23 ' HG2' ' A' ' 44' ' ' GLU . 55.4 t -77.32 122.37 31.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.166 -0.959 . . . . 0.0 109.194 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.736 HG21 ' N ' ' A' ' 84' ' ' ALA . 30.1 t -114.94 -11.92 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.496 -0.753 . . . . 0.0 110.881 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -176.35 117.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.118 179.353 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.98 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -115.73 125.31 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 110.057 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.511 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 15.8 t-20 -126.81 115.97 20.17 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 109.418 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.599 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -116.22 153.49 31.77 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.93 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -139.42 169.03 18.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.112 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.79 125.75 35.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 110.357 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.939 HG11 ' CD ' ' A' ' 78' ' ' LYS . 2.4 m . . . . . 0 C--N 1.3 -1.554 0 O-C-N 121.709 -0.62 . . . . 0.0 110.048 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.506 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.273 0.558 . . . . 0.0 110.371 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.699 ' CG ' HG13 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -123.5 142.45 51.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.36 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.939 ' CD ' HG11 ' A' ' 59' ' ' VAL . 13.6 mtpt -100.41 150.97 22.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.419 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.799 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -123.25 129.96 52.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.024 -1.048 . . . . 0.0 112.167 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.799 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.6 mp -109.65 111.35 35.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.201 178.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.98 HG13 HG23 ' A' ' 54' ' ' VAL . 3.2 t -100.79 143.9 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.421 -0.799 . . . . 0.0 110.19 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' LYS . 9.2 tp60 -122.54 147.1 46.78 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.354 -0.841 . . . . 0.0 109.39 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.491 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.3 m -125.01 156.8 33.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.178 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.847 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -45.17 175.81 0.03 OUTLIER Pre-proline 0 C--N 1.296 -1.726 0 CA-C-O 121.292 0.568 . . . . 0.0 110.916 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.847 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.8 Cg_endo -74.1 142.67 31.25 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 O-C-N 124.221 1.642 . . . . 0.0 110.542 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.82 -15.74 45.77 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.527 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 57.4 mt-30 -93.7 165.05 12.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -1.219 . . . . 0.0 110.629 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 90' ' ' GLU . 8.2 ptmt 179.63 102.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.47 -0.769 . . . . 0.0 110.241 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 54.8 mt -42.18 98.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 110.189 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.73 -28.47 34.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.089 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.462 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . -55.8 -23.69 31.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.197 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.843 HD13 ' HD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -107.73 -23.03 12.25 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.875 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.4 ' OE2' ' CZ ' ' A' ' 21' ' ' PHE . 6.2 mm-40 -84.11 1.72 42.82 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 118.055 -1.458 . . . . 0.0 110.247 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.21 -16.85 8.06 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.46 ' O ' ' OXT' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -60.19 -26.98 66.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.431 -1.041 . . . . 0.0 110.047 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.46 ' OXT' ' O ' ' A' ' 95' ' ' LEU . 10.1 mt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.238 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 8' ' ' ILE . 2.5 t . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.882 HG23 ' HB3' ' A' ' 28' ' ' PHE . 2.2 mp -49.94 155.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.362 -0.837 . . . . 0.0 110.519 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 9' ' ' LEU . 24.0 mt -139.93 -96.73 0.16 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.179 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.37 140.31 21.62 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.082 -1.011 . . . . 0.0 110.255 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.778 ' HG3' HD22 ' A' ' 92' ' ' LEU . 45.7 Cg_endo -73.54 162.55 39.67 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.003 1.528 . . . . 0.0 110.204 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.911 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.5 m -98.35 140.59 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.91 . . . . 0.0 110.335 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.863 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.0 mm? -102.76 113.2 26.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 15' ' ' GLU . 3.7 m -170.67 143.88 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 109.952 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.1 mt-10 -42.74 -49.34 5.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.119 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.6 -17.9 3.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.256 -0.903 . . . . 0.0 110.318 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.481 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -106.6 -49.8 3.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.863 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.3 m-85 -56.25 -53.52 56.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.828 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.79 -12.37 34.95 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.185 -0.947 . . . . 0.0 109.209 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -90.86 -48.64 3.33 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 9.4 m-30 -46.83 -27.66 1.3 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.347 -1.09 . . . . 0.0 108.151 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -40.18 -28.14 0.05 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.476 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.547 ' HG3' ' CE ' ' A' ' 25' ' ' LYS . 3.5 pm0 -104.62 17.07 24.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.343 -0.848 . . . . 0.0 111.471 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 87.32 7.22 76.82 Favored Glycine 0 N--CA 1.486 1.975 0 O-C-N 120.965 -1.084 . . . . 0.0 110.543 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.56 ' HD2' ' CG ' ' A' ' 82' ' ' GLN . 3.2 mptp? -84.94 134.97 34.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -1.195 . . . . 0.0 110.241 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.866 ' HD1' HD12 ' A' ' 92' ' ' LEU . 86.3 m-85 -126.94 110.44 13.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.718 -1.239 . . . . 0.0 111.544 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.827 HG23 HD11 ' A' ' 80' ' ' ILE . 2.4 m -76.0 135.76 39.99 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 121.466 0.65 . . . . 0.0 109.674 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.882 ' HB3' HG23 ' A' ' 8' ' ' ILE . 21.3 m-85 -129.58 165.23 22.14 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.588 -0.695 . . . . 0.0 110.703 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.911 ' NE1' HG12 ' A' ' 12' ' ' VAL . 19.9 m95 -104.43 122.49 45.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.0 p -151.17 165.21 2.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 118.472 -1.291 . . . . 0.0 111.51 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.45 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -59.04 149.42 66.71 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.773 -0.579 . . . . 0.0 110.791 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 47.9 Cg_endo -73.33 69.97 4.01 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.26 1.663 . . . . 0.0 109.88 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.26 -33.71 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 110.273 -178.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' LYS . . . -42.11 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.414 -0.804 . . . . 0.0 110.307 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -47.62 142.63 4.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.209 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 12.5 mttt -49.75 -44.59 48.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.308 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -64.75 -49.75 69.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.981 . . . . 0.0 110.545 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.7 OUTLIER -55.29 -41.93 72.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 0.0 109.73 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.687 ' HA ' HD11 ' A' ' 8' ' ' ILE . 10.1 mt -57.42 -30.8 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.396 -0.815 . . . . 0.0 109.817 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.522 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.6 tttt -60.75 -46.18 91.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.0 111.025 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -58.97 -34.87 72.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 112.415 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.65 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . . . -70.1 -50.28 42.41 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.588 -1.32 . . . . 0.0 111.715 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.879 HG23 HG21 ' A' ' 51' ' ' VAL . 15.1 m -68.54 -27.32 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.51 -1.369 . . . . 0.0 110.36 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.83 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -56.43 -53.0 62.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.939 -1.101 . . . . 0.0 109.237 179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.3 p -80.54 -45.11 17.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 109.884 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -56.61 -63.09 1.31 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 110.848 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.722 ' CD1' HG23 ' A' ' 89' ' ' ILE . 35.2 m-85 -71.51 -21.16 61.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.131 -0.98 . . . . 0.0 109.807 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 71.26 50.85 0.28 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.499 -0.751 . . . . 0.0 110.108 179.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.701 HG11 HG12 ' A' ' 89' ' ' ILE . 1.5 p -149.3 171.99 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.541 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.57 ' N ' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -89.97 110.57 21.53 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.534 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 43' ' ' VAL . 22.0 t -77.87 138.49 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.786 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.787 HG11 ' OE1' ' A' ' 82' ' ' GLN . 11.3 p -110.28 -29.34 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.226 -0.921 . . . . 0.0 110.842 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.558 ' HG3' ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -159.12 149.63 19.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.987 -1.07 . . . . 0.0 110.467 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.009 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.4 t -133.0 117.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 110.121 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.554 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.6 m-20 -116.86 114.69 24.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.2 -0.937 . . . . 0.0 109.157 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.656 HG21 HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -119.66 150.66 39.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.99 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.938 HD21 ' HD2' ' A' ' 78' ' ' LYS . 3.0 pp -140.61 170.34 15.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.57 120.98 32.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.33 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.823 HG13 HD11 ' A' ' 57' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.4 -0.813 . . . . 0.0 109.938 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.132 0.492 . . . . 0.0 110.146 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 32' ' ' PRO . 8.7 pttt -123.05 141.92 51.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.294 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.938 ' HD2' HD21 ' A' ' 57' ' ' LEU . 3.9 ptpt -100.85 149.18 24.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.671 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.828 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -116.89 123.67 47.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.03 -1.044 . . . . 0.0 112.585 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.827 HD11 HG23 ' A' ' 27' ' ' THR . 1.7 mp -101.98 111.45 31.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.009 HG22 ' CG2' ' A' ' 54' ' ' VAL . 89.0 t -108.99 133.96 52.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.254 -0.904 . . . . 0.0 110.861 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.787 ' OE1' HG11 ' A' ' 52' ' ' VAL . 2.7 tm0? -103.22 153.45 20.36 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.332 -0.855 . . . . 0.0 109.345 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 89' ' ' ILE . 3.7 m -109.39 157.18 9.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 C-N-CA 118.799 -1.16 . . . . 0.0 108.419 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 1.029 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -70.87 179.97 0.8 Allowed Pre-proline 0 C--N 1.283 -2.284 0 C-N-CA 119.071 -1.051 . . . . 0.0 109.988 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.922 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.0 Cg_endo -73.25 137.83 26.65 Favored 'Trans proline' 0 C--N 1.297 -2.136 0 O-C-N 124.242 1.653 . . . . 0.0 110.389 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.23 -36.65 4.26 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 1.029 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -105.95 -178.89 3.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.239 -1.154 . . . . 0.0 110.608 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 90' ' ' GLU . 5.8 ptpt -179.86 104.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 0.0 110.056 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.722 HG23 ' CD1' ' A' ' 47' ' ' PHE . 71.3 mt -54.35 86.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.351 -0.843 . . . . 0.0 109.885 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.557 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 2.8 pt-20 -71.11 -12.22 61.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.443 -0.785 . . . . 0.0 110.925 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.989 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -53.37 -27.35 23.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.992 -1.068 . . . . 0.0 110.562 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.866 HD12 ' HD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.92 -23.67 12.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.98 -1.075 . . . . 0.0 109.683 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 1.5 pp20? -66.23 -29.67 69.97 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.349 -0.941 . . . . 0.0 109.485 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.52 -22.63 28.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.989 HD13 ' O ' ' A' ' 91' ' ' ALA . 0.5 OUTLIER -44.73 -25.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -1.08 . . . . 0.0 109.857 179.665 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.556 HD13 ' CE2' ' A' ' 18' ' ' TYR . 12.5 mm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.188 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.573 ' C ' HG23 ' A' ' 30' ' ' VAL . 3.2 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.349 0.595 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.908 HG23 ' HB3' ' A' ' 28' ' ' PHE . 4.5 mt -49.74 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.169 -0.957 . . . . 0.0 110.078 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' TRP . 0.7 OUTLIER -57.88 -106.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 110.664 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.537 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -108.13 162.88 18.33 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.877 -1.139 . . . . 0.0 110.525 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.636 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.8 Cg_endo -73.72 133.47 18.69 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.105 1.582 . . . . 0.0 110.439 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 27' ' ' THR . 2.1 p -93.91 116.78 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.89 . . . . 0.0 109.968 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.841 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.4 mm? -100.96 109.24 21.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.399 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -159.13 163.92 35.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.004 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.9 mt-10 -42.88 -52.94 4.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 110.069 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -57.63 -39.5 77.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 110.099 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 21' ' ' PHE . . . -91.33 23.72 3.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.875 . . . . 0.0 109.692 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.947 ' OH ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -125.51 -63.24 1.15 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.0 109.518 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.05 -12.06 35.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.548 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.38 -40.54 2.21 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -74.01 -29.41 61.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.57 -0.959 . . . . 0.0 108.78 179.128 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -46.13 -23.54 0.34 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.689 -0.632 . . . . 0.0 110.57 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.74 -14.71 34.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 110.508 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 132.42 -1.23 4.83 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 12.5 mmtt -81.69 147.45 29.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -1.153 . . . . 0.0 109.602 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 1.017 ' CD2' HD12 ' A' ' 89' ' ' ILE . 20.6 m-85 -127.2 106.69 9.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.91 -1.119 . . . . 0.0 111.661 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.788 ' O ' HG12 ' A' ' 12' ' ' VAL . 2.9 m -75.73 126.75 31.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.908 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -135.32 164.01 28.71 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.177 -0.952 . . . . 0.0 110.46 -178.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.537 ' CZ3' ' HD3' ' A' ' 76' ' ' ARG . 23.3 m95 -101.92 122.28 43.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.573 HG23 ' C ' ' A' ' 7' ' ' VAL . 13.7 p -146.24 166.49 8.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.06 -1.025 . . . . 0.0 111.488 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.517 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -71.92 169.59 15.6 Favored Pre-proline 0 C--N 1.293 -1.85 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.963 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.517 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 48.6 Cg_endo -75.41 -53.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.043 0 O-C-N 124.245 1.655 . . . . 0.0 109.643 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HG3' ' HB3' ' A' ' 31' ' ' HIS 0.256 0.0 OUTLIER -46.54 -22.45 0.28 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.874 179.027 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -66.05 102.76 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 110.306 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -67.17 143.27 56.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 110.18 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 13.9 mttt -42.45 -38.61 1.96 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -68.33 -52.28 35.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.388 -0.82 . . . . 0.0 110.608 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -55.19 -43.54 74.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.678 HG23 HD11 ' A' ' 8' ' ' ILE . 11.4 mt -56.87 -30.3 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.112 -0.993 . . . . 0.0 109.403 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.565 ' HG3' HG11 ' A' ' 51' ' ' VAL . 15.1 ttpt -63.67 -47.02 82.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.461 -0.774 . . . . 0.0 111.039 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -58.73 -34.94 71.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.368 -0.832 . . . . 0.0 112.189 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.68 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -65.34 -50.43 65.62 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.682 -1.262 . . . . 0.0 111.289 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.508 HG23 HG21 ' A' ' 51' ' ' VAL . 9.4 m -76.23 -32.22 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.614 -1.304 . . . . 0.0 110.612 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.79 -51.64 68.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.698 -1.251 . . . . 0.0 109.415 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -79.71 -46.23 17.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 110.035 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -59.16 -64.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.389 -0.819 . . . . 0.0 110.404 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.639 ' CE1' ' CB ' ' A' ' 91' ' ' ALA . 7.5 m-85 -72.03 -19.9 61.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.242 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 66.9 41.92 2.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 110.251 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.777 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -122.55 -164.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.556 -0.715 . . . . 0.0 109.931 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.777 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -119.28 106.79 12.67 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 110.145 179.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.58 HG13 ' CG1' ' A' ' 81' ' ' VAL . 76.3 t -78.43 119.7 27.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.796 HG12 ' O ' ' A' ' 82' ' ' GLN . 12.2 p -104.23 4.96 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.919 . . . . 0.0 110.7 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 167.77 119.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.217 -0.927 . . . . 0.0 110.504 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.062 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -112.16 120.01 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 109.861 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -107.66 115.22 29.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.181 -0.95 . . . . 0.0 109.047 178.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.55 HG21 HD12 ' A' ' 39' ' ' ILE . 2.3 p -116.68 139.07 50.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.101 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.822 HD11 ' HD2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -136.38 144.1 44.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 110.264 -179.569 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -76.34 115.16 15.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.321 -0.862 . . . . 0.0 109.892 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.537 ' HD3' ' CZ3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.267 0.556 . . . . 0.0 110.214 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.53 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 1.8 tttp -117.59 134.77 54.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 109.682 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.822 ' HD2' HD11 ' A' ' 57' ' ' LEU . 6.7 ptpt -102.04 150.3 23.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.022 . . . . 0.0 110.798 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.806 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -117.29 134.14 55.16 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.148 -0.97 . . . . 0.0 111.978 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.806 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.6 mp -110.76 110.86 33.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.062 HG13 HG23 ' A' ' 54' ' ' VAL . 2.4 t -104.98 127.72 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.335 -0.853 . . . . 0.0 111.011 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.796 ' O ' HG12 ' A' ' 52' ' ' VAL . 9.9 tp60 -110.02 146.03 36.01 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.066 -1.021 . . . . 0.0 108.761 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 87' ' ' GLN . 1.6 m -113.26 155.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 118.083 -1.447 . . . . 0.0 109.623 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.951 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -55.83 179.48 0.1 OUTLIER Pre-proline 0 C--N 1.29 -1.996 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.195 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.951 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.5 Cg_endo -72.27 141.51 35.76 Favored 'Trans proline' 0 C--N 1.299 -2.048 0 O-C-N 124.193 1.628 . . . . 0.0 110.55 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.57 -19.63 46.52 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.575 ' NE2' ' CB ' ' A' ' 50' ' ' LYS . 49.9 mt-30 -93.11 168.96 10.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -1.141 . . . . 0.0 110.672 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.8 OUTLIER 179.65 122.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.395 -0.815 . . . . 0.0 110.339 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.017 HD12 ' CD2' ' A' ' 26' ' ' TYR . 15.2 mt -83.86 106.74 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.146 -0.971 . . . . 0.0 109.958 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -61.94 -13.97 30.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.368 -0.832 . . . . 0.0 110.946 -179.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.639 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . -55.03 -34.12 63.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.098 -1.001 . . . . 0.0 110.792 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.776 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -105.86 -23.23 12.74 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.011 -1.056 . . . . 0.0 109.592 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.9 mm-40 -66.49 -37.67 85.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.344 -0.847 . . . . 0.0 109.95 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.07 -8.92 86.82 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 92' ' ' LEU . 4.8 mp -81.34 8.87 8.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -1.153 . . . . 0.0 110.091 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.947 HD13 ' OH ' ' A' ' 18' ' ' TYR . 15.5 mm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.92 ' C ' HG23 ' A' ' 30' ' ' VAL . 1.7 t . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 121.056 0.455 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.926 ' CD1' HG23 ' A' ' 39' ' ' ILE . 2.6 mm -32.83 126.05 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 121.267 0.556 . . . . 0.0 110.919 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 29' ' ' TRP . 1.3 mt -115.03 -94.54 0.48 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.85 . . . . 0.0 109.751 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.85 153.88 42.14 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.892 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.643 ' CB ' HD22 ' A' ' 92' ' ' LEU . 48.4 Cg_endo -76.02 158.25 38.25 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.943 1.496 . . . . 0.0 110.314 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.045 HG12 ' NE1' ' A' ' 29' ' ' TRP . 1.4 m -103.69 129.14 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.204 -0.935 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.906 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 2.9 mm? -102.84 113.01 26.09 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.111 -0.993 . . . . 0.0 110.275 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 15' ' ' GLU . 68.8 m -161.58 144.05 11.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 14' ' ' SER . 69.7 mt-10 -42.87 -51.61 5.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 110.043 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -54.86 -34.03 62.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.288 -0.882 . . . . 0.0 110.172 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -86.03 -58.5 2.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.25 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.906 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -46.13 -31.28 2.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.876 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.25 -8.75 50.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.084 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.14 -37.55 1.96 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -71.12 -18.3 62.53 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.698 -0.883 . . . . 0.0 108.843 178.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.621 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -58.72 -20.02 45.27 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.676 -0.64 . . . . 0.0 110.474 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -88.62 17.32 5.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.487 -0.758 . . . . 0.0 109.953 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 91.96 3.27 68.2 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 72.9 mttt -82.72 136.94 34.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.563 -0.963 . . . . 0.0 109.382 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.946 ' CD2' HD12 ' A' ' 89' ' ' ILE . 24.6 m-85 -127.95 96.9 4.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.658 -1.277 . . . . 0.0 111.538 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.837 HG22 ' HG2' ' A' ' 78' ' ' LYS . 2.8 m -75.61 117.57 17.52 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.53 -0.731 . . . . 0.0 109.695 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.679 ' CZ ' ' CZ ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -116.86 162.96 16.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 110.349 -179.663 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 1.045 ' NE1' HG12 ' A' ' 12' ' ' VAL . 97.7 m95 -92.65 122.77 35.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.92 HG23 ' C ' ' A' ' 7' ' ' VAL . 8.9 p -147.03 166.97 6.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.038 -177.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.502 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -60.5 141.11 92.0 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.148 179.822 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.546 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.5 Cg_endo -72.2 77.46 2.02 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 124.169 1.615 . . . . 0.0 110.278 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 178.67 -34.71 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.349 -0.844 . . . . 0.0 109.906 -179.264 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.49 ' CB ' HG13 ' A' ' 7' ' ' VAL . . . -52.8 92.05 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.493 -0.754 . . . . 0.0 109.917 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -41.98 151.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.335 -0.853 . . . . 0.0 110.319 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.619 ' O ' HG11 ' A' ' 54' ' ' VAL . 6.8 mmtp -42.49 -35.07 0.95 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 110.044 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.6 m -75.08 -39.75 60.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 110.096 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.68 -43.52 76.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.061 -1.024 . . . . 0.0 109.536 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.926 HG23 ' CD1' ' A' ' 8' ' ' ILE . 30.0 mt -57.99 -30.32 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.432 -0.792 . . . . 0.0 109.646 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.685 ' HG3' HG21 ' A' ' 51' ' ' VAL . 11.5 tttm -60.14 -47.42 85.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.556 -0.715 . . . . 0.0 111.523 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -58.22 -38.87 77.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.379 -0.826 . . . . 0.0 112.108 -178.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.605 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -73.56 -50.87 19.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.7 -1.25 . . . . 0.0 111.818 -178.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.116 HG12 ' CE2' ' A' ' 47' ' ' PHE . 6.1 m -65.59 -44.75 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.711 -1.243 . . . . 0.0 111.054 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.623 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -56.91 -48.15 78.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.719 -1.238 . . . . 0.0 110.103 -179.945 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 m -79.0 -47.79 15.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 0.0 110.673 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -68.49 -63.79 0.99 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 110.575 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 1.116 ' CE2' HG12 ' A' ' 43' ' ' VAL . 21.3 m-85 -71.72 -4.13 25.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.174 -0.954 . . . . 0.0 110.165 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 12.4 mtmt 46.79 46.15 15.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.432 -0.793 . . . . 0.0 110.25 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.778 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -118.13 -163.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.57 -0.706 . . . . 0.0 109.87 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.778 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -117.2 112.62 21.07 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.448 -0.782 . . . . 0.0 109.436 179.083 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.685 HG21 ' HG3' ' A' ' 40' ' ' LYS . 17.3 t -77.67 119.53 26.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.076 -1.015 . . . . 0.0 109.337 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.808 HG21 ' N ' ' A' ' 84' ' ' ALA . 25.6 t -116.06 -10.7 12.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 121.685 0.755 . . . . 0.0 110.149 -178.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 82' ' ' GLN . 0.3 OUTLIER 175.39 116.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.593 -0.692 . . . . 0.0 109.581 179.371 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -105.19 136.62 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.996 . . . . 0.0 109.978 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.543 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.1 t-20 -131.39 114.86 15.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.139 -0.975 . . . . 0.0 109.722 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -108.44 150.08 27.89 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.624 -179.662 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.612 HD12 ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -128.9 -177.14 4.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.06 -1.025 . . . . 0.0 110.514 -178.934 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.5 119.92 26.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.557 -0.714 . . . . 0.0 109.298 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.795 HG11 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.617 0 O-C-N 121.104 -0.998 . . . . 0.0 108.911 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.562 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.282 0.563 . . . . 0.0 110.546 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.546 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 9.3 tttt -123.13 141.13 52.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.47 -0.769 . . . . 0.0 109.604 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.837 ' HG2' HG22 ' A' ' 27' ' ' THR . 6.5 tttt -101.24 134.26 44.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.003 -1.061 . . . . 0.0 109.834 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -124.79 120.35 31.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.924 . . . . 0.0 111.618 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.0 mt -95.57 111.63 26.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.576 -0.702 . . . . 0.0 109.987 178.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.939 HG21 HG11 ' A' ' 43' ' ' VAL . 2.9 t -95.41 133.52 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 23' ' ' GLU . 13.9 tp60 -112.26 144.04 42.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 109.6 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.2 m -125.32 156.79 34.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.459 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 1.018 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -47.97 173.07 0.06 OUTLIER Pre-proline 0 C--N 1.296 -1.73 0 CA-C-O 121.29 0.567 . . . . 0.0 111.035 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 47.3 Cg_endo -79.88 55.46 5.65 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 124.499 1.789 . . . . 0.0 110.344 179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.73 -35.01 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 1.018 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -105.79 177.83 4.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -1.185 . . . . 0.0 109.978 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 90' ' ' GLU . 6.2 ptpt 179.61 115.14 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.31 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.946 HD12 ' CD2' ' A' ' 26' ' ' TYR . 73.7 mt -44.2 94.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.994 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' LYS . 1.9 mt-10 -56.91 -14.33 3.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.384 -0.822 . . . . 0.0 110.977 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.56 ' HB3' HG22 ' A' ' 89' ' ' ILE . . . -55.05 -30.08 58.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 0.0 110.345 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.901 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -106.43 -23.23 12.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.176 -0.952 . . . . 0.0 109.495 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 73.7 mm-40 -56.58 -27.58 58.23 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.269 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.2 21.66 28.62 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.837 HD23 HD11 ' A' ' 13' ' ' LEU . 1.4 tp -99.29 2.13 45.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -1.165 . . . . 0.0 110.152 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.463 HD11 ' HZ ' ' A' ' 21' ' ' PHE . 1.5 mp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.235 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.036 HG13 ' HB1' ' A' ' 34' ' ' ALA . 98.5 t . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.599 0.714 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.046 HD11 HG23 ' A' ' 39' ' ' ILE 0.25 75.1 mt -85.85 104.07 13.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.125 -0.985 . . . . 0.0 110.117 -179.572 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -86.89 -94.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.688 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.498 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -108.09 152.5 41.81 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 110.449 -179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.547 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 47.0 Cg_endo -73.15 174.49 11.95 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.93 1.49 . . . . 0.0 110.197 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.841 HG12 ' CD1' ' A' ' 29' ' ' TRP . 2.5 m -114.98 138.33 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.095 -1.003 . . . . 0.0 110.338 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.81 112.66 25.57 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 110.213 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 17' ' ' ALA . 4.1 m -163.87 141.42 7.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -42.83 -54.99 3.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 110.054 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.71 -25.09 25.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.325 -0.859 . . . . 0.0 110.075 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -87.71 -62.02 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.201 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.755 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -46.12 -43.57 15.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.309 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.65 -8.64 57.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.987 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -105.66 -39.73 2.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -77.5 -20.78 53.76 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.51 -0.994 . . . . 0.0 108.979 179.28 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -57.03 -16.2 6.66 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.553 -0.717 . . . . 0.0 110.192 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 25' ' ' LYS . 4.7 tt0 -96.62 16.39 19.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 110.447 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.68 -2.13 60.29 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 23.0 mttt -82.74 143.36 30.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -1.123 . . . . 0.0 109.73 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 1.146 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.1 m-85 -128.03 97.19 4.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.693 -1.254 . . . . 0.0 111.608 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.965 HG23 HD11 ' A' ' 80' ' ' ILE . 8.7 m -76.95 120.68 22.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.755 ' CB ' HG23 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -120.87 163.73 17.75 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.987 -1.071 . . . . 0.0 111.677 -178.527 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.841 ' CD1' HG12 ' A' ' 12' ' ' VAL . 10.2 m95 -94.4 122.77 37.32 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 178.059 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 7' ' ' VAL 0.259 3.8 p -144.4 160.36 15.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 C-N-CA 118.148 -1.421 . . . . 0.0 111.823 -176.31 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.598 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 2.3 t60 -67.3 152.73 95.85 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.612 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.598 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 47.0 Cg_endo -73.19 71.78 3.55 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.071 1.564 . . . . 0.0 109.876 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.37 -33.3 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.782 -179.051 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 1.036 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.31 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.683 -0.636 . . . . 0.0 109.919 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -45.99 137.52 5.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 0.0 110.697 -179.415 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.553 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -43.4 -48.82 7.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.345 -0.847 . . . . 0.0 109.763 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.9 m -59.1 -50.15 75.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.728 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 2.2 mm-40 -55.07 -39.38 69.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 0.0 109.487 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.046 HG23 HD11 ' A' ' 8' ' ' ILE . 34.8 mt -57.61 -31.83 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.543 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.5 ttmp? -62.97 -45.98 89.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 178.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 45' ' ' THR . 32.7 m-80 -72.27 -33.73 67.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.686 -0.634 . . . . 0.0 110.914 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.857 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.44 -46.17 83.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.84 -1.163 . . . . 0.0 110.494 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.19 HG12 ' CE2' ' A' ' 47' ' ' PHE . 6.6 m -76.12 -33.13 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.78 -1.2 . . . . 0.0 109.657 178.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.52 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -68.2 -42.83 79.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.119 -0.988 . . . . 0.0 109.861 179.441 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -79.07 -28.56 43.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.879 179.752 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -95.67 -57.58 2.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 110.967 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 1.19 ' CE2' HG12 ' A' ' 43' ' ' VAL . 6.7 m-30 -76.52 -16.54 59.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.908 . . . . 0.0 110.569 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.4 mtpt 57.33 47.7 16.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 110.48 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.782 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -123.83 -160.22 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.526 -0.734 . . . . 0.0 110.016 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.782 ' N ' HG13 ' A' ' 49' ' ' VAL . 3.8 tmtt? -117.65 105.76 12.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.645 HG21 HG23 ' A' ' 43' ' ' VAL . 45.3 t -78.93 119.72 28.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.349 -0.845 . . . . 0.0 110.613 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.4 p -107.32 -5.91 10.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.346 -0.846 . . . . 0.0 109.658 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.588 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.96 142.78 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.413 -0.804 . . . . 0.0 109.904 179.353 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.96 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -133.48 130.1 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.075 -1.015 . . . . 0.0 109.849 179.698 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.499 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 1.2 t30 -131.18 115.62 16.6 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.863 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.539 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -115.32 164.78 13.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.744 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -149.3 172.13 15.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.201 -0.937 . . . . 0.0 110.438 -179.423 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -81.71 118.82 23.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.115 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 O-C-N 121.282 -0.886 . . . . 0.0 110.158 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.596 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 6.4 ttm180 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.322 0.582 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.688 ' NZ ' ' HB3' ' A' ' 34' ' ' ALA . 18.1 tttt -122.97 139.59 53.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 109.724 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HE2' HG11 ' A' ' 12' ' ' VAL . 25.1 mttt -101.71 147.81 26.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 110.443 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.605 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -132.89 119.54 20.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.325 -0.859 . . . . 0.0 111.216 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.965 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -99.09 112.08 30.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.359 0.6 . . . . 0.0 109.595 179.128 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.049 HG11 HG21 ' A' ' 43' ' ' VAL . 2.5 t -104.24 127.38 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.475 -0.765 . . . . 0.0 110.14 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.691 ' O ' HG12 ' A' ' 52' ' ' VAL . 4.2 tp60 -102.54 147.47 26.72 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.027 -1.046 . . . . 0.0 109.334 179.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 1.5 m -116.35 156.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.311 -1.356 . . . . 0.0 108.891 177.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.789 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -69.06 176.14 1.71 Allowed Pre-proline 0 C--N 1.287 -2.116 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.125 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.789 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.1 Cg_endo -75.18 136.9 20.63 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 O-C-N 124.204 1.634 . . . . 0.0 110.291 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.25 -21.72 21.65 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -115.35 -179.91 3.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -1.234 . . . . 0.0 110.352 -179.988 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER 179.5 101.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.827 . . . . 0.0 110.149 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.146 HD12 ' CD2' ' A' ' 26' ' ' TYR . 48.5 mt -53.94 101.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -0.971 . . . . 0.0 110.172 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 19.4 pt-20 -60.92 -13.5 16.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.423 -0.798 . . . . 0.0 110.918 -179.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.71 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.69 -36.14 64.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 110.524 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.97 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.41 -23.11 12.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.022 -1.049 . . . . 0.0 109.8 179.762 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.8 mm-40 -52.15 -45.5 65.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.353 -0.842 . . . . 0.0 110.456 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -83.2 -23.98 53.12 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.1 tp -42.13 -27.19 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -1.115 . . . . 0.0 110.268 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 94' ' ' GLY . 17.3 mm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.278 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.006 HG13 ' HB1' ' A' ' 34' ' ' ALA . 53.7 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.992 0.425 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.954 HG13 HG12 ' A' ' 7' ' ' VAL . 11.8 mt -81.42 106.31 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.533 -1.354 . . . . 0.0 111.027 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -83.97 -105.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 110.217 179.715 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.65 151.43 41.68 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.948 -1.095 . . . . 0.0 110.415 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.505 ' CB ' HD11 ' A' ' 92' ' ' LEU . 47.3 Cg_endo -74.43 175.69 10.68 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.045 1.55 . . . . 0.0 110.154 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.988 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.4 m -115.06 136.28 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.145 -0.972 . . . . 0.0 110.396 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.741 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.67 107.9 18.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.172 -0.955 . . . . 0.0 110.17 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -163.14 138.54 6.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.201 179.88 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -43.25 -51.07 6.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 110.141 179.908 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -18.17 4.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -103.84 -43.42 5.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.006 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.588 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -62.72 -39.58 94.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 179.852 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.74 -13.53 44.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.036 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -105.46 -47.73 1.1 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 178.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.88 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -51.08 -24.09 3.64 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.897 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.73 -29.93 63.01 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.259 0.552 . . . . 0.0 110.674 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -88.73 16.25 7.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.273 -0.892 . . . . 0.0 110.504 -179.571 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 87.42 13.28 65.84 Favored Glycine 0 N--CA 1.482 1.712 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' CG ' ' OE1' ' A' ' 82' ' ' GLN . 11.3 mttm -82.45 146.33 29.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.183 -1.187 . . . . 0.0 109.505 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 1.131 ' CE2' HD12 ' A' ' 89' ' ' ILE . 28.7 m-85 -127.02 98.3 5.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.911 -1.118 . . . . 0.0 112.146 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.849 HG22 ' HD3' ' A' ' 78' ' ' LYS . 2.5 m -79.13 126.42 30.71 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 178.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.808 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 13.4 m-85 -126.58 164.93 20.13 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.28 -0.888 . . . . 0.0 111.618 -178.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.988 ' NE1' HG12 ' A' ' 12' ' ' VAL . 43.9 m95 -104.24 122.36 45.23 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 176.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 7' ' ' VAL . 1.2 p -144.28 157.6 15.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 117.708 -1.597 . . . . 0.0 112.259 -176.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -62.13 151.75 80.15 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.952 -179.109 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.8 Cg_endo -73.67 70.03 4.28 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.211 1.637 . . . . 0.0 109.848 179.471 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.54 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 109.911 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 1.006 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -44.75 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.639 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -43.22 138.93 2.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.92 . . . . 0.0 110.544 -179.243 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.543 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -43.54 -38.08 2.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.701 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 5.6 m -70.59 -44.45 67.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.469 -0.769 . . . . 0.0 109.685 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.497 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 2.8 mm-40 -55.6 -41.16 73.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.562 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.815 ' O ' HD11 ' A' ' 8' ' ' ILE . 74.7 mt -57.4 -30.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.903 . . . . 0.0 108.633 179.038 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 37' ' ' THR . 17.7 tttm -64.96 -44.46 89.32 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.415 -0.803 . . . . 0.0 109.404 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.5 ' O ' ' HB ' ' A' ' 45' ' ' THR . 40.3 m-80 -73.17 -43.37 61.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.696 -0.627 . . . . 0.0 111.277 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.854 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.23 -51.32 70.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.603 -1.311 . . . . 0.0 110.261 -179.142 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.767 HG21 ' HE2' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -63.98 -47.22 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.056 -1.028 . . . . 0.0 109.968 179.981 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.481 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -57.0 -44.88 83.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.027 -1.046 . . . . 0.0 109.41 179.497 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -78.53 -12.58 60.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.4 -0.813 . . . . 0.0 109.446 179.309 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -97.3 -71.71 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.832 . . . . 0.0 110.236 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.812 ' CG ' HD13 ' A' ' 89' ' ' ILE . 43.3 m-85 -72.1 -22.12 61.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.192 -0.942 . . . . 0.0 110.198 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 68.78 44.2 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 110.006 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.67 HG22 ' H ' ' A' ' 50' ' ' LYS . 1.1 p -118.65 -160.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.541 -0.724 . . . . 0.0 110.383 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.67 ' H ' HG22 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.11 104.97 11.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.423 -0.798 . . . . 0.0 109.584 179.268 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.735 HG22 ' CG1' ' A' ' 81' ' ' VAL . 25.1 t -78.23 119.71 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.963 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.2 p -102.98 -8.94 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 110.227 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 4.9 ptmt -175.39 131.24 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.873 179.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.038 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -123.62 127.62 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.974 -1.078 . . . . 0.0 110.332 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.543 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 37.7 t30 -131.06 115.65 16.72 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.472 -0.767 . . . . 0.0 109.02 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.598 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.92 157.78 22.9 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 110.239 -179.379 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -145.94 171.37 14.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.786 . . . . 0.0 110.159 -179.67 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -85.26 128.47 34.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.192 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.538 HG21 ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.305 -0.872 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.133 0.492 . . . . 0.0 109.897 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 20.4 tttt -123.08 127.5 48.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.744 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.849 ' HD3' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -101.81 151.01 22.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.285 179.378 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.808 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -127.16 129.34 47.7 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.974 -1.078 . . . . 0.0 111.91 -179.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.79 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.5 mp -109.72 111.43 36.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.164 178.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.038 HG13 HG23 ' A' ' 54' ' ' VAL . 19.3 t -112.29 128.29 69.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.572 -0.705 . . . . 0.0 110.162 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.713 ' O ' HG12 ' A' ' 52' ' ' VAL . 2.5 tp60 -101.55 151.27 22.17 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.037 -1.039 . . . . 0.0 109.012 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.0 m -112.57 155.84 13.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 C-N-CA 118.082 -1.447 . . . . 0.0 108.443 177.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.713 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -58.01 169.98 0.8 Allowed Pre-proline 0 C--N 1.284 -2.244 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.646 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.615 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 45.4 Cg_endo -79.63 53.48 4.75 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 O-C-N 124.416 1.745 . . . . 0.0 110.733 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.475 ' N ' ' OE1' ' A' ' 87' ' ' GLN . . . -168.72 23.47 0.1 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.713 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -150.31 -175.53 5.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.941 -1.329 . . . . 0.0 110.268 -179.965 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER 179.88 113.25 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.455 -0.778 . . . . 0.0 109.998 179.865 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.131 HD12 ' CE2' ' A' ' 26' ' ' TYR . 16.8 mt -59.92 100.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.28 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -53.95 -27.99 34.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.72 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.2 73.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.414 -0.804 . . . . 0.0 110.22 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.88 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -107.67 1.23 22.98 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.977 -1.089 . . . . 0.0 112.079 -179.51 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -95.11 3.31 54.91 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 117.958 -1.497 . . . . 0.0 110.118 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -118.54 -17.78 5.09 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -56.31 -33.75 65.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.366 -1.079 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.517 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 4.6 mt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.214 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.596 HG12 HG13 ' A' ' 8' ' ' ILE . 9.2 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.052 0.454 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.101 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.2 mt -63.08 156.42 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.224 -0.922 . . . . 0.0 110.032 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.557 HD12 ' H ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -144.61 -81.72 0.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.069 -1.019 . . . . 0.0 110.594 179.483 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.557 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -108.15 145.23 31.03 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.981 -1.074 . . . . 0.0 110.573 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 47.7 Cg_endo -74.53 169.8 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.037 1.546 . . . . 0.0 110.563 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.8 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.3 m -115.13 136.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.127 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.007 HD11 HD23 ' A' ' 95' ' ' LEU . 3.2 mm? -102.93 110.26 22.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.136 -0.978 . . . . 0.0 110.435 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -164.0 145.72 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.473 -0.767 . . . . 0.0 109.559 179.821 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 14' ' ' SER . 2.1 mm-40 -43.42 -33.48 1.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 109.986 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -28.23 66.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 110.024 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -91.96 19.36 6.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.296 -0.877 . . . . 0.0 109.807 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.584 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.7 m-85 -138.49 -41.92 0.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.54 -0.725 . . . . 0.0 109.854 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.12 79.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.177 -0.952 . . . . 0.0 108.883 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.85 -31.1 7.93 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 178.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -72.31 -10.83 60.29 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.522 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -66.84 -8.39 28.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.655 -0.653 . . . . 0.0 110.216 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -1.98 19.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 110.385 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.588 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 119.48 4.09 12.23 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 27.4 mttt -84.35 132.71 34.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -1.152 . . . . 0.0 109.772 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.859 ' CD2' HD12 ' A' ' 89' ' ' ILE . 62.7 m-85 -126.94 111.15 13.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.719 -1.238 . . . . 0.0 111.79 -179.328 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.728 HG22 ' HB2' ' A' ' 78' ' ' LYS . 7.5 m -79.27 128.95 33.95 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.458 0.647 . . . . 0.0 109.932 179.09 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.695 ' CE1' ' CZ ' ' A' ' 47' ' ' PHE . 19.0 m-85 -124.76 164.73 19.35 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.519 -0.738 . . . . 0.0 109.879 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.8 ' NE1' HG12 ' A' ' 12' ' ' VAL . 4.4 m95 -95.14 122.86 38.25 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.536 HG23 ' N ' ' A' ' 8' ' ' ILE . 8.1 p -137.1 165.01 28.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.844 -177.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.479 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -61.45 145.31 91.15 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.908 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.39 70.68 2.49 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.1 1.579 . . . . 0.0 109.934 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 178.83 -32.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.413 -0.805 . . . . 0.0 110.12 -178.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -56.27 96.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.463 -0.773 . . . . 0.0 110.379 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.439 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 1.3 p -46.17 159.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 109.962 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.773 ' O ' HG11 ' A' ' 54' ' ' VAL . 11.0 mttp -47.71 -40.22 19.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.289 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.9 m -75.28 -38.97 60.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.591 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.439 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 2.4 mt-10 -55.6 -43.88 76.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.038 -1.039 . . . . 0.0 109.944 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.776 ' O ' HD11 ' A' ' 8' ' ' ILE . 13.0 mt -57.5 -30.24 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.774 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.916 ' HG3' HG11 ' A' ' 51' ' ' VAL . 39.8 tttm -57.6 -41.99 82.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 111.537 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.425 ' O ' HG23 ' A' ' 45' ' ' THR . 6.6 m-80 -58.29 -49.53 76.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.465 -0.772 . . . . 0.0 112.397 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.101 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -73.49 -39.18 65.06 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.711 -1.243 . . . . 0.0 111.631 -178.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.843 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -62.41 -45.54 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.898 -1.126 . . . . 0.0 110.401 -179.343 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.477 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -56.41 -38.75 71.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.012 . . . . 0.0 109.846 -179.818 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 41' ' ' ASN . 43.0 p -79.38 -45.43 19.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 109.975 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.64 -60.58 2.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 110.497 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.843 ' CD2' HG22 ' A' ' 43' ' ' VAL . 44.4 m-85 -71.65 -21.52 61.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.957 . . . . 0.0 110.158 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 56.32 40.75 29.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 110.295 179.734 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.77 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -120.99 -165.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.519 -0.738 . . . . 0.0 109.896 179.708 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.77 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -106.66 112.17 25.04 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.23 178.812 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.916 HG11 ' HG3' ' A' ' 40' ' ' LYS . 19.6 t -77.59 135.68 25.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.482 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.765 HG21 ' N ' ' A' ' 84' ' ' ALA . 2.5 t -128.57 -5.87 3.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.48 -0.763 . . . . 0.0 110.573 -178.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.537 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER 170.45 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.424 -0.797 . . . . 0.0 109.118 179.498 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.863 HG22 HG22 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -115.47 133.04 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.332 -0.855 . . . . 0.0 110.564 -179.26 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.557 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -131.58 116.09 16.95 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.437 -0.79 . . . . 0.0 109.372 178.515 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -116.6 149.46 39.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 110.436 -179.295 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.531 HD12 ' HG3' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -130.11 143.38 50.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.477 -0.765 . . . . 0.0 109.521 179.884 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.21 112.58 7.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.018 -1.051 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.285 -0.884 . . . . 0.0 110.089 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.637 ' NE ' ' CH2' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.283 0.563 . . . . 0.0 109.859 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.51 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 6.5 ptmt -123.3 141.79 51.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.437 -179.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.728 ' HB2' HG22 ' A' ' 27' ' ' THR . 1.7 ptpt -101.0 151.14 22.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.361 -0.837 . . . . 0.0 109.626 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -115.61 118.77 34.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.019 -1.051 . . . . 0.0 111.992 -179.109 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 12.1 mt -94.94 110.96 24.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.528 -0.732 . . . . 0.0 109.585 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.863 HG22 HG22 ' A' ' 54' ' ' VAL . 6.4 t -102.09 143.22 15.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.09 -1.006 . . . . 0.0 110.458 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.537 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 29.6 tp60 -116.44 150.58 37.6 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.298 -0.876 . . . . 0.0 109.098 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.511 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.5 m -124.91 155.75 33.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 118.324 -1.351 . . . . 0.0 109.973 178.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.939 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -47.76 178.34 0.03 OUTLIER Pre-proline 0 C--N 1.291 -1.969 0 O-C-N 121.839 -0.538 . . . . 0.0 110.73 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.939 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.7 Cg_endo -74.23 142.78 30.95 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.386 1.73 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.65 -40.98 2.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.521 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 6.6 mt-30 -70.18 176.88 3.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -1.199 . . . . 0.0 110.387 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 178.42 102.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.18 -179.192 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.859 HD12 ' CD2' ' A' ' 26' ' ' TYR . 8.3 mt -55.99 87.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.914 -1.116 . . . . 0.0 109.597 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' LYS . 11.1 pt-20 -57.99 -13.22 4.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.429 -0.795 . . . . 0.0 110.946 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.757 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.27 -33.53 58.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.108 -0.995 . . . . 0.0 110.777 -179.16 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.757 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.24 -23.04 12.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.927 -1.108 . . . . 0.0 109.929 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.2 mm-40 -52.9 -33.83 52.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.436 -0.79 . . . . 0.0 110.413 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.67 6.06 58.72 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.007 HD23 HD11 ' A' ' 13' ' ' LEU . 1.3 tp -76.02 -25.43 55.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -1.17 . . . . 0.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.584 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 8.2 mt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.158 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.535 ' C ' HG23 ' A' ' 30' ' ' VAL . 5.4 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.231 0.538 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.973 HD12 ' HB3' ' A' ' 42' ' ' ALA . 4.8 mt -56.02 148.0 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.02 -100.36 0.44 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 110.663 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.38 161.66 23.13 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.042 -1.037 . . . . 0.0 110.718 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HG3' HD22 ' A' ' 92' ' ' LEU . 49.8 Cg_endo -76.6 157.99 35.99 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.126 1.593 . . . . 0.0 110.308 179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.017 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.4 m -100.03 140.0 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.0 110.272 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.759 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.64 113.17 26.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.95 . . . . 0.0 110.19 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 52.7 m -167.01 135.13 2.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.3 mm-40 -42.86 -47.45 5.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.92 . . . . 0.0 110.038 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -54.79 -35.92 64.36 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 19' ' ' ALA . . . -79.91 -63.71 1.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 0.0 110.183 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.854 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 1.3 m-85 -42.87 -26.25 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 110.406 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -88.42 -35.32 17.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.691 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -83.23 -38.34 11.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 178.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.69 -15.06 60.35 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.728 -0.866 . . . . 0.0 108.882 178.871 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -63.97 -17.15 62.99 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.485 0.66 . . . . 0.0 109.916 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.18 -2.76 52.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.412 -0.805 . . . . 0.0 110.203 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 117.78 0.77 17.56 Favored Glycine 0 N--CA 1.478 1.5 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 73.2 mttt -81.96 140.33 34.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -1.108 . . . . 0.0 109.617 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 64.4 m-85 -127.85 104.85 8.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.572 -1.33 . . . . 0.0 111.982 -178.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.002 HG23 HD11 ' A' ' 80' ' ' ILE . 1.9 m -79.44 140.15 37.45 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.43 0.634 . . . . 0.0 109.291 178.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.859 ' HB3' HG23 ' A' ' 8' ' ' ILE . 17.0 m-85 -140.24 165.18 28.08 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 110.404 -179.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 1.017 ' NE1' HG12 ' A' ' 12' ' ' VAL . 96.3 m95 -105.12 121.8 44.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 176.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 7' ' ' VAL . 4.9 p -144.03 165.46 13.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.778 -176.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.483 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -59.62 149.6 70.34 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.75 -179.369 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.483 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 47.1 Cg_endo -73.65 71.66 3.92 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.208 1.636 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.487 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.08 -34.05 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.356 -0.84 . . . . 0.0 110.156 -179.095 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -47.65 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.364 -0.835 . . . . 0.0 110.212 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -43.34 167.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.545 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.2 mtpt -64.13 -58.06 7.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.925 . . . . 0.0 110.349 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.495 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.5 m -58.74 -39.29 80.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.951 . . . . 0.0 110.177 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 6.4 mt-10 -55.89 -45.98 78.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 0.0 109.651 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.711 ' O ' HD11 ' A' ' 8' ' ' ILE . 17.7 mt -57.13 -30.13 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.493 -0.755 . . . . 0.0 110.015 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.552 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.0 ttmm -57.77 -47.51 82.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.414 -0.804 . . . . 0.0 111.799 -179.283 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -58.7 -45.95 88.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 112.63 -177.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.973 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.75 -48.45 81.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.768 -1.207 . . . . 0.0 111.893 -178.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.959 HG13 HD13 ' A' ' 8' ' ' ILE . 19.1 m -74.47 -28.89 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.424 -1.422 . . . . 0.0 110.467 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -52.61 64.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.836 -1.165 . . . . 0.0 109.219 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.2 p -80.25 -45.42 17.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.853 179.011 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -58.44 -65.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.419 -0.801 . . . . 0.0 110.57 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.663 ' HE1' HD21 ' A' ' 92' ' ' LEU . 31.8 m-85 -71.48 -19.07 62.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.996 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER 68.08 46.31 1.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 110.517 179.643 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.753 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -134.01 -165.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.437 -0.789 . . . . 0.0 110.259 179.907 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.753 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -118.74 111.18 18.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.545 -0.722 . . . . 0.0 109.881 179.274 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.898 HG13 ' CG1' ' A' ' 81' ' ' VAL . 89.4 t -78.77 136.32 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 110.134 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.673 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.7 p -118.25 -7.3 11.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.277 -0.889 . . . . 0.0 110.164 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -176.67 131.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.819 179.41 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.087 HG23 HG13 ' A' ' 81' ' ' VAL . 1.2 t -123.68 119.64 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.999 -1.063 . . . . 0.0 110.258 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.488 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 1.6 t-20 -116.74 115.91 26.51 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.218 178.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -109.55 145.44 36.33 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.57 -179.611 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.58 160.45 28.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.275 -0.891 . . . . 0.0 110.903 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -72.98 115.12 11.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.25 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.745 HG11 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.267 -0.895 . . . . 0.0 110.229 -179.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.587 ' CG ' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.152 0.501 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HA ' HG23 ' A' ' 59' ' ' VAL . 13.2 tttt -121.15 137.99 54.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.068 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.69 ' HD3' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -105.44 150.67 25.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 110.001 -179.901 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.785 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -128.88 128.64 44.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.091 -1.006 . . . . 0.0 112.347 -179.212 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.002 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -108.69 111.88 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.087 HG13 HG23 ' A' ' 54' ' ' VAL . 5.0 t -108.37 137.46 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 111.234 -178.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.673 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.4 tp60 -111.17 154.08 24.86 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.265 -0.897 . . . . 0.0 108.742 178.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 87' ' ' GLN . 2.9 m -116.45 155.82 17.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 C-N-CA 118.257 -1.377 . . . . 0.0 108.643 177.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.966 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -56.19 -179.6 0.09 OUTLIER Pre-proline 0 C--N 1.284 -2.244 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.032 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.966 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.3 Cg_endo -71.68 140.4 35.73 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 124.103 1.581 . . . . 0.0 110.387 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.05 -23.34 29.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.534 ' HB2' HG23 ' A' ' 83' ' ' VAL . 35.7 mt-30 -87.1 167.93 13.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.259 -1.142 . . . . 0.0 110.641 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HD3' ' OH ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER 179.45 115.49 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.332 -0.855 . . . . 0.0 110.653 179.89 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.629 ' CG2' ' CD1' ' A' ' 47' ' ' PHE . 9.2 mt -78.05 75.53 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.548 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.71 -13.09 1.49 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.508 -0.745 . . . . 0.0 111.479 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.748 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -53.59 -20.6 5.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.933 -1.105 . . . . 0.0 110.629 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.748 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.47 -23.21 12.56 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.001 -1.062 . . . . 0.0 109.609 179.506 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -54.61 -35.71 63.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 110.373 -179.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.11 -4.9 71.1 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 95' ' ' LEU . 3.0 tp -69.24 -5.47 23.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.091 -1.24 . . . . 0.0 110.194 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.614 ' CG1' ' CZ ' ' A' ' 18' ' ' TYR . 20.3 mt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.21 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 8' ' ' ILE . 11.3 t . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.973 HD12 ' HB3' ' A' ' 42' ' ' ALA . 6.8 mt -74.07 158.13 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.991 -1.068 . . . . 0.0 110.151 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 9' ' ' LEU . 34.1 mt -140.71 -99.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 110.251 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.68 155.96 39.69 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 110.346 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.957 ' HG3' HD22 ' A' ' 92' ' ' LEU . 46.0 Cg_endo -73.71 153.76 48.83 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.978 1.514 . . . . 0.0 110.255 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.941 HG12 ' CE2' ' A' ' 29' ' ' TRP . 2.3 m -92.14 141.12 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.271 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.766 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.83 107.5 18.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.932 . . . . 0.0 110.204 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 15' ' ' GLU . 22.3 m -161.54 143.06 11.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.104 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' SER . 9.8 tm-20 -43.19 -51.31 6.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.004 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -42.67 71.87 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.23 -0.919 . . . . 0.0 110.218 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 18' ' ' TYR . . . -70.83 -65.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.703 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.6 m-85 -42.55 -27.62 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 110.317 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -90.38 -34.85 15.5 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.24 -0.913 . . . . 0.0 109.562 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -78.58 -44.98 9.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.158 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.629 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.04 -22.36 64.96 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.56 -0.964 . . . . 0.0 108.734 178.936 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -52.6 -19.37 2.28 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.333 0.587 . . . . 0.0 110.661 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.53 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 1.6 tt0 -95.06 15.08 19.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.868 . . . . 0.0 110.498 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 97.61 1.01 59.04 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HD2' HG21 ' A' ' 80' ' ' ILE . 2.8 mttp -82.5 143.37 31.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -1.089 . . . . 0.0 109.552 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 1.079 ' CD2' HD12 ' A' ' 89' ' ' ILE . 23.1 m-85 -127.81 103.87 7.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.761 -1.212 . . . . 0.0 111.918 -179.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.058 HG23 HD11 ' A' ' 80' ' ' ILE . 1.9 m -75.62 141.28 42.88 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.785 ' CB ' HG23 ' A' ' 8' ' ' ILE . 18.4 m-85 -138.0 165.24 27.05 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.353 -0.842 . . . . 0.0 110.48 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.941 ' CE2' HG12 ' A' ' 12' ' ' VAL . 22.4 m95 -101.68 120.79 40.89 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.287 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.785 HG13 ' HE2' ' A' ' 77' ' ' LYS . 1.9 p -152.57 165.31 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 118.481 -1.288 . . . . 0.0 111.522 -176.693 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.566 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -70.9 172.55 6.2 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.713 -0.617 . . . . 0.0 110.683 -179.51 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.9 Cg_endo -75.35 -59.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.241 1.653 . . . . 0.0 110.413 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -38.46 -26.0 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.552 179.283 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.725 ' HB3' ' NZ ' ' A' ' 77' ' ' LYS . . . -62.95 90.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.82 -1.175 . . . . 0.0 110.051 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -49.49 162.66 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 -179.84 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -57.47 -56.22 24.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.86 . . . . 0.0 110.117 -179.964 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.6 m -60.49 -34.77 74.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.307 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -55.79 -42.65 75.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 109.642 179.776 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.775 ' O ' HD11 ' A' ' 8' ' ' ILE . 9.0 mt -57.65 -30.96 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.145 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HG3' HG11 ' A' ' 51' ' ' VAL . 13.3 tttp -62.22 -46.25 89.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 110.52 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -59.12 -49.12 79.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.477 -0.764 . . . . 0.0 112.003 -178.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.973 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -66.12 -47.65 73.43 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.849 -1.157 . . . . 0.0 111.417 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.907 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -63.7 -39.54 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.864 -1.147 . . . . 0.0 110.395 -179.325 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.24 -47.33 78.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.0 -1.063 . . . . 0.0 109.609 179.939 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.3 p -79.42 -45.07 20.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.357 -0.839 . . . . 0.0 109.883 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.12 -69.61 0.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.418 -0.801 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.907 ' CD2' HG22 ' A' ' 43' ' ' VAL . 77.5 m-85 -71.63 -21.81 61.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.132 -0.98 . . . . 0.0 110.219 -179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 9.2 mttt 65.2 40.08 5.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.744 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -117.88 -162.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.485 0.659 . . . . 0.0 110.313 -179.896 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.744 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -118.2 104.52 10.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.522 -0.736 . . . . 0.0 109.486 178.946 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.817 HG22 HG11 ' A' ' 81' ' ' VAL . 27.0 t -78.81 119.8 28.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.694 -179.223 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.652 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.5 p -103.17 -0.57 10.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.295 -0.878 . . . . 0.0 109.812 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.571 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.97 146.87 0.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 179.385 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.924 HG22 HG22 ' A' ' 81' ' ' VAL . 1.2 t -133.37 122.25 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.516 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -121.99 115.8 23.17 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 109.086 178.639 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.641 ' C ' HD23 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -120.67 140.84 51.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 110.305 -179.481 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.677 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -148.55 149.93 32.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.634 -0.667 . . . . 0.0 109.345 -179.847 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.616 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 1.7 m80 -86.34 143.51 27.82 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.151 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.461 ' H ' HG22 ' A' ' 59' ' ' VAL . 15.9 m . . . . . 0 C--N 1.289 -2.051 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.785 ' HE2' HG13 ' A' ' 30' ' ' VAL . 3.4 ttpt -96.29 128.99 43.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 111.077 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 28.7 pttt -119.54 151.3 38.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.413 -0.804 . . . . 0.0 109.348 179.147 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.761 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -118.06 128.77 55.08 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.89 -1.131 . . . . 0.0 113.03 -178.356 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.058 HD11 HG23 ' A' ' 27' ' ' THR . 1.7 mp -107.58 111.24 34.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.924 HG22 HG22 ' A' ' 54' ' ' VAL . 23.4 t -107.37 139.0 30.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 111.005 -178.703 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.652 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.6 tp60 -105.59 153.32 21.95 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.341 -0.849 . . . . 0.0 108.789 179.008 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.53 HG11 ' HE2' ' A' ' 26' ' ' TYR . 1.5 m -119.16 156.52 21.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 C-N-CA 118.171 -1.412 . . . . 0.0 109.327 178.343 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -64.46 177.03 0.61 Allowed Pre-proline 0 C--N 1.287 -2.138 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.223 -179.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.5 Cg_endo -74.81 138.4 23.46 Favored 'Trans proline' 0 C--N 1.298 -2.093 0 O-C-N 124.296 1.682 . . . . 0.0 110.19 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.68 -31.88 7.0 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.531 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -108.45 174.09 6.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.037 -1.272 . . . . 0.0 110.669 -179.917 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 178.99 130.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.487 -0.758 . . . . 0.0 110.081 179.827 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.079 HD12 ' CD2' ' A' ' 26' ' ' TYR . 40.1 mt -83.74 82.5 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 110.118 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -13.83 10.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.522 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.766 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.09 -19.6 7.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 0.0 110.525 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.957 HD22 ' HG3' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -106.21 -23.07 12.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.086 -1.009 . . . . 0.0 109.674 179.834 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -58.87 -54.74 43.75 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.426 -0.796 . . . . 0.0 110.442 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -73.9 -21.9 78.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.688 HD23 HD11 ' A' ' 13' ' ' LEU . 6.8 tp -42.71 -27.15 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -1.145 . . . . 0.0 110.363 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.516 HG13 ' CE1' ' A' ' 18' ' ' TYR . 40.0 mt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.779 HG12 HG13 ' A' ' 8' ' ' ILE . 15.5 t . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.237 0.541 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.059 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.3 mt -69.57 157.62 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 110.83 -178.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -152.13 -93.23 0.05 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 110.723 179.836 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -91.81 141.63 25.75 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.088 -1.008 . . . . 0.0 110.909 -179.455 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.2 Cg_endo -77.16 173.49 14.3 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.207 1.635 . . . . 0.0 110.821 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.978 HG12 ' NE1' ' A' ' 29' ' ' TRP . 1.2 m -115.21 127.4 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.339 -0.85 . . . . 0.0 110.032 179.841 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.802 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.0 mm? -103.08 113.27 26.62 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 110.351 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.7 m -158.15 161.54 37.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.133 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -58.03 -55.26 37.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -54.66 -21.61 11.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.45 -52.03 3.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.802 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -49.5 -34.99 18.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.925 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.41 -8.63 50.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.38 -42.8 1.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -66.31 -17.05 64.53 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.56 -0.964 . . . . 0.0 108.91 178.879 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.72 -20.13 46.15 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.747 -0.596 . . . . 0.0 110.658 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.468 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 3.2 tt0 -88.54 17.71 5.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.458 -0.776 . . . . 0.0 110.123 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.09 4.12 69.26 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -178.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 48.2 mttm -82.76 134.96 35.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.591 -0.947 . . . . 0.0 109.445 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 1.032 ' CD2' HD12 ' A' ' 89' ' ' ILE . 24.6 m-85 -128.21 98.03 4.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.562 -1.336 . . . . 0.0 111.537 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.4 m -75.02 132.89 41.66 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.638 -0.664 . . . . 0.0 109.915 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.67 ' CB ' HG23 ' A' ' 8' ' ' ILE . 34.8 m-85 -126.72 163.72 22.9 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.244 -179.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.978 ' NE1' HG12 ' A' ' 12' ' ' VAL . 95.8 m95 -95.11 122.61 37.96 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.117 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.628 HG23 ' C ' ' A' ' 7' ' ' VAL . 2.7 p -149.02 164.38 4.23 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 C-N-CA 117.649 -1.62 . . . . 0.0 112.224 -176.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.453 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -56.75 140.78 75.09 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.281 -179.905 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 48.9 Cg_endo -74.83 80.02 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.199 1.631 . . . . 0.0 110.262 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 178.47 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 110.112 -179.133 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -54.36 97.03 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.406 -0.809 . . . . 0.0 110.282 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.475 ' OG1' ' CG ' ' A' ' 38' ' ' GLU . 2.2 p -42.82 149.52 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 110.168 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.631 ' O ' HG11 ' A' ' 54' ' ' VAL . 5.7 mmtp -42.61 -40.72 2.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.183 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 3.5 m -75.12 -39.07 60.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.31 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.475 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 7.8 mt-10 -55.68 -44.25 77.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 109.808 179.825 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.685 ' O ' HD11 ' A' ' 8' ' ' ILE . 14.5 mt -57.24 -30.32 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.618 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.672 ' HG3' HG11 ' A' ' 51' ' ' VAL . 24.2 tttt -57.82 -42.98 85.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 0.0 111.258 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -58.19 -49.11 78.2 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.404 -0.81 . . . . 0.0 112.428 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.059 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -68.47 -47.98 65.71 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.711 -1.243 . . . . 0.0 111.759 -178.357 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.034 HG11 HG11 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -59.78 -47.09 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.908 -1.12 . . . . 0.0 110.013 -179.431 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.503 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -56.82 -43.38 80.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.095 -1.003 . . . . 0.0 109.831 179.897 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -79.14 -27.39 42.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 109.97 179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.42 -61.64 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.074 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.842 ' CD2' HG22 ' A' ' 43' ' ' VAL . 52.1 m-85 -71.8 -20.88 61.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.961 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 62.86 39.92 10.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.458 -0.776 . . . . 0.0 110.104 179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.771 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -119.32 -164.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.807 179.705 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.771 ' N ' HG13 ' A' ' 49' ' ' VAL . 5.4 tmtm? -113.42 106.6 14.78 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.443 -0.786 . . . . 0.0 109.364 179.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.799 HG22 ' CG1' ' A' ' 81' ' ' VAL . 44.7 t -78.22 130.72 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 110.145 -179.397 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.665 HG12 ' C ' ' A' ' 82' ' ' GLN . 13.3 p -114.96 -9.77 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.409 -0.807 . . . . 0.0 110.271 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.615 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 176.75 129.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 109.932 179.696 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.1 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.6 OUTLIER -109.15 141.56 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.104 179.847 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.56 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.6 m-20 -130.04 115.52 17.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.285 -0.884 . . . . 0.0 109.561 178.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -108.85 159.82 16.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.916 -179.459 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.903 HD11 ' HE3' ' A' ' 78' ' ' LYS . 1.8 pp -148.47 177.88 9.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.211 -0.931 . . . . 0.0 110.853 -179.37 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.83 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -74.95 134.53 41.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.967 179.642 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.902 . . . . 0.0 109.358 179.677 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.104 0.478 . . . . 0.0 110.266 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.562 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 6.3 tttp -123.78 142.2 51.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.903 ' HE3' HD11 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -100.59 138.39 37.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.073 . . . . 0.0 109.792 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -133.22 119.36 19.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.097 -1.002 . . . . 0.0 111.836 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.626 HG12 HG23 ' A' ' 27' ' ' THR . 16.7 mt -99.9 109.91 25.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.857 178.327 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.1 HG22 ' CG2' ' A' ' 54' ' ' VAL . 52.8 t -96.73 129.46 46.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 110.02 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.665 ' C ' HG12 ' A' ' 52' ' ' VAL . 2.5 tp60 -98.86 153.2 18.97 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.013 179.358 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 1.5 m -119.66 156.6 22.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 C-N-CA 118.327 -1.349 . . . . 0.0 108.632 177.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.907 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -69.84 179.29 0.81 Allowed Pre-proline 0 C--N 1.283 -2.309 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.133 -179.71 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.907 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.06 140.76 31.76 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 124.263 1.665 . . . . 0.0 110.432 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.45 -37.1 3.95 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.887 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -104.31 176.8 5.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.125 -1.221 . . . . 0.0 110.643 -179.897 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.55 115.04 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.488 -0.757 . . . . 0.0 110.001 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.032 HD12 ' CD2' ' A' ' 26' ' ' TYR . 14.1 mt -60.94 109.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.23 -0.919 . . . . 0.0 110.464 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 17.8 pt-20 -78.12 -14.33 59.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.318 -0.863 . . . . 0.0 110.745 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.705 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.15 -28.67 54.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.0 110.373 -179.638 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.764 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.02 -23.13 12.71 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.165 -0.959 . . . . 0.0 109.467 179.788 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 25.3 mm-40 -54.53 -24.42 20.66 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.43 -0.794 . . . . 0.0 110.165 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.63 -36.35 4.85 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.433 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 3.5 mp -49.32 -31.94 10.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.375 -1.073 . . . . 0.0 110.114 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.783 HG22 ' CD1' ' A' ' 18' ' ' TYR . 46.4 pt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.181 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 30' ' ' VAL . 8.4 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.369 0.604 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.048 HD11 HG23 ' A' ' 39' ' ' ILE . 14.7 mm -87.04 102.8 12.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 121.371 -0.83 . . . . 0.0 110.466 -178.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.607 ' H ' HD12 ' A' ' 9' ' ' LEU . 4.5 mp -62.51 -107.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 110.431 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.539 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -108.64 164.22 15.22 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.961 -1.087 . . . . 0.0 110.257 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 45.9 Cg_endo -73.31 153.5 50.79 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.982 1.517 . . . . 0.0 110.176 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.749 HG12 ' O ' ' A' ' 27' ' ' THR . 1.4 p -112.96 114.64 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.939 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.84 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.5 mm? -101.49 112.5 25.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 110.345 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.526 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -158.31 154.95 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.951 -179.981 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.0 mm-40 -43.08 -58.07 2.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 110.038 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 22.4 ttmt -54.72 -19.17 5.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.526 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -99.84 -54.58 2.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 110.065 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.567 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 3.1 m-85 -53.82 -50.86 65.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.968 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -12.7 37.93 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.224 -0.922 . . . . 0.0 109.14 179.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' N ' ' A' ' 22' ' ' ALA . . . -94.46 -40.47 4.46 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 178.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 3.4 m-30 -51.44 -24.67 5.24 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.601 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 20' ' ' GLY . . . -43.27 -36.3 1.76 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.467 0.651 . . . . 0.0 110.25 -179.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.449 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 2.2 tt0 -95.9 16.48 17.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.412 -0.805 . . . . 0.0 110.515 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 80.64 6.74 89.17 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HG2' ' HG3' ' A' ' 82' ' ' GLN . 49.9 mttt -82.17 132.62 35.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.241 -1.152 . . . . 0.0 109.755 179.812 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.861 ' CD2' HD12 ' A' ' 89' ' ' ILE . 70.7 m-85 -126.46 111.84 14.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.775 -1.203 . . . . 0.0 111.988 -178.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.749 ' O ' HG12 ' A' ' 12' ' ' VAL . 36.8 m -75.73 141.97 42.53 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.606 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.896 ' CD1' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -141.11 164.72 29.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 -179.221 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.6 ' CE3' ' HG2' ' A' ' 76' ' ' ARG . 79.6 m95 -93.5 122.4 35.89 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.166 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 7' ' ' VAL . 7.6 p -137.05 164.64 29.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.68 -178.101 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.57 ' CD2' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.14 150.03 97.9 Favored Pre-proline 0 C--N 1.294 -1.835 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.343 -179.839 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.54 67.3 3.7 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 O-C-N 124.222 1.643 . . . . 0.0 109.769 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.57 ' HE3' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 179.35 -32.38 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.455 -0.778 . . . . 0.0 109.828 -178.886 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.619 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -49.54 101.06 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.368 -0.833 . . . . 0.0 110.218 -179.765 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.468 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -49.8 141.5 10.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.348 -179.974 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.539 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -43.84 -36.06 2.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 110.209 179.846 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.0 m -75.11 -49.04 20.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.468 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 1.6 mm-40 -54.79 -42.29 71.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 0.0 109.859 -179.74 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.048 HG23 HD11 ' A' ' 8' ' ' ILE . 21.3 mt -57.54 -30.69 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.9 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.737 ' HG3' HG11 ' A' ' 51' ' ' VAL . 7.8 tttt -60.94 -44.04 97.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.469 -0.77 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -58.43 -34.35 70.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.767 . . . . 0.0 111.927 -178.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . -72.97 -50.4 23.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.594 -1.316 . . . . 0.0 111.754 -178.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.08 HG21 HG11 ' A' ' 81' ' ' VAL . 27.7 m -66.53 -31.35 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.578 -1.326 . . . . 0.0 110.557 -179.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.781 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.02 -52.93 61.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.057 -1.027 . . . . 0.0 109.97 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -80.18 -24.49 40.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 110.28 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -84.97 -56.38 3.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 0.0 110.812 -179.467 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.843 ' CE2' HG12 ' A' ' 43' ' ' VAL . 8.1 m-30 -71.72 -16.21 62.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.064 -1.022 . . . . 0.0 110.238 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 66.0 46.52 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.473 -0.767 . . . . 0.0 110.724 179.585 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.799 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -136.54 -164.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.365 -0.835 . . . . 0.0 110.253 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.799 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -114.52 105.13 12.73 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.422 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.798 HG21 HG23 ' A' ' 43' ' ' VAL . 57.9 t -77.71 119.19 25.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 110.33 -179.029 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.612 HG12 ' C ' ' A' ' 82' ' ' GLN . 7.3 p -96.2 -20.64 5.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.547 -0.721 . . . . 0.0 109.619 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.581 ' HG3' ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -167.9 146.17 4.53 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.428 -0.795 . . . . 0.0 109.942 179.865 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.874 HG23 HG13 ' A' ' 81' ' ' VAL . 1.2 t -132.14 116.78 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.684 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.523 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -114.1 115.1 27.0 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.0 -1.062 . . . . 0.0 109.614 179.17 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.678 HG21 HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -110.75 141.44 44.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.345 -0.847 . . . . 0.0 110.248 -179.249 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.06 148.61 49.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 109.944 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.94 126.56 30.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 110.403 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.556 HG21 ' CE ' ' A' ' 78' ' ' LYS . 1.6 m . . . . . 0 C--N 1.302 -1.492 0 O-C-N 121.585 -0.697 . . . . 0.0 110.168 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.6 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.255 0.55 . . . . 0.0 110.181 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.527 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 81.2 tttt -106.62 136.87 45.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.577 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.613 ' HG3' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.67 151.09 30.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.485 179.555 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -125.56 120.13 30.03 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.027 -1.045 . . . . 0.0 112.867 -179.169 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 10.2 mt -96.68 110.52 24.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.237 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.08 HG11 HG21 ' A' ' 43' ' ' VAL . 2.2 t -101.3 130.94 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 110.369 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.612 ' C ' HG12 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -112.55 153.63 27.21 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.023 -1.048 . . . . 0.0 109.639 179.346 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 1.9 m -115.41 157.21 16.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.065 177.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.937 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -61.93 174.81 0.62 Allowed Pre-proline 0 C--N 1.29 -2.019 0 O-C-N 121.238 -0.914 . . . . 0.0 110.827 -179.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.5 Cg_endo -76.73 58.13 5.86 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.465 1.771 . . . . 0.0 110.57 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.19 -33.79 0.02 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.937 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -112.38 -179.94 3.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.119 -1.224 . . . . 0.0 110.457 -179.779 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HA ' HG21 ' A' ' 83' ' ' VAL . 4.2 ptpt -170.73 125.54 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.861 HD12 ' CD2' ' A' ' 26' ' ' TYR . 59.8 mt -68.43 98.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.152 -0.968 . . . . 0.0 110.161 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 1.9 mt-10 -70.65 -13.52 62.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.415 -0.803 . . . . 0.0 110.81 -179.587 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.722 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.48 -28.88 47.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.067 -1.02 . . . . 0.0 110.407 -179.376 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.85 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.19 -22.55 12.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.162 -0.961 . . . . 0.0 109.402 179.605 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.624 ' O ' HD12 ' A' ' 96' ' ' ILE . 13.2 mm-40 -56.53 -54.09 49.92 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.494 -0.753 . . . . 0.0 110.33 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.65 -14.71 79.6 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.581 HD23 HD21 ' A' ' 13' ' ' LEU . 2.2 tp -67.92 -7.71 30.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.134 -1.216 . . . . 0.0 110.132 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 93' ' ' GLU . 45.4 mt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.205 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.675 ' O ' HG23 ' A' ' 30' ' ' VAL . 2.1 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.478 0.656 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.675 ' CD1' HG23 ' A' ' 39' ' ' ILE . 5.6 mm -102.83 121.64 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 110.589 -178.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 9' ' ' LEU . 20.0 mt -96.41 -107.19 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.507 -0.746 . . . . 0.0 109.867 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.79 158.02 36.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.066 -1.021 . . . . 0.0 110.127 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.685 ' HG3' HD22 ' A' ' 92' ' ' LEU . 46.9 Cg_endo -73.62 140.16 29.19 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.915 1.481 . . . . 0.0 109.65 179.38 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.676 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.6 m -85.39 132.21 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.015 -1.053 . . . . 0.0 110.172 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.848 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 2.8 mm? -102.77 112.73 25.66 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.168 -0.958 . . . . 0.0 110.119 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' ALA . 3.1 m -163.54 148.62 11.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 110.045 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 14' ' ' SER . 58.7 mt-10 -42.88 -53.67 4.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 110.004 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -54.9 -21.98 13.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.19 -0.944 . . . . 0.0 110.116 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -100.31 -57.28 2.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 110.272 -179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.848 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -47.03 -34.7 5.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.938 . . . . 0.0 110.303 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.07 -8.88 50.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.994 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -103.61 -34.01 3.97 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -80.24 -18.95 48.01 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.702 -0.881 . . . . 0.0 108.95 179.164 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -55.21 -21.73 14.98 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.416 0.627 . . . . 0.0 110.732 -179.522 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.508 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -88.99 17.08 6.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.702 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.533 ' HA2' ' CE ' ' A' ' 88' ' ' LYS . . . 93.17 0.69 67.67 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.233 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 62.4 mttt -82.43 142.23 32.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.479 -1.012 . . . . 0.0 109.293 179.628 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.722 ' CD1' HD12 ' A' ' 92' ' ' LEU . 26.7 m-85 -128.79 111.02 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.662 -1.274 . . . . 0.0 111.511 -179.267 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.8 HG23 HD11 ' A' ' 80' ' ' ILE . 26.7 m -82.78 125.29 31.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.612 0.72 . . . . 0.0 110.151 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.983 ' CE2' HG11 ' A' ' 43' ' ' VAL . 22.0 m-30 -119.3 165.53 14.16 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.706 -0.621 . . . . 0.0 109.662 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.676 ' CD1' HG12 ' A' ' 12' ' ' VAL . 1.9 m95 -103.02 122.84 45.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.062 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.5 p -149.01 164.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.571 -1.251 . . . . 0.0 111.596 -176.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -62.69 151.4 84.36 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.896 -0.503 . . . . 0.0 110.659 -179.346 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.537 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 46.7 Cg_endo -73.81 70.1 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.236 1.651 . . . . 0.0 109.906 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.24 -33.75 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 110.324 -178.988 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . . . -41.75 98.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 110.179 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -41.33 138.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 0.0 110.322 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.527 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 1.4 mttt -42.56 -35.89 1.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.9 m -75.04 -36.07 61.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 110.019 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.441 ' OE1' ' HA ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -55.91 -46.21 78.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.998 179.807 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.703 ' O ' HG22 ' A' ' 43' ' ' VAL . 6.2 mt -57.31 -30.24 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.542 179.585 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.534 ' HG3' HG11 ' A' ' 51' ' ' VAL . 12.5 tttm -62.99 -47.55 82.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.628 -0.67 . . . . 0.0 111.324 -179.433 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.62 -34.65 78.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.311 -0.868 . . . . 0.0 111.76 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -49.49 29.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.981 -1.075 . . . . 0.0 111.705 -178.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.983 HG11 ' CE2' ' A' ' 28' ' ' PHE . 26.7 m -71.21 -28.5 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.683 -1.26 . . . . 0.0 110.765 -179.301 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.53 -51.66 67.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.8 -1.188 . . . . 0.0 109.22 179.542 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -79.41 -45.09 20.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.83 . . . . 0.0 109.728 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -61.17 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.46 -0.775 . . . . 0.0 110.531 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CD1' ' CG2' ' A' ' 89' ' ' ILE . 24.5 m-85 -71.69 -21.09 61.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.026 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.8 mttt 63.76 47.4 3.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.858 . . . . 0.0 110.556 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.769 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -130.33 -162.84 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.514 -0.741 . . . . 0.0 110.017 179.967 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.769 ' N ' HG13 ' A' ' 49' ' ' VAL . 2.2 tmtt? -118.1 107.43 13.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.423 -0.798 . . . . 0.0 109.839 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.663 HG22 HG11 ' A' ' 81' ' ' VAL . 49.2 t -78.6 119.84 28.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.216 -0.927 . . . . 0.0 110.166 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.5 p -112.59 4.96 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.893 . . . . 0.0 110.035 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER 171.88 120.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.222 179.902 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.086 HG23 HG13 ' A' ' 81' ' ' VAL . 1.2 t -115.87 136.27 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 0.0 110.125 179.664 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.527 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 1.1 t-20 -131.26 116.51 17.72 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.468 -0.77 . . . . 0.0 109.482 179.154 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -113.75 166.3 11.69 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.07 -1.019 . . . . 0.0 109.871 -179.724 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.717 ' C ' HD12 ' A' ' 57' ' ' LEU . 2.8 pp -152.63 146.29 25.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.918 . . . . 0.0 110.64 -179.027 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -81.75 122.13 27.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.05 -1.032 . . . . 0.0 109.759 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.731 HG13 ' CG ' ' A' ' 76' ' ' ARG . 1.2 p . . . . . 0 C--N 1.298 -1.662 0 O-C-N 121.818 -0.551 . . . . 0.0 110.437 -178.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.731 ' CG ' HG13 ' A' ' 59' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.622 ' CG ' HG13 ' A' ' 30' ' ' VAL . 7.5 pttt -123.88 131.32 53.56 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.758 -1.214 . . . . 0.0 110.717 -179.013 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 12.5 ptpt -101.7 151.42 22.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.404 -0.81 . . . . 0.0 108.908 179.085 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -116.37 120.1 37.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.773 -1.204 . . . . 0.0 112.712 -178.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.8 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -97.07 112.17 28.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.227 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.086 HG13 HG23 ' A' ' 54' ' ' VAL . 6.4 t -109.53 132.25 58.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 111.14 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.69 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -103.52 149.89 24.43 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.395 -0.816 . . . . 0.0 108.84 179.078 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.529 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.3 m -116.11 157.98 16.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.445 -1.302 . . . . 0.0 109.744 179.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.915 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -76.36 -178.37 0.92 Allowed Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.048 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.915 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.2 Cg_endo -72.09 135.9 26.03 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 O-C-N 124.087 1.572 . . . . 0.0 109.937 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.79 -50.56 0.76 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.815 ' NE2' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -98.18 174.58 6.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.166 -1.196 . . . . 0.0 110.53 179.889 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.533 ' CE ' ' HA2' ' A' ' 24' ' ' GLY . 0.3 OUTLIER 178.68 115.72 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.478 -0.763 . . . . 0.0 110.315 -179.855 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' CD2' ' A' ' 26' ' ' TYR . 7.5 mt -68.26 63.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.886 -1.134 . . . . 0.0 109.48 179.347 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 88' ' ' LYS . 2.4 mm-40 -54.3 -12.83 0.72 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.64 -0.663 . . . . 0.0 111.72 -179.558 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.917 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -53.42 -16.03 1.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.882 -1.136 . . . . 0.0 110.968 -179.058 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.754 HD23 ' N ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -101.76 -23.04 14.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.862 -1.149 . . . . 0.0 109.514 179.43 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -54.19 -29.0 44.34 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.458 -0.776 . . . . 0.0 110.396 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -96.91 -24.64 12.71 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.917 HD13 ' O ' ' A' ' 91' ' ' ALA . 3.5 mp -42.42 -28.9 0.24 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -1.144 . . . . 0.0 110.182 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.556 HG12 ' CE1' ' A' ' 18' ' ' TYR . 72.8 mt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 120.764 0.316 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.7 ' HA ' ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -85.61 65.66 9.27 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.19 -1.404 . . . . 0.0 108.08 178.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.813 HG22 ' CB ' ' A' ' 45' ' ' THR . 13.3 p -108.64 -104.87 0.36 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.519 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -84.13 -5.08 59.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.019 -1.051 . . . . 0.0 109.133 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.896 ' CZ ' HG23 ' A' ' 7' ' ' VAL 0.25 0.1 OUTLIER -52.83 -139.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.976 0.893 . . . . 0.0 111.178 178.496 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.661 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 31.6 m-20 -30.04 -59.04 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.788 -0.57 . . . . 0.0 112.019 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.04 HG13 ' HB1' ' A' ' 34' ' ' ALA . 66.3 t -51.41 -109.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.451 -0.78 . . . . 0.0 111.06 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.026 HG13 HG12 ' A' ' 7' ' ' VAL . 29.0 mt -84.99 104.44 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.657 -1.277 . . . . 0.0 110.749 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 54.2 mt -75.42 -93.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.761 . . . . 0.0 110.987 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.33 157.77 34.18 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.122 -0.986 . . . . 0.0 110.92 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 48.8 Cg_endo -77.01 160.95 33.24 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.149 1.605 . . . . 0.0 110.415 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 27' ' ' THR . 1.2 p -115.31 116.56 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 109.831 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.836 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.4 mm? -98.85 112.06 24.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.401 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.637 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -155.36 157.42 37.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.048 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 5.5 tm-20 -43.52 -61.24 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 110.069 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.74 -17.68 3.76 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.31 -0.869 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.637 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -99.4 -52.16 3.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 109.995 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.605 ' CE1' ' CG1' ' A' ' 96' ' ' ILE . 2.1 m-85 -56.47 -58.1 9.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.157 -0.964 . . . . 0.0 109.931 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.66 -12.82 37.18 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.272 -0.892 . . . . 0.0 109.186 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 21' ' ' PHE . . . -86.31 -47.19 5.02 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 7.7 m-30 -47.88 -28.42 2.63 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -38.31 -38.26 0.35 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.399 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.15 -17.88 23.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.359 -0.838 . . . . 0.0 110.44 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 118.05 4.52 14.32 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 1.7 mmtm -81.69 135.72 35.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.291 -1.123 . . . . 0.0 109.505 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.69 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.1 m-85 -127.15 111.16 13.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.017 -1.052 . . . . 0.0 112.167 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.778 HG23 HD11 ' A' ' 80' ' ' ILE . 24.9 m -77.99 140.05 39.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.935 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -137.5 164.33 28.97 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.066 -1.021 . . . . 0.0 111.349 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.507 ' CZ3' HG21 ' A' ' 59' ' ' VAL . 70.7 m95 -99.31 122.59 42.67 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.934 HG23 ' C ' ' A' ' 7' ' ' VAL . 2.6 p -144.02 156.71 15.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.787 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -62.36 151.73 81.58 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.778 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.9 Cg_endo -73.41 71.12 3.87 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.183 1.622 . . . . 0.0 110.047 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.57 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.3 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 1.04 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -44.27 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.94 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -42.67 144.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 110.338 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -42.53 -52.86 4.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 109.909 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.8 m -62.37 -36.51 82.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.475 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.2 OUTLIER -56.47 -44.14 80.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.184 -0.947 . . . . 0.0 109.569 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.978 HG23 HD11 ' A' ' 8' ' ' ILE . 1.7 mt -57.61 -32.56 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.315 -0.865 . . . . 0.0 108.805 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG3' HG11 ' A' ' 51' ' ' VAL . 6.4 ttmm -59.25 -45.81 90.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.851 . . . . 0.0 109.621 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 1.024 ' O ' HG23 ' A' ' 45' ' ' THR . 2.8 m-80 -71.83 -34.0 68.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.645 -0.659 . . . . 0.0 111.146 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.903 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.51 -50.16 73.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.176 . . . . 0.0 110.501 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.123 HG12 ' CE2' ' A' ' 47' ' ' PHE . 3.3 m -76.25 -34.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.879 -1.138 . . . . 0.0 110.641 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -60.95 -29.84 69.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.031 -1.043 . . . . 0.0 110.374 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 1.024 HG23 ' O ' ' A' ' 41' ' ' ASN . 34.4 p -78.52 -46.47 19.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.51 -55.03 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 110.72 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 1.123 ' CE2' HG12 ' A' ' 43' ' ' VAL . 6.6 m-30 -71.54 -14.72 62.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.065 -1.022 . . . . 0.0 110.141 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 16.0 mttm 42.48 47.03 4.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.147 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.777 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.88 -163.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.569 -0.707 . . . . 0.0 110.008 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.777 ' N ' HG13 ' A' ' 49' ' ' VAL . 1.2 tmtp? -118.08 110.27 17.43 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.431 -0.793 . . . . 0.0 109.709 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.554 HG11 ' HG3' ' A' ' 40' ' ' LYS . 30.0 t -78.63 119.72 28.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.359 -0.838 . . . . 0.0 110.043 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.79 HG12 ' O ' ' A' ' 82' ' ' GLN . 10.9 p -110.0 7.02 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.309 -0.87 . . . . 0.0 110.025 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER 169.68 119.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 109.987 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.98 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -121.12 120.83 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.115 -0.99 . . . . 0.0 110.072 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.49 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -121.63 115.95 23.69 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.23 178.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.54 HG21 HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -116.35 150.62 37.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.147 -0.97 . . . . 0.0 110.588 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.718 HD21 ' HE2' ' A' ' 78' ' ' LYS . 1.2 pp -141.5 154.88 45.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 109.79 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.612 ' CD2' ' NH1' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -67.43 134.04 50.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.42 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.507 HG21 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -120.0 133.22 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.367 -0.833 . . . . 0.0 110.092 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.612 ' NH1' ' CD2' ' A' ' 58' ' ' HIS . 27.9 mmt180 -118.48 151.88 36.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.111 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.31 156.76 0.5 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -45.14 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -1.141 . . . . 0.0 110.202 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -78.53 3.97 14.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -0.83 . . . . 0.0 110.18 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.536 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 8.2 pttm 38.56 32.94 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.535 -0.728 . . . . 0.0 110.558 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -160.56 -49.47 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.221 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.3 OUTLIER 53.56 104.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . 44.75 -169.36 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -51.8 -173.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.392 -1.064 . . . . 0.0 110.344 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ARG . 5.9 t80 -42.26 102.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.272 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.31 40.36 0.31 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 72' ' ' LYS . . . 151.26 -65.0 0.37 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER 65.84 142.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -1.148 . . . . 0.0 110.135 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 1.6 tmm_? -42.59 103.91 0.33 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.245 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.16 -166.48 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.051 1.553 . . . . 0.0 110.319 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.27 89.4 3.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.422 -0.799 . . . . 0.0 109.3 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -118.35 145.85 44.82 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.537 -0.727 . . . . 0.0 110.267 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HG2' HG13 ' A' ' 30' ' ' VAL . 12.8 tttt -123.59 140.92 52.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -0.945 . . . . 0.0 110.648 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.718 ' HE2' HD21 ' A' ' 57' ' ' LEU . 2.1 ttpt -107.97 150.55 26.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.333 -0.855 . . . . 0.0 109.623 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.67 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -133.18 121.79 23.06 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.056 -1.027 . . . . 0.0 112.495 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.778 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -101.62 111.95 33.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.98 HG13 HG23 ' A' ' 54' ' ' VAL . 3.8 t -107.46 131.24 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.435 -0.791 . . . . 0.0 110.454 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.79 ' O ' HG12 ' A' ' 52' ' ' VAL . 2.3 tp60 -111.38 146.63 36.8 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.923 -1.111 . . . . 0.0 108.952 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 87' ' ' GLN . 1.5 m -114.52 156.08 15.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.654 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.942 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -57.34 178.79 0.15 Allowed Pre-proline 0 C--N 1.29 -1.981 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.525 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.942 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.5 Cg_endo -72.7 145.16 40.82 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 O-C-N 124.149 1.605 . . . . 0.0 110.572 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.84 -18.38 47.62 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.54 ' HB2' HG23 ' A' ' 83' ' ' VAL . 57.7 mt-30 -94.59 171.58 8.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 110.557 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 3.1 pttt 179.68 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.823 . . . . 0.0 110.303 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.69 HD12 ' CD2' ' A' ' 26' ' ' TYR . 7.5 mt -63.08 118.62 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.95 . . . . 0.0 110.085 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -76.59 -14.74 59.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.379 -0.826 . . . . 0.0 110.678 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.742 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -56.23 -34.67 66.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 110.946 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.23 -23.5 12.56 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.985 -1.072 . . . . 0.0 110.149 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.683 ' O ' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -65.67 -43.24 89.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.259 -0.901 . . . . 0.0 110.289 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.3 8.27 75.31 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.786 HD23 HD21 ' A' ' 13' ' ' LEU . 2.3 tp -88.58 24.87 1.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -1.155 . . . . 0.0 110.245 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 93' ' ' GLU . 6.9 mt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.248 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.538 ' O ' ' N ' ' A' ' 3' ' ' THR . 5.8 tpt . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.688 ' HA ' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -64.76 76.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.22 -1.392 . . . . 0.0 108.936 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.741 HG21 ' CB ' ' A' ' 45' ' ' THR . 0.9 OUTLIER -120.59 -97.41 0.46 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 111.299 -179.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.868 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -88.69 -31.0 18.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.975 . . . . 0.0 110.352 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.917 ' CE1' HG23 ' A' ' 7' ' ' VAL . 1.9 p90 -34.04 -28.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.862 -0.524 . . . . 0.0 112.255 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.585 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 3.6 m-20 -164.0 -51.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.8 -1.187 . . . . 0.0 111.165 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.993 HG13 ' HB1' ' A' ' 34' ' ' ALA . 39.0 t -43.96 -67.97 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 122.128 0.966 . . . . 0.0 109.281 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.932 HD11 HG23 ' A' ' 39' ' ' ILE . 8.7 mt -115.05 95.48 3.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.487 -0.758 . . . . 0.0 110.217 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.6 mt -79.04 -97.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.553 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -108.16 167.28 9.51 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.076 -1.015 . . . . 0.0 110.497 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.716 ' HB3' HD13 ' A' ' 92' ' ' LEU . 46.7 Cg_endo -73.68 171.11 18.47 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.14 1.6 . . . . 0.0 110.529 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.706 HG12 ' CD1' ' A' ' 29' ' ' TRP . 3.0 m -115.36 144.32 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.411 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.3 mm? -102.65 107.49 18.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.212 -0.93 . . . . 0.0 110.328 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 17' ' ' ALA . 5.5 m -164.9 134.79 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.868 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' SER . 7.2 mt-10 -42.88 -59.34 2.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.117 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 -17.44 6.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.958 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.16 17.24 17.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.887 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.721 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 2.2 m-85 -139.18 -38.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.388 -0.82 . . . . 0.0 109.933 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.35 80.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.05 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 25' ' ' LYS . . . -95.52 -34.95 5.84 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.09 -17.73 64.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -70.5 -17.05 62.96 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.725 -0.61 . . . . 0.0 110.654 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -88.7 16.37 6.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 110.341 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 102.07 -2.06 51.33 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.48 136.45 34.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.514 -0.992 . . . . 0.0 109.534 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.758 ' HD1' HD12 ' A' ' 92' ' ' LEU . 99.5 m-85 -126.69 116.01 20.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 0.0 111.626 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.093 HG23 HD11 ' A' ' 80' ' ' ILE . 3.7 m -83.26 141.29 31.97 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.83 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 26.5 m-85 -134.06 164.37 27.47 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.33 -0.856 . . . . 0.0 110.933 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.706 ' CD1' HG12 ' A' ' 12' ' ' VAL . 19.6 m95 -97.01 122.35 39.91 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 7' ' ' VAL . 11.6 p -138.69 164.91 25.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.059 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.602 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 1.6 t60 -81.13 152.85 71.66 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.304 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 44.5 Cg_endo -70.89 65.7 2.46 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.06 1.558 . . . . 0.0 109.727 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.73 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.665 -179.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.993 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -42.42 95.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.44 -0.787 . . . . 0.0 109.602 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -39.39 134.27 1.23 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.382 -0.824 . . . . 0.0 110.894 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.651 ' HA ' HD12 ' A' ' 39' ' ' ILE . 1.9 mttt -46.9 -48.02 21.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.83 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.8 m -62.04 -39.53 92.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 0.0 109.424 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 4.7 mt-10 -55.83 -40.9 73.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 108.937 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.932 HG23 HD11 ' A' ' 8' ' ' ILE . 30.6 mt -58.0 -31.03 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.469 -0.77 . . . . 0.0 109.003 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.611 ' O ' HG21 ' A' ' 51' ' ' VAL . 3.8 tttt -59.54 -47.3 86.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.777 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.4 m-80 -72.75 -34.02 66.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.701 -0.624 . . . . 0.0 111.194 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.696 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.0 -50.43 73.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.786 -1.196 . . . . 0.0 110.553 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.785 HG11 ' CE2' ' A' ' 28' ' ' PHE . 3.7 m -67.3 -32.84 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.651 -1.281 . . . . 0.0 109.489 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -69.04 -44.51 72.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 108.812 178.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.741 ' CB ' HG21 ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.07 -16.44 56.77 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.868 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -104.23 -67.44 0.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.498 -0.751 . . . . 0.0 110.315 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.752 ' HE1' HD21 ' A' ' 92' ' ' LEU . 52.4 m-85 -71.95 -21.91 61.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.0 110.343 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 64.94 46.4 2.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.789 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -123.56 -158.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.512 -0.743 . . . . 0.0 110.136 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.789 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -116.89 110.4 18.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 109.762 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.611 HG21 ' O ' ' A' ' 40' ' ' LYS . 92.3 t -78.73 120.4 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.931 . . . . 0.0 110.321 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 82' ' ' GLN . 10.1 p -112.83 3.85 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.263 -0.898 . . . . 0.0 109.988 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 1.8 mttp 169.12 119.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.055 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.031 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.87 131.39 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.048 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.513 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 13.1 t30 -131.17 115.97 17.07 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.34 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.57 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -116.61 161.36 19.29 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.193 -0.942 . . . . 0.0 109.945 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -156.65 170.83 21.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.383 -0.823 . . . . 0.0 110.188 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.461 ' NE2' ' OD2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -80.76 129.77 34.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 110.219 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.099 HG11 ' CD ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -120.16 125.94 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.48 -0.762 . . . . 0.0 110.074 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' A' ' 74' ' ' PRO . 15.7 mmt85 -114.95 131.09 57.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 110.264 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -107.59 138.51 14.59 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -79.47 -2.36 41.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -1.17 . . . . 0.0 110.272 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -117.53 177.58 4.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.213 -0.929 . . . . 0.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.87 25.33 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.269 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 67' ' ' GLY . 36.9 ptt180 -104.58 -29.76 10.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.205 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -41.79 100.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -0.834 . . . . 0.0 110.401 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 65' ' ' ARG . . . -179.23 155.62 16.42 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.573 ' O ' ' CD2' ' A' ' 69' ' ' TYR . 7.5 mtt85 -89.39 179.39 6.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -1.157 . . . . 0.0 110.3 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER 50.72 113.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.851 0.834 . . . . 0.0 111.106 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 42.73 40.22 1.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.069 -1.02 . . . . 0.0 110.15 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 72' ' ' LYS . . . -99.83 -178.12 30.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 71' ' ' GLY . 14.6 mtpt 56.77 111.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -1.168 . . . . 0.0 110.1 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER 44.16 77.27 0.46 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 110.088 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 50.9 Cg_endo -77.4 -165.01 0.3 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.179 1.621 . . . . 0.0 110.393 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.461 ' OD2' ' NE2' ' A' ' 58' ' ' HIS . 0.3 OUTLIER -114.68 89.4 3.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.62 ' HB3' HG23 ' A' ' 59' ' ' VAL . 4.3 mpt_? -101.81 143.11 32.13 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.581 -0.699 . . . . 0.0 110.201 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.598 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.4 tttt -120.87 133.69 55.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 1.099 ' CD ' HG11 ' A' ' 59' ' ' VAL . 3.8 mttt -110.23 151.48 27.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.367 -0.833 . . . . 0.0 109.942 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -123.14 119.77 31.25 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.933 -1.104 . . . . 0.0 112.193 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.093 HD11 HG23 ' A' ' 27' ' ' THR . 1.5 mp -102.42 111.88 33.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.031 HG22 ' CG2' ' A' ' 54' ' ' VAL . 24.0 t -111.08 136.09 48.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.486 -0.759 . . . . 0.0 110.433 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.815 ' O ' HG12 ' A' ' 52' ' ' VAL . 1.9 tp60 -111.47 151.32 28.72 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.222 -0.924 . . . . 0.0 108.868 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.583 HG21 ' C ' ' A' ' 87' ' ' GLN . 2.0 m -112.68 155.71 13.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 C-N-CA 118.069 -1.453 . . . . 0.0 109.531 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.971 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -49.16 179.03 0.03 OUTLIER Pre-proline 0 C--N 1.291 -1.936 0 O-C-N 121.543 -0.723 . . . . 0.0 110.482 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.971 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.4 Cg_endo -71.79 140.07 34.76 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.22 1.642 . . . . 0.0 110.492 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.19 -24.58 12.97 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.684 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 87.1 mt-30 -95.82 164.37 12.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -1.148 . . . . 0.0 110.619 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.525 ' N ' HG21 ' A' ' 83' ' ' VAL . 0.0 OUTLIER 179.43 108.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.245 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.591 ' HB ' ' CE1' ' A' ' 26' ' ' TYR . 91.4 mt -51.11 91.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.126 -0.984 . . . . 0.0 109.541 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 4.1 mm-40 -63.01 -13.39 34.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 111.206 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.768 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.65 -33.76 61.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 110.804 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -106.87 -23.67 12.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.952 -1.092 . . . . 0.0 110.507 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -48.95 -30.97 6.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.163 -0.961 . . . . 0.0 110.14 -179.149 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.48 -19.89 11.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.524 ' CD2' ' HG2' ' A' ' 11' ' ' PRO . 26.7 tp -53.13 -19.14 2.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -1.114 . . . . 0.0 110.054 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.638 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 32.4 mt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.131 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.774 0.321 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.708 ' HA ' ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -85.22 65.9 9.45 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.14 -1.424 . . . . 0.0 108.017 178.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.767 HG22 HG21 ' A' ' 45' ' ' THR . 11.7 p -108.87 -105.71 0.35 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 8' ' ' ILE . . . -83.51 -5.12 59.07 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.983 -1.073 . . . . 0.0 109.198 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.911 ' CZ ' HG23 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -52.54 -140.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.094 0.95 . . . . 0.0 111.394 178.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.648 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 14.2 m-20 -29.87 -58.43 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.81 -0.556 . . . . 0.0 112.144 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.071 HG13 ' HB1' ' A' ' 34' ' ' ALA . 58.2 t -52.71 -109.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.497 -0.752 . . . . 0.0 110.994 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.034 HD11 HG23 ' A' ' 39' ' ' ILE . 24.0 mt -88.28 113.19 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 120.681 -1.262 . . . . 0.0 111.268 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.4 mp -92.06 -88.22 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.291 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.03 150.85 40.91 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.45 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.487 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.8 Cg_endo -74.32 -178.21 3.8 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.065 1.561 . . . . 0.0 110.177 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.673 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.16 133.33 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.149 -0.969 . . . . 0.0 110.347 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.746 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -103.12 112.83 25.87 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.193 -0.942 . . . . 0.0 110.185 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 17' ' ' ALA . 60.6 m -163.79 128.65 2.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.145 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -42.96 -58.63 2.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.898 . . . . 0.0 110.048 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -17.63 3.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 110.215 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -97.7 -48.04 5.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 110.149 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.586 ' CE2' HG13 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -52.79 -33.1 47.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 109.772 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.47 -21.6 66.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -100.81 -37.59 3.64 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 105.683 -2.967 . . . . 0.0 105.683 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.612 ' CD1' ' HA ' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -64.64 -19.17 65.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' TYR . . . -93.36 4.63 53.66 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.219 0.533 . . . . 0.0 110.629 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -111.87 16.58 20.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.764 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 95.69 -24.82 27.79 Favored Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 39.7 mttm -81.79 140.42 34.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.352 -1.087 . . . . 0.0 109.153 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.905 ' CD2' HD12 ' A' ' 89' ' ' ILE . 35.4 m-85 -126.92 110.18 12.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.803 -1.186 . . . . 0.0 112.234 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.668 HG23 HD11 ' A' ' 80' ' ' ILE . 28.3 m -80.57 118.25 21.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.914 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -116.99 164.97 13.9 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 111.638 -178.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.673 ' CD1' HG12 ' A' ' 12' ' ' VAL . 7.4 m95 -97.81 123.0 41.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.0 p -145.56 157.45 12.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 C-N-CA 118.195 -1.402 . . . . 0.0 111.712 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.602 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -59.21 149.57 67.3 Favored Pre-proline 0 C--N 1.297 -1.679 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.044 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.602 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 47.7 Cg_endo -73.02 71.57 3.47 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.061 1.558 . . . . 0.0 109.808 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.48 -33.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.417 -0.802 . . . . 0.0 109.932 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 1.071 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -42.36 93.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.484 -0.76 . . . . 0.0 109.799 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -42.17 141.68 0.88 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 110.443 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 4.3 mmtp -42.63 -41.13 2.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.372 -0.83 . . . . 0.0 109.778 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 62.1 m -70.97 -35.93 72.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.728 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 5.8 mt-10 -58.54 -42.53 88.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.553 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.034 HG23 HD11 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -57.48 -31.68 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.57 ' HG3' HG11 ' A' ' 51' ' ' VAL . 8.1 tttm -62.97 -46.37 88.02 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.552 -0.717 . . . . 0.0 109.627 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.982 ' O ' HG23 ' A' ' 45' ' ' THR . 38.4 m-80 -72.97 -34.12 66.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.601 -0.687 . . . . 0.0 110.921 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 3' ' ' THR . . . -57.74 -50.27 73.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.932 -1.105 . . . . 0.0 110.43 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 39' ' ' ILE . 2.7 m -76.64 -36.61 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.869 -1.144 . . . . 0.0 110.654 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -56.92 -32.31 65.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.942 -1.099 . . . . 0.0 110.256 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.982 HG23 ' O ' ' A' ' 41' ' ' ASN . 35.4 p -77.99 -46.01 22.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.234 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.06 -55.61 4.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 0.0 110.735 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.894 ' CD1' HG23 ' A' ' 89' ' ' ILE . 21.0 m-85 -71.67 -21.33 61.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.155 -0.966 . . . . 0.0 110.372 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 51.08 44.52 28.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.778 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -115.29 -162.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.633 -0.667 . . . . 0.0 109.923 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.778 ' N ' HG13 ' A' ' 49' ' ' VAL . 8.0 tmtt? -117.2 108.32 15.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.893 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.57 HG11 ' HG3' ' A' ' 40' ' ' LYS . 33.5 t -78.44 119.64 27.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.242 -0.911 . . . . 0.0 109.769 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 82' ' ' GLN . 3.3 p -107.26 -12.75 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.43 -0.794 . . . . 0.0 110.167 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -173.15 123.4 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.979 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.945 ' CG2' HG13 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -123.63 131.2 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.192 -0.942 . . . . 0.0 110.085 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 2.5 m-20 -131.07 115.82 16.95 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.645 HG21 HD13 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.8 146.04 41.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 58' ' ' HIS . 2.3 pp -128.01 153.45 46.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.279 -0.888 . . . . 0.0 110.608 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.566 ' NE2' ' NH2' ' A' ' 60' ' ' ARG . 2.0 t-160 -66.32 118.32 9.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.144 -0.973 . . . . 0.0 109.279 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.581 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -103.87 121.29 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.246 -0.909 . . . . 0.0 110.013 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.566 ' NH2' ' NE2' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -130.57 122.07 26.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 47.19 -174.04 0.02 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.48 -30.44 3.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -1.097 . . . . 0.0 110.141 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 64' ' ' LYS . 7.7 tptp -160.41 68.65 0.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.173 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 63' ' ' LYS . 7.3 mttt 52.95 171.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.22 -9.01 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.928 . . . . 0.0 110.406 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER 41.29 51.83 3.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.249 -0.907 . . . . 0.0 110.203 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 66' ' ' LEU . . . 41.19 44.67 3.85 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -153.34 -177.55 6.41 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.497 -1.002 . . . . 0.0 110.193 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.419 ' N ' ' HG3' ' A' ' 68' ' ' ARG . 22.3 t80 -93.32 92.63 7.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.0 110.132 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.36 39.91 1.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 110.156 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 72' ' ' LYS . . . 128.6 -38.52 2.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 7.1 mttt 63.11 -176.31 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -1.134 . . . . 0.0 109.984 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.36 78.4 22.63 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 110.453 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HG2' ' NE ' ' A' ' 76' ' ' ARG . 51.5 Cg_endo -77.02 -165.73 0.34 Allowed 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.063 1.56 . . . . 0.0 110.265 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' HA ' ' NH2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -115.07 89.39 3.09 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.53 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.582 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -124.1 151.45 43.88 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.624 -0.673 . . . . 0.0 110.365 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.581 ' HA ' HG23 ' A' ' 59' ' ' VAL . 19.9 tttt -123.5 137.51 54.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.561 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 6.9 mttt -101.06 147.69 25.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.164 -0.96 . . . . 0.0 109.936 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.62 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -133.44 121.87 22.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.0 111.873 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 80' ' ' ILE . 1.6 mp -98.67 111.7 28.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.945 HG13 ' CG2' ' A' ' 54' ' ' VAL . 2.4 t -107.41 122.27 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.505 -0.747 . . . . 0.0 110.659 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.741 ' O ' HG12 ' A' ' 52' ' ' VAL . 4.5 tp-100 -104.37 142.81 33.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 109.016 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.486 ' N ' ' OE1' ' A' ' 82' ' ' GLN . 1.1 m -109.76 156.99 10.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 C-N-CA 118.15 -1.42 . . . . 0.0 109.896 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -72.14 178.83 1.19 Allowed Pre-proline 0 C--N 1.291 -1.965 0 O-C-N 121.65 -0.656 . . . . 0.0 110.235 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.1 Cg_endo -73.04 140.4 31.29 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 124.234 1.65 . . . . 0.0 110.345 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.63 -30.36 9.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.555 ' HB2' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -112.19 176.39 5.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.204 -1.174 . . . . 0.0 110.467 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.3 OUTLIER 179.3 115.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 110.331 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.905 HD12 ' CD2' ' A' ' 26' ' ' TYR . 39.5 mt -67.91 60.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.174 -0.954 . . . . 0.0 109.655 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 88' ' ' LYS . 14.1 pt-20 -58.2 -13.08 4.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.445 -0.785 . . . . 0.0 111.022 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.714 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.24 -16.63 2.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.989 -1.07 . . . . 0.0 110.627 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.811 HD21 ' CE1' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -106.21 -23.23 12.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.062 -1.024 . . . . 0.0 109.634 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.4 -19.75 6.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.352 -0.842 . . . . 0.0 110.332 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.08 -20.16 11.67 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.631 HD23 HD11 ' A' ' 13' ' ' LEU . 14.5 tp -46.36 -24.37 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.586 HG13 ' CE2' ' A' ' 18' ' ' TYR . 2.0 mp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.21 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.516 ' O ' ' N ' ' A' ' 3' ' ' THR . 4.1 ptm . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 120.585 0.231 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.735 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -61.5 87.8 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.08 -1.448 . . . . 0.0 108.848 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.769 HG22 ' HB ' ' A' ' 45' ' ' THR . 3.2 p -133.72 -19.95 2.04 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.756 0.789 . . . . 0.0 110.984 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.605 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . 178.71 -27.24 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.628 -0.67 . . . . 0.0 109.337 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.735 ' CE1' ' HA ' ' A' ' 2' ' ' LYS 0.277 0.1 OUTLIER -45.97 -135.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.857 0.837 . . . . 0.0 112.059 178.17 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.646 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 5.7 t0 -24.39 -58.62 0.05 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.866 0.841 . . . . 0.0 111.305 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.966 HG12 HG13 ' A' ' 8' ' ' ILE . 39.6 t -70.24 156.67 7.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.779 -0.576 . . . . 0.0 110.977 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.966 HG13 HG12 ' A' ' 7' ' ' VAL . 16.2 mt 24.56 51.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.302 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 30' ' ' VAL . 3.5 mt -44.71 -99.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.307 -0.87 . . . . 0.0 111.262 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -99.56 151.68 37.53 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.924 -1.11 . . . . 0.0 110.816 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.632 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 49.8 Cg_endo -76.33 153.6 35.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.103 1.581 . . . . 0.0 110.519 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 27' ' ' THR . 1.5 p -115.15 105.21 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.058 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.818 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.12 106.75 17.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.667 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -135.57 -178.54 5.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.184 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -57.34 -67.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.251 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -45.66 74.46 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.258 -0.901 . . . . 0.0 110.354 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.667 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -56.21 -48.9 75.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.665 ' CE1' HG22 ' A' ' 96' ' ' ILE . 1.9 m-85 -57.9 -33.33 68.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.875 . . . . 0.0 110.147 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.37 -8.88 49.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.858 . . . . 0.0 109.865 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -103.33 -38.23 2.88 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.626 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -74.94 -18.88 60.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.571 -0.958 . . . . 0.0 108.873 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.404 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -56.92 -20.7 24.79 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.702 -0.624 . . . . 0.0 110.729 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.6 17.27 5.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.38 -0.825 . . . . 0.0 110.059 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.04 0.89 67.74 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 48.8 mttt -82.79 143.47 30.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.567 -0.961 . . . . 0.0 109.545 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 1.126 ' CD2' HD12 ' A' ' 89' ' ' ILE . 22.9 m-85 -128.01 99.41 5.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.611 -1.306 . . . . 0.0 111.083 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.79 HG23 HD11 ' A' ' 80' ' ' ILE . 2.7 m -74.63 127.32 32.83 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.641 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -131.44 165.23 23.98 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.314 -0.866 . . . . 0.0 111.162 -178.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.515 ' NE1' ' HB ' ' A' ' 12' ' ' VAL . 46.1 m95 -100.0 123.27 44.06 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.807 ' HA ' HD12 ' A' ' 9' ' ' LEU . 2.0 p -142.55 164.81 17.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.081 -176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 2.5 t60 -65.34 149.76 96.64 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.545 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 48.1 Cg_endo -73.18 67.49 4.22 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.088 1.573 . . . . 0.0 109.434 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.72 -32.19 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.405 -0.81 . . . . 0.0 110.062 -178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.717 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.09 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.692 . . . . 0.0 109.882 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -45.99 142.12 2.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.0 110.388 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -42.81 -38.62 2.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.841 . . . . 0.0 109.675 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.6 m -73.17 -36.24 66.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.556 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -59.32 -43.46 92.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.158 -0.963 . . . . 0.0 109.207 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.821 ' O ' HD11 ' A' ' 8' ' ' ILE . 13.4 mt -57.75 -30.46 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.673 ' HG3' HG11 ' A' ' 51' ' ' VAL . 14.5 tttt -65.29 -45.09 85.82 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.595 0.712 . . . . 0.0 110.127 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 1.056 ' O ' HG23 ' A' ' 45' ' ' THR . 10.1 m-80 -71.27 -49.31 44.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.59 -0.694 . . . . 0.0 111.905 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.608 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.16 -51.07 70.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.792 -1.192 . . . . 0.0 110.946 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.792 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -59.45 -40.92 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.84 -1.162 . . . . 0.0 110.249 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -65.6 -29.56 70.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.181 -0.949 . . . . 0.0 110.755 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 1.056 HG23 ' O ' ' A' ' 41' ' ' ASN . 28.1 p -66.17 -47.08 75.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.081 . . . . 0.0 110.979 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.56 -56.67 3.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 111.338 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.792 ' CD2' HG22 ' A' ' 43' ' ' VAL . 8.8 m-85 -71.59 -21.19 61.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.147 -0.971 . . . . 0.0 110.694 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 31.1 mtmt 48.42 41.02 16.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 109.665 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -102.87 -161.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.721 -0.612 . . . . 0.0 109.625 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.788 ' N ' HG13 ' A' ' 49' ' ' VAL . 6.0 tmtm? -114.48 112.38 22.9 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.68 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 40' ' ' LYS . 48.8 t -77.64 119.79 27.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.79 HG21 ' N ' ' A' ' 84' ' ' ALA . 41.1 t -114.21 -14.5 10.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.487 -0.758 . . . . 0.0 110.554 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.9 OUTLIER -178.75 115.1 0.07 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.463 -0.773 . . . . 0.0 109.998 179.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.884 ' CG2' HG13 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -112.76 130.9 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.808 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.485 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 17.3 m120 -130.48 115.96 17.54 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.793 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.568 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.58 160.27 19.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.6 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.544 HD11 HG13 ' A' ' 59' ' ' VAL . 1.7 pp -141.71 166.64 24.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.592 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.591 ' CD2' ' HG2' ' A' ' 60' ' ' ARG . 5.7 t-160 -77.47 118.36 19.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.127 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -119.6 130.93 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.284 -0.885 . . . . 0.0 110.187 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.591 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 15.7 mmt85 -145.21 137.26 25.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . -50.75 -178.06 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 62' ' ' LYS . 0.7 OUTLIER -139.45 48.96 1.83 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.35 -1.088 . . . . 0.0 110.122 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 64' ' ' LYS . 1.3 tttp -148.42 -90.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -42.31 -71.65 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 0.0 110.249 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -52.21 159.1 1.0 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.262 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER 178.38 107.08 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.396 -0.815 . . . . 0.0 110.145 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.51 ' O ' ' CG ' ' A' ' 68' ' ' ARG . . . -43.35 94.36 0.01 OUTLIER Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 66' ' ' LEU . 28.4 mtt180 -165.39 -172.29 2.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -1.106 . . . . 0.0 110.126 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 18.6 p90 -47.73 135.21 12.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 110.119 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER 40.86 41.22 1.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.424 -0.798 . . . . 0.0 110.358 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.1 147.25 18.37 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.56 160.53 31.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -1.149 . . . . 0.0 110.259 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.501 ' HG3' ' HD2' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -96.42 146.96 32.22 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 0.0 110.17 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HD2' ' HG3' ' A' ' 73' ' ' ARG . 48.4 Cg_endo -73.86 -165.28 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.033 1.544 . . . . 0.0 110.464 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.543 ' CB ' ' HG3' ' A' ' 32' ' ' PRO . 76.6 m-20 -114.71 89.64 3.14 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.475 -0.766 . . . . 0.0 109.261 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.512 ' HG2' ' HB ' ' A' ' 59' ' ' VAL . 6.8 ttm180 -129.35 112.49 13.9 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.625 -0.672 . . . . 0.0 109.961 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.613 ' HA ' HG23 ' A' ' 59' ' ' VAL . 13.7 tttt -123.06 139.21 54.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.912 . . . . 0.0 110.076 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.663 ' HE2' HG21 ' A' ' 12' ' ' VAL . 15.4 mttt -101.88 147.22 26.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.335 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.716 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -131.49 126.71 35.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.12 -0.987 . . . . 0.0 111.847 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.79 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -105.61 111.77 36.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.884 HG13 ' CG2' ' A' ' 54' ' ' VAL . 1.4 t -96.44 141.47 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.435 -0.791 . . . . 0.0 110.284 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 53' ' ' LYS . 7.5 tp60 -121.13 142.46 49.84 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.376 -0.828 . . . . 0.0 109.507 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.6 m -125.24 156.65 34.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.437 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.79 ' N ' HG21 ' A' ' 52' ' ' VAL . . . -44.19 171.87 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.798 0 CA-C-O 121.302 0.572 . . . . 0.0 110.854 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.4 Cg_endo -77.8 53.94 4.6 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 O-C-N 124.39 1.732 . . . . 0.0 110.232 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -167.42 -47.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.565 ' HB3' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -51.04 -173.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -1.155 . . . . 0.0 110.848 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 3.4 pttt 178.98 80.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.505 -0.747 . . . . 0.0 110.416 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.126 HD12 ' CD2' ' A' ' 26' ' ' TYR . 5.2 mt -47.69 109.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.736 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 4.7 mm-40 -67.43 -14.64 63.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 0.0 110.74 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.728 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -57.47 -36.8 71.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.201 -0.937 . . . . 0.0 110.84 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.861 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.99 -23.55 12.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.009 -1.057 . . . . 0.0 110.107 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.0 mm-40 -60.63 -31.9 71.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -0.903 . . . . 0.0 110.239 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.35 -12.8 40.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -80.4 -10.66 59.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.208 -1.172 . . . . 0.0 110.203 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.74 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.03 -0.985 . . . . 0.0 110.216 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.561 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.754 0.312 . . . . 0.0 110.583 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.768 ' HA ' HD21 ' A' ' 9' ' ' LEU . 48.1 mmtt -44.6 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.616 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.4 m 4.45 -71.74 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.636 0 CA-C-O 121.233 0.54 . . . . 0.0 110.865 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.002 ' O ' HG23 ' A' ' 7' ' ' VAL 0.26 . . -55.69 81.02 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 177.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.906 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER 23.56 47.9 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.827 0.822 . . . . 0.0 110.405 -178.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.619 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 4.7 t0 65.77 52.89 1.23 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.0 0.905 . . . . 0.0 111.447 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 4' ' ' ALA . 3.0 t -134.48 -126.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.239 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.897 HD11 ' HA ' ' A' ' 39' ' ' ILE . 2.7 mt -57.55 152.0 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.16 -0.962 . . . . 0.0 110.315 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 2' ' ' LYS . 2.2 mt -132.87 -99.34 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.479 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.58 153.66 42.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.02 . . . . 0.0 110.504 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.616 ' HG3' HD22 ' A' ' 92' ' ' LEU . 47.7 Cg_endo -74.94 161.53 38.76 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.07 1.563 . . . . 0.0 110.354 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.78 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.7 m -104.86 143.02 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.226 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.718 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.41 106.89 17.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -154.78 142.11 19.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.997 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 9.7 tm-20 -42.52 -52.65 4.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.895 . . . . 0.0 110.145 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -54.72 -42.02 71.02 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.107 -0.996 . . . . 0.0 110.094 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.54 ' N ' ' CG ' ' A' ' 16' ' ' LYS . . . -65.97 -63.24 1.13 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.34 -0.85 . . . . 0.0 110.028 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.541 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 1.6 m-85 -48.8 -30.66 5.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 110.302 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.21 -9.2 55.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.48 -38.39 1.78 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -73.61 -23.47 59.91 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.533 -0.98 . . . . 0.0 108.974 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -51.39 -21.09 2.06 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.628 -0.67 . . . . 0.0 110.064 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.36 16.37 13.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.266 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.73 2.36 65.08 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.582 ' HB3' HG23 ' A' ' 80' ' ' ILE . 77.0 mttt -82.26 142.53 32.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -1.14 . . . . 0.0 109.544 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 1.107 ' CD2' HD12 ' A' ' 89' ' ' ILE . 19.9 m-85 -127.7 104.23 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.751 -1.218 . . . . 0.0 112.073 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.86 HG23 HD11 ' A' ' 80' ' ' ILE . 2.8 m -76.01 124.54 27.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.801 ' CB ' HG23 ' A' ' 8' ' ' ILE . 14.9 m-85 -124.72 164.92 18.91 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.525 -0.734 . . . . 0.0 110.989 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.78 ' NE1' HG12 ' A' ' 12' ' ' VAL . 33.4 m95 -102.88 122.24 44.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.698 HG23 ' C ' ' A' ' 7' ' ' VAL . 5.2 p -144.49 165.49 12.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.496 -1.282 . . . . 0.0 111.81 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.479 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 1.5 t60 -60.81 148.53 82.65 Favored Pre-proline 0 C--N 1.297 -1.678 0 O-C-N 121.927 -0.483 . . . . 0.0 110.495 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.9 Cg_endo -72.39 71.05 3.14 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.15 1.605 . . . . 0.0 109.915 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.538 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.18 -33.85 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.947 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -50.3 90.63 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.412 -0.805 . . . . 0.0 109.98 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -48.41 176.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.546 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -69.01 -28.84 66.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 110.185 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.2 m -75.06 -52.25 11.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.872 . . . . 0.0 110.583 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.722 ' H ' HG23 ' A' ' 35' ' ' THR . 89.4 mt-10 -55.1 -42.82 73.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.919 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.897 ' HA ' HD11 ' A' ' 8' ' ' ILE . 26.7 mt -57.07 -30.69 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.163 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.62 ' HG3' HG11 ' A' ' 51' ' ' VAL . 10.1 tttp -62.87 -47.29 83.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.867 . . . . 0.0 111.322 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -62.39 -35.06 78.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.452 -0.78 . . . . 0.0 112.695 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.784 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -69.85 -50.26 44.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.484 -1.385 . . . . 0.0 111.896 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.59 HG13 HD13 ' A' ' 8' ' ' ILE . 14.4 m -69.87 -32.14 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.575 -1.328 . . . . 0.0 110.787 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -60.33 -52.68 64.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.989 -1.069 . . . . 0.0 109.91 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -79.84 -24.43 41.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 110.251 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -84.8 -64.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.877 . . . . 0.0 110.505 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.515 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 11.3 m-85 -71.69 -21.22 61.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 109.991 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER 66.48 44.12 2.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.377 -0.827 . . . . 0.0 110.335 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.796 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -125.77 -162.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.585 -0.697 . . . . 0.0 109.858 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.796 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -115.01 114.74 25.8 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 109.811 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.62 HG11 ' HG3' ' A' ' 40' ' ' LYS . 11.7 t -77.95 119.76 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.266 -0.896 . . . . 0.0 109.236 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.795 HG21 ' N ' ' A' ' 84' ' ' ALA . 25.5 t -114.01 -14.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.521 -0.737 . . . . 0.0 110.721 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.15 115.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -0.792 . . . . 0.0 110.091 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.052 HG22 HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.03 116.77 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.653 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.504 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -116.43 116.26 27.35 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.377 -0.827 . . . . 0.0 109.679 179.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -115.92 155.26 28.3 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.89 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.803 HD11 ' HD2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -144.89 161.02 40.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.839 . . . . 0.0 109.922 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -82.35 124.36 29.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.0 110.408 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.903 HG11 ' CE ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -120.28 114.09 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.592 -0.692 . . . . 0.0 110.005 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 74' ' ' PRO . 3.5 mmt85 -99.03 100.57 11.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.43 94.32 0.09 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -169.48 -36.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.131 . . . . 0.0 110.214 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 2.5 mmtt -74.07 148.15 42.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.188 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 4.2 mttp -41.83 142.61 0.64 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 110.553 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 5.8 mtm105 -142.02 -46.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 109.954 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.468 ' O ' ' C ' ' A' ' 67' ' ' GLY . 0.9 OUTLIER 58.89 49.29 9.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.812 . . . . 0.0 110.6 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 66' ' ' LEU . . . 37.42 79.84 0.03 OUTLIER Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -135.13 150.4 50.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -1.226 . . . . 0.0 110.325 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 69' ' ' TYR . 34.8 p90 -44.03 118.46 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.04 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER 40.3 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.415 -0.803 . . . . 0.0 110.363 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.17 -167.17 30.26 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.99 79.57 1.27 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -1.161 . . . . 0.0 110.238 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.455 ' CB ' ' HB3' ' A' ' 60' ' ' ARG . 11.3 mtm180 -77.34 141.45 66.2 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.459 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 49.2 Cg_endo -73.22 -165.48 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.092 1.574 . . . . 0.0 110.433 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.73 89.39 3.08 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 109.201 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.4 OUTLIER -125.9 144.89 50.49 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.632 -0.667 . . . . 0.0 110.365 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.538 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 0.3 OUTLIER -124.06 141.96 51.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 110.155 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.903 ' CE ' HG11 ' A' ' 59' ' ' VAL . 1.9 ptpt -100.96 150.2 23.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.004 -1.06 . . . . 0.0 109.518 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.735 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -117.95 128.63 54.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.147 -0.971 . . . . 0.0 112.124 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.86 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -105.57 111.74 36.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.413 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.052 HG22 HG22 ' A' ' 54' ' ' VAL . 13.5 t -102.83 137.62 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.48 -0.763 . . . . 0.0 110.724 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 39.1 tp60 -117.93 153.47 33.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.866 . . . . 0.0 109.831 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 84' ' ' ALA . 2.4 m -125.34 157.11 34.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.697 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -45.47 177.2 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.686 0 CA-C-O 121.275 0.559 . . . . 0.0 110.926 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.8 Cg_endo -73.48 140.53 30.16 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.25 1.658 . . . . 0.0 110.299 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.27 -21.71 19.48 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.511 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 49.1 mt-30 -89.28 167.22 13.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -1.16 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.533 ' HA ' ' OH ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER 179.67 99.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 110.522 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.107 HD12 ' CD2' ' A' ' 26' ' ' TYR . 24.5 mt -44.12 104.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 109.623 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 15.4 mm-40 -56.34 -13.97 2.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.455 -0.778 . . . . 0.0 111.677 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.723 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.0 -36.46 65.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.861 -1.149 . . . . 0.0 110.732 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.817 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.56 -23.33 12.5 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.046 -1.034 . . . . 0.0 109.827 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 15.3 mm-40 -49.99 -44.6 51.09 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.444 -0.785 . . . . 0.0 110.555 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.59 1.57 58.5 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.479 ' HA ' HD12 ' A' ' 95' ' ' LEU . 15.9 tp -77.52 3.06 14.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -1.172 . . . . 0.0 110.196 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.299 -179.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.16 0.505 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -95.9 82.22 3.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.014 -1.054 . . . . 0.0 109.171 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.968 ' HB ' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -133.61 -94.1 0.32 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.37 -0.831 . . . . 0.0 110.254 179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.532 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -77.14 -17.57 58.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.106 -0.996 . . . . 0.0 109.808 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.803 ' CZ ' HG23 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -54.08 -139.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.779 0.8 . . . . 0.0 110.311 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 62.2 m-20 -31.99 -58.37 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.5 -0.75 . . . . 0.0 112.022 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.017 HG12 HG13 ' A' ' 8' ' ' ILE . 62.0 t -45.64 -101.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.293 -0.88 . . . . 0.0 111.29 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.017 HG13 HG12 ' A' ' 7' ' ' VAL . 37.3 mt -88.25 104.15 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.852 -1.155 . . . . 0.0 110.925 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 mt -70.39 -98.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.855 . . . . 0.0 110.352 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.46 159.26 31.43 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.024 -1.048 . . . . 0.0 110.467 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 48.3 Cg_endo -75.0 171.09 19.01 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.088 1.572 . . . . 0.0 110.5 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.045 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.19 132.85 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.917 . . . . 0.0 110.315 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.683 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.1 mm? -103.23 106.65 17.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.131 -0.98 . . . . 0.0 110.114 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.438 ' OG ' ' C ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -165.72 140.82 4.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.938 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -43.03 -41.03 3.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.121 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -54.64 -24.55 22.08 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.247 -0.908 . . . . 0.0 110.145 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -100.74 -51.4 3.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.547 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.5 m-85 -54.77 -47.33 74.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.71 -9.41 43.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.88 . . . . 0.0 109.012 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 21' ' ' PHE . . . -98.29 -41.27 3.26 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.864 -2.495 . . . . 0.0 106.864 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.631 ' CE1' ' HA ' ' A' ' 26' ' ' TYR . 4.4 m-30 -48.4 -27.36 2.56 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -37.8 -42.91 0.63 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.62 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.45 -18.25 21.69 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.384 -0.823 . . . . 0.0 110.573 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.509 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 123.01 5.15 8.24 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.498 ' HG2' ' HB2' ' A' ' 82' ' ' GLN . 23.7 mttt -82.67 127.96 33.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 109.596 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 1.064 ' CD1' HD12 ' A' ' 92' ' ' LEU . 65.9 m-85 -127.11 114.66 18.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.711 -1.243 . . . . 0.0 112.297 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 5.4 m -81.47 123.98 29.06 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.469 0.652 . . . . 0.0 110.61 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.666 ' CB ' HG23 ' A' ' 8' ' ' ILE . 61.5 m-85 -122.27 148.67 44.71 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.435 -0.79 . . . . 0.0 110.538 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 1.045 ' CD1' HG12 ' A' ' 12' ' ' VAL . 96.9 m95 -76.62 122.8 25.16 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.785 HG12 ' HA ' ' A' ' 8' ' ' ILE . 1.9 m -135.91 154.65 34.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.866 -1.146 . . . . 0.0 111.412 -177.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.518 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 0.6 OUTLIER -52.26 130.92 42.42 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 176.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 38.8 Cg_endo -65.01 72.99 0.23 Allowed 'Trans proline' 0 C--N 1.294 -2.315 0 O-C-N 123.443 1.233 . . . . 0.0 109.361 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 31' ' ' HIS . 0.1 OUTLIER 179.68 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.997 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.75 95.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.387 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -38.36 128.11 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.499 -0.751 . . . . 0.0 110.81 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.567 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 1.5 mttt -41.96 -31.79 0.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.417 -0.802 . . . . 0.0 109.674 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.0 m -72.97 -51.06 19.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.84 . . . . 0.0 109.473 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 4.2 mt-10 -55.43 -38.94 69.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.162 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.918 HG23 HD11 ' A' ' 8' ' ' ILE . 38.6 mt -58.08 -30.68 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -0.847 . . . . 0.0 108.969 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.522 ' O ' HG21 ' A' ' 51' ' ' VAL . 3.5 tttm -62.04 -47.51 84.43 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.716 0.769 . . . . 0.0 110.083 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.658 ' O ' HG23 ' A' ' 45' ' ' THR . 45.9 m-80 -72.42 -33.93 67.47 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.693 -0.629 . . . . 0.0 111.052 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.862 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.24 -50.89 71.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.861 -1.149 . . . . 0.0 110.643 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.802 HG21 HG11 ' A' ' 81' ' ' VAL . 1.1 m -64.72 -33.26 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.517 -1.364 . . . . 0.0 109.783 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -58.48 -29.05 65.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.848 . . . . 0.0 110.326 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.968 HG21 ' HB ' ' A' ' 3' ' ' THR . 1.3 p -77.99 -48.94 15.06 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.109 -0.994 . . . . 0.0 110.346 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . -82.94 -56.24 3.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.543 -0.723 . . . . 0.0 110.907 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.526 ' CE1' HD21 ' A' ' 92' ' ' LEU . 14.3 m-85 -71.41 -11.34 60.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.124 -0.985 . . . . 0.0 110.092 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 21.9 mtpt 41.7 47.86 3.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.434 -0.791 . . . . 0.0 110.17 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.766 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -122.01 -164.25 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.52 -0.738 . . . . 0.0 109.987 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.766 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -116.64 109.94 17.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.415 -0.803 . . . . 0.0 109.636 179.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.82 HG13 ' CG1' ' A' ' 81' ' ' VAL . 61.0 t -78.23 148.13 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.196 -0.94 . . . . 0.0 109.974 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.1 p -139.46 9.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 110.082 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.08 117.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 109.948 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.062 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.24 117.26 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 110.116 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.567 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 20.2 m-20 -115.96 115.67 26.58 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.355 -0.841 . . . . 0.0 109.428 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -114.63 167.05 11.09 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 110.024 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 58' ' ' HIS . 2.0 pp -158.77 160.63 36.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.489 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.545 ' NE2' ' HA ' ' A' ' 75' ' ' ASP . 3.1 t-160 -75.51 130.85 39.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.063 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.726 HG21 ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -120.61 138.29 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.452 -0.78 . . . . 0.0 110.486 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.453 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 14.8 mmt85 -112.44 157.68 20.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 110.014 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.36 146.85 17.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.75 23.88 12.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -1.144 . . . . 0.0 110.103 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -106.18 26.46 9.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 3.9 tmtt? 172.8 55.24 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.219 -0.925 . . . . 0.0 110.087 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 66' ' ' LEU . 5.9 ttm180 -115.75 -25.94 7.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 68' ' ' ARG . 1.7 mm? 55.8 108.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -55.48 82.57 0.01 OUTLIER Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -136.08 166.54 23.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.25 -1.147 . . . . 0.0 110.338 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -61.98 149.79 39.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.119 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER 42.4 47.88 4.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 0.0 110.325 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 70' ' ' LEU . . . -43.9 169.4 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.09 128.53 55.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.166 -1.196 . . . . 0.0 110.768 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HD2' ' HD3' ' A' ' 65' ' ' ARG . 7.3 mtp180 -137.47 129.62 16.64 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.403 -0.811 . . . . 0.0 109.764 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.59 -170.01 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.782 1.412 . . . . 0.0 110.516 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.545 ' HA ' ' NE2' ' A' ' 58' ' ' HIS . 0.6 OUTLIER -116.56 89.29 3.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.4 -0.812 . . . . 0.0 109.809 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.71 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.6 mpt_? -99.5 135.76 40.44 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.405 -0.809 . . . . 0.0 109.828 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.713 ' NZ ' HD11 ' A' ' 39' ' ' ILE . 29.1 tttt -123.06 128.12 49.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.118 -0.989 . . . . 0.0 110.62 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.91 ' HD2' HG11 ' A' ' 12' ' ' VAL . 13.4 mtmt -101.34 148.25 25.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.376 -0.827 . . . . 0.0 108.99 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.66 118.96 25.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.97 -1.081 . . . . 0.0 112.007 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 17.5 mt -97.15 110.53 25.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.812 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.062 HG22 ' CG2' ' A' ' 54' ' ' VAL . 21.9 t -105.99 133.07 51.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.759 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.617 ' O ' HG12 ' A' ' 52' ' ' VAL . 42.0 tp60 -111.25 153.46 25.84 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.922 -1.111 . . . . 0.0 109.103 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.7 m -114.66 155.76 15.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 118.179 -1.408 . . . . 0.0 109.611 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.938 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -49.92 178.93 0.03 OUTLIER Pre-proline 0 C--N 1.289 -2.023 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.353 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.938 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -72.45 142.39 36.72 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.244 1.655 . . . . 0.0 110.546 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.37 -36.83 3.63 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 11.7 mt-30 -80.53 173.03 13.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.136 . . . . 0.0 110.618 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 179.63 93.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -0.793 . . . . 0.0 110.216 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.716 HD12 ' CD2' ' A' ' 26' ' ' TYR . 14.8 mt -43.09 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -0.971 . . . . 0.0 110.026 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.483 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 2.9 mt-10 -75.17 -14.19 60.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 0.0 110.744 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.752 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.11 -24.03 23.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.096 -1.002 . . . . 0.0 110.506 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.064 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -105.86 -23.2 12.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.11 -0.994 . . . . 0.0 109.592 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 40.0 mm-40 -60.66 -23.17 64.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.399 -0.813 . . . . 0.0 110.196 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.97 -19.47 8.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 95' ' ' LEU . 14.4 tp -50.47 -21.05 1.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.29 -1.123 . . . . 0.0 110.13 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.547 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 43.8 mt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.141 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.869 0.366 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -85.83 60.92 6.53 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.152 178.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.685 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -104.62 -106.29 0.3 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.524 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -83.96 -3.41 57.96 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.925 -1.109 . . . . 0.0 108.962 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.891 ' CZ ' HG23 ' A' ' 7' ' ' VAL 0.258 0.3 OUTLIER -53.92 -141.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.827 0.822 . . . . 0.0 110.529 178.501 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.65 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 40.0 t0 -27.8 -62.31 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.382 0.611 . . . . 0.0 111.692 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.922 HG12 HG13 ' A' ' 8' ' ' ILE . 84.6 t -49.9 -103.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 111.109 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.922 HG13 HG12 ' A' ' 7' ' ' VAL . 9.8 mt -84.22 88.65 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 0.0 111.143 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -54.97 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.408 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' TRP . . . -108.51 164.78 13.99 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.574 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.3 Cg_endo -80.22 155.04 22.21 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.013 1.533 . . . . 0.0 110.261 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.72 HG11 HG22 ' A' ' 27' ' ' THR . 1.8 p -115.24 112.54 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.085 -1.009 . . . . 0.0 110.32 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.774 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.55 110.72 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.923 . . . . 0.0 110.391 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.812 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -144.71 162.46 36.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.981 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' SER . 52.9 mt-10 -42.79 -65.32 0.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -14.61 32.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 110.344 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.812 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -100.51 23.74 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 110.418 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -134.36 -49.67 0.79 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.075 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.75 -35.29 80.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.102 -0.999 . . . . 0.0 109.324 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -88.76 -34.4 9.15 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.596 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -72.47 -8.69 56.38 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -78.2 -16.59 57.72 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.54 -0.725 . . . . 0.0 110.813 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 2.0 mm-40 -88.74 17.36 5.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.527 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.577 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 101.56 -3.35 53.57 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 28.3 mttt -82.44 137.04 34.8 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.603 -0.94 . . . . 0.0 109.516 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.647 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 99.3 m-85 -127.15 112.21 14.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.708 -1.245 . . . . 0.0 111.435 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.033 HG23 HD11 ' A' ' 80' ' ' ILE . 3.9 m -82.38 127.96 33.76 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.059 ' CE2' HG11 ' A' ' 43' ' ' VAL . 22.7 m-85 -123.08 147.43 46.74 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.163 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.604 ' CZ3' ' CG ' ' A' ' 76' ' ' ARG . 3.9 m95 -84.35 122.6 29.16 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 8' ' ' ILE . 1.5 m -138.51 164.07 27.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 118.207 -1.397 . . . . 0.0 112.043 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -61.64 134.36 93.76 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 176.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.502 ' CD ' ' HB3' ' A' ' 75' ' ' ASP . 38.3 Cg_endo -64.2 75.9 0.18 Allowed 'Trans proline' 0 C--N 1.293 -2.359 0 O-C-N 123.22 1.116 . . . . 0.0 109.398 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.551 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.47 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.829 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -38.46 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.821 -0.55 . . . . 0.0 109.84 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -46.76 140.58 4.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.108 -0.995 . . . . 0.0 110.76 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.502 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 8.6 mttt -43.42 -45.36 6.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.308 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 3.4 m -61.01 -48.53 81.37 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 109.296 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 2.1 mt-10 -58.43 -44.51 89.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.358 -0.839 . . . . 0.0 109.356 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.767 ' O ' HG22 ' A' ' 43' ' ' VAL . 15.3 mt -57.3 -30.71 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 54.9 tttt -66.55 -47.6 72.32 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.425 -0.797 . . . . 0.0 109.366 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.971 ' O ' HG23 ' A' ' 45' ' ' THR . 72.2 m-20 -73.65 -34.38 64.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.625 -0.672 . . . . 0.0 110.8 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.685 ' HB1' ' O ' ' A' ' 3' ' ' THR . . . -57.96 -50.49 73.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.84 -1.163 . . . . 0.0 110.365 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.059 HG11 ' CE2' ' A' ' 28' ' ' PHE . 3.2 m -73.47 -36.33 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.837 -1.164 . . . . 0.0 110.022 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -58.0 -34.71 70.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.088 -1.008 . . . . 0.0 109.48 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.971 HG23 ' O ' ' A' ' 41' ' ' ASN . 39.9 p -79.3 -45.06 20.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.511 -0.743 . . . . 0.0 110.078 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HB2' ' OG1' ' A' ' 3' ' ' THR . . . -80.46 -56.83 3.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.384 -0.822 . . . . 0.0 111.018 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CG ' HD13 ' A' ' 89' ' ' ILE . 6.4 m-85 -71.49 -21.39 61.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.018 -1.051 . . . . 0.0 110.245 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.95 44.45 19.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 110.38 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.786 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -123.55 -164.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.515 -0.74 . . . . 0.0 109.791 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.786 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.23 107.3 15.1 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 109.489 179.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.859 HG13 HG13 ' A' ' 81' ' ' VAL . 75.6 t -78.07 119.4 26.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.214 -0.929 . . . . 0.0 110.026 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.658 HG12 ' C ' ' A' ' 82' ' ' GLN . 7.1 p -103.43 -0.21 10.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.404 -0.81 . . . . 0.0 110.086 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.555 ' CG ' ' HB3' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 178.91 141.58 0.11 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.82 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.08 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -134.3 127.73 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.073 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.502 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 47.0 t30 -131.27 115.1 15.86 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.406 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.32 149.23 39.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.63 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -130.68 170.98 13.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 110.665 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.544 ' CD2' ' HG2' ' A' ' 60' ' ' ARG . 5.0 t-160 -80.23 115.56 19.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 110.007 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.54 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -119.64 137.29 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.349 -0.845 . . . . 0.0 110.042 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.544 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 11.7 mmt180 -145.68 151.4 37.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 110.186 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.51 108.78 1.64 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.9 62.5 7.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -1.142 . . . . 0.0 110.196 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -108.2 114.65 28.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.266 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.57 74.19 0.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 110.185 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 3.9 ttm180 -136.36 -50.63 0.69 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.212 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 67' ' ' GLY . 4.8 mp 54.41 57.02 6.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.932 . . . . 0.0 110.265 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' A' ' 68' ' ' ARG . . . 42.32 52.52 5.14 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 36.5 mtt85 -150.62 -177.54 6.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -1.196 . . . . 0.0 110.199 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.452 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 6.1 t80 -102.2 56.28 0.8 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.24 -0.912 . . . . 0.0 110.214 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.33 41.47 1.36 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.081 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.51 178.88 48.85 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -95.37 158.97 15.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -1.163 . . . . 0.0 110.171 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -114.89 99.09 51.58 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.175 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 60' ' ' ARG . 47.7 Cg_endo -73.23 -164.8 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.053 1.554 . . . . 0.0 110.523 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.502 ' HB3' ' CD ' ' A' ' 32' ' ' PRO . 1.5 m-20 -114.45 89.46 3.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 109.365 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.604 ' CG ' ' CZ3' ' A' ' 29' ' ' TRP . 0.5 OUTLIER -120.83 114.37 21.51 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.703 -0.623 . . . . 0.0 109.646 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.54 ' HA ' HG23 ' A' ' 59' ' ' VAL . 4.3 tttp -123.06 140.84 52.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.144 -0.972 . . . . 0.0 110.753 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.556 ' HD2' ' CG2' ' A' ' 27' ' ' THR . 0.4 OUTLIER -106.96 143.33 35.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.427 -0.796 . . . . 0.0 109.646 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.656 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -133.69 118.96 18.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.083 -1.011 . . . . 0.0 111.247 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.033 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -100.83 111.85 31.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.523 0.678 . . . . 0.0 109.911 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.08 HG22 ' CG2' ' A' ' 54' ' ' VAL . 35.1 t -109.1 136.09 46.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 110.265 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.658 ' C ' HG12 ' A' ' 52' ' ' VAL . 6.6 tp60 -110.33 153.44 24.9 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.102 -0.999 . . . . 0.0 109.0 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.476 HG21 ' C ' ' A' ' 87' ' ' GLN . 2.3 m -116.18 155.44 17.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.832 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.975 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -50.09 179.26 0.03 OUTLIER Pre-proline 0 C--N 1.288 -2.066 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.617 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.975 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 41.5 Cg_endo -71.5 141.31 38.13 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.366 1.719 . . . . 0.0 110.499 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.6 -25.48 11.13 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.525 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 60.3 mt-30 -94.05 163.77 13.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -1.164 . . . . 0.0 110.689 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER 179.51 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.457 -0.777 . . . . 0.0 110.113 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.635 HD13 ' CG ' ' A' ' 47' ' ' PHE . 9.4 mt -44.28 95.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.953 . . . . 0.0 109.596 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.548 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -68.53 -13.27 62.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.439 -0.788 . . . . 0.0 111.155 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.731 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.44 -35.08 62.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.087 -1.008 . . . . 0.0 110.969 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -106.89 -23.67 12.29 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.889 -1.132 . . . . 0.0 110.773 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.548 ' HG2' ' HA ' ' A' ' 90' ' ' GLU . 1.9 pp20? -51.1 -22.93 2.73 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.038 -1.039 . . . . 0.0 110.234 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -99.08 -23.77 11.11 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.636 HD23 ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -42.75 -29.58 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -1.128 . . . . 0.0 110.147 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.566 HG13 ' CE1' ' A' ' 18' ' ' TYR . 2.6 mp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptm . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.029 0.442 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.649 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -92.27 84.44 5.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.081 -1.012 . . . . 0.0 109.382 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.837 HG21 ' CB ' ' A' ' 45' ' ' THR . 1.3 p -136.88 -89.45 0.27 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.611 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.888 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -76.3 -22.59 54.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.893 -1.129 . . . . 0.0 110.126 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.883 ' CZ ' HG23 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -52.15 -139.09 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.837 0.827 . . . . 0.0 110.814 178.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.644 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 11.8 t70 -30.56 -56.56 0.2 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.466 -0.771 . . . . 0.0 111.819 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.883 HG23 ' CZ ' ' A' ' 5' ' ' TYR . 99.1 t -53.71 -103.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.887 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.882 HG13 HG12 ' A' ' 7' ' ' VAL . 3.6 mt -86.1 90.55 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.846 -1.159 . . . . 0.0 111.26 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -72.75 -97.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.402 -0.811 . . . . 0.0 110.198 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -108.38 162.36 20.21 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.998 . . . . 0.0 110.242 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 46.8 Cg_endo -73.96 163.5 36.73 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.994 1.523 . . . . 0.0 110.388 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.157 HG12 ' CD1' ' A' ' 29' ' ' TRP . 2.4 m -115.13 139.4 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.942 . . . . 0.0 110.317 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.67 111.48 23.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -0.958 . . . . 0.0 110.042 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 15' ' ' GLU . 54.3 m -145.66 139.56 26.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 110.183 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 8.7 tm-20 -42.79 -58.71 2.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 110.176 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -42.26 71.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.264 -0.897 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -58.93 -66.0 0.57 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.699 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.6 m-85 -44.92 -31.08 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 110.58 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.77 -8.77 48.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -110.98 -31.97 2.75 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -76.08 -17.22 59.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.686 -0.891 . . . . 0.0 108.92 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.615 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -57.0 -21.31 29.72 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.791 -0.568 . . . . 0.0 110.725 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -88.99 17.08 6.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.51 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.11 0.18 66.0 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 1.7 mttp -82.36 137.21 34.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -1.015 . . . . 0.0 109.064 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 1.006 ' CD1' HD12 ' A' ' 92' ' ' LEU . 27.6 m-85 -128.86 105.52 8.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.34 -1.475 . . . . 0.0 112.244 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 4.3 m -74.88 141.02 44.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.445 0.641 . . . . 0.0 109.37 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.735 ' CB ' HG23 ' A' ' 8' ' ' ILE . 21.7 m-85 -133.3 166.18 23.09 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.434 -0.791 . . . . 0.0 110.032 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 1.157 ' CD1' HG12 ' A' ' 12' ' ' VAL . 14.0 m95 -98.28 122.96 42.08 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.0 p -143.9 160.39 16.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 C-N-CA 117.792 -1.563 . . . . 0.0 112.768 -176.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -62.2 151.99 79.86 Favored Pre-proline 0 C--N 1.3 -1.572 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.69 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.9 Cg_endo -73.06 69.54 3.85 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.082 1.569 . . . . 0.0 109.647 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.2 OUTLIER 179.72 -34.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.399 -0.813 . . . . 0.0 110.017 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.874 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -43.75 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.381 -0.825 . . . . 0.0 109.603 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -41.55 136.04 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.535 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.793 ' HA ' HD12 ' A' ' 39' ' ' ILE . 7.5 mttt -43.74 -41.34 4.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 109.385 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.5 m -67.66 -40.26 84.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.267 -0.896 . . . . 0.0 108.997 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.517 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 5.1 mt-10 -55.79 -39.46 71.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.899 . . . . 0.0 108.763 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.797 HG21 ' HB1' ' A' ' 79' ' ' ALA . 32.3 mt -57.75 -34.66 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.6 ttmt -57.99 -47.91 81.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.37 -0.831 . . . . 0.0 109.945 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -73.79 -34.82 64.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.696 -0.627 . . . . 0.0 111.345 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 3' ' ' THR . . . -58.77 -50.5 73.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.824 -1.173 . . . . 0.0 110.672 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.727 HG13 ' CD1' ' A' ' 8' ' ' ILE . 2.6 m -65.02 -33.21 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.774 -1.204 . . . . 0.0 109.811 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -60.65 -44.29 96.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 0.0 109.204 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.837 ' CB ' HG21 ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.06 -15.28 58.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.0 109.323 179.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.888 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -102.66 -68.79 0.81 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.406 -0.809 . . . . 0.0 110.459 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD2' HG12 ' A' ' 43' ' ' VAL . 29.9 m-85 -74.08 -21.56 59.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 4.3 tttp 65.15 47.21 2.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 110.107 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.771 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -125.29 -162.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.498 -0.752 . . . . 0.0 110.413 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.771 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -118.29 114.58 23.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.473 -0.767 . . . . 0.0 109.788 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.059 HG13 HG13 ' A' ' 81' ' ' VAL . 90.4 t -78.94 123.31 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.0 110.435 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.682 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.4 p -114.93 9.94 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.924 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.55 120.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.402 -0.811 . . . . 0.0 109.902 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.15 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -113.12 125.51 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.196 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.554 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -125.12 115.6 20.72 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.224 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.548 ' CG2' ' HG2' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -119.2 150.46 40.04 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.902 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.538 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 3.3 pp -146.86 145.38 29.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.408 -0.807 . . . . 0.0 110.054 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 132.49 44.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.357 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -120.2 125.85 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.366 -0.834 . . . . 0.0 110.106 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -132.77 133.98 44.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 110.188 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . -44.5 166.06 0.04 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -139.28 -54.84 0.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -1.144 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -76.2 -31.39 58.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.227 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 63' ' ' LYS . 6.0 ttpt -43.32 -26.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 110.295 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 4.9 ttp180 -73.78 -19.82 60.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.415 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER 52.24 53.1 12.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 66' ' ' LEU . . . 40.99 42.7 3.04 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.512 ' HG3' ' N ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -159.88 177.41 10.81 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.468 -1.019 . . . . 0.0 110.114 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.512 ' N ' ' HG3' ' A' ' 68' ' ' ARG . 3.6 t80 -89.51 92.79 9.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 110.102 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.468 HD13 ' HD2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -130.33 40.33 3.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 110.2 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.433 ' C ' ' HG3' ' A' ' 72' ' ' LYS . . . 144.79 -166.07 27.49 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HG3' ' C ' ' A' ' 71' ' ' GLY . 41.7 mtpt -148.73 129.33 14.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -1.171 . . . . 0.0 110.217 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.5 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -43.8 106.55 0.51 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.02 -167.39 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.966 1.509 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.66 89.44 3.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.435 -0.791 . . . . 0.0 109.604 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.579 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 1.8 tpt180 -107.43 112.82 25.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.58 -0.7 . . . . 0.0 109.906 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -110.03 129.41 55.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 10.4 ptpt -114.65 151.51 33.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.996 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.797 ' HB1' HG21 ' A' ' 39' ' ' ILE . . . -122.23 125.71 46.64 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.106 -0.996 . . . . 0.0 112.585 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 22.7 mt -104.22 110.93 31.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.452 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.15 HG22 ' CG2' ' A' ' 54' ' ' VAL . 97.9 t -104.26 134.55 45.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 110.346 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.682 ' C ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -102.51 150.71 23.12 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.171 -0.956 . . . . 0.0 108.704 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.515 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.4 m -115.33 156.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 118.069 -1.452 . . . . 0.0 109.754 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.92 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -67.65 -179.71 0.49 Allowed Pre-proline 0 C--N 1.288 -2.104 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.163 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.92 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.0 Cg_endo -73.2 139.53 29.52 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 O-C-N 124.264 1.665 . . . . 0.0 110.195 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.503 ' O ' ' CE ' ' A' ' 88' ' ' LYS . . . 109.09 -48.31 0.95 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.819 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -94.07 176.87 6.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.16 -1.2 . . . . 0.0 110.672 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 86' ' ' GLY . 0.4 OUTLIER 179.56 100.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -0.772 . . . . 0.0 110.088 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.925 HD12 ' CD2' ' A' ' 26' ' ' TYR . 10.4 mt -44.19 108.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 110.05 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 10.0 mm-40 -75.75 -13.65 60.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.416 -0.803 . . . . 0.0 110.799 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.864 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.82 -31.38 59.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.0 110.577 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.006 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.31 -23.04 12.66 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.19 -0.944 . . . . 0.0 109.715 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 36.1 mm-40 -50.84 -35.25 31.51 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 110.382 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -94.78 -24.22 18.41 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.864 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.3 mp -43.0 -27.22 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -1.181 . . . . 0.0 110.173 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.54 HG22 ' OXT' ' A' ' 96' ' ' ILE . 22.8 mm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.18 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.564 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.686 0.279 . . . . 0.0 110.565 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 4' ' ' ALA . 4.6 mmpt? -45.11 97.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.629 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.4 m 3.86 -70.68 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 CA-C-O 121.407 0.622 . . . . 0.0 110.739 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.982 ' O ' HG23 ' A' ' 7' ' ' VAL 0.27 . . -55.19 80.46 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.095 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.5 p90 24.37 46.61 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.842 0.829 . . . . 0.0 110.321 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.604 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 5.9 t70 64.67 52.54 1.69 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.925 0.869 . . . . 0.0 111.406 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.095 HG21 ' CE2' ' A' ' 5' ' ' TYR . 3.3 t -131.98 -125.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.134 -0.978 . . . . 0.0 109.638 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.884 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.8 mt -57.04 120.33 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.157 -0.965 . . . . 0.0 110.121 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -111.65 -89.59 0.51 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.175 -0.953 . . . . 0.0 110.297 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.25 142.42 24.55 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.095 -1.003 . . . . 0.0 110.212 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.593 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 47.5 Cg_endo -73.69 175.73 10.33 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.058 1.557 . . . . 0.0 110.506 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.156 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.9 m -115.08 133.15 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.926 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.738 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.98 110.23 22.07 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.152 -0.968 . . . . 0.0 110.293 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 71.7 m -166.07 138.39 3.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 110.008 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 14' ' ' SER . 13.2 mt-10 -43.41 -46.36 6.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 110.064 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.72 -18.05 4.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.574 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -101.62 -49.81 3.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.752 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.985 ' CE1' HD11 ' A' ' 96' ' ' ILE . 2.4 m-85 -58.64 -44.74 90.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.496 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -12.61 38.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 108.876 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' N ' ' A' ' 22' ' ' ALA . . . -98.95 -39.59 3.53 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 3.6 m-30 -49.96 -25.43 3.28 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 20' ' ' GLY . . . -40.21 -31.68 0.14 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.724 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 3.6 tp10 -104.05 -1.26 27.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.771 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.543 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 103.52 9.1 39.11 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 15.4 mttt -82.58 131.54 35.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -1.133 . . . . 0.0 109.668 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.906 ' CD1' HD12 ' A' ' 92' ' ' LEU . 70.1 m-85 -126.86 108.09 10.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.887 -1.133 . . . . 0.0 112.003 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 27.1 m -75.85 121.9 23.3 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.74 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -116.4 164.03 15.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 110.618 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 1.156 ' CD1' HG12 ' A' ' 12' ' ' VAL . 68.1 m95 -97.5 123.22 41.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.802 ' HA ' HD21 ' A' ' 9' ' ' LEU . 2.6 p -151.4 164.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 C-N-CA 117.827 -1.549 . . . . 0.0 111.997 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.481 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -51.01 140.46 20.89 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.207 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.4 Cg_endo -72.17 76.57 2.14 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.06 1.558 . . . . 0.0 110.059 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 179.03 -33.81 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.418 -0.801 . . . . 0.0 110.03 -178.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.676 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -48.43 107.5 0.13 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 110.194 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -59.45 147.51 36.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -0.927 . . . . 0.0 110.012 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.542 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 21.8 mttt -46.56 -34.4 4.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 110.102 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.3 m -75.18 -51.19 13.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 110.447 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.49 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 1.8 mt-10 -55.19 -42.82 73.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.779 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.764 HG23 HD11 ' A' ' 8' ' ' ILE . 20.9 mt -57.19 -30.59 35.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.656 ' HG3' HG11 ' A' ' 51' ' ' VAL . 1.2 ttpm? -62.71 -46.35 88.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 111.046 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.405 ' O ' HG23 ' A' ' 45' ' ' THR . 13.5 m-80 -58.97 -34.89 72.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.421 -0.799 . . . . 0.0 112.336 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.884 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -72.43 -49.27 34.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.666 -1.271 . . . . 0.0 111.652 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -69.52 -37.63 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.888 -1.133 . . . . 0.0 110.84 -178.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.68 -44.12 81.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.072 -1.017 . . . . 0.0 110.424 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 41' ' ' ASN . 34.0 p -78.99 -46.19 18.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 110.295 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.68 -55.93 22.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.311 -0.868 . . . . 0.0 110.554 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.67 ' CD1' HG22 ' A' ' 43' ' ' VAL . 70.6 m-85 -83.2 3.02 32.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.112 -0.992 . . . . 0.0 110.333 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 4.5 pttm 38.23 42.57 0.51 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.735 0.779 . . . . 0.0 110.326 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.773 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -115.39 -165.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.599 -0.688 . . . . 0.0 109.792 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.773 ' N ' HG13 ' A' ' 49' ' ' VAL . 2.8 tmtm? -118.27 103.16 9.56 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.443 -0.785 . . . . 0.0 109.831 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.656 HG11 ' HG3' ' A' ' 40' ' ' LYS . 97.7 t -78.37 119.63 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.36 -0.838 . . . . 0.0 109.69 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.3 p -101.02 -5.61 9.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -0.903 . . . . 0.0 110.381 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER 176.08 119.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.344 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.937 HG23 HG13 ' A' ' 81' ' ' VAL . 1.1 t -109.56 124.51 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 109.743 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.542 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 12.9 m120 -122.83 116.32 23.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.219 -0.926 . . . . 0.0 109.818 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.543 ' OG1' ' CE ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -110.17 155.43 21.98 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.36 -0.837 . . . . 0.0 110.185 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.584 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -138.58 156.96 47.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.778 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.32 122.91 25.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.463 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.593 HG21 ' HG3' ' A' ' 78' ' ' LYS . 4.3 m -120.33 132.78 69.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.701 -0.625 . . . . 0.0 110.21 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.494 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -135.89 109.22 7.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.224 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 60.9 144.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.76 -49.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -1.145 . . . . 0.0 110.243 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 64' ' ' LYS . 18.6 mmtt -105.45 -57.8 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.181 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -41.55 -37.41 1.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.386 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -52.52 -57.46 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 110.236 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER 61.19 135.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.202 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . 44.58 -169.73 0.02 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -42.71 166.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.372 -1.075 . . . . 0.0 110.237 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -44.77 134.5 5.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 110.242 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.12 41.01 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.078 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.1 -152.75 8.19 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 145.18 50.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -1.18 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 15.6 mtt85 -107.68 99.8 31.4 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.239 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 73' ' ' ARG . 47.9 Cg_endo -73.02 -165.05 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.948 1.499 . . . . 0.0 110.366 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.6 89.47 3.1 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.444 -0.785 . . . . 0.0 109.337 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.538 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -120.95 147.64 45.18 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.681 -0.637 . . . . 0.0 110.116 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.543 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 0.1 OUTLIER -121.92 142.14 50.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 0.0 110.379 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.842 ' HD3' HG11 ' A' ' 12' ' ' VAL . 1.8 mttt -100.91 151.22 22.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 109.718 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -119.55 119.24 33.22 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.985 -1.072 . . . . 0.0 111.944 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 9.1 mt -95.95 110.87 25.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 109.527 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.049 HG11 HG11 ' A' ' 43' ' ' VAL . 2.9 t -99.8 125.95 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.14 -0.975 . . . . 0.0 110.263 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.68 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -106.75 143.15 35.27 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.011 -1.056 . . . . 0.0 108.932 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.47 ' CA ' HG12 ' A' ' 52' ' ' VAL . 1.3 m -115.0 156.84 15.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.442 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.853 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -68.18 177.17 1.1 Allowed Pre-proline 0 C--N 1.29 -1.999 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.671 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.853 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -73.49 141.91 32.2 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.348 1.709 . . . . 0.0 110.36 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.97 -26.74 14.52 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -113.72 177.68 4.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -1.132 . . . . 0.0 110.305 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.6 OUTLIER 179.71 122.68 0.06 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -0.933 . . . . 0.0 110.373 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.684 HG22 ' HG ' ' A' ' 92' ' ' LEU . 12.5 mt -73.6 93.94 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 110.101 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 20.0 pt-20 -72.55 -14.66 61.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.855 . . . . 0.0 110.409 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.756 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.7 -23.82 30.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.892 . . . . 0.0 110.495 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.906 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.22 -23.01 12.69 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.174 -0.954 . . . . 0.0 109.713 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.3 mm-40 -61.34 -31.06 70.92 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.359 -0.838 . . . . 0.0 110.369 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.68 -6.22 56.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.1 tp -61.86 -12.07 15.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.167 . . . . 0.0 110.193 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.985 HD11 ' CE1' ' A' ' 18' ' ' TYR . 2.9 mp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.15 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 120.871 0.367 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.644 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -83.89 76.37 10.03 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.784 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.718 HG21 ' CG2' ' A' ' 45' ' ' THR . 0.0 OUTLIER -120.51 -90.72 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.592 -0.693 . . . . 0.0 109.777 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -88.87 -27.63 20.89 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.201 -0.937 . . . . 0.0 109.091 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.799 ' CE1' HG23 ' A' ' 7' ' ' VAL . 1.1 p90 -35.44 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.597 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 28.3 m-20 -162.16 -58.02 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.912 -1.118 . . . . 0.0 110.311 -177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.975 HG13 ' HB1' ' A' ' 34' ' ' ALA . 46.4 t -43.02 -73.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 121.807 0.813 . . . . 0.0 109.075 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.861 HG23 ' HB3' ' A' ' 28' ' ' PHE . 6.4 mt -110.59 67.77 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 121.232 -0.918 . . . . 0.0 109.932 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 mt -54.28 -94.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.806 . . . . 0.0 110.742 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.17 150.45 36.73 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 110.61 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.22 162.02 37.22 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.121 1.59 . . . . 0.0 110.276 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.724 HG13 ' HB ' ' A' ' 27' ' ' THR . 1.1 p -115.35 110.33 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.287 -0.883 . . . . 0.0 110.027 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.818 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.12 106.92 17.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.245 -0.909 . . . . 0.0 110.234 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.651 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -137.76 174.58 10.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 110.253 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -55.7 -65.58 0.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.317 -0.865 . . . . 0.0 110.243 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -54.69 -34.79 62.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.169 -0.957 . . . . 0.0 110.302 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.651 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -71.98 -49.52 36.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.156 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 13' ' ' LEU . 1.3 m-85 -58.07 -31.53 67.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.39 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.46 -8.52 50.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 110.177 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -107.63 -35.41 2.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.401 -1.879 . . . . 0.0 108.401 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -76.02 -16.6 59.93 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.63 -0.924 . . . . 0.0 109.118 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.622 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -59.09 -20.29 52.09 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.442 0.639 . . . . 0.0 110.75 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -88.86 17.27 5.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.395 -0.816 . . . . 0.0 110.434 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.29 -0.25 65.95 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 19.7 mttt -82.4 142.71 31.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.572 -0.958 . . . . 0.0 109.395 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.954 ' CD1' HD12 ' A' ' 92' ' ' LEU . 22.9 m-85 -128.29 110.65 12.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.676 -1.265 . . . . 0.0 111.368 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.992 HG23 HD11 ' A' ' 80' ' ' ILE . 3.0 m -81.55 131.18 35.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.478 0.656 . . . . 0.0 109.277 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.041 ' CE2' HG11 ' A' ' 43' ' ' VAL . 23.3 m-85 -124.65 165.06 18.57 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.488 -0.758 . . . . 0.0 110.672 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.637 ' CE3' ' CG ' ' A' ' 76' ' ' ARG . 3.1 m95 -103.12 122.29 44.38 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.6 p -139.42 161.57 27.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 C-N-CA 118.025 -1.47 . . . . 0.0 112.327 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.593 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -74.03 150.26 87.87 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.259 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 44.0 Cg_endo -70.31 67.14 2.07 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.986 1.519 . . . . 0.0 109.729 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.88 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.577 -0.702 . . . . 0.0 109.575 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.975 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -43.98 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.338 -0.851 . . . . 0.0 109.306 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -38.0 130.86 1.13 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.496 -0.752 . . . . 0.0 110.964 -179.127 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.834 ' HA ' HD12 ' A' ' 39' ' ' ILE . 1.5 mttt -42.84 -43.31 3.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 109.619 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 4.5 m -61.79 -44.52 96.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 19.6 mm-40 -55.36 -38.83 69.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.392 -0.817 . . . . 0.0 109.422 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 36' ' ' LYS . 25.0 mt -57.38 -30.87 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.706 ' HG3' HG11 ' A' ' 51' ' ' VAL . 59.9 tttm -67.85 -47.05 70.04 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.444 -0.785 . . . . 0.0 109.582 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.476 ' O ' ' HB ' ' A' ' 45' ' ' THR . 58.0 m-80 -73.6 -34.31 65.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.604 -0.685 . . . . 0.0 111.325 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 3' ' ' THR . . . -58.15 -50.56 73.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.739 -1.226 . . . . 0.0 110.454 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.041 HG11 ' CE2' ' A' ' 28' ' ' PHE . 3.6 m -68.31 -32.89 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.854 -1.154 . . . . 0.0 109.372 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CD ' ' O ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.42 -42.02 79.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.12 -0.987 . . . . 0.0 108.483 178.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.718 ' CG2' HG21 ' A' ' 3' ' ' THR . 0.9 OUTLIER -79.52 -12.8 59.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.601 -0.687 . . . . 0.0 109.49 178.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.8 -62.2 1.57 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 110.678 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 43' ' ' VAL . 24.0 m-85 -71.59 -22.48 61.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.996 -1.065 . . . . 0.0 110.071 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER 65.88 46.78 2.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.845 . . . . 0.0 110.038 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.676 HG22 ' H ' ' A' ' 50' ' ' LYS . 1.2 p -125.28 -164.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.631 -0.668 . . . . 0.0 110.412 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.676 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.3 tmtp? -118.46 106.73 13.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.451 -0.781 . . . . 0.0 109.763 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.706 HG11 ' HG3' ' A' ' 40' ' ' LYS . 40.6 t -78.8 140.54 16.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 110.542 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.669 HG12 ' C ' ' A' ' 82' ' ' GLN . 13.6 p -118.91 -6.46 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.616 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -179.18 131.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.041 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -120.26 129.47 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.918 -1.114 . . . . 0.0 110.117 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 3.8 m-80 -131.53 115.71 16.49 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.437 -0.789 . . . . 0.0 109.387 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.561 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -115.5 159.58 21.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 109.311 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.634 HD11 ' HD2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -148.33 144.71 27.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.11 -0.993 . . . . 0.0 110.968 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.05 103.36 2.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.858 . . . . 0.0 109.034 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -95.86 109.36 22.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.385 -0.822 . . . . 0.0 109.319 -179.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 2.1 mmt180 -114.36 134.29 55.08 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.397 -0.815 . . . . 0.0 110.457 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.577 ' HA3' ' CB ' ' A' ' 73' ' ' ARG . . . -85.25 114.32 3.95 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 61' ' ' GLY . 16.0 mmmt -53.62 -172.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -1.158 . . . . 0.0 110.174 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 64' ' ' LYS . 1.1 ttpt -53.73 -29.24 38.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 63' ' ' LYS . 1.6 mptt -41.61 100.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -159.83 -57.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.28 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 67' ' ' GLY . 23.2 tp -41.95 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 110.435 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 65' ' ' ARG . . . 42.22 87.36 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 64' ' ' LYS . 23.2 mtt85 -144.94 131.24 19.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -1.122 . . . . 0.0 110.196 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.431 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 1.8 p90 -44.86 134.04 5.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 43.45 40.37 2.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.871 . . . . 0.0 109.931 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 72' ' ' LYS . . . -89.51 -124.17 2.49 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.428 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 0.1 OUTLIER 42.95 54.25 4.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -1.121 . . . . 0.0 110.114 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.577 ' CB ' ' HA3' ' A' ' 61' ' ' GLY . 3.5 mtm180 -103.31 103.81 37.28 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 110.166 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 55.3 Cg_endo -77.33 -165.38 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.091 1.574 . . . . 0.0 110.888 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -114.83 90.01 3.24 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.637 ' CG ' ' CE3' ' A' ' 29' ' ' TRP . 0.3 OUTLIER -137.42 153.85 50.07 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.62 -0.675 . . . . 0.0 111.102 -178.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 59' ' ' VAL . 4.8 ptmt -98.59 141.2 31.73 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.402 -0.812 . . . . 0.0 110.18 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.634 ' HD2' HD11 ' A' ' 57' ' ' LEU . 19.2 ptpt -109.3 151.41 26.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -0.936 . . . . 0.0 110.483 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.898 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -116.9 122.68 45.01 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.234 -0.916 . . . . 0.0 111.931 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.992 HD11 HG23 ' A' ' 27' ' ' THR . 1.5 mp -103.18 112.77 37.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.559 -0.713 . . . . 0.0 109.468 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.041 HG22 ' CG2' ' A' ' 54' ' ' VAL . 23.8 t -113.3 128.68 69.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.417 -0.802 . . . . 0.0 110.866 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.669 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.5 tp60 -98.82 153.36 18.83 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.193 -0.942 . . . . 0.0 108.679 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 84' ' ' ALA . 1.5 m -116.66 156.69 17.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 C-N-CA 118.264 -1.375 . . . . 0.0 108.679 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.986 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -69.27 178.79 0.85 Allowed Pre-proline 0 C--N 1.285 -2.229 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.002 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.893 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.6 138.41 26.68 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 124.243 1.654 . . . . 0.0 110.458 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.42 -30.1 8.52 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.986 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -111.69 176.9 4.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.242 . . . . 0.0 110.705 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 90' ' ' GLU . 8.2 ptpt 179.46 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.459 -0.776 . . . . 0.0 110.012 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.827 HD12 ' CD2' ' A' ' 26' ' ' TYR . 14.9 mt -45.07 95.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.002 . . . . 0.0 110.075 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 88' ' ' LYS . 1.1 pt-20 -68.13 -13.89 62.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.384 -0.823 . . . . 0.0 110.666 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.769 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.96 -28.68 53.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.125 -0.985 . . . . 0.0 110.347 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.954 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.23 -23.04 12.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.492 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 13.9 mm-40 -51.07 -31.92 20.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.436 -0.79 . . . . 0.0 110.45 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -98.02 -26.63 9.45 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.769 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.4 mp -43.56 -26.18 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.227 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.412 HG13 ' CE1' ' A' ' 18' ' ' TYR . 40.5 mt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.23 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.548 ' O ' HG22 ' A' ' 3' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.727 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -60.92 89.97 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.004 -1.478 . . . . 0.0 108.84 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.602 ' HA ' HG21 ' A' ' 45' ' ' THR 0.265 12.0 t -134.1 -24.43 1.65 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 122.113 0.958 . . . . 0.0 110.363 -178.038 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.63 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . 179.86 -29.0 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 121.376 0.607 . . . . 0.0 109.525 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.727 ' CE1' ' HA ' ' A' ' 2' ' ' LYS 0.288 0.1 OUTLIER -43.31 -136.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.36 1.076 . . . . 0.0 112.685 177.914 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.633 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 22.9 m-20 -23.06 -62.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.687 0.756 . . . . 0.0 112.293 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.025 HG12 HG13 ' A' ' 8' ' ' ILE . 45.7 t -57.33 -111.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.575 -0.703 . . . . 0.0 111.199 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.025 HG13 HG12 ' A' ' 7' ' ' VAL . 5.7 mt -86.37 100.2 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.861 -1.15 . . . . 0.0 111.109 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.496 HD21 ' HA ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -91.63 -86.01 0.23 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.226 -0.921 . . . . 0.0 111.067 179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.544 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -107.99 140.64 21.85 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.9 -1.125 . . . . 0.0 110.592 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.628 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.1 Cg_endo -72.96 170.38 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.079 1.568 . . . . 0.0 110.393 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.076 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.6 m -115.27 133.16 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.165 -0.959 . . . . 0.0 110.405 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.838 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -102.83 112.66 25.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.163 -0.961 . . . . 0.0 110.215 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 15' ' ' GLU . 40.5 m -159.69 145.62 15.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.007 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' SER . 36.5 mt-10 -42.76 -54.13 4.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 110.165 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -54.61 -28.17 44.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 0.0 110.182 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -87.05 -55.41 3.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.838 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -53.7 -26.24 21.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.02 -15.65 31.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -101.49 -36.44 3.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -77.67 -23.08 49.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.574 -0.956 . . . . 0.0 108.835 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -50.61 -20.58 1.24 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.606 -0.684 . . . . 0.0 110.338 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.3 13.63 25.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.53 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 99.94 -0.53 56.34 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 20.7 mttt -82.38 147.45 28.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -1.138 . . . . 0.0 109.396 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 1.076 ' CE2' HD12 ' A' ' 89' ' ' ILE . 22.0 m-85 -128.07 102.88 6.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.693 -1.254 . . . . 0.0 112.209 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.799 HG22 ' HD3' ' A' ' 78' ' ' LYS . 3.4 m -75.82 125.92 30.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.652 ' CG ' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -130.28 164.96 23.44 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.934 -1.103 . . . . 0.0 112.085 -177.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 1.076 ' CD1' HG12 ' A' ' 12' ' ' VAL . 24.9 m95 -101.33 123.31 45.22 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 7' ' ' VAL . 1.4 p -145.96 158.81 11.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 117.772 -1.571 . . . . 0.0 112.003 -176.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.593 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -59.97 151.17 66.34 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.852 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 49.0 Cg_endo -73.36 70.01 4.03 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.227 1.646 . . . . 0.0 109.763 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.57 -33.42 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 110.071 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.996 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -42.61 93.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.45 -0.781 . . . . 0.0 109.831 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -51.52 140.29 18.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 110.421 -179.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 8.5 mttt -42.26 -43.27 3.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.88 . . . . 0.0 110.027 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -64.32 -53.36 50.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.865 . . . . 0.0 110.07 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.8 OUTLIER -55.47 -40.43 71.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.769 HG23 HD11 ' A' ' 8' ' ' ILE . 14.9 mt -57.68 -31.4 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.271 -0.893 . . . . 0.0 108.968 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 37' ' ' THR . 6.7 tttt -63.12 -42.54 99.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.371 -0.831 . . . . 0.0 109.833 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 1.045 ' O ' HG23 ' A' ' 45' ' ' THR . 44.1 m-80 -71.39 -44.89 64.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.69 -0.631 . . . . 0.0 111.836 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.856 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.78 -52.11 66.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.768 -1.208 . . . . 0.0 110.964 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.797 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -59.69 -38.64 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.547 -1.346 . . . . 0.0 109.862 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -64.37 -32.73 74.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 1.045 HG23 ' O ' ' A' ' 41' ' ' ASN . 26.7 p -62.95 -47.47 83.07 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.153 -0.967 . . . . 0.0 110.65 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.88 -52.11 5.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.222 -0.924 . . . . 0.0 110.828 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.797 ' CD2' HG22 ' A' ' 43' ' ' VAL . 78.1 m-85 -71.76 -21.39 61.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.231 -0.918 . . . . 0.0 110.499 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 14.0 mtpt 46.83 42.62 12.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.669 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.78 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.39 -162.59 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 121.398 0.618 . . . . 0.0 109.727 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.78 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.21 107.55 15.44 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.881 179.09 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.591 ' CG2' HG11 ' A' ' 43' ' ' VAL . 22.8 t -78.33 119.5 27.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.261 -0.9 . . . . 0.0 109.316 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.625 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.4 p -105.9 9.06 9.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.248 -0.908 . . . . 0.0 110.683 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 168.15 117.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 110.46 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.96 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -115.28 116.66 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.0 109.519 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 82.8 m-20 -118.56 115.87 25.46 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 109.409 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.545 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -115.0 162.45 16.96 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.987 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -154.79 153.01 30.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 110.469 -179.325 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.423 ' NE2' ' HA ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -66.36 130.59 43.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.745 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.687 HG11 ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.91 127.21 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.29 -0.881 . . . . 0.0 110.154 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.578 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.4 OUTLIER -107.6 124.06 49.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.271 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.96 174.02 45.49 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -53.56 -44.54 69.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -1.079 . . . . 0.0 110.245 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -43.71 166.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.182 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 63' ' ' LYS . 8.0 pttt 174.28 89.32 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.32 -0.863 . . . . 0.0 110.041 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.544 ' CA ' ' HB2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -153.01 -158.21 0.87 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.181 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' HD3' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 71.28 123.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.204 -0.935 . . . . 0.0 109.915 -179.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 68' ' ' ARG . . . 54.0 79.26 0.09 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' HA ' ' CE ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -42.38 133.34 3.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.286 -1.126 . . . . 0.0 110.435 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 49.0 t80 -162.87 59.44 0.2 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.364 -0.835 . . . . 0.0 109.863 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER 43.08 40.49 2.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.927 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.1 96.22 1.89 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.544 ' HB2' ' CA ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -92.92 154.71 18.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -1.178 . . . . 0.0 110.47 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.32 142.49 14.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.436 -0.79 . . . . 0.0 109.803 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.09 -168.55 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.828 1.436 . . . . 0.0 110.207 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.498 ' HB3' ' HG3' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -116.06 89.41 3.1 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.414 -0.804 . . . . 0.0 109.501 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -106.59 127.5 53.39 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.481 -0.762 . . . . 0.0 109.899 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.524 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 51.1 tttt -117.86 128.59 54.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.573 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.799 ' HD3' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -101.7 151.11 22.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.56 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.812 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -129.4 131.41 46.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.915 -1.115 . . . . 0.0 112.053 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.812 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.6 mp -110.63 111.43 36.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.96 HG13 HG23 ' A' ' 54' ' ' VAL . 2.6 t -106.16 133.92 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.505 -0.747 . . . . 0.0 110.431 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.625 ' C ' HG12 ' A' ' 52' ' ' VAL . 4.7 tp60 -117.14 152.77 34.04 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.005 -1.06 . . . . 0.0 108.674 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.545 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -118.79 155.76 20.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.142 -1.423 . . . . 0.0 109.711 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.778 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -50.85 174.11 0.09 OUTLIER Pre-proline 0 C--N 1.289 -2.024 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.871 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.778 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.8 Cg_endo -76.66 55.54 4.85 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.307 1.688 . . . . 0.0 110.609 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -163.81 -50.28 0.02 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.546 ' HB3' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -51.27 -172.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -1.174 . . . . 0.0 111.025 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 179.25 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.63 -0.669 . . . . 0.0 110.172 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.076 HD12 ' CE2' ' A' ' 26' ' ' TYR . 5.6 mt -68.72 109.16 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.0 110.146 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 3.3 mt-10 -78.3 -14.49 59.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 110.585 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.757 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -56.29 -33.04 65.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 111.137 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.757 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.11 -23.44 12.61 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.952 -1.092 . . . . 0.0 110.138 -179.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mm-40 -62.71 -23.02 66.94 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.179 -0.95 . . . . 0.0 110.228 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -113.51 -26.32 3.99 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.518 HD23 HD11 ' A' ' 13' ' ' LEU . 8.0 tp -42.87 -27.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -1.132 . . . . 0.0 110.115 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.625 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 52.0 mt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.215 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.579 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 1.3 ptt? . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.751 0.31 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.886 ' HD2' HD11 ' A' ' 9' ' ' LEU . 22.3 mmtt -44.31 97.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.4 m 4.29 -71.53 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 121.365 0.602 . . . . 0.0 110.843 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.968 ' O ' HG23 ' A' ' 7' ' ' VAL 0.265 . . -55.41 81.04 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.087 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.7 p90 24.18 47.19 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.819 0.818 . . . . 0.0 110.408 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.615 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 4.3 t0 64.75 52.64 1.63 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.993 0.901 . . . . 0.0 111.333 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.087 HG21 ' CE2' ' A' ' 5' ' ' TYR . 3.2 t -133.38 -124.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.133 -0.979 . . . . 0.0 109.993 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.088 HD13 HG13 ' A' ' 43' ' ' VAL . 4.9 mt -56.12 156.07 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 121.217 -0.927 . . . . 0.0 110.812 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.886 HD11 ' HD2' ' A' ' 2' ' ' LYS . 14.2 mt -143.52 -93.78 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 110.155 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.21 149.81 39.68 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.068 -1.02 . . . . 0.0 110.277 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.619 ' HG3' HD22 ' A' ' 92' ' ' LEU . 45.9 Cg_endo -73.33 173.57 13.54 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.1 1.579 . . . . 0.0 110.357 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.626 HG12 ' CE2' ' A' ' 29' ' ' TRP . 2.4 m -112.8 139.35 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.206 -0.934 . . . . 0.0 110.152 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.753 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.77 112.28 24.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.197 -0.939 . . . . 0.0 110.243 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -161.99 138.07 7.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 0.0 110.098 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 2.2 tm-20 -42.87 -50.11 5.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.178 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -46.75 74.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.849 . . . . 0.0 110.23 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -67.86 -60.37 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.187 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.717 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.2 m-85 -44.61 -29.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.117 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.75 -19.27 23.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.86 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -96.19 -40.55 3.97 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.244 -1.943 . . . . 0.0 108.244 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.626 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -69.79 -17.08 63.39 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.638 -0.919 . . . . 0.0 108.952 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.626 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -58.34 -21.2 48.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.272 0.558 . . . . 0.0 110.89 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -88.53 16.96 5.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.25 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.67 1.96 65.52 Favored Glycine 0 N--CA 1.48 1.594 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 24.7 mttm -82.24 137.7 34.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.607 -0.937 . . . . 0.0 109.246 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.966 ' CD1' HD12 ' A' ' 92' ' ' LEU . 24.8 m-85 -128.76 103.89 7.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.518 -1.363 . . . . 0.0 112.007 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 78' ' ' LYS . 1.4 m -75.03 140.96 43.91 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.619 -0.676 . . . . 0.0 109.339 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.814 ' CB ' HG23 ' A' ' 8' ' ' ILE . 22.0 m-85 -134.56 165.64 24.74 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.453 -0.779 . . . . 0.0 110.438 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.626 ' CE2' HG12 ' A' ' 12' ' ' VAL . 10.0 m95 -98.96 122.33 42.07 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.76 HG23 ' C ' ' A' ' 7' ' ' VAL . 7.4 p -148.06 165.68 5.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.617 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.483 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -61.14 152.91 69.8 Favored Pre-proline 0 C--N 1.298 -1.669 0 O-C-N 121.851 -0.53 . . . . 0.0 110.383 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.497 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.9 Cg_endo -73.4 71.53 3.77 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.099 1.578 . . . . 0.0 110.349 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.02 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.264 -0.898 . . . . 0.0 110.101 -179.256 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.415 ' CB ' HG13 ' A' ' 7' ' ' VAL . . . -42.74 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 110.186 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -48.09 155.81 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 110.26 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.584 ' O ' HG11 ' A' ' 54' ' ' VAL . 7.2 mmtp -57.33 -36.25 70.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.88 . . . . 0.0 110.204 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -75.14 -50.21 17.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 23.0 mt-10 -54.97 -37.92 67.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.942 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.718 HG23 HD11 ' A' ' 8' ' ' ILE . 17.8 mt -57.91 -30.83 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 109.401 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HG3' HG11 ' A' ' 51' ' ' VAL . 2.4 ttpt -61.69 -45.89 92.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 111.096 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -58.9 -36.67 75.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.457 -0.777 . . . . 0.0 112.314 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.942 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -73.22 -50.49 22.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.603 -1.311 . . . . 0.0 111.685 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.088 HG13 HD13 ' A' ' 8' ' ' ILE . 4.7 m -66.01 -30.57 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.518 -1.364 . . . . 0.0 110.583 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -62.76 -52.41 63.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.088 -1.007 . . . . 0.0 109.964 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -79.72 -15.72 56.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.895 . . . . 0.0 110.224 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.25 -62.05 1.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.471 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.611 ' CE2' ' CZ ' ' A' ' 28' ' ' PHE . 9.7 m-85 -71.73 -15.96 62.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.183 -0.948 . . . . 0.0 110.096 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 5.9 mmtt 61.56 45.36 8.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.48 -0.762 . . . . 0.0 110.235 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.776 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -128.28 -162.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.528 -0.733 . . . . 0.0 110.007 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.776 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.06 106.14 12.58 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 109.358 178.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.832 HG13 HG13 ' A' ' 81' ' ' VAL . 97.8 t -78.23 119.77 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.322 -0.861 . . . . 0.0 110.184 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.65 HG12 ' C ' ' A' ' 82' ' ' GLN . 7.6 p -106.01 -3.97 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.569 ' HG3' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 178.34 147.94 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.859 . . . . 0.0 109.875 179.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.103 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.1 t -132.79 131.32 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.002 -1.061 . . . . 0.0 109.871 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -131.61 115.88 16.66 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.39 -0.819 . . . . 0.0 109.22 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.761 ' O ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -113.83 166.27 11.74 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.39 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 56' ' ' THR . 7.0 mt -143.17 179.76 6.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.432 -0.793 . . . . 0.0 109.852 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.499 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 1.4 t-160 -104.15 102.17 11.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.339 -0.85 . . . . 0.0 109.387 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.548 ' CG1' ' HE2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -110.64 134.5 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.271 -0.893 . . . . 0.0 110.095 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.573 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -130.46 168.39 17.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 110.339 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.09 131.09 25.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -96.4 -28.07 14.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -1.121 . . . . 0.0 110.256 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 64' ' ' LYS . 18.0 mttt -122.67 15.29 10.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.295 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 63' ' ' LYS . 14.6 tptt -43.77 -27.73 0.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 110.417 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -74.16 -1.72 21.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.21 -0.931 . . . . 0.0 110.364 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 65' ' ' ARG . 8.2 tp -41.14 143.27 0.42 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 68' ' ' ARG . . . 53.47 -168.59 1.18 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 67' ' ' GLY . 15.5 ptt180 -40.94 155.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.461 -1.023 . . . . 0.0 110.273 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.9 112.61 7.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.46 40.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.055 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -168.88 117.47 0.72 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 1.2 mtpm? -101.58 108.24 19.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -1.152 . . . . 0.0 110.143 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -40.79 100.25 0.22 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.384 -0.823 . . . . 0.0 110.311 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 54.3 Cg_endo -81.36 -166.18 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.059 1.557 . . . . 0.0 110.449 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.15 89.48 3.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.504 -0.748 . . . . 0.0 108.984 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -106.82 142.88 35.75 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.609 -0.682 . . . . 0.0 110.531 -179.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.516 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 5.9 ptmt -123.15 141.19 52.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.982 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.676 ' HB2' HG22 ' A' ' 27' ' ' THR . 5.2 ptpt -101.57 151.12 22.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.105 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -115.48 119.96 37.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.217 -0.927 . . . . 0.0 112.25 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.592 HG12 HG23 ' A' ' 27' ' ' THR . 12.8 mt -98.2 110.78 26.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.784 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.103 HG22 ' CG2' ' A' ' 54' ' ' VAL . 50.4 t -103.63 133.04 48.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.91 -1.119 . . . . 0.0 110.257 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.65 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.4 tp60 -102.71 153.28 20.29 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.07 -1.019 . . . . 0.0 109.065 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.1 m -120.94 156.19 24.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 C-N-CA 118.35 -1.34 . . . . 0.0 109.053 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.868 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -63.3 177.74 0.44 Allowed Pre-proline 0 C--N 1.286 -2.168 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.194 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.868 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.6 Cg_endo -74.23 138.92 25.77 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 124.233 1.649 . . . . 0.0 110.301 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.47 -30.32 10.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.81 176.35 5.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.112 -1.228 . . . . 0.0 110.548 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 7.9 pttt 179.56 104.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.449 -0.782 . . . . 0.0 110.195 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 26' ' ' TYR . 9.8 mt -42.65 100.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.54 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 3.1 mm-40 -63.06 -13.72 39.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.419 -0.801 . . . . 0.0 110.985 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.757 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.75 -32.73 60.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.099 -1.0 . . . . 0.0 110.418 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.966 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.12 -23.02 12.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.148 -0.97 . . . . 0.0 109.599 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 64.9 mm-40 -48.05 -58.76 4.03 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.38 -0.825 . . . . 0.0 110.423 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -76.5 -33.66 47.22 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 8.0 tp -41.64 -27.34 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.299 -1.118 . . . . 0.0 110.331 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.451 HG12 ' CE1' ' A' ' 18' ' ' TYR . 50.4 mt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.263 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.86 0.362 . . . . 0.0 110.364 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.636 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 1.2 mttt -79.89 78.2 6.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.692 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.808 HG21 ' CB ' ' A' ' 45' ' ' THR . 0.6 OUTLIER -121.12 -88.91 0.62 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.409 0.623 . . . . 0.0 110.157 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.824 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -90.21 -30.59 17.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.456 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.748 ' CE1' HG23 ' A' ' 7' ' ' VAL . 1.8 p90 -34.36 -26.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.583 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 46.2 t0 -160.19 -59.55 0.06 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.891 -1.131 . . . . 0.0 110.727 -176.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.994 HG13 ' HB1' ' A' ' 34' ' ' ALA . 40.9 t -42.01 -68.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.046 0.926 . . . . 0.0 109.611 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.805 HG23 ' CB ' ' A' ' 28' ' ' PHE . 4.7 mt -114.06 99.04 7.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 O-C-N 121.326 -0.859 . . . . 0.0 110.068 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 4' ' ' ALA . 75.0 mt -93.05 -95.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.328 -0.857 . . . . 0.0 110.854 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.95 154.95 41.8 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.7 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.61 158.17 39.9 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.134 1.597 . . . . 0.0 110.167 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 27' ' ' THR . 1.5 p -115.2 117.24 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.818 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.5 mm? -102.07 106.96 17.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 110.174 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.592 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -144.72 152.8 40.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.6 tt0 -43.07 -63.78 0.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -25.8 28.46 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.592 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -84.39 -51.19 7.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.143 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.617 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 2.1 m-85 -55.75 -32.47 63.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.17 -8.48 51.09 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.256 -0.903 . . . . 0.0 109.901 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.76 -34.0 3.4 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.584 -1.807 . . . . 0.0 108.584 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -79.37 -19.81 49.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.574 -0.956 . . . . 0.0 109.026 179.244 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -54.6 -17.65 3.55 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.65 -0.656 . . . . 0.0 110.879 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.8 OUTLIER -93.17 17.07 11.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.507 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.53 -2.01 67.07 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 1.7 mttp -82.13 139.51 34.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.524 -0.986 . . . . 0.0 109.376 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 1.001 ' CD1' HD12 ' A' ' 92' ' ' LEU . 23.8 m-85 -128.42 102.88 6.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.533 -1.354 . . . . 0.0 112.033 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.652 HG21 ' NZ ' ' A' ' 78' ' ' LYS . 8.1 m -74.88 141.15 44.2 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.449 0.642 . . . . 0.0 109.659 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.805 ' CB ' HG23 ' A' ' 8' ' ' ILE . 44.8 m-85 -134.22 165.18 25.7 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.49 -0.756 . . . . 0.0 110.056 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.605 ' CZ3' ' HG2' ' A' ' 76' ' ' ARG . 52.9 m95 -89.92 122.0 32.54 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 7' ' ' VAL . 10.6 p -134.14 165.26 32.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 118.344 -1.342 . . . . 0.0 112.394 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.597 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 1.9 t60 -82.75 152.4 66.22 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.297 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 43.8 Cg_endo -70.61 65.56 2.29 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.173 1.617 . . . . 0.0 109.544 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.87 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.559 -0.713 . . . . 0.0 109.647 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.994 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -48.37 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.501 -0.75 . . . . 0.0 109.575 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -40.31 134.35 1.66 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.301 -0.875 . . . . 0.0 110.797 -179.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.643 ' HA ' HD12 ' A' ' 39' ' ' ILE . 3.5 tttm -42.4 -43.36 3.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.7 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 5.2 m -61.27 -44.32 97.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.92 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 35' ' ' THR . 6.7 mt-10 -55.13 -39.61 69.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.376 -0.827 . . . . 0.0 109.494 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.718 HG23 HD11 ' A' ' 8' ' ' ILE . 10.4 mt -57.67 -30.67 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.379 -0.826 . . . . 0.0 108.914 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.591 ' HG3' HG11 ' A' ' 51' ' ' VAL . 9.6 tttt -61.79 -47.64 84.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.827 . . . . 0.0 109.541 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.449 ' O ' ' HB ' ' A' ' 45' ' ' THR . 24.3 m-80 -73.48 -34.33 65.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.653 -0.654 . . . . 0.0 110.97 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.64 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . . . -58.37 -50.27 74.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.912 -1.118 . . . . 0.0 110.656 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.004 HG21 HG11 ' A' ' 81' ' ' VAL . 2.7 m -68.11 -36.94 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.715 -1.241 . . . . 0.0 109.835 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -63.36 -42.6 98.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.092 -1.005 . . . . 0.0 108.886 179.154 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.808 ' CB ' HG21 ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.2 -20.43 48.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.578 -0.701 . . . . 0.0 109.315 179.083 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.824 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -100.04 -67.14 0.87 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 110.456 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.711 ' CD2' HG12 ' A' ' 43' ' ' VAL . 62.6 m-85 -72.58 -21.61 61.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 110.432 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 64.06 47.87 3.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.311 -0.868 . . . . 0.0 110.274 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -122.28 -158.82 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.483 -0.761 . . . . 0.0 110.062 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.788 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -117.16 111.3 19.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.436 179.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.78 HG13 HG13 ' A' ' 81' ' ' VAL . 57.7 t -78.3 119.8 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.189 -0.944 . . . . 0.0 110.424 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 82' ' ' GLN . 12.2 p -113.8 -1.41 9.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.489 -0.757 . . . . 0.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 175.83 119.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.81 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.081 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -113.68 132.04 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 110.304 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.553 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 2.4 m120 -131.05 115.56 16.61 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.457 -0.777 . . . . 0.0 109.573 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -116.28 144.61 44.01 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 109.982 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.45 162.01 34.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -0.804 . . . . 0.0 109.973 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 127.49 32.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.944 HG11 ' HD3' ' A' ' 78' ' ' LYS . 1.9 m -118.63 123.37 71.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.607 -0.683 . . . . 0.0 109.979 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.577 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -105.16 142.26 35.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.475 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' O ' ' HE2' ' A' ' 62' ' ' LYS . . . 87.55 153.92 25.94 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -144.05 -65.64 0.36 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -1.122 . . . . 0.0 110.176 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -124.59 -11.76 7.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 0.0 110.18 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 177.64 131.24 0.06 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.31 -0.869 . . . . 0.0 110.427 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -128.96 1.07 5.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -41.32 129.26 3.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.413 -0.805 . . . . 0.0 110.335 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.52 51.62 2.62 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HG2' ' HB3' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -125.06 12.54 8.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -1.233 . . . . 0.0 109.463 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.581 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 29.1 t80 -166.25 69.33 0.12 Allowed 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.795 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.3 OUTLIER 43.36 38.84 1.86 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 109.941 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 72' ' ' LYS . . . -87.53 141.01 17.06 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 71' ' ' GLY . 8.4 mttt -166.07 109.52 0.78 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -1.131 . . . . 0.0 110.236 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -45.33 105.38 0.45 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 110.014 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 49.0 Cg_endo -72.6 -166.85 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.57 . . . . 0.0 110.388 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.34 89.39 3.09 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.397 -0.814 . . . . 0.0 109.489 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.605 ' HG2' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -105.52 143.22 33.99 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.515 -0.74 . . . . 0.0 110.018 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.0 tttt -110.18 141.87 42.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.554 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.944 ' HD3' HG11 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -116.57 151.32 36.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.417 -0.802 . . . . 0.0 109.82 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -126.98 123.24 36.66 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.997 -1.064 . . . . 0.0 112.63 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 14.9 mt -103.29 111.36 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.829 -0.544 . . . . 0.0 110.019 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.081 HG22 ' CG2' ' A' ' 54' ' ' VAL . 60.2 t -104.29 130.37 55.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 120.94 -1.1 . . . . 0.0 109.969 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.782 ' O ' HG12 ' A' ' 52' ' ' VAL . 3.6 tp60 -102.64 149.76 24.11 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.143 -0.973 . . . . 0.0 109.205 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.539 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.5 m -112.89 156.65 13.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 118.45 -1.3 . . . . 0.0 109.405 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.895 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -62.87 175.49 0.64 Allowed Pre-proline 0 C--N 1.291 -1.951 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.916 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.846 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.3 Cg_endo -76.26 55.29 4.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.525 1.803 . . . . 0.0 110.415 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -158.67 -37.08 0.02 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.895 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -110.64 -179.57 3.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.297 -1.12 . . . . 0.0 110.219 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.439 ' HA ' HG21 ' A' ' 83' ' ' VAL . 2.6 pttt -176.17 100.35 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.743 HD12 ' CD2' ' A' ' 26' ' ' TYR . 11.2 mt -42.35 113.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.006 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 1.2 pt-20 -77.95 -13.36 59.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 0.0 110.914 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.639 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.52 -28.8 47.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.064 -1.022 . . . . 0.0 110.575 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.001 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.26 -23.15 12.64 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.077 -1.014 . . . . 0.0 109.605 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.549 ' O ' HD12 ' A' ' 96' ' ' ILE . 20.5 mm-40 -58.14 -37.69 75.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.487 -0.758 . . . . 0.0 110.296 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.42 25.08 29.41 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.556 HD23 HD21 ' A' ' 13' ' ' LEU . 1.2 tp -106.45 -15.1 14.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -1.143 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 96' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.197 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' A' ' 1' ' ' MET . 6.5 ptp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.087 0.47 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -90.35 84.81 6.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.058 -1.026 . . . . 0.0 109.075 179.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.963 HG21 HG21 ' A' ' 45' ' ' THR . 28.9 p -136.26 -88.61 0.31 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 110.621 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.019 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -78.15 -20.79 51.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.681 -1.262 . . . . 0.0 110.155 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.818 ' CZ ' HG23 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -52.13 -138.46 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.483 0.659 . . . . 0.0 110.802 178.179 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.65 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 55.3 t0 -31.13 -56.42 0.23 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.46 -0.775 . . . . 0.0 110.791 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.818 HG23 ' CZ ' ' A' ' 5' ' ' TYR . 74.7 t -56.35 167.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.659 -0.651 . . . . 0.0 110.374 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.933 HD11 HG23 ' A' ' 39' ' ' ILE . 58.0 mt 11.59 86.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.222 0.534 . . . . 0.0 112.283 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.1 mt -68.29 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 110.149 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.41 158.54 33.59 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.956 -1.09 . . . . 0.0 110.359 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.435 ' HG3' HD22 ' A' ' 92' ' ' LEU . 46.4 Cg_endo -73.35 161.69 42.07 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.012 1.533 . . . . 0.0 110.344 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.073 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.2 m -104.65 135.13 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.145 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.835 HD11 HD23 ' A' ' 95' ' ' LEU . 3.2 mm? -102.85 107.18 17.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.118 -0.989 . . . . 0.0 110.334 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 15' ' ' GLU . 14.9 m -162.11 147.16 12.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.947 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.1 tt0 -42.78 -55.48 3.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.917 . . . . 0.0 109.989 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -29.95 54.56 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 110.154 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -82.96 -64.88 1.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.812 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.6 m-85 -42.95 -51.72 5.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.299 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.74 -24.56 67.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.21 -0.931 . . . . 0.0 109.943 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -87.43 -44.75 5.47 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.52 -23.9 56.74 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.509 -0.995 . . . . 0.0 108.957 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -50.43 -21.57 1.52 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.657 -0.652 . . . . 0.0 110.204 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.516 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -91.85 16.26 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.235 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 94.63 0.02 64.9 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 14.6 mttt -82.18 146.95 29.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -1.128 . . . . 0.0 109.694 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 1.0 ' CD2' HD12 ' A' ' 89' ' ' ILE . 22.3 m-85 -127.31 104.69 8.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.773 -1.204 . . . . 0.0 112.0 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.857 HG23 HD11 ' A' ' 80' ' ' ILE . 3.9 m -78.27 131.43 37.08 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.858 ' CB ' HG23 ' A' ' 8' ' ' ILE . 24.1 m-85 -136.32 164.42 28.14 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.177 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 1.073 ' NE1' HG12 ' A' ' 12' ' ' VAL . 99.6 m95 -100.43 121.91 42.32 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.6 p -145.78 164.99 10.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.503 -176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.623 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -73.46 171.47 10.58 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.767 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 48.4 Cg_endo -75.18 -53.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.927 1.488 . . . . 0.0 109.374 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' THR 0.252 0.0 OUTLIER -47.12 -22.63 0.39 Allowed 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.678 178.927 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -67.02 61.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.363 -0.835 . . . . 0.0 109.617 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -38.33 148.65 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.65 -0.656 . . . . 0.0 110.919 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 14.1 mttt -42.67 -46.56 5.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -0.826 . . . . 0.0 109.955 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -58.78 -53.06 62.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.325 -0.86 . . . . 0.0 110.025 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -55.4 -41.85 73.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.862 . . . . 0.0 109.701 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.933 HG23 HD11 ' A' ' 8' ' ' ILE . 21.9 mt -57.63 -31.44 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.182 -0.949 . . . . 0.0 108.87 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.596 ' HG3' HG11 ' A' ' 51' ' ' VAL . 15.7 tttp -63.27 -45.35 91.9 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.368 -0.832 . . . . 0.0 109.864 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.462 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.3 m-80 -71.22 -34.36 70.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.688 -0.633 . . . . 0.0 111.412 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.924 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.56 -50.73 72.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.768 -1.208 . . . . 0.0 110.6 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.595 HG12 ' CE2' ' A' ' 47' ' ' PHE . 2.9 m -71.05 -34.19 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.838 -1.163 . . . . 0.0 109.582 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -64.88 -38.06 89.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.28 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.963 HG21 HG21 ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.22 -33.43 43.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.516 -0.74 . . . . 0.0 109.72 179.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 1.019 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -90.12 -62.42 1.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.39 -0.819 . . . . 0.0 110.72 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.595 ' CE2' HG12 ' A' ' 43' ' ' VAL . 21.8 m-85 -71.69 -21.45 61.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.415 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 7.4 mttt 60.64 46.89 8.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 0.0 110.272 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -123.19 -162.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.472 -0.768 . . . . 0.0 110.163 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.788 ' N ' HG13 ' A' ' 49' ' ' VAL . 2.2 tmtm? -118.16 111.41 18.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.411 -0.805 . . . . 0.0 109.845 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.596 HG11 ' HG3' ' A' ' 40' ' ' LYS . 64.9 t -78.74 119.53 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 82' ' ' GLN . 12.1 p -107.81 7.54 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.984 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER 169.25 117.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.814 . . . . 0.0 110.07 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.02 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -119.01 117.25 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.948 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 80' ' ' ILE . 2.5 m120 -116.27 116.11 27.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.285 -0.884 . . . . 0.0 109.523 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.547 ' CB ' ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -114.82 139.76 49.48 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.356 -0.84 . . . . 0.0 109.809 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 58' ' ' HIS . 1.4 pp -125.36 167.81 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.646 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.729 ' O ' HD12 ' A' ' 57' ' ' LEU . 23.7 t-160 -72.95 128.23 34.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.465 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.567 ' HB ' ' CG ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -111.33 138.66 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.576 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -113.59 173.51 6.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 110.152 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.63 92.18 0.38 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -111.8 91.96 3.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -1.137 . . . . 0.0 110.279 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.11 55.14 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.228 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 46.44 59.55 3.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.312 -0.867 . . . . 0.0 110.159 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.622 ' HA ' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -177.84 -42.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.327 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.49 ' N ' ' HD2' ' A' ' 65' ' ' ARG . 1.6 mp 45.27 94.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.786 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 68' ' ' ARG . . . 75.52 -158.47 50.41 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 67' ' ' GLY . 4.5 ptp85 -51.65 -169.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.599 -0.942 . . . . 0.0 110.657 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.573 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 6.1 t80 -38.3 108.75 0.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.443 -0.786 . . . . 0.0 110.862 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER 34.92 41.44 0.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.814 0.816 . . . . 0.0 110.804 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 66' ' ' LEU . . . -88.55 -145.85 11.69 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.57 139.64 47.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -1.14 . . . . 0.0 110.156 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.95 113.35 8.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.175 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.09 -165.5 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.86 1.452 . . . . 0.0 110.32 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 75' ' ' ASP . 18.7 p-10 -114.05 89.48 3.1 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.415 -0.803 . . . . 0.0 109.42 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.567 ' CG ' ' HB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -95.16 153.6 17.58 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.565 -0.709 . . . . 0.0 110.308 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.761 ' CE ' HD11 ' A' ' 39' ' ' ILE . 20.9 tttt -123.21 135.06 54.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 109.398 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 5.2 ttpp -101.36 150.59 22.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.08 -1.012 . . . . 0.0 109.926 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.821 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -132.53 130.88 40.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.099 -1.001 . . . . 0.0 112.626 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.857 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -111.93 111.86 37.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.02 HG22 ' CG2' ' A' ' 54' ' ' VAL . 20.2 t -108.65 130.35 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.312 -0.868 . . . . 0.0 111.189 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.739 ' O ' HG12 ' A' ' 52' ' ' VAL . 3.1 tp60 -105.88 148.18 27.89 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.321 -0.862 . . . . 0.0 108.706 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.523 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.2 m -114.74 156.88 15.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.696 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.917 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -69.13 178.34 0.95 Allowed Pre-proline 0 C--N 1.291 -1.972 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.026 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.917 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.3 Cg_endo -74.16 139.36 26.54 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 O-C-N 124.23 1.648 . . . . 0.0 110.552 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.94 -40.17 2.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.666 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -96.44 -179.51 4.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.107 -1.231 . . . . 0.0 110.718 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HE2' ' HG2' ' A' ' 90' ' ' GLU . 5.6 ptmt 179.39 90.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 110.266 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.0 HD12 ' CD2' ' A' ' 26' ' ' TYR . 15.5 mt -46.28 97.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.076 -1.015 . . . . 0.0 109.821 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -58.26 -13.6 5.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.402 -0.811 . . . . 0.0 111.125 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.959 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -54.99 -36.7 65.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.052 -1.03 . . . . 0.0 110.823 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.95 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.8 -23.07 12.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.936 -1.103 . . . . 0.0 109.921 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 7.5 mm-40 -54.79 -40.1 69.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 110.409 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.81 -6.65 67.2 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.959 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.3 mp -63.47 -28.72 70.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -1.163 . . . . 0.0 110.126 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.425 HD13 ' CE1' ' A' ' 18' ' ' TYR . 17.4 mm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.16 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.612 ' O ' HG22 ' A' ' 3' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 120.659 0.266 . . . . 0.0 110.445 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.707 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -62.59 93.76 0.06 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.071 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.704 ' HA ' HG22 ' A' ' 45' ' ' THR . 9.3 t -137.49 -38.81 0.59 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.422 1.106 . . . . 0.0 109.198 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.624 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -160.4 -24.5 0.06 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.628 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.707 ' CE1' ' HA ' ' A' ' 2' ' ' LYS 0.267 0.0 OUTLIER -46.85 -135.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.955 0.883 . . . . 0.0 111.891 178.418 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.598 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -24.6 -63.44 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.71 0.767 . . . . 0.0 111.854 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.029 HG12 HG13 ' A' ' 8' ' ' ILE . 60.8 t -56.71 -108.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.672 -0.642 . . . . 0.0 111.657 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.029 HG13 HG12 ' A' ' 7' ' ' VAL . 17.1 mt -81.6 93.8 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.775 -1.203 . . . . 0.0 112.118 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 29' ' ' TRP . 39.4 mt -70.06 -106.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.365 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' TRP . . . -108.51 162.92 18.23 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.786 -1.196 . . . . 0.0 110.769 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -75.05 166.56 28.89 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.0 1.527 . . . . 0.0 110.545 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.863 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.5 m -115.25 137.95 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.929 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -102.8 113.03 26.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 110.294 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -152.54 146.64 25.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 110.103 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -42.72 -60.41 1.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 110.283 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -54.63 -42.22 70.95 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 110.371 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.542 ' N ' ' CG ' ' A' ' 16' ' ' LYS . . . -63.11 -60.01 4.01 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.929 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.3 m-85 -48.69 -36.24 15.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 0.0 110.106 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.37 -8.66 50.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.049 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -102.57 -34.77 4.02 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.628 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -79.06 -20.77 48.01 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.569 -0.959 . . . . 0.0 108.801 179.107 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.33 -21.45 5.71 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.705 -0.622 . . . . 0.0 110.819 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.91 17.19 5.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.35 -0.844 . . . . 0.0 110.48 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.72 -1.2 68.33 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 5.3 mttt -82.15 142.43 32.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.496 -1.002 . . . . 0.0 109.229 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.654 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.3 m-85 -128.01 113.09 15.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.611 -1.306 . . . . 0.0 111.743 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.806 HG23 HD11 ' A' ' 80' ' ' ILE . 9.2 m -84.25 122.35 28.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.766 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 19.8 m-85 -116.8 165.33 13.43 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.562 -0.712 . . . . 0.0 110.991 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.863 ' CD1' HG12 ' A' ' 12' ' ' VAL . 22.8 m95 -99.74 123.1 43.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 177.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 7' ' ' VAL . 1.4 p -144.22 156.28 15.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 117.407 -1.717 . . . . 0.0 112.463 -176.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -62.64 151.45 83.93 Favored Pre-proline 0 C--N 1.3 -1.575 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.832 -179.359 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.3 Cg_endo -72.13 69.19 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.001 1.527 . . . . 0.0 109.478 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.77 -32.49 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.483 -0.761 . . . . 0.0 109.774 -178.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.881 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -40.29 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.758 -0.589 . . . . 0.0 109.897 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -42.87 137.45 2.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.087 -1.008 . . . . 0.0 110.533 -179.132 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.525 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -42.21 -39.18 1.97 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 0.0 109.737 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 14.3 m -74.79 -33.99 62.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.678 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -60.4 -43.96 96.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.385 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.86 ' O ' HD11 ' A' ' 8' ' ' ILE . 10.2 mt -57.36 -30.33 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.545 ' HG3' HG11 ' A' ' 51' ' ' VAL . 30.0 tttt -66.51 -44.53 82.28 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.518 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 45' ' ' THR . 1.7 m-80 -73.35 -45.35 55.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.707 -0.621 . . . . 0.0 112.037 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.673 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.36 -51.82 68.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.583 -1.323 . . . . 0.0 110.462 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.735 HG21 ' CE2' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -61.3 -47.38 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 110.296 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.5 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -58.33 -43.26 88.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.066 -1.021 . . . . 0.0 109.536 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -73.76 -13.57 60.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.521 -0.737 . . . . 0.0 109.737 179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.597 ' HB2' ' OG1' ' A' ' 3' ' ' THR . . . -102.61 -69.03 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.393 -0.817 . . . . 0.0 110.351 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.448 ' O ' ' HB2' ' A' ' 48' ' ' LYS . 17.1 m-85 -71.99 -21.56 61.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.893 . . . . 0.0 110.11 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.3 mttt 62.72 43.12 7.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.406 -0.809 . . . . 0.0 109.934 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.805 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -113.65 -159.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.635 -0.666 . . . . 0.0 109.952 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.805 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.16 105.06 11.41 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 109.946 179.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG22 ' CG1' ' A' ' 81' ' ' VAL . 21.5 t -78.67 119.61 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.898 . . . . 0.0 109.783 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 82' ' ' GLN . 14.6 p -113.27 11.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 110.244 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 4.1 mttt 169.47 119.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.035 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.013 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.1 t -123.62 116.71 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 110.101 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.525 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -119.8 115.86 24.71 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.36 -0.838 . . . . 0.0 109.203 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.649 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -117.16 150.2 39.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.973 . . . . 0.0 110.043 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.542 ' HG ' ' CG ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -148.42 149.0 30.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 110.1 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.516 ' NE2' ' HB3' ' A' ' 32' ' ' PRO . 1.1 m80 -66.63 127.31 31.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.176 -0.953 . . . . 0.0 110.58 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -120.42 138.27 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.689 -0.632 . . . . 0.0 110.225 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -160.1 149.78 17.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.115 -0.99 . . . . 0.0 110.593 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.49 103.65 2.76 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -122.21 -66.94 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -1.112 . . . . 0.0 110.076 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -156.78 159.91 38.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 52.86 81.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.097 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' LEU . 18.3 mtm180 -82.65 -85.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 110.351 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 68' ' ' ARG . 5.6 mp 43.34 84.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 0.0 109.952 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.5 57.61 0.19 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -125.01 18.35 8.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.063 -1.257 . . . . 0.0 109.288 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 11.1 t80 -157.81 52.58 0.45 Allowed 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.92 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER 41.17 40.43 1.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.822 0.82 . . . . 0.0 110.199 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 72' ' ' LYS . . . -104.51 -94.47 2.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 71' ' ' GLY . 12.1 pttp 40.06 -165.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.601 -0.94 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -71.43 113.64 21.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.115 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 52.0 Cg_endo -73.37 -169.21 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.877 1.461 . . . . 0.0 110.41 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.83 89.1 3.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.632 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.535 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.4 OUTLIER -121.41 150.17 41.91 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.375 -0.828 . . . . 0.0 110.11 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HG2' HG13 ' A' ' 30' ' ' VAL . 8.8 tttp -123.22 125.88 45.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.512 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.631 ' HD3' HD11 ' A' ' 80' ' ' ILE . 5.2 ptpt -101.73 151.51 21.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 109.471 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -126.82 120.29 28.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.895 -1.128 . . . . 0.0 112.592 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.806 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -96.19 112.53 28.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.013 HG22 ' CG2' ' A' ' 54' ' ' VAL . 40.7 t -113.09 126.34 70.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.378 -0.826 . . . . 0.0 110.661 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.663 ' O ' HG12 ' A' ' 52' ' ' VAL . 34.1 tp60 -102.19 151.41 22.23 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.08 -1.013 . . . . 0.0 108.888 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.482 HG11 ' HE2' ' A' ' 26' ' ' TYR . 1.1 m -118.82 157.04 20.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 118.451 -1.3 . . . . 0.0 109.647 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.962 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -69.29 178.83 0.84 Allowed Pre-proline 0 C--N 1.29 -1.986 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.302 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.928 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.3 140.81 31.12 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 O-C-N 124.343 1.707 . . . . 0.0 110.438 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.22 -32.47 6.82 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.962 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -109.94 173.41 6.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -1.155 . . . . 0.0 110.49 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 90' ' ' GLU . 1.1 pttp 178.8 110.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.463 -0.773 . . . . 0.0 110.364 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.654 HD12 ' CD2' ' A' ' 26' ' ' TYR . 13.1 mt -63.44 77.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 109.698 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.526 ' HA ' ' OE1' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -53.83 -14.1 0.88 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.473 -0.767 . . . . 0.0 111.465 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.71 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.49 -21.01 8.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.913 -1.117 . . . . 0.0 110.999 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.84 -24.19 12.14 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.926 -1.109 . . . . 0.0 110.165 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.526 ' OE1' ' HA ' ' A' ' 90' ' ' GLU . 8.4 mp0 -54.04 -26.86 28.78 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.275 -0.89 . . . . 0.0 110.237 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.42 -15.79 31.37 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -53.36 -31.81 46.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -1.115 . . . . 0.0 110.118 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.591 HG13 ' CE1' ' A' ' 18' ' ' TYR . 71.8 mt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.138 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.514 ' HG2' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.798 0.809 . . . . 0.0 110.497 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.907 ' HD2' HD22 ' A' ' 9' ' ' LEU . 1.2 mmtt -82.65 109.06 16.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -32.52 -36.1 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.1 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.054 ' O ' HG23 ' A' ' 7' ' ' VAL 0.291 . . -63.17 68.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.147 ' CE2' HG21 ' A' ' 7' ' ' VAL . 0.4 OUTLIER 30.28 37.13 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.388 1.09 . . . . 0.0 108.724 -176.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 4' ' ' ALA . 2.6 t0 63.57 56.02 1.65 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.005 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.147 HG21 ' CE2' ' A' ' 5' ' ' TYR . 2.8 t -129.12 -128.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.826 -1.171 . . . . 0.0 110.01 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.5 mt -50.56 149.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.192 -0.942 . . . . 0.0 109.626 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.907 HD22 ' HD2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -143.01 -92.75 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.138 -0.976 . . . . 0.0 110.572 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.608 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -96.67 138.15 21.42 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 46.4 Cg_endo -74.18 173.51 14.02 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.011 1.532 . . . . 0.0 110.11 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.039 HG12 ' NE1' ' A' ' 29' ' ' TRP . 1.4 m -105.34 129.21 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.234 -0.916 . . . . 0.0 110.17 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.851 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.1 mm? -103.37 107.14 17.85 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.241 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -158.87 148.64 19.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.014 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 14' ' ' SER . 13.6 mm-40 -43.25 -52.83 5.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.33 -0.856 . . . . 0.0 109.98 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.6 -41.42 69.92 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.157 -0.964 . . . . 0.0 110.006 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -73.25 -61.77 1.7 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.851 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -46.73 -32.93 3.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.949 . . . . 0.0 110.197 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.39 -8.76 49.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 0.0 110.02 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -106.63 -38.17 2.27 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -73.13 -19.0 61.22 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.582 -0.952 . . . . 0.0 108.938 179.112 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -22.08 22.86 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.588 -0.695 . . . . 0.0 110.364 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.409 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 1.5 tt0 -88.75 17.01 5.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 110.074 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 91.37 3.74 69.06 Favored Glycine 0 N--CA 1.48 1.59 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 41.2 mttt -82.67 139.68 33.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -1.044 . . . . 0.0 109.48 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.982 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.4 m-85 -127.64 100.1 5.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.67 -1.269 . . . . 0.0 111.481 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.864 HG23 HD11 ' A' ' 80' ' ' ILE . 17.7 m -80.64 116.2 20.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.85 ' HB3' HG23 ' A' ' 8' ' ' ILE . 3.5 m-85 -119.24 163.22 17.43 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 109.992 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 1.039 ' NE1' HG12 ' A' ' 12' ' ' VAL . 97.2 m95 -98.9 122.08 41.68 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG23 ' C ' ' A' ' 7' ' ' VAL . 9.8 p -131.17 165.31 31.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 118.493 -1.283 . . . . 0.0 112.193 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -60.29 147.65 81.22 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.067 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.79 70.96 3.43 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.22 1.642 . . . . 0.0 109.93 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 178.94 -33.19 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.368 -0.833 . . . . 0.0 110.076 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -53.39 108.44 0.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.382 -0.824 . . . . 0.0 110.363 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 36.3 p -60.0 -170.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 110.153 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -77.33 -43.67 32.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.918 . . . . 0.0 110.336 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 6.3 m -71.56 -43.78 65.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.74 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 9.2 mt-10 -55.59 -46.21 77.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.361 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.858 HG23 HD11 ' A' ' 8' ' ' ILE . 27.1 mt -56.77 -30.4 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.911 . . . . 0.0 109.942 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.932 ' HG3' HG11 ' A' ' 51' ' ' VAL . 27.2 tttm -60.01 -44.69 94.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 111.664 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.629 ' O ' HG23 ' A' ' 45' ' ' THR . 54.9 m-80 -58.23 -36.55 73.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.302 -0.874 . . . . 0.0 112.685 -177.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.917 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -73.23 -50.2 23.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.658 -1.276 . . . . 0.0 111.965 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.883 HG11 HG11 ' A' ' 81' ' ' VAL . 0.7 OUTLIER -67.01 -43.02 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.791 -1.193 . . . . 0.0 110.748 -179.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.7 -42.1 78.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.929 -1.107 . . . . 0.0 110.149 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 41' ' ' ASN . 33.6 p -79.21 -46.68 17.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 0.0 109.98 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.2 -67.81 0.38 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.827 . . . . 0.0 110.494 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.876 ' CD2' HG22 ' A' ' 43' ' ' VAL . 90.5 m-85 -72.14 -3.84 25.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.89 . . . . 0.0 110.455 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 3.0 mtpp 43.35 42.81 3.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.455 -0.778 . . . . 0.0 110.347 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.754 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -112.39 -166.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.53 -0.731 . . . . 0.0 109.681 179.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.754 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -109.31 109.19 20.03 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.286 178.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.932 HG11 ' HG3' ' A' ' 40' ' ' LYS . 22.7 t -77.34 119.64 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.161 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.75 HG21 ' N ' ' A' ' 84' ' ' ALA . 6.2 t -111.79 -6.81 11.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.493 0.663 . . . . 0.0 110.667 -178.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.532 ' CG ' ' HB3' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 175.87 135.97 0.05 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.526 -0.734 . . . . 0.0 109.069 179.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.923 ' CG2' HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -132.38 118.49 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.493 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.7 m120 -117.33 115.94 26.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.294 -0.878 . . . . 0.0 109.574 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -116.1 151.08 36.3 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.657 HD21 ' HD2' ' A' ' 78' ' ' LYS . 1.2 pp -147.79 143.01 27.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 110.323 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -67.26 127.2 31.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.888 HG11 ' HE3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -120.22 110.38 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.508 -0.745 . . . . 0.0 110.032 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 73' ' ' ARG . 1.4 mmt85 -97.28 117.38 31.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 110.277 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 164.04 124.29 0.7 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HB3' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -168.82 -53.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 110.189 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -122.81 -177.97 3.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' LYS . 3.2 tttm -41.68 136.77 1.81 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.206 -0.934 . . . . 0.0 110.323 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.432 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -125.93 -161.22 1.03 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.253 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 65' ' ' ARG . 1.4 tp 42.12 51.53 4.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.222 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.85 118.44 0.45 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 68' ' ' ARG . 3.8 ptt180 -61.75 124.39 20.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.172 -1.193 . . . . 0.0 110.22 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.571 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 17.6 t80 -164.91 66.47 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.785 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 42.64 39.19 1.53 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.874 . . . . 0.0 109.975 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 72' ' ' LYS . . . -158.12 -100.67 0.17 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER 67.36 152.61 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.216 -1.167 . . . . 0.0 110.265 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 7.2 mtm-85 -50.99 109.23 1.27 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.458 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 50.2 Cg_endo -73.63 -166.64 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.915 1.481 . . . . 0.0 110.354 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' OD1' ' NH1' ' A' ' 60' ' ' ARG . 70.5 m-20 -115.53 89.44 3.1 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.418 -0.801 . . . . 0.0 109.352 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.547 ' HG2' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -111.96 140.85 46.29 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.499 -0.75 . . . . 0.0 110.104 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.486 ' CE ' HD11 ' A' ' 39' ' ' ILE . 9.2 tttt -123.29 127.41 48.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.925 . . . . 0.0 110.387 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.888 ' HE3' HG11 ' A' ' 59' ' ' VAL . 13.7 ptpt -102.71 151.11 22.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.038 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.642 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -122.88 125.9 46.27 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.023 -1.048 . . . . 0.0 112.258 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.864 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -100.77 111.88 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.612 -0.68 . . . . 0.0 109.204 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.923 HG13 ' CG2' ' A' ' 54' ' ' VAL . 1.6 t -100.01 144.56 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.356 -0.84 . . . . 0.0 110.35 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.532 ' HB3' ' CG ' ' A' ' 53' ' ' LYS . 42.6 tp60 -124.52 147.94 48.07 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.129 -0.982 . . . . 0.0 109.486 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -125.17 156.5 34.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.219 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.778 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -43.83 173.23 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 CA-C-O 121.216 0.532 . . . . 0.0 111.194 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.767 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.4 Cg_endo -76.11 54.42 4.16 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 O-C-N 124.347 1.709 . . . . 0.0 110.459 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 87' ' ' GLN . . . -169.22 -50.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.778 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 5.2 mp0 -50.86 179.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 0.0 110.314 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER 179.53 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.889 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.982 HD12 ' CD2' ' A' ' 26' ' ' TYR . 6.9 mt -64.54 77.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.057 -1.027 . . . . 0.0 109.207 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 88' ' ' LYS . 14.0 pt-20 -53.67 -14.36 0.87 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.384 -0.823 . . . . 0.0 111.263 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.749 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.43 -22.2 11.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.913 -1.117 . . . . 0.0 110.295 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.749 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.24 -23.27 12.61 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.219 -0.926 . . . . 0.0 109.629 179.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' HA ' ' A' ' 90' ' ' GLU . 5.3 mm-40 -61.29 -52.21 65.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.456 -0.778 . . . . 0.0 110.459 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.6 4.57 83.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 18.6 tp -75.13 -17.34 60.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 110.226 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.589 HG12 ' CZ ' ' A' ' 18' ' ' TYR . 52.3 mt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.208 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.571 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.73 0.3 . . . . 0.0 110.549 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.713 ' HA ' HD21 ' A' ' 9' ' ' LEU . 1.9 mmpt? -43.85 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.636 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.3 m 4.79 -71.52 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.661 0 CA-C-O 121.074 0.464 . . . . 0.0 111.082 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.922 ' HB1' ' HB1' ' A' ' 42' ' ' ALA 0.251 . . -56.95 79.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.43 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.891 ' CE1' ' HB2' ' A' ' 42' ' ' ALA . 0.7 OUTLIER 25.09 49.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.901 0.858 . . . . 0.0 110.409 -177.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.611 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 5.5 t70 64.79 53.74 1.44 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.019 0.914 . . . . 0.0 111.398 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 4' ' ' ALA . 4.7 t -137.58 -121.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -0.848 . . . . 0.0 109.663 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.926 HD12 ' HB3' ' A' ' 42' ' ' ALA . 4.9 mt -61.34 151.86 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 121.127 -0.983 . . . . 0.0 110.004 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.713 HD21 ' HA ' ' A' ' 2' ' ' LYS . 15.3 mt -133.69 -99.74 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 110.367 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.83 155.42 40.76 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 110.344 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.673 ' HG3' HD22 ' A' ' 92' ' ' LEU . 47.2 Cg_endo -73.92 155.52 48.25 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.036 1.545 . . . . 0.0 110.113 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.872 HG11 ' CE ' ' A' ' 78' ' ' LYS . 2.7 m -99.58 141.25 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.264 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.731 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.3 mm? -102.78 110.51 22.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -162.62 142.29 9.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 0.0 109.901 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.3 mm-40 -42.64 -47.16 5.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 110.106 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -54.81 -48.5 72.7 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.205 -0.934 . . . . 0.0 110.129 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -65.93 -62.45 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.123 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.616 ' CZ ' ' CG1' ' A' ' 96' ' ' ILE . 1.1 m-85 -45.95 -31.45 2.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.87 . . . . 0.0 110.375 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.42 -8.67 49.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.05 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.54 -37.17 1.95 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.53 -19.95 60.78 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 108.953 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.94 -21.31 11.28 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.427 0.632 . . . . 0.0 110.392 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -92.31 16.45 11.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.31 -0.868 . . . . 0.0 110.261 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 93.91 2.99 64.29 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HB3' HG23 ' A' ' 80' ' ' ILE . 17.5 mttm -82.58 142.18 31.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -1.133 . . . . 0.0 109.488 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.899 ' CD2' HD12 ' A' ' 89' ' ' ILE . 22.8 m-85 -127.62 103.95 7.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.707 -1.246 . . . . 0.0 111.461 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.78 HG23 HD11 ' A' ' 80' ' ' ILE . 4.3 m -76.76 126.78 31.56 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.455 0.645 . . . . 0.0 109.451 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.824 ' CB ' HG23 ' A' ' 8' ' ' ILE . 15.2 m-85 -125.95 164.67 20.28 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.48 -0.762 . . . . 0.0 110.861 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.723 ' NE1' HG12 ' A' ' 12' ' ' VAL . 18.6 m95 -97.74 122.14 40.48 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.709 HG23 ' C ' ' A' ' 7' ' ' VAL . 9.8 p -146.06 166.72 8.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 118.816 -1.154 . . . . 0.0 111.585 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.483 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -69.6 151.86 96.45 Favored Pre-proline 0 C--N 1.297 -1.695 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.557 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.0 69.12 4.75 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.169 1.615 . . . . 0.0 109.988 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.22 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.307 -0.871 . . . . 0.0 110.039 -179.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.71 101.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.506 -0.746 . . . . 0.0 110.373 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -53.27 135.94 37.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.527 ' HE3' HG23 ' A' ' 56' ' ' THR . 2.6 mttp -42.21 -46.81 4.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.298 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -60.4 -53.24 59.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 110.551 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 17.5 mt-10 -55.72 -42.29 75.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 109.688 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.787 HG23 HD11 ' A' ' 8' ' ' ILE . 11.5 mt -57.74 -30.99 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.627 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.528 ' HG3' HG11 ' A' ' 51' ' ' VAL . 22.2 tttt -60.73 -45.51 93.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.623 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.737 ' O ' HG23 ' A' ' 45' ' ' THR . 31.7 m-80 -64.32 -46.39 83.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.467 -0.77 . . . . 0.0 111.989 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.926 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.76 -40.6 84.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.716 -1.24 . . . . 0.0 111.092 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.752 HG21 ' HE2' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -76.3 -44.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.916 -1.115 . . . . 0.0 110.367 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.2 -37.8 70.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.961 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 41' ' ' ASN . 34.8 p -79.44 -45.22 19.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.969 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.22 -62.69 1.28 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.449 -0.782 . . . . 0.0 110.734 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.702 ' CD2' HG22 ' A' ' 43' ' ' VAL . 46.3 m-85 -71.8 -21.37 61.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 0.0 110.387 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 61.82 40.91 12.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.425 -0.797 . . . . 0.0 110.371 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.769 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -118.14 -164.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.512 -0.743 . . . . 0.0 110.034 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.769 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -115.86 101.45 8.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.458 -0.776 . . . . 0.0 109.386 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.733 HG22 ' CG1' ' A' ' 81' ' ' VAL . 25.6 t -78.3 119.24 26.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.365 -0.834 . . . . 0.0 110.197 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.878 HG12 ' O ' ' A' ' 82' ' ' GLN . 8.1 p -102.3 -2.37 9.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.52 -0.738 . . . . 0.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.579 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.42 143.44 0.14 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.293 -0.88 . . . . 0.0 110.09 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -133.96 118.35 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 0.0 110.146 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.51 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.7 t-20 -118.85 115.97 25.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.208 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.527 HG23 ' HE3' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -115.99 165.48 13.06 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.17 -178.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -153.7 150.2 28.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.797 . . . . 0.0 109.984 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.572 ' CD2' ' HD2' ' A' ' 60' ' ' ARG . 6.6 t-160 -67.17 125.77 27.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.095 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -119.64 137.52 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.355 -0.84 . . . . 0.0 109.889 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.572 ' HD2' ' CD2' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -156.9 -167.26 2.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.181 -0.95 . . . . 0.0 110.53 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.04 50.55 38.56 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.85 -35.95 2.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.344 -1.092 . . . . 0.0 110.089 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 65' ' ' ARG . 2.3 mptp? -61.49 139.02 58.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 110.179 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 69' ' ' TYR . 9.5 mttp -41.28 96.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.324 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.568 ' HA ' ' HB3' ' A' ' 69' ' ' TYR . 1.1 mtp85 -107.02 -66.05 1.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 110.226 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.53 HD23 ' HE ' ' A' ' 68' ' ' ARG . 1.1 mp 49.63 -178.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 109.53 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.482 ' C ' ' CG ' ' A' ' 68' ' ' ARG . . . -86.39 38.51 3.09 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.53 ' HE ' HD23 ' A' ' 66' ' ' LEU . 11.4 mtm180 -147.48 18.97 1.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.403 1.097 . . . . 0.0 109.239 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.635 ' O ' HD12 ' A' ' 70' ' ' LEU . 8.2 t80 -138.38 -161.95 1.24 Allowed 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.891 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -165.65 103.05 0.7 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.455 -0.778 . . . . 0.0 109.865 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.15 72.81 0.35 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -43.75 161.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -1.172 . . . . 0.0 110.17 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 72' ' ' LYS . 3.8 mtm180 -42.48 102.05 0.26 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.127 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 49.5 Cg_endo -73.09 -165.71 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.01 1.531 . . . . 0.0 110.51 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -114.74 89.26 3.05 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.392 -0.818 . . . . 0.0 109.174 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.63 ' CD ' ' CZ3' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -136.2 122.64 20.72 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.729 -0.607 . . . . 0.0 109.441 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.526 ' O ' HG12 ' A' ' 30' ' ' VAL . 8.7 tttt -119.84 141.9 49.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 110.456 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.872 ' CE ' HG11 ' A' ' 12' ' ' VAL . 2.1 tptm -101.2 146.84 26.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 109.725 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.757 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -128.23 123.53 34.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.201 -0.937 . . . . 0.0 111.382 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.78 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -106.17 113.0 41.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.462 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 54' ' ' VAL . 5.9 t -104.27 133.28 48.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.479 -0.763 . . . . 0.0 110.428 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.878 ' O ' HG12 ' A' ' 52' ' ' VAL . 3.1 tp60 -107.69 140.34 40.88 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.094 -1.004 . . . . 0.0 108.559 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 87' ' ' GLN . 2.4 m -109.15 155.48 10.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 117.71 -1.596 . . . . 0.0 108.991 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.927 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -52.84 177.87 0.07 OUTLIER Pre-proline 0 C--N 1.289 -2.059 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.383 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.927 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.7 Cg_endo -73.1 144.17 37.24 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 O-C-N 124.374 1.723 . . . . 0.0 110.544 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.04 -26.15 14.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.568 ' HB2' HG23 ' A' ' 83' ' ' VAL . 29.8 mt-30 -83.32 169.85 15.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -1.157 . . . . 0.0 110.467 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' A' ' 88' ' ' LYS . 0.1 OUTLIER 179.71 129.85 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.302 -0.874 . . . . 0.0 110.476 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.899 HD12 ' CD2' ' A' ' 26' ' ' TYR . 6.5 mt -91.16 116.04 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 109.958 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 10.9 pt-20 -78.05 -14.7 59.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.55 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.837 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -55.82 -29.14 59.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -0.914 . . . . 0.0 110.922 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.755 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.04 -23.3 12.67 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.014 -1.054 . . . . 0.0 110.131 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.2 mm-40 -62.6 -39.13 92.78 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.271 -0.893 . . . . 0.0 110.429 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.25 -13.77 59.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.837 HD13 ' O ' ' A' ' 91' ' ' ALA . 0.9 OUTLIER -56.8 -17.26 8.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -1.171 . . . . 0.0 110.17 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.747 HG22 ' OXT' ' A' ' 96' ' ' ILE . 61.0 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.184 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.594 ' O ' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.721 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 2.3 pttt -58.1 92.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.13 -1.428 . . . . 0.0 108.897 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.908 ' OG1' ' HB2' ' A' ' 46' ' ' ALA 0.264 10.1 t -136.97 -34.89 0.72 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 122.185 0.993 . . . . 0.0 109.741 -178.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' A' ' 5' ' ' TYR . . . -170.41 -26.83 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.799 -0.563 . . . . 0.0 110.459 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.721 ' CE1' ' HA ' ' A' ' 2' ' ' LYS 0.272 0.0 OUTLIER -47.39 -134.55 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.974 0.892 . . . . 0.0 112.033 178.384 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.627 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 27.9 m-20 -24.04 -65.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.539 0.685 . . . . 0.0 112.215 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.033 HG13 ' HB1' ' A' ' 34' ' ' ALA . 58.6 t -53.91 -110.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.583 -0.698 . . . . 0.0 110.971 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.018 HG13 HG12 ' A' ' 7' ' ' VAL . 21.4 mt -77.78 82.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 120.96 -1.087 . . . . 0.0 110.854 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -52.27 -94.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.48 -0.762 . . . . 0.0 111.064 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.21 155.96 39.28 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 0.0 110.985 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 49.5 Cg_endo -76.86 158.37 34.9 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.248 1.657 . . . . 0.0 110.449 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 27' ' ' THR . 1.6 p -115.15 109.39 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.055 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -102.06 107.2 18.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 110.446 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.7 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -154.25 160.6 41.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.864 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 10.1 pt-20 -40.54 -36.89 0.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 110.291 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -27.83 42.67 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.331 -0.856 . . . . 0.0 110.388 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.7 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -97.0 11.02 37.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.223 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.618 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 1.5 m-85 -120.93 -33.6 3.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.211 -0.931 . . . . 0.0 109.927 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.19 -8.59 50.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -0.842 . . . . 0.0 109.506 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -110.79 -33.11 2.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -76.38 -17.94 59.12 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.641 -0.917 . . . . 0.0 108.935 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.621 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -59.66 -18.68 43.92 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.717 -0.614 . . . . 0.0 110.499 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.3 17.62 5.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.464 -0.772 . . . . 0.0 109.855 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 92.82 -0.05 69.45 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 18.8 mttt -82.56 143.27 31.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.578 -0.954 . . . . 0.0 109.532 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.843 ' HD1' HD13 ' A' ' 92' ' ' LEU . 60.7 m-85 -128.27 101.52 6.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.743 -1.223 . . . . 0.0 111.376 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.673 ' O ' HG12 ' A' ' 12' ' ' VAL . 4.3 m -74.84 132.28 41.4 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.824 ' HB3' HG23 ' A' ' 8' ' ' ILE . 2.8 m-85 -136.99 164.2 28.92 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.632 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.597 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 68.7 m95 -101.09 122.62 43.91 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.957 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.8 p -141.4 156.45 21.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 C-N-CA 118.181 -1.408 . . . . 0.0 111.863 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.591 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 2.9 t60 -63.93 151.26 89.87 Favored Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.891 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.591 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 47.2 Cg_endo -73.82 72.11 3.94 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.166 1.614 . . . . 0.0 109.961 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HE2' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.35 -32.0 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.524 -0.735 . . . . 0.0 109.552 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 1.033 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -47.4 90.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.568 -0.707 . . . . 0.0 109.659 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -41.73 142.04 0.71 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.144 -0.973 . . . . 0.0 110.453 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.511 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -43.58 -42.77 5.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.632 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 8.7 m -71.13 -26.72 63.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.388 -0.82 . . . . 0.0 109.727 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.4 OUTLIER -66.65 -46.41 75.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.212 179.431 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.787 HG23 HD11 ' A' ' 8' ' ' ILE . 16.6 mt -57.5 -30.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.587 ' HG3' HG11 ' A' ' 51' ' ' VAL . 4.3 tttt -62.87 -47.34 83.74 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.501 -0.749 . . . . 0.0 110.007 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.511 ' O ' ' HB ' ' A' ' 45' ' ' THR . 29.5 m-20 -73.01 -35.02 66.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.704 -0.622 . . . . 0.0 111.688 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.763 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.39 -52.77 64.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.649 -1.282 . . . . 0.0 110.361 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.673 HG13 HD13 ' A' ' 8' ' ' ILE . 2.7 m -68.37 -36.61 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.673 -1.267 . . . . 0.0 110.45 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.657 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -65.13 -41.37 94.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.989 -1.07 . . . . 0.0 109.775 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -79.27 -12.91 59.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.936 179.456 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.908 ' HB2' ' OG1' ' A' ' 3' ' ' THR . . . -110.82 -59.47 1.95 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.324 -0.86 . . . . 0.0 110.62 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CD2' HG12 ' A' ' 43' ' ' VAL . 10.2 m-85 -71.7 -20.91 61.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.475 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 mttt 63.24 43.01 6.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.793 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -118.21 -161.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.638 -0.664 . . . . 0.0 109.831 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.793 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -116.91 109.18 16.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.398 -0.814 . . . . 0.0 109.516 178.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.657 HG23 ' HG2' ' A' ' 44' ' ' GLU . 55.4 t -77.32 122.37 31.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.166 -0.959 . . . . 0.0 109.194 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.736 HG21 ' N ' ' A' ' 84' ' ' ALA . 30.1 t -114.94 -11.92 11.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.496 -0.753 . . . . 0.0 110.881 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -176.35 117.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.118 179.353 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.98 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -115.73 125.31 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 110.057 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.511 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 15.8 t-20 -126.81 115.97 20.17 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 109.418 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.599 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -116.22 153.49 31.77 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.93 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -139.42 169.03 18.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.112 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.43 ' CG ' ' HE ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -88.79 125.75 35.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 110.357 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.939 HG11 ' CD ' ' A' ' 78' ' ' LYS . 2.4 m -120.26 120.58 63.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.709 -0.62 . . . . 0.0 110.048 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.557 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -132.99 117.73 17.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.154 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.39 131.89 3.05 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -96.57 -65.19 0.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -1.138 . . . . 0.0 110.386 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -76.12 57.8 1.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 0.0 110.281 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 54.53 108.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.192 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.542 ' CB ' ' HG3' ' A' ' 73' ' ' ARG . 3.7 ptt85 -56.13 -160.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.378 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 66' ' ' LEU . 7.2 tp 54.91 106.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.154 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.08 -176.03 43.03 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.517 ' O ' ' C ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -61.62 -175.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -1.148 . . . . 0.0 110.268 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 7.9 t80 27.89 70.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.652 0.739 . . . . 0.0 111.018 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER 36.46 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.816 . . . . 0.0 110.875 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 70' ' ' LEU . . . -43.15 165.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -102.84 133.89 47.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -1.17 . . . . 0.0 110.394 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.542 ' HG3' ' CB ' ' A' ' 65' ' ' ARG . 3.8 ttm180 -166.55 79.67 1.05 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.322 -0.861 . . . . 0.0 110.198 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 52.3 Cg_endo -76.41 -167.0 0.41 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.087 1.572 . . . . 0.0 110.461 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -115.33 89.39 3.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.539 -0.726 . . . . 0.0 109.249 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.506 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -129.67 147.34 51.45 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.587 -0.695 . . . . 0.0 110.371 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.699 ' CG ' HG13 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -123.5 142.45 51.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.36 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.939 ' CD ' HG11 ' A' ' 59' ' ' VAL . 13.6 mtpt -100.41 150.97 22.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.419 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.799 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -123.25 129.96 52.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.024 -1.048 . . . . 0.0 112.167 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.799 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.6 mp -109.65 111.35 35.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.201 178.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.98 HG13 HG23 ' A' ' 54' ' ' VAL . 3.2 t -100.79 143.9 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.421 -0.799 . . . . 0.0 110.19 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' LYS . 9.2 tp60 -122.54 147.1 46.78 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.354 -0.841 . . . . 0.0 109.39 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.491 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.3 m -125.01 156.8 33.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.68 -1.208 . . . . 0.0 110.178 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.847 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -45.17 175.81 0.03 OUTLIER Pre-proline 0 C--N 1.296 -1.726 0 CA-C-O 121.292 0.568 . . . . 0.0 110.916 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.847 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.8 Cg_endo -74.1 142.67 31.25 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 O-C-N 124.221 1.642 . . . . 0.0 110.542 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.82 -15.74 45.77 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.527 ' OE1' ' CB ' ' A' ' 50' ' ' LYS . 57.4 mt-30 -93.7 165.05 12.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -1.219 . . . . 0.0 110.629 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 90' ' ' GLU . 8.2 ptmt 179.63 102.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.47 -0.769 . . . . 0.0 110.241 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 26' ' ' TYR . 54.8 mt -42.18 98.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 110.189 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.73 -28.47 34.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.089 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . -55.8 -23.69 31.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.197 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.843 HD13 ' HD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -107.73 -23.03 12.25 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.875 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.4 ' OE2' ' CZ ' ' A' ' 21' ' ' PHE . 6.2 mm-40 -84.11 1.72 42.82 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 118.055 -1.458 . . . . 0.0 110.247 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.21 -16.85 8.06 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.46 ' O ' ' OXT' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -60.19 -26.98 66.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.431 -1.041 . . . . 0.0 110.047 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.46 ' OXT' ' O ' ' A' ' 95' ' ' LEU . 10.1 mt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.238 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 2.3 ptp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.684 0.278 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.791 ' HD2' HD11 ' A' ' 9' ' ' LEU . 13.2 mmtt -43.67 98.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.613 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.5 m 4.51 -71.56 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.7 0 CA-C-O 121.33 0.586 . . . . 0.0 110.829 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.01 ' O ' HG23 ' A' ' 7' ' ' VAL 0.26 . . -55.58 81.44 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.058 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.097 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.5 p90 23.52 47.54 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.74 0.781 . . . . 0.0 110.416 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.619 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 4.4 t70 64.94 52.33 1.58 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.03 0.919 . . . . 0.0 111.505 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.097 HG21 ' CE2' ' A' ' 5' ' ' TYR . 2.5 t -133.42 -129.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.146 -0.971 . . . . 0.0 109.525 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.882 HG23 ' HB3' ' A' ' 28' ' ' PHE . 2.2 mp -49.94 155.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.362 -0.837 . . . . 0.0 110.519 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.791 HD11 ' HD2' ' A' ' 2' ' ' LYS . 24.0 mt -139.93 -96.73 0.16 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.179 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.37 140.31 21.62 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.082 -1.011 . . . . 0.0 110.255 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.778 ' HG3' HD22 ' A' ' 92' ' ' LEU . 45.7 Cg_endo -73.54 162.55 39.67 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.003 1.528 . . . . 0.0 110.204 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.911 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.5 m -98.35 140.59 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.91 . . . . 0.0 110.335 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.863 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.0 mm? -102.76 113.2 26.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 15' ' ' GLU . 3.7 m -170.67 143.88 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 109.952 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.1 mt-10 -42.74 -49.34 5.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.119 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.6 -17.9 3.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.256 -0.903 . . . . 0.0 110.318 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.481 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -106.6 -49.8 3.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 110.041 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.863 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.3 m-85 -56.25 -53.52 56.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.828 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.79 -12.37 34.95 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.185 -0.947 . . . . 0.0 109.209 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -90.86 -48.64 3.33 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 9.4 m-30 -46.83 -27.66 1.3 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.347 -1.09 . . . . 0.0 108.151 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 21' ' ' PHE . . . -40.18 -28.14 0.05 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.476 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.547 ' HG3' ' CE ' ' A' ' 25' ' ' LYS . 3.5 pm0 -104.62 17.07 24.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.343 -0.848 . . . . 0.0 111.471 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 87.32 7.22 76.82 Favored Glycine 0 N--CA 1.486 1.975 0 O-C-N 120.965 -1.084 . . . . 0.0 110.543 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.56 ' HD2' ' CG ' ' A' ' 82' ' ' GLN . 3.2 mptp? -84.94 134.97 34.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -1.195 . . . . 0.0 110.241 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.866 ' HD1' HD12 ' A' ' 92' ' ' LEU . 86.3 m-85 -126.94 110.44 13.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.718 -1.239 . . . . 0.0 111.544 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.827 HG23 HD11 ' A' ' 80' ' ' ILE . 2.4 m -76.0 135.76 39.99 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 121.466 0.65 . . . . 0.0 109.674 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.882 ' HB3' HG23 ' A' ' 8' ' ' ILE . 21.3 m-85 -129.58 165.23 22.14 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.588 -0.695 . . . . 0.0 110.703 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.911 ' NE1' HG12 ' A' ' 12' ' ' VAL . 19.9 m95 -104.43 122.49 45.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 8' ' ' ILE . 2.0 p -151.17 165.21 2.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 118.472 -1.291 . . . . 0.0 111.51 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.45 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -59.04 149.42 66.71 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.773 -0.579 . . . . 0.0 110.791 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 47.9 Cg_endo -73.33 69.97 4.01 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.26 1.663 . . . . 0.0 109.88 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.26 -33.71 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 110.273 -178.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' LYS . . . -42.11 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.414 -0.804 . . . . 0.0 110.307 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -47.62 142.63 4.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.209 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 12.5 mttt -49.75 -44.59 48.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.308 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -64.75 -49.75 69.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.981 . . . . 0.0 110.545 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.7 OUTLIER -55.29 -41.93 72.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 0.0 109.73 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.687 ' HA ' HD11 ' A' ' 8' ' ' ILE . 10.1 mt -57.42 -30.8 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.396 -0.815 . . . . 0.0 109.817 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.522 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.6 tttt -60.75 -46.18 91.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.0 111.025 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -58.97 -34.87 72.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 112.415 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.836 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -70.1 -50.28 42.41 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.588 -1.32 . . . . 0.0 111.715 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.879 HG23 HG21 ' A' ' 51' ' ' VAL . 15.1 m -68.54 -27.32 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.51 -1.369 . . . . 0.0 110.36 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.83 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -56.43 -53.0 62.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.939 -1.101 . . . . 0.0 109.237 179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.3 p -80.54 -45.11 17.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 109.884 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -56.61 -63.09 1.31 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 110.848 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.722 ' CD1' HG23 ' A' ' 89' ' ' ILE . 35.2 m-85 -71.51 -21.16 61.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.131 -0.98 . . . . 0.0 109.807 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 71.26 50.85 0.28 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.499 -0.751 . . . . 0.0 110.108 179.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.701 HG11 HG12 ' A' ' 89' ' ' ILE . 1.5 p -149.3 171.99 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.541 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.57 ' N ' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -89.97 110.57 21.53 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.534 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 43' ' ' VAL . 22.0 t -77.87 138.49 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.786 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.787 HG11 ' OE1' ' A' ' 82' ' ' GLN . 11.3 p -110.28 -29.34 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.226 -0.921 . . . . 0.0 110.842 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.558 ' HG3' ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -159.12 149.63 19.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.987 -1.07 . . . . 0.0 110.467 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.009 ' CG2' HG22 ' A' ' 81' ' ' VAL . 1.4 t -133.0 117.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 110.121 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.554 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.6 m-20 -116.86 114.69 24.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.2 -0.937 . . . . 0.0 109.157 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.656 HG21 HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -119.66 150.66 39.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.99 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.938 HD21 ' HD2' ' A' ' 78' ' ' LYS . 3.0 pp -140.61 170.34 15.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.428 ' ND1' ' NH1' ' A' ' 60' ' ' ARG . 0.4 OUTLIER -90.57 120.98 32.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.33 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.823 HG13 HD11 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -117.51 130.71 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.4 -0.813 . . . . 0.0 109.938 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.502 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 4.7 mmt85 -115.66 174.18 6.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 110.136 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -45.17 126.86 7.54 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.495 ' CA ' ' HE2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -99.67 -61.64 1.34 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 110.277 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.98 139.91 57.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.234 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.3 tttm 56.86 76.61 0.3 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 110.186 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -105.02 -81.45 0.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.333 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 68' ' ' ARG . 4.4 mm? 43.65 72.3 0.19 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.932 . . . . 0.0 109.904 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.37 57.32 0.18 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -137.25 21.89 2.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.015 -1.285 . . . . 0.0 110.035 179.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 9.6 t80 -168.56 58.32 0.06 Allowed 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.838 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER 43.05 41.74 2.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 0.0 109.946 -179.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 70' ' ' LEU . . . -52.93 -169.93 0.02 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.58 109.74 21.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -1.151 . . . . 0.0 110.26 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 7.7 ttm105 -158.1 79.46 3.23 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.481 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 51.9 Cg_endo -77.89 -165.94 0.36 Allowed 'Trans proline' 0 C--N 1.302 -1.869 0 O-C-N 124.169 1.615 . . . . 0.0 110.377 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.468 ' OD2' ' HG3' ' A' ' 32' ' ' PRO . 11.7 p-10 -114.6 89.36 3.07 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.408 -0.808 . . . . 0.0 109.407 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -126.05 142.13 51.66 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.146 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 32' ' ' PRO . 8.7 pttt -123.05 141.92 51.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.294 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.938 ' HD2' HD21 ' A' ' 57' ' ' LEU . 3.9 ptpt -100.85 149.18 24.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.671 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.828 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -116.89 123.67 47.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.03 -1.044 . . . . 0.0 112.585 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.827 HD11 HG23 ' A' ' 27' ' ' THR . 1.7 mp -101.98 111.45 31.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.009 HG22 ' CG2' ' A' ' 54' ' ' VAL . 89.0 t -108.99 133.96 52.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.254 -0.904 . . . . 0.0 110.861 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.787 ' OE1' HG11 ' A' ' 52' ' ' VAL . 2.7 tm0? -103.22 153.45 20.36 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.332 -0.855 . . . . 0.0 109.345 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 89' ' ' ILE . 3.7 m -109.39 157.18 9.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 C-N-CA 118.799 -1.16 . . . . 0.0 108.419 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 1.029 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -70.87 179.97 0.8 Allowed Pre-proline 0 C--N 1.283 -2.284 0 C-N-CA 119.071 -1.051 . . . . 0.0 109.988 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.922 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.0 Cg_endo -73.25 137.83 26.65 Favored 'Trans proline' 0 C--N 1.297 -2.136 0 O-C-N 124.242 1.653 . . . . 0.0 110.389 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.23 -36.65 4.26 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 1.029 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -105.95 -178.89 3.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.239 -1.154 . . . . 0.0 110.608 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 90' ' ' GLU . 5.8 ptpt -179.86 104.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 0.0 110.056 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.722 HG23 ' CD1' ' A' ' 47' ' ' PHE . 71.3 mt -54.35 86.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.351 -0.843 . . . . 0.0 109.885 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.557 ' HA ' ' CG ' ' A' ' 93' ' ' GLU . 2.8 pt-20 -71.11 -12.22 61.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.443 -0.785 . . . . 0.0 110.925 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.989 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -53.37 -27.35 23.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.992 -1.068 . . . . 0.0 110.562 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.866 HD12 ' HD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.92 -23.67 12.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.98 -1.075 . . . . 0.0 109.683 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 90' ' ' GLU . 1.5 pp20? -66.23 -29.67 69.97 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.349 -0.941 . . . . 0.0 109.485 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.52 -22.63 28.48 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.989 HD13 ' O ' ' A' ' 91' ' ' ALA . 0.5 OUTLIER -44.73 -25.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -1.08 . . . . 0.0 109.857 179.665 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.556 HD13 ' CE2' ' A' ' 18' ' ' TYR . 12.5 mm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.188 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.566 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.801 0.334 . . . . 0.0 110.633 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.621 ' CB ' ' HA ' ' A' ' 6' ' ' ASP . 43.1 mmtt -43.91 98.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.638 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.5 m 4.56 -72.07 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.308 0.575 . . . . 0.0 110.704 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.039 ' O ' HG23 ' A' ' 7' ' ' VAL 0.258 . . -55.51 81.96 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.036 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.4 p90 22.81 48.18 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 121.761 0.791 . . . . 0.0 110.502 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.621 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 5.9 t70 64.07 53.64 1.8 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.002 0.906 . . . . 0.0 111.492 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.039 HG23 ' O ' ' A' ' 4' ' ' ALA . 3.2 t -131.42 -125.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.491 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.908 HG23 ' HB3' ' A' ' 28' ' ' PHE . 4.5 mt -49.74 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.169 -0.957 . . . . 0.0 110.078 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.52 HD21 ' HE3' ' A' ' 2' ' ' LYS . 0.7 OUTLIER -57.88 -106.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 110.664 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.537 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -108.13 162.88 18.33 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.877 -1.139 . . . . 0.0 110.525 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.636 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 46.8 Cg_endo -73.72 133.47 18.69 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.105 1.582 . . . . 0.0 110.439 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 27' ' ' THR . 2.1 p -93.91 116.78 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.89 . . . . 0.0 109.968 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.841 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.4 mm? -100.96 109.24 21.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.399 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -159.13 163.92 35.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.004 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.9 mt-10 -42.88 -52.94 4.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 110.069 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -57.63 -39.5 77.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 110.099 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 21' ' ' PHE . . . -91.33 23.72 3.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.875 . . . . 0.0 109.692 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.947 ' OH ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -125.51 -63.24 1.15 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.0 109.518 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.05 -12.06 35.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.548 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.38 -40.54 2.21 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -74.01 -29.41 61.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.57 -0.959 . . . . 0.0 108.78 179.128 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -46.13 -23.54 0.34 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.689 -0.632 . . . . 0.0 110.57 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.74 -14.71 34.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 110.508 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 132.42 -1.23 4.83 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 12.5 mmtt -81.69 147.45 29.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -1.153 . . . . 0.0 109.602 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 1.017 ' CD2' HD12 ' A' ' 89' ' ' ILE . 20.6 m-85 -127.2 106.69 9.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.91 -1.119 . . . . 0.0 111.661 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.788 ' O ' HG12 ' A' ' 12' ' ' VAL . 2.9 m -75.73 126.75 31.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.908 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -135.32 164.01 28.71 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.177 -0.952 . . . . 0.0 110.46 -178.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.537 ' CZ3' ' HD3' ' A' ' 76' ' ' ARG . 23.3 m95 -101.92 122.28 43.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.573 HG23 ' C ' ' A' ' 7' ' ' VAL . 13.7 p -146.24 166.49 8.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.06 -1.025 . . . . 0.0 111.488 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.517 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -71.92 169.59 15.6 Favored Pre-proline 0 C--N 1.293 -1.85 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.963 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.517 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 48.6 Cg_endo -75.41 -53.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.043 0 O-C-N 124.245 1.655 . . . . 0.0 109.643 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HG3' ' HB3' ' A' ' 31' ' ' HIS 0.256 0.0 OUTLIER -46.54 -22.45 0.28 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.874 179.027 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -66.05 102.76 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 110.306 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -67.17 143.27 56.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 110.18 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 13.9 mttt -42.45 -38.61 1.96 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -68.33 -52.28 35.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.388 -0.82 . . . . 0.0 110.608 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 29.5 mm-40 -55.19 -43.54 74.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.678 HG23 HD11 ' A' ' 8' ' ' ILE . 11.4 mt -56.87 -30.3 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.112 -0.993 . . . . 0.0 109.403 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.565 ' HG3' HG11 ' A' ' 51' ' ' VAL . 15.1 ttpt -63.67 -47.02 82.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.461 -0.774 . . . . 0.0 111.039 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -58.73 -34.94 71.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.368 -0.832 . . . . 0.0 112.189 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.728 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -65.34 -50.43 65.62 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.682 -1.262 . . . . 0.0 111.289 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.508 HG23 HG21 ' A' ' 51' ' ' VAL . 9.4 m -76.23 -32.22 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.614 -1.304 . . . . 0.0 110.612 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.79 -51.64 68.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.698 -1.251 . . . . 0.0 109.415 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -79.71 -46.23 17.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 110.035 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -59.16 -64.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.389 -0.819 . . . . 0.0 110.404 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.639 ' CE1' ' CB ' ' A' ' 91' ' ' ALA . 7.5 m-85 -72.03 -19.9 61.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.242 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 66.9 41.92 2.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 110.251 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.777 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -122.55 -164.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.556 -0.715 . . . . 0.0 109.931 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.777 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -119.28 106.79 12.67 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 110.145 179.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.58 HG13 ' CG1' ' A' ' 81' ' ' VAL . 76.3 t -78.43 119.7 27.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.796 HG12 ' O ' ' A' ' 82' ' ' GLN . 12.2 p -104.23 4.96 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.919 . . . . 0.0 110.7 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 167.77 119.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.217 -0.927 . . . . 0.0 110.504 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.062 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -112.16 120.01 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 109.861 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -107.66 115.22 29.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.181 -0.95 . . . . 0.0 109.047 178.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.55 HG21 HD12 ' A' ' 39' ' ' ILE . 2.3 p -116.68 139.07 50.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.101 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.822 HD11 ' HD2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -136.38 144.1 44.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 110.264 -179.569 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.496 ' CG ' ' NE ' ' A' ' 60' ' ' ARG . 2.0 t-160 -76.34 115.16 15.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -109.48 121.14 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.321 -0.862 . . . . 0.0 109.892 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.532 ' N ' ' HD3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -133.65 167.68 20.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 110.302 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 60' ' ' ARG . . . -43.61 147.91 0.94 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.33 29.01 0.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -1.1 . . . . 0.0 110.202 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -110.53 -20.98 12.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.147 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 0.8 OUTLIER 168.31 115.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 110.064 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.439 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -145.75 51.74 1.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 110.435 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.504 HD23 ' CZ ' ' A' ' 68' ' ' ARG . 2.3 mp -42.57 126.0 3.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.051 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.15 52.0 1.72 Allowed Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.504 ' CZ ' HD23 ' A' ' 66' ' ' LEU . 16.4 ptt180 -154.22 22.95 0.49 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.049 -1.265 . . . . 0.0 110.02 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 40.1 t80 -166.54 55.99 0.09 Allowed 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.751 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER 41.21 94.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.283 -0.885 . . . . 0.0 110.416 -179.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.69 153.79 37.1 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 3.2 mppt? -97.29 62.51 1.77 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -1.141 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.14 78.9 1.44 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.284 -0.885 . . . . 0.0 110.335 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 50.3 Cg_endo -76.16 -165.01 0.28 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.021 1.537 . . . . 0.0 110.394 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' OD2' ' O ' ' A' ' 75' ' ' ASP . 6.4 p-10 -114.2 89.47 3.1 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.411 -0.806 . . . . 0.0 109.327 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.537 ' HD3' ' CZ3' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -120.2 112.67 19.37 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.627 -0.671 . . . . 0.0 110.214 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.53 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 1.8 tttp -117.59 134.77 54.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 109.682 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.822 ' HD2' HD11 ' A' ' 57' ' ' LEU . 6.7 ptpt -102.04 150.3 23.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.022 . . . . 0.0 110.798 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.806 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -117.29 134.14 55.16 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.148 -0.97 . . . . 0.0 111.978 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.806 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.6 mp -110.76 110.86 33.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.062 HG13 HG23 ' A' ' 54' ' ' VAL . 2.4 t -104.98 127.72 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.335 -0.853 . . . . 0.0 111.011 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.796 ' O ' HG12 ' A' ' 52' ' ' VAL . 9.9 tp60 -110.02 146.03 36.01 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.066 -1.021 . . . . 0.0 108.761 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 87' ' ' GLN . 1.6 m -113.26 155.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 118.083 -1.447 . . . . 0.0 109.623 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.951 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -55.83 179.48 0.1 OUTLIER Pre-proline 0 C--N 1.29 -1.996 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.195 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.951 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.5 Cg_endo -72.27 141.51 35.76 Favored 'Trans proline' 0 C--N 1.299 -2.048 0 O-C-N 124.193 1.628 . . . . 0.0 110.55 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.57 -19.63 46.52 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.575 ' NE2' ' CB ' ' A' ' 50' ' ' LYS . 49.9 mt-30 -93.11 168.96 10.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -1.141 . . . . 0.0 110.672 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.8 OUTLIER 179.65 122.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.395 -0.815 . . . . 0.0 110.339 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.017 HD12 ' CD2' ' A' ' 26' ' ' TYR . 15.2 mt -83.86 106.74 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.146 -0.971 . . . . 0.0 109.958 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -61.94 -13.97 30.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.368 -0.832 . . . . 0.0 110.946 -179.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.639 ' CB ' ' CE1' ' A' ' 47' ' ' PHE . . . -55.03 -34.12 63.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.098 -1.001 . . . . 0.0 110.792 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.776 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -105.86 -23.23 12.74 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.011 -1.056 . . . . 0.0 109.592 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.9 mm-40 -66.49 -37.67 85.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.344 -0.847 . . . . 0.0 109.95 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.07 -8.92 86.82 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 92' ' ' LEU . 4.8 mp -81.34 8.87 8.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -1.153 . . . . 0.0 110.091 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.947 HD13 ' OH ' ' A' ' 18' ' ' TYR . 15.5 mm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.538 ' HB2' ' CB ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.273 0.558 . . . . 0.0 110.509 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.615 ' O ' ' N ' ' A' ' 4' ' ' ALA . 5.7 mmtm -47.56 100.11 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.624 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.2 m 3.01 -68.7 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 121.118 0.485 . . . . 0.0 111.337 -179.18 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.053 ' O ' HG23 ' A' ' 7' ' ' VAL 0.262 . . -56.7 73.94 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.945 ' CE2' HG21 ' A' ' 7' ' ' VAL . 5.0 p90 31.08 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.742 0.782 . . . . 0.0 109.674 -178.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.597 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER 85.24 39.75 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.877 0.846 . . . . 0.0 111.755 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 4' ' ' ALA . 1.7 t -134.78 -137.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.134 -0.979 . . . . 0.0 109.987 178.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.926 ' CD1' HG23 ' A' ' 39' ' ' ILE . 2.6 mm -32.83 126.05 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 121.267 0.556 . . . . 0.0 110.919 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.608 HD21 ' HA ' ' A' ' 2' ' ' LYS . 1.3 mt -115.03 -94.54 0.48 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.85 . . . . 0.0 109.751 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.85 153.88 42.14 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.892 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.643 ' CB ' HD22 ' A' ' 92' ' ' LEU . 48.4 Cg_endo -76.02 158.25 38.25 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.943 1.496 . . . . 0.0 110.314 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.045 HG12 ' NE1' ' A' ' 29' ' ' TRP . 1.4 m -103.69 129.14 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.204 -0.935 . . . . 0.0 109.952 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.906 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 2.9 mm? -102.84 113.01 26.09 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.111 -0.993 . . . . 0.0 110.275 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 15' ' ' GLU . 68.8 m -161.58 144.05 11.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 14' ' ' SER . 69.7 mt-10 -42.87 -51.61 5.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 110.043 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -54.86 -34.03 62.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.288 -0.882 . . . . 0.0 110.172 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' GLY . . . -86.03 -58.5 2.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.25 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.906 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -46.13 -31.28 2.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.876 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.25 -8.75 50.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.084 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -109.14 -37.55 1.96 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -71.12 -18.3 62.53 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.698 -0.883 . . . . 0.0 108.843 178.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.621 ' N ' ' CD1' ' A' ' 21' ' ' PHE . . . -58.72 -20.02 45.27 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.676 -0.64 . . . . 0.0 110.474 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -88.62 17.32 5.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.487 -0.758 . . . . 0.0 109.953 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 91.96 3.27 68.2 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 72.9 mttt -82.72 136.94 34.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.563 -0.963 . . . . 0.0 109.382 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.946 ' CD2' HD12 ' A' ' 89' ' ' ILE . 24.6 m-85 -127.95 96.9 4.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.658 -1.277 . . . . 0.0 111.538 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.837 HG22 ' HG2' ' A' ' 78' ' ' LYS . 2.8 m -75.61 117.57 17.52 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.53 -0.731 . . . . 0.0 109.695 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.679 ' CZ ' ' CZ ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -116.86 162.96 16.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 110.349 -179.663 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 1.045 ' NE1' HG12 ' A' ' 12' ' ' VAL . 97.7 m95 -92.65 122.77 35.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.92 HG23 ' C ' ' A' ' 7' ' ' VAL . 8.9 p -147.03 166.97 6.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.038 -177.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.502 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -60.5 141.11 92.0 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.148 179.822 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.546 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 46.5 Cg_endo -72.2 77.46 2.02 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 124.169 1.615 . . . . 0.0 110.278 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 178.67 -34.71 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.349 -0.844 . . . . 0.0 109.906 -179.264 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.49 ' CB ' HG13 ' A' ' 7' ' ' VAL . . . -52.8 92.05 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.493 -0.754 . . . . 0.0 109.917 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -41.98 151.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.335 -0.853 . . . . 0.0 110.319 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.619 ' O ' HG11 ' A' ' 54' ' ' VAL . 6.8 mmtp -42.49 -35.07 0.95 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 110.044 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.6 m -75.08 -39.75 60.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 110.096 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.68 -43.52 76.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.061 -1.024 . . . . 0.0 109.536 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.926 HG23 ' CD1' ' A' ' 8' ' ' ILE . 30.0 mt -57.99 -30.32 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.432 -0.792 . . . . 0.0 109.646 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.685 ' HG3' HG21 ' A' ' 51' ' ' VAL . 11.5 tttm -60.14 -47.42 85.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.556 -0.715 . . . . 0.0 111.523 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -58.22 -38.87 77.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.379 -0.826 . . . . 0.0 112.108 -178.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.765 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . . . -73.56 -50.87 19.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.7 -1.25 . . . . 0.0 111.818 -178.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.116 HG12 ' CE2' ' A' ' 47' ' ' PHE . 6.1 m -65.59 -44.75 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.711 -1.243 . . . . 0.0 111.054 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.623 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -56.91 -48.15 78.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.719 -1.238 . . . . 0.0 110.103 -179.945 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 m -79.0 -47.79 15.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 0.0 110.673 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -68.49 -63.79 0.99 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 110.575 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 1.116 ' CE2' HG12 ' A' ' 43' ' ' VAL . 21.3 m-85 -71.72 -4.13 25.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.174 -0.954 . . . . 0.0 110.165 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 12.4 mtmt 46.79 46.15 15.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.432 -0.793 . . . . 0.0 110.25 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.778 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -118.13 -163.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.57 -0.706 . . . . 0.0 109.87 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.778 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -117.2 112.62 21.07 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.448 -0.782 . . . . 0.0 109.436 179.083 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.685 HG21 ' HG3' ' A' ' 40' ' ' LYS . 17.3 t -77.67 119.53 26.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.076 -1.015 . . . . 0.0 109.337 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.808 HG21 ' N ' ' A' ' 84' ' ' ALA . 25.6 t -116.06 -10.7 12.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 121.685 0.755 . . . . 0.0 110.149 -178.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 82' ' ' GLN . 0.3 OUTLIER 175.39 116.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.593 -0.692 . . . . 0.0 109.581 179.371 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -105.19 136.62 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.996 . . . . 0.0 109.978 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.543 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.1 t-20 -131.39 114.86 15.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.139 -0.975 . . . . 0.0 109.722 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -108.44 150.08 27.89 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.624 -179.662 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.612 HD12 ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -128.9 -177.14 4.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.06 -1.025 . . . . 0.0 110.514 -178.934 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.5 119.92 26.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.557 -0.714 . . . . 0.0 109.298 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.795 HG11 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -108.98 121.86 62.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.104 -0.998 . . . . 0.0 108.911 179.53 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' O ' ' NE ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -32.69 125.16 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.601 0.715 . . . . 0.0 111.541 -178.422 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 74' ' ' PRO . . . 165.76 77.59 0.03 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -96.47 -179.57 4.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -1.222 . . . . 0.0 110.299 -179.851 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 65' ' ' ARG . 4.1 tttt -72.8 -19.67 61.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.277 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -41.75 99.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 110.293 -179.938 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -120.88 22.69 11.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.313 -179.861 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 68' ' ' ARG . 10.0 tp -41.98 138.42 1.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 110.164 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -55.15 84.25 0.01 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.541 ' CG ' ' HA3' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -126.21 145.25 50.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -1.174 . . . . 0.0 110.225 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.507 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -59.14 147.83 33.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.572 -179.859 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 41.51 42.99 2.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.378 -0.826 . . . . 0.0 110.411 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.541 ' HA3' ' CG ' ' A' ' 68' ' ' ARG . . . -114.17 -126.24 4.28 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER 56.57 72.23 0.52 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -1.127 . . . . 0.0 110.256 179.943 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 62' ' ' LYS . 1.8 mtp180 -100.97 108.49 54.58 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.094 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.522 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 48.7 Cg_endo -74.23 -164.66 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.978 1.515 . . . . 0.0 110.653 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 2.1 m-20 -114.14 90.06 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.41 -0.806 . . . . 0.0 108.965 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.562 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -95.55 153.15 17.85 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.645 -0.659 . . . . 0.0 110.546 -179.504 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.546 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 9.3 tttt -123.13 141.13 52.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.47 -0.769 . . . . 0.0 109.604 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.837 ' HG2' HG22 ' A' ' 27' ' ' THR . 6.5 tttt -101.24 134.26 44.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.003 -1.061 . . . . 0.0 109.834 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -124.79 120.35 31.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.924 . . . . 0.0 111.618 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.0 mt -95.57 111.63 26.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.576 -0.702 . . . . 0.0 109.987 178.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.939 HG21 HG11 ' A' ' 43' ' ' VAL . 2.9 t -95.41 133.52 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 23' ' ' GLU . 13.9 tp60 -112.26 144.04 42.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 109.6 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.2 m -125.32 156.79 34.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.459 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 1.018 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -47.97 173.07 0.06 OUTLIER Pre-proline 0 C--N 1.296 -1.73 0 CA-C-O 121.29 0.567 . . . . 0.0 111.035 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 47.3 Cg_endo -79.88 55.46 5.65 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 124.499 1.789 . . . . 0.0 110.344 179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.73 -35.01 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 1.018 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -105.79 177.83 4.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -1.185 . . . . 0.0 109.978 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 90' ' ' GLU . 6.2 ptpt 179.61 115.14 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.31 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.946 HD12 ' CD2' ' A' ' 26' ' ' TYR . 73.7 mt -44.2 94.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.994 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' LYS . 1.9 mt-10 -56.91 -14.33 3.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.384 -0.822 . . . . 0.0 110.977 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.56 ' HB3' HG22 ' A' ' 89' ' ' ILE . . . -55.05 -30.08 58.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 0.0 110.345 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.901 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -106.43 -23.23 12.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.176 -0.952 . . . . 0.0 109.495 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 73.7 mm-40 -56.58 -27.58 58.23 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.269 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.2 21.66 28.62 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.837 HD23 HD11 ' A' ' 13' ' ' LEU . 1.4 tp -99.29 2.13 45.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -1.165 . . . . 0.0 110.152 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.463 HD11 ' HZ ' ' A' ' 21' ' ' PHE . 1.5 mp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.235 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.859 0.362 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.635 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 1.6 mttt -80.89 76.06 7.83 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.712 -1.195 . . . . 0.0 108.869 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.911 HG21 HG21 ' A' ' 45' ' ' THR . 74.0 p -119.79 -87.58 0.63 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.725 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.902 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -92.98 -27.41 17.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.99 . . . . 0.0 108.892 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.75 ' CE1' HG23 ' A' ' 7' ' ' VAL 0.252 1.2 p90 -34.7 -25.54 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.643 178.299 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 4' ' ' ALA . 26.6 t0 -161.84 -58.76 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.829 -1.17 . . . . 0.0 110.589 -176.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.036 HG13 ' HB1' ' A' ' 34' ' ' ALA . 98.5 t -38.81 -97.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.599 0.714 . . . . 0.0 110.427 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.046 HD11 HG23 ' A' ' 39' ' ' ILE 0.25 75.1 mt -85.85 104.07 13.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.125 -0.985 . . . . 0.0 110.117 -179.572 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -86.89 -94.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.688 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.498 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -108.09 152.5 41.81 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 110.449 -179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.547 ' N ' ' CE1' ' A' ' 28' ' ' PHE . 47.0 Cg_endo -73.15 174.49 11.95 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.93 1.49 . . . . 0.0 110.197 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.841 HG12 ' CD1' ' A' ' 29' ' ' TRP . 2.5 m -114.98 138.33 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.095 -1.003 . . . . 0.0 110.338 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.81 112.66 25.57 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 110.213 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 17' ' ' ALA . 4.1 m -163.87 141.42 7.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -42.83 -54.99 3.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 110.054 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.71 -25.09 25.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.325 -0.859 . . . . 0.0 110.075 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -87.71 -62.02 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.201 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.755 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -46.12 -43.57 15.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.309 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.65 -8.64 57.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.987 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -105.66 -39.73 2.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -77.5 -20.78 53.76 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.51 -0.994 . . . . 0.0 108.979 179.28 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -57.03 -16.2 6.66 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.553 -0.717 . . . . 0.0 110.192 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 25' ' ' LYS . 4.7 tt0 -96.62 16.39 19.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 110.447 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.68 -2.13 60.29 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 23.0 mttt -82.74 143.36 30.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -1.123 . . . . 0.0 109.73 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 1.146 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.1 m-85 -128.03 97.19 4.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.693 -1.254 . . . . 0.0 111.608 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.965 HG23 HD11 ' A' ' 80' ' ' ILE . 8.7 m -76.95 120.68 22.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.755 ' CB ' HG23 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -120.87 163.73 17.75 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.987 -1.071 . . . . 0.0 111.677 -178.527 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.841 ' CD1' HG12 ' A' ' 12' ' ' VAL . 10.2 m95 -94.4 122.77 37.32 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 178.059 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 7' ' ' VAL 0.259 3.8 p -144.4 160.36 15.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 C-N-CA 118.148 -1.421 . . . . 0.0 111.823 -176.31 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.598 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 2.3 t60 -67.3 152.73 95.85 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.612 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.598 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 47.0 Cg_endo -73.19 71.78 3.55 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.071 1.564 . . . . 0.0 109.876 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.37 -33.3 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.782 -179.051 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 1.036 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -41.31 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.683 -0.636 . . . . 0.0 109.919 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -45.99 137.52 5.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 0.0 110.697 -179.415 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.553 ' HG3' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -43.4 -48.82 7.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.345 -0.847 . . . . 0.0 109.763 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.9 m -59.1 -50.15 75.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.728 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 2.2 mm-40 -55.07 -39.38 69.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 0.0 109.487 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.046 HG23 HD11 ' A' ' 8' ' ' ILE . 34.8 mt -57.61 -31.83 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.543 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 1.5 ttmp? -62.97 -45.98 89.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 178.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 45' ' ' THR . 32.7 m-80 -72.27 -33.73 67.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.686 -0.634 . . . . 0.0 110.914 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.857 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -57.44 -46.17 83.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.84 -1.163 . . . . 0.0 110.494 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.19 HG12 ' CE2' ' A' ' 47' ' ' PHE . 6.6 m -76.12 -33.13 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.78 -1.2 . . . . 0.0 109.657 178.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.52 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -68.2 -42.83 79.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.119 -0.988 . . . . 0.0 109.861 179.441 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.911 HG21 HG21 ' A' ' 3' ' ' THR . 0.8 OUTLIER -79.07 -28.56 43.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.879 179.752 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.902 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -95.67 -57.58 2.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 110.967 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 1.19 ' CE2' HG12 ' A' ' 43' ' ' VAL . 6.7 m-30 -76.52 -16.54 59.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.908 . . . . 0.0 110.569 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.4 mtpt 57.33 47.7 16.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 110.48 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.782 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -123.83 -160.22 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.526 -0.734 . . . . 0.0 110.016 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.782 ' N ' HG13 ' A' ' 49' ' ' VAL . 3.8 tmtt? -117.65 105.76 12.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.645 HG21 HG23 ' A' ' 43' ' ' VAL . 45.3 t -78.93 119.72 28.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.349 -0.845 . . . . 0.0 110.613 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.4 p -107.32 -5.91 10.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.346 -0.846 . . . . 0.0 109.658 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.588 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.96 142.78 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.413 -0.804 . . . . 0.0 109.904 179.353 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.96 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -133.48 130.1 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.075 -1.015 . . . . 0.0 109.849 179.698 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.499 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 1.2 t30 -131.18 115.62 16.6 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.863 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.539 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -115.32 164.78 13.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.744 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -149.3 172.13 15.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.201 -0.937 . . . . 0.0 110.438 -179.423 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.605 ' CD2' ' HG2' ' A' ' 60' ' ' ARG . 5.5 t-160 -81.71 118.82 23.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.115 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -120.41 123.92 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.282 -0.886 . . . . 0.0 110.158 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.605 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 11.1 mmt85 -141.61 102.3 4.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.97 -1.081 . . . . 0.0 110.665 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 58.88 150.28 0.01 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -91.44 -16.29 27.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -1.207 . . . . 0.0 109.767 179.685 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 62' ' ' LYS . 8.5 pttm -178.57 176.11 1.04 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.458 -0.776 . . . . 0.0 109.975 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 66.31 44.49 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 110.282 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' LEU . 24.5 ptt85 -144.74 -41.06 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 68' ' ' ARG . 2.4 mp 46.83 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.896 . . . . 0.0 110.086 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' A' ' 68' ' ' ARG . . . -66.98 56.08 0.23 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 66' ' ' LEU . 3.5 mmm180 -130.54 14.07 5.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.092 -1.24 . . . . 0.0 109.209 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.59 ' CG ' ' N ' ' A' ' 70' ' ' LEU . 29.0 t80 -163.17 173.73 13.06 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.909 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.59 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -84.92 45.42 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 110.274 179.85 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.479 ' N ' ' CD2' ' A' ' 69' ' ' TYR . . . -64.44 -113.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 1.2 ptmt -111.95 111.98 23.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -1.159 . . . . 0.0 110.265 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -133.52 80.51 56.94 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.265 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' O ' ' NH1' ' A' ' 60' ' ' ARG . 47.6 Cg_endo -74.96 -163.09 0.17 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.111 1.585 . . . . 0.0 110.544 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.556 ' HA ' ' NH2' ' A' ' 60' ' ' ARG . 17.9 p-10 -113.18 89.71 3.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.826 0.822 . . . . 0.0 108.898 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.596 ' HG3' ' CZ3' ' A' ' 29' ' ' TRP . 6.4 ttm180 -126.42 113.51 16.96 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.718 -0.614 . . . . 0.0 110.124 -179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.688 ' NZ ' ' HB3' ' A' ' 34' ' ' ALA . 18.1 tttt -122.97 139.59 53.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 109.724 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HE2' HG11 ' A' ' 12' ' ' VAL . 25.1 mttt -101.71 147.81 26.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 110.443 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.605 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -132.89 119.54 20.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.325 -0.859 . . . . 0.0 111.216 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.965 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -99.09 112.08 30.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.359 0.6 . . . . 0.0 109.595 179.128 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.049 HG11 HG21 ' A' ' 43' ' ' VAL . 2.5 t -104.24 127.38 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.475 -0.765 . . . . 0.0 110.14 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.691 ' O ' HG12 ' A' ' 52' ' ' VAL . 4.2 tp60 -102.54 147.47 26.72 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.027 -1.046 . . . . 0.0 109.334 179.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 1.5 m -116.35 156.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.311 -1.356 . . . . 0.0 108.891 177.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.789 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -69.06 176.14 1.71 Allowed Pre-proline 0 C--N 1.287 -2.116 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.125 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.789 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.1 Cg_endo -75.18 136.9 20.63 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 O-C-N 124.204 1.634 . . . . 0.0 110.291 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.25 -21.72 21.65 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -115.35 -179.91 3.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -1.234 . . . . 0.0 110.352 -179.988 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER 179.5 101.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.827 . . . . 0.0 110.149 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.146 HD12 ' CD2' ' A' ' 26' ' ' TYR . 48.5 mt -53.94 101.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -0.971 . . . . 0.0 110.172 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 19.4 pt-20 -60.92 -13.5 16.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.423 -0.798 . . . . 0.0 110.918 -179.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.71 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.69 -36.14 64.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 110.524 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.97 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -106.41 -23.11 12.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.022 -1.049 . . . . 0.0 109.8 179.762 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.8 mm-40 -52.15 -45.5 65.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.353 -0.842 . . . . 0.0 110.456 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 96' ' ' ILE . . . -83.2 -23.98 53.12 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 91' ' ' ALA . 1.1 tp -42.13 -27.19 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -1.115 . . . . 0.0 110.268 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 94' ' ' GLY . 17.3 mm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.278 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.691 ' HA ' ' CE1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -59.57 87.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.109 -1.436 . . . . 0.0 109.171 179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.911 HG22 HG21 ' A' ' 45' ' ' THR . 45.5 p -129.61 -56.68 1.14 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 8' ' ' ILE . . . -138.91 -4.8 1.53 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.88 0.848 . . . . 0.0 109.484 178.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.775 ' CZ ' HG23 ' A' ' 7' ' ' VAL 0.284 0.1 OUTLIER -56.21 -137.89 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.912 0.863 . . . . 0.0 110.842 177.659 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.621 ' N ' ' CG ' ' A' ' 5' ' ' TYR . 3.3 m-20 -27.57 -59.78 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.08 178.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.006 HG13 ' HB1' ' A' ' 34' ' ' ALA . 53.7 t -54.4 -111.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.542 -0.724 . . . . 0.0 110.94 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.954 HG13 HG12 ' A' ' 7' ' ' VAL . 11.8 mt -81.42 106.31 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.533 -1.354 . . . . 0.0 111.027 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -83.97 -105.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 110.217 179.715 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.65 151.43 41.68 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.948 -1.095 . . . . 0.0 110.415 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.505 ' CB ' HD11 ' A' ' 92' ' ' LEU . 47.3 Cg_endo -74.43 175.69 10.68 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.045 1.55 . . . . 0.0 110.154 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.988 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.4 m -115.06 136.28 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.145 -0.972 . . . . 0.0 110.396 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.741 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.67 107.9 18.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.172 -0.955 . . . . 0.0 110.17 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -163.14 138.54 6.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.201 179.88 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -43.25 -51.07 6.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 110.141 179.908 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -18.17 4.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -103.84 -43.42 5.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.006 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.588 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -62.72 -39.58 94.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 179.852 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.74 -13.53 44.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.036 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -105.46 -47.73 1.1 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 178.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.88 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -51.08 -24.09 3.64 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.897 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.73 -29.93 63.01 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.259 0.552 . . . . 0.0 110.674 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.519 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -88.73 16.25 7.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.273 -0.892 . . . . 0.0 110.504 -179.571 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 87.42 13.28 65.84 Favored Glycine 0 N--CA 1.482 1.712 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' CG ' ' OE1' ' A' ' 82' ' ' GLN . 11.3 mttm -82.45 146.33 29.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.183 -1.187 . . . . 0.0 109.505 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 1.131 ' CE2' HD12 ' A' ' 89' ' ' ILE . 28.7 m-85 -127.02 98.3 5.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.911 -1.118 . . . . 0.0 112.146 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.849 HG22 ' HD3' ' A' ' 78' ' ' LYS . 2.5 m -79.13 126.42 30.71 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 178.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.808 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 13.4 m-85 -126.58 164.93 20.13 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.28 -0.888 . . . . 0.0 111.618 -178.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.988 ' NE1' HG12 ' A' ' 12' ' ' VAL . 43.9 m95 -104.24 122.36 45.23 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 176.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 7' ' ' VAL . 1.2 p -144.28 157.6 15.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 117.708 -1.597 . . . . 0.0 112.259 -176.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -62.13 151.75 80.15 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.952 -179.109 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 46.8 Cg_endo -73.67 70.03 4.28 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.211 1.637 . . . . 0.0 109.848 179.471 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.54 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 109.911 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 1.006 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -44.75 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.639 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -43.22 138.93 2.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.92 . . . . 0.0 110.544 -179.243 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.543 ' CE ' ' HA ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -43.54 -38.08 2.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.701 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 5.6 m -70.59 -44.45 67.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.469 -0.769 . . . . 0.0 109.685 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.497 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 2.8 mm-40 -55.6 -41.16 73.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.562 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.815 ' O ' HD11 ' A' ' 8' ' ' ILE . 74.7 mt -57.4 -30.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.903 . . . . 0.0 108.633 179.038 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 37' ' ' THR . 17.7 tttm -64.96 -44.46 89.32 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.415 -0.803 . . . . 0.0 109.404 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.5 ' O ' ' HB ' ' A' ' 45' ' ' THR . 40.3 m-80 -73.17 -43.37 61.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.696 -0.627 . . . . 0.0 111.277 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.854 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.23 -51.32 70.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.603 -1.311 . . . . 0.0 110.261 -179.142 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.767 HG21 ' HE2' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -63.98 -47.22 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.056 -1.028 . . . . 0.0 109.968 179.981 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.481 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -57.0 -44.88 83.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.027 -1.046 . . . . 0.0 109.41 179.497 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.911 HG21 HG22 ' A' ' 3' ' ' THR . 0.3 OUTLIER -78.53 -12.58 60.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.4 -0.813 . . . . 0.0 109.446 179.309 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -97.3 -71.71 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.832 . . . . 0.0 110.236 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.812 ' CG ' HD13 ' A' ' 89' ' ' ILE . 43.3 m-85 -72.1 -22.12 61.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.192 -0.942 . . . . 0.0 110.198 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 68.78 44.2 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 110.006 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.67 HG22 ' H ' ' A' ' 50' ' ' LYS . 1.1 p -118.65 -160.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.541 -0.724 . . . . 0.0 110.383 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.67 ' H ' HG22 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -118.11 104.97 11.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.423 -0.798 . . . . 0.0 109.584 179.268 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.735 HG22 ' CG1' ' A' ' 81' ' ' VAL . 25.1 t -78.23 119.71 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.963 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.2 p -102.98 -8.94 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 110.227 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 4.9 ptmt -175.39 131.24 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.873 179.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.038 HG23 HG13 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -123.62 127.62 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.974 -1.078 . . . . 0.0 110.332 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.543 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 37.7 t30 -131.06 115.65 16.72 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.472 -0.767 . . . . 0.0 109.02 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.598 HG21 ' CD1' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -114.92 157.78 22.9 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 110.239 -179.379 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -145.94 171.37 14.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.786 . . . . 0.0 110.159 -179.67 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -85.26 128.47 34.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.192 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.538 HG21 ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -118.5 130.4 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.305 -0.872 . . . . 0.0 109.962 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 74' ' ' PRO . 7.9 mmt85 -115.42 128.78 56.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 110.277 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.77 154.29 0.92 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -82.63 -22.06 34.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -1.122 . . . . 0.0 110.11 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 64' ' ' LYS . 6.8 mttp -69.68 62.33 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' LYS . 2.9 ptpp? -44.2 169.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -56.34 -16.39 5.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 110.252 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 67' ' ' GLY . 29.7 tp 55.5 108.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.217 -0.927 . . . . 0.0 109.972 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' LEU . . . 45.34 -169.95 0.02 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.71 127.29 32.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -1.126 . . . . 0.0 109.812 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.572 ' CG ' ' N ' ' A' ' 70' ' ' LEU . 39.7 t80 -167.34 173.89 8.5 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.679 -0.638 . . . . 0.0 109.742 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 70' ' ' LEU . 1.4 pp -90.12 70.89 7.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.034 -1.041 . . . . 0.0 109.963 179.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 72' ' ' LYS . . . -163.79 -174.86 34.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER 170.1 -173.15 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.495 -1.003 . . . . 0.0 110.114 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -101.08 120.46 55.16 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.059 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 47.5 Cg_endo -72.42 -165.98 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.823 1.433 . . . . 0.0 110.386 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.88 89.27 3.06 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.44 -0.787 . . . . 0.0 109.383 179.293 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -95.1 147.28 23.6 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.647 -0.658 . . . . 0.0 109.897 179.842 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 20.4 tttt -123.08 127.5 48.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.744 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.849 ' HD3' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -101.81 151.01 22.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.285 179.378 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.808 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -127.16 129.34 47.7 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.974 -1.078 . . . . 0.0 111.91 -179.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.79 HD12 ' C ' ' A' ' 79' ' ' ALA . 1.5 mp -109.72 111.43 36.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.164 178.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.038 HG13 HG23 ' A' ' 54' ' ' VAL . 19.3 t -112.29 128.29 69.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.572 -0.705 . . . . 0.0 110.162 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.713 ' O ' HG12 ' A' ' 52' ' ' VAL . 2.5 tp60 -101.55 151.27 22.17 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.037 -1.039 . . . . 0.0 109.012 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 2.0 m -112.57 155.84 13.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 C-N-CA 118.082 -1.447 . . . . 0.0 108.443 177.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.713 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -58.01 169.98 0.8 Allowed Pre-proline 0 C--N 1.284 -2.244 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.646 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.615 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 45.4 Cg_endo -79.63 53.48 4.75 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 O-C-N 124.416 1.745 . . . . 0.0 110.733 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.475 ' N ' ' OE1' ' A' ' 87' ' ' GLN . . . -168.72 23.47 0.1 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.713 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -150.31 -175.53 5.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.941 -1.329 . . . . 0.0 110.268 -179.965 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER 179.88 113.25 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.455 -0.778 . . . . 0.0 109.998 179.865 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.131 HD12 ' CE2' ' A' ' 26' ' ' TYR . 16.8 mt -59.92 100.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.28 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -53.95 -27.99 34.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.72 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.2 73.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.414 -0.804 . . . . 0.0 110.22 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.88 HD22 ' CZ ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -107.67 1.23 22.98 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.977 -1.089 . . . . 0.0 112.079 -179.51 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -95.11 3.31 54.91 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 117.958 -1.497 . . . . 0.0 110.118 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -118.54 -17.78 5.09 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.486 ' HA ' HD12 ' A' ' 95' ' ' LEU . 0.7 OUTLIER -56.31 -33.75 65.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.366 -1.079 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.517 ' CG1' ' CE1' ' A' ' 18' ' ' TYR . 4.6 mt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.214 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.57 ' HG2' ' HB2' ' A' ' 6' ' ' ASP . 5.8 tpp . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.781 0.8 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -86.31 112.56 21.53 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.738 -0.601 . . . . 0.0 109.456 179.075 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.616 ' O ' ' N ' ' A' ' 5' ' ' TYR . 6.5 t -35.98 -33.46 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.959 ' O ' HG23 ' A' ' 7' ' ' VAL 0.29 . . -60.69 65.67 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 176.804 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.151 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.2 p90 30.68 46.38 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.683 1.23 . . . . 0.0 107.857 -176.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 2.8 p30 47.2 63.41 1.97 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.978 -1.465 . . . . 0.0 111.759 -178.131 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.151 HG21 ' CE2' ' A' ' 5' ' ' TYR . 9.2 t -128.07 -117.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.574 -0.703 . . . . 0.0 110.348 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.101 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.2 mt -63.08 156.42 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.224 -0.922 . . . . 0.0 110.032 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.557 HD12 ' H ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -144.61 -81.72 0.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.069 -1.019 . . . . 0.0 110.594 179.483 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.557 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -108.15 145.23 31.03 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.981 -1.074 . . . . 0.0 110.573 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 47.7 Cg_endo -74.53 169.8 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.037 1.546 . . . . 0.0 110.563 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.8 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.3 m -115.13 136.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.127 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.007 HD11 HD23 ' A' ' 95' ' ' LEU . 3.2 mm? -102.93 110.26 22.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.136 -0.978 . . . . 0.0 110.435 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -164.0 145.72 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.473 -0.767 . . . . 0.0 109.559 179.821 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 14' ' ' SER . 2.1 mm-40 -43.42 -33.48 1.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 109.986 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -28.23 66.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 110.024 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -91.96 19.36 6.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.296 -0.877 . . . . 0.0 109.807 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.584 ' CZ ' HG13 ' A' ' 96' ' ' ILE . 2.7 m-85 -138.49 -41.92 0.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.54 -0.725 . . . . 0.0 109.854 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.12 79.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.177 -0.952 . . . . 0.0 108.883 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.85 -31.1 7.93 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 178.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -72.31 -10.83 60.29 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.522 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -66.84 -8.39 28.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.655 -0.653 . . . . 0.0 110.216 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -1.98 19.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 110.385 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.588 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 119.48 4.09 12.23 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HB3' ' CG2' ' A' ' 80' ' ' ILE . 27.4 mttt -84.35 132.71 34.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -1.152 . . . . 0.0 109.772 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.859 ' CD2' HD12 ' A' ' 89' ' ' ILE . 62.7 m-85 -126.94 111.15 13.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.719 -1.238 . . . . 0.0 111.79 -179.328 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.728 HG22 ' HB2' ' A' ' 78' ' ' LYS . 7.5 m -79.27 128.95 33.95 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.458 0.647 . . . . 0.0 109.932 179.09 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.695 ' CE1' ' CZ ' ' A' ' 47' ' ' PHE . 19.0 m-85 -124.76 164.73 19.35 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.519 -0.738 . . . . 0.0 109.879 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.8 ' NE1' HG12 ' A' ' 12' ' ' VAL . 4.4 m95 -95.14 122.86 38.25 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.536 HG23 ' N ' ' A' ' 8' ' ' ILE . 8.1 p -137.1 165.01 28.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.844 -177.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.498 ' CE1' ' HE3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.45 145.31 91.15 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.908 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.39 70.68 2.49 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.1 1.579 . . . . 0.0 109.934 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 178.83 -32.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.413 -0.805 . . . . 0.0 110.12 -178.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -56.27 96.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.463 -0.773 . . . . 0.0 110.379 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.439 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 1.3 p -46.17 159.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 109.962 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.773 ' O ' HG11 ' A' ' 54' ' ' VAL . 11.0 mttp -47.71 -40.22 19.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.289 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.9 m -75.28 -38.97 60.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.591 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.439 ' HG3' ' OG1' ' A' ' 35' ' ' THR . 2.4 mt-10 -55.6 -43.88 76.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.038 -1.039 . . . . 0.0 109.944 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.776 ' O ' HD11 ' A' ' 8' ' ' ILE . 13.0 mt -57.5 -30.24 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.774 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.916 ' HG3' HG11 ' A' ' 51' ' ' VAL . 39.8 tttm -57.6 -41.99 82.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 111.537 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.489 ' HB2' ' OH ' ' A' ' 5' ' ' TYR . 6.6 m-80 -58.29 -49.53 76.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.465 -0.772 . . . . 0.0 112.397 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.101 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -73.49 -39.18 65.06 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.711 -1.243 . . . . 0.0 111.631 -178.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.843 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -62.41 -45.54 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.898 -1.126 . . . . 0.0 110.401 -179.343 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.477 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -56.41 -38.75 71.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.012 . . . . 0.0 109.846 -179.818 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 41' ' ' ASN . 43.0 p -79.38 -45.43 19.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 109.975 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.64 -60.58 2.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 110.497 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.843 ' CD2' HG22 ' A' ' 43' ' ' VAL . 44.4 m-85 -71.65 -21.52 61.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.957 . . . . 0.0 110.158 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 56.32 40.75 29.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 110.295 179.734 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.77 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -120.99 -165.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.519 -0.738 . . . . 0.0 109.896 179.708 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.77 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -106.66 112.17 25.04 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.23 178.812 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.916 HG11 ' HG3' ' A' ' 40' ' ' LYS . 19.6 t -77.59 135.68 25.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.482 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.765 HG21 ' N ' ' A' ' 84' ' ' ALA . 2.5 t -128.57 -5.87 3.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.48 -0.763 . . . . 0.0 110.573 -178.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.537 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER 170.45 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.424 -0.797 . . . . 0.0 109.118 179.498 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.863 HG22 HG22 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -115.47 133.04 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.332 -0.855 . . . . 0.0 110.564 -179.26 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.557 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -131.58 116.09 16.95 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.437 -0.79 . . . . 0.0 109.372 178.515 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -116.6 149.46 39.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 110.436 -179.295 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.531 HD12 ' HG3' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -130.11 143.38 50.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.477 -0.765 . . . . 0.0 109.521 179.884 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.445 ' CD2' ' HE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -71.21 112.58 7.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.018 -1.051 . . . . 0.0 110.054 179.874 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -113.33 126.28 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.285 -0.884 . . . . 0.0 110.089 -179.778 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.562 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -125.15 155.7 39.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.074 -1.016 . . . . 0.0 110.284 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -43.2 119.08 2.2 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -98.08 -21.87 16.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.275 -1.133 . . . . 0.0 110.202 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 6.3 ptmt -62.74 134.67 56.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 110.113 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 67.14 79.67 0.23 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 0.0 110.151 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' ' 66' ' ' LEU . 2.2 ttp-105 -144.89 -36.44 0.31 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.384 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 65' ' ' ARG . 1.1 mm? -38.9 144.22 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.516 -0.74 . . . . 0.0 110.718 -179.689 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 68' ' ' ARG . . . 71.34 -179.56 32.54 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -48.26 178.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -1.068 . . . . 0.0 110.486 -179.799 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.47 ' O ' HD12 ' A' ' 70' ' ' LEU . 30.5 t80 -47.74 132.59 14.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 110.362 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -158.43 40.81 0.25 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 110.028 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 72' ' ' LYS . . . -177.59 -118.27 0.54 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 71' ' ' GLY . 24.6 mttt -160.69 161.04 32.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -1.121 . . . . 0.0 110.235 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -152.09 81.92 5.53 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.897 . . . . 0.0 110.212 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.35 -164.59 0.23 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.059 1.557 . . . . 0.0 110.499 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -114.44 89.67 3.15 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.767 0.794 . . . . 0.0 109.134 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.637 ' NE ' ' CH2' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -122.46 122.02 37.98 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.693 -0.629 . . . . 0.0 109.859 -179.892 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.51 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 6.5 ptmt -123.3 141.79 51.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.437 -179.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.728 ' HB2' HG22 ' A' ' 27' ' ' THR . 1.7 ptpt -101.0 151.14 22.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.361 -0.837 . . . . 0.0 109.626 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -115.61 118.77 34.03 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.019 -1.051 . . . . 0.0 111.992 -179.109 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 12.1 mt -94.94 110.96 24.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.528 -0.732 . . . . 0.0 109.585 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.863 HG22 HG22 ' A' ' 54' ' ' VAL . 6.4 t -102.09 143.22 15.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.09 -1.006 . . . . 0.0 110.458 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.537 ' CB ' ' HG2' ' A' ' 53' ' ' LYS . 29.6 tp60 -116.44 150.58 37.6 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.298 -0.876 . . . . 0.0 109.098 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.511 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 2.5 m -124.91 155.75 33.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 118.324 -1.351 . . . . 0.0 109.973 178.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.939 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -47.76 178.34 0.03 OUTLIER Pre-proline 0 C--N 1.291 -1.969 0 O-C-N 121.839 -0.538 . . . . 0.0 110.73 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.939 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.7 Cg_endo -74.23 142.78 30.95 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 124.386 1.73 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.65 -40.98 2.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.521 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 6.6 mt-30 -70.18 176.88 3.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -1.199 . . . . 0.0 110.387 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 178.42 102.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.18 -179.192 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.859 HD12 ' CD2' ' A' ' 26' ' ' TYR . 8.3 mt -55.99 87.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.914 -1.116 . . . . 0.0 109.597 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 88' ' ' LYS . 11.1 pt-20 -57.99 -13.22 4.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.429 -0.795 . . . . 0.0 110.946 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.757 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.27 -33.53 58.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.108 -0.995 . . . . 0.0 110.777 -179.16 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.757 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.24 -23.04 12.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.927 -1.108 . . . . 0.0 109.929 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.2 mm-40 -52.9 -33.83 52.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.436 -0.79 . . . . 0.0 110.413 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.67 6.06 58.72 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.007 HD23 HD11 ' A' ' 13' ' ' LEU . 1.3 tp -76.02 -25.43 55.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -1.17 . . . . 0.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.584 HG13 ' CZ ' ' A' ' 18' ' ' TYR . 8.2 mt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.158 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' HG3' ' HE3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.794 0.806 . . . . 0.0 110.564 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.888 ' CD ' HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -76.24 108.72 9.37 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.59 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.554 ' C ' ' O ' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -30.13 -37.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.408 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.024 ' O ' HG23 ' A' ' 7' ' ' VAL 0.291 . . -63.78 68.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.348 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.121 ' CE2' HG21 ' A' ' 7' ' ' VAL . 0.6 OUTLIER 29.61 38.06 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 122.311 1.053 . . . . 0.0 108.857 -176.886 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 4' ' ' ALA . 2.2 t0 64.92 55.33 1.19 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.976 -179.389 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.121 HG21 ' CE2' ' A' ' 5' ' ' TYR . 5.4 t -127.96 -120.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.898 -1.126 . . . . 0.0 110.31 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.973 HD12 ' HB3' ' A' ' 42' ' ' ALA . 4.8 mt -56.02 148.0 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.888 HD21 ' CD ' ' A' ' 2' ' ' LYS . 0.6 OUTLIER -119.02 -100.36 0.44 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 110.663 -179.572 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.38 161.66 23.13 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.042 -1.037 . . . . 0.0 110.718 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HG3' HD22 ' A' ' 92' ' ' LEU . 49.8 Cg_endo -76.6 157.99 35.99 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.126 1.593 . . . . 0.0 110.308 179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.017 HG12 ' NE1' ' A' ' 29' ' ' TRP . 2.4 m -100.03 140.0 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.0 110.272 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.759 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.64 113.17 26.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.95 . . . . 0.0 110.19 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 52.7 m -167.01 135.13 2.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 14' ' ' SER . 1.3 mm-40 -42.86 -47.45 5.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.92 . . . . 0.0 110.038 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -54.79 -35.92 64.36 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 19' ' ' ALA . . . -79.91 -63.71 1.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 0.0 110.183 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.854 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 1.3 m-85 -42.87 -26.25 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 110.406 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -88.42 -35.32 17.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.691 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . -83.23 -38.34 11.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 178.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -75.69 -15.06 60.35 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.728 -0.866 . . . . 0.0 108.882 178.871 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -63.97 -17.15 62.99 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.485 0.66 . . . . 0.0 109.916 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.18 -2.76 52.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.412 -0.805 . . . . 0.0 110.203 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 117.78 0.77 17.56 Favored Glycine 0 N--CA 1.478 1.5 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 73.2 mttt -81.96 140.33 34.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -1.108 . . . . 0.0 109.617 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 64.4 m-85 -127.85 104.85 8.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.572 -1.33 . . . . 0.0 111.982 -178.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.002 HG23 HD11 ' A' ' 80' ' ' ILE . 1.9 m -79.44 140.15 37.45 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.43 0.634 . . . . 0.0 109.291 178.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.859 ' HB3' HG23 ' A' ' 8' ' ' ILE . 17.0 m-85 -140.24 165.18 28.08 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 110.404 -179.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 1.017 ' NE1' HG12 ' A' ' 12' ' ' VAL . 96.3 m95 -105.12 121.8 44.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 176.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 7' ' ' VAL . 4.9 p -144.03 165.46 13.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.778 -176.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.483 ' CD2' ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -59.62 149.6 70.34 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.75 -179.369 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.483 ' HD2' ' CD2' ' A' ' 31' ' ' HIS . 47.1 Cg_endo -73.65 71.66 3.92 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.208 1.636 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.487 ' CE ' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 179.08 -34.05 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.356 -0.84 . . . . 0.0 110.156 -179.095 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' N ' ' CE ' ' A' ' 33' ' ' LYS . . . -47.65 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.364 -0.835 . . . . 0.0 110.212 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -43.34 167.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.545 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.2 mtpt -64.13 -58.06 7.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.925 . . . . 0.0 110.349 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.495 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.5 m -58.74 -39.29 80.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.951 . . . . 0.0 110.177 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.467 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 6.4 mt-10 -55.89 -45.98 78.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 0.0 109.651 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.711 ' O ' HD11 ' A' ' 8' ' ' ILE . 17.7 mt -57.13 -30.13 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.493 -0.755 . . . . 0.0 110.015 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.552 ' HG3' ' CG1' ' A' ' 51' ' ' VAL . 3.0 ttmm -57.77 -47.51 82.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.414 -0.804 . . . . 0.0 111.799 -179.283 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -58.7 -45.95 88.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 112.63 -177.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.973 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -58.75 -48.45 81.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.768 -1.207 . . . . 0.0 111.893 -178.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.959 HG13 HD13 ' A' ' 8' ' ' ILE . 19.1 m -74.47 -28.89 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.424 -1.422 . . . . 0.0 110.467 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -52.61 64.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.836 -1.165 . . . . 0.0 109.219 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.2 p -80.25 -45.42 17.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.853 179.011 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -58.44 -65.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.419 -0.801 . . . . 0.0 110.57 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.663 ' HE1' HD21 ' A' ' 92' ' ' LEU . 31.8 m-85 -71.48 -19.07 62.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.996 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER 68.08 46.31 1.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 110.517 179.643 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.753 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -134.01 -165.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.437 -0.789 . . . . 0.0 110.259 179.907 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.753 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -118.74 111.18 18.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.545 -0.722 . . . . 0.0 109.881 179.274 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.898 HG13 ' CG1' ' A' ' 81' ' ' VAL . 89.4 t -78.77 136.32 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 110.134 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.673 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.7 p -118.25 -7.3 11.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.277 -0.889 . . . . 0.0 110.164 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -176.67 131.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.819 179.41 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.087 HG23 HG13 ' A' ' 81' ' ' VAL . 1.2 t -123.68 119.64 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.999 -1.063 . . . . 0.0 110.258 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.488 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 1.6 t-20 -116.74 115.91 26.51 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.218 178.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -109.55 145.44 36.33 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.57 -179.611 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.58 160.45 28.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.275 -0.891 . . . . 0.0 110.903 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.429 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 3.3 t-160 -72.98 115.12 11.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.25 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.745 HG11 ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -106.08 139.46 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -0.895 . . . . 0.0 110.229 -179.279 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.605 ' N ' ' CD ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -138.64 134.49 33.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.176 -0.953 . . . . 0.0 110.277 -179.279 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.475 ' HA3' ' HG3' ' A' ' 73' ' ' ARG . . . -54.95 -171.14 0.07 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -42.59 165.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -1.124 . . . . 0.0 110.304 -179.982 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -77.18 -142.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 0.0 110.2 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? 51.33 87.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.257 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 67' ' ' GLY . 11.5 tpp180 -88.32 -7.63 56.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.256 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' ARG . 2.6 mp -42.0 93.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 110.371 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 65' ' ' ARG . . . -67.16 58.44 0.25 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -117.11 15.57 15.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.12 -1.223 . . . . 0.0 109.393 179.902 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 8.6 t80 -155.66 53.17 0.59 Allowed 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.137 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER 40.98 41.3 1.21 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.847 0.832 . . . . 0.0 110.283 179.955 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 72' ' ' LYS . . . -105.79 -111.1 3.56 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER 63.13 70.95 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.281 -1.129 . . . . 0.0 110.228 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.475 ' HG3' ' HA3' ' A' ' 61' ' ' GLY . 2.1 mpt_? -45.7 137.99 5.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 110.146 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.73 -167.24 0.36 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.991 1.522 . . . . 0.0 110.413 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.61 89.47 3.11 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.469 -0.769 . . . . 0.0 109.472 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.587 ' CG ' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -94.91 152.55 18.27 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.577 -0.702 . . . . 0.0 109.908 179.603 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HA ' HG23 ' A' ' 59' ' ' VAL . 13.2 tttt -121.15 137.99 54.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.068 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.69 ' HD3' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -105.44 150.67 25.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 110.001 -179.901 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.785 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -128.88 128.64 44.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.091 -1.006 . . . . 0.0 112.347 -179.212 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.002 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -108.69 111.88 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.087 HG13 HG23 ' A' ' 54' ' ' VAL . 5.0 t -108.37 137.46 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 111.234 -178.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.673 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.4 tp60 -111.17 154.08 24.86 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.265 -0.897 . . . . 0.0 108.742 178.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 87' ' ' GLN . 2.9 m -116.45 155.82 17.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 C-N-CA 118.257 -1.377 . . . . 0.0 108.643 177.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.966 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -56.19 -179.6 0.09 OUTLIER Pre-proline 0 C--N 1.284 -2.244 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.032 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.966 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.3 Cg_endo -71.68 140.4 35.73 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 124.103 1.581 . . . . 0.0 110.387 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.05 -23.34 29.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.534 ' HB2' HG23 ' A' ' 83' ' ' VAL . 35.7 mt-30 -87.1 167.93 13.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.259 -1.142 . . . . 0.0 110.641 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HD3' ' OH ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER 179.45 115.49 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.332 -0.855 . . . . 0.0 110.653 179.89 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.629 ' CG2' ' CD1' ' A' ' 47' ' ' PHE . 9.2 mt -78.05 75.53 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.548 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.71 -13.09 1.49 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.508 -0.745 . . . . 0.0 111.479 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.748 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -53.59 -20.6 5.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.933 -1.105 . . . . 0.0 110.629 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.748 HD23 ' C ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -106.47 -23.21 12.56 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.001 -1.062 . . . . 0.0 109.609 179.506 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -54.61 -35.71 63.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 110.373 -179.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.11 -4.9 71.1 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.497 ' HA ' HD12 ' A' ' 95' ' ' LEU . 3.0 tp -69.24 -5.47 23.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.091 -1.24 . . . . 0.0 110.194 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.614 ' CG1' ' CZ ' ' A' ' 18' ' ' TYR . 20.3 mt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.21 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HB2' ' A' ' 6' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.756 0.312 . . . . 0.0 110.609 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.611 ' O ' ' N ' ' A' ' 4' ' ' ALA . 4.8 mttp -44.86 98.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.165 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.615 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.3 m 4.37 -70.93 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.668 0 CA-C-O 121.102 0.477 . . . . 0.0 111.099 -178.448 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.801 ' HB1' ' HB1' ' A' ' 42' ' ' ALA 0.259 . . -56.76 79.04 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.484 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.868 ' CE1' ' HB2' ' A' ' 42' ' ' ALA . 0.6 OUTLIER 25.38 48.32 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.923 0.868 . . . . 0.0 110.192 -178.019 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.608 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 6.7 t0 64.85 54.42 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.111 0.958 . . . . 0.0 111.288 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 4' ' ' ALA . 11.3 t -137.45 -110.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.351 -0.843 . . . . 0.0 109.778 179.006 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.973 HD12 ' HB3' ' A' ' 42' ' ' ALA . 6.8 mt -74.07 158.13 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.991 -1.068 . . . . 0.0 110.151 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.598 HD21 ' CA ' ' A' ' 2' ' ' LYS . 34.1 mt -140.71 -99.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 110.251 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.68 155.96 39.69 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 110.346 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.957 ' HG3' HD22 ' A' ' 92' ' ' LEU . 46.0 Cg_endo -73.71 153.76 48.83 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.978 1.514 . . . . 0.0 110.255 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.941 HG12 ' CE2' ' A' ' 29' ' ' TRP . 2.3 m -92.14 141.12 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.271 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.766 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.2 mm? -102.83 107.5 18.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.932 . . . . 0.0 110.204 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 15' ' ' GLU . 22.3 m -161.54 143.06 11.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.104 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' SER . 9.8 tm-20 -43.19 -51.31 6.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.004 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.74 -42.67 71.87 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.23 -0.919 . . . . 0.0 110.218 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 18' ' ' TYR . . . -70.83 -65.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.703 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.6 m-85 -42.55 -27.62 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 110.317 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -90.38 -34.85 15.5 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.24 -0.913 . . . . 0.0 109.562 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . -78.58 -44.98 9.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.158 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.629 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.04 -22.36 64.96 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.56 -0.964 . . . . 0.0 108.734 178.936 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -52.6 -19.37 2.28 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.333 0.587 . . . . 0.0 110.661 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 1.6 tt0 -95.06 15.08 19.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.868 . . . . 0.0 110.498 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 82' ' ' GLN . . . 97.61 1.01 59.04 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HD2' HG21 ' A' ' 80' ' ' ILE . 2.8 mttp -82.5 143.37 31.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -1.089 . . . . 0.0 109.552 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 1.079 ' CD2' HD12 ' A' ' 89' ' ' ILE . 23.1 m-85 -127.81 103.87 7.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.761 -1.212 . . . . 0.0 111.918 -179.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.058 HG23 HD11 ' A' ' 80' ' ' ILE . 1.9 m -75.62 141.28 42.88 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.785 ' CB ' HG23 ' A' ' 8' ' ' ILE . 18.4 m-85 -138.0 165.24 27.05 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.353 -0.842 . . . . 0.0 110.48 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.941 ' CE2' HG12 ' A' ' 12' ' ' VAL . 22.4 m95 -101.68 120.79 40.89 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.287 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.785 HG13 ' HE2' ' A' ' 77' ' ' LYS . 1.9 p -152.57 165.31 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 C-N-CA 118.481 -1.288 . . . . 0.0 111.522 -176.693 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.566 ' CG ' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -70.9 172.55 6.2 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.713 -0.617 . . . . 0.0 110.683 -179.51 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 31' ' ' HIS . 45.9 Cg_endo -75.35 -59.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.241 1.653 . . . . 0.0 110.413 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -38.46 -26.0 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.552 179.283 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.725 ' HB3' ' NZ ' ' A' ' 77' ' ' LYS . . . -62.95 90.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.82 -1.175 . . . . 0.0 110.051 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -49.49 162.66 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 -179.84 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -57.47 -56.22 24.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.86 . . . . 0.0 110.117 -179.964 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.6 m -60.49 -34.77 74.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.307 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -55.79 -42.65 75.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 109.642 179.776 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.775 ' O ' HD11 ' A' ' 8' ' ' ILE . 9.0 mt -57.65 -30.96 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.145 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HG3' HG11 ' A' ' 51' ' ' VAL . 13.3 tttp -62.22 -46.25 89.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 110.52 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -59.12 -49.12 79.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.477 -0.764 . . . . 0.0 112.003 -178.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.973 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -66.12 -47.65 73.43 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.849 -1.157 . . . . 0.0 111.417 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.907 HG22 ' CD2' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -63.7 -39.54 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.864 -1.147 . . . . 0.0 110.395 -179.325 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -56.24 -47.33 78.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.0 -1.063 . . . . 0.0 109.609 179.939 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.3 p -79.42 -45.07 20.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.357 -0.839 . . . . 0.0 109.883 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.12 -69.61 0.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.418 -0.801 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.907 ' CD2' HG22 ' A' ' 43' ' ' VAL . 77.5 m-85 -71.63 -21.81 61.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.132 -0.98 . . . . 0.0 110.219 -179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 9.2 mttt 65.2 40.08 5.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.744 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -117.88 -162.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.485 0.659 . . . . 0.0 110.313 -179.896 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.744 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -118.2 104.52 10.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.522 -0.736 . . . . 0.0 109.486 178.946 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.817 HG22 HG11 ' A' ' 81' ' ' VAL . 27.0 t -78.81 119.8 28.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.694 -179.223 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.652 HG12 ' C ' ' A' ' 82' ' ' GLN . 8.5 p -103.17 -0.57 10.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.295 -0.878 . . . . 0.0 109.812 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.571 ' CG ' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 179.97 146.87 0.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 179.385 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.924 HG22 HG22 ' A' ' 81' ' ' VAL . 1.2 t -133.37 122.25 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.516 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -121.99 115.8 23.17 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 109.086 178.639 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.641 ' C ' HD23 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -120.67 140.84 51.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 110.305 -179.481 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.677 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -148.55 149.93 32.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.634 -0.667 . . . . 0.0 109.345 -179.847 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.616 ' HA ' ' O ' ' A' ' 76' ' ' ARG . 1.7 m80 -86.34 143.51 27.82 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.151 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.733 HG23 ' NE ' ' A' ' 60' ' ' ARG . 15.9 m -100.88 139.18 22.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.529 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.733 ' NE ' HG23 ' A' ' 59' ' ' VAL . 10.7 mtm180 66.18 -166.05 0.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.918 -1.114 . . . . 0.0 110.111 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 44.51 96.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 179.409 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.03 -58.87 1.84 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -1.148 . . . . 0.0 110.098 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 tttm -155.34 140.23 17.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.148 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.4 mttt 57.6 25.21 11.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.511 ' HD3' ' HB3' ' A' ' 72' ' ' LYS . 5.1 mtt180 -101.82 -48.89 4.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.276 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 1.9 mp 63.61 -167.57 0.21 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.422 -0.799 . . . . 0.0 109.611 -179.202 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.73 44.83 0.32 Allowed Glycine 0 N--CA 1.481 1.699 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.56 20.64 5.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.366 1.079 . . . . 0.0 109.076 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.599 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 31.0 t80 -156.9 173.09 17.53 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.965 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.581 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 3.7 mm? -85.93 43.99 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.158 -0.964 . . . . 0.0 110.347 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.599 ' N ' ' CD2' ' A' ' 69' ' ' TYR . . . -100.43 -121.97 4.82 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.511 ' HB3' ' HD3' ' A' ' 65' ' ' ARG . 1.5 mmpt? -70.78 -174.24 0.89 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -1.151 . . . . 0.0 110.149 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.544 ' CB ' ' HB3' ' A' ' 60' ' ' ARG . 0.5 OUTLIER -93.1 154.6 41.63 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.921 . . . . 0.0 110.417 -179.882 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.407 ' HG2' ' NH2' ' A' ' 60' ' ' ARG . 49.2 Cg_endo -73.14 -164.21 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.216 1.64 . . . . 0.0 110.848 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.515 ' OD1' ' CB ' ' A' ' 58' ' ' HIS . 2.6 t0 -114.63 90.54 3.37 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.482 -0.761 . . . . 0.0 109.319 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -93.32 128.67 39.44 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.642 -0.661 . . . . 0.0 109.339 179.856 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.785 ' HE2' HG13 ' A' ' 30' ' ' VAL . 3.4 ttpt -96.29 128.99 43.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 111.077 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 28.7 pttt -119.54 151.3 38.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.413 -0.804 . . . . 0.0 109.348 179.147 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.761 ' C ' HD12 ' A' ' 80' ' ' ILE . . . -118.06 128.77 55.08 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.89 -1.131 . . . . 0.0 113.03 -178.356 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.058 HD11 HG23 ' A' ' 27' ' ' THR . 1.7 mp -107.58 111.24 34.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.924 HG22 HG22 ' A' ' 54' ' ' VAL . 23.4 t -107.37 139.0 30.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 111.005 -178.703 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.652 ' C ' HG12 ' A' ' 52' ' ' VAL . 1.6 tp60 -105.59 153.32 21.95 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.341 -0.849 . . . . 0.0 108.789 179.008 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.53 HG11 ' HE2' ' A' ' 26' ' ' TYR . 1.5 m -119.16 156.52 21.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 C-N-CA 118.171 -1.412 . . . . 0.0 109.327 178.343 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -64.46 177.03 0.61 Allowed Pre-proline 0 C--N 1.287 -2.138 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.223 -179.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.5 Cg_endo -74.81 138.4 23.46 Favored 'Trans proline' 0 C--N 1.298 -2.093 0 O-C-N 124.296 1.682 . . . . 0.0 110.19 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.68 -31.88 7.0 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.531 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -108.45 174.09 6.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.037 -1.272 . . . . 0.0 110.669 -179.917 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 178.99 130.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.487 -0.758 . . . . 0.0 110.081 179.827 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.079 HD12 ' CD2' ' A' ' 26' ' ' TYR . 40.1 mt -83.74 82.5 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 0.0 110.118 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -13.83 10.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.522 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.766 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.09 -19.6 7.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 0.0 110.525 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.957 HD22 ' HG3' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -106.21 -23.07 12.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.086 -1.009 . . . . 0.0 109.674 179.834 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -58.87 -54.74 43.75 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.426 -0.796 . . . . 0.0 110.442 -179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -73.9 -21.9 78.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.688 HD23 HD11 ' A' ' 13' ' ' LEU . 6.8 tp -42.71 -27.15 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -1.145 . . . . 0.0 110.363 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.516 HG13 ' CE1' ' A' ' 18' ' ' TYR . 40.0 mt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.549 ' HB3' ' CB ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.197 0.522 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.7 ' HD2' HD22 ' A' ' 9' ' ' LEU . 10.8 mmpt? -71.17 119.15 14.89 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.258 -0.901 . . . . 0.0 110.473 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.596 ' O ' ' N ' ' A' ' 5' ' ' TYR . 6.1 t -37.33 -32.67 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.94 ' O ' HG23 ' A' ' 7' ' ' VAL 0.273 . . -63.01 64.31 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.66 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.14 ' CE2' HG21 ' A' ' 7' ' ' VAL . 0.5 OUTLIER 32.96 36.16 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 122.667 1.222 . . . . 0.0 108.293 -176.582 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 13.4 t0 61.88 59.78 1.67 Allowed 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.072 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.14 HG21 ' CE2' ' A' ' 5' ' ' TYR . 15.5 t -128.57 -113.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -0.827 . . . . 0.0 111.505 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.059 HD12 ' HB3' ' A' ' 42' ' ' ALA . 3.3 mt -69.57 157.62 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 110.83 -178.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.7 HD22 ' HD2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -152.13 -93.23 0.05 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 110.723 179.836 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -91.81 141.63 25.75 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.088 -1.008 . . . . 0.0 110.909 -179.455 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 50.2 Cg_endo -77.16 173.49 14.3 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.207 1.635 . . . . 0.0 110.821 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.978 HG12 ' NE1' ' A' ' 29' ' ' TRP . 1.2 m -115.21 127.4 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.339 -0.85 . . . . 0.0 110.032 179.841 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.802 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 3.0 mm? -103.08 113.27 26.62 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 110.351 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.7 m -158.15 161.54 37.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.133 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -58.03 -55.26 37.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -54.66 -21.61 11.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.45 -52.03 3.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.802 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -49.5 -34.99 18.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.925 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.41 -8.63 50.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.38 -42.8 1.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -66.31 -17.05 64.53 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.56 -0.964 . . . . 0.0 108.91 178.879 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.72 -20.13 46.15 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.747 -0.596 . . . . 0.0 110.658 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.468 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 3.2 tt0 -88.54 17.71 5.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.458 -0.776 . . . . 0.0 110.123 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.09 4.12 69.26 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -178.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 48.2 mttm -82.76 134.96 35.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.591 -0.947 . . . . 0.0 109.445 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 1.032 ' CD2' HD12 ' A' ' 89' ' ' ILE . 24.6 m-85 -128.21 98.03 4.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.562 -1.336 . . . . 0.0 111.537 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.4 m -75.02 132.89 41.66 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.638 -0.664 . . . . 0.0 109.915 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.67 ' CB ' HG23 ' A' ' 8' ' ' ILE . 34.8 m-85 -126.72 163.72 22.9 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.244 -179.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.978 ' NE1' HG12 ' A' ' 12' ' ' VAL . 95.8 m95 -95.11 122.61 37.96 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.117 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.628 HG23 ' C ' ' A' ' 7' ' ' VAL . 2.7 p -149.02 164.38 4.23 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 C-N-CA 117.649 -1.62 . . . . 0.0 112.224 -176.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.453 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -56.75 140.78 75.09 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.281 -179.905 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HA ' ' CD ' ' A' ' 77' ' ' LYS . 48.9 Cg_endo -74.83 80.02 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.199 1.631 . . . . 0.0 110.262 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 178.47 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 110.112 -179.133 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -54.36 97.03 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.406 -0.809 . . . . 0.0 110.282 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.475 ' OG1' ' CG ' ' A' ' 38' ' ' GLU . 2.2 p -42.82 149.52 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 110.168 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.631 ' O ' HG11 ' A' ' 54' ' ' VAL . 5.7 mmtp -42.61 -40.72 2.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.183 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 3.5 m -75.12 -39.07 60.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.31 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.475 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 7.8 mt-10 -55.68 -44.25 77.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 109.808 179.825 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.685 ' O ' HD11 ' A' ' 8' ' ' ILE . 14.5 mt -57.24 -30.32 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.618 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.672 ' HG3' HG11 ' A' ' 51' ' ' VAL . 24.2 tttt -57.82 -42.98 85.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 0.0 111.258 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.423 ' HB2' ' OH ' ' A' ' 5' ' ' TYR . 42.6 m-80 -58.19 -49.11 78.2 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.404 -0.81 . . . . 0.0 112.428 -178.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.059 ' HB3' HD12 ' A' ' 8' ' ' ILE . . . -68.47 -47.98 65.71 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.711 -1.243 . . . . 0.0 111.759 -178.357 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.034 HG11 HG11 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -59.78 -47.09 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.908 -1.12 . . . . 0.0 110.013 -179.431 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.503 ' N ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -56.82 -43.38 80.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.095 -1.003 . . . . 0.0 109.831 179.897 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -79.14 -27.39 42.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 109.97 179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.42 -61.64 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.074 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.842 ' CD2' HG22 ' A' ' 43' ' ' VAL . 52.1 m-85 -71.8 -20.88 61.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.961 179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 62.86 39.92 10.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.458 -0.776 . . . . 0.0 110.104 179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.771 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -119.32 -164.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.807 179.705 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.771 ' N ' HG13 ' A' ' 49' ' ' VAL . 5.4 tmtm? -113.42 106.6 14.78 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.443 -0.786 . . . . 0.0 109.364 179.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.799 HG22 ' CG1' ' A' ' 81' ' ' VAL . 44.7 t -78.22 130.72 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 110.145 -179.397 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.665 HG12 ' C ' ' A' ' 82' ' ' GLN . 13.3 p -114.96 -9.77 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.409 -0.807 . . . . 0.0 110.271 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.615 ' HG2' ' CB ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER 176.75 129.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 109.932 179.696 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.1 ' CG2' HG22 ' A' ' 81' ' ' VAL . 0.6 OUTLIER -109.15 141.56 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.104 179.847 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.56 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 1.6 m-20 -130.04 115.52 17.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.285 -0.884 . . . . 0.0 109.561 178.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -108.85 159.82 16.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.916 -179.459 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.903 HD11 ' HE3' ' A' ' 78' ' ' LYS . 1.8 pp -148.47 177.88 9.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.211 -0.931 . . . . 0.0 110.853 -179.37 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.83 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -74.95 134.53 41.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.967 179.642 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -120.7 122.12 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.902 . . . . 0.0 109.358 179.677 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.508 ' O ' ' NH2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -37.68 105.31 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.433 0.635 . . . . 0.0 110.81 -179.141 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.527 ' HA3' ' NE ' ' A' ' 76' ' ' ARG . . . 150.4 108.56 0.44 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 74' ' ' PRO . 16.9 pttt -118.94 -162.44 0.9 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -1.11 . . . . 0.0 110.201 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -72.74 -160.84 0.08 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt 61.08 62.62 1.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 66' ' ' LEU . 17.8 ptt180 -111.35 -6.52 14.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.877 . . . . 0.0 110.348 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 68' ' ' ARG . 6.0 mp -42.08 114.28 0.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 110.111 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.77 57.1 0.21 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.537 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 66' ' ' LEU . 9.6 ptt85 -140.14 23.65 2.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.25 . . . . 0.0 110.08 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.559 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 57.4 t80 -161.69 52.3 0.24 Allowed 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.039 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER 41.36 39.18 0.95 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -0.841 . . . . 0.0 110.156 -179.905 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 72' ' ' LYS . . . -125.06 165.64 18.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 71' ' ' GLY . 10.4 ptpt 179.33 58.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -1.159 . . . . 0.0 110.331 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -144.18 115.1 5.41 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.241 179.905 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 61' ' ' GLY . 51.5 Cg_endo -80.67 -164.85 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.014 1.534 . . . . 0.0 110.591 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 1.9 t70 -114.66 90.34 3.32 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.446 -0.784 . . . . 0.0 108.886 179.241 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -96.03 153.72 17.63 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.603 -0.686 . . . . 0.0 110.266 -179.604 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.562 ' CD ' ' HA ' ' A' ' 32' ' ' PRO . 6.3 tttp -123.78 142.2 51.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.903 ' HE3' HD11 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -100.59 138.39 37.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.073 . . . . 0.0 109.792 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -133.22 119.36 19.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.097 -1.002 . . . . 0.0 111.836 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.626 HG12 HG23 ' A' ' 27' ' ' THR . 16.7 mt -99.9 109.91 25.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.857 178.327 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.1 HG22 ' CG2' ' A' ' 54' ' ' VAL . 52.8 t -96.73 129.46 46.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 110.02 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.665 ' C ' HG12 ' A' ' 52' ' ' VAL . 2.5 tp60 -98.86 153.2 18.97 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.013 179.358 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 50' ' ' LYS . 1.5 m -119.66 156.6 22.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 C-N-CA 118.327 -1.349 . . . . 0.0 108.632 177.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.907 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -69.84 179.29 0.81 Allowed Pre-proline 0 C--N 1.283 -2.309 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.133 -179.71 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.907 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 43.3 Cg_endo -73.06 140.76 31.76 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 124.263 1.665 . . . . 0.0 110.432 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.45 -37.1 3.95 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.887 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -104.31 176.8 5.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.125 -1.221 . . . . 0.0 110.643 -179.897 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.55 115.04 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.488 -0.757 . . . . 0.0 110.001 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.032 HD12 ' CD2' ' A' ' 26' ' ' TYR . 14.1 mt -60.94 109.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.23 -0.919 . . . . 0.0 110.464 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 17.8 pt-20 -78.12 -14.33 59.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.318 -0.863 . . . . 0.0 110.745 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.705 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -55.15 -28.67 54.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.0 110.373 -179.638 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.764 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.02 -23.13 12.71 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.165 -0.959 . . . . 0.0 109.467 179.788 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 25.3 mm-40 -54.53 -24.42 20.66 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.43 -0.794 . . . . 0.0 110.165 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.63 -36.35 4.85 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.433 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 3.5 mp -49.32 -31.94 10.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.375 -1.073 . . . . 0.0 110.114 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.783 HG22 ' CD1' ' A' ' 18' ' ' TYR . 46.4 pt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.181 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 1.7 ptt? . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.921 0.391 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -99.43 34.07 2.3 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.711 -1.195 . . . . 0.0 109.801 178.687 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 5' ' ' TYR . 12.1 t -35.51 -34.51 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 177.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.973 ' O ' HG23 ' A' ' 7' ' ' VAL 0.268 . . -54.11 74.84 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.769 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.042 ' CE2' HG21 ' A' ' 7' ' ' VAL . 0.3 OUTLIER 34.52 35.73 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.674 1.226 . . . . 0.0 108.058 -176.179 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.65 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 6.0 t0 62.35 62.91 1.1 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.904 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.042 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.4 t -132.17 -79.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -0.853 . . . . 0.0 110.573 179.053 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.048 HD11 HG23 ' A' ' 39' ' ' ILE . 14.7 mm -87.04 102.8 12.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 121.371 -0.83 . . . . 0.0 110.466 -178.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.607 ' H ' HD12 ' A' ' 9' ' ' LEU . 4.5 mp -62.51 -107.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 110.431 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.539 ' C ' ' CE1' ' A' ' 28' ' ' PHE . . . -108.64 164.22 15.22 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.961 -1.087 . . . . 0.0 110.257 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 45.9 Cg_endo -73.31 153.5 50.79 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.982 1.517 . . . . 0.0 110.176 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.749 HG12 ' O ' ' A' ' 27' ' ' THR . 1.4 p -112.96 114.64 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.939 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.84 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.5 mm? -101.49 112.5 25.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 110.345 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.526 ' H ' ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -158.31 154.95 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 109.951 -179.981 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' SER . 3.0 mm-40 -43.08 -58.07 2.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 110.038 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 22.4 ttmt -54.72 -19.17 5.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.526 ' HB3' ' H ' ' A' ' 14' ' ' SER . . . -99.84 -54.58 2.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 110.065 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.567 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 3.1 m-85 -53.82 -50.86 65.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.968 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -12.7 37.93 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.224 -0.922 . . . . 0.0 109.14 179.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' N ' ' A' ' 22' ' ' ALA . . . -94.46 -40.47 4.46 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 178.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 17' ' ' ALA . 3.4 m-30 -51.44 -24.67 5.24 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.601 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 20' ' ' GLY . . . -43.27 -36.3 1.76 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.467 0.651 . . . . 0.0 110.25 -179.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.449 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 2.2 tt0 -95.9 16.48 17.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.412 -0.805 . . . . 0.0 110.515 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 26' ' ' TYR . . . 80.64 6.74 89.17 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HG2' ' HG3' ' A' ' 82' ' ' GLN . 49.9 mttt -82.17 132.62 35.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.241 -1.152 . . . . 0.0 109.755 179.812 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.861 ' CD2' HD12 ' A' ' 89' ' ' ILE . 70.7 m-85 -126.46 111.84 14.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.775 -1.203 . . . . 0.0 111.988 -178.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.749 ' O ' HG12 ' A' ' 12' ' ' VAL . 36.8 m -75.73 141.97 42.53 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.606 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.896 ' CD1' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -141.11 164.72 29.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 -179.221 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.6 ' CE3' ' HG2' ' A' ' 76' ' ' ARG . 79.6 m95 -93.5 122.4 35.89 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.166 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 7' ' ' VAL . 7.6 p -137.05 164.64 29.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.68 -178.101 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.57 ' CD2' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -68.14 150.03 97.9 Favored Pre-proline 0 C--N 1.294 -1.835 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.343 -179.839 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.54 67.3 3.7 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 O-C-N 124.222 1.643 . . . . 0.0 109.769 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.57 ' HE3' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER 179.35 -32.38 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.455 -0.778 . . . . 0.0 109.828 -178.886 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.619 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -49.54 101.06 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.368 -0.833 . . . . 0.0 110.218 -179.765 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.468 ' OG1' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -49.8 141.5 10.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.348 -179.974 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.539 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -43.84 -36.06 2.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 110.209 179.846 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 2.0 m -75.11 -49.04 20.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.477 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 1.6 mm-40 -54.79 -42.29 71.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 0.0 109.859 -179.74 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.048 HG23 HD11 ' A' ' 8' ' ' ILE . 21.3 mt -57.54 -30.69 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.9 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.737 ' HG3' HG11 ' A' ' 51' ' ' VAL . 7.8 tttt -60.94 -44.04 97.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.469 -0.77 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -58.43 -34.35 70.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.767 . . . . 0.0 111.927 -178.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.957 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -72.97 -50.4 23.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.594 -1.316 . . . . 0.0 111.754 -178.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.08 HG21 HG11 ' A' ' 81' ' ' VAL . 27.7 m -66.53 -31.35 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.578 -1.326 . . . . 0.0 110.557 -179.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.781 ' HG2' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.02 -52.93 61.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.057 -1.027 . . . . 0.0 109.97 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -80.18 -24.49 40.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 110.28 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -84.97 -56.38 3.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 0.0 110.812 -179.467 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.843 ' CE2' HG12 ' A' ' 43' ' ' VAL . 8.1 m-30 -71.72 -16.21 62.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.064 -1.022 . . . . 0.0 110.238 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 66.0 46.52 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.473 -0.767 . . . . 0.0 110.724 179.585 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.799 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -136.54 -164.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.365 -0.835 . . . . 0.0 110.253 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.799 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -114.52 105.13 12.73 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.422 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.798 HG21 HG23 ' A' ' 43' ' ' VAL . 57.9 t -77.71 119.19 25.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 110.33 -179.029 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.612 HG12 ' C ' ' A' ' 82' ' ' GLN . 7.3 p -96.2 -20.64 5.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.547 -0.721 . . . . 0.0 109.619 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.581 ' HG3' ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -167.9 146.17 4.53 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.428 -0.795 . . . . 0.0 109.942 179.865 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.874 HG23 HG13 ' A' ' 81' ' ' VAL . 1.2 t -132.14 116.78 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.684 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.523 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -114.1 115.1 27.0 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.0 -1.062 . . . . 0.0 109.614 179.17 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.678 HG21 HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -110.75 141.44 44.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.345 -0.847 . . . . 0.0 110.248 -179.249 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.06 148.61 49.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 109.944 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.94 126.56 30.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 110.403 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.556 HG21 ' CE ' ' A' ' 78' ' ' LYS . 1.6 m -120.29 138.14 51.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.585 -0.697 . . . . 0.0 110.168 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.519 ' CB ' ' HG2' ' A' ' 73' ' ' ARG . 11.2 mmt85 -104.99 109.05 20.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 110.298 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.25 178.91 36.52 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.55 179.67 1.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -1.151 . . . . 0.0 110.242 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -58.7 159.34 6.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.234 -0.916 . . . . 0.0 110.169 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mttt 57.26 46.19 19.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 110.21 -180.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 67' ' ' GLY . 2.4 mtm180 -158.69 20.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.5 mm? -58.87 78.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.321 -0.862 . . . . 0.0 110.266 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' ARG . . . 50.82 44.06 48.57 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.74 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.542 ' O ' ' C ' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -124.56 20.3 8.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.407 -1.055 . . . . 0.0 109.153 179.671 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER 19.62 77.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.344 179.662 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 tp -140.42 40.39 1.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 110.162 -179.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.2 -103.28 0.17 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.21 175.93 2.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -1.134 . . . . 0.0 110.16 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.519 ' HG2' ' CB ' ' A' ' 60' ' ' ARG . 2.2 mtp180 -118.97 94.46 48.2 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 110.232 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.5 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 47.9 Cg_endo -73.58 -164.55 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.094 1.576 . . . . 0.0 110.355 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -114.21 89.6 3.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.457 -0.777 . . . . 0.0 109.328 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.6 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -100.85 153.24 19.65 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.67 -0.643 . . . . 0.0 110.181 -179.977 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.527 ' CE ' ' OG1' ' A' ' 56' ' ' THR . 81.2 tttt -106.62 136.87 45.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.577 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.613 ' HG3' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.67 151.09 30.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.485 179.555 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -125.56 120.13 30.03 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.027 -1.045 . . . . 0.0 112.867 -179.169 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 10.2 mt -96.68 110.52 24.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.237 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.08 HG11 HG21 ' A' ' 43' ' ' VAL . 2.2 t -101.3 130.94 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 110.369 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.612 ' C ' HG12 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -112.55 153.63 27.21 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.023 -1.048 . . . . 0.0 109.639 179.346 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 1.9 m -115.41 157.21 16.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.065 177.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.937 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -61.93 174.81 0.62 Allowed Pre-proline 0 C--N 1.29 -2.019 0 O-C-N 121.238 -0.914 . . . . 0.0 110.827 -179.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 44.5 Cg_endo -76.73 58.13 5.86 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.465 1.771 . . . . 0.0 110.57 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.19 -33.79 0.02 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.937 ' OE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -112.38 -179.94 3.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.119 -1.224 . . . . 0.0 110.457 -179.779 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HA ' HG21 ' A' ' 83' ' ' VAL . 4.2 ptpt -170.73 125.54 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.861 HD12 ' CD2' ' A' ' 26' ' ' TYR . 59.8 mt -68.43 98.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.152 -0.968 . . . . 0.0 110.161 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 93' ' ' GLU . 1.9 mt-10 -70.65 -13.52 62.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.415 -0.803 . . . . 0.0 110.81 -179.587 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.722 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -54.48 -28.88 47.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.067 -1.02 . . . . 0.0 110.407 -179.376 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.85 HD12 ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -106.19 -22.55 12.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.162 -0.961 . . . . 0.0 109.402 179.605 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.624 ' O ' HD12 ' A' ' 96' ' ' ILE . 13.2 mm-40 -56.53 -54.09 49.92 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.494 -0.753 . . . . 0.0 110.33 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.65 -14.71 79.6 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.581 HD23 HD21 ' A' ' 13' ' ' LEU . 2.2 tp -67.92 -7.71 30.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.134 -1.216 . . . . 0.0 110.132 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 93' ' ' GLU . 45.4 mt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.205 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.624 ' CG ' ' HB2' ' A' ' 6' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.916 ' HA ' HD21 ' A' ' 9' ' ' LEU . 10.9 mttm -43.45 98.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 4' ' ' ALA . 1.4 m 4.52 -70.97 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.716 0 CA-C-O 121.556 0.693 . . . . 0.0 110.571 -177.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.034 ' O ' HG23 ' A' ' 7' ' ' VAL 0.281 . . -55.72 80.02 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.772 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.109 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.9 p90 24.62 45.59 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 121.862 0.839 . . . . 0.0 110.496 -178.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.658 ' HA ' ' CB ' ' A' ' 2' ' ' LYS . 2.2 t70 65.29 54.34 1.2 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.012 0.91 . . . . 0.0 111.56 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.109 HG21 ' CE2' ' A' ' 5' ' ' TYR . 2.1 t -135.96 -73.88 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.785 -1.197 . . . . 0.0 110.839 178.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.675 ' CD1' HG23 ' A' ' 39' ' ' ILE . 5.6 mm -102.83 121.64 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 110.589 -178.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 2' ' ' LYS . 20.0 mt -96.41 -107.19 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.507 -0.746 . . . . 0.0 109.867 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.79 158.02 36.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.066 -1.021 . . . . 0.0 110.127 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.685 ' HG3' HD22 ' A' ' 92' ' ' LEU . 46.9 Cg_endo -73.62 140.16 29.19 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.915 1.481 . . . . 0.0 109.65 179.38 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.676 HG12 ' CD1' ' A' ' 29' ' ' TRP . 1.6 m -85.39 132.21 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.015 -1.053 . . . . 0.0 110.172 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.848 HD12 ' CZ ' ' A' ' 18' ' ' TYR . 2.8 mm? -102.77 112.73 25.66 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.168 -0.958 . . . . 0.0 110.119 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' ALA . 3.1 m -163.54 148.62 11.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 110.045 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 14' ' ' SER . 58.7 mt-10 -42.88 -53.67 4.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 110.004 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -54.9 -21.98 13.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.19 -0.944 . . . . 0.0 110.116 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -100.31 -57.28 2.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 110.272 -179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.848 ' CZ ' HD12 ' A' ' 13' ' ' LEU . 1.4 m-85 -47.03 -34.7 5.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.938 . . . . 0.0 110.303 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.07 -8.88 50.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.994 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -103.61 -34.01 3.97 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -80.24 -18.95 48.01 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.702 -0.881 . . . . 0.0 108.95 179.164 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 18' ' ' TYR . . . -55.21 -21.73 14.98 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.416 0.627 . . . . 0.0 110.732 -179.522 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -88.99 17.08 6.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.702 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.533 ' HA2' ' CE ' ' A' ' 88' ' ' LYS . . . 93.17 0.69 67.67 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.233 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 62.4 mttt -82.43 142.23 32.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.479 -1.012 . . . . 0.0 109.293 179.628 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.722 ' CD1' HD12 ' A' ' 92' ' ' LEU . 26.7 m-85 -128.79 111.02 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.662 -1.274 . . . . 0.0 111.511 -179.267 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.8 HG23 HD11 ' A' ' 80' ' ' ILE . 26.7 m -82.78 125.29 31.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.612 0.72 . . . . 0.0 110.151 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.983 ' CE2' HG11 ' A' ' 43' ' ' VAL . 22.0 m-30 -119.3 165.53 14.16 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.706 -0.621 . . . . 0.0 109.662 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.676 ' CD1' HG12 ' A' ' 12' ' ' VAL . 1.9 m95 -103.02 122.84 45.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.062 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 7' ' ' VAL . 2.5 p -149.01 164.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.571 -1.251 . . . . 0.0 111.596 -176.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.46 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -62.69 151.4 84.36 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.896 -0.503 . . . . 0.0 110.659 -179.346 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.537 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 46.7 Cg_endo -73.81 70.1 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.236 1.651 . . . . 0.0 109.906 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 179.24 -33.75 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 110.324 -178.988 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HB3' ' HE2' ' A' ' 77' ' ' LYS . . . -41.75 98.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 110.179 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -41.33 138.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 0.0 110.322 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.527 ' NZ ' ' HA ' ' A' ' 55' ' ' ASN . 1.4 mttt -42.56 -35.89 1.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 1.9 m -75.04 -36.07 61.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 110.019 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.459 ' O ' ' OH ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -55.91 -46.21 78.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.998 179.807 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.703 ' O ' HG22 ' A' ' 43' ' ' VAL . 6.2 mt -57.31 -30.24 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.542 179.585 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.534 ' HG3' HG11 ' A' ' 51' ' ' VAL . 12.5 tttm -62.99 -47.55 82.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.628 -0.67 . . . . 0.0 111.324 -179.433 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.62 -34.65 78.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.311 -0.868 . . . . 0.0 111.76 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.904 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -72.86 -49.49 29.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.981 -1.075 . . . . 0.0 111.705 -178.622 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.983 HG11 ' CE2' ' A' ' 28' ' ' PHE . 26.7 m -71.21 -28.5 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.683 -1.26 . . . . 0.0 110.765 -179.301 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -56.53 -51.66 67.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.8 -1.188 . . . . 0.0 109.22 179.542 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.3 p -79.41 -45.09 20.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.83 . . . . 0.0 109.728 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . . . -61.17 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.46 -0.775 . . . . 0.0 110.531 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CD1' ' CG2' ' A' ' 89' ' ' ILE . 24.5 m-85 -71.69 -21.09 61.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.026 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 47' ' ' PHE . 1.8 mttt 63.76 47.4 3.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.858 . . . . 0.0 110.556 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.769 HG13 ' N ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -130.33 -162.84 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.514 -0.741 . . . . 0.0 110.017 179.967 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.769 ' N ' HG13 ' A' ' 49' ' ' VAL . 2.2 tmtt? -118.1 107.43 13.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.423 -0.798 . . . . 0.0 109.839 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.663 HG22 HG11 ' A' ' 81' ' ' VAL . 49.2 t -78.6 119.84 28.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.216 -0.927 . . . . 0.0 110.166 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 82' ' ' GLN . 7.5 p -112.59 4.96 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.893 . . . . 0.0 110.035 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER 171.88 120.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.222 179.902 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.086 HG23 HG13 ' A' ' 81' ' ' VAL . 1.2 t -115.87 136.27 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 0.0 110.125 179.664 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.527 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 1.1 t-20 -131.26 116.51 17.72 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.468 -0.77 . . . . 0.0 109.482 179.154 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -113.75 166.3 11.69 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.07 -1.019 . . . . 0.0 109.871 -179.724 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.717 ' C ' HD12 ' A' ' 57' ' ' LEU . 2.8 pp -152.63 146.29 25.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.918 . . . . 0.0 110.64 -179.027 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.605 ' CD2' ' NE ' ' A' ' 60' ' ' ARG . 1.3 t-160 -81.75 122.13 27.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.05 -1.032 . . . . 0.0 109.759 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.731 HG13 ' CG ' ' A' ' 76' ' ' ARG . 1.2 p -121.35 135.75 60.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.818 -0.551 . . . . 0.0 110.437 -178.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.605 ' NE ' ' CD2' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -173.53 146.28 1.32 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 110.686 -179.329 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 74' ' ' PRO . . . 145.44 112.51 0.78 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.545 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.08 157.83 42.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -1.137 . . . . 0.0 110.179 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -46.87 -73.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.316 -179.983 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' LYS . 12.2 mtmt -41.52 138.99 1.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 110.463 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 66' ' ' LEU . 16.0 mmm-85 -138.98 -59.49 0.59 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.6 mp 42.7 91.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 110.149 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.18 54.72 1.09 Allowed Glycine 0 N--CA 1.485 1.907 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -179.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.49 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -138.69 26.69 2.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -1.225 . . . . 0.0 109.844 179.917 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.62 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 27.5 t80 -162.53 173.43 14.0 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.019 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.588 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -86.81 44.08 1.14 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.067 179.86 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.62 ' N ' ' CD2' ' A' ' 69' ' ' TYR . . . -92.89 -114.11 2.21 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 21.0 mtpt 59.22 -176.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.109 . . . . 0.0 110.008 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 60' ' ' ARG . 46.2 mtt180 -43.06 110.71 0.93 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.909 . . . . 0.0 109.878 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 60' ' ' ARG . 49.1 Cg_endo -70.8 -169.18 0.36 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.011 1.532 . . . . 0.0 110.78 -179.604 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.586 ' HA ' ' NE2' ' A' ' 58' ' ' HIS . 0.9 OUTLIER -117.71 89.67 3.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.392 -0.817 . . . . 0.0 109.57 179.324 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.731 ' CG ' HG13 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -123.48 131.0 53.51 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.705 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.622 ' CG ' HG13 ' A' ' 30' ' ' VAL . 7.5 pttt -123.88 131.32 53.56 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.758 -1.214 . . . . 0.0 110.717 -179.013 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 12.5 ptpt -101.7 151.42 22.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.404 -0.81 . . . . 0.0 108.908 179.085 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HB3' ' HB2' ' A' ' 28' ' ' PHE . . . -116.37 120.1 37.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.773 -1.204 . . . . 0.0 112.712 -178.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.8 HD11 HG23 ' A' ' 27' ' ' THR . 1.6 mp -97.07 112.17 28.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.227 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.086 HG13 HG23 ' A' ' 54' ' ' VAL . 6.4 t -109.53 132.25 58.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 111.14 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.69 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -103.52 149.89 24.43 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.395 -0.816 . . . . 0.0 108.84 179.078 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.529 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 1.3 m -116.11 157.98 16.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.445 -1.302 . . . . 0.0 109.744 179.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.915 ' HB1' ' HD2' ' A' ' 85' ' ' PRO . . . -76.36 -178.37 0.92 Allowed Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.048 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.915 ' HD2' ' HB1' ' A' ' 84' ' ' ALA . 42.2 Cg_endo -72.09 135.9 26.03 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 O-C-N 124.087 1.572 . . . . 0.0 109.937 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.79 -50.56 0.76 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.815 ' NE2' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -98.18 174.58 6.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.166 -1.196 . . . . 0.0 110.53 179.889 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.533 ' CE ' ' HA2' ' A' ' 24' ' ' GLY . 0.3 OUTLIER 178.68 115.72 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.478 -0.763 . . . . 0.0 110.315 -179.855 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' CD2' ' A' ' 26' ' ' TYR . 7.5 mt -68.26 63.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.886 -1.134 . . . . 0.0 109.48 179.347 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 88' ' ' LYS . 2.4 mm-40 -54.3 -12.83 0.72 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.64 -0.663 . . . . 0.0 111.72 -179.558 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.917 ' O ' HD13 ' A' ' 95' ' ' LEU . . . -53.42 -16.03 1.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.882 -1.136 . . . . 0.0 110.968 -179.058 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.754 HD23 ' N ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -101.76 -23.04 14.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.862 -1.149 . . . . 0.0 109.514 179.43 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -54.19 -29.0 44.34 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.458 -0.776 . . . . 0.0 110.396 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -96.91 -24.64 12.71 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.917 HD13 ' O ' ' A' ' 91' ' ' ALA . 3.5 mp -42.42 -28.9 0.24 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -1.144 . . . . 0.0 110.182 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.556 HG12 ' CE1' ' A' ' 18' ' ' TYR . 72.8 mt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 stop_ save_